Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7543916090803027,-2.9033033594845272,0.0,0.0,0.0,67/87,15.95%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;SEC61B;RPL22;RPL24;SRP19
prerank,cytoplasmic translation (GO:0002181),-0.7457256070341779,-2.892741152147933,0.0,0.0,0.0,69/91,15.86%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL22L1;RPL12;RPS20;RPL13A;ZC3H15;EIF3I;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;EIF4A1;RPL22;EIF2B3;RPL24
prerank,protein targeting to ER (GO:0045047),-0.7185047205352777,-2.8510465824112114,0.0,0.0,0.0,68/99,15.95%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;SPCS1;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15;RPL22;SGTA;RPL24;SRP19
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7341921111342117,-2.8374191536266786,0.0,0.0,0.0,63/91,13.61%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;RPL12;RPS20;RPL13A;SEC63;RPL10A;RPS7;RPL36;RPS6;RPL3;RPL15
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6853821735414317,-2.7561276938239545,0.0,0.0,0.0,71/110,14.63%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;PPP2R1A;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22
prerank,peptide biosynthetic process (GO:0043043),-0.6371523715192994,-2.718449873667995,0.0,0.0,0.0,80/153,15.21%,EEF1A1;DMD;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;GGTA1;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;RPL8;MRPL51;HBS1L;RPS18;CARNS1;WARS1;MRPL28;RPL12;RPS20;RPL13A;GGT5;RPS6KB2;RPL10A;RPS7;MRPL43;RPL36;RPS6;RPL3;COPS5;MRPL32;RPL15;RPL22;MRPL24;MRPS17
prerank,translation (GO:0006412),-0.5692385441454646,-2.5043571885496334,0.0,0.0,0.0,92/208,15.21%,EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;SARS1;QRSL1;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;RPL27;MRPL52;PTCD3;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;WARS2;RPL8;EEFSEC;MRPL51;HBS1L;RPS18;CARS1;RPL22L1;LARS2;WARS1;MRPL28;RPL12;RPS20;RPL13A;ZC3H15;RPS6KB2;EEF1B2;RPL10A;RPS7;SARS2;MRPL43;RPL36;TSFM;TARS1;RPS6;RPL3;COPS5;GATC;MRPL32;RPL15;RPL22;FARS2;MRPL24;MRPS17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5658354038457409,-2.4228089628059877,0.0,0.0,0.0,78/168,14.94%,DDX5;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;RPS5;RPL21;RPS24;RPS27A;RPL18;RPS13;RPS19;CNOT7;RPL35;RPL27;PPP2R1A;RPL23A;DCPS;ERI1;RPL29;RPL34;RPL31;RPL35A;RC3H1;RPL8;RPS18;PNRC2;RPL12;RPS20;RPL13A;SMG9;DIS3L2;RPL10A;UPF3A;RPS7;RPL36;RNPS1;SMG8;PPP2R2A;RPS6;RPL3;RPL15;MAGOH;RPL22;PAN2
prerank,cellular response to copper ion (GO:0071280),-0.8378738231270355,-2.268875172489486,0.0,0.0,0.0,9/16,3.96%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A
prerank,regulation of bone mineralization (GO:0030500),0.6220796291119857,2.1358340239073694,0.0,0.06108890655160668,0.06,15/55,2.10%,BMP6;ENPP1;ADGRV1;WNT4;NELL1;NOTUM;BMP2;PTN;FBN2;DDR2;SLC8A1;BCOR;CYP27B1;KL;AHSG
prerank,response to copper ion (GO:0046688),-0.759074945699016,-2.132787600462153,0.0,0.00137247449489898,0.012,10/20,4.92%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A;ATP5F1D
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.84528734624317,2.127673508869227,0.0,0.03431020778925854,0.069,5/13,0.82%,LTBP1;GREM2;FBN1;BMP2;FBN2
prerank,establishment of endothelial barrier (GO:0061028),-0.6780385364190384,-2.1066175881747586,0.0,0.0022874574914982996,0.022,13/29,9.53%,PECAM1;RAP1A;RAP1B;F11R;RAPGEF1;PDE4D;PPP1R16B;TJP2;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5871357049794487,-2.0983811524087015,0.0,0.002478078949123158,0.026,20/58,12.89%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;ST8SIA6;KDSR;SPTSSB;SPNS2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,rRNA processing (GO:0006364),-0.4887690731516365,-2.0835770616804745,0.0,0.0029033114315170725,0.032,87/172,25.93%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RRP15;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;PRKDC;ERI1;RPL29;RPL34;RPL31;NOP56;RPL35A;THUMPD1;RPL8;NOP2;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74;RPL24;EMG1;EXOSC8;RPLP2;HELQ;RPL7;WDR12;DDX10;RPL5;UTP4;PIH1D2;DDX49;NSA2;PWP2;MRM2;TBL3;RSL1D1;WDR55;DDX47;RPL7A;RIOK2;UTP15;DIS3
prerank,cellular response to zinc ion (GO:0071294),-0.7935628840866223,-2.082413439568862,0.0,0.0028593218643728747,0.034,9/15,3.96%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A
prerank,rRNA metabolic process (GO:0016072),-0.48655770003696397,-2.066210244170331,0.0,0.003507434820297393,0.044,59/160,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,positive regulation of synapse assembly (GO:0051965),0.6995663429207909,2.0521502538906504,0.0,0.08703077097763143,0.234,14/27,10.63%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;VSTM5
prerank,positive regulation of bone mineralization (GO:0030501),0.6460477950469682,2.0415181297645697,0.0,0.07677955035767005,0.269,9/35,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.6374124965029659,-2.0327153565171754,0.0,0.006790889427885577,0.084,20/36,20.94%,CAV1;NOS3;NOSTRIN;SCARB1;GCH1;CALM1;AKT1;APOE;S100A1;LYPLA1;WASL;EGFR;NPR3;SPR;HSP90AA1;NOSIP;CYGB;NUS1;DNM2;DDAH1
prerank,activation of protein kinase A activity (GO:0034199),0.7632378715522009,2.0205750540906555,0.0,0.08887180651754287,0.366,5/16,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6171386684623508,2.013602775426662,0.0,0.08187029257030393,0.398,9/40,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.43601944957568484,-2.01164299482169,0.0,0.008947995481449231,0.113,135/306,25.02%,ST3GAL4;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;ING5;RPS24;RPS27A;RPL18;RPS13;RPS19;PTMA;RPL35;RPL27;MRPL52;RPL23A;RPL29;RPL34;EEF1D;RPL31;RPL35A;RPL8;EEFSEC;RAD1;MRPL51;HBS1L;RPS18;WARS1;MRPL28;FAM111A;RPL12;RPS20;RPL13A;INHBA;XAB2;RPS6KB2;EEF1B2;RPL10A;PPP5C;E2F1;RPS7;APOE;MRPL43;RPL36;TSFM;RNPS1;RPS6;RPL3;COPS5;MRPL32;RPL15;EPC1;PTMS;RAD9B;POLR3A;RPL22;MRPL24;MRPS17;HUS1;RPA3;RAD9A;RPL24;RAD17;MED20;RPS26;RPLP2;CHEK1;TYMS;MRPS18C;RPL7;MRPS18A;MRPL35;ALAS2;RPL5;PWP1;FARSB;MRPS6;RHNO1;EIF4G1;RRAGC;MLF1;TUFM;MRPL13;RFC3;MRPL11;DHPS;POLE3;LARGE1;MCM5;RFC2;POLL;GOLPH3;EXO1;RPL7A;HOXD3
prerank,response to cadmium ion (GO:0046686),-0.6562267102995145,-1.9978929765886637,0.0,0.010293558711742349,0.133,10/26,3.96%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MAPK3;MT2A
prerank,ribosome assembly (GO:0042255),-0.5788660661932689,-1.9960802962937512,0.0,0.009932381213084722,0.135,20/47,15.86%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL11;RPS28;RPS5;RPS19;RPL23A;NOP2;RPS27L;DHX37;RPL3;PPAN;MTERF3;MDN1;ERAL1;RPL24
prerank,presynapse assembly (GO:0099054),0.7600682733850618,1.9897430492379957,0.0021231422505307855,0.09922464273548638,0.501,8/16,10.35%,LRP4;PTPRD;LRRTM3;NLGN2;NLGN3;IL1RAPL1;NLGN1;PTEN
prerank,cellular response to mechanical stimulus (GO:0071260),-0.5805985945959118,-1.9879626126582348,0.0,0.011437287457491499,0.161,21/46,20.22%,PIEZO2;F11R;MAPK3;PIEZO1;MAP3K1;CRADD;PDE2A;CASP8;TLR3;MAP3K2;FAS;TLR4;BAK1;TNFRSF1A;BAD;CHEK1;PTGER4;GADD45A;SOX9;CASP1;LTBR
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6381639143427211,-1.98645752755449,0.0018115942028985507,0.01127389763667019,0.166,15/30,6.76%,PECAM1;ACTB;OCLN;CLDN5;ESAM;SLC12A2;JAM2;LSR;DMD;ACTG1;F11R;TJP2;JAM3;SLC1A1;MFSD2A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.649323182148905,-1.9807092574418448,0.0,0.012009151830366074,0.185,13/26,16.86%,ACER2;SPTLC2;NOS3;GCH1;CYP1B1;SPTLC1;AKT1;ASAH2;ABCA2;SPHK2;ACER3;SPR;NQO1
prerank,tight junction assembly (GO:0120192),-0.5745012749981478,-1.980473172011123,0.0,0.0114870147942632,0.185,9/49,2.77%,PECAM1;OCLN;CLDN5;ESAM;LSR;ACTG1;PARD3;F11R;RAMP2
prerank,cellular response to glucagon stimulus (GO:0071377),0.7298658888546188,1.975304209216763,0.0021691973969631237,0.10701019075735212,0.558,5/17,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6586818367946217,-1.9748398091810695,0.0,0.011818530372741215,0.197,11/26,5.47%,SLC39A10;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A;SLC39A8
prerank,negative regulation of vascular permeability (GO:0043116),-0.7880871821904972,-1.9654073511532684,0.0,0.013999239847969594,0.231,7/12,5.68%,CLDN5;PTPRJ;RAMP2;FERMT2;SLIT2;PDE2A;VEGFA
prerank,negative regulation of reproductive process (GO:2000242),0.7471164505624629,1.9638805072333734,0.0,0.11055511398761086,0.627,4/17,1.53%,IGF1;SULF1;HYAL3;GJA1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.6906131436601591,-1.958328755972501,0.0,0.015352358933325125,0.258,9/22,9.03%,TMSB4X;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1;TMSB10
prerank,cellular response to cadmium ion (GO:0071276),-0.6572199954533386,-1.9550163140985954,0.0,0.015927481792654827,0.273,10/24,3.96%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MAPK3;MT2A
prerank,cAMP biosynthetic process (GO:0006171),0.8329015701506535,1.9532408818390925,0.0,0.11665470648347903,0.683,4/10,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,positive regulation of ossification (GO:0045778),0.615077258584893,1.9502875556711199,0.0,0.11122289088225276,0.695,9/39,1.96%,BMP6;ADGRV1;WNT4;NELL1;BMP2;PTN;FBN2;SLC8A1;KL
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6962865869274976,-1.949639633615735,0.0,0.017074236275826594,0.298,9/19,12.36%,IFIH1;LIFR;MAP2K5;KLF4;ELF1;IRAK2;CBFB;DHX9;MAVS
prerank,neurotransmitter uptake (GO:0001504),0.8006714538986006,1.9391782638818653,0.0,0.120434408235873,0.739,7/12,8.62%,SLC1A3;ATP1A2;SLC29A1;SLC22A3;SLC38A1;SNAP25;GLUL
prerank,axonal fasciculation (GO:0007413),0.7721844954355801,1.9368267292844132,0.0021929824561403508,0.11438881658820343,0.746,7/12,14.10%,SEMA5A;CNTN4;EPHA3;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,positive regulation of nervous system development (GO:0051962),0.583848522295127,1.9322762641858389,0.0,0.11291286152249022,0.765,14/42,9.52%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;SERPINF1;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2
prerank,skeletal system development (GO:0001501),0.47078562237302085,1.9302600723926124,0.0,0.10806320729722568,0.771,38/148,11.14%,IGF1;BMP6;COL13A1;FBN1;NOTUM;BMP2;TBX3;COL1A2;FGFR2;SULF1;HYAL3;BMP5;SULF2;GJA1;MATN3;TRPS1;AHSG;GLI2;CHD7;SH3PXD2B;MMP16;ANKRD11;EVC;CDH11;ANKH;COL10A1;SPEF2;PAPSS1;TGFBR1;IGF2;HES5;CNMD;SOX5;RAB33B;COL9A2;FRZB;UFD1;EXTL1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5791962065624702,-1.9277877753820896,0.0,0.02315064737085348,0.386,28/39,33.97%,RPS16;RPS14;RPSA;RPS25;RPS15;NOP14;RPS27;RPS28;RPS5;RPS24;RPS19;NOB1;RPS27L;RPS7;RPS6;ERAL1;EMG1;UTP4;PWP2;NOM1;RIOK2;NPM1;LSM6;RIOK1;LTV1;RIOK3;RRP36;RRP7A
prerank,regulation of synapse assembly (GO:0051963),0.5838358038591227,1.9252117477201962,0.0,0.10721939934143297,0.79,17/46,10.84%,GPC6;SRPX2;ROBO2;GRID2;NRXN1;CLSTN2;GPC4;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;MUSK
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5487683431990827,1.9197577435034814,0.0,0.10864078707445281,0.817,13/57,12.65%,ADCY7;ADCY2;ADCY1;LPAR1;ADCY5;GNAI1;CHRM2;OPRK1;CHRM3;ADCY8;HTR4;HTR5A;GRM4
prerank,gene expression (GO:0010467),-0.4078495939764866,-1.916822520627315,0.0,0.026458258318330333,0.436,144/348,23.30%,TSPAN5;EEF1A1;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;HNRNPA2B1;RPL37A;RPL38;RPL39;DDX17;RPL11;RPL18A;RPS28;RPS8;RPL32;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;NR4A2;RPS5;SARS1;RPL21;RPS24;RPS27A;RPL18;RPS13;SRSF2;RPS19;PTMA;RPL35;SRSF5;RPL27;MRPL52;RPL23A;RPL29;RPL34;RPL31;RPL35A;NUP93;RPL8;SRSF6;MRPL51;HBS1L;RPS18;WARS1;NDC1;HHEX;NUP54;MRPL28;RPL12;RPS20;U2AF1;HSPD1;TSPAN14;RPL13A;XAB2;RPS6KB2;RPL10A;LMF2;ZC3H11A;PPP5C;E2F1;RPS7;RBMS2;MRPL43;RPL36;RNPS1;RPS6;RPL3;COPS5;DKC1;NUP188;MRPL32;RBM6;RPL15;EPC1;SRSF4;MAGOH;NUP155;POLR3A;RANBP2;RPL22;CHTOP;HNRNPK;MRPL24;MRPS17;ALYREF;AGFG1;RPL24;TSPAN17;NUP37;DDX20;DDX39B;MED20;RPS26;RPLP2;DUSP11;SMG7;CASC3;MRPS18C;RPL7;SYNCRIP;MRPS18A;MRPL35;THOC6;RPL5;CPSF4;PWP1;FARSB;MRPS6;NUP160;EIF4G1;DDX39A;RRAGC;NCBP2;MLF1;MRPL13;MRPL11;DHPS
prerank,negative regulation of growth (GO:0045926),-0.46423024997922135,-1.9158229505943947,0.0,0.02578923849285986,0.438,58/121,23.46%,APBB2;PTPRJ;SERTAD2;NOTCH1;OSGIN2;RACK1;BMPR2;SH3BP4;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;MT2A;TGFB1;TGFB2;ING5;PPP2R1A;NDUFA13;BCL6;SIPA1;RB1;WFDC1;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1;FGFR3
prerank,ribosomal small subunit assembly (GO:0000028),-0.7230912615032103,-1.9155657432881963,0.001893939393939394,0.02498332478995799,0.438,10/16,14.99%,RPS14;RPSA;RPS15;RPS27;RPS28;RPS5;RPS19;PRKDC;RPS27L;ERAL1
prerank,diol biosynthetic process (GO:0034312),-0.7274397174142229,-1.909316248295759,0.0,0.026721662514321048,0.47,9/15,16.60%,ACER2;SPTLC2;GCH1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3;SPR
prerank,response to glucagon (GO:0033762),0.6904164062771498,1.9033880076352587,0.0022471910112359553,0.12464182531572109,0.876,5/19,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,ribosome biogenesis (GO:0042254),-0.4380514874072063,-1.9024814122802487,0.0,0.029030526693574008,0.506,60/187,15.02%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;RPL23;RPL17;RPL14;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;CUL4A;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;RPL15;RPL22;MDN1;WDR74
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7682491492939573,-1.9018639861318631,0.0,0.028397150858743177,0.508,7/12,14.62%,CAV1;PDE4D;CAMK2D;CALM1;GJD3;CALM3;SRI
prerank,renal water homeostasis (GO:0003091),0.6572607157406688,1.897853860295247,0.0,0.1264500726097064,0.889,5/23,2.64%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5765916354354269,-1.8905159124606314,0.0,0.03291397168322553,0.57,21/37,25.92%,HSP90AB1;RPL11;RPL23;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;RPS7;SDCBP;SGTA;CSNK2A1;CSNK2A2;CCAR2;MAP1A;RPL5;TAF9;TRIM39;PARK7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.5130609034069725,-1.8842721427837965,0.0,0.03545559111822365,0.608,20/67,9.77%,UTRN;FN1;CDK6;LIMS2;RREB1;VIT;DOCK1;PTK2B;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;JUP;NPNT;PPM1F;FBLN2;S100A10;EMP2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6626151614072571,1.8819382203866963,0.0022026431718061676,0.1471573180424662,0.922,4/24,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,cAMP metabolic process (GO:0046058),0.7396704038487122,1.876972391136944,0.0022522522522522522,0.14983319545599552,0.939,4/13,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,sphingoid biosynthetic process (GO:0046520),-0.7763104796998561,-1.869559722967583,0.0,0.04187806792127657,0.682,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),-0.7763104796998561,-1.869559722967583,0.0,0.04187806792127657,0.682,7/11,12.89%,ACER2;SPTLC2;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,ncRNA processing (GO:0034470),-0.42989666909307805,-1.869526505979038,0.0,0.04085970944188838,0.682,78/200,20.81%,RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;NOP14;RPL28;RPL30;RPS27;RPL27A;RPS9;RPL10;HNRNPA2B1;RPL37A;RPL38;RPL39;RPL11;RPL18A;RPS28;RPL32;ADAR;RPL23;RPL17;RPL14;SARS1;RPL21;RPS24;RPL18;RPS19;MTREX;RPL35;RPL27;RPL23A;RPL29;RPL34;RPL31;NOP56;RPL35A;RPL8;WDR18;RPL12;RPL13A;UTP14A;NOB1;PELP1;PES1;DHX37;INTS8;RPL10A;RPS7;RPL36;RPS6;RPL3;DKC1;INTS1;RPL15;RPL22;FARS2;MDN1;WDR74;RPL24;EMG1;EXOSC8;TRPT1;RPLP2;SMAD2;HELQ;RPP21;RPL7;WDR12;DDX10;RPL5;UTP4
prerank,neuron cell-cell adhesion (GO:0007158),0.7482633135818059,1.8631527213457193,0.002136752136752137,0.16653003292835247,0.957,9/14,9.26%,NRXN1;CNTN4;NCAM2;ASTN2;NLGN2;NLGN3;NRXN3;NLGN1;CDK5R1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6269472024810198,1.8593841997698342,0.0021551724137931034,0.1670757944520416,0.967,7/25,7.40%,ERRFI1;SLC6A9;CBLB;PPARA;VPS25;CALCR;ZFYVE28
prerank,zinc ion homeostasis (GO:0055069),-0.6158689371025751,-1.8583367738952974,0.0,0.04580494147610009,0.736,11/28,5.47%,SLC39A10;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A;SLC39A8
prerank,neuron projection fasciculation (GO:0106030),0.783916177631383,1.853078219542765,0.002127659574468085,0.17165564323833316,0.973,6/10,14.10%,SEMA5A;CNTN4;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5619187009163211,1.8511725206759617,0.0020242914979757085,0.16850496196207562,0.974,8/43,3.61%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;CCN4
prerank,negative regulation of viral life cycle (GO:1903901),-0.7131389732473814,-1.8507957325459587,0.0,0.05016067499214128,0.769,8/15,19.76%,LY6E;MID2;PPIA;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7723865971214164,-1.8424377512633172,0.0,0.05553734002614476,0.814,7/10,13.25%,NOTCH1;DPP4;FAP;TGFB1;TNFRSF1B;CST3;TNFRSF1A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5815476315883589,-1.839934356686908,0.0019342359767891683,0.056120690047100324,0.822,18/32,12.82%,THBS1;NOTCH1;RHOJ;MAP2K5;KDR;STARD13;KLF4;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,positive regulation of protein processing (GO:0010954),0.6719983095336574,1.8391164667493611,0.008928571428571428,0.18445759928728023,0.986,2/19,0.75%,CCBE1;CLEC3B
prerank,regulation of phospholipase activity (GO:0010517),0.7715007178010821,1.8378826982805039,0.002173913043478261,0.18007435163106789,0.987,4/10,2.26%,FGFR2;LRP1;PLA2G5;PDPK1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5783016707161612,-1.8340942618450444,0.0,0.05934681380720589,0.853,19/30,28.05%,HSP90AB1;RPL11;N4BP1;GIPC1;USP7;SVIP;CAMLG;DDRGK1;BAG5;UBXN1;STYX;SDCBP;SGTA;CCAR2;MAP1A;TAF9;TRIM39;PARK7;USP14
prerank,cellular protein metabolic process (GO:0044267),-0.38562051820546894,-1.8262266817943928,0.0,0.06459581046644111,0.883,126/396,14.63%,FN1;ST3GAL6;ST8SIA4;IGFBP7;GPC3;EEF1A1;IGFBP6;RPLP1;RPS16;RPS14;RPL41;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;MANBA;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;RPS3;PLOD2;RPL37A;DAB2IP;RPL38;RPL39;IGFBP5;RPL11;APP;RPL18A;RPS28;RPS8;RPL32;RPS10;RPL23;RPL17;RPL14;RPS15A;WWP2;RPS5;MSLN;ADAM10;SARS1;SPARCL1;RPL21;IGFBP3;RPS24;RPS27A;RPL18;RPS13;RPS19;RPL35;SFTPA2;SFTPA1;RPL27;LTA4H;MRPL52;GATA6;RPL23A;PRKDC;MSRA;NUCB1;CSNK1G3;RPL29;IDE;RPL34;RIPK1;SPCS1;RPL31;RPL35A;RPL8;QSOX1;DENND3;MFGE8;MRPL51;HBS1L;UBE2L6;RPS18;CST3;PSENEN;SPP1;WARS1;CPE;PNPLA2;ATG3;MRPL28;RPL12;RPS20;RPL13A;UBE2G2;ABL2;RPS6KB2;RPL10A;STK38;CHRDL1;SEC11A;MMP15;RPS7;APOE;MRPL43;RPL36;ICMT;FSTL1;RNF5;RPS6;RPL3;COPS5;MRPL32;RPL15;FBXL2;LOX;FUCA2;APH1A;UBE2G1;RPL22
prerank,response to zinc ion (GO:0010043),-0.609104690423248,-1.8255755049908127,0.001869158878504673,0.06402447510778751,0.887,10/25,4.64%,MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A;CRIP1
prerank,cell-substrate junction assembly (GO:0007044),-0.5844476929634965,-1.823727670557515,0.0,0.06464450181703006,0.89,14/33,12.21%,FN1;ITGA6;THSD1;SORBS1;PEAK1;FERMT2;ITGB4;CD151;LAMA3;ACTN1;BCR;LAMC2;TAOK2;RCC2
prerank,regulation of glucose import (GO:0046324),0.6020636740305212,1.823015711138856,0.0,0.20221503998442797,0.992,7/30,5.54%,IGF1;ENPP1;PIK3R1;PID1;PRKAG2;OSBPL8;IRS2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.702573884338111,1.8200700421000546,0.002183406113537118,0.20127308606398514,0.994,6/16,6.49%,IGF1;IGFBP2;BMP2;BMP5;PHIP;MYORG
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6312875003700342,1.819299534818216,0.004464285714285714,0.19598660156693537,0.994,4/26,1.48%,CCBE1;RORA;SULF1;SULF2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.663524039660435,-1.8150764125153132,0.0036429872495446266,0.07070110960967703,0.926,10/18,16.67%,MSN;CD81;EZR;CTSC;PTTG1IP;APOE;ABCA2;VPS11;ATP5IF1;HSP90AA1
prerank,regulation of protein processing (GO:0070613),0.660912065413664,1.8147952168963029,0.0023148148148148147,0.19870766289278688,0.994,2/21,1.70%,CCBE1;SERPINE2
prerank,embryonic digestive tract development (GO:0048566),0.6727002211450513,1.811945301368433,0.006369426751592357,0.19838203985466107,0.994,6/18,3.86%,SALL1;FGFR2;RARB;GLI2;PDGFRA;GLI3
prerank,diterpenoid metabolic process (GO:0016101),0.5293262683645493,1.8115164351780937,0.0021321961620469083,0.19285227659816057,0.995,8/55,4.05%,ALDH1A1;GPC6;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4200696514063795,1.8102887022442131,0.0,0.18941991330425667,0.995,65/224,14.97%,SLC1A3;NOVA1;GRIA4;CACNA1E;NRXN1;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;PCDHB13;KCND2;NLGN2;CHRM3;NLGN3;GABRR2;SYT1;HRH1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;CHRNA7;CHRFAM7A;HTR4;HTR5A;GRM4;AMPH;APBA1;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;GABRB1;GRIA1;PCDHB16;GABRG1;HCRTR1
prerank,diol metabolic process (GO:0034311),-0.6531033631558841,-1.808989174646718,0.0017921146953405018,0.07528022604520904,0.939,11/19,20.39%,NOS3;DEGS2;GCH1;CALM1;PLPP1;AKT1;ASAH2;SPHK2;SPR;HSP90AA1;PLPP2
prerank,retinoid metabolic process (GO:0001523),0.4941324699898766,1.8089664920458601,0.0,0.18630323281805058,0.996,9/71,4.05%,ALDH1A1;GPC6;ALDH1A2;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,cellular response to ketone (GO:1901655),0.5669265973086424,1.808890566937668,0.004081632653061225,0.1813141062033988,0.996,8/35,4.24%,ADCY2;ADCY1;AR;PTGFR;ADCY5;ROCK2;GNAI1;SFRP1
prerank,amide transport (GO:0042886),-0.6019418082096025,-1.808660917324588,0.0,0.07414053398915077,0.94,6/26,6.03%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11
prerank,chemical synaptic transmission (GO:0007268),0.4066335385368939,1.806978693737145,0.0,0.1794670394250274,0.997,82/284,14.97%,SLC1A3;NOVA1;GRIA4;GRID2;CACNA1E;NRXN1;CDH8;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;RIMS1;PRKACA;DLG2;GABRA2;RIT2;GABRR3;UNC13C;CHRNB4;GRIK5;GRIK2;GRM1;GLRB;CHRM2;OPRK1;CAMK4;GABRB3;DLGAP1;RIMBP2;PCDHB13;KCND2;NLGN2;CHRM3;TBC1D24;NLGN3;GABRR2;SYT1;HRH1;GRID1;ASIC2;SNAP25;CACNB4;CACNB2;NLGN1;GRIK1;HRH2;CACNB1;PDZD11;MYCBPAP;GABRA5;ATXN3;SLC6A1;CHRNA4;GRIA3;PTEN;CBLN2;STAC3;BRSK1;CHRNA7;CHRFAM7A;PTPRN2;HTR4;HTR5A;STXBP3;GRM4;AMPH;APBA1;SNAPIN;CHRNB1;SLC1A2;DLG4;GLRA3;GRIN2A;PNOC;DRD2;GABRB1;GRIA1;PCDHB16;GABRG1;FCHSD2;HCRTR1
prerank,response to progesterone (GO:0032570),-0.6484627697041567,-1.8046296300185936,0.0018018018018018018,0.07667381553233724,0.947,7/18,11.52%,ABHD2;CAV1;THBS1;TGFB1;TGFB2;TGFB3;WBP2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6657730833959381,-1.8043466086126496,0.0,0.07539977806882131,0.947,7/18,4.80%,TEK;RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.48871223775871064,-1.802822778993971,0.0,0.07552845754336053,0.949,35/66,26.03%,CDK6;CCND3;KLF4;FHL1;ANXA1;PKD1;RGCC;AKT1;KANK2;RB1;FAM107A;LSM11;CDK4;E2F1;EGFR;PTPN6;CDKN1A;ANKRD17;CDKN2C;CCND1;CDK2AP2;FGF10;E2F7;RBL1;PKD2;EIF4G1;LSM10;HYAL1;AIF1;CCL2;CDKN2B;RPTOR;DCUN1D3;RDX;PLK5
prerank,regulation of cell junction assembly (GO:1901888),-0.6003544955408738,-1.8028223070083917,0.005309734513274336,0.07415521286075397,0.949,10/27,9.23%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;RAP1B;F11R;RAPGEF1;CBFB;FLOT1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7564340321089867,1.7993745463586561,0.009592326139088728,0.1880454841543509,0.998,3/11,1.32%,WNT4;BMP2;BMP5
prerank,activation of adenylate cyclase activity (GO:0007190),0.5716556871813261,1.7977817842259598,0.004366812227074236,0.18635656951201404,0.998,5/35,1.26%,ADCY7;ADCY2;ADCY1;LGR4;ADCY5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6587845405983851,1.7977520071951794,0.009195402298850575,0.1818022595662541,0.998,3/19,2.16%,CCBE1;ROBO1;DCN
prerank,synaptic membrane adhesion (GO:0099560),0.7173452400073204,1.796645985969825,0.0022026431718061676,0.17936829628316722,0.998,4/14,3.62%,GPC6;LRRC4C;GPC4;PTPRD
prerank,endothelial cell development (GO:0001885),-0.6056101770674562,-1.795518866818739,0.0036101083032490976,0.07983635119881118,0.959,12/25,9.53%,PECAM1;RAP1A;RAP1B;RAPGEF1;PDE4D;PPP1R16B;COL18A1;MSN;PDE2A;ROBO4;EZR;SOX18
prerank,sodium-independent organic anion transport (GO:0043252),-0.7571371812073239,-1.7946080492287824,0.0,0.07949918053786197,0.962,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5858281425237215,-1.7934487744899805,0.001996007984031936,0.07923279483482903,0.963,11/28,14.53%,FOXP1;CD55;GATA6;N4BP1;CASP8;ERAP1;TIRAP;LRP8;DHX58;SAMHD1;TRIM5
prerank,negative regulation of type I interferon production (GO:0032480),-0.5331192810801266,-1.7891121890381465,0.005780346820809248,0.082232158296066,0.967,14/40,15.59%,TAX1BP1;IFIH1;TRIM25;REL;NLRC5;RNF125;OTUD5;YY1;UBE2L6;RELB;DHX58;MAVS;ITCH;TNFAIP3
prerank,ceramide metabolic process (GO:0006672),-0.5158679264598025,-1.786958869143106,0.005703422053231939,0.08284408548376342,0.971,14/49,12.89%,SGMS1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;DEGS2;PLPP1;SPTLC1;PPP2R1A;SPTSSB;ASAH2;SGPL1;ABCA2;ACER3
prerank,bicellular tight junction assembly (GO:0070830),-0.5216192088818088,-1.7836783110431467,0.0,0.0849921705652606,0.972,7/46,2.77%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;RAMP2
prerank,apical junction assembly (GO:0043297),-0.5009882187696173,-1.7833421604249824,0.0036900369003690036,0.08391648490988521,0.972,15/53,19.08%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;CTNNA1;RAMP2;WDR1;VCL;STRN;CLDN11;CLDN10;ECT2;ARL2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.7318359743537567,1.7816615059074237,0.010845986984815618,0.20327104521835987,0.998,7/11,23.90%,BLM;FBXO5;SMARCAL1;DONSON;ZRANB3;FBH1;TIMELESS
prerank,endoderm formation (GO:0001706),-0.5570456021864312,-1.781464347572675,0.0,0.08459961833636567,0.975,12/35,15.46%,FN1;COL12A1;COL4A2;SOX17;LAMA3;COL6A1;MMP14;SOX7;INHBA;MMP15;ITGA7;ITGA4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6417687630674397,-1.7814300967341936,0.005535055350553505,0.0832956200615123,0.975,5/18,7.38%,ESR1;DDX5;NCOR1;TGFB1;RIPK1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.7130536659386136,-1.7795045108448653,0.005253940455341506,0.08400247741856064,0.978,7/12,19.76%,LY6E;MID2;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6865418731618925,-1.778227326871675,0.001841620626151013,0.08402940436572164,0.979,5/14,7.63%,DMD;ACTN4;WNK1;CHP1;ATP1B1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.45522031386031214,-1.7770804426209406,0.0,0.08391896289705703,0.98,29/92,13.75%,TEK;FOXP1;RREB1;THBS1;NRP2;DOCK1;PLCG2;FGF1;PTK2B;RAB11A;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB2;RAC1;BCAS3;VEGFA;PPM1F;EDN1;FLT4;AKT1;PFN1;RHOB;FOXC2;PRKCE;FGF2;EMC10
prerank,retina homeostasis (GO:0001895),-0.6031070312719364,-1.7737233486239572,0.003472222222222222,0.08658699386936211,0.983,7/23,12.92%,ACTB;POTEF;B2M;ACTG1;HSPB1;WHRN;POC1B
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7226688564146808,-1.7711115381427618,0.0018214936247723133,0.08823287121192354,0.985,6/12,12.43%,FOXP1;MAP2K5;KLF4;TIRAP;CD74;TLR4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6472279275692235,1.7708852918341866,0.02092050209205021,0.2204377331984864,0.998,5/17,7.84%,IGF1;NRP1;CCN4;PDGFRB;DOCK7
prerank,positive regulation of glycolytic process (GO:0045821),0.6314372917130403,1.7705853538812018,0.01263157894736842,0.2113657570367006,0.998,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6314372917130403,1.7705853538812018,0.01263157894736842,0.2113657570367006,0.998,3/20,3.87%,IGF1;ZBTB20;PFKFB4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.47959391483540065,-1.764601366670483,0.0038022813688212928,0.09349165547395193,0.988,18/64,11.89%,UTRN;CDK6;ACER2;THBS1;ACTG1;PTK2B;LIMCH1;PEAK1;PTK2;ADAM15;MINK1;MYOC;JUP;VCL;EMP2;NF1;CIB1;DUSP3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5009417787717413,-1.764145508037533,0.0,0.0926259195501072,0.988,23/48,14.08%,TMSB4X;THBS1;NOS3;RHOJ;KDR;ETS1;ANXA1;TGFB1;MAP3K3;HDAC7;HDAC9;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;AKT1;PIK3C2A;JCAD;FOXC2;CIB1;FGF2;STAT5A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7330674291563094,-1.7597495856472085,0.003703703703703704,0.0963273765864284,0.991,6/11,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6854603580872981,-1.7595714385902164,0.005309734513274336,0.0951958336872854,0.992,5/14,2.59%,THBS1;NOTCH1;MAP2K5;STARD13;KLF4
prerank,endodermal cell differentiation (GO:0035987),-0.5626704135286796,-1.7558175615921217,0.003929273084479371,0.09877797856868671,0.993,10/31,15.46%,FN1;COL12A1;COL4A2;LAMA3;COL6A1;MMP14;INHBA;MMP15;ITGA7;ITGA4
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7453580046689581,-1.7544038128923496,0.001834862385321101,0.09947390144695606,0.993,4/10,3.16%,PODXL;DPP4;WNK1;PIEZO1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7312676427150463,-1.7528467697285304,0.0017574692442882249,0.09995587275349808,0.994,8/11,14.82%,ADIPOR2;CD34;KDR;VEGFA;GATA2;PRCP;MCAM;SRF
prerank,negative regulation of protein polymerization (GO:0032272),-0.5861719644893724,-1.7494756509029366,0.007207207207207207,0.10251968575533289,0.995,8/27,8.84%,KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;STMN2;PFN1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.545630708388715,-1.7489085087917209,0.0,0.1019824798292992,0.995,14/33,13.86%,BMPER;SEMA6A;THBS1;RHOJ;FGF1;KLF2;KLF4;PPP1R16B;EPN1;VEGFA;PKM;FGF2;S100A1;EPN2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5477132039932527,-1.7481510350471068,0.001834862385321101,0.10161812742295295,0.995,21/34,21.80%,FLT1;SEMA6A;GAB1;NOTCH1;KDR;MT1G;RAMP2;VEGFC;ANXA1;DAB2IP;VEGFA;HSPB1;FLT4;VEGFD;PIK3CA;RELA;DLL4;PGF;NUS1;PRKD2;EGR3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6080380801426498,1.7451483896133733,0.00411522633744856,0.2634572795355473,1.0,3/23,3.87%,IGF1;ZBTB20;PFKFB4
prerank,tryptophan catabolic process (GO:0006569),0.7295720498845407,1.7420853312463256,0.015873015873015872,0.2656503893179748,1.0,5/11,10.07%,IL4I1;AFMID;TDO2;KMO;KYNU
prerank,sphingolipid metabolic process (GO:0006665),-0.43435977454422314,-1.74114509621066,0.002074688796680498,0.10885438337667534,0.996,28/108,13.77%,SGMS1;CERT1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;ESYT2;DEGS2;ELOVL7;SUMF2;HEXA;PLPP1;CSNK1G2;PRKD3;SPTLC1;PSAP;PPP2R1A;KDSR;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;ABCA2;SPHK2;ACER3;SUMF1;CERKL
prerank,proteoglycan metabolic process (GO:0006029),0.5903681102923936,1.7407749918848077,0.006772009029345372,0.26309722853033574,1.0,6/26,1.48%,IGF1;ADAMTS12;CHST8;GAL3ST3;SULF1;SULF2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6521548582556688,1.7405516711971742,0.010964912280701754,0.2582744013922135,1.0,3/16,6.04%,ADCY7;PPARA;ABCD2
prerank,granulocyte differentiation (GO:0030851),-0.6288286671224446,-1.7403995141277129,0.0055658627087198514,0.108371828686725,0.996,8/18,15.87%,LEF1;CBFA2T3;LBR;RARA;TAL1;CDK4;E2F1;CDKN1A
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4924743782607196,-1.7392544986034104,0.0036429872495446266,0.1082218455886299,0.996,23/54,21.43%,CAV1;NXN;RPS3;SMAD7;RPL11;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;TNFAIP3;UFL1;HSPA1A;USP4;COPS9;RPL5;HSPA1B
prerank,amyloid fibril formation (GO:1990000),-0.4957640397090598,-1.737697353421638,0.001937984496124031,0.10848887247328982,0.996,18/51,10.13%,B2M;TSPAN5;APP;FKBP1A;UBB;ADAM10;UBC;RPS27A;TGFBI;BACE1;RIPK1;MFGE8;UBE2L6;CST3;PSENEN;USP9X;H3-3A;TSPAN14
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5475490858046791,1.7376902745604847,0.00625,0.26013832178948565,1.0,18/35,19.40%,CDH8;PCDHB10;CDH18;DCHS1;PCDHB13;CDH11;CDH20;CDH19;CDH7;NLGN1;CDH10;CDHR3;CDH12;PCDHGB4;PCDHB16;PCDHB14;CDH9;CDH24
prerank,peptide cross-linking (GO:0018149),-0.5813295903357815,-1.7358646158175568,0.0055762081784386614,0.10953925904228465,0.997,5/25,3.46%,FN1;THBS1;TGM2;COL3A1;ANXA1
prerank,positive regulation of protein maturation (GO:1903319),0.7303604698176004,1.7343661889931334,0.008888888888888889,0.2629136582531275,1.0,1/11,0.01%,CCBE1
prerank,regulation of epithelial cell migration (GO:0010632),-0.49988851033528653,-1.7328986795894583,0.001937984496124031,0.11182976006966099,0.998,15/51,9.77%,PTPRG;BMPER;RREB1;DOCK1;PLCG2;RHOJ;RAB11A;BMPR2;PTK2;DAB2IP;TGFB2;ADIPOR1;PPM1F;PFN1;EMP2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.7428920524050032,1.7307882479238919,0.008849557522123894,0.26593629630276616,1.0,5/10,10.39%,CHDH;ALDH7A1;SLC44A1;HNMT;COMT
prerank,melanocyte differentiation (GO:0030318),0.7244650807817615,1.7279508309101892,0.015909090909090907,0.2671869931936645,1.0,6/11,4.30%,ENPP1;LRMDA;SLC24A5;KIT;MITF;HPS6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.46718821354145923,-1.727324499906972,0.0019569471624266144,0.11799024921263322,0.998,24/69,20.78%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,positive regulation of locomotion (GO:0040017),-0.5594029708742196,-1.7264601669676316,0.005535055350553505,0.11785664604185205,0.998,9/27,14.21%,THBS1;SPOCK2;STX3;TGFB1;CAVIN1;PPM1F;TWIST1;CSF1R;NTN1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5606604108964344,1.7257241048322716,0.0021008403361344537,0.2672600919302407,1.0,7/32,5.08%,IGF1;ZBTB20;PID1;PPARA;PFKFB4;ACTN3;IL4
prerank,regulation of interleukin-8 production (GO:0032677),-0.4684999641034955,-1.725289806036983,0.00375234521575985,0.11789503923511976,0.999,35/69,31.60%,TMSB4X;AFAP1L2;LBP;NOD1;MAP2K5;F3;KLF4;ANXA1;TLR3;ANXA4;RIPK1;TIRAP;MAPKBP1;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;PTPN22;BCL10;PARK7;LAMTOR5;TLR6;HYAL2;TLR1;C5AR2;NOS2;TLR5;CD14
prerank,positive regulation of angiogenesis (GO:0045766),-0.4290314988584838,-1.7236806691127229,0.0,0.11860081566875173,0.999,38/108,18.89%,TEK;FLT1;BMPER;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;PKM;GATA2;HSPB1;JUP;TWIST1;RHOB;FOXC2;VEGFD;FGF2;S100A1;EMC10;RAPGEF3;JMJD8;XBP1;NINJ1;SP1;PGF;ANGPTL4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.46759163161664596,-1.722948944427265,0.0,0.11828696850481207,0.999,42/69,31.61%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8;COX7A2L;SDHC;COA6;NDUFA2
prerank,positive regulation of integrin activation (GO:0033625),-0.7162426179449392,-1.7212011508979277,0.009328358208955223,0.1192871376473097,0.999,4/11,3.56%,RASIP1;RAP1B;PIEZO1;FERMT2
prerank,aerobic electron transport chain (GO:0019646),-0.4673131666179769,-1.7178969524703986,0.0,0.12222979378484393,0.999,38/68,28.25%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;COX6C;NDUFC1;UQCRB;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;UQCC3;NDUFA8
prerank,negative regulation of GTPase activity (GO:0034260),-0.602941034354221,-1.7178792610818192,0.0018975332068311196,0.12091549492694238,0.999,9/22,13.58%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;GMIP;RCC2;HRAS
prerank,platelet aggregation (GO:0070527),-0.5438564194890666,-1.7160114708040326,0.005780346820809248,0.12185578073061422,0.999,10/33,9.38%,FN1;ACTB;ACTG1;CLIC1;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6307392131183024,1.7147610324967506,0.01762114537444934,0.28729283524469174,1.0,4/18,8.31%,IGF1;IGFBP2;IGF2;IL18
prerank,positive regulation of cell projection organization (GO:0031346),0.4305316938803682,1.7141285185293085,0.0,0.2837466138947915,1.0,37/115,14.65%,PLXNA2;ROBO1;CAMK1D;ROBO2;PTN;NTRK3;TENM3;MAGI2;PTK7;GRIP1;EPHA3;RIT2;PTPRD;GPC2;LYN;NPTN;IL1RAPL1;CUX1;CAMK2B;DPYSL3;CDKL3;LRRC7;DVL3;CUX2;PRKCI;FUT9;PLXNB2;NGFR;CBFA2T2;ROR1;OBSL1;DLG4;EP300;CAPRIN2;AMIGO1;MAP6;PLPPR5
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6059251171911666,1.7132385374972243,0.00437636761487965,0.2806184474471065,1.0,4/23,8.44%,IGF1;GSTP1;NLRP12;NLRP2B
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6265812128259725,1.7130439529657635,0.008492569002123142,0.27619861552135255,1.0,4/21,1.26%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,regulation of cellular component biogenesis (GO:0044087),-0.528383126514392,-1.7115508957588252,0.0019011406844106464,0.1262796927806614,1.0,24/39,29.98%,RAP1A;TIE1;NOTCH1;RAP1B;RAPGEF1;DAB2IP;MSN;HSPA8;EZR;HCFC1;BAG5;NCLN;APOE;VPS11;HSP90AA1;GFAP;RAPGEF2;TJP1;RDX;ANKRA2;PARP10;CD36;METTL18;IRGM
prerank,intraciliary retrograde transport (GO:0035721),0.7075863879509999,1.7107378330250564,0.02242152466367713,0.27711981801840985,1.0,11/12,26.28%,DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;DYNLT2B;IFT43;WDR19;TTC21A;WDR35;TTC21B
prerank,regulation of interferon-beta production (GO:0032648),-0.5014410290725286,-1.7104702823757034,0.003787878787878788,0.12647733713409348,1.0,15/46,16.67%,IFIH1;REL;TLR3;YY1;DHX9;FLOT1;RELB;TIRAP;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5691945887270903,-1.7098514366839017,0.007326007326007326,0.12593986323037804,1.0,11/26,17.01%,NOD1;IFIH1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,organic anion transport (GO:0015711),-0.4512901091903409,-1.7079390837716564,0.0,0.12708226849451523,1.0,13/76,5.47%,ABCG2;SLC4A10;ABCC4;SLC26A7;SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;LRRC8C;SLC35A3;LRRC8D;CA4;SLC39A8
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.5588283823806589,-1.7048337779391378,0.011090573012939002,0.1303966298310167,1.0,14/28,17.87%,NOTCH3;ZBTB7A;WWP2;GATA2;MMP14;AKT1;ARRDC1;TCIM;LFNG;YTHDF2;HEY1;EGFR;RITA1;DLL4
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5704374790266579,-1.7036102159885513,0.008944543828264758,0.13086544308861772,1.0,12/27,20.35%,MAP3K5;MAPK3;MAP3K20;UBB;UBC;RPS27A;IKBKB;MAP3K8;TAOK2;CUL1;CHUK;MAPK11
prerank,positive regulation of cellular component movement (GO:0051272),-0.5765339685373949,-1.7015753529963105,0.009107468123861567,0.13252532189606236,1.0,9/24,14.21%,SPOCK2;ACTN4;ETS1;CAVIN1;RPS19;VEGFA;TWIST1;CSF1R;NTN1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.637366627614765,1.7010019398803222,0.027139874739039668,0.2962811967752924,1.0,5/16,10.29%,AUTS2;BCOR;KMT2A;DNMT1;PAXIP1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.48731187974952417,-1.7008290990212471,0.0018115942028985507,0.1321903743493797,1.0,20/50,18.87%,CAV1;NXN;RPS3;SMAD7;IVNS1ABP;CHP1;SH3RF2;N4BP1;AKT1;DNAJA1;CAMLG;BAG5;UBXN1;SOX4;PRMT3;LIMK1;TNFAIP3;UFL1;HSPA1A;USP4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.661959451079473,1.7004214844222796,0.026570048309178744,0.29264508299098896,1.0,4/13,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,homotypic cell-cell adhesion (GO:0034109),-0.5222369685587476,-1.6991145401026608,0.005870841487279843,0.1334609300500877,1.0,12/39,9.38%,FN1;ACTB;ACTG1;MEGF11;CLIC1;TJP2;PPIA;ACTN1;HSPB1;MYL12A;MYL9;VCL
prerank,response to lipid (GO:0033993),-0.43037780816319926,-1.6978799438872454,0.0,0.1340252136965855,1.0,38/105,20.86%,FOXP1;ACER2;LBP;NOS3;ESR1;PPARD;FOXO1;RPS6KA3;FOXO3;ANXA1;GCH1;SOCS2;TGFB1;MAPKAPK3;SMAD6;RARA;GATA6;OTUD5;TRIM16;TNFRSF11A;ABCG1;SPP1;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;ABCA2;JAK2;STRN3;TAB2;PELI1;HSD17B2;SOX9;GGT1;LGALS9;RXRB;PAQR7
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6740504703176374,1.6961092292500086,0.029082774049217,0.2978860290751125,1.0,5/14,10.29%,AUTS2;PRDM9;KMT2A;DNMT1;PAXIP1
prerank,nucleotide catabolic process (GO:0009166),-0.6338267424184678,-1.69596400526985,0.011363636363636364,0.13561355128168492,1.0,7/16,14.01%,NT5E;GPX1;NT5C;VCP;GDA;NT5C1A;SAMHD1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.6622299949632222,-1.694797700151757,0.009025270758122744,0.13617925000094358,1.0,8/14,21.52%,TMSB4X;NFKBIA;PKD1;MDFI;CCDC22;KEAP1;PKD2;NFKBIE
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.46518513834605996,-1.6943825480158394,0.0,0.1354944446833292,1.0,31/68,31.23%,LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;POU2F2;XBP1;ARHGEF2;LGALS9;AIF1;BCL10;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;NOS2;MBP;TYROBP
prerank,regulation of integrin activation (GO:0033623),-0.6299853612541224,-1.6915000331817076,0.012915129151291513,0.1383276377497722,1.0,12/15,32.37%,RASIP1;RAP1B;PIEZO1;FERMT2;JAM3;PTGER4;SELP;SKAP1;SRC;FARP2;PLEK;FBLIM1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.727396341559162,1.6911285638456497,0.021367521367521368,0.3051655879792589,1.0,2/10,0.66%,ENPP1;PID1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.45237232011095285,-1.6883431158285178,0.008264462809917356,0.14153905551752555,1.0,20/71,12.89%,SGMS1;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;KDSR;A4GALT;SPTSSB;SPNS2;ASAH2;ELOVL5;SGPL1;SPHK2;ACER3
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.47510798325790266,-1.686323769628176,0.0019083969465648854,0.1431844414337413,1.0,18/56,18.78%,LBP;PLCG2;NOD1;RPS6KA3;IRAK2;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;TLR3;CTSB;TLR4;S100A1;NOD2;TAB2;IRAK4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4189758500945539,-1.6855637170294133,0.0,0.14300730866894099,1.0,42/114,23.43%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;CARD14;LIMS1;IKBKB;PSMA6;TNFRSF1B;RIPK1;TNFRSF11A;PSMB5;PSMC4;PSMC5;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;LTBR;PSMA1;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;TNFRSF9;TNFRSF12A
prerank,clathrin coat assembly (GO:0048268),-0.6361072741933493,-1.6830234856079989,0.013207547169811321,0.145345457484354,1.0,9/15,25.64%,HIP1R;PIK3C2A;HIP1;FCHO2;SGIP1;CLTA;NSG2;EPS15;CLTB
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5087623742350241,-1.6812072671715328,0.001953125,0.14681226068222494,1.0,19/36,26.64%,OPHN1;HSP90AB1;RPL11;AQP11;N4BP1;GIPC1;USP7;CAMLG;DDRGK1;BAG5;UBXN1;SDCBP;CCAR2;MAP1A;TAF9;ALAD;TRIM39;PARK7;F8A1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5951639031931173,-1.679682072774968,0.009487666034155597,0.14823326507406745,1.0,5/19,4.11%,SLCO1C1;MAP2K5;KLF2;KLF4;APP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7182661820043763,-1.6796594723850933,0.011029411764705883,0.14569723858564815,1.0,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7182661820043763,-1.6796594723850933,0.011029411764705883,0.14569723858564815,1.0,3/10,2.77%,MAP2K5;KLF4;WNK1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.43036419429279493,-1.6786214834131215,0.0019083969465648854,0.14593783286571843,1.0,23/86,9.48%,PLCE1;ARHGEF28;NOTCH1;EPS8;OPHN1;STARD13;STARD8;RAPGEF1;ARHGAP17;SHOC2;DAB2IP;DENND1A;NGF;EPS8L2;TGFB2;ARHGDIA;ARHGDIB;GABARAP;SHC1;BCR;DENND3;KANK2;MAPKAP1
prerank,positive regulation of type I interferon production (GO:0032481),-0.442397513673859,-1.6785104210351909,0.0,0.14479799773514027,1.0,36/73,34.37%,IFIH1;LRRFIP1;PRKDC;TLR3;GAPDH;DDX41;DHX9;FLOT1;HSPD1;DHX58;TRIM56;MAVS;TLR4;POLR3E;POLR3A;OAS2;STAT1;HSP90AA1;RELA;CHUK;CGAS;PTPN22;POLR3B;SETD2;CTNNB1;MRE11;POLR1C;POLR2F;PQBP1;POLR2L;CD14;RIOK3;CREBBP;TLR2;IRF3;TLR8
prerank,positive regulation of wound healing (GO:0090303),-0.5203728709332409,-1.6784450916822529,0.007272727272727273,0.14368693066344362,1.0,12/36,13.58%,ST3GAL4;OCLN;RREB1;THBS1;ACTG1;PTK2;ANXA1;FERMT2;ENPP4;FOXC2;PRKCE;HRAS
prerank,regulation of dendrite development (GO:0050773),0.5272286908674452,1.6756821369699604,0.012422360248447204,0.341009992051777,1.0,12/37,10.12%,CAMK1D;HECW2;PTN;ADGRB3;BMP5;CSMD3;RAP2A;HECW1;TNIK;BCL11A;DCC;ALK
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5261566476369925,-1.6720456717989198,0.007827788649706457,0.1526591943388678,1.0,10/32,17.02%,PPP1R13B;DDX5;HIPK1;DYRK2;RPS27L;HINT1;TMEM109;AEN;PHLDA3;DDIT4
prerank,regulation of angiogenesis (GO:0045765),-0.38359773960668236,-1.6712977552373844,0.0,0.15270196601303734,1.0,63/192,18.89%,TEK;FLT1;CLDN5;BMPER;SEMA6A;THBS1;NOS3;CD34;GAB1;TIE1;RHOJ;FGF1;KDR;HIPK1;F3;KLF4;RAMP2;VEGFC;ETS1;PPP1R16B;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;CYP1B1;PTPRM;PIK3R6;AMOT;VEGFA;GATA6;GATA2;HSPB1;RGCC;JUP;TWIST1;WARS1;NAXE;HHEX;EMP2;ISM1;RHOB;PLXND1;EGLN1;NF1;HTATIP2;VEGFD;FGF2;EMC10;ERBB2;EPHA2;TNFAIP3;PGK1;STAT1;RAPGEF3;RNH1;XBP1;NINJ1;SP1;KRIT1;PGF;ANGPTL4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6153833081035398,1.6660449741353158,0.011737089201877934,0.3626711269881476,1.0,3/19,8.44%,IGF1;GSTP1;NLRP2B
prerank,regulation of transmembrane transport (GO:0034762),-0.5240128877399026,-1.6650875114995227,0.007736943907156673,0.16090950977080662,1.0,11/31,12.17%,ACTB;OCLN;SLC2A1;CTTNBP2NL;KCNJ2;NEDD4L;WWP2;KCNJ10;ACE2;KCNJ8;KCNJ15
prerank,positive regulation of response to stimulus (GO:0048584),-0.4969106160390512,-1.6648184953545533,0.002044989775051125,0.15995464946647867,1.0,17/40,23.42%,B2M;IL15;IFIH1;TGFB2;ABI3;DHX9;YPEL3;MAVS;HOMER1;FMR1;CDKN2AIP;NSMCE4A;CGAS;RSAD2;TAF9;IER5;PRKCD
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.4875148935323725,-1.6647696858492493,0.0074211502782931356,0.15872003432944654,1.0,26/49,31.60%,AFAP1L2;LBP;NOD1;F3;TLR3;RIPK1;TIRAP;CD74;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;LGALS9;HSPA1B;PRKD2;BCL10;PARK7;LAMTOR5;HYAL2;TLR1;NOS2;TLR5;CD14
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7298461424076971,-1.6640506279780962,0.01092896174863388,0.1584750550110022,1.0,6/10,15.49%,NAMPT;KDR;IL33;TLR4;JAK2;NOD2
prerank,regulation of macrophage migration (GO:1905521),-0.7097095236433371,-1.6628721602929546,0.014787430683918669,0.15918707154129236,1.0,5/10,19.17%,MTUS1;PTK2B;CD81;CX3CR1;CD200
prerank,stress-activated MAPK cascade (GO:0051403),-0.46646661408713885,-1.6626654318307477,0.00927643784786642,0.15833888825009096,1.0,23/61,20.35%,MAP3K5;NOD1;MAP4K3;MAPK3;IRAK2;MAP3K20;UBB;MINK1;UBC;RPS27A;IKBKB;MAP3K8;MAP3K11;TRIB1;TAOK2;NOD2;TAB2;CUL1;CHUK;PTGER4;ARHGEF6;LGALS9;MAPK11
prerank,sphingosine metabolic process (GO:0006670),-0.6342677667544477,-1.660962016940049,0.007547169811320755,0.1596573846019204,1.0,8/17,12.89%,ACER2;SPTLC2;PLPP1;SPTLC1;ASAH2;ABCA2;SPHK2;ACER3
prerank,regulation of adaptive immune response (GO:0002819),0.6143021530736785,1.659109323167287,0.030634573304157548,0.37715869951932174,1.0,4/18,11.53%,ADCY7;IL4I1;TRIM27;AHR
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6763749712610845,1.6583052621926222,0.03160270880361174,0.3736777563301919,1.0,8/13,17.29%,B3GALT1;GAL3ST3;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,positive regulation of interferon-beta production (GO:0032728),-0.5194368384028383,-1.6577491740472081,0.0149812734082397,0.16350888007058778,1.0,11/33,16.67%,IFIH1;TLR3;DHX9;FLOT1;DHX58;TRIM56;MAVS;TLR4;POLR3A;OAS2;HSP90AA1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7148857490906604,-1.6570247464989727,0.016423357664233577,0.1635884022958438,1.0,3/10,5.58%,CD55;TGFBR2;CD81
prerank,cellular response to fatty acid (GO:0071398),0.6743293490205398,1.656795454249388,0.02178649237472767,0.3724897307622947,1.0,3/12,5.80%,PID1;PDK4;PDK3
prerank,regulation of viral entry into host cell (GO:0046596),-0.5306781234838732,-1.6561313977408056,0.005504587155963303,0.1635881336572658,1.0,15/30,20.27%,LY6E;MID2;TRIM25;IFITM1;IFITM3;IFITM2;TRIM14;CD74;TRIM62;TRIM68;TRIM5;NECTIN2;LGALS1;SNX3;LGALS9
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6574365573226505,-1.6560708603318863,0.011152416356877323,0.16248746340177128,1.0,6/13,10.73%,SEMA7A;PLCG2;TGFB1;TGFB2;TGFB3;CD74
prerank,regulation of cell growth (GO:0001558),-0.37856479836238244,-1.6552493458684743,0.0,0.162314887789588,1.0,79/204,22.04%,PLCE1;APBB2;PTPRJ;SERTAD2;NET1;LTBP4;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;TFRC;CCN3;RPS6KA3;CAMK2D;DCUN1D5;SOX17;SLIT2;NPR1;SOCS2;ADAM15;CDKN1B;TGFB1;TGFB2;ADAM10;PPP2R1A;MFSD2A;EGLN2;PABIR1;MMP14;AKT1;NDUFA13;BCL6;SIPA1;RB1;FAM107A;WFDC1;H3-3A;WNT11;INHBA;CCDC85B;TAOK2;CRLF3;AKAP6;CIB1;KIF26A;ITCH;FXN;SPHK2;SMARCA4;NDUFS3;CISH;CDKN2AIP;LAMTOR2;SDCBP;EGFR;ERBB2;OSGIN1;SMAD4;CDKN1A;CSNK2A1;SMARCA2;OGFR;TMEM97;HSPA1A;CCAR2;DERL2;CDKN2C;SLC25A33;NME6;TSPYL2;ESR2;BRAT1;MSX1;NDRG3;HSPA1B;ADNP2;DDX49;EIF4G1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.6774997852087418,-1.6542554998467995,0.009074410163339383,0.16281917577545363,1.0,4/11,14.67%,DDX5;TGFB1;RIPK1;EGFR
prerank,indolalkylamine catabolic process (GO:0046218),0.6968500033403456,1.6540748307405733,0.035555555555555556,0.3746228378940994,1.0,4/10,10.07%,IL4I1;TDO2;KMO;KYNU
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6885479966040242,-1.6529298879165264,0.015789473684210527,0.16395139768694478,1.0,9/11,25.30%,CAV1;FOXO1;ATP6V0A2;FAS;ATG7;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.5137239385324417,-1.6514700957945,0.009174311926605505,0.16512583766753353,1.0,23/33,39.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;RHOB;IMPACT;FXN;TNFAIP3;RELA;ECT2;PRKCD;RNF112;PARK7;AQP1;ABL1;MAPK7;ANKZF1;SIGMAR1;OSER1;PLEKHA1;PPIF
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6159685786451468,-1.6504472679797055,0.02462121212121212,0.16535646180330957,1.0,8/17,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,gliogenesis (GO:0042063),-0.6302437746690424,-1.6492933871616449,0.009074410163339383,0.16618047160156668,1.0,5/15,11.96%,CDK6;ANXA1;TGFB2;CD9;NDUFS2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5031538247025535,-1.6492928061837735,0.003745318352059925,0.16498492864040432,1.0,22/38,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.4372188234059034,-1.6491026863483056,0.0020161290322580645,0.16409239705083875,1.0,27/76,16.33%,NOS3;TSPAN5;NOTCH3;NOTCH1;CCN3;ZBTB7A;TGFB2;WWP2;NEPRO;JAG2;NOTCH4;GATA2;MMP14;AKT1;ARRDC1;TSPAN14;TCIM;LFNG;YTHDF2;TM2D3;MFNG;POGLUT1;EPN2;HEY1;EGFR;NOD2;RITA1
prerank,skeletal muscle contraction (GO:0003009),0.5961118985292353,1.6484184692636572,0.017204301075268817,0.386043634122208,1.0,6/19,14.25%,CHRNA1;TNNC1;TNNI3;TNNI1;STAC3;TNNT3
prerank,neurotransmitter transport (GO:0006836),0.4450661594732356,1.6481688714339586,0.0,0.38132537018408846,1.0,21/73,13.98%,SLC1A3;ATP1A2;NRXN1;RIMS1;GABRA2;SLC29A1;SLC22A3;SLC38A1;SYT1;SNAP25;PDZD11;GLUL;GLS2;BRSK1;PTPRN2;STXBP3;GRM4;APBA1;SNAPIN;SLC1A2;PPFIA2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.5843430158470843,-1.6480831094738133,0.026119402985074626,0.16454281991150002,1.0,8/19,18.03%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK
prerank,negative regulation of hydrolase activity (GO:0051346),-0.4727200826476367,-1.6477117718421732,0.003780718336483932,0.16402842188155942,1.0,16/49,19.08%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;CHP1;SH3RF2;CST3;EGLN1;GMIP;RCC2;HRAS;ATP5IF1;NEIL1;ARL2
prerank,lamellipodium organization (GO:0097581),-0.5358892629896431,-1.6467149119271478,0.014059753954305799,0.16448099060371518,1.0,17/29,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;CTTN;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5504526557230505,1.6466935231980295,0.013921113689095127,0.38034120585897585,1.0,6/26,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4433339930774202,-1.6464699287067444,0.004008016032064128,0.1637120618568158,1.0,24/73,20.78%,LBP;THBS1;PTPRJ;PLCG2;IFIH1;APP;IL33;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;OAS2;IFNGR1;ARHGEF2;LGALS9;FZD5
prerank,purine nucleotide catabolic process (GO:0006195),-0.6631964099736742,-1.6453570915497155,0.003738317757009346,0.164365652440833,1.0,6/13,12.56%,NT5E;GPX1;NT5C;GDA;NT5C1A;HINT1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.42238607894199626,1.644870474706519,0.002004008016032064,0.3804386454734793,1.0,16/113,4.24%,IGF1;BMP6;TCF7L2;NRP1;BMP2;AREG;PTN;FGFR2;SEMA5A;BMP5;PRKCA;VEGFB;AKT3;TGFA;STXBP4;SFRP1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6571539016650674,-1.6439101184216653,0.015122873345935728,0.1652844712778172,1.0,7/13,13.89%,EPS8;PLEKHM1;EPS8L2;PFN1;FAM98A;HRAS;NDEL1
prerank,regulation of GTPase activity (GO:0043087),-0.37854791191510767,-1.643148678202324,0.0,0.16523379165629043,1.0,59/177,20.09%,DOCK9;PKP4;CHN2;FGD5;ITGA6;RAP1A;NET1;PRKG1;RASIP1;RACK1;SIPA1L1;TGM2;SH3BP4;AGRN;F11R;CAV2;LRCH1;SGSM2;WNK1;PTK2;RAPGEF1;ARHGAP27;DAB2IP;FERMT2;PLXNA4;BCAS3;LIMS1;CHN1;CRK;FGD6;GPR137B;RGS6;CCL15;S100A10;ZC3H15;ADAP1;WNT11;PLXNA1;PLXND1;GMIP;NF1;RCC2;ARHGEF5;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;PLXNA3;ECT2;RAB3GAP2;ARL2;PIN1;FGD2;RGS10
prerank,tryptophan metabolic process (GO:0006568),0.6799114599099738,1.6423592874206658,0.037694013303769404,0.3821505773969723,1.0,4/11,10.07%,IL4I1;TDO2;KMO;KYNU
prerank,myoblast differentiation (GO:0045445),0.6397825202847754,1.6422536532664902,0.021413276231263382,0.37742344347299495,1.0,4/14,1.40%,IGF1;TCF7L2;EPAS1;NRG1
prerank,regulation of viral release from host cell (GO:1902186),-0.5682310135635892,-1.6418587218329972,0.011472275334608031,0.16584839603055748,1.0,8/21,18.15%,MID2;TRIM25;CHMP2B;TRIM28;TRIM62;TSG101;TRIM5;CHMP2A
prerank,presynapse organization (GO:0099172),0.7155695289777346,1.6409975100132688,0.03879310344827586,0.3755954742937735,1.0,4/10,7.72%,LRRTM3;NLGN2;NLGN3;NLGN1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.524495205996916,-1.6392093964133874,0.005747126436781609,0.16918741802051684,1.0,19/33,26.38%,MEF2C;THBS1;NOTCH1;MAP2K5;STARD13;KLF4;TGFB1;RGCC;JUP;CSNK2B;APOE;FGF2;DLL4;GADD45A;PDCD10;TBXA2R;ANGPT4;HDAC5;CARD10
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4876358308372523,-1.6391733769831072,0.007272727272727273,0.16809000133360005,1.0,13/42,11.33%,VIT;NOTCH1;PTK2;FZD4;RAC1;LIMS1;MINK1;NPNT;PPM1F;FBLN2;FZD7;EMP2;NF1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.701224618863308,-1.637813757066867,0.005434782608695652,0.16905219785678988,1.0,5/10,13.19%,ATP5PD;ATP5F1D;ATP5F1A;ATP5MC3;ATP5MC1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5800713198661354,-1.6367215263193446,0.012612612612612612,0.16966312999441996,1.0,13/18,12.82%,RHOJ;KDR;ANXA1;MAP3K3;HDAC7;HDAC9;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5210596290565314,1.6364870491011008,0.010416666666666666,0.3836831092150725,1.0,15/32,17.48%,HECW2;ADGRB3;RAP2A;PTPRD;HECW1;IL1RAPL1;CUX1;TNIK;CDKL3;CUX2;OBSL1;SARM1;CAPRIN2;NEDD4;CUL7
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5936986932792225,-1.636159316565161,0.020484171322160148,0.1694512628015799,1.0,6/17,10.63%,TMSB4X;MAP2K5;KLF4;ANXA1;ANXA4;MAPKBP1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5282377119783842,1.6355899352421364,0.014893617021276596,0.38111366832327426,1.0,5/30,8.31%,IGF1;IGFBP2;CD274;IGF2;IL18
prerank,negative regulation of protein binding (GO:0032091),-0.4310719567540921,-1.6350314447961962,0.005893909626719057,0.17025219329580205,1.0,27/71,24.41%,CAV1;ACTB;B2M;RACK1;ADAM15;CTSZ;RALB;ATP2A3;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;STYX;MITD1;ITGA4;CDKN1A;GTF2F1;KDM1A;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6225470464643305,-1.634835410788143,0.024253731343283583,0.16942681116868535,1.0,8/16,13.19%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5580120508915227,-1.6345659447158403,0.02394106813996317,0.168787969132288,1.0,6/22,14.98%,MAP2K5;KLF4;WNK1;CD44;FLOT1;FLOT2
prerank,lipid transport (GO:0006869),-0.41475398725011425,-1.6343689850278484,0.002012072434607646,0.16800428238513945,1.0,25/97,12.95%,PITPNC1;ABCC4;CERT1;SLCO3A1;SLCO2A1;SLCO1C1;LBP;PLTP;ATP8B1;ATP8A1;SLCO2B1;SCARB1;PPARD;TNFAIP8L3;MFSD2A;PITPNA;ABCG1;SPNS2;CHKA;FABP5;PRELID2;STARD5;APOE;ABCA2;MFSD2B
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4633255341054699,-1.6326762472839902,0.0,0.16962655505784704,1.0,22/54,15.34%,MEF2C;TMSB4X;THBS1;NOS3;KDR;ETS1;TGFB1;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;RGCC;JUP;PRCP;AKT1;CSNK2B;NF1;APOE;FGF2;STAT5A;EPHA2
prerank,negative regulation of viral process (GO:0048525),-0.45943834116372134,-1.6318992510830215,0.0018975332068311196,0.16961713097336448,1.0,18/57,18.62%,IFIH1;MID2;PPIA;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;TRIM28;TRIM14;IFIT1;FAM111A;TRIM62;MAVS;TRIM5;OAS2;STAT1;RSAD2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6271224043823297,1.6303068026543002,0.04439746300211417,0.391659655078742,1.0,5/16,5.80%,RORA;PDK1;PDK4;PRKN;PDK3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6579869537496733,-1.6298562443122562,0.013157894736842105,0.17173087117423488,1.0,4/12,5.18%,MEF2C;PRKG1;IGFBP5;DOCK4
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5507601203656682,-1.6276737692590622,0.011299435028248588,0.1741309255639948,1.0,7/24,15.46%,PECAM1;F11R;NT5E;MSN;EZR;SYK;ITGA4
prerank,response to hydrogen peroxide (GO:0042542),-0.4751688202788179,-1.6262636737024894,0.013133208255159476,0.1755553024185084,1.0,28/45,39.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;STK25;GPX1;RHOB;IMPACT;FXN;TNFAIP3;STK26;RELA;ECT2;PDCD10;PRKCD;PARK7;SOD1;AQP1;ABL1;HP;MAPK7;ANKZF1;FYN;OSER1;PLEKHA1;PPIF
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6851586897076185,1.6261725735044712,0.040380047505938245,0.39947333087316905,1.0,2/10,3.55%,AREG;TGFA
prerank,regulation of establishment of cell polarity (GO:2000114),-0.625595887491101,-1.6254691555299405,0.020833333333333332,0.17571322239908105,1.0,6/16,4.80%,RAP1B;RACK1;PTK2B;CYRIB;BCAS3;SHTN1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5582211856202051,1.6223454985972467,0.016842105263157894,0.4059989598621747,1.0,6/24,5.18%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.6801630467292407,-1.6219182418021407,0.0216998191681736,0.18031860030542693,1.0,3/11,4.12%,MEF2C;TGFB1;TGFB2
prerank,striated muscle cell development (GO:0055002),-0.6281949505484173,-1.6214535065112063,0.024074074074074074,0.17998824613407532,1.0,5/14,8.19%,PGM5;TMOD3;LMOD1;FLII;TMOD1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.38876797098571375,-1.6206794912353073,0.0,0.18021995664193077,1.0,49/149,21.58%,PRKCH;CAV1;SLCO3A1;RPS6KA5;NOD1;NFKBIA;TFRC;MID2;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;UBB;PPIA;PRKCZ;UBC;RPS27A;IKBKB;PSMA6;RIPK1;TNFRSF11A;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;CIB1;TRIM62;TLR4;EDA2R;TRAF1;AIM2;TRIM68;TRIM5;FLOT2;NOD2;CX3CR1;HSPA1A;TAB2;RELA;CHUK;ARHGEF2;LGALS9;CLOCK;HSPA1B;PRKD2;BTK
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.42152199501655474,-1.6204304603751074,0.008,0.17951062368162254,1.0,24/84,8.42%,TEK;FOXP1;TMSB4X;THBS1;NOS3;NRP2;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;ETS1;TGFB1;RAC1;BCAS3;VEGFA;ATP5F1A;GATA2;ATP5F1B;HSPB1;EDN1;FLT4;AKT1
prerank,apical protein localization (GO:0045176),-0.7033300662016166,-1.6202720385483151,0.014598540145985401,0.17870761652330464,1.0,6/10,15.89%,ACTB;ATP8B1;JAM3;MAL;CELSR1;SHROOM3
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5544792773292768,1.619322850048488,0.031578947368421054,0.40899767922965935,1.0,5/25,7.60%,CEMIP;PDPK1;ANK2;CALCR;CACNB2
prerank,regulation of actin filament polymerization (GO:0030833),-0.4429335862935271,-1.618229501739058,0.003738317757009346,0.18079035333693957,1.0,27/69,23.65%,ESAM;KANK3;BAIAP2L1;PTK2B;CYRIB;SLIT2;KANK4;SSH2;HIP1R;LMOD1;PFN1;DBNL;DBN1;PRKCE;WASHC5;NCKAP1;HCK;CDC42EP3;RASA1;CTTN;NCK1;HCLS1;PLEKHG2;PRKCD;CARMIL1;NCK2;ARHGAP18
prerank,regulation of vasculature development (GO:1901342),-0.5395692673207935,-1.6181181143890688,0.00945179584120983,0.17992871515479567,1.0,12/26,16.99%,BMPER;ETS1;WARS1;EMP2;PLXND1;EGLN1;NF1;HTATIP2;FGF2;ERBB2;EPHA2;RNH1
prerank,odontogenesis (GO:0042476),0.5184066982709374,1.61770432309001,0.015810276679841896,0.4089196025614893,1.0,7/35,5.19%,BMP2;COL1A2;FGFR2;BCOR;GLI2;ANKRD11;AXIN2
prerank,hemidesmosome assembly (GO:0031581),-0.6718652874800878,-1.6156541258501127,0.026833631484794274,0.18309692640282443,1.0,5/11,9.08%,ITGA6;ITGB4;CD151;LAMA3;LAMC2
prerank,positive regulation of vasculature development (GO:1904018),-0.4145006040553029,-1.6153888473005833,0.0,0.18250452997576258,1.0,21/94,7.35%,TEK;FLT1;THBS1;NOS3;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;RAMP2;VEGFC;ETS1;CYP1B1;PIK3R6;VEGFA;GATA6;GATA2;HSPB1;JUP
prerank,regulation of endothelial cell migration (GO:0010594),-0.41898819911436264,-1.615291699415613,0.0038461538461538464,0.18164131381189536,1.0,31/85,13.75%,TEK;FOXP1;BMPER;THBS1;NRP2;RHOJ;FGF1;PTK2B;BMPR2;SCARB1;KDR;GPI;PTK2;ETS1;DAB2IP;SLIT2;RAC1;BCAS3;PTPRM;VEGFA;PRCP;EDN1;FLT4;AKT1;EMP2;RHOB;FOXC2;NF1;APOE;FGF2;EMC10
prerank,protein localization to cell-cell junction (GO:0150105),-0.6150438889083929,-1.6152153189728193,0.022900763358778626,0.18077487336547768,1.0,5/15,3.37%,ACTB;LSR;ACTG1;F11R;TJP2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.36956220453859473,1.6140911907124373,0.0,0.4145219035723748,1.0,48/248,12.02%,BICC1;TCF7L2;IGFBP2;RNF220;LGR4;NOTUM;BMP2;LRRK1;WLS;RBMS3;DAAM2;CDK14;FGFR2;LYPD6;SEMA5A;TBL1XR1;PRICKLE1;PTK7;LRP4;DKK3;GLI3;ZEB2;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;CTNND2;FRAT1;SMURF2;TLE1;PSMA3;SOX2;ADGRA2;PSMF1;NPHP3;DVL3;GPC5;DACT3;FRZB;FUZ;SIAH2;NKD2;USP47;BTRC;RNF146;PSME3
prerank,positive regulation of blood coagulation (GO:0030194),-0.591126903292291,-1.6140294947515832,0.022304832713754646,0.18145419941131083,1.0,5/17,2.91%,ANO6;ST3GAL4;THBS1;F3;THBD
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5967652364939908,1.6139389603832788,0.03854389721627409,0.4101078954574903,1.0,7/17,7.60%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1;CACNA1G;CACNB2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5868696768777248,1.6132968601012017,0.015184381778741865,0.4072074803076834,1.0,4/22,4.07%,AREG;FGFR2;VDR;STXBP4
prerank,cristae formation (GO:0042407),-0.541974673481764,-1.6132135759701465,0.01904761904761905,0.18174889523359217,1.0,15/27,27.79%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;CHCHD3;ATP5ME;ATP5MC3;ATP5MC1;CHCHD6;APOO;ATP5F1E;ATP5PO;MICOS13;UQCC3
prerank,female gamete generation (GO:0007292),0.5162305448197199,1.6124259697311234,0.039647577092511016,0.40537409505761485,1.0,11/29,15.77%,PTN;DMC1;PRDM9;NANOS3;DIAPH2;MCM9;FMN2;PIWIL2;MCM8;PARN;METTL3
prerank,regulation of ossification (GO:0030278),0.5131358863864793,1.6120969358856725,0.013043478260869565,0.4018326331327353,1.0,11/36,8.08%,ENPP1;NOTUM;BMP2;PTN;DDR2;CYP27B1;AHSG;LRP4;SFRP1;ANKH;RBPJ
prerank,positive regulation of immune system process (GO:0002684),-0.6167169642771985,-1.6120322304648447,0.01675977653631285,0.18276397652411838,1.0,6/16,20.27%,IL15;ANXA1;TGFB2;VEGFA;RSAD2;LGALS9
prerank,receptor clustering (GO:0043113),0.5469127497798866,1.6114226587425788,0.020833333333333332,0.3991887836922366,1.0,9/27,13.19%,PTN;MAGI2;NRXN1;LRP4;DLG2;NLGN1;LRRC7;MUSK;DLG4
prerank,chordate embryonic development (GO:0043009),0.45999205748559885,1.6107766907368224,0.014028056112224449,0.3963898287977997,1.0,14/55,9.13%,ARNT2;BMP2;ALDH1A2;FGFR2;SULF1;BMP5;SULF2;CHD7;SIX4;TGFBR1;IGF2;FOXD3;HES5;GATA3
prerank,ketone body metabolic process (GO:1902224),0.6842968929434994,1.6079315985584812,0.04176334106728538,0.40042982792159587,1.0,2/10,0.55%,ACSS3;HMGCLL1
prerank,skeletal system morphogenesis (GO:0048705),0.4953015123595572,1.6078538807107747,0.023157894736842106,0.39629563440148896,1.0,13/42,12.50%,FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;ANKRD11;HOXC9;SPEF2;TGFBR1;HOXB9;RAB33B;FUZ;FGFR1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.591715181453925,-1.606796339816076,0.014285714285714285,0.1905400686878949,1.0,8/18,16.13%,HEG1;RASIP1;CCDC125;MYOC;TNFAIP1;ABL2;MET;KCTD10
prerank,neuronal action potential (GO:0019228),0.5633340810582549,1.6044998268004054,0.034408602150537634,0.40208540127537845,1.0,6/22,7.51%,SCN7A;CHRNA1;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5302126013220286,-1.6038832852782092,0.012567324955116697,0.1942230317571894,1.0,17/26,25.76%,CCND3;ANXA1;RGCC;AKT1;LSM11;CDK10;EGFR;MTBP;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,histone deubiquitination (GO:0016578),-0.5783242347032073,-1.603337109299035,0.022857142857142857,0.1940081655219933,1.0,9/18,19.41%,TRRAP;BRCC3;USP7;UIMC1;USP3;ENY2;USP15;USP22;USP49
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5785196985741029,-1.6016391388591587,0.03214285714285714,0.19591883846382535,1.0,6/19,6.72%,PRKCH;OCLN;CLDN5;F11R;IKBKB;CBFB
prerank,purine-containing compound catabolic process (GO:0072523),-0.6291800299547599,-1.6009864418680464,0.023508137432188065,0.19602379541842435,1.0,5/13,11.45%,NT5E;GPX1;NT5C;GDA;NT5C1A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6782644370212794,1.6000682560871768,0.050997782705099776,0.4109212691065376,1.0,3/10,8.25%,KDM1B;PCGF5;IGF2
prerank,cellular response to alcohol (GO:0097306),0.48367791315448777,1.5983390603432175,0.025793650793650792,0.411528700256375,1.0,7/42,4.24%,ADCY7;ADCY2;ADCY1;PTGFR;ADCY5;GNAI1;SFRP1
prerank,circulatory system development (GO:0072359),-0.39061426885058975,-1.5978454024411801,0.0,0.20082751796260892,1.0,40/118,16.10%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;NXN;NOTCH1;TGFBR2;MEF2A;RAMP2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;CRIP1;HDAC9;STRA6;PKD1;MICAL2;NOTCH4;CASP8;FLT4;SOX18;SMG9;FOXC2;NF1;TCF25;ACVR1;SOX4;HEY1;SRF;PIK3CA;PDLIM3;CDKN1A;ZFPM2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4905704656446843,-1.5950478679633475,0.019011406844106463,0.20501337767553512,1.0,11/36,12.63%,MECOM;NCOR1;FOXO1;PPIA;TAOK3;EZR;SH3RF2;AIDA;ZMYND11;DUSP3;ITCH
prerank,response to cAMP (GO:0051591),-0.47941229803774327,-1.5941311127386615,0.011363636363636364,0.20554969372252826,1.0,15/37,23.48%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;NDUFS4;AKAP6;HCN2;STAT1;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.44559049067467954,-1.5940561150390036,0.011695906432748537,0.2045737185071423,1.0,23/57,20.67%,RPS16;RPL26;RPS25;RPS15;NOP14;RPL38;RPL11;RPS28;RPL14;RPS24;RPS19;RPL35A;CUL4A;PES1;DHX37;RPS7;RPS6;WDR74;EMG1;TGS1;RPL7;WDR12;RPL5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5177466998098837,-1.5940314954783068,0.027624309392265192,0.20349808999233002,1.0,11/28,17.07%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2;RELA
prerank,extracellular structure organization (GO:0043062),0.371863056263801,1.5933270981117518,0.0018050541516245488,0.4217209203852996,1.0,36/204,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,macrophage activation (GO:0042116),-0.5036405739114073,-1.59150451243402,0.016227180527383367,0.20683239307435958,1.0,11/34,17.22%,FOXP1;LBP;PLCG2;CD93;APP;DYSF;TLR4;SYK;JAK2;C1QA;IFNGR1
prerank,cellular response to cAMP (GO:0071320),-0.5017036853303627,-1.5913297577776833,0.015065913370998116,0.20602246110597783,1.0,13/30,23.48%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;AKAP6;HCN2;RAPGEF3;RAPGEF2;PKD2;DMTN
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.40834402123179014,1.5909677783626506,0.013861386138613862,0.42452519610103956,1.0,19/102,10.66%,ADCY7;ENPP1;ADCY2;PIK3R1;ADCY1;TBC1D4;ADCY5;PDPK1;PRKACA;SLC30A10;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3;ADCY8
prerank,external encapsulating structure organization (GO:0045229),0.371774206894039,1.5892606513254142,0.001841620626151013,0.4247702778170425,1.0,36/205,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;MATN3;ITGA11;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;MMP16;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MMP11
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5515243794727827,-1.588959765533794,0.018148820326678767,0.20933847822196017,1.0,12/24,14.62%,DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,membrane depolarization during action potential (GO:0086010),0.5359038382926063,1.5886866726738569,0.037199124726477024,0.4219335629486646,1.0,8/26,7.51%,ATP1A2;SCN7A;SLC8A1;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,regulation of osteoblast proliferation (GO:0033688),0.6156748622450173,1.587738835018895,0.033112582781456956,0.4205510957193142,1.0,4/17,4.24%,NELL1;BMP2;FGFR2;SFRP1
prerank,regulation of interleukin-6 production (GO:0032675),-0.40852850297035087,-1.58769378089899,0.002061855670103093,0.2105359108470909,1.0,38/96,31.23%,AFAP1L2;LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;TIRAP;CD74;MAVS;TLR4;SPHK2;SYK;NOD2;IL17RA;PTPN6;TNFAIP3;POU2F2;XBP1;ARHGEF2;CD200;LGALS9;PTPN22;AIF1;BCL10;TREM2;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;C5AR2;NOS2;MBP;TYROBP
prerank,ribosomal large subunit assembly (GO:0000027),-0.5392048214370613,-1.5874747722438416,0.019267822736030827,0.20972530183119956,1.0,9/24,15.86%,RPL6;RPL10;RPL11;RPL23A;NOP2;RPL3;PPAN;MDN1;RPL24
prerank,regulation of interleukin-12 production (GO:0032655),-0.4617299803502127,-1.5874659826517978,0.0149812734082397,0.2086445682918967,1.0,13/47,20.35%,FOXP1;THBS1;PLCG2;CMKLR1;TLR3;HSPD1;TIRAP;TLR4;SYK;JAK3;LAPTM5;LGALS9;MAPK11
prerank,negative regulation of binding (GO:0051100),-0.4149777968008236,-1.5858644910256905,0.0,0.2103753431098591,1.0,33/81,25.92%,LEF1;CAV1;ACTB;RACK1;NFKBIA;CTSZ;SMO;RALB;NES;BAX;AKT1;DISC1;IFIT1;CTNNBIP1;CAMK1;E2F1;STYX;MITD1;SUMO3;JAK2;CDKN1A;GTF2F1;KDM1A;WAPL;MDFI;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD;CARD16;BTAF1;PARK7
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5071747300492082,1.5858295791082948,0.019271948608137045,0.42176450550698313,1.0,5/35,1.87%,IRAG1;ADCY2;ADCY1;KSR1;PDE7B
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5225471734793542,-1.5855672874823914,0.017605633802816902,0.20979504362410942,1.0,18/27,31.78%,IRAK2;MAP3K1;UBB;UBC;RPS27A;HSPD1;TIRAP;TLR4;TAB2;IRAK4;BTK;TRAF6;CD36;TLR6;TLR1;TLR5;CD14;LY96
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4158803043423953,-1.5850136805804205,0.0038684719535783366,0.20971083502414767,1.0,38/76,32.30%,TMSB4X;NR3C2;NOD1;ACTN4;NFKBIA;CCN3;RPS3;APP;HDAC7;LIMS1;ADIPOR1;EZR;RASSF2;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;ADGRG3;LAPTM5;TRIP6;LGALS9;TSPAN6;PTPN22;TRAF6;PTP4A3;PDCD4;SPI1;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44;NLRP3;NLRC3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5751163786428295,1.58464347740013,0.034782608695652174,0.4210261222690507,1.0,7/20,9.35%,IGF1;NRP1;LRP1;CCN4;SERPINE1;PDGFRB;BMPR1A
prerank,keratan sulfate catabolic process (GO:0042340),0.6558162845713296,1.5838986648553552,0.05021834061135371,0.4190671365782514,1.0,6/11,7.32%,FMOD;OMD;GNS;LUM;GALNS;OGN
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5481731737588003,-1.5819651769230894,0.0311284046692607,0.2139933900485681,1.0,6/21,4.89%,MTUS1;THBS1;PTK2B;MAPK3;PTK2;CMKLR1
prerank,lamellipodium assembly (GO:0030032),-0.5295326457218249,-1.5800319354836916,0.03146853146853147,0.2166615040179753,1.0,16/26,24.65%,ABLIM1;PARVB;S1PR1;RAC1;ABLIM3;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;ARHGEF6;PTPRO;DMTN;CARMIL1;GOLPH3;CCDC88A
prerank,regulation of amyloid-beta formation (GO:1902003),0.5020072830567257,1.579342684923877,0.023655913978494623,0.42778327554130896,1.0,8/34,11.12%,IGF1;SLC2A13;ROCK2;LRRTM3;RTN4;CASP3;TMED10;CHRNA7
prerank,toll-like receptor signaling pathway (GO:0002224),-0.41187514872049025,-1.579328097738006,0.00390625,0.21675671315167558,1.0,22/84,13.56%,SCARA3;LBP;PLCG2;RPS6KA3;IRAK2;MAP3K1;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;IKBKB;CASP8;TLR3;RIPK1;HSPD1;TIRAP;CTSB;PIK3AP1;TLR4;S100A1
prerank,regulation of T cell cytokine production (GO:0002724),-0.6016525824703708,-1.5792282264928974,0.02819548872180451,0.21587308211642328,1.0,4/15,7.20%,B2M;CD55;SMAD7;TNFRSF1B
prerank,ethanol metabolic process (GO:0006067),0.6456245387364571,1.578948343333049,0.046357615894039736,0.4249046267309013,1.0,1/12,0.10%,ALDH1A1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.3960580606128977,-1.5788242733547382,0.0,0.21564123521221656,1.0,37/110,17.44%,WWP1;GPC3;NEDD4L;MAP2K5;NFKBIA;KLF2;FOXO1;KLF4;DAB2IP;CDKN1B;TGFB1;APP;RNF41;WWP2;EGLN2;IDE;PLK2;AKT1;NDUFA13;ATG7;VCP;PAEP;INHBA;RAB7A;OAZ2;APOE;ABCA2;ITCH;SMURF1;RAB1A;LDB1;SNF8;TNFAIP3;CSNK2A1;NR1H2;FZR1;NSF
prerank,response to ethanol (GO:0045471),0.6263782214710654,1.5751272488652113,0.029612756264236904,0.4321538827390733,1.0,2/14,2.71%,ADCY7;GRIN3A
prerank,positive regulation of JNK cascade (GO:0046330),-0.4199585109287313,-1.574631342909745,0.014373716632443531,0.2227156941289248,1.0,22/70,15.49%,MAP3K5;PTK2B;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;SDCBP;NOD2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.6456297009648653,-1.5742728507449781,0.027726432532347505,0.22228340002975966,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,phospholipid transport (GO:0015914),-0.45222937457397305,-1.5735398769829088,0.01171875,0.22256737131740076,1.0,16/52,14.03%,PITPNC1;ATP10A;PLTP;ATP8B1;ATP8A1;SCARB1;ATP11C;TNFAIP8L3;ATP11A;MFSD2A;PITPNA;ATP9B;ABCG1;PRELID2;APOE;PITPNM1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4071220221633918,-1.5731029333925965,0.0038684719535783366,0.22234644733824813,1.0,31/87,15.00%,CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18;EID2;SMAD4
prerank,regulation of membrane repolarization (GO:0060306),-0.626766787617574,-1.5727906468881803,0.018214936247723135,0.22178343921211427,1.0,7/13,14.41%,CAV1;KCNJ2;NEDD4L;KCNQ1;CACNB3;AKAP6;CASQ2
prerank,neuromuscular junction development (GO:0007528),0.5376962782116077,1.5720982066429245,0.030042918454935622,0.43671021033608565,1.0,10/24,12.54%,PDZRN3;PPFIBP2;CHRNA1;LRP4;UNC13C;CACNB4;CACNB2;CACNB1;MUSK;DOK7
prerank,regulation of JNK cascade (GO:0046328),-0.3982496296505673,-1.5712035096819594,0.006276150627615063,0.22360173242377943,1.0,32/101,15.49%,MECOM;IGF1R;MAP3K5;PTK2B;NCOR1;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;AIDA;FLT4;ZMYND11;FZD7;MAP3K11;TIRAP;TAOK2;ULK4;GADD45G;DUSP3;ITCH;EDA2R;COPS5;TRAF1;HRAS;SDCBP;EGFR;NOD2
prerank,ceramide biosynthetic process (GO:0046513),-0.4741109816171042,-1.5711840156489805,0.017578125,0.22259270844553525,1.0,10/40,8.90%,SGMS1;ST6GALNAC3;SGMS2;ST8SIA4;SPTLC2;DEGS2;SPTLC1;ST8SIA6;SPTSSB;ASAH2
prerank,heme catabolic process (GO:0042167),-0.6193271838337857,-1.5686867601034233,0.03409090909090909,0.22521108269272905,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6193271838337857,-1.5686867601034233,0.03409090909090909,0.22521108269272905,1.0,2/14,1.27%,ABCG2;SLCO2B1
prerank,regulation of interferon-alpha production (GO:0032647),-0.5387449111627507,-1.5670067225422615,0.03213610586011342,0.22723342535805738,1.0,13/23,34.37%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;STAT1;CHUK;SETD2;PTPRS;NLRC3;IRF3;TLR8
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5322940898056515,-1.566561359365859,0.02722323049001815,0.22698699645589496,1.0,10/24,17.01%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TNFAIP3;TAB2
prerank,regulation of biomineral tissue development (GO:0070167),0.5315412037897255,1.5662339519583242,0.029473684210526315,0.449542756393273,1.0,8/26,6.28%,ENPP1;NOTUM;DDR2;CYP27B1;AHSG;ROCK2;CEBPB;ANKH
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5732338166509172,-1.5650655782535532,0.028933092224231464,0.22885314152032285,1.0,7/17,17.85%,PODXL;PIEZO1;TGFB2;FOXC2;CIB1;SYK;RET
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6598422135939779,1.5636958006439934,0.05714285714285714,0.4522437010593117,1.0,3/11,5.95%,GRK3;GTF2H2;ADM
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6137491015147222,-1.5625480080488032,0.03423423423423423,0.23280758955529426,1.0,6/13,16.67%,NOS3;GCH1;CALM1;AKT1;SPR;HSP90AA1
prerank,regulation of wound healing (GO:0061041),-0.4685087223610344,-1.5624941725951391,0.01607142857142857,0.23183115692906023,1.0,17/42,24.19%,CAV1;OCLN;ACTG1;PTK2;ANXA1;CD109;CRK;SRSF6;PRKCE;FGF2;HRAS;TNFAIP3;PLAU;CADM4;TNFRSF12A;DMTN;CLDN1
prerank,modulation by symbiont of host process (GO:0044003),-0.6553064394976151,-1.5622725505003434,0.04735883424408015,0.23113910745111987,1.0,7/10,23.23%,B2M;UBB;UBC;RPS27A;PGK1;MRC1;ENO1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6285768842956134,-1.5610361268872637,0.03825136612021858,0.23254060950438935,1.0,7/13,15.49%,NAMPT;KDR;IL33;EDN1;TLR4;JAK2;NOD2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5934310453387729,1.5608775066866527,0.049891540130151846,0.4566376745770411,1.0,4/18,2.77%,BMP2;DDR2;EFEMP2;SMAD3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.45062921865735117,-1.5604611259086445,0.019157088122605363,0.23265960990363213,1.0,14/47,12.21%,LIMS2;RREB1;DOCK1;ACTN4;PTK2;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1;RCC2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.41863220845985627,-1.5586084001310139,0.007984031936127744,0.23505975852704786,1.0,24/72,18.03%,TAX1BP1;RACK1;LIFR;HIPK1;ELF1;IRAK2;HSP90AB1;IKBKB;CBFB;CASP8;RIPK1;CD74;SYK;TRAF1;AGPAT1;TNFRSF1A;JAK2;SIGIRR;MADD;PTPN6;TNFAIP3;STAT1;IFNGR1;CHUK
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.463255130684078,-1.558053490003899,0.009861932938856016,0.23512463629089453,1.0,16/42,11.58%,UTRN;TEK;CDK6;PTPRJ;PTK2B;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;JUP;PPM1F;S100A10;EMP2;CIB1
prerank,regulation of metal ion transport (GO:0010959),0.5905295330633332,1.5569358093114065,0.047109207708779445,0.4636816128039019,1.0,5/16,7.17%,ANK2;SLC30A10;CACNA2D1;BCL2;CAMK2B
prerank,neutrophil activation involved in immune response (GO:0002283),-0.32686370705198675,-1.556148286401105,0.0,0.2381025888435606,1.0,144/428,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;SYK;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5562191973991044,-1.5557509252554647,0.016853932584269662,0.23767404607047535,1.0,7/19,17.02%,HIPK1;DYRK2;RPS27L;TMEM109;AEN;PHLDA3;DDIT4
prerank,positive regulation of cell migration (GO:0030335),-0.34615793737306466,-1.5555387128313114,0.002074688796680498,0.23702367827825657,1.0,52/253,9.90%,FN1;LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;RREB1;SEMA6A;SEMA3C;THBS1;GAB1;NOTCH1;ACTG1;SEMA7A;DOCK1;PLCG2;FGF1;RACK1;PTK2B;RAB11A;BMPR2;ACTN4;KDR;F3;PTK2;DAB2IP;FERMT2;TGFB1;TGFB2;SMO;SHTN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PLAA;PFN1;PDGFC;PDGFA;LAMC2;FAM107A;SEMA3G;DDRGK1
prerank,embryonic organ morphogenesis (GO:0048562),0.47267049665911065,1.5555176780073636,0.019455252918287938,0.4638527895829616,1.0,11/42,11.03%,FBN1;FBN2;FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;MFAP2;RARG;HOXB9;FUZ
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5779258980990422,-1.5553498281936808,0.04129263913824058,0.23630763429471607,1.0,10/18,20.88%,SEL1L;UBB;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,neutrophil degranulation (GO:0043312),-0.3258096639054768,-1.554845385904503,0.0,0.23617744437776444,1.0,143/425,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3955050460989877,1.5534086788876416,0.006024096385542169,0.46594639621941913,1.0,21/108,7.51%,NOTUM;BMP2;SALL1;WLS;DAAM2;TRABD2B;CDK14;FGFR2;SULF1;SULF2;LRP1;PTK7;SFRP1;RNF43;WIF1;PRKN;SENP2;TAX1BP3;CTNND2;TLE1;CXXC4
prerank,heart contraction (GO:0060047),0.47100917201446796,1.5530653762408415,0.02968036529680365,0.46285747581170483,1.0,8/41,4.22%,ATP1A2;SGCZ;SLC8A1;SCN3B;SGCD;TNNC1;CSRP3;TNNI3
prerank,primary alcohol metabolic process (GO:0034308),0.5345201009395341,1.552794022869073,0.02564102564102564,0.4596112479697474,1.0,2/25,2.06%,IGF1;DHRS3
prerank,activation of protein kinase activity (GO:0032147),0.399207541698293,1.5526008215129095,0.007858546168958742,0.45629113596942866,1.0,13/106,5.08%,IGF1;ADCY7;ADCY2;ADCY1;NRK;NTRK3;ADCY5;NRG1;PDPK1;PRKACA;OSBPL8;GHR;IL4
prerank,membrane repolarization during action potential (GO:0086011),-0.6172422245089608,-1.5524262885701035,0.03008849557522124,0.23996542450082936,1.0,7/13,25.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,negative regulation of potassium ion transport (GO:0043267),-0.622804971425597,-1.551769981533125,0.030141843971631204,0.2402737287545615,1.0,5/13,15.37%,CAV1;NEDD4L;PTK2B;CASQ2;CAB39
prerank,neutrophil mediated immunity (GO:0002446),-0.3265324483742757,-1.5515835834987468,0.0,0.23966133577592713,1.0,145/432,24.91%,PTPRB;ANO6;PECAM1;B2M;RAP1A;EEF1A1;PTPRJ;ATP8A1;OSTF1;CD55;ADGRE5;RAP1B;CD93;GPI;IQGAP1;EEF2;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;RAC1;IGF2R;ANXA2;PGM1;HSPA8;PPIA;ADAM10;ATP11A;VAT1;DIAPH1;RAB18;PSAP;LTA4H;ACLY;PKM;CTSC;FTL;CAP1;TNFRSF1B;JUP;PRCP;SVIP;STOM;ARPC5;QSOX1;IMPDH1;NHLRC3;SPTAN1;CTSD;CST3;TMC6;ENPP4;VCL;COMMD9;ATP6V0C;CSNK2B;LAMP1;ATG7;FCER1G;PGLYRP1;CEP290;TSPAN14;FABP5;VCP;TOLLIP;MOSPD2;RAB4B;LRG1;ILF2;CTSB;SURF4;FRK;RAB24;PDAP1;RAB7A;DBNL;FTH1;TUBB4B;PSMD14;COMMD3;FAF2;ERP44;ACE;CCT2;HRNR;FUCA2;LAMTOR2;SDCBP;GDI2;DYNC1LI1;GUSB;CFP;CAB39;TIMP2;PTPN6;PSMD11;CDK13;SLC15A4;DSP;PSMD12;SLC2A3;HSP90AA1;HMOX2;IST1;HSPA1A;TMEM30A;ATP11B;IRAK4;PLAU;ADGRG3;CCT8;CYBB;PYGL;CPNE3;TMEM179B;CANT1;PSMB1;HSPA1B;PSMC3;C3;PGM2;PGAM1;PFKL;CD68;ARHGAP45;LCN2;NRAS;PSMA2;ABCA13;TOM1;PRKCD;RAB3D;DOK3;CTSS;SLC27A2;STXBP2;DPP7;CYB5R3;ALAD;PLAUR;MLEC;ANXA3
prerank,axon guidance (GO:0007411),0.3666921126219637,1.5513192194088354,0.0,0.4561963046100664,1.0,38/201,9.90%,LAMA1;PLXNA2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;RHOH;KIF5C;DAB1;SEMA3D;EFNA3;IRS2;NPTN;NRXN3;EPHB1;ALCAM;UNC5C;RYK;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,protein targeting to lysosome (GO:0006622),-0.5474546275628553,-1.5510423472085946,0.034482758620689655,0.23965861949682515,1.0,10/20,25.20%,AP3M1;HSPA8;NCOA4;RAB7A;AP4M1;GCC2;LAPTM5;ZFYVE16;GNPTAB;VPS4A
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4893073957649691,-1.5505569338008887,0.026717557251908396,0.23948685389251764,1.0,11/34,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;S100A10;CIB1
prerank,response to chemokine (GO:1990868),-0.6078023909157856,-1.5502614703801125,0.0273224043715847,0.2390739663084132,1.0,3/13,2.77%,SLC12A2;LRCH1;WNK1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.520360252378176,1.5499281676266603,0.03361344537815126,0.4562236414408416,1.0,4/26,4.89%,IGF1;FHL2;CAMTA1;ACTN3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.586693439949443,1.5491665724894355,0.044967880085653104,0.4548159456810998,1.0,4/17,1.70%,BMP2;IL34;PTN;SERPINE2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5092718817865864,-1.5477720834750601,0.022429906542056073,0.24308179739396157,1.0,12/29,20.15%,ESR1;UFM1;CBFB;KANK2;DDRGK1;KMT2D;WBP2;VPS11;STRN3;UFL1;UBA5;SRARP
prerank,response to prostaglandin E (GO:0034695),0.6718958578730138,1.546901029877225,0.06320541760722348,0.4575461470042768,1.0,2/10,4.24%,TGFBR3;SFRP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6646999748932965,-1.5456171870073339,0.03231597845601436,0.2463778249212074,1.0,10/10,33.58%,FN1;HSP90AB1;GATA6;TSKU;LAPTM4B;LILRB1;CD24;CDH3;TYROBP;FURIN
prerank,cardiac muscle tissue development (GO:0048738),0.46299481993496727,1.5450691502533482,0.027196652719665274,0.4585506363739587,1.0,9/50,3.68%,BMP2;SGCZ;GJB6;BMP5;NRG1;GJA1;TBX18;SGCD;CSRP3
prerank,positive regulation of cell motility (GO:2000147),-0.35529692348069336,-1.5449172506158493,0.00205761316872428,0.24676680848990312,1.0,54/205,14.67%,LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;SEMA6A;SEMA3C;THBS1;SPOCK2;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;ACTN4;KDR;F3;PTK2;FERMT2;TGFB1;SMO;CAVIN1;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;PPM1F;EDN1;MMP14;ELP6;INSR;PDGFC;PDGFA;TWIST1;LAMC2;FAM107A;SEMA3G;DDRGK1;WNT11;HSPA5;CIB1;ACVR1;CSF1R;PIK3R3;HRAS;NTN1;SDCBP;SPAG9;EGFR
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5560143098469814,-1.5444431051852638,0.03429602888086643,0.24663171996101346,1.0,7/18,14.31%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APOE;APH1A
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6056845342281991,1.5444194944699878,0.04,0.45674006518659716,1.0,3/15,2.65%,IGF1;ROCK2;PRKCA
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6424905945163408,1.5433871303903532,0.05263157894736842,0.4560474991714832,1.0,7/12,17.29%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,inositol phosphate metabolic process (GO:0043647),-0.43896789502849215,-1.5432901192843196,0.013333333333333334,0.24784020363394713,1.0,15/46,16.69%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;FGF2;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.553774776433075,1.543149839702687,0.045548654244306416,0.4529433331990315,1.0,4/21,9.35%,IGF1;GJA1;DNMT1;BMPR1A
prerank,histone H2A monoubiquitination (GO:0035518),0.5903148613596729,1.5430515174245918,0.046413502109704644,0.44958757352106277,1.0,9/17,22.64%,BCOR;DDB2;RNF2;PCGF5;PCGF6;SKP1;TRIM37;PCGF2;KDM2B
prerank,positive regulation of lyase activity (GO:0051349),-0.6063924931725281,-1.542928534014451,0.03770197486535009,0.24756177606829383,1.0,10/14,33.87%,NOS3;ORAI1;NF1;FXN;CACNA1D;CACNA1C;PARK7;NOS2;NOS1;AKAP5
prerank,pyruvate metabolic process (GO:0006090),-0.44629615265096273,-1.542615702461936,0.01171875,0.2471367151581577,1.0,17/52,23.23%,BSG;ME1;GPI;DLD;HK1;PGM1;PKM;GAPDH;GLO1;LDHA;SLC16A1;ME2;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,sodium ion transmembrane transport (GO:0035725),0.41183686466779934,1.5420150243671,0.013100436681222707,0.44897490452219646,1.0,17/84,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;SLC9A7;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,T-helper cell differentiation (GO:0042093),-0.5946457607909412,-1.54178966871511,0.035842293906810034,0.24770101928335456,1.0,2/14,0.18%,LEF1;FOXP1
prerank,positive regulation of cell aging (GO:0090343),-0.6314633942996444,-1.5412223870906057,0.034926470588235295,0.24795086100553443,1.0,4/11,18.59%,B2M;ABI3;YPEL3;CGAS
prerank,innate immune response (GO:0045087),-0.3478462598268569,-1.540959844877007,0.004338394793926247,0.24741083278896442,1.0,56/217,18.09%,B2M;LBP;PLCG2;PTK2B;IFIH1;PTK2;MID2;GCH1;RPL39;TRIM25;ADAM15;APP;ADAR;MFHAS1;REL;NLRC5;NCF2;S100B;STYK1;IKBKB;IFITM1;IFITM3;TLR3;SRPK1;IFITM2;TRIM28;TRIM14;CLPB;RELB;IFIT1;FCER1G;PGLYRP1;DHX58;CD74;FRK;TRIM56;TTC4;TRIM62;ZDHHC1;MAVS;TLR4;NRROS;SYK;PHB2;TRIM68;TRIM5;POLR3A;CFP;NOD2;YES1;CX3CR1;ANKRD17;RELA;HCK;CHUK;SLA
prerank,ureteric bud development (GO:0001657),0.5843148116980661,1.5401533321091103,0.0511727078891258,0.4506319954867683,1.0,4/17,1.11%,BMP2;ROBO2;SALL1;FGFR2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6151901012278378,-1.5381148493069066,0.02411873840445269,0.251927523934539,1.0,8/13,29.27%,SLC35A3;UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,phosphate ion homeostasis (GO:0055062),0.6585957322198759,1.5369796201739072,0.06818181818181818,0.4561204776740093,1.0,2/10,8.80%,ENPP1;FGFR4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4479770999828089,1.5366420034864487,0.014644351464435146,0.4535252877600006,1.0,13/49,13.70%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TSLP
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.575895765404414,-1.5366022673997681,0.0297029702970297,0.2539595552855427,1.0,8/16,29.58%,VAMP7;LYST;PLEKHM2;TUBB4B;ARL8B;KIF5B;VAMP2;CORO1A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4764158527794152,-1.5364691913311865,0.020754716981132074,0.2532468563384808,1.0,14/35,11.52%,NR3C2;ESR1;DDX5;DDX17;PLPP1;PPARGC1B;RBFOX2;KDM3A;SAFB;NR3C1;EGLN2;ARID1A;NCOA4;WBP2
prerank,cell junction organization (GO:0034330),-0.4141970327269963,-1.5355948424529273,0.009487666034155597,0.2538144159444134,1.0,16/71,4.86%,ACTB;OCLN;LIMS2;APBB2;CXADR;ACTG1;OPHN1;AGRN;TJP2;RAB8B;FERMT2;TGFB1;APP;TGFB2;SDK1;LIMS1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.5199156633326835,-1.5349431939531841,0.028680688336520075,0.2540286634562685,1.0,5/25,3.46%,SPTBN1;PLCG2;PDE4D;RPS3;ANXA1
prerank,camera-type eye development (GO:0043010),0.529885672515569,1.5321487209301021,0.039301310043668124,0.4622286642618197,1.0,4/25,1.47%,LAMA1;FBN1;FBN2;TENM3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5464268326509121,-1.5320685984608065,0.0392156862745098,0.25881146067270133,1.0,6/21,6.72%,PRKCH;FOXP1;SLC39A10;ELF1;CD81;CBFB
prerank,regulation of type I interferon production (GO:0032479),-0.39459529975920254,-1.5311430729162765,0.009523809523809525,0.25963564890397434,1.0,39/84,34.35%,TAX1BP1;IFIH1;TRIM25;NLRC5;LRRFIP1;RNF125;PRKDC;GAPDH;OTUD5;DDX41;UBE2L6;DHX9;TIRAP;DHX58;TRIM56;MAVS;ITCH;POLR3E;POLR3A;NLRP4;TNFAIP3;RELA;IRF8;CGAS;PIN1;PTPN22;POLR3B;CTNNB1;MRE11;UBA7;POLR1C;POLR2F;PQBP1;POLR2L;CD14;IKBKE;CREBBP;POLA1;IRF3
prerank,axon extension (GO:0048675),0.5294455148996333,1.529664339829993,0.04139433551198257,0.4659314719294247,1.0,6/23,7.19%,AUTS2;NRP1;SEMA5A;SEMA3A;NLGN3;ALCAM
prerank,membrane depolarization (GO:0051899),0.49870712187430977,1.529633887586876,0.034261241970021415,0.46249044320805427,1.0,11/32,9.64%,SCN7A;CACNA1E;SCN3B;P2RX4;SCN3A;CACNA1I;CACNG4;SCN2A;CACNA1G;CACNB4;CHRNA4
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4523085805060875,1.5282522533358027,0.02301255230125523,0.4629833155615279,1.0,13/55,7.32%,CEMIP;GPC6;SPAM1;HYAL3;FMOD;DCN;GPC4;GPC2;OMD;GNS;LUM;GALNS;OGN
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4850277622317984,-1.5281086361341893,0.018050541516245487,0.2647709079968604,1.0,18/33,26.03%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;PLK3;CCL2;CDKN2B;DCUN1D3;PLK5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4895330838609026,-1.5272716069336523,0.026737967914438502,0.26545486697339465,1.0,16/31,25.13%,CDK6;KLF4;FHL1;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;E2F7;RBL1;PKD2;CCL2;CDKN2B;DCUN1D3
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5498344634998612,-1.5270916577879732,0.04056437389770723,0.264821049867344,1.0,10/19,9.73%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10
prerank,positive regulation of nuclear division (GO:0051785),0.5141256460195018,1.5270009709738388,0.034274193548387094,0.46308163960485976,1.0,6/25,8.25%,IGF1;TGFA;PHIP;PDGFRB;SIRT2;IGF2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4195406683340211,1.525764736531066,0.010245901639344262,0.4632900849072077,1.0,16/74,7.96%,IGF1;TCF7L2;AR;BMP5;EYA2;GDNF;BCL2;SH3RF1;PHIP;CFLAR;IL4;SERPINE1;GSTP1;EYA1;SCG2;TGFBR1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5524491877722688,1.525055798359618,0.04966139954853273,0.46201869836159737,1.0,7/18,7.76%,GRID2;CDH8;UNC13C;GRIK5;GRIK2;GRID1;GRIK1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6069032231702842,1.5227712668174607,0.04740406320541761,0.4648828528070323,1.0,6/13,9.45%,GJA1;SCN3B;ANK2;KCNJ3;CACNB2;KCNJ5
prerank,activation of protein kinase B activity (GO:0032148),0.5110904871281996,1.5227399594353663,0.04042553191489362,0.46156264861778257,1.0,5/29,3.11%,IGF1;NTRK3;NRG1;PDPK1;OSBPL8
prerank,epithelial tube morphogenesis (GO:0060562),-0.4730834621157554,-1.5220427325701147,0.030852994555353903,0.27436781800804605,1.0,16/32,21.51%,MEF2C;PODXL;RASIP1;SOX17;SLIT2;COL4A1;PKD1;CSNK2B;RHOB;ACVR1;HES1;CSF1R;MET;FGF10;PKD2;PRKD2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.40365731136495075,-1.5219718110507845,0.015296367112810707,0.2734325422396732,1.0,22/76,19.95%,TMSB4X;TAX1BP1;MAP2K5;NFKBIA;KLF4;IRAK2;DAB2IP;CMKLR1;NLRC5;CYP1B1;CHP1;USP7;ANXA4;COMMD7;ITCH;AIM2;TNFAIP3;UFL1;CHUK;CDK5RAP3;CD200;CCDC22
prerank,gonad development (GO:0008406),0.4615657535510833,1.521740124928222,0.0440251572327044,0.46118602517781393,1.0,9/41,9.13%,WNT4;SALL1;AR;NR2F2;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,adenine nucleotide transport (GO:0051503),-0.5605499841414873,-1.521588002209568,0.04664179104477612,0.27313953538739244,1.0,3/17,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6026341038335592,-1.5213193651068997,0.048824593128390596,0.27256177313894153,1.0,3/14,4.91%,PTK2B;WNK1;ADAM10
prerank,axonogenesis (GO:0007409),0.3525787818822827,1.5206727183811668,0.0,0.46108974192606533,1.0,43/237,9.90%,LAMA1;AUTS2;ROBO1;EPHA7;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;FGFR2;SEMA5A;NRXN1;GDNF;CNTN4;GLI2;EPHA3;PRKCA;EPHA6;DOK2;SEMA3A;ARTN;CTNNA2;KIF5C;DAB1;SLITRK4;SEMA3D;EFNA3;IRS2;NPTN;NLGN3;NRXN3;EPHB1;UNC5C;DOCK7;NRCAM;RYK;RAB10;UNC5D;CDK5R1;EPHA8;DCC;NCAM1;EPHA5
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5718513125763853,-1.51846783404561,0.03942652329749104,0.27757760536482295,1.0,9/15,25.92%,SMAD7;RPL11;RPL23;BAG5;RPS7;LIMK1;RPL5;DTX3L;PARK7
prerank,positive regulation of programmed cell death (GO:0043068),-0.33026007917950384,-1.5183148287449006,0.0021231422505307855,0.276844660760946,1.0,81/272,19.61%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FOXO3;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;HTATIP2;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;SYK;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;GADD45A;LAPTM5;ARHGEF6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.44685964033756687,1.517452783955355,0.036170212765957444,0.46711973953665165,1.0,9/47,7.28%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,neuron projection extension (GO:1990138),0.48963332326762676,1.517408415285005,0.0392156862745098,0.4639598142962464,1.0,8/32,8.01%,AUTS2;NRP1;SEMA5A;SEMA3A;FLRT1;NLGN3;ALCAM;CDKL3
prerank,aorta development (GO:0035904),0.597714511397824,1.517157317279126,0.05442176870748299,0.4614000227092086,1.0,5/14,6.77%,ROBO1;ROBO2;LRP1;EFEMP2;PDGFRB
prerank,energy reserve metabolic process (GO:0006112),0.5444376902234135,1.5162431869501012,0.054466230936819175,0.4606191886504422,1.0,4/19,2.85%,PID1;PRKAG2;PHKA1;LEPR
prerank,positive regulation of behavior (GO:0048520),-0.6505273661251001,-1.5160767201066947,0.03745318352059925,0.2804883922520938,1.0,4/10,11.50%,MEF2C;STRA6;AGRP;SGIP1
prerank,regulation of axonogenesis (GO:0050770),0.44508909103976757,1.5152329092537238,0.026,0.4604147093025532,1.0,15/51,15.34%,PLXNA2;ROBO1;ROBO2;LRRC4C;KIF13B;LRP4;MCF2;RTN4;PTEN;PLXNB2;BRSK1;NGFR;AMIGO1;MAP6;PAK1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5382842682002595,-1.515155115324588,0.04267161410018553,0.2815206612751122,1.0,6/20,6.56%,B2M;CD55;PRKCZ;IL1R1;CD81;DENND1B
prerank,negative regulation of JNK cascade (GO:0046329),-0.4887096080461058,-1.5148498246555737,0.03925233644859813,0.2809657643067075,1.0,9/31,12.63%,MECOM;NCOR1;TAOK3;SH3RF2;AIDA;ZMYND11;DNAJA1;DUSP3;ITCH
prerank,negative regulation of cell growth (GO:0030308),-0.37104554327675804,-1.514026684783464,0.001949317738791423,0.28169469334479924,1.0,48/121,23.23%,APBB2;PTPRJ;SERTAD2;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;TGFB1;TGFB2;PPP2R1A;NDUFA13;BCL6;SIPA1;DIP2B;RB1;WFDC1;SEMA3G;WNT11;INHBA;CCDC85B;CRLF3;SPHK2;SMARCA4;NDUFS3;CDKN2AIP;OSGIN1;SMAD4;CDKN1A;SMARCA2;HSPA1A;CCAR2;CDKN2C;NME6;TSPYL2;ESR2;MSX1;NDRG3;HSPA1B;SESN2;HYAL1;ENO1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6230595852081418,1.5138177731770825,0.06956521739130435,0.45830627152643727,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6230595852081418,1.5138177731770825,0.06956521739130435,0.45830627152643727,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.42709772425362014,-1.513388878588133,0.01727447216890595,0.2819858857267637,1.0,25/54,27.42%,RPL6;RPL26;RPL10;RPL11;RPL14;RRP15;RPL23A;RPL35A;NOP2;PES1;RPL10A;RPL3;PPAN;MDN1;WDR74;RPL24;RPL7;WDR12;RPL5;NSA2;RSL1D1;RPL7A;RPF2;NPM1;TRAF7
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.532098716367267,-1.5131457084411124,0.041353383458646614,0.28135727145429085,1.0,7/21,7.58%,CAV1;DMD;RACK1;PDE4D;SMAD7;RASSF2;PPM1F
prerank,small GTPase mediated signal transduction (GO:0007264),-0.37646159408415797,-1.5123985171424863,0.00196078431372549,0.2820374434735432,1.0,33/103,15.87%,ARHGAP31;RAPGEF5;PLCE1;RREB1;RASGRP3;RGL1;SHOC2;ARHGAP1;RAC1;SHTN1;RALB;CHP1;RAB18;SHC1;BCR;NUCB1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;NF1;ABR;FGF2;GNB1;HRAS;ARHGEF18;NTN1;RGL2;CDKN1A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5099228357130561,1.5121964396418106,0.043933054393305436,0.45963125922561593,1.0,7/27,5.39%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1;PRKN
prerank,purine ribonucleotide transport (GO:0015868),-0.5640063578140154,-1.5121313174746245,0.042435424354243544,0.2815773852883784,1.0,3/16,2.31%,ABCC4;LRRC8C;LRRC8D
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6221937451417828,-1.5120116425863122,0.0498220640569395,0.28081120547417754,1.0,7/11,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6009464317695281,-1.5118052970270055,0.05319148936170213,0.2802178263368029,1.0,7/12,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;UAP1;GNPDA1
prerank,embryonic eye morphogenesis (GO:0048048),0.6420769921829642,1.5114901394802411,0.0625,0.4584560405351753,1.0,4/11,7.78%,FBN1;FBN2;MFAP2;RARG
prerank,regulation of intracellular protein transport (GO:0033157),-0.48022567827099943,-1.511272612020666,0.03759398496240601,0.28021781035311544,1.0,14/32,22.97%,PTPN14;TGFB1;BCAS3;PRR5L;CEP290;PCM1;OAZ2;NDEL1;UHMK1;GCC2;RIPOR1;PDCD10;PLK3;PTPN1
prerank,renal system development (GO:0072001),0.43970738283211497,1.5106264218296943,0.032119914346895075,0.45770932969986,1.0,12/52,9.13%,WNT4;SALL1;GREB1L;SULF1;SULF2;GLI2;TBX18;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,negative regulation of cytokine production (GO:0001818),-0.35468969097604536,-1.5105922681713342,0.008368200836820083,0.2805451815270117,1.0,47/163,19.57%,FN1;LEF1;TMSB4X;THBS1;RPS6KA5;CD34;TAX1BP1;SRGN;IFIH1;MAP2K5;KLF4;ANXA1;TRIM25;RAC1;HDAC7;HDAC9;CMKLR1;SARS1;NLRC5;RNF125;RARA;EZR;N4BP1;TNFRSF21;RGCC;ANXA4;OTUD5;TRIB2;UBE2L6;DHX58;MAPKBP1;INHBA;MAVS;TLR4;ITCH;INHBB;SIGIRR;PTPN6;TNFAIP3;CD84;ATP2B1;VSIR;JAK3;PTGER4;CD200;PIN1;LAPTM5
prerank,regulation of actin filament depolymerization (GO:0030834),0.6141638152498745,1.5100635046121544,0.05672268907563025,0.45618555228118507,1.0,2/12,1.18%,PLEKHH2;SEMA5A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5262977262106818,-1.5096885908699207,0.05009276437847866,0.28141657590777414,1.0,6/20,12.54%,RPS6KA5;MAPK3;PPARGC1A;DIP2B;TADA2B;SOX4
prerank,alpha-amino acid catabolic process (GO:1901606),0.5106043802986951,1.5094406910891744,0.05829596412556054,0.4550947362444945,1.0,8/29,10.07%,ALDH4A1;IL4I1;PRODH;ACADSB;TDO2;KMO;DDO;KYNU
prerank,positive regulation of catabolic process (GO:0009896),-0.4150633695075018,-1.5084253438742679,0.019417475728155338,0.28315938279906905,1.0,24/65,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;SNF8;TNFAIP3;CSNK2A1;FZR1;VSIR;NSF
prerank,positive regulation of cellular senescence (GO:2000774),-0.6344662527674902,-1.5073333724819153,0.04562043795620438,0.28442683757339704,1.0,4/10,18.59%,B2M;ABI3;YPEL3;CGAS
prerank,negative regulation of biosynthetic process (GO:0009890),0.570827480894247,1.5072751900843846,0.07013574660633484,0.45779760751808385,1.0,5/16,6.61%,PPARA;SLC30A10;ABCD2;GSTP1;ASXL3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4382618174578412,1.5072348589526001,0.027426160337552744,0.45491183960810394,1.0,14/50,11.92%,RORA;FGFR2;IFT81;ZIC1;GLI3;SFRP1;EVC;IFT122;TULP3;KIF7;KCTD21;MGRN1;FUZ;BTRC
prerank,histone lysine methylation (GO:0034968),0.4803163495739744,1.505888097330865,0.04132231404958678,0.45572918169930815,1.0,14/33,15.53%,PRDM5;WDR5B;PRDM9;SETMAR;MEN1;KMT2A;SMYD1;CXXC1;SMYD3;PAXIP1;EHMT2;DYDC2;EZH2;WDR82
prerank,muscle tissue morphogenesis (GO:0060415),0.5883805545211448,1.503552985654301,0.05694760820045558,0.45942205064153513,1.0,4/16,6.27%,TGFBR3;BMP2;EFEMP2;MYLK
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5761891910215268,-1.5025555579054823,0.04736842105263158,0.2935779921552076,1.0,7/16,20.07%,SCARB1;GCH1;AKT1;APOE;S100A1;NPR3;NUS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5360032948090163,1.5025044151762363,0.0709812108559499,0.4591395524260884,1.0,6/20,8.08%,TGFBR3;BMP2;TBX3;OLFM1;TGFBR1;RBPJ
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.36081871281947125,-1.5024959884196687,0.0078125,0.29264428798168396,1.0,42/136,19.39%,TMSB4X;ESR1;TAX1BP1;ID1;ID3;MAP2K5;NFKBIA;FZD6;KLF4;IRAK2;DAB2IP;SMAD7;ZNF431;WWP2;CMKLR1;NLRC5;CYP1B1;PKD1;CHP1;BHLHE40;HEYL;USP7;ANXA4;HDAC4;TRIB1;RB1;CTNNBIP1;EGLN1;COMMD7;ITCH;HES1;AIM2;PHB2;SIGIRR;TNFAIP3;UFL1;KDM1A;CHUK;CDK5RAP3;MDFI;CD200;ADGRG3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5046740378992038,-1.5011029851014133,0.029250457038391225,0.2944831184418702,1.0,15/25,34.58%,HSPA8;DNAJB12;HSPA5;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4699399196068331,-1.5006014582798093,0.023121387283236993,0.29444799285944145,1.0,19/31,28.98%,PPP1R13B;PPP3CC;HIP1R;CASP8;BAX;BBC3;YWHAZ;E2F1;BAK1;CHCHD10;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.5562520037991903,-1.4998877969106874,0.04945054945054945,0.29499530772580507,1.0,8/17,13.25%,CLDN5;F11R;VEGFA;IKBKB;S1PR3;ADD1;VCL;TNFRSF1A
prerank,nitric oxide metabolic process (GO:0046209),-0.5653284611336613,-1.499585121753486,0.044169611307420496,0.2946253477314168,1.0,6/14,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.37884427595854897,1.49869359721119,0.010526315789473684,0.46637624990477944,1.0,10/110,1.71%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1
prerank,negative regulation of viral genome replication (GO:0045071),-0.45722688014454416,-1.498292992438937,0.04896421845574388,0.29611916110820735,1.0,14/40,21.38%,IFIH1;MPHOSPH8;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;MAVS;TASOR;OAS2;RSAD2;SETDB1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6313750999808412,-1.4981835653532936,0.05945945945945946,0.2942476235460615,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6313750999808412,-1.4981835653532936,0.05945945945945946,0.2942476235460615,1.0,7/11,21.50%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.603055095572375,-1.4977253083702209,0.05457746478873239,0.29423030350751,1.0,7/12,12.36%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS
prerank,mitochondrial gene expression (GO:0140053),-0.43960508285430755,-1.4977100587673793,0.029411764705882353,0.29324315923255323,1.0,21/42,32.74%,FOXO3;QRSL1;PTCD3;MRPL51;LARS2;GATC;MRPS17;MRPL16;SLC25A33;MRPL47;MRPS18A;MRPS6;GATB;NDUFA7;MRPS24;MRPL2;MRPS14;MRPS2;IARS2;TWNK;MRPS12
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.408191182059225,-1.4968119083291027,0.01744186046511628,0.29435309068856025,1.0,26/71,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5073451160126382,-1.4966095641503958,0.036968576709796676,0.29372559424165534,1.0,12/25,26.64%,OPHN1;HSP90AB1;RPL11;RPL23;RPS7;SGTA;CSNK2A1;CSNK2A2;RPL5;ALAD;TRIM39;F8A1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.389270486472773,-1.4964253565160655,0.009633911368015413,0.29303850105685475,1.0,36/94,23.10%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;PSMB5;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,sodium ion transport (GO:0006814),0.395168424016836,1.4948274584001486,0.025477707006369428,0.47474822414703,1.0,16/85,9.33%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SCN3B;SCN3A;ASIC2;SCN2A;SLC24A4;SLC24A2;SLC6A11;SLC6A1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5768629293311309,-1.4935522899279332,0.040998217468805706,0.29836973840761183,1.0,6/13,16.86%,NOS3;GCH1;CYP1B1;AKT1;SPR;NQO1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4987236419884874,-1.491729926085861,0.04970178926441352,0.30118587432764327,1.0,11/25,19.70%,CXADR;JAM3;JUP;CTNNA3;ITGA7;DSG2;ITGA4;DSP;NINJ1;CD200;ITGB3
prerank,negative regulation of signal transduction (GO:0009968),0.3372740991714799,1.49166758536521,0.004073319755600814,0.4800970889633246,1.0,54/249,11.44%,ENPP1;ADAMTS12;LGR4;NOTUM;BMP2;PID1;TRABD2B;SULF1;BMP5;SULF2;LRP1;AHSG;DCN;PIP4K2A;LEPROT;DKK3;BCL2;GLI3;PTPRT;CREB3L1;LYN;SFRP1;RNF43;TMEM25;WIF1;TSPAN15;TAX1BP3;NLRP12;IFT122;SMPDL3B;TLE1;CXXC4;CRY1;TULP3;MAPK8IP2;LRRC14;KIF7;ERBB3;NLRP2B;KCTD21;GPR108;CNMD;GATA3;PRKCB;DCC;MGRN1;PTEN;DACT3;FRZB;PIP4K2B;SIAH2;PTGIR;NKD2;FSTL3
prerank,anterior/posterior axis specification (GO:0009948),0.5769518034693162,1.4910717430951075,0.06779661016949153,0.47881997451208697,1.0,2/15,0.85%,WLS;TBX3
prerank,regulation of hydrolase activity (GO:0051336),-0.39433160840388903,-1.4904449370483264,0.019762845849802372,0.302925858528107,1.0,18/71,11.33%,CHN2;FGD5;CAV1;PRKG1;RASIP1;SIPA1L1;PTK2;ARHGAP27;DAB2IP;PLXNA4;CHN1;CRK;FGD6;GPR137B;ADAP1;PLXNA1;PLXND1;NF1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.45981259605057717,1.4899248473022748,0.03418803418803419,0.4791548109178025,1.0,6/40,7.31%,SLC7A11;SLC13A3;SLC38A1;SLC36A2;SLC7A9;SLC25A10
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5285863930480021,-1.4893653546281118,0.023853211009174313,0.30436988259720915,1.0,9/20,21.50%,CCND3;CCNY;HSP90AB1;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2
prerank,negative regulation of DNA binding (GO:0043392),-0.4968845807287699,-1.4892639936660832,0.03018867924528302,0.3036069224154109,1.0,9/28,18.98%,LEF1;NFKBIA;SMO;E2F1;SUMO3;JAK2;HEY1;KDM1A;MDFI
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4049181615616945,-1.4880923600278244,0.021568627450980392,0.30522673370290493,1.0,26/73,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6004140295834047,1.487578869062512,0.05405405405405406,0.48269425951609884,1.0,6/13,12.72%,BMP2;BMP5;CYP27B1;DKK3;SCAP;ERLIN1
prerank,positive regulation of protein polymerization (GO:0032273),-0.413114107732608,-1.487105585700965,0.027184466019417475,0.30647246172784043,1.0,21/65,23.92%,OCLN;BAIAP2L1;PTK2B;RPS3;RAC1;LMOD1;SLAIN2;PFN1;DCTN1;PRKCE;MET;NCKAP1;HSP90AA1;HCK;CDC42EP3;ARL2;CTTN;NCK1;CARMIL1;NCK2;CLIP1
prerank,endothelial cell proliferation (GO:0001935),-0.5539806823765875,-1.4861092943483147,0.05009276437847866,0.3076241302682305,1.0,4/17,2.11%,TEK;BMPER;CD34;BMPR2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5433148309033021,-1.4860489834963362,0.047706422018348627,0.30674417256332626,1.0,5/18,12.88%,LBP;PLCG2;DYSF;FCER1G;SYK
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3821395711465545,-1.48572117454011,0.014344262295081968,0.3064188412006726,1.0,28/93,15.49%,MAP3K5;PTK2B;ARL6IP5;TPD52L1;DAB2IP;APP;TGFB2;MID1;MFHAS1;MINK1;VEGFA;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;STK25;FZD7;MAP3K11;TIRAP;TAOK2;GADD45G;EDA2R;TRAF1;HRAS;EMC10;SDCBP;NOD2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5794126606440757,-1.485696526580923,0.04814814814814815,0.3054294882545533,1.0,6/14,14.31%,ADAM10;BACE1;ADAM19;ABCG1;PSENEN;APH1A
prerank,cranial nerve development (GO:0021545),0.6305288480586114,1.4855868010500013,0.07727272727272727,0.4854812759805809,1.0,3/11,8.27%,SALL1;CHD7;ERBB3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.39659989697354014,1.4852693482546764,0.020876826722338204,0.48342651678589,1.0,10/85,4.43%,IGF1;BMP6;TCF7L2;TGFBR3;FGFR2;BMP5;MTSS1;TGFA;SFRP1;MCC
prerank,extracellular matrix organization (GO:0030198),0.33778921153325714,1.4851838458918833,0.001841620626151013,0.4806806674865694,1.0,44/276,6.84%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;FLRT2;ADAMTS12;FBN1;LAMA2;LAMC3;FBN2;DDR2;ADAMTS10;COL1A2;NID2;COL22A1;DPT;MATN3;ITGA11;SCUBE1;ADAMTS5;DCN;NID1;RECK;MIA;COL4A4;TNC;SH3PXD2B;MMP16;CREB3L1;DDR1;COL16A1;LUM;ADAM12;SERPINE1;COL4A3;PLG;ITGAD;COL10A1;COL8A2;P4HA2;LOXL2;MMP11
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5141387808387851,1.4846251990161692,0.0611353711790393,0.479325679287502,1.0,7/22,11.12%,SLC2A13;ROCK2;LYN;LRRTM3;EFNA3;CASP3;CHRNA7
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6152627693633042,-1.484619427101435,0.06204379562043796,0.30687240132590277,1.0,4/11,3.82%,SEMA6A;THBS1;KLF2;EPN1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.559806985214262,-1.484368457538289,0.05730129390018484,0.305421324264853,1.0,10/15,34.36%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.559806985214262,-1.484368457538289,0.05730129390018484,0.305421324264853,1.0,10/15,34.36%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;CUL3;KCTD13
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4752693493530095,-1.4841516277744535,0.036036036036036036,0.3048550075463598,1.0,11/30,17.33%,ACKR3;TPT1;RPS3;CD44;TWIST1;PTTG1IP;CD74;BCL2L1;DDX39B;CCAR2;KDM1A
prerank,regulation of osteoclast differentiation (GO:0045670),0.4795801513029576,1.4836242559196924,0.03877551020408163,0.479192261837175,1.0,6/33,5.13%,FBN1;OCSTAMP;GPR55;CEBPB;IL4;CAMK4
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5308329035811814,-1.4835988763398913,0.052158273381294966,0.3050309416187873,1.0,10/18,29.30%,HIP1R;ACAA2;BAX;BAK1;CHCHD10;HSPA1A;SLC35F6;TMEM14A;MUL1;FZD9
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5693445496424354,-1.4830705416913388,0.05046728971962617,0.3052245878218548,1.0,5/15,3.06%,IGF1R;PTK2B;KDR;MAPK3;BMX
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.628782197289711,-1.4830052675212861,0.055456171735241505,0.30436352566565944,1.0,4/11,15.37%,CAV1;NEDD4L;CASQ2;CAB39
prerank,regulation of intracellular pH (GO:0051453),-0.4654097065964143,-1.4829441705615145,0.03333333333333333,0.3034743604458597,1.0,11/34,17.65%,SLC4A10;SLC9A2;TMEM165;CHP1;ATP5F1B;SLC4A8;SLC4A2;VPS33A;GPR89B;GPR89A;SLC9B1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5300924870313981,-1.4828352792688535,0.04693140794223827,0.3027367761133926,1.0,6/19,9.83%,CYTH3;PARD3;OPHN1;MSN;EZR;SIPA1L3
prerank,kidney development (GO:0001822),0.41661121902973414,1.4820618019598455,0.025210084033613446,0.48064991336235363,1.0,13/65,9.13%,WNT4;ROBO2;SALL1;GREB1L;SULF1;SULF2;GDNF;GLI2;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,negative regulation of angiogenesis (GO:0016525),-0.38072975046205326,-1.4818544775806477,0.012048192771084338,0.30406419883325203,1.0,20/84,10.11%,TEK;CLDN5;SEMA6A;SLC12A2;THBS1;KLF2;KLF4;COL4A2;DAB2IP;NPR1;EPN1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4828712094498604,1.4818018413123903,0.04291845493562232,0.4785018735097082,1.0,10/33,7.76%,LRRC4C;NRG3;GRID2;GRIK5;GRIK2;NLGN2;NLGN3;GRID1;NLGN1;GRIK1
prerank,cellular component maintenance (GO:0043954),-0.6073016067621159,-1.4817448798537922,0.05675146771037182,0.30335176937985003,1.0,5/12,25.89%,IGF1R;INSR;CLDN1;TREM2;MTMR2
prerank,purine nucleotide metabolic process (GO:0006163),-0.49713502489232986,-1.48149275532172,0.05805243445692884,0.3028808399220297,1.0,8/24,11.45%,NT5E;PRPS2;GPX1;NT5C;GDA;PRPS1;PRPS1L1;NT5C1A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.49099208075962214,-1.480808742167248,0.04807692307692308,0.3034681307229187,1.0,9/26,18.62%,CAV1;LBP;MFHAS1;TLR3;FLOT1;TIRAP;SLC15A4;NINJ1;RSAD2
prerank,maturation of SSU-rRNA (GO:0030490),-0.45467339336052986,-1.4804667016246091,0.03783783783783784,0.3032462537523582,1.0,8/34,10.81%,RPS16;RPS14;NOP14;RPS28;RPS8;RPS19;NOB1;DHX37
prerank,detection of mechanical stimulus (GO:0050982),-0.5306957812971147,-1.4798937449516483,0.036968576709796676,0.3035280132949667,1.0,5/19,7.35%,PIEZO2;PTK2;PIEZO1;PKD1;JUP
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4398357806044688,1.4797857835189079,0.035789473684210524,0.481346131499598,1.0,8/48,8.32%,ADCY7;ADCY2;ADCY1;ADCY5;AMPD3;SLC26A1;PAPSS1;GUCY2F
prerank,negative regulation of peptidase activity (GO:0010466),0.43752646866540906,1.4788757147620586,0.04384133611691023,0.4808975550632293,1.0,9/47,7.28%,TIMP3;LRP1;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,sensory perception (GO:0007600),0.4422397725340894,1.478536504070912,0.04842105263157895,0.47907072737070033,1.0,13/45,18.99%,ADGRV1;TTC8;P2RX4;OPRK1;PCDH15;TRPA1;CHRNA4;CHRNA7;PNOC;PTGES;CLRN1;SCN9A;PDYN
prerank,regulation of innate immune response (GO:0045088),-0.4073350744277616,-1.4784761470445287,0.033271719038817,0.30561674475470174,1.0,28/57,35.07%,GBP5;HSP90AB1;N4BP1;CASP8;ERAP1;DHX9;TIRAP;LRP8;DHX58;SAMHD1;AKIRIN2;PTPN6;TNFAIP3;SLC15A4;PTPN22;PTPN1;POLR3B;XIAP;TREM2;MUL1;PARP9;RIOK3;NLRC3;LYAR;CCL5;USP18;TLR8;FCGR2B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6017183082698474,-1.4784364246908952,0.06111111111111111,0.3047381466739208,1.0,6/12,19.15%,CAV1;JUP;CTNNA3;DSG2;DSP;CACNA1C
prerank,heme biosynthetic process (GO:0006783),-0.5126020512716059,-1.4774293271551273,0.05675146771037182,0.3059746711247011,1.0,10/22,27.27%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5523767072161158,-1.4771059802141207,0.04251386321626617,0.3057375145915259,1.0,9/17,25.43%,CCND3;CCNY;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2;SPDYA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5102037672958928,1.4758460932800461,0.057777777777777775,0.4838633845334628,1.0,7/23,6.87%,TGFBR3;SMAD3;DKK3;TGFBR3L;IL4;NREP;SMURF2
prerank,regulation of defense response (GO:0031347),-0.3953139352533799,-1.4752055522759184,0.014084507042253521,0.30914591120116763,1.0,28/76,20.25%,FOXP1;TMSB4X;SEMA7A;ANXA1;MGLL;IL1R1;BRD4;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;APOE;SAMHD1;BCL6B;JAK2;NOD2;UFL1;RELA;HCK;DAGLB;CASP1;GGT1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6332125798574952,1.4751935297702148,0.10491071428571429,0.4830590342098006,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,microvillus organization (GO:0032528),-0.5757734759537577,-1.4749533139338014,0.0626118067978533,0.3087204422016479,1.0,5/13,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.43242660446708325,-1.4746699016273377,0.04142011834319527,0.3083406649982034,1.0,16/45,18.51%,B2M;CAMK2D;TRIM25;CD44;MT2A;MID1;TRIM62;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8
prerank,negative regulation of cell death (GO:0060548),-0.3804972570136179,-1.4730267329232531,0.01568627450980392,0.311126386214743,1.0,30/88,22.04%,MECOM;CD34;CCN3;FERMT2;PPARGC1A;PDE8A;DCPS;TNFRSF1B;DUS2;SRSF6;AKT1;KANK2;SPEF1;WNT11;INPP5A;PSMC5;IMPACT;SOX4;CCN5;FGF2;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CD200;NCK1;HSPA1B;ADNP2;EIF4G1
prerank,positive regulation of immune response (GO:0050778),-0.40052338695151296,-1.471895982166418,0.022181146025878003,0.3128080304534427,1.0,31/64,40.24%,IL15;GBP5;TGFB2;CD81;DHX9;CD74;SPHK2;AKIRIN2;NOD2;SLC15A4;XBP1;RSAD2;LGALS9;IL6ST;POLR3B;STX4;SKAP1;LILRB1;KARS1;NLRP3;RIOK3;SASH3;CCL5;TLR8;FCGR2B;CD226;GRN;MYB;IL12RB1;ITGB2;ADAM8
prerank,glycerolipid catabolic process (GO:0046503),-0.5342002436173783,-1.4718352878622507,0.07393715341959335,0.3119751030951532,1.0,3/19,3.57%,GPCPD1;ABHD2;MGLL
prerank,microvillus assembly (GO:0030033),-0.5628455953369154,-1.4716669394445345,0.06227758007117438,0.3113952000926501,1.0,5/14,6.47%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,regulation of cell killing (GO:0031341),-0.5510069129242178,-1.4716571038174031,0.061371841155234655,0.31045881398501923,1.0,4/16,8.56%,CD55;TGFB2;RAC1;FZD7
prerank,positive regulation of histone methylation (GO:0031062),0.5018891877072998,1.4711981279928328,0.06290672451193059,0.4913025860111275,1.0,11/24,24.81%,AUTS2;KMT2A;DNMT1;PAXIP1;RIF1;MTF2;PAF1;DNMT3B;CTR9;SIRT1;WDR5
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5466494639887964,-1.470108260475441,0.07550644567219153,0.31282212904119283,1.0,8/16,15.28%,CAV1;TRIM25;TRIM14;TRIM62;TRIM68;FUCA2;TRIM5;NECTIN2
prerank,maturation of LSU-rRNA (GO:0000470),-0.4862462599360258,-1.4698040851876046,0.06093189964157706,0.3126238683319486,1.0,14/26,26.10%,RRP15;RPL35;NOP2;PES1;RPL10A;URB1;RPL7;WDR12;NSA2;RSL1D1;RPL7A;FTSJ3;RPF2;ZNHIT6
prerank,regulation of stress fiber assembly (GO:0051492),0.3997548824562089,1.4696546838815105,0.02834008097165992,0.4928954240944703,1.0,12/74,5.18%,ARHGAP6;PIK3R1;PPM1E;NRP1;ARHGAP28;LPAR1;PHLDB2;ROCK2;ASAP3;CGNL1;SFRP1;DLC1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.40073143219251983,-1.4694054276341142,0.02091254752851711,0.3123918438121875,1.0,25/70,17.97%,ACTB;ACTG1;DOCK1;PLCG2;WASF2;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;PRKCE;ACTR3;SYK;ABI1;WASL;PIK3CA;LIMK1;YES1;PIK3R2;NCKAP1;HSP90AA1;HCK;WIPF1
prerank,engulfment of apoptotic cell (GO:0043652),0.5607979732201085,1.4691637961088333,0.08035714285714286,0.4913957041321829,1.0,5/15,4.66%,XKR4;MEGF10;RHOH;XKR6;RHOBTB1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.364767318740241,-1.467862884132326,0.015968063872255488,0.3148496940241707,1.0,34/99,25.08%,MEF2C;ACTB;RAP1A;CDH1;RAP1B;SH3BP4;CTNNA1;RAPGEF1;CAPN2;SLIT2;IGFBP5;PDE2A;KCNQ1;DIAPH1;EZR;JUP;AKAP6;IMPACT;LAMTOR2;HCN2;RRAGD;RAPGEF3;RELA;XBP1;SOX9;RRAGA;RAPGEF2;PKD2;RRAGC;SESN2;DMTN;NSMF;GOLPH3;RPTOR
prerank,oxoacid metabolic process (GO:0043436),0.48651020233236575,1.467765808979328,0.0611353711790393,0.4925214199218118,1.0,8/27,14.01%,ENPP1;TPST1;SULT6B1;DDO;PPA2;PPA1;ABHD14B;GRHPR
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5442091264485673,-1.467706635728207,0.07076350093109869,0.3142646766435354,1.0,7/17,12.63%,FGF1;LPCAT3;MBTPS2;ABCG1;ERLIN2;APOE;ABCA2
prerank,positive regulation of cyclase activity (GO:0031281),-0.5759443528471384,-1.4676511831232375,0.05156537753222836,0.31344406153958065,1.0,6/14,19.15%,NOS3;MAPK3;ORAI1;NF1;CACNA1D;CACNA1C
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5312002403127568,-1.4673625895283413,0.0509433962264151,0.313198541520993,1.0,5/18,6.08%,ESR1;NCOR1;TGFB1;RPS13;PTBP3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5863075132325264,1.4673469948102686,0.1023454157782516,0.4910357922359739,1.0,2/14,5.08%,IGF1;IL4
prerank,regulation of small molecule metabolic process (GO:0062012),0.4946974821253075,1.467326607301566,0.06981519507186858,0.4883783680359734,1.0,6/28,5.80%,RORA;PPARA;PDK1;PDK4;PRKN;PDK3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.49454339090210625,1.4671792742811867,0.06535947712418301,0.4860536136963979,1.0,4/27,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,positive regulation of filopodium assembly (GO:0051491),0.49756649984960827,1.4669443561833533,0.07847082494969819,0.4840377841520747,1.0,7/24,7.72%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,substantia nigra development (GO:0021762),-0.44986164918423244,-1.466855935607305,0.03682170542635659,0.3132645474878108,1.0,21/37,31.13%,ACTB;CALM1;COX6B1;RAD1;CKB;MAPKAP1;GNB4;HSPA5;CALM3;S100A1;NDUFS3;INA;YWHAH;FGF9;SYNGR3;CDC42;YWHAE;YWHAQ;CNP;MBP;RHOA
prerank,pancreas development (GO:0031016),0.6015877867472209,1.4663997331591565,0.07327586206896551,0.48286250808398457,1.0,3/12,8.91%,TCF7L2;NKX6-1;NPHP3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4960787759400358,1.4662093036581985,0.04631578947368421,0.4808178690783437,1.0,6/26,10.17%,IGF1;PIK3R1;OSBPL8;IRS2;C2CD5;PRKCI
prerank,regulation of glucose metabolic process (GO:0010906),0.47703198366682936,1.4662083049089778,0.05578512396694215,0.4782373258808059,1.0,6/34,5.80%,RORA;PDK1;PDK4;PRKN;IRS2;PDK3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.3847794083344179,-1.4661124170144515,0.02040816326530612,0.3139483887768545,1.0,32/86,23.92%,OCLN;BAIAP2L1;PTK2B;RPS3;APP;RAC1;WDR1;LMOD1;SLAIN2;EDN1;GPX1;STMN2;PFN1;RB1;SYNPO;DCTN1;TRPV4;APOE;PRKCE;KATNB1;LIMK1;MET;NCKAP1;HCK;CDC42EP3;ARL2;CTTN;NCK1;COLGALT1;CARMIL1;NCK2;CLIP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.39731287769701035,-1.4657154859418955,0.019305019305019305,0.3139432676954553,1.0,34/69,31.16%,SEL1L;TRIM25;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;TMEM129;EDEM2;TMUB2;SGTB;TMUB1;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,organophosphate ester transport (GO:0015748),-0.4995593529274977,-1.465597451195502,0.04488330341113106,0.31324511170890895,1.0,7/24,14.03%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PITPNA;PRELID2;PITPNM1
prerank,oogenesis (GO:0048477),0.5536902846381853,1.4655109809809324,0.06487695749440715,0.4775281026456228,1.0,6/15,19.11%,PTN;NANOS3;FMN2;PIWIL2;METTL3;MARF1
prerank,regulation of presynapse organization (GO:0099174),0.5382085957446412,1.4641224552575796,0.07053941908713693,0.4762162974017181,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,regulation of presynapse assembly (GO:1905606),0.5382085957446412,1.4641224552575796,0.07053941908713693,0.4762162974017181,1.0,4/18,7.06%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,membrane raft organization (GO:0031579),-0.5572608276703415,-1.4640172457885265,0.08029197080291971,0.31601633719601063,1.0,7/15,14.98%,ANXA2;FLOT1;NAXE;S100A10;EMP2;NPC1;FLOT2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4594202552956204,-1.4639547163563038,0.03888888888888889,0.3152041758500068,1.0,19/33,25.76%,CCND3;PLCG2;ANXA1;RGCC;AKT1;DDRGK1;LSM11;PHB2;EGFR;ANKRD17;GLI1;CCND1;FGF10;EIF4G1;LSM10;HYAL1;AIF1;RPTOR;RDX
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3510505799931307,-1.4637856330053232,0.008113590263691683,0.31466752522102054,1.0,36/140,11.85%,ARHGAP31;CHN2;PLCE1;MCF2L;ARHGEF3;NET1;RHOJ;OPHN1;TGM2;RASGRF2;ARAP3;STARD13;ARHGAP23;STARD8;ARHGAP17;CYRIB;ARHGAP26;CD2AP;SLIT2;ARAP2;ARHGAP1;ARHGDIA;TRIO;RAC1;ARHGDIB;CHN1;ARHGAP25;SOS2;BCR;ITSN1;RHOT1;RHOB;PREX1;RHOT2;GMIP;ABR
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5085915330541386,1.4637568853602914,0.05128205128205128,0.47459517847645116,1.0,4/23,4.22%,TGFBR3;FGFR2;TNNC1;TNNI3
prerank,cellular response to fluid shear stress (GO:0071498),-0.5789685919614328,-1.4631616947869404,0.06382978723404255,0.3151360685116374,1.0,4/12,2.59%,MEF2C;MAP2K5;KLF2;KLF4
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6308170306771705,-1.463084965371423,0.06956521739130435,0.3143740292176082,1.0,4/10,22.15%,HK1;PFKP;GFPT1;PFKL
prerank,regulation of multicellular organism growth (GO:0040014),0.5599501588121629,1.4624978696361124,0.08035714285714286,0.4754270549901703,1.0,3/15,4.95%,IGF1;STAT5B;GHR
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5100189954799589,1.461999263072964,0.07223476297968397,0.4743020111842853,1.0,4/22,3.80%,IGF1;ROCK2;PRKCA;P2RX4
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4916070068611605,-1.461935239985182,0.05734767025089606,0.3161487620104666,1.0,8/23,13.54%,MAP3K5;RPS3;DAB2IP;TAOK3;EDN1;TNFRSF11A;MAP3K11;ARHGEF5
prerank,response to nitric oxide (GO:0071731),-0.5824942363833122,-1.4608524920426849,0.07011070110701106,0.31769574090256647,1.0,4/13,10.80%,MTR;FOXO1;GUCY1B1;EGLN1
prerank,response to laminar fluid shear stress (GO:0034616),-0.6095066649265443,-1.4598281798048849,0.05985915492957746,0.31909031660559517,1.0,5/10,5.65%,MAP2K5;KLF2;KLF4;SMAD7;SMAD6
prerank,autophagosome maturation (GO:0097352),-0.45722528831021,-1.459558768622887,0.04460966542750929,0.3187645159845922,1.0,15/32,20.98%,MAP1LC3B;CALM1;VAMP7;GABARAP;LIX1L;TECPR1;VCP;VMP1;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;RUBCNL
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5549786361301347,-1.4590209071778153,0.07017543859649122,0.31906385335038023,1.0,9/16,25.67%,THBS1;PPP1R16B;VEGFA;GATA2;JCAD;FGF2;DLL4;PDCD10;APLNR
prerank,response to cholesterol (GO:0070723),-0.5386017282374989,-1.4579107878342257,0.05860805860805861,0.32050188361371695,1.0,9/17,19.13%,TGFBR2;TGFB1;SMO;GRAMD1C;GRAMD1A;ABCA2;MLC1;SMAD2;OSBPL7
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.48689298406399256,1.4574647260223998,0.06153846153846154,0.4837336056869507,1.0,4/28,2.24%,ENPP1;PID1;AHSG;PIP4K2A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.37793201417526895,-1.4566912325270465,0.019083969465648856,0.32206017140027426,1.0,37/87,25.25%,CDK6;KLF4;FHL1;PSMA6;RGCC;PSMB5;KANK2;RB1;FAM107A;PSMC4;CDK4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;CDKN1A;PSMB4;PSMD12;PSMC1;CUL1;CDKN2C;CDK2AP2;PSMA1;E2F7;PSMB1;RBL1;PSMC3;PKD2;PSMA4;PSMA2;CCL2;CDKN2B;DCUN1D3;PSMB8
prerank,I-kappaB phosphorylation (GO:0007252),-0.6294193526588094,-1.4550695725159977,0.055944055944055944,0.3247860980242025,1.0,7/10,34.24%,DAB2IP;TLR3;TLR4;CHUK;PRDX4;ERC1;TLR2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4594726829426989,-1.454844243346844,0.041666666666666664,0.3242847867567783,1.0,11/33,14.41%,ANO6;KCNJ2;NEDD4L;WNK1;WWP2;KCNQ1;KCNJ10;KCNJ8;AKAP6;KCNJ15;CASQ2
prerank,regulation of cellular response to heat (GO:1900034),-0.38695732291612794,-1.4545832872583269,0.01768172888015717,0.32393339096390705,1.0,35/77,27.54%,CD34;MAPK3;CAMK2D;HSP90AB1;HSPA8;NUP93;NDC1;HSBP1;NUP54;BAG5;NUP188;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;FKBP4;HSPA1B;IER5;NUP160;DNAJB1;BAG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NUP98
prerank,dicarboxylic acid transport (GO:0006835),0.4760325970715545,1.4545223353472168,0.04899777282850779,0.48965161264645385,1.0,7/28,7.31%,SLC1A3;SLC13A3;GJA1;ABCC2;SLC26A1;SLC25A13;SLC25A10
prerank,muscle contraction (GO:0006936),-0.35159473538545344,-1.4541186531007302,0.009560229445506692,0.3239815327737912,1.0,21/126,8.19%,UTRN;ITGA1;SORBS3;EDNRA;TMOD3;SORBS1;DMD;VIM;PXN;MYL6;MYOF;CALM1;MYH11;MYOM1;DYSF;ACTA2;LMOD1;MYL12A;MYL9;GJC1;TMOD1
prerank,JNK cascade (GO:0007254),-0.4476427972472293,-1.4535805214484467,0.04562043795620438,0.3241951117496227,1.0,14/40,19.61%,MAP3K5;NOD1;MAP4K3;IRAK2;UBB;MINK1;UBC;RPS27A;MAP3K11;TRIB1;NOD2;TAB2;PTGER4;ARHGEF6
prerank,monocarboxylic acid transport (GO:0015718),-0.4133023564354273,-1.4535216571982637,0.02857142857142857,0.3234419532631739,1.0,10/51,3.19%,ABCG2;ABCC4;SLCO3A1;SLCO2A1;SLCO1C1;ATP8B1;SLCO2B1;SLC16A6;SLC16A9;SLC5A6
prerank,focal adhesion assembly (GO:0048041),-0.5097828259054438,-1.452573882631045,0.06066176470588235,0.32468972890623315,1.0,11/21,20.26%,THSD1;SORBS1;PEAK1;FERMT2;ACTN1;BCR;TAOK2;RCC2;CTTN;TRIP6;PTPRK
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5087284887789733,1.4523965413178932,0.06637168141592921,0.4929555045083601,1.0,6/20,4.22%,ATP1A2;SLC8A1;ANK2;PRKACA;ATP2A2;TNNI3
prerank,protein-containing complex disassembly (GO:0032984),-0.4128137977455472,-1.4522129654125022,0.02574257425742574,0.32463532283921576,1.0,21/54,25.20%,CAV1;MAP1LC3B;VAMP7;RPL23;HSPA8;GABARAP;LIX1L;TECPR1;VCP;MAP1LC3A;TSG101;VPS16;VPS33A;VTI1B;WIPI2;FZD5;RUBCNL;PPP1CA;PYM1;GABARAPL1;VPS4A
prerank,digestive tract development (GO:0048565),0.47115423601097883,1.4516235906487767,0.057692307692307696,0.49271610245097247,1.0,7/32,3.86%,SALL1;FGFR2;RARB;CLMP;KIT;GLI2;GLI3
prerank,cell chemotaxis (GO:0060326),0.41412119204899095,1.451027002738684,0.04219409282700422,0.49167627965525806,1.0,14/60,9.84%,NRP1;LPAR1;SEMA5A;KIT;PDGFRA;CCR6;ACKR4;ACKR2;CCR10;PDGFRB;EPHB1;CCR9;HOXB9;CCL25
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.47910649767311647,-1.4508592657242194,0.06297709923664122,0.3266791293651989,1.0,10/26,19.08%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;TRPV4;KATNB1;MET;ARL2
prerank,positive regulation of signal transduction (GO:0009967),0.33448178347518925,1.450769620408901,0.003861003861003861,0.48987352232441367,1.0,40/238,9.52%,CCBE1;IGF1;BMP6;ROBO1;PIK3R1;NRP1;BMP2;SALL1;WLS;NTRK3;FGFR2;SULF1;SULF2;NRXN1;CYP27B1;RIMS1;PRKCA;PTGIS;PHIP;SFRP1;EVC;AAK1;AXL;MAML3;NPTN;NLGN2;NLGN3;MYORG;LOXL3;NLGN1;CITED2;TGFBR1;RBPJ;KIF7;IGF2;STX1B;GATA3;PRKCB;MN1;CUX2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.579035437232581,-1.4506157722382034,0.060218978102189784,0.32630549079003474,1.0,7/13,14.62%,CAV1;PDE4D;CAMK2D;CALM1;CALM3;CASQ2;SRI
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.46440173828935594,-1.4506124443890889,0.058712121212121215,0.32540041248473156,1.0,7/29,5.58%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1;CD81
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.43606019293704357,-1.4502014203346985,0.04780114722753346,0.3253892352286613,1.0,14/39,8.42%,PODXL;CDH1;NOTCH1;MAP2K5;FXYD5;KLF4;WNK1;PTK2;TGFB1;VEGFA;NOTCH4;RGCC;PPM1F;AKT1
prerank,synapse organization (GO:0050808),0.3693871122925013,1.4501934653293809,0.021825396825396824,0.48891730709868175,1.0,39/125,14.68%,GPC6;PDZRN3;PPFIBP2;LRRC4C;SDK2;NRXN1;PCDHB10;CHRNA1;LRP4;GPM6A;GPC4;UNC13C;PTPRD;CTNND2;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;CACNB4;CACNB2;NLGN1;CACNB1;NRCAM;RYK;ARHGAP39;SLC6A1;FARP1;PTEN;CBLN2;MUSK;RAB39B;CHRNA7;DOK7;OBSL1;MAPT;PPFIA2;DRD2;PCDHB16
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.615151935328392,1.4499500627301127,0.08520179372197309,0.4870292153968434,1.0,3/11,4.95%,IGF1;PIK3R1;GHR
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.46164616751969184,-1.4492348069001388,0.04963235294117647,0.326563150130026,1.0,12/31,20.69%,CRIM1;CDK6;NOTCH1;LRP5;HDAC7;SMAD6;TWIST1;LIMD1;GREM1;SKI;SOX9;BAMBI
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5208474008241459,1.4482343794796126,0.0746606334841629,0.4892816320351236,1.0,5/21,7.11%,PPARA;SLC30A10;PRKN;ABCD2;SIRT2
prerank,response to acidic pH (GO:0010447),-0.5753756090044919,-1.4482316185099093,0.06352087114337568,0.3279871874651939,1.0,6/13,26.90%,CHP1;GPR4;IMPACT;RAB11B;CTSS;RAB11FIP5
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.43732497052526254,-1.4481122604035268,0.03770197486535009,0.3272896706413106,1.0,10/39,14.84%,ACER2;THBS1;NOTCH1;ACTN4;FZD4;ADAM15;MYOC;FZD7;RCC2;NEXMIF
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5643793410316553,-1.4473103369493163,0.0695970695970696,0.32813357161790485,1.0,4/14,7.13%,ANXA1;PRKCZ;RARA;NFKBIZ
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5999165198459446,-1.4466222150730312,0.08178438661710037,0.32883772496257496,1.0,5/11,20.27%,THBS1;CD34;GATA6;CD200;LGALS9
prerank,regulation of pH (GO:0006885),0.6062008270403527,1.4465542892161367,0.12529002320185614,0.491449606354981,1.0,3/11,5.93%,ATP6V0A4;PDK4;SLC9A7
prerank,positive regulation of proteolysis (GO:0045862),0.4166337655739005,1.4461305229818167,0.03815261044176707,0.49003452247176865,1.0,14/55,17.43%,CCBE1;SH3D19;AURKAIP1;SNX33;ASPH;FGFR4;SNX9;NKD2;BTRC;NRDC;TANK;TBC1D10A;FADD;CTSH
prerank,macrophage activation involved in immune response (GO:0002281),-0.5836996788749331,-1.4456551618181934,0.061837455830388695,0.3300989170436827,1.0,5/13,15.81%,LBP;PLCG2;DYSF;SYK;CX3CR1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5045953747923659,-1.4456162326744586,0.04631217838765009,0.3293126302856199,1.0,5/21,5.58%,PRKCH;FOXP1;SLC39A10;RPS3;CD81
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5793912137085487,1.4449298737506586,0.07603686635944701,0.4909346063848498,1.0,3/13,7.11%,ENPP1;TPST1;SULT6B1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5546666755514371,-1.444823791387992,0.048561151079136694,0.330157403415288,1.0,7/14,21.90%,TLR3;DHX58;USP15;ANKRD17;ZDHHC5;PUM2;ZCCHC3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.4888528467820345,-1.4443808073510138,0.05916030534351145,0.3303480220500622,1.0,10/24,27.27%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4059208320296966,-1.4442218660693593,0.021032504780114723,0.3288621994669204,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4059208320296966,-1.4442218660693593,0.021032504780114723,0.3288621994669204,1.0,31/56,31.64%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1;NDUFAF3;BCS1L;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,carbohydrate derivative transport (GO:1901264),-0.5350690267421402,-1.44394793816189,0.06571936056838366,0.3285060246550658,1.0,8/18,16.27%,LBP;PLTP;SCARB1;MFSD2A;ABCG1;SLC10A7;SLC15A2;SLC15A4
prerank,platelet degranulation (GO:0002576),-0.35470731397333766,-1.443779929686328,0.011857707509881422,0.3280195595570727,1.0,28/118,9.38%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;CYRIB;VEGFC;CALM1;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;VEGFA;PSAP;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.35779045942976007,1.443650729469042,0.0019723865877712033,0.4920136864522954,1.0,41/138,12.96%,EPHA7;IL31RA;PTN;NTRK3;DDR2;FGFR2;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;EPHA6;PTPRD;PTPRT;STAP1;LYN;DDR1;AXL;SHC4;PDGFRB;EPHB1;POLR1G;ERBB3;GUCY2F;RYK;FGFR4;EPHA8;AHI1;SH2D6;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;GFRA2;FGFR1;ROR1;EPHA1;BCAR1
prerank,response to metal ion (GO:0010038),-0.39184595376801523,-1.443334159240266,0.0273972602739726,0.3280937688878258,1.0,17/67,13.91%,CAV1;THBS1;TRPC3;NEDD4L;MT1A;MT1X;CALM1;ITPR3;MT2A;CRIP1;ATP5F1D;SLC25A12;CALM3;PPP5C;HOMER1;FXN;PEF1
prerank,endocrine system development (GO:0035270),0.5202627563502232,1.4432392327325418,0.07755102040816327,0.4907139675963846,1.0,8/21,13.61%,WNT4;SALL1;GLI2;DKK3;SOX2;TGFBR1;PAX8;NKX2-1
prerank,cellular response to dsRNA (GO:0071359),-0.5523969350284065,-1.4431310353657776,0.07846715328467153,0.32768440185363273,1.0,13/15,32.10%,CAV1;IFIH1;RALB;DHX9;FLOT1;IFIT1;MAVS;CGAS;ZCCHC3;NPM1;MUL1;PQBP1;RIOK3
prerank,protein localization to lysosome (GO:0061462),-0.4738752301507361,-1.4428478712258073,0.06439393939393939,0.32746021470960857,1.0,13/28,26.83%,SH3BP4;AP3M1;CD81;GLMP;NCOA4;RAB7A;AP4M1;MFSD1;GCC2;LAPTM5;ZFYVE16;VPS4A;LAMTOR5
prerank,response to exogenous dsRNA (GO:0043330),-0.5249825855846791,-1.4421628052911282,0.0724907063197026,0.3280767656190813,1.0,9/18,13.81%,CAV1;IFIH1;RALB;TLR3;DHX9;FLOT1;IFIT1;MAVS;SLC3A2
prerank,regulation of blood coagulation (GO:0030193),-0.48753123209921906,-1.4409680734388328,0.04038461538461539,0.32986411207971034,1.0,8/27,9.15%,CAV1;ST3GAL4;THBS1;CD34;THBD;FAP;EDN1;ENPP4
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3469863406677684,-1.4409210922536493,0.011881188118811881,0.3290882792960709,1.0,40/132,19.27%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL38;HSP90AB1;RPL11;RPS28;RPS5;RPS19;SRSF5;SNRPC;RPL23A;PRKDC;SRPK1;ISY1;SRSF6;NOP2;DHX9;SNRPD3;LUC7L2;RPS27L;XAB2;RPL3;PPAN;ZRSR2;DDX23;MDN1;ERAL1;SMN1;RPL24;HSP90AA1;DDX20;DDX39B;EIF5;SCAF11;SNRPG;TGS1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.540065679640393,1.4405498782828088,0.08817204301075268,0.4958021095428593,1.0,4/17,2.64%,ATP1A2;SLC8A1;GJA1;PRKACA
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4979781886779733,-1.4403201007593744,0.058931860036832415,0.32962322807569433,1.0,13/21,35.38%,PPP1R16B;FKBP1A;MFHAS1;PPP1R8;BOD1;ARPP19;YWHAB;YWHAE;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34520349053136506,-1.4399633544240422,0.01616161616161616,0.3295654380876175,1.0,41/137,20.09%,DOCK9;PKP4;ITGA6;RAP1A;NET1;RACK1;TGM2;AGRN;F11R;CAV2;SGSM2;RAPGEF1;ARHGAP27;RPS3;FERMT2;CALM1;BCAS3;LIMS1;PSAP;RGS6;NDUFA13;CCL15;S100A10;ZC3H15;WNT11;NF1;CALM3;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;BCAR3;RAPGEF3;MAPRE2;TBC1D2;MAPK12;ECT2;CD200;PIN1;RGS10
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4281375009802679,-1.4397646623563305,0.041666666666666664,0.32911770280565295,1.0,24/44,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;CAST;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;XIAP;YWHAE;LAMTOR5;DNAJB6;SRC;RPS6KA1;AQP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5870791438730952,-1.4394952546673705,0.06533575317604355,0.3288280025114971,1.0,6/12,29.94%,LPCAT3;MFSD2A;APOC1;P4HB;SOAT2;MTTP
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6327760610152107,1.4382719511644484,0.09345794392523364,0.4996866565930947,1.0,2/10,2.34%,ADGRV1;STRC
prerank,B cell activation (GO:0042113),-0.3910309668832434,-1.437767425084996,0.03877551020408163,0.3316723775564513,1.0,33/68,32.98%,MEF2C;PTPRJ;PLCG2;CTPS1;TPD52;ZBTB7A;HDAC9;CASP8;HDAC4;HHEX;HSPD1;PHB2;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;BTK;LAT2;BANK1;DCAF1;NFAM1;HDAC5;PTPN2;LAX1;RASGRP1;CD86;CHRNB2;LYL1;CD40;BLNK;CR2
prerank,acylglycerol catabolic process (GO:0046464),-0.4700220228737692,-1.437754973599379,0.06324110671936758,0.3308443889298693,1.0,5/30,13.79%,ABHD2;MGLL;PNPLA2;FABP5;FAAH
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.46932181134659107,1.437579867957176,0.07659574468085106,0.4990455558676412,1.0,5/29,4.22%,TGFBR3;BMP2;FGFR2;TNNC1;TNNI3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5330720516741749,1.437574702128621,0.09978308026030369,0.4966811032349809,1.0,3/17,11.12%,IGF1;RTN4;CHRNA7
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3447151232316848,1.4374202574785129,0.012096774193548387,0.4947118701894282,1.0,28/161,11.35%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;PRICKLE1;TBX18;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;AXIN2;PRKN;HECW1;TLE1;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5042226644877736,1.437213182395177,0.07770961145194274,0.49302963337482403,1.0,3/22,1.77%,ALDH1A2;VDR;CYP27B1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.35864631203788205,-1.4371279017744982,0.021442495126705652,0.3312535520091031,1.0,33/112,13.86%,MEF2C;CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PDE2A;LIMS1;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;NR3C1;USP9X;ACVR1;NRROS;ZMIZ2;ENG;USP15;SMURF1;ARHGEF18
prerank,response to ketone (GO:1901654),-0.48099610841141455,-1.4368294155156216,0.054924242424242424,0.33100280289218464,1.0,7/24,6.78%,ABHD2;CAV1;THBS1;SLIT2;TGFB1;TGFB2;TGFB3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.46941914303301446,-1.4364279373717732,0.05927342256214149,0.3311464140373294,1.0,10/27,22.04%,DDX5;TGFB1;RIPK1;DHX9;WTIP;LIMD1;FMR1;EGFR;PUM2;EIF4G1
prerank,histone H4 acetylation (GO:0043967),-0.4090746135825542,-1.4360311254907931,0.03460837887067395,0.33121559105635556,1.0,14/47,18.10%,LEF1;MSL2;PHF20;TRRAP;JADE2;ING5;HCFC1;TRIM16;KANSL2;EPC1;NAA60;MCRS1;BRCA2;EP400
prerank,myotube differentiation (GO:0014902),0.5303643319467859,1.435990760557944,0.10955710955710955,0.4940112032095681,1.0,5/17,7.46%,IGF1;ADGRB3;ADAMTS5;ADAM12;SIX4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5961654193171182,-1.4353198153590012,0.08159722222222222,0.3311475961859039,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5961654193171182,-1.4353198153590012,0.08159722222222222,0.3311475961859039,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;MEPCE;CCT7;CCT4;CCT6A
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3429516155632385,-1.4349400922867133,0.012605042016806723,0.33115481152496484,1.0,48/151,21.70%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DMD;DEGS2;GCH1;LPCAT3;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;CDO1;MFSD2A;KDSR;SPTSSB;SPNS2;GSTA4;CHKA;CSNK2B;ELOVL5;INHBA;CEPT1;GSTM2;APOE;SGPL1;SPHK2;ACER3;GSTA3;GSTM1;TYW1;CSNK2A1;CSNK2A2;GSTO2;ELOVL1;LCAT;MGST3;PLPP2;HACD4;ALAS2;GSTK1;PCYT1A;CHAT;PRKD2;LPCAT2
prerank,synapse assembly (GO:0007416),0.39920789223631103,1.4348439875784127,0.05416666666666667,0.49461992849782827,1.0,26/67,17.65%,SDK2;GRID2;NRXN1;PCDHB10;GPM6A;GABRA2;LRRTM3;GABRB3;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;NLGN1;NRCAM;RYK;FARP1;PTEN;PLXNB2;OBSL1;DRD2;PCDHB16;PCDHB14;ACHE;FLRT3;GABRG2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.4486394926803576,-1.4346469851299177,0.060109289617486336,0.33098692952876285,1.0,16/33,24.12%,ACER2;DPP4;PTK2;JAM3;TGFB2;CYP1B1;FOXC2;CIB1;SYK;NEXMIF;EPHA2;RET;PLAU;ADA;PIK3CG;SNAI2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5622482167472382,-1.4344226075126403,0.08243727598566308,0.3305725305366417,1.0,5/13,6.98%,ABHD2;NR3C2;ESR1;PLPP1;NR3C1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5469335329826961,-1.4340422678848765,0.07857142857142857,0.330589859088569,1.0,8/15,17.07%,BMPER;FGF1;KLF4;VEGFA;PKM;FGF2;S100A1;JMJD8
prerank,negative regulation of cell junction assembly (GO:1901889),0.4930166974198259,1.4339681335827548,0.06637168141592921,0.49475981315074424,1.0,5/25,5.18%,ARHGAP6;ROBO2;PHLDB2;ROCK2;DLC1
prerank,positive regulation of cell adhesion (GO:0045785),-0.3790744630045614,-1.4336560907247573,0.022857142857142857,0.330630264027489,1.0,20/74,15.65%,FRMD5;PTPRJ;VIT;TGM2;STX3;SMAD7;TGFB2;RAC1;LIMS1;VEGFA;ADGRG1;NPNT;PPM1F;FBLN2;FOXC2;CIB1;SYK;JAK2;ERBB2;ZFHX3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5111966973522498,-1.4328342765398843,0.08303249097472924,0.3316351250047989,1.0,9/18,31.46%,MAPK3;MSN;EZR;VPS11;SNX3;RDX;MTMR2;SRC;SNX12
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5442248162417128,-1.4316999358875449,0.0671785028790787,0.3333263466295274,1.0,10/17,24.46%,PARD3;SMAD7;CALM1;CALM3;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2
prerank,vesicle organization (GO:0016050),-0.4242916505788527,-1.4312884382555375,0.054307116104868915,0.33339405569556124,1.0,21/46,25.53%,CAV1;CD34;FNBP1L;SRGN;CAV2;SNX11;PI4K2A;CHMP2B;USP8;ALS2CL;WASL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;ZFYVE16;ANXA8L1;ANXA8;PHETA2;EPS15
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.6118510162082016,-1.4312242185481618,0.08145580589254767,0.3326760076326042,1.0,6/10,26.65%,PDE8A;RIPK1;GPR37L1;STK26;PARK7;TXN
prerank,response to molecule of bacterial origin (GO:0002237),-0.38571431536551404,-1.4304235572154012,0.03731343283582089,0.3336056598819764,1.0,23/69,22.09%,FOXP1;LBP;NOS3;CYRIB;RPS6KA3;GCH1;MAPKAPK3;SMAD6;OTUD5;TNFRSF11A;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;TNFAIP3;TAB2;PELI1;GGT1;LGALS9;FZD5;PTPN22
prerank,cGMP metabolic process (GO:0046068),-0.5666534713339777,-1.4303391490514412,0.08829174664107485,0.33295341362536846,1.0,5/12,15.32%,NPR1;PDE2A;GUCY1B1;GUCY1A1;GUCY2C
prerank,regulation of axon guidance (GO:1902667),0.6033035257312108,1.428361271715815,0.11904761904761904,0.5073734329594725,1.0,3/10,7.97%,NRP1;MYCBP2;ZSWIM5
prerank,regulation of osteoblast differentiation (GO:0045667),0.38672111756132066,1.428068029701512,0.03885480572597137,0.5058065824263167,1.0,11/82,3.69%,IGF1;BMP6;WNT4;NELL1;BMP2;FBN2;DDR2;FGFR2;PRKACA;CCN4;RANBP3L
prerank,regulation of ruffle assembly (GO:1900027),-0.4886717871529034,-1.4277032556422298,0.06203007518796992,0.3378722659954877,1.0,9/23,13.89%,CAV1;EPS8;PLEKHM1;EPS8L2;ABI3;PFN1;FAM98A;HRAS;NDEL1
prerank,positive regulation of glucose import (GO:0046326),0.5141355359403883,1.4274184261649068,0.08425720620842572,0.5051600374181088,1.0,4/21,5.54%,IGF1;PIK3R1;OSBPL8;IRS2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.5022321122394748,-1.4269553096608716,0.06690777576853527,0.33868561057124574,1.0,7/21,9.48%,CYRIB;DAB2IP;CD2AP;SLIT2;TGFB2;ARHGAP25;MAPKAP1
prerank,striated muscle contraction (GO:0006941),0.40788996440379377,1.4268919960571962,0.05296610169491525,0.504267200281221,1.0,9/53,8.07%,ATP1A2;SLC8A1;SCN3B;CHRNA1;TNNC1;CSRP3;TNNI3;KLHL41;TNNI1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3874876792675637,-1.426353057256322,0.03838383838383838,0.339112742102876,1.0,19/65,15.87%,LEF1;FOXP1;CBFA2T3;IL15;TGFBR2;MT1G;VEGFA;RARA;CASP8;OSTM1;TNFRSF11A;PIR;GLO1;CDK4;E2F1;CSF1R;GAB2;EPHA2;CDKN1A
prerank,pre-miRNA processing (GO:0031054),0.5728943201450215,1.4263523331611618,0.09502262443438914,0.5034585556943341,1.0,9/14,23.08%,TUT4;AGO4;LIN28B;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6089691414123467,-1.4263036222022465,0.0989010989010989,0.33839685961883736,1.0,4/10,5.46%,PARD3;DGKH;PLPP1;PRKD3
prerank,regulation of protein localization to nucleus (GO:1900180),-0.42028030132274113,-1.4256842406393049,0.05252918287937743,0.339042329401841,1.0,19/43,31.36%,LIMK2;CTNNA1;TFRC;FERMT2;TGFB1;MFHAS1;AKT1;SUMO3;CDK5RAP3;PIN1;SESN2;DTX3L;PARK7;CARD10;LAMTOR5;PLK1;ATP13A2;PARP9;CDK1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5520731141935223,-1.4251789035554783,0.08112874779541446,0.33938675204328334,1.0,5/15,18.26%,PLTP;SCARB1;ABCG1;APOE;LCAT
prerank,embryonic hemopoiesis (GO:0035162),-0.5864871265281606,-1.425168062270674,0.07335907335907337,0.33858295433596525,1.0,5/12,8.66%,KITLG;TGFBR2;KDR;ATF4;TAL1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.550207450995942,1.4251494760831445,0.10986547085201794,0.5043536173148981,1.0,5/15,14.41%,IL4I1;TDO2;KMO;KYNU;GSTZ1
prerank,nervous system development (GO:0007399),0.3094164312588587,1.4250002502338386,0.0,0.5025340970583392,1.0,92/429,13.69%,ROBO1;ADGRV1;NELL1;ARNT2;LDB2;ALDH1A2;ROBO2;RBFOX1;PTN;ATXN1;CNTFR;TBX3;LPAR1;SDK2;SEMA5A;CHST8;NRG1;NRXN1;GDNF;CNTN4;ZIC1;TEAD1;PCDHB10;LSAMP;CHD7;GPM6A;DCHS1;ARTN;ZEB2;GLRB;CHRM2;PRKN;PCDHB13;AXL;KIRREL3;GSTP1;NLGN2;CHRM3;NLGN3;RAB29;SCD5;IGF2BP2;ASIC2;APAF1;EPHB1;SCN2A;NLGN1;GRIK1;TGFBR1;ADGRA2;SCIN;NRCAM;ERBB3;HES5;ATXN3;RYK;ATN1;GMFB;TMEM223;AHI1;CYP46A1;FARP1;ERBB4;PTEN;ZIC4;ANKLE2;NFASC;APLP1;RPS6KA6;ST8SIA2;PCDHB15;NAB2;MST1R;SDHA;EDNRB;MERTK;COX7B;GFRA2;KALRN;APBA1;OBSL1;ATXN10;DLG4;PAX8;GBA2;EP300;VCAN;NAV3;YAP1;CNTN6;TENM1;POU6F2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4043494265298482,1.4249183423781027,0.04184100418410042,0.5004832224265146,1.0,8/62,5.54%,IGF1;AUTS2;ROBO1;LPAR1;GPR55;GPR174;LYN;IRS2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5780097123387246,-1.4248771369927686,0.07706422018348624,0.3384206670184893,1.0,6/12,23.47%,PPP1R3B;AKT1;PPP1R3F;PPP1R3C;RUBCNL;PPP1R3E
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4656039629251256,-1.4248161538086836,0.056530214424951264,0.3377403090374172,1.0,6/27,4.03%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1
prerank,myelin maintenance (GO:0043217),0.6146107092466706,1.4239445199012735,0.11328976034858387,0.5009798415221658,1.0,4/10,13.93%,EPB41L3;ABCD2;PTEN;CXCR4
prerank,metal ion homeostasis (GO:0055065),-0.4287512284802851,-1.4228120351411873,0.050522648083623695,0.34151851659869686,1.0,7/40,8.00%,SLC12A7;CAV1;TMTC2;SLC12A2;FAM20A;LETM2;JPH2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5042211906725912,1.4225266430201717,0.08225108225108226,0.5026956839887463,1.0,6/22,14.06%,SH3D19;TIMP3;SNX33;TIMP4;SNX9;NRDC
prerank,myeloid cell differentiation (GO:0030099),-0.4107685398150464,-1.4222848191124904,0.05063291139240506,0.3418610773125499,1.0,24/47,28.12%,RPS14;MFHAS1;ZBTB16;RPS19;SLC25A38;TAL1;TIRAP;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;UBA5;RASGRP4;SNRK;ALAS2;HCLS1;ZFPM1;CDKN2B;ACIN1;INHA;PTPN2;SPI1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5441316288395244,-1.421926241878743,0.0843806104129264,0.3418807381330988,1.0,9/16,11.48%,ESR1;DDX5;DDX17;PPARGC1B;RBFOX2;SAFB;EGLN2;ARID1A;NCOA4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.40329781294432654,-1.4219043786141,0.043151969981238276,0.341104666585491,1.0,25/50,31.99%,NR3C2;NOD1;ACTN4;RPS3;APP;LIMS1;TLR3;TCIM;TLR4;PHB2;EGFR;NOD2;RELA;LAPTM5;TRIP6;LGALS9;TRAF6;PTP4A3;PDCD4;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44
prerank,regulation of apoptotic process (GO:0042981),-0.2879259436279065,-1.4218798055303774,0.0,0.3403213112502018,1.0,194/676,20.37%,LEF1;TEK;ANO6;MEF2C;PPP1R13B;IGF1R;ITGA6;MAP3K5;ACER2;THBS1;MCF2L;TPT1;ARHGEF3;NET1;TAX1BP1;RACK1;PTK2B;UNC13B;TGM2;ACTN4;RASGRF2;NFKBIA;KDR;ARL6IP5;FOXO1;EGLN3;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;FOXO3;RPS3;ANXA1;DAB2IP;CARD14;SLIT2;ZBTB7A;NGF;MAP3K20;CD44;SOCS2;TMBIM4;CRADD;CTNNBL1;REST;ARHGDIA;TRIO;UBB;PPIA;HTT;ADAM10;CYP1B1;TNFSF10;ING5;IGFBP3;CD38;UBC;RPS27A;SMAD6;VEGFA;SPTLC1;PTMA;SOS2;HIP1R;TNFAIP8;RHBDD1;UFM1;IKBKB;TMEM219;GATA6;SH3RF2;ATF4;ANP32A;ACTN1;SHC1;TGFB3;PRKDC;RASSF2;CASP8;HSPB1;TOX3;EGLN2;ANXA4;RIPK1;FLT4;PLK2;BAX;AKT1;PERP;GLO1;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;PIM3;ATG7;DDRGK1;HSPD1;HIP1;RHOB;TCIM;VCP;WNT11;LRP8;CD74;PREX1;CFL1;HSPA5;CTSB;RTKN;NF1;HTATIP2;CIB1;GADD45G;ABR;GRK5;SERPINB9;YWHAZ;BCL2L1;E2F1;AVEN;SOX4;ITCH;BAK1;FXN;FSTL1;RNPS1;SPHK2;HIGD2A;RPS6;COPS5;RPS6KA2;ARHGEF5;DHCR24;ARHGEF18;PHB2;NUAK2;APH1A;JAK2;BNIP3L;EGFR;OSGIN1;HNRNPK;TOP2A;OPN3;MADD;HYPK;PTPN6;STK26;LGALS1;OPA1;STAT1;GREM1;PHLDA3;PDCD2;HSP90AA1;DDX20;HSPA1A;RELA;BAD;XBP1;BABAM2;CCAR2;JAK3;HCK;FOXL2;ARHGEF12;CALHM2;HSPA9;ARHGEF17;CRYAB;ASNS;ARHGEF4;ARHGEF2;ECT2;ANGPTL4;RASA1;GADD45A;SRA1;SOX9;LCMT1;FAIM2;GCLC;ARHGEF6;FGD2;MCL1;CASP1;HIGD1A;DNM2;TMBIM6
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.5434782816422612,-1.4217128399216135,0.08317929759704251,0.33984964901634174,1.0,8/16,25.17%,NCOR1;ERLIN2;ACADL;WDTC1;ACADVL;SOX9;TRIB3;APOC1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.49460047941544044,-1.4213193993939122,0.05740740740740741,0.3399205716443049,1.0,17/23,45.09%,PIK3R6;PVR;LAMP1;NECTIN2;LGALS9;RASGRP1;LILRB1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.44343590810311023,-1.4207966718514649,0.06534653465346535,0.34027024663305866,1.0,20/37,26.21%,PPP1R16B;CALM1;TGFB1;MFHAS1;PPIA;HTT;PPP2R5A;PPP1R8;CALM3;PPP1R16A;PPP6R3;CDCA2;PIN1;CNEP1R1;CDH5;ARPP19;PRKCD;YWHAB;NSMF;SMPD1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5778114455927773,1.4206663004304356,0.10457516339869281,0.5052961240606074,1.0,3/12,7.13%,MYCBP2;GLI2;EPHB1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6070917772979554,-1.419662915509102,0.07308377896613191,0.34183841183511166,1.0,8/10,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,ion homeostasis (GO:0050801),-0.45583667944154055,-1.4191073762321438,0.06099815157116451,0.3422308723649492,1.0,8/30,13.02%,SLC4A10;NEDD4L;FHL1;WNK1;CAMK2D;SLC4A8;SLC4A2;KLHL3
prerank,regulation of focal adhesion assembly (GO:0051893),-0.40215029960326487,-1.418634092167481,0.0525328330206379,0.34246661683880725,1.0,20/54,12.21%,TEK;THBS1;PTPRJ;ACTG1;LIMCH1;PEAK1;KDR;PTK2;FERMT2;RAC1;BCAS3;LIMS1;VEGFA;MYOC;PPM1F;VCL;FAM107A;S100A10;DUSP3;RCC2
prerank,receptor metabolic process (GO:0043112),-0.40174085122460335,-1.4183298846835959,0.03718199608610567,0.34234620028271057,1.0,16/53,13.59%,CAV1;DNM3;ACKR3;RAMP2;TFRC;TGFB1;CD81;CD9;AP2M1;FCER1G;LMTK2;KIF16B;REP15;RAB11B;SYK;SMURF1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5320452715420658,-1.4182754362342782,0.09108159392789374,0.3416666560262407,1.0,5/17,5.35%,CAV1;ADIPOR2;PPARD;NCOR1;ADIPOR1
prerank,smooth muscle cell differentiation (GO:0051145),-0.5777160393988593,-1.4179514503826507,0.07733812949640288,0.341599946168479,1.0,6/12,14.52%,MEF2C;MRTFB;GATA6;TMEM204;MRTFA;HEY1
prerank,regulation of interleukin-2 production (GO:0032663),-0.4222309745341759,-1.417485617047026,0.05103969754253308,0.3418753232999541,1.0,8/43,6.47%,CD34;SPTBN1;PLCG2;PDE4D;RPS3;ANXA1;HDAC7;EZR
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5552515234303836,1.4172029049565764,0.10869565217391304,0.5123416845530863,1.0,1/14,0.21%,ENPP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5363556996475068,-1.4165952822163113,0.08075601374570447,0.34310251486917104,1.0,5/16,17.25%,ACKR3;TPT1;RPS3;BCL2L1;CCAR2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.563449288398056,-1.4164456193181272,0.08273381294964029,0.3427222025201293,1.0,6/13,26.65%,RACK1;PDE8A;GPR37L1;MET;PARK7;TXN
prerank,amino sugar metabolic process (GO:0006040),-0.608490029831644,-1.4162689531892831,0.08226691042047532,0.3422982388533782,1.0,4/10,12.61%,CSGALNACT1;SLC35A3;ST6GAL1;GFPT1
prerank,regulation of protein metabolic process (GO:0051246),-0.40630018871603457,-1.4160338429631611,0.06680161943319839,0.3420708722164013,1.0,8/44,4.23%,LTBP4;NEDD4L;MAP2K5;KLF2;KLF4;HSP90AB1;APP;FKBP1A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3789836823256018,-1.416033041043277,0.03339517625231911,0.3412753585600841,1.0,19/67,7.83%,FLT1;NRP2;DOCK1;WASF2;PXN;CLEC14A;PTK2B;KDR;SHB;PTK2;VEGFC;DAB2IP;MAPKAPK3;RAC1;CRK;VEGFA;NCF2;HSPB1;FLT4
prerank,regulation of interleukin-4 production (GO:0032673),-0.49580400025807736,-1.4154024429772936,0.06578947368421052,0.34181832886298835,1.0,6/21,12.88%,LEF1;SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.38518658315386556,-1.4150343986441893,0.03962264150943396,0.34176574087965744,1.0,24/72,11.08%,HEG1;ARHGEF28;ARHGEF3;NET1;EPS8;RASIP1;OPHN1;F11R;STARD13;STARD8;COL3A1;EPS8L2;ARHGDIA;RAC1;ARHGDIB;CCDC125;GPR4;MYOC;BCR;ADGRG1;KANK2;LPAR6;TNFAIP1;ABL2
prerank,canonical glycolysis (GO:0061621),-0.48036322016236904,-1.414803707221997,0.08844765342960288,0.3406335172564467,1.0,10/24,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.48036322016236904,-1.414803707221997,0.08844765342960288,0.3406335172564467,1.0,10/24,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,positive regulation of protein modification process (GO:0031401),-0.32062663677276204,-1.413739645287162,0.00819672131147541,0.3421457969754871,1.0,69/203,21.55%,TEK;PECAM1;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;PPP1R16B;CARD14;CALM1;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;CHP1;VEGFA;PDE8A;PPP2R5A;RIPK1;KRAS;SVIP;FLT4;AKT1;INSR;FLOT1;FAS;ATG7;CD74;CAMK1;CIB1;VEGFD;CALM3;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;ACE;EGFR;ERBB2;HSP90AA1;RAPGEF3;RAMP1;CDCA2;PGF;FGF9;RAB3GAP2;WDFY2;CCND1;SOX9;PIN1;ITGB3;BRAT1;FGF10;CNEP1R1;CDH5;C3
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5257431036049137,-1.4126204883592972,0.07550644567219153,0.3439423182801698,1.0,6/18,15.28%,LBP;THBS1;IL33;HSPD1;TLR4;NECTIN2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.34295552950956265,1.4124543368683427,0.012552301255230125,0.523564668455515,1.0,25/152,12.26%,ADCY7;ADCY2;ADCY1;LGR4;ADGRB3;LPAR1;PTGFR;ADCY5;GPHB5;ABCA1;GNAI1;CHRM2;OPRK1;ADM;MC5R;IAPP;CALCR;GLP2R;ADRA1D;ADCY8;ADRA1B;PTGIR;GPR161;GNA15;CRHR1
prerank,negative regulation of inflammatory response (GO:0050728),0.33599344391748165,1.412169944084055,0.013513513513513514,0.5220530711229605,1.0,28/182,11.33%,IGF1;ADCY7;RORA;ADCY2;ADCY1;ADCY5;GPHB5;PPARA;HTR7;PRKACA;PTGIS;LYN;IL4;PTGDR;ADM;GSTP1;NLRP12;MC5R;SMPDL3B;IAPP;CALCR;HRH2;GLP2R;GATA3;TNFAIP6;ADCY8;HTR4;PTGIR
prerank,defense response to virus (GO:0051607),-0.3584119752805218,-1.4120653221047474,0.024,0.3443775105135443,1.0,29/100,18.62%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;CLPB;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;ZDHHC1;MAVS;PHB2;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.45956886034284206,-1.4115535841863176,0.06358381502890173,0.3447140992125366,1.0,9/31,20.35%,PLCG2;TLR3;HSPD1;TIRAP;TLR4;SYK;LAPTM5;LGALS9;MAPK11
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3395452910113821,1.4111900545212732,0.02584493041749503,0.5224429529870014,1.0,27/159,7.85%,ROBO1;GPC6;ROBO2;LRRC4C;SDK2;TENM3;GRID2;CDH8;CNTN4;PCDHB10;GPC4;CDH18;DCHS1;PTPRD;TENM2;PTPRT;PCDHB13;KIRREL3;CDH11;NPTN;CDH20;CDH19;CDH7;IL1RAPL1;ALCAM;NLGN1;TRO
prerank,cellular response to chemical stress (GO:0062197),-0.3580425862087451,-1.4111884647139858,0.028680688336520075,0.34467399060677745,1.0,46/96,33.91%,CAV1;LRRC8D;FOXO1;FOXO3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;FAS;ATG7;TRPV4;STX2;ETV5;PIK3CA;VKORC1L1;GSR;HSPA1A;CCS;CYBB;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;NUDT2;AIF1;GPX3;PARK7;STX4;SOD1;NOX1;RAD52;LRRC8E;ATP13A2;RBM11;ABL1;NCF1;SLC4A11;HTRA2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4393937100775955,-1.4100351193500853,0.043875685557586835,0.34644063585444357,1.0,12/35,18.55%,HEG1;RASIP1;DAB2IP;TGFB2;CCDC125;MYOC;MAPKAP1;TNFAIP1;ABL2;MET;KCTD10;SPRY1
prerank,cellular response to metal ion (GO:0071248),-0.34323664519407815,-1.4097675530898282,0.008438818565400843,0.34624118474488547,1.0,22/123,4.75%,MEF2C;ITPKB;B2M;CLIC4;SLC12A2;CDH1;PLCG2;MEF2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MAPK3;IQGAP1;CAMK2D;CDKN1B;MT2A;CARF
prerank,inner ear morphogenesis (GO:0042472),0.503797381585724,1.4096585966750492,0.1111111111111111,0.5243364855877629,1.0,7/22,13.22%,FGFR2;ZIC1;TBX18;CHD7;TMIE;TTC39C;PAX8
prerank,cellular response to reactive oxygen species (GO:0034614),-0.3917380484334964,-1.4090215033016065,0.03275529865125241,0.34698453039024096,1.0,31/59,34.49%,MAP3K5;NET1;PXN;MAPK3;RPS3;ANXA1;CYP1B1;RIPK1;AKT1;RHOB;IMPACT;FXN;EGFR;TNFAIP3;RELA;CHUK;ECT2;PTPRK;PKD2;PRKCD;PARK7;CAMKK2;ROMO1;AQP1;TPM1;ABL1;MAPK9;FOS;NCF1;JUN;MAPK7
prerank,response to nutrient levels (GO:0031667),-0.5205721808983601,-1.40786179589886,0.09533073929961089,0.3486978513084107,1.0,8/17,30.00%,KCNB1;ATF4;FAM107A;EIF4G1;CD68;MEAK7;RPTOR;RPS6KB1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5916817608733758,-1.4077731902306594,0.07956600361663653,0.3481082691763578,1.0,2/11,1.19%,MECOM;CD34
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3621770886734639,-1.4076731169663803,0.022,0.3475290473825102,1.0,45/87,31.64%,NDUFV2;UQCC2;NDUFB2;NDUFB8;NDUFB4;COA8;NDUFS4;NDUFA13;IMMP2L;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;COA3;CHCHD4;NDUFA9;NDUFB9;NDUFS3;SURF1;NDUFS6;NDUFC1;FASTKD3;DMAC2;NDUFA3;SLC25A33;ECSIT;LYRM7;NDUFA10;NDUFB10;SDHAF4;NDUFB3;SCO1;NDUFA7;PET100;NDUFA1;NDUFAF3;BCS1L;UQCC3;SDHAF1;NDUFA8;ACAD9;NDUFAF4;NDUFA2;NDUFAF5
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39485310231511184,1.4062617877289307,0.04771784232365145,0.5312671640505398,1.0,12/63,7.96%,IGF1;TCF7L2;AR;DEPTOR;SH3RF1;PHIP;CFLAR;IL4;BCL2L12;GSTP1;SCG2;TGFBR1
prerank,cellular response to interferon-gamma (GO:0071346),-0.3640429516179456,-1.4059595233149216,0.03231939163498099,0.3505785047143958,1.0,30/88,24.97%,B2M;CAMK2D;GBP5;TRIM25;CD44;MT2A;MID1;GBP7;GAPDH;CCL15;RPL13A;TRIM62;TLR4;TRIM68;JAK2;TRIM5;IRF9;OAS2;STAT1;IFNGR1;HCK;IRF8;AQP4;SYNCRIP;CASP1;LGALS9;PRKCD;AIF1;CCL2;ICAM1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3302998816565313,1.405673749535936,0.014285714285714285,0.530736138976458,1.0,33/186,11.35%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;TRABD2B;LRP1;PRICKLE1;LRP4;DKK3;GLI3;ZNRF3;SFRP1;MCC;RNF43;AXIN2;WIF1;PRKN;HECW1;TAX1BP3;TLE1;CXXC4;PSMA3;SOX2;PSMF1;NPHP3;DVL3;DACT3;FRZB;FUZ;SIAH2;NKD2
prerank,signal release from synapse (GO:0099643),0.42429425137343574,1.4054487894459153,0.06666666666666667,0.5291189069689126,1.0,12/43,12.98%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,triglyceride biosynthetic process (GO:0019432),0.5217419325867022,1.4054383470936171,0.09210526315789473,0.5268922641322547,1.0,6/18,16.49%,AGMO;MOGAT3;LPIN3;MOGAT2;DGAT2;LPIN1
prerank,negative regulation of bone mineralization (GO:0030502),0.5687299911090002,1.4051165990867536,0.0823045267489712,0.5255709682013344,1.0,3/13,2.10%,ENPP1;BCOR;AHSG
prerank,positive regulation of cell junction assembly (GO:1901890),0.40626461639747413,1.404514903297697,0.05060728744939271,0.5249211094550317,1.0,16/56,7.72%,NRP1;SRPX2;GRID2;NRXN1;CLSTN2;CNTNAP2;PTPRD;SFRP1;IL1RAP;COL16A1;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1
prerank,regulation of protein phosphorylation (GO:0001932),-0.3100838136811891,-1.4042938687566675,0.002105263157894737,0.35358105513720195,1.0,61/256,13.58%,FN1;TEK;PLCE1;PECAM1;OCLN;BMPER;SLCO3A1;CCND3;FGF1;RACK1;LIMCH1;LIMK2;KDR;MAPK3;TFRC;PTK2;NIBAN1;TBX1;VEGFC;DAB2IP;CARD14;SLIT2;FNIP2;TGFB1;APP;FAM20A;RAC1;PPIA;RALB;PRR5L;CHP1;IGFBP3;VEGFA;BRD4;ATF4;PDE8A;PRKDC;HSPB1;PPP2R5A;RIPK1;KRAS;FLT4;NDUFS4;AKT1;INSR;PDGFA;WARS1;FLOT1;FAS;CD74;IMPACT;CIB1;VEGFD;MAVS;SMG8;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4259025110220118,-1.4042683063434749,0.06566604127579738,0.352865847723116,1.0,18/35,30.77%,CDK6;FOXO3;ETS1;PRKDC;TAL1;INHBA;LDB1;STAT1;HSPA1A;FAM210B;HSPA9;MAPK11;HSPA1B;ZFPM1;SPI1;HMGB2;ANKRD54;ABCB10
prerank,amide biosynthetic process (GO:0043604),-0.404281962171596,-1.4041167143168038,0.07768924302788845,0.35245185785486716,1.0,8/47,8.90%,SGMS1;SGMS2;SPTLC2;DMD;DEGS2;SPTLC1;SPTSSB;ASAH2
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3650810636685072,-1.4039470328510648,0.036,0.3520142917472383,1.0,30/84,17.44%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;MSN;WWP2;EZR;TNFRSF1B;EGLN2;IDE;PLK2;NDUFA13;PTTG1IP;ATG7;VCP;RAB7A;OAZ2;APOE;ITCH;SMURF1;VPS11;SNF8;TNFAIP3;CSNK2A1;HSP90AA1;FZR1;NSF
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.34411833715493056,1.4031641008354703,0.015748031496062992,0.5264074747646305,1.0,22/152,8.56%,RNF220;LGR4;BMP2;LRRK1;SALL1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;SULF1;TBL1XR1;SULF2;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,negative regulation of leukocyte activation (GO:0002695),0.5406424686443383,1.4031530311123994,0.0944206008583691,0.5242364456192844,1.0,3/15,8.04%,IL31RA;IL4;CD300LF
prerank,regulation of fibroblast migration (GO:0010762),-0.5026441263830641,-1.4025795842295983,0.08409506398537477,0.3544189680508164,1.0,8/20,12.82%,THBS1;PTK2;TGFB1;RAC1;PRR5L;HAS1;PRKCE;FGF2
prerank,negative regulation of RNA splicing (GO:0033119),-0.5052491489235139,-1.4019538584117717,0.07156673114119923,0.3550468036085093,1.0,9/19,20.37%,RPS13;PTBP3;SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP;RPS26;TMBIM6
prerank,positive regulation of inflammatory response (GO:0050729),-0.36274582801894045,-1.401938673303633,0.024193548387096774,0.35428575891778796,1.0,19/86,15.55%,LBP;IL15;NFKBIA;ETS1;VAMP7;APP;PDE2A;CD81;IL33;RPS19;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;IL17RA
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5738870429702922,-1.401816877288934,0.0922242314647378,0.3537547972149496,1.0,4/12,5.29%,ACTB;ACTG1;LAMA5;LAMA3
prerank,negative regulation of response to stimulus (GO:0048585),-0.38474863378049073,-1.4014060095186813,0.044061302681992334,0.35394257093176873,1.0,15/60,11.97%,CDK6;CD34;MAP2K5;KLF4;COL3A1;SLIT2;KLF7;LPCAT3;MAP3K3;IGFBP3;AQP11;TWIST1;PIM3;KIF26A;ACVR1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5981908865598046,-1.4005419304154605,0.10654205607476636,0.3549873176389664,1.0,5/10,15.42%,ACAD11;ACADL;ACADVL;ETFB;ETFDH
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4061547412311389,-1.3993830337838757,0.05747126436781609,0.35686339018350716,1.0,25/47,30.91%,ATP5PD;ATP5MF;ATP5F1D;ATP5F1A;ATP5F1B;NDUFA13;CHCHD3;ATP5ME;ATP5MC3;TIMM29;ATP5MC1;OPA1;TIMM13;HSPA9;CHCHD6;TIMM10;APOO;ATP5F1E;TIMM8B;ATP5PO;TIMM10B;MICOS13;UQCC3;ROMO1;LETM1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.565216292328405,-1.3991929765858757,0.08139534883720931,0.35653371285610835,1.0,5/12,19.53%,CSGALNACT1;SLC35A3;FUT8;GFPT1;GALT
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5494330128481011,1.3991089034583435,0.10893246187363835,0.5331541292910942,1.0,7/14,17.90%,SEC24D;SCAP;SEC24A;SEC31A;SEC23A;TBC1D20;MIA3
prerank,in utero embryonic development (GO:0001701),0.47468436500288036,1.3986675341386543,0.1032258064516129,0.5322613613181141,1.0,7/25,8.48%,ARNT2;BMP2;FGFR2;CHD7;TGFBR1;IGF2;FOXD3
prerank,regulation of monooxygenase activity (GO:0032768),-0.47658192456046433,-1.3983257398321915,0.06566604127579738,0.3577927382862193,1.0,14/23,20.94%,CAV1;NOS3;NOSTRIN;CALM1;AKT1;LYPLA1;WASL;EGFR;SPR;HSP90AA1;NOSIP;CYGB;DNM2;DDAH1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.49382081650618553,1.3982960574056154,0.10416666666666667,0.5311097061221962,1.0,4/21,3.11%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,amino acid import across plasma membrane (GO:0089718),0.47544515427929257,1.3978462391448578,0.10307017543859649,0.5301638240438186,1.0,5/24,1.76%,SLC1A3;SLC6A9;SLC7A2;SLC6A13;SLC22A4
prerank,carbohydrate catabolic process (GO:0016052),-0.4315764214713621,-1.3965989132819434,0.06048387096774194,0.360838960183341,1.0,18/38,29.48%,GPI;MANBA;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;NEU3;PGAM1;PGAM4;PFKL;ENO1;NEU1;NEU2;NAGA;PFKFB1;PFKFB2
prerank,cellular response to acid chemical (GO:0071229),-0.4579875181590143,-1.3962065698583983,0.08687258687258688,0.36098411330856195,1.0,18/27,35.88%,SH3BP4;KLF2;CAPN2;VEGFA;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;NSMF;RPTOR;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.39153311322154694,1.396005962922835,0.04149377593360996,0.5330257460998795,1.0,16/66,9.92%,ROBO1;TGFBR3;FGFR2;NR2F2;SULF1;VDR;APOH;MTSS1;SFRP1;MCC;SCG2;SOX2;ATOH8;CNMD;GATA3;AIMP1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5436529187894522,-1.3958478620489472,0.0947176684881603,0.36097762626118296,1.0,4/15,6.78%,SMAD7;TGFB1;TGFB2;TGFB3
prerank,sensory perception of smell (GO:0007608),0.5752366318872139,1.3958094640909826,0.12155963302752294,0.5313385688100607,1.0,4/11,14.15%,OMP;SLC24A4;UBR3;DRD2
prerank,eye morphogenesis (GO:0048592),0.509155092059761,1.3954777794405155,0.08932461873638345,0.5301175432328866,1.0,6/19,7.78%,FBN1;FBN2;TENM3;IFT122;MFAP2;RARG
prerank,sphingoid metabolic process (GO:0046519),-0.5755444750043235,-1.3948084026623395,0.10088495575221239,0.3624607318871982,1.0,7/12,24.77%,DEGS2;PLPP1;KDSR;ASAH2;SPHK2;PLPP2;SGPP1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.35888183486682795,1.3944675687470982,0.038,0.5306884889596011,1.0,25/107,11.12%,ATP1A2;LRRC4C;NRG3;GRID2;CLSTN2;RIMS1;CHRNB4;GRIK5;GRIK2;GRM1;DLGAP1;NLGN2;NLGN3;SYT1;GRID1;CPLX2;NLGN1;GRIK1;MAPK8IP2;STX1B;MCTP2;PTEN;CNTNAP4;BAIAP3;CHRNA7
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4790310455458735,1.3941202597062454,0.09333333333333334,0.5294900546486115,1.0,10/23,13.71%,ENPP1;GLI3;IFT122;TULP3;KIF7;KCTD21;MGRN1;GPR161;BTRC;SUFU
prerank,regulation of kinase activity (GO:0043549),0.3626785644982177,1.3938263568403515,0.03875968992248062,0.5280391054395851,1.0,29/89,12.88%,EPHA7;LDB2;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;IRS2;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1
prerank,positive regulation of heart contraction (GO:0045823),0.5045955340283708,1.3934897369353447,0.12474012474012475,0.5267838673782219,1.0,4/19,5.95%,ATP1A2;SCN3B;ATP2A2;ADM
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4267793560091933,-1.3932235366725751,0.05390334572490706,0.36529808763476834,1.0,16/36,16.04%,SGMS1;RPS3;TPD52L1;DAB2IP;CRADD;NR4A2;PPIA;ING5;ASAH2;FAS;RB1;TRAF1;MADD;CX3CR1;CSNK2A1;CSNK2A2
prerank,cellular response to interferon-beta (GO:0035458),-0.5408771627430815,-1.3922517560723728,0.1141804788213628,0.3667704422604951,1.0,5/14,16.32%,IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,manganese ion transport (GO:0006828),-0.5478841824967442,-1.392193053503899,0.08364312267657993,0.3661208250233738,1.0,6/14,10.93%,TRPC3;TMEM165;ATP2C1;SLC39A8;TRPC6;TRPC4
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.4511596860143121,-1.3920803275660776,0.06088560885608856,0.36565522312171217,1.0,18/30,35.82%,HSPA8;DNAJB12;HSPA5;CHCHD4;CCT2;HSPA1A;HSPA9;HSPE1;HSPA1B;DNAJB1;ERO1A;BAG1;SDF2L1;SDF2;HSPA14;DNAJC7;ST13;UGGT1
prerank,regulation of cellular component organization (GO:0051128),-0.33867670311000553,-1.3918574455706445,0.024742268041237112,0.3653357989974063,1.0,52/135,25.92%,PLCE1;RAP1A;MLLT3;NET1;LTBP4;RAP1B;OPHN1;TFRC;RAPGEF1;CAMK2D;DCUN1D5;DAB2IP;SOCS2;HSPA8;HIP1R;HCFC1;EGLN2;FAM107A;WFDC1;HIP1;RAB4B;BAG5;ABL2;TAOK2;NCLN;RUFY1;RAB4A;APOE;ITCH;CISH;LAMTOR2;SETD1A;STK38L;OGFR;TMEM97;HSP90AA1;PACSIN1;TSC2;GFAP;PACSIN3;PACSIN2;RAPGEF2;MKI67;CAMSAP3;PTPN1;ANGPTL7;ZFYVE16;TJP1;RPTOR;RAB5C;ANKRA2;PARK7
prerank,calcium-mediated signaling (GO:0019722),0.36567229890839925,1.3909393819732416,0.04480651731160896,0.5318298917422171,1.0,17/93,8.81%,RCAN2;PTGFR;SLC8A1;PDPK1;ANK2;PRKACA;DMPK;P2RX4;ATP2A2;TNNI3;CCR6;ACKR4;ACKR2;CCR10;CHRM3;PPP1R9A;CCR9
prerank,homeostasis of number of cells (GO:0048872),-0.5526054961611112,-1.3902026062779125,0.10990990990990991,0.3682904107473947,1.0,6/12,15.81%,NOS3;NOTCH1;CCN3;LPCAT3;OCIAD1;CX3CR1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5654311187468338,1.3900891163635283,0.14047619047619048,0.5321070901393372,1.0,6/11,16.52%,PARP16;PARP11;PARP12;TIPARP;PARP4;PARP3
prerank,mesenchymal to epithelial transition (GO:0060231),0.5993107607506593,1.3896056297419912,0.11904761904761904,0.5313798806285515,1.0,3/10,13.22%,SALL1;GATA3;PAX8
prerank,polyol metabolic process (GO:0019751),-0.3963170660365637,-1.3894021233988265,0.04980842911877394,0.3694633203236392,1.0,14/46,16.69%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;IP6K1;MINPP1;SYNJ1;IMPA2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.509430591696955,-1.3890313336482603,0.0838095238095238,0.3695312300251982,1.0,7/16,20.94%,BMPR2;PLCB3;PRCP;ACE;GPR37L1;SPX;DDAH1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5394440420798369,-1.388059798136126,0.10128913443830571,0.37098247297764636,1.0,7/13,22.97%,RACK1;DDRGK1;HSPA5;UFL1;NCK1;BFAR;PTPN1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4818752396376515,1.3877872218310754,0.13263157894736843,0.5344208570669895,1.0,4/24,8.25%,IGF1;ENPP1;IRS2;IGF2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4157558034544825,1.3877282821927621,0.06493506493506493,0.5325154277902827,1.0,11/46,9.61%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5075190774223997,1.3871753978174115,0.10434782608695652,0.5318834050684116,1.0,5/18,10.66%,CAMK1D;ADCY1;LPAR5;EPHA5;ADCY8
prerank,neurotransmitter secretion (GO:0007269),0.41398834981236615,1.3871005639894733,0.09,0.5300091897186487,1.0,12/44,12.98%,NRXN1;RIMS1;SYT1;CPLX2;SNAP25;OTOF;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,cellular protein catabolic process (GO:0044257),-0.38854727387653115,-1.386658189572902,0.03992015968063872,0.3733512675050867,1.0,20/59,15.15%,FAP;CAPN2;DAB2IP;CTSZ;CTSO;CTSC;CASP8;PSMA6;IDE;RIPK1;DENND3;AP2M1;CTSF;UBE2G2;CTSB;RAB7A;RNF5;BNIP3L;UBE2G1;AP2A1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5724004096681452,-1.3862937163100852,0.10251798561151079,0.3734081320483506,1.0,4/12,5.49%,FOXP1;NCOR1;ZBTB7A;HEYL
prerank,positive regulation of phosphorylation (GO:0042327),0.31674209602645226,1.3856231721724637,0.020036429872495445,0.5319444495789555,1.0,55/240,13.39%,IGF1;EPHA7;NRP1;ZBTB20;BMP2;IL34;AR;NTRK3;DDR2;FGFR2;PELI2;KIT;PDGFRA;EPHA3;ROCK2;EPHA6;VEGFB;LEPR;RAP2A;LMO4;PFKFB4;LYN;FNIP1;DDR1;AXIN2;GLMN;AXL;NPTN;PDGFRB;EPHB1;TNIK;THPO;IGF2;ERBB3;RYK;FGFR4;DVL3;EPHA8;MYDGF;ERBB4;AKTIP;EPHA5;ALK;ANG;MUSK;CHRNA7;FXR2;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;P2RY1;DAXX
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5387159161248335,1.3855492345293088,0.11304347826086956,0.5301232434887482,1.0,3/15,3.98%,BMP2;GLI2;ANKRD11
prerank,cellular response to lipid (GO:0071396),0.32604477644325996,1.384211009948152,0.022727272727272728,0.5317953463591024,1.0,42/191,15.40%,RORA;ADCY2;ADCY1;ATP1A2;PID1;AR;ADCY5;PTK7;EPHA3;ROCK2;GNAI1;PDK4;STAP1;LYN;SFRP1;TICAM1;ZNF35;BRINP1;AXL;SERPINE1;PDK3;BRINP3;GSTP1;PPBP;CD274;ABCB4;NUGGC;PABPN1;TNIP3;PDE4B;ADCY8;AHR;FZD10;ATP1A3;BRINP2;ATM;CD180;WNT6;CXCL1;WNT5B;KAT5;NCOA3
prerank,mesonephric tubule development (GO:0072164),0.5384856058678086,1.383949407277279,0.12663755458515283,0.5303766248286477,1.0,3/15,1.11%,ROBO2;SALL1;FGFR2
prerank,muscle tissue development (GO:0060537),-0.5417831044820197,-1.3839160518775127,0.11235955056179775,0.3780300407449911,1.0,6/13,13.24%,PGM5;SMO;STRA6;NF1;POGLUT1;ENG
prerank,positive regulation of innate immune response (GO:0045089),-0.436293167141987,-1.383738794425663,0.06716417910447761,0.37764433453917673,1.0,9/30,16.27%,LBP;GBP5;NLRC5;RPS19;DHX9;TRIM62;MAVS;AKIRIN2;SLC15A4
prerank,negative chemotaxis (GO:0050919),0.4451147868858822,1.3837369706134541,0.08403361344537816,0.5289751212819088,1.0,6/33,7.40%,ROBO1;EPHA7;LRTM1;SEMA3A;SEMA3D;UNC5C
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3367392975387278,-1.3834196865685569,0.02574257425742574,0.3775863401191769,1.0,38/128,14.15%,CLDN5;DDX5;PARD3;ID1;PXN;TGFBR2;BMPR2;F11R;NLK;MAPK3;PTK2;COL3A1;SMAD9;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;INHBA;HIVEP1;ACVR1;NRROS;RNF111;ZMIZ2;TMEM100;ENG;USP15;SMURF1;INHBB;ARHGEF18;EID2
prerank,cellular amino acid catabolic process (GO:0009063),0.36967708240809344,1.3826034239491938,0.045275590551181105,0.5298879563914117,1.0,20/87,10.99%,HMGCLL1;ASPA;ALDH4A1;IL4I1;ABAT;PRODH;ACADSB;GLDC;ALDH7A1;ALDH6A1;BCKDHB;TDO2;KMO;DDO;GLUL;GLS2;HIBADH;KYNU;HNMT;DBT
prerank,cellular response to ionizing radiation (GO:0071479),-0.40209499429485285,-1.3825592914656888,0.05675146771037182,0.3788517724465395,1.0,24/47,29.47%,NET1;RPL26;MAP3K20;EEF1D;RAD1;RHOB;HRAS;TMEM109;RAD9B;HUS1;RAD9A;CDKN1A;KDM1A;CRYAB;ECT2;GADD45A;NIPBL;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;TSPYL5;SWI5
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5256990802854314,-1.382465009502304,0.10666666666666667,0.3782805224928075,1.0,11/15,39.88%,SCARB1;MFSD2A;NR1H2;CNEP1R1;C3;SIK1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,hemopoiesis (GO:0030097),-0.3544173808013408,-1.3819312450406565,0.026694045174537988,0.37873624308194975,1.0,33/87,24.03%,MECOM;KITLG;TEK;FLT1;CD34;TGFBR2;KDR;HIPK1;TGFB1;TGFB2;ZBTB16;NOTCH4;ATF4;FLT4;TAL1;TIRAP;INHBA;YTHDF2;GLRX5;CSF1R;CDK13;BMI1;L3MBTL1;RASGRP4;SNRK;ARMC6;ETV6;WNT10B;ZFPM1;PGM3;MKNK2;ASH2L;PLD4
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4993933262034194,-1.3811694885123769,0.09142857142857143,0.37970605451651657,1.0,7/20,13.36%,LPCAT3;MBTPS2;ACADL;ACADVL;APOE;ABCA2;FMO5
prerank,endocytic recycling (GO:0032456),-0.40135451403043965,-1.3811405914824886,0.06563706563706563,0.37899421481806733,1.0,30/50,39.44%,EHD4;VPS53;DENND1A;DENND1B;EHD2;LMTK2;RAB11B;RAB7A;RAB11FIP3;SNF8;EHD1;VPS29;EHD3;SNX3;CCDC22;ANKRD50;ARL4C;MICALL2;EPS15;VPS26C;ENTR1;SNX12;CMTM6;DENND1C;SNX27;WASHC1;SNX17;ANKRD27;RAB17;EIPR1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4383475374635724,1.3810170712689214,0.1115702479338843,0.5323027137504258,1.0,9/34,8.87%,LGR4;LYN;TICAM1;BPIFB1;SMPDL3B;CD300LF;LRRC14;NLRP2B;GPR108
prerank,positive regulation of phospholipase activity (GO:0010518),0.482934937633857,1.3803860074317624,0.0962800875273523,0.5319550614755416,1.0,6/22,2.26%,NTRK3;FGFR2;KIT;PLA2G5;PDGFRA;PDPK1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3847029177136211,-1.3800989501423793,0.043052837573385516,0.380466221608711,1.0,23/63,22.40%,RPL26;CRADD;CDKN1B;CNOT7;PRKDC;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;CCND1;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.564368779486228,-1.3800744322582064,0.11711711711711711,0.3797203066646387,1.0,3/12,4.03%,ESR1;NCOR1;TGFB1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2855527253497394,-1.3799719188865596,0.0,0.3791637657428393,1.0,142/532,18.78%,FN1;ADIPOR2;TMSB4X;B2M;LBP;ACKR3;RPS6KA5;PTPRJ;VIM;IL15;RAP1B;NOD1;PTK2B;LIFR;ACTN4;NFKBIA;TNFRSF11B;MAOA;F3;FOXO1;MAPK3;STX3;RAPGEF1;LAMA5;CAMK2D;FOXO3;S1PR1;IRAK2;HNRNPA2B1;ANXA1;CARD14;TRIM25;CD44;SOCS2;CDKN1B;MT2A;TGFB1;MID1;MAP3K3;MSN;ADAR;UBB;ANXA2;HSPA8;PPIA;LIMS1;INPP5D;ADIPOR1;UBC;RPS27A;IL1R1;IL33;CRK;VEGFA;STX1A;IKBKB;IFITM1;IFITM3;SHC1;PITPNA;PSMA6;MAP3K8;TNFRSF1B;RIPK1;IL20RB;TNFRSF11A;PSMB5;IFITM2;AKT1;BCL6;CCL15;TWIST1;IFNAR1;CSNK2B;IFIT1;FCER1G;TALDO1;JUNB;LRP8;HNRNPDL;GRB10;TOLLIP;PSMC4;CFL1;ABL2;PSMC5;IL17RE;PSMD14;YWHAZ;TRIM62;BCL2L1;COMMD7;POU2F1;FGF2;EDA2R;SYK;TRAF1;IL18BP;CSF1R;TNFRSF1A;AIM2;TRIM68;SMARCA4;SAMHD1;STAT5A;CISH;RBX1;JAK2;TRIM5;F13A1;PSMD8;GAB2;IRF9;PIK3CA;SMAD4;CLCF1;TNFSF13;NOD2;IL17RA;PTPN6;PSMD11;NDN;CDKN1A;OAS2;STAT1;PSMB4;PSMD12;PSMC1;HSP90AA1;TAB2;RELA;IFNGR1;JAK3;HCK;CUL1;CHUK;SLA;PELI1;HSPA9;IRF8;RSAD2;IRAK4
prerank,sulfur compound transport (GO:0072348),-0.45841513383795246,-1.3793310986414737,0.09981515711645102,0.37984502456046765,1.0,5/27,3.19%,ABCG2;SLC26A7;SLC6A6;LRRC8D;SLC5A6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.508345850361062,1.3784384811549932,0.1111111111111111,0.5350737622414159,1.0,3/19,5.08%,CAMK1D;DAPK2;IL4
prerank,regulation of organelle organization (GO:0033043),-0.3539202187492631,-1.3784334368775446,0.034220532319391636,0.3811528886886207,1.0,35/80,28.21%,CLIC4;F11R;MAPK3;PTK2;CAPN2;MSN;PDE2A;DIAPH1;EZR;CPLANE2;RHOT1;SPEF1;MIEF2;RHOT2;SURF4;MAVS;ARHGEF5;VPS11;MTM1;TBC1D25;ARMH3;EHD3;TMEM33;FIS1;PDCD10;STX5;CAMSAP3;GOLPH3;TJP1;PLXNB1;RDX;CAPN6;CENPV;MFF;MUL1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3109279151826401,-1.3776481447978062,0.013861386138613862,0.3821647731185582,1.0,65/234,17.33%,PRKCH;CAV1;SLCO3A1;RPS6KA5;ESR1;PLCG2;NOD1;NFKBIA;TFRC;MID2;FZD4;RPS3;IRAK2;CARD14;ZBTB7A;TRIM25;APP;SMO;UBB;PPARGC1B;PPIA;PRKCZ;PPARGC1A;UBC;RPS27A;VEGFA;IKBKB;PSMA6;RGCC;JUP;RIPK1;EDN1;MBTPS2;TNFRSF11A;HDAC4;AKT1;DHX9;FLOT1;TRIM14;DDRGK1;TIRAP;LRP8;STK36;CIB1;TRIM62;MAVS;TLR4;EDA2R;COPS5;TRAF1;AIM2;ARHGEF5;PHB2;TRIM68;SMARCA4;TRIM5;SRF;FLOT2;NOD2;CX3CR1;TCF3;HSPA1A;TAB2;RELA;KDM1A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.57664414792478,1.377582714177067,0.13815789473684212,0.5353984594311045,1.0,5/11,15.34%,NRP1;SIRT2;MST1R;BCAR1;PAK1
prerank,regulation of myotube differentiation (GO:0010830),-0.46472153487350243,-1.3767879391176838,0.0994263862332696,0.3832613976783087,1.0,7/24,8.40%,NOTCH1;CCN3;PIEZO1;HDAC9;ATP11A;HDAC4;MMP14
prerank,ceramide transport (GO:0035627),-0.5609154926341574,-1.376765477512431,0.10931899641577061,0.38254225334862896,1.0,7/12,24.77%,CERT1;PLTP;PSAP;ABCA2;GLTP;ABCA13;SGPP1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.42118207825014975,-1.3764570013584116,0.06851851851851852,0.3824619608239367,1.0,12/36,13.50%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;FZD3;NFATC1;WNT11;PPP3CB;GNB1
prerank,necroptotic process (GO:0070266),-0.5219721695048896,-1.3763564891927298,0.10986964618249534,0.38195658338984867,1.0,7/16,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.46218632298528106,-1.3755971564957243,0.08795411089866156,0.3829496152780252,1.0,4/25,1.79%,B2M;PLCG2;CD55;SLC7A5
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5505115161084514,-1.375465692551622,0.10036496350364964,0.3825031777610583,1.0,5/13,14.67%,CAV1;TMEM259;RNF185;BCAP31;SGTA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.48501093573725296,-1.3754071887132446,0.09107806691449814,0.3818321088460116,1.0,5/20,4.11%,ANO6;ENTPD1;NT5E;HSP90AB1;APP
prerank,cellular response to chemokine (GO:1990869),-0.39984076946220104,-1.37530754008258,0.056074766355140186,0.3813274650897921,1.0,5/46,2.77%,SLC12A2;ACKR3;PTK2B;LRCH1;WNK1
prerank,endocardial cushion development (GO:0003197),-0.4793276908088353,-1.3752927858117234,0.06805293005671077,0.380594725584956,1.0,10/21,14.52%,NOS3;NOTCH1;BMPR2;TGFB2;TBX2;HEYL;CRELD1;ACVR1;ENG;HEY1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.370762653371154,-1.375058131317571,0.04038461538461539,0.38042530996159074,1.0,36/70,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;FCER1G;PSMC4;PSMC5;PSMD14;LNPEP;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,negative regulation of cell development (GO:0010721),0.476677002906284,1.3750521895310264,0.09090909090909091,0.5401328488702168,1.0,2/25,0.45%,IGF1;FBN1
prerank,sister chromatid segregation (GO:0000819),-0.43976732065359714,-1.3750519119261844,0.0622568093385214,0.3796812709235234,1.0,15/31,32.82%,SMC4;ZW10;RB1;TOP2A;KIF18A;KNSTRN;KIF18B;NSL1;NDC80;CDCA8;SGO1;TOP2B;TUBG2;PLK1;ESPL1
prerank,lipid oxidation (GO:0034440),-0.5600403875041953,-1.3748694678130489,0.10943396226415095,0.379342800560112,1.0,3/12,5.35%,ADIPOR2;PPARGC1A;ADIPOR1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.496029885144698,1.374828530438638,0.11428571428571428,0.5387035490103133,1.0,3/19,11.12%,IGF1;RTN4;CHRNA7
prerank,mammary gland development (GO:0030879),0.48849951148721493,1.374729921830737,0.09913793103448276,0.5370058917780048,1.0,4/21,2.15%,WNT4;TBX3;NRG1;GLI2
prerank,regulation of microtubule depolymerization (GO:0031114),-0.44859109865133207,-1.3747115383665256,0.09695817490494296,0.3789326288411375,1.0,11/25,22.33%,STMN2;SPEF1;TRPV4;CIB1;KATNB1;MAP1B;ARHGEF2;TPX2;MAP1A;APC2;CAMSAP3
prerank,regulation of leukocyte migration (GO:0002685),-0.5206512212292553,-1.374689371664066,0.08424908424908426,0.3782096797845625,1.0,4/16,5.68%,ANXA1;RAC1;CD81;VEGFA
prerank,response to amyloid-beta (GO:1904645),0.4166519174645672,1.374634016915366,0.08977035490605428,0.5352651802889098,1.0,10/44,13.96%,IGF1;LRP1;GJA1;CACNA2D1;CALCR;CACNB1;CHRNA7;NGFR;ATP1A3;GRIN2A
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5718619630170299,1.3745065675418267,0.14558472553699284,0.5336326426505654,1.0,3/13,2.89%,PLXNA2;NRP1;SEMA3A
prerank,negative regulation of macrophage activation (GO:0043031),0.5285879099408926,1.3740775527113143,0.12526096033402923,0.5328243767133287,1.0,2/16,5.08%,IL31RA;IL4
prerank,negative regulation of innate immune response (GO:0045824),-0.4212346904183205,-1.373955480892584,0.07240704500978473,0.37916085901076835,1.0,21/34,40.05%,NLRC5;RPS19;CNOT7;DHX58;YTHDF2;USP15;SAMHD1;TNFAIP3;TTLL12;FAM3A;PTPN2;MUL1;A2M;YTHDF3;NLRC3;LYAR;USP18;GRN;SUSD4;OAS3;CACTIN
prerank,regulation of neuroinflammatory response (GO:0150077),0.5122640320634381,1.3732619924624265,0.09482758620689655,0.5331978543941905,1.0,3/19,8.31%,IGF1;IL4;IL18
prerank,negative regulation of metabolic process (GO:0009892),0.4058537519124039,1.3732279345579825,0.07399103139013453,0.5313776314295446,1.0,12/54,9.61%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;GSTP1;PLCL2;ACOT11;DOCK7;RBPJ;HOXC10
prerank,dendritic cell differentiation (GO:0097028),0.485942010263306,1.3731938988801597,0.1154639175257732,0.5295524064355922,1.0,5/22,5.75%,PRTN3;LYN;IL4;CAMK4;AXL
prerank,bone development (GO:0060348),0.4312282097638772,1.371361696850181,0.06924643584521385,0.5323686278432114,1.0,7/39,3.83%,NOTUM;FGFR2;SULF1;SULF2;GJA1;RANBP3L;SH3PXD2B
prerank,cAMP-mediated signaling (GO:0019933),0.47315724288661826,1.3711042836651723,0.10786516853932585,0.5310707228471793,1.0,4/24,1.87%,ADCY2;ADCY1;KSR1;PDE7B
prerank,positive regulation of apoptotic process (GO:0043065),-0.2971784038100862,-1.3709173776613166,0.006521739130434782,0.38503265137154413,1.0,81/293,18.67%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;RACK1;UNC13B;TGM2;RASGRF2;ARL6IP5;FOXO1;FAP;FOXO3;RPS3;TPD52L1;DAB2IP;SLIT2;NGF;MAP3K20;CRADD;CTNNBL1;REST;TGFB2;TRIO;UBB;HTT;CYP1B1;TNFSF10;ING5;IGFBP3;UBC;RPS27A;SOS2;BACE1;HIP1R;TNFAIP8;ATF4;TGFB3;RASSF2;CASP8;RIPK1;BAX;CTSD;BCL6;MAP3K11;PSENEN;ITSN1;DNAJA1;FAS;ATG7;HSPD1;RHOB;PREX1;NF1;GADD45G;ABR;E2F1;SOX4;BAK1;RNPS1;SPHK2;RPS6;RPS6KA2;ARHGEF5;ARHGEF18;APH1A;BNIP3L;TOP2A;PHLDA3;PDCD2;DDX20;BAD;CCAR2;FOXL2;ARHGEF12;CALHM2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.37106082719734385,-1.3708821126402515,0.045889101338432124,0.38434947880665243,1.0,27/73,23.10%,KITLG;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PDCD2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.4920285681838153,-1.3708676383069291,0.10564663023679417,0.3836170188583171,1.0,10/20,24.81%,HSP90AB1;HSPD1;HSPA4;CCT2;HSP90AA1;HSPA1A;PTGES3L;PFDN6;PSMG2;MKKS
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.39500707889433434,-1.370379079398371,0.07421875,0.3840221535431347,1.0,20/54,22.40%,RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3
prerank,positive regulation of macrophage activation (GO:0043032),-0.5036725203707196,-1.370029893404422,0.10200364298724955,0.3840632122487489,1.0,5/17,12.43%,LBP;THBS1;IL33;HSPD1;TLR4
prerank,potassium ion transport (GO:0006813),0.3477464727777176,1.3699925871565193,0.039014373716632446,0.5320556717469365,1.0,34/120,20.15%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNMA1;KCNK10;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;SLC9A9;KCNH4
prerank,positive regulation of neuron projection development (GO:0010976),0.36707149710881637,1.3693359267152316,0.044715447154471545,0.5318919041671397,1.0,25/85,14.65%,CAMK1D;PTN;NTRK3;BMP5;TENM3;MAGI2;PTK7;EPHA3;RIT2;GPC2;LYN;NPTN;CAMK2B;DPYSL3;LRRC7;CUX2;ALK;PRKCI;FUT9;PLXNB2;CBFA2T2;ROR1;EP300;CAPRIN2;PLPPR5
prerank,ureteric bud morphogenesis (GO:0060675),0.5306878404332384,1.3692621561152485,0.11958762886597939,0.5302134706014748,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3767660955138513,-1.3690326524038496,0.0697211155378486,0.38556466696089714,1.0,12/62,11.27%,MEF2C;CDK6;THBS1;TNRC6C;PTK2B;KMT2C;RBBP5;ZBTB16;CBFB;MYL9;H3-3A;KMT2D
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.516486504882538,1.3689985323208382,0.11724137931034483,0.5290098704528233,1.0,3/16,2.65%,IGF1;ROCK2;PRKCA
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.594728368037557,-1.3689732853471979,0.10701754385964912,0.38493424371148743,1.0,2/10,4.91%,WNK1;ADAM10
prerank,endocardial cushion morphogenesis (GO:0003203),-0.49104824413007714,-1.3686649284332537,0.10313075506445672,0.3849755146724061,1.0,9/18,14.52%,NOS3;NOTCH1;TGFBR2;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1
prerank,atrial septum morphogenesis (GO:0060413),-0.5832709565898984,-1.3685491201606979,0.10971223021582734,0.3844760338786507,1.0,4/10,12.54%,BMPR2;TGFB2;ACVR1;SOX4
prerank,artery development (GO:0060840),0.4810883605464289,1.3681263011647429,0.11061946902654868,0.5295830693621882,1.0,4/23,2.13%,ROBO1;NRP1;ROBO2;EFEMP2
prerank,regulation of protein binding (GO:0043393),-0.33595500975290987,-1.36806878830059,0.033073929961089495,0.38475882213479734,1.0,27/114,11.06%,CAV1;ACTB;CLDN5;B2M;RACK1;RPL11;APP;FKBP1A;CTSZ;RALB;PKD1;CRK;HIP1R;IDE;NMD3;NES;HDAC4;BAX;AKT1;DISC1;PRMT8;ADD1;FLOT1;IFIT1;CTNNBIP1;CAMK1;GAS8
prerank,regulation of receptor binding (GO:1900120),0.5751580678074448,1.3680347723938369,0.14502164502164502,0.5279511216270028,1.0,2/10,3.83%,GREM2;ATP2A2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5971494187735855,1.3679741791641062,0.11740041928721175,0.5262513471142373,1.0,6/10,21.66%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2;GABRB2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.501474107327406,1.3678568452459037,0.11496746203904555,0.5247448707758688,1.0,8/21,17.48%,EPHA7;NLRP12;SOX2;NGFR;BIRC2;DELE1;PSMB9;GRIN2B
prerank,myelination in peripheral nervous system (GO:0022011),-0.5553684893440471,-1.3666790403252664,0.10714285714285714,0.38729459024100543,1.0,8/13,29.51%,ADGRG6;PARD3;MYOC;NF1;SKI;SOD1;CNTNAP1;LGI4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5168629301786998,-1.365712229077111,0.11290322580645161,0.38871897777613773,1.0,13/16,45.09%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.4373352978146075,-1.3651777836756254,0.09363295880149813,0.38923571729849843,1.0,15/29,30.24%,DCUN1D5;SMAD7;DCUN1D1;BAG5;FEM1A;LIMK1;BMI1;PIN1;TRIB3;DTX3L;DCUN1D3;PARK7;MAGEC2;RPS2;PLK1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4611761906271965,-1.3641865428436057,0.09981515711645102,0.3907636643382835,1.0,10/25,23.23%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PGAM1;PFKL;ENO1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4022790209229718,-1.3638280974293886,0.080078125,0.3908284514045666,1.0,13/43,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ACVR1;HES1;ENG;SRF
prerank,response to iron ion (GO:0010039),0.5566397561731702,1.3635567669280173,0.14375,0.5344572241988377,1.0,2/12,3.67%,BMP6;BCL2
prerank,protein catabolic process (GO:0030163),-0.3804414537596357,-1.3635330457700754,0.05283757338551859,0.39076076583332076,1.0,30/59,33.91%,MANBA;TPP1;DAB2IP;RNF41;HSPA8;FBXO17;IDE;RIPK1;DENND3;CTSD;UBE2G2;VCP;APOE;RNF5;UBE2G1;UCHL3;HSP90AA1;OGA;USE1;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;PMAIP1;CAPN3;PRPF19;PSMA8;TRIM24;HTRA2
prerank,regulation of cell migration (GO:0030334),-0.2923339885069665,-1.3629771784525198,0.0043859649122807015,0.39119482165663905,1.0,95/382,14.97%,LEF1;PECAM1;PODXL;CAV1;TMSB4X;FLT1;FRMD5;IGF1R;ITGA6;CLDN5;DACH1;SEMA6A;CLIC4;SEMA3C;CDH1;THBS1;PTPRJ;NOTCH1;ACTG1;SEMA7A;FGF1;RACK1;PTK2B;LIMCH1;ACTN4;KDR;F3;PTK2;CYRIB;FOXO3;ANXA1;FERMT2;SMAD7;SLIT2;IGFBP5;ADAM15;TGFB1;RNF41;PLXNA4;SMO;RAC1;ADAM10;ROBO4;PRR5L;CYP1B1;NEDD9;CD151;MINK1;AMOT;VEGFA;IFITM1;SH3RF2;MYOC;SPATA13;ABI3;PPM1F;EDN1;MMP14;AKT1;ELP6;INSR;PDGFC;PDGFA;TMSB10;LAMC2;ZMYND8;VCL;FAM107A;SEMA3G;DDRGK1;RHOB;WNT11;PLXNA1;PLXND1;CD74;HSPA5;NF1;ULK4;CIB1;DUSP3;ACVR1;RCC2;SRCIN1;FGF2;CSF1R;ENG;PIK3R3;HRAS;ACE;RNF20;SDCBP;SPAG9;EGFR;OSGIN1;LDB1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3273627186296555,-1.362845888958843,0.024439918533604887,0.3907425227847873,1.0,55/145,25.79%,RAB11A;DCTN2;FHL1;TUBA1A;CEP164;PPP2R1A;BRD4;PRKAR2B;CEP192;CEP57;PSMA6;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;CDK4;PSMC5;PCM1;TUBB4B;PSMD14;RCC2;AVEN;FBXL7;HAUS1;NDE1;RBX1;PSMD8;CETN2;CEP72;YWHAG;PSMD11;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;CUL1;CCND1;TPX2;PSMA1;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;DTL;PSMA2;PSMB8;HAUS4;YWHAE;CEP63;NEDD1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4836483334715085,-1.362207480266681,0.11275415896487985,0.3913633809137307,1.0,11/22,20.88%,SEL1L;UBB;EDEM3;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.45995001000145097,-1.362061742033852,0.07572815533980583,0.3909103025193949,1.0,11/25,29.01%,RIN3;APP;RAC1;ANKRD13A;ABCA2;SDCBP;NEU3;ITGB3;APOC1;MTMR2;UBQLN2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3794854482092538,-1.361271514399838,0.06031128404669261,0.39195409501747674,1.0,19/59,19.19%,NFKBIA;IRAK2;DAB2IP;UBB;REL;UBC;RPS27A;IKBKB;TLR3;RIPK1;FAIM;AKT1;RELB;TLR4;TNFRSF1A;TAB2;RELA;CHUK;NKIRAS2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.44216075406191624,-1.3609208598150808,0.09836065573770492,0.39199178692881437,1.0,12/29,24.44%,RPS16;RPS14;NOP14;RPS21;RPS8;RPS19;DHX37;UTP4;PWP2;TBL3;ABT1;TSR1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4567540660355422,-1.3603831342709707,0.0916030534351145,0.39174120213036917,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4567540660355422,-1.3603831342709707,0.0916030534351145,0.39174120213036917,1.0,15/23,28.98%,PPP1R13B;PPP3CC;CASP8;BBC3;YWHAZ;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;NMT1;PMAIP1;YWHAQ
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3288451829486826,1.3603830198195437,0.04206500956022945,0.5410482665304114,1.0,31/150,9.82%,TCF7L2;PIK3R1;AREG;FGFR2;SEMA5A;NRG1;KL;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5291721169931045,-1.3602784956018326,0.10497237569060773,0.3912115510223257,1.0,3/14,7.21%,ANO6;THBS1;RGCC
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3963699309331575,-1.3602766396531394,0.05835010060362173,0.390474182738249,1.0,18/47,16.62%,IGF1R;ARL6IP5;FOXO1;MAPK3;DAB2IP;TGFB2;MID1;PPIA;TAOK3;STK25;FAS;TAOK2;ULK4;COPS5;EGFR;NOD2;GREM1;IGBP1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4513620207147998,-1.3601002246279201,0.11401869158878504,0.39017766666540854,1.0,10/24,24.95%,MTR;TXN2;CDO1;MSRA;SMS;CTH;ADI1;GCLC;AHCY;MTRR
prerank,negative regulation of cell adhesion (GO:0007162),-0.3706005863012947,-1.3594887608328343,0.052104208416833664,0.39089891518793396,1.0,19/72,10.56%,PODXL;ACER2;SEMA6A;CDH1;NOTCH1;PTK2;FZD4;TGFB1;JAM3;PLXNA4;ARHGDIA;ADAM10;CYP1B1;ARHGDIB;TGFBI;FZD7;SIPA1;PLXNA1;PLXND1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5283906391746948,-1.3594147897292204,0.12724014336917563,0.3903361320760393,1.0,6/14,9.62%,MEF2C;PRKG1;SLIT2;IGFBP5;IGFBP3;TRIB1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4440190370483869,-1.3590872765704605,0.0842911877394636,0.39036985633524457,1.0,11/26,19.97%,EEF1A1;IQGAP1;DAB2IP;PDE8A;DUSP3;PTPN12;EGFR;ERBB2;ZPR1;SOX9;KNSTRN
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.548009925395311,1.3589880454403007,0.15,0.5428593565278956,1.0,3/12,4.13%,IL34;OCSTAMP;LYN
prerank,cellular response to BMP stimulus (GO:0071773),0.372839108024245,1.358927787121196,0.06823027718550106,0.5411519089439043,1.0,7/66,4.24%,BMP6;TGFBR3;ADAMTS12;BMP2;BMP5;SMAD3;SFRP1
prerank,cardiac muscle contraction (GO:0060048),0.4239236320102981,1.3585187702050094,0.09649122807017543,0.5403735508735047,1.0,6/34,4.22%,ATP1A2;SLC8A1;SCN3B;TNNC1;CSRP3;TNNI3
prerank,negative regulation of immune effector process (GO:0002698),-0.5350771310490392,-1.358378780503287,0.10654205607476636,0.39132229254839734,1.0,3/13,7.75%,CD55;RPS19;RC3H1
prerank,positive regulation of synaptic transmission (GO:0050806),0.3712643171113435,1.3580153742139813,0.06694560669456066,0.5398613182851126,1.0,20/72,13.96%,ADCY1;NRXN1;CLSTN2;RIMS1;MPP2;GRIK2;NPTN;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;STX1B;SLC24A2;ADCY8;BAIAP3;CHRNA7;ZDHHC2;DLG4;GRIN2A
prerank,collagen fibril organization (GO:0030199),0.36071483268692495,1.3579417744174347,0.058091286307053944,0.5382072901209904,1.0,21/88,11.06%,COL4A6;COL4A5;COL13A1;DDR2;COL1A2;COL22A1;DPT;COL4A4;COL16A1;LUM;COL4A3;COL10A1;COL8A2;P4HA2;LOXL2;LOXL3;TGFBR1;COL20A1;COL26A1;COL9A2;COL6A3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.45763611667685167,-1.3578377727939792,0.1001890359168242,0.39197828818100067,1.0,5/24,2.97%,MEF2C;CDON;CTNNA1;MEF2A;BOC
prerank,neutrophil activation (GO:0042119),-0.5540958886344174,-1.357655130931342,0.10909090909090909,0.39162893959388895,1.0,4/12,12.88%,IL15;FCER1G;PREX1;SYK
prerank,bicarbonate transport (GO:0015701),-0.4561671333865367,-1.3564186495907558,0.12015503875968993,0.3937387375054155,1.0,7/25,12.98%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC4A2;CYB5R1
prerank,positive regulation of telomerase activity (GO:0051973),-0.4252091769905519,-1.3561686704983134,0.08614232209737828,0.3935659901497028,1.0,10/33,16.67%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5213547755377121,-1.3560141294976507,0.11171171171171171,0.3931795672678135,1.0,6/15,14.95%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCNJ8;KCND3
prerank,positive regulation of neuron migration (GO:2001224),-0.5628010395791809,-1.355481591686965,0.137291280148423,0.39374344683751566,1.0,8/11,24.50%,SEMA6A;DAB2IP;SHTN1;PLAA;ARHGEF2;NIPBL;RAPGEF2;NSMF
prerank,positive regulation of growth (GO:0045927),-0.3762743986932592,-1.3554742287957804,0.06640625,0.393049465715694,1.0,28/64,25.08%,RPS6KA3;TGFB2;ADAM10;MFSD2A;PPM1F;PABIR1;MMP14;AKT1;INSR;H3-3A;AKAP6;CIB1;FXN;CDKN2AIP;SDCBP;EGFR;ERBB2;CSNK2A1;DERL2;SLC25A33;ZPR1;BRAT1;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;RPTOR
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5226837334720014,1.3554592874612768,0.12291666666666666,0.5428834670009709,1.0,4/15,9.25%,HECW2;ANAPC1;CDC23;CDC16
prerank,response to interferon-beta (GO:0035456),-0.4714156488630027,-1.3548743402112053,0.12429378531073447,0.3937929818436012,1.0,7/22,16.32%,IFITM1;IFITM3;IFITM2;NDUFA13;UBE2G2;AIM2;STAT1
prerank,mitochondrial fission (GO:0000266),-0.5159259703377133,-1.3548224811340424,0.09505703422053231,0.3931857181749425,1.0,10/16,28.21%,DNM3;MIEF1;MTFR1;OPA1;DNM1;DNM2;FIS1;MTFR2;MFF;MUL1
prerank,regulation of JUN kinase activity (GO:0043506),-0.4278582672483334,-1.354667488542041,0.07846715328467153,0.39284559485426496,1.0,9/33,8.98%,MAP3K5;RPS3;DAB2IP;TAOK3;AIDA;EDN1;TNFRSF11A;MAP3K11;DNAJA1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5074183827925609,1.3535030676434376,0.1456953642384106,0.5462230467674981,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5178157733988452,-1.3533950836557194,0.13924050632911392,0.39508378189399346,1.0,7/15,15.81%,TMSB4X;THBS1;NOTCH1;FGF1;HSPB1;FGF2;MET
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3893060965122135,1.353313437978309,0.06485355648535565,0.5448074243768011,1.0,12/57,12.14%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4546983558505957,-1.3531879870418098,0.09242144177449169,0.39476028081074094,1.0,12/26,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RNF111;RBX1;CETN2;GTF2H4;ERCC4
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3377344858711946,-1.3525331990857261,0.03288201160541586,0.39554196396866215,1.0,34/104,19.47%,CRIM1;CAV1;BMPER;NOTCH1;TGFBR2;BMPR2;CCN3;SMAD9;SMAD7;ZBTB7A;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;ASPN;IL17RD;HTRA3;HTRA4;SKIL;ACVR1;SMURF1;EID2;SMAD4;GREM1;HSPA1A;SMAD2;SPRY1;SKI;BMPR1B;PIN1
prerank,bile acid and bile salt transport (GO:0015721),-0.45143859142787457,-1.3513513037867926,0.11091234347048301,0.3975083520353706,1.0,4/24,1.27%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4266498811136386,1.351336100111825,0.09406952965235174,0.5482363776289063,1.0,6/36,7.92%,EPHA7;ENPP1;ERRFI1;RAP2A;NLRP12;PDGFD
prerank,glycolipid metabolic process (GO:0006664),-0.3949099690606117,-1.3513329680467663,0.0945179584120983,0.3968301255879591,1.0,25/47,32.56%,ST3GAL6;ST3GAL4;ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;ST8SIA6;ABCA2;SUMF1;ESYT3;NEU3;PIGW;SCCPDH;GLTP;SMPD1;NEU1;NEU2;NAGA;B4GALNT1;ARSA;SMPD2;FUCA1;ST3GAL2;HEXB
prerank,modified amino acid transport (GO:0072337),0.5152779059287383,1.3511106846081014,0.14412416851441243,0.546977949206054,1.0,5/15,11.57%,SLC16A12;SLC6A13;SLC7A9;CTNS;SLC46A1
prerank,positive regulation of cell differentiation (GO:0045597),0.31068776151113603,1.3509189974504505,0.022684310018903593,0.545680359154868,1.0,36/237,9.73%,IGF1;BMP6;TCF4;WNT4;NELL1;BMP2;AR;PTN;FBN2;DDR2;RIN2;ZEB1;GJA1;GDNF;PLA2G5;SMAD3;CCN4;RANBP3L;CTNNA2;SFRP1;SP7;OLFM1;CEBPB;AXIN2;BRINP1;BRINP3;MEDAG;LOXL2;RRAS;TGFBR1;NRCAM;IL18;SMYD1;BMPR1A;SOX5;KCTD11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.38968250409882427,-1.3496709375280849,0.0841300191204589,0.3999161932386477,1.0,18/48,20.47%,HIPK1;FNIP2;CRIP1;PRKDC;TNFRSF1B;BAX;DYRK2;RPS27L;BCL2L1;E2F1;BAK1;TMEM109;AEN;EPHA2;PHLDA3;DDIT4;MCL1;SFN
prerank,amino acid transport (GO:0006865),0.40189428717855463,1.3496003186460896,0.09438202247191012,0.5471892358351311,1.0,11/49,11.87%,SLC7A11;SLC6A12;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A47;SLC1A5;SLC38A3;SLC38A9
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5416439019329244,-1.3492513834480129,0.12743362831858407,0.40013485092662815,1.0,8/13,24.02%,NFKBIA;PKD1;DBN1;MDFI;KEAP1;PKD2;NFKBIE;YWHAB
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5632366942122708,-1.3492117293718162,0.11942959001782531,0.39948870390020036,1.0,8/11,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.47379021094400253,-1.3491783525619734,0.125,0.3988386890759707,1.0,10/19,15.00%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL;SMAD6;ACVR1;SOX4;HEY1;SMAD4
prerank,organelle fusion (GO:0048284),-0.47934620447990206,-1.34881617181411,0.10036496350364964,0.39893217361883926,1.0,15/22,41.33%,EEA1;MIEF1;BAX;CHCHD3;MIEF2;VPS11;OPA1;FIS1;STX4;MFF;THG1L;MIGA1;CYP26C1;GDAP1;MFN1
prerank,mitochondrion organization (GO:0007005),-0.3140615588340067,-1.3483142856981891,0.014373716632443531,0.39939007801560317,1.0,51/165,20.82%,DNM3;CXADR;NOS3;VPS13D;TRAK1;CAV2;MEF2A;ATP5F1D;PPARGC1A;MIEF1;TMEM70;CHCHD2;ATP5F1B;HCFC1;TRAK2;BAX;CHCHD3;RHOT1;IMMP2L;ESRRA;HSPD1;MIEF2;GABPA;RHOT2;TIMM17A;BCL2L1;AGTPBP1;MTFR1;HIGD2A;TOMM22;CHCHD4;PHB2;BCAP31;BNIP3L;MTM1;CHCHD10;NIPSNAP2;ADCK1;OPA1;TIMM13;DNM1;HSD17B10;SLC25A33;RAB32;BIK;PTCD2;HIGD1A;DNM2;TOMM5;HIGD1B;TIMM50
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.49478121772412914,1.347789705140602,0.1324200913242009,0.5501615824319752,1.0,3/20,1.32%,WNT4;BMP2;BMP5
prerank,negative regulation of blood pressure (GO:0045776),-0.5334428712819391,-1.3476474205633782,0.11786372007366483,0.40012609626241796,1.0,8/13,33.71%,NOS3;BMPR2;PRCP;GPR37L1;SCPEP1;APLN;NOS2;NOS1
prerank,heart development (GO:0007507),-0.31762858734389576,-1.3475955654412175,0.016359918200409,0.39951040567179863,1.0,30/150,5.81%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;GPC3;NOTCH1;TGFBR2;BMPR2;MEF2A;RAMP2;PTK2;TBX1;COL3A1;SOX17;CDKN1B;PDLIM1;TGFB1;RBM20;TGFB2;FKBP1A;TBX2;CRIP1;HDAC9;NDUFV2;STRA6;PKD1;VEGFA;MICAL2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.582308397386333,1.3475557993327119,0.14672686230248308,0.5489550117042659,1.0,2/10,2.64%,ABCA1;PRKACA
prerank,negative regulation of chemotaxis (GO:0050922),0.4386575609142208,1.3473968305186266,0.11496746203904555,0.5475078404854224,1.0,6/31,4.77%,ROBO1;ROBO2;ANGPT2;SEMA5A;SEMA3A;SEMA3D
prerank,epithelial to mesenchymal transition (GO:0001837),0.4046945543441804,1.3469780724974902,0.08281573498964803,0.546739107050014,1.0,11/47,8.08%,TGFBR3;WNT4;BMP2;TBX3;ROCK2;OLFM1;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,regulation of lymphocyte migration (GO:2000401),-0.5726625759919738,-1.3468837208383464,0.11091549295774648,0.4004054959737467,1.0,5/10,14.29%,JAM2;STK10;MSN;AKT1;WASL
prerank,organelle fission (GO:0048285),-0.4562601514613357,-1.3467738027005012,0.10246679316888045,0.39995723652780646,1.0,15/24,28.21%,DNM3;MIEF1;MTFR1;WASHC5;ACOT8;OPA1;DNM1;DNM2;FIS1;MTFR2;PEX11G;PEX11A;SEC16B;MFF;MUL1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3457170875180745,1.3467713240487538,0.054878048780487805,0.5454595952921205,1.0,18/116,11.33%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R;ADCY8;HTR4;PTGIR
prerank,positive regulation of defense response (GO:0031349),-0.34415357207159375,-1.3465590005205128,0.04734848484848485,0.3997148152844855,1.0,21/89,18.87%,MEF2C;IL15;NFKBIA;ETS1;GBP5;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;AKIRIN2;IL17RA;SLC15A4;NINJ1;PTGER4
prerank,insulin receptor signaling pathway (GO:0008286),-0.36575184424060986,-1.3462966133732186,0.06274509803921569,0.3996404343257243,1.0,22/69,16.30%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;ATP6V0B;ATP6V0A2;SHC1;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;GRB10;FOXC2;PIK3R3;PIK3CA;ATP6V1G1;BCAR3;PIK3R2
prerank,regulation of neuron projection development (GO:0010975),0.32243973493102407,1.3461178870511135,0.02443609022556391,0.5453178992349372,1.0,39/163,14.65%,CAMK1D;PTN;LPAR1;NTRK3;LRRC4C;CSMD3;TENM3;MAGI2;PTK7;KIF13B;EPHA3;SEMA3A;RIT2;CTNNA2;GPC2;LYN;NPTN;RAB29;IL1RAPL1;CAMK2B;DPYSL3;STX1B;LRRC7;CDK5R1;DCC;PRKCI;FUT9;PTEN;PLXNB2;BRSK1;FBXO7;KIF1A;CBFA2T2;ROR1;FRMD7;EP300;PPFIA2;PDLIM5;PLPPR5
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.33493175522980684,-1.3458928339181502,0.032719836400818,0.399824776343169,1.0,28/112,17.36%,FOXP1;LBP;THBS1;PTPRJ;CD34;PLCG2;IFIH1;APP;IL33;RARA;TLR3;HSPB1;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SPHK2;SYK;JAK2;NOD2;PTPN6;TNFAIP3;CX3CR1;OAS2;IFNGR1;VSIR
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.40938416869221556,-1.3457145808758826,0.07909604519774012,0.3995412208551835,1.0,20/40,28.58%,PTK2B;PTK2;RPL11;RPL23;FOXF2;RPS7;SMURF1;SGTA;CSNK2A1;CSNK2A2;UFL1;CDK5RAP3;LAPTM5;CCDC22;RPL5;UBE3A;RAD23A;TRIM39;RAD23B;XPO1
prerank,regulation of neuron differentiation (GO:0045664),0.3651816450066253,1.344058470710836,0.0783132530120482,0.5488597425278752,1.0,16/76,10.12%,TCF4;BMP2;ZEB1;CNTN4;BRINP1;NREP;HES3;BRINP3;DTX1;NLGN1;SOX2;NRCAM;HES5;CDK5R1;KCTD11;ALK
prerank,regulation of sensory perception of pain (GO:0051930),-0.5653924638595941,-1.343777422507957,0.1252336448598131,0.4031806059793519,1.0,6/11,25.04%,CCN3;MGLL;ZFHX2;TMEM100;SPX;ATPSCKMT
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.4731919927447726,-1.3434524389707685,0.11171171171171171,0.4032301725831892,1.0,10/20,29.73%,GATM;PLOD2;GCLM;CNDP2;GCLC;GGT1;GGCT;MTHFS;SLC27A1;MGST2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.48963202095045716,1.3431542416912439,0.13551401869158877,0.5494143457314798,1.0,5/19,7.88%,ENPP1;TPST1;SLC26A1;SULT6B1;PAPSS1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5452606913441589,1.3415221655390657,0.15560640732265446,0.5518502676783656,1.0,6/12,23.13%,MCM3;GINS2;MCM2;CDC7;MCMDC2;MCM7
prerank,defense response to symbiont (GO:0140546),-0.3452720035268836,-1.3414250623922013,0.0547945205479452,0.4072866560944698,1.0,26/92,18.62%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;IFIT1;ATG7;TRIM56;TTC4;BCL2L1;MAVS;SAMHD1;BNIP3L;TRIM5;OAS2;MLKL;STAT1;DDIT4;RELA;CGAS;RSAD2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.538516509630581,1.3411097953280464,0.13270142180094788,0.5511552906961837,1.0,4/13,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,protein phosphorylation (GO:0006468),-0.27954801122608547,-1.3405299483115611,0.00211864406779661,0.4086500448237796,1.0,121/479,16.04%,PRKCH;TEK;ERG;FLT1;IGF1R;CDK6;MAP3K5;RPS6KA5;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;KDR;HIPK1;NLK;MAPK3;WNK1;PTK2;STK10;BMX;NEK7;RPS6KA3;CAMK2D;DAB2IP;SMAD7;MAP3K1;RICTOR;MAP3K20;FNIP2;TGFB1;MAPKAPK3;APP;TGFB2;FAM20A;MAP3K3;CSNK1G2;ADAM10;PRKCZ;PKD1;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;ABI3;BCR;TLR3;CSNK1G3;SRPK1;RIPK1;TRIB2;FLT4;STK25;PLK2;DYRK2;AKT1;INSR;GTF2H3;MAP3K11;CDC42BPB;VRK3;TRIB1;CSNK2B;STK32B;PIM3;LMTK2;WNT11;CAMK1;CDK4;ABL2;TAOK2;ULK3;RPS6KB2;FRK;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;TLR4;SYK;CSF1R;FASTK;USP15;RPS6KA2;CDKL4;ABI1;TBCK;NUAK1;CAD;NUAK2;MAST4;JAK2;EGFR;UHMK1;ERBB2;PRKAG1;COQ8A;LMTK3;LIMK1;CAB39;NEK3;PTPN6;STK38L;STK26;CDK13;CSNK2A1;CSNK2A2
prerank,regulation of chemokine production (GO:0032642),-0.41545302700243236,-1.3403240849167979,0.10150375939849623,0.4084138561867303,1.0,12/36,25.40%,FOXP1;APP;IL33;TLR3;CD74;TLR4;CSF1R;SIGIRR;LGALS9;AIF1;SNAI2;TREM2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4352913169171913,1.3401558121222366,0.11036036036036036,0.5519958400526912,1.0,4/34,2.77%,RORA;ENPP1;RUNX1T1;SMAD3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.336660115647767,-1.3393052494316857,0.05162523900573614,0.40998353888703926,1.0,48/96,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,positive regulation of catalytic activity (GO:0043085),-0.40868190236788693,-1.3392488976183006,0.09770114942528736,0.40938867510344173,1.0,11/37,15.49%,CAV1;MAPK3;BCAS3;PSENEN;PHACTR4;ABL2;CIB1;FXN;APH1A;CHTOP;NOD2
prerank,T cell homeostasis (GO:0043029),-0.5746314418609039,-1.338471554884649,0.13221601489757914,0.4104704259590972,1.0,5/10,17.47%,AKT1;FAS;ZC3H8;PPP2R3C;JAK3
prerank,plasma membrane repair (GO:0001778),-0.5320328267711479,-1.3382283936876864,0.12162162162162163,0.4103186861148454,1.0,8/13,31.52%,AHNAK2;MYOF;DYSF;ARL8B;MYH9;SMPD1;SYT7;RAB3A
prerank,embryonic skeletal system development (GO:0048706),0.429539330237632,1.337607231781117,0.09437751004016064,0.5571653739886395,1.0,8/35,11.03%,SULF1;SULF2;HOXC4;PDGFRA;HOXB3;HOXC9;HOXB9;FUZ
prerank,cardiac conduction system development (GO:0003161),0.465904707329383,1.3375621321434656,0.14012738853503184,0.5555350140807975,1.0,6/24,12.23%,GJB6;GJA1;TBX18;CACNA1G;BMPR1A;MAML1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4787236590709633,1.3373318230145783,0.14814814814814814,0.5544160732017598,1.0,6/20,10.59%,GRK3;CRY1;GPRASP1;BICD1;MGRN1;APLP1
prerank,mitochondrion morphogenesis (GO:0070584),0.5595271819673202,1.337274222768538,0.18202764976958524,0.552778226554995,1.0,3/11,10.46%,PID1;NUBPL;PNPT1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5180642164696403,-1.3363070824292305,0.13628318584070798,0.41411763155423403,1.0,6/14,22.09%,CD55;TGFBR2;CD81;SYK;LGALS9;PTPN22
prerank,positive regulation of GTPase activity (GO:0043547),-0.30807471577731965,-1.3359046172895659,0.02385685884691849,0.41427289813363366,1.0,49/188,15.69%,DOCK9;PKP4;ITGA6;ARHGAP42;RAP1A;NET1;RACK1;SIPA1L1;TGM2;AGRN;F11R;CAV2;SGSM2;RALGAPA2;RAPGEF1;TBC1D8;ARHGAP27;ARHGEF15;GRTP1;FERMT2;BCAS3;LIMS1;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;CCL15;S100A10;SIPA1L3;ZC3H15;WNT11;GMIP;NF1;ABR;TBC1D9B;ARHGEF5;TBCK;HRAS;NDEL1;SNX18;RAP1GDS1;ERBB2;EPHA2;BCAR3
prerank,cellular response to amyloid-beta (GO:1904646),0.42852592772636666,1.3351713217288683,0.09188034188034189,0.5566272441513008,1.0,4/35,3.32%,IGF1;LRP1;GJA1;CACNA2D1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.421928223326825,-1.3349195801614029,0.08058608058608059,0.41577026274820184,1.0,19/29,42.79%,HSP90AB1;NLRC5;CNOT7;YTHDF2;MAVS;SAMHD1;PTPN6;TTLL12;PTPN1;PTPN2;MUL1;YTHDF3;USP18;IFNAR2;CDC37;OAS3;CACTIN;STAT2;ZBP1
prerank,positive regulation of developmental growth (GO:0048639),-0.38669332979743604,-1.3347960009264777,0.08128544423440454,0.41534429976273035,1.0,14/49,15.29%,SEMA7A;NEDD4L;AGRN;ITSN2;NGF;SHTN1;INSR;PLAA;DBNL;DBN1;SYT2;SMURF1;NTN1;LIMK1
prerank,cellular response to oxygen levels (GO:0071453),-0.573274406483693,-1.334414453637724,0.14513274336283186,0.41557195667903074,1.0,7/10,30.69%,ATP6V0A2;NDUFS2;ATP6V1G1;ATP6AP1;CCDC115;ATP6V0D1;CPEB4
prerank,negative regulation of programmed cell death (GO:0043069),-0.28558153085094534,-1.3341161659192782,0.006369426751592357,0.41550794674505837,1.0,114/355,22.71%,MECOM;LEF1;TEK;IGF1R;THBS1;TPT1;TAX1BP1;PTK2B;NFKBIA;KDR;FOXO1;TFRC;PTK2;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;ARHGDIA;UBB;ADAM10;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;DCPS;PRKDC;HSPB1;ANXA4;RIPK1;FLT4;PLK2;AKT1;GLO1;KANK2;DNAJA1;FAS;PIM3;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;HSPA5;PSMC5;HTATIP2;CIB1;RAB7A;GRK5;SERPINB9;YWHAZ;BCL2L1;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;HNRNPK;OPN3;GPX4;HYPK;MET;OPA1;GREM1;HSPA1A;RELA;XBP1;BABAM2;HCK;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;LAPTM5;MCL1;HIGD1A;TMBIM6;THOC6;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,mitochondrion localization (GO:0051646),-0.4906316578080883,-1.3336739157488964,0.12830188679245283,0.4158056473125368,1.0,7/19,21.48%,TRAK1;MEF2A;TRAK2;MTM1;NECTIN2;BRAT1;TLE6
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3484555326667339,-1.3327813678310647,0.05534351145038168,0.4172105550420429,1.0,33/86,23.10%,KLF2;EGLN3;UBB;UBC;RPS27A;VEGFA;ATF4;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;IMPACT;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;CHEK1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;DNAJB1;ATF3;PSMA4;PSMA2
prerank,negative regulation of apoptotic process (GO:0043066),-0.2778704629265967,-1.3326942291978094,0.004415011037527594,0.41667750847932067,1.0,138/444,22.71%,PRKCH;LEF1;TEK;MEF2C;CAV1;IGF1R;THBS1;TPT1;NOTCH1;TAX1BP1;PTK2B;MAP2K5;NFKBIA;KDR;FOXO1;KLF4;MAPK3;TFRC;PTK2;TBX1;RNF144B;RPS6KA3;RPL10;ANXA1;CARD14;NGF;CD44;SOCS2;TMBIM4;SIX1;ARHGDIA;UBB;NR4A2;ADAM10;PPARGC1A;CD38;UBC;RPS27A;SMAD6;VEGFA;PTMA;TNFAIP8;RHBDD1;UFM1;IKBKB;GATA6;SH3RF2;SHC1;TGFB3;PRKDC;HSPB1;TOX3;ANXA4;RIPK1;FOXQ1;FLT4;GPX1;PLK2;FZD3;AKT1;GLO1;ASAH2;DNAJA1;FAS;PIM3;RB1;DDRGK1;HSPD1;TCIM;WNT11;CD74;CFL1;MAEA;HSPA5;SFPQ;HTATIP2;BEX3;CIB1;GRK5;SERPINB9;YWHAZ;BCL2L1;APOE;AVEN;ITCH;FXN;FSTL1;HIGD2A;COPS5;DHCR24;PHB2;NUAK2;BNIP3L;EGFR;PIK3CA;HNRNPK;OPN3;CLCF1;HYPK;CX3CR1;CSNK2A1;CSNK2A2;OPA1;GREM1;IGBP1;HSPA1A;RELA;XBP1;BABAM2;HCK;AGAP2;HSPA9;CRYAB;ASNS;ANGPTL4;RASA1;SOX9;FAIM2;GCLC;PTRH2;MCL1;HIGD1A;TMBIM6;SFN;THOC6;HCLS1;IL6ST;HSPA1B;TAF9;BFAR;PDCD10;EGR3;TMEM14A;TRIAP1;API5;PLK3;DSTYK;BAG1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4369221340683884,-1.3313666056723867,0.11895910780669144,0.41911959539674254,1.0,13/28,21.45%,PTK2;DAB2IP;CTSC;DDRGK1;PSMC5;FMR1;SMURF1;ATP5IF1;CDK5RAP3;OSBPL7;LAPTM5;CCDC22;PSMC3
prerank,regulation of protein modification process (GO:0031399),-0.38098510358562,-1.3311227823964578,0.08490566037735849,0.41901669870852387,1.0,20/50,24.65%,FN1;PTK2;PPP1R16B;FNIP2;HSPB1;NDUFS4;WARS1;ATG7;HPF1;ABCA2;CCAR2;PPP1R16A;PIN1;ROPN1L;CDH5;CADM4;SESN2;PPIB;SPRED3;CCDC88A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2970943479154228,-1.3306824389662488,0.0099601593625498,0.4193900552370748,1.0,64/259,15.75%,FGD5;ANO6;ABLIM1;ABCC4;DNM3;RAP1A;EXOC4;PARVB;NOTCH1;EXOC6;FNBP1L;RAP1B;RAB11A;OPHN1;CDC14A;FXYD5;EHD4;S1PR1;RAB8B;CD2AP;IFT20;CEP164;RAC1;SHTN1;ABLIM3;PKD1;MINK1;FGD6;EZR;SPATA13;EHD2;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;VCL;EMP2;RAB8A;CEP290;SPEF1;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ABLIM2;EMP1;ARL6;RFX2;NTN1;RAB11FIP3;RAB1A;SDCBP;CCDC28B;KIF24;STK26;DNAH5
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4909437324420413,-1.329619949071106,0.13957597173144876,0.4212577806159522,1.0,14/17,47.79%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5759241066046363,-1.3294676939631043,0.14412811387900357,0.4209058407244589,1.0,3/10,10.73%,CD81;FCER1G;CD74
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3384999819602316,1.329390077623506,0.06896551724137931,0.5701191302158198,1.0,15/117,8.40%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;HRH2;GLP2R
prerank,neuromuscular synaptic transmission (GO:0007274),0.4920071946318237,1.3288809909028088,0.1391509433962264,0.569734184428767,1.0,7/18,14.81%,CHRNA1;CHRNB4;RIMBP2;TBC1D24;STAC3;CHRNB1;FCHSD2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.49599031785992587,-1.3286863783141167,0.13102119460500963,0.42198329955599295,1.0,8/18,24.02%,PPP1R16B;MFHAS1;CHP1;SH3RF2;PPP1R8;PPP1R26;ARPP19;YWHAB
prerank,translational elongation (GO:0006414),-0.33431954741901393,-1.3283739191019224,0.05578512396694215,0.42194254156953837,1.0,39/101,25.95%,EEF1A1;RACK1;EEF2;MRPL52;PTCD3;EEF1D;EEFSEC;MRPL51;MRPL38;MRPL28;EEF1B2;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;LTN1;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42
prerank,regulation of cellular component size (GO:0032535),-0.4248579916559734,-1.3279647994301362,0.10458715596330276,0.4222941685111216,1.0,15/30,32.66%,EPS8;RIN3;MSN;RAC1;EZR;AP2M1;PPP1CA;PEX11G;PEX11A;RPTOR;RDX;LAMTOR5;ATP13A2;RAB3B;VAV3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5554289054307451,1.3275944146356562,0.16590909090909092,0.5714004534010956,1.0,3/11,6.04%,PPARA;SLC30A10;ABCD2
prerank,response to muramyl dipeptide (GO:0032495),-0.5440419814310624,-1.3275368048959235,0.15579710144927536,0.4225631855184596,1.0,5/12,22.09%,VIM;NOD1;NOD2;ARHGEF2;PTPN22
prerank,limb development (GO:0060173),0.4320496815616783,1.327532722985911,0.11160714285714286,0.5698031147098899,1.0,6/28,6.38%,SALL1;CHD7;LRP4;GLI3;ZNRF3;IFT122
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3308462764609429,-1.3275011079963868,0.04085603112840467,0.4219526917227778,1.0,31/108,14.41%,MAP3K5;ACER2;NOD1;RACK1;ARL6IP5;F3;EGLN3;RPS3;NGF;CRADD;REST;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;PPM1F;BAX;NDUFA13;CTSD;SOX7;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3;SYK;BCAP31;JAK2
prerank,negative regulation of cyclase activity (GO:0031280),0.5273853531795999,1.3273725326773516,0.13002364066193853,0.5684842452212503,1.0,4/14,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5418166720785696,1.327153188868947,0.17016317016317017,0.5672749231801073,1.0,10/12,28.14%,PARP16;PARP11;PARP12;TIPARP;PARP3;PARP1;TNKS;PARP8;TNKS2;PARP6
prerank,actin cytoskeleton reorganization (GO:0031532),0.3771043537725648,1.3270343809378704,0.08731808731808732,0.5657932808162378,1.0,11/63,7.54%,AUTS2;NRP1;NRK;PTK7;ANTXR1;KIT;EFS;RAP2A;THSD7B;THSD7A;TNIK
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.50562728202478,1.3266794845370273,0.13863636363636364,0.5649329132129745,1.0,6/16,9.82%,IGF1;TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.46938898331944395,-1.3263761692591511,0.11310592459605028,0.4238886704705806,1.0,12/21,31.14%,VEGFA;FZD3;NES;DISC1;CX3CR1;KDM1A;DLL4;TOX;LRP2;CTNNB1;FZD9;SMARCD3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.49393978728518995,-1.3256254317664151,0.12007168458781362,0.42498684306844503,1.0,13/16,35.00%,DDX5;DDX17;SRSF6;DHX9;SFPQ;CDK13;RBM17;SRSF9;PQBP1;SRSF1;RSRC1;HNRNPM;PUF60
prerank,positive regulation of kinase activity (GO:0033674),0.3358425952766133,1.3253828238817256,0.0682261208576998,0.5665574446899756,1.0,31/107,13.81%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PRKAG2;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;SNX9;MST1R;MERTK;FGFR1;NBN;ROR1;EPHA1;DAXX;MAPT
prerank,filopodium assembly (GO:0046847),-0.49129504445217853,-1.3245141181614652,0.11720226843100189,0.42697473585626217,1.0,6/16,10.18%,FGD5;DNM3;FGD6;EZR;SPATA13;SPEF1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4400686283139382,-1.3244887087804638,0.1347517730496454,0.4263147982537684,1.0,9/27,11.12%,AHNAK;DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;CACNB3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.568891836056016,-1.3243403395424413,0.1349911190053286,0.42598330656064093,1.0,4/10,5.14%,ACER2;WNK1;JAM3;CYP1B1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.40190861284644497,1.3241139973090421,0.1168032786885246,0.5683285952821968,1.0,8/43,12.94%,ENPP1;PID1;AHSG;PIP4K2A;IGF2;PRKCB;PIP4K2B;GKAP1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4632864641353242,-1.3235249498547683,0.14084507042253522,0.4272200445114148,1.0,8/22,11.93%,CALM1;HTT;ATP1B1;JPH2;AKAP6;GSTM2;VMP1;CALM3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.551498815019441,-1.323439917375454,0.1384335154826958,0.4266988012987213,1.0,9/11,39.88%,SCARB1;MFSD2A;NR1H2;CNEP1R1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4903915930924638,1.3225490022030457,0.16559139784946236,0.5707875546592247,1.0,2/16,6.54%,AUTS2;ARHGAP24
prerank,hyaluronan catabolic process (GO:0030214),0.48174623971681885,1.322316184368432,0.16017316017316016,0.5696622178311599,1.0,3/18,1.32%,CEMIP;SPAM1;HYAL3
prerank,negative regulation of viral transcription (GO:0032897),-0.5256065980086676,-1.3222915190542806,0.14473684210526316,0.42868060840882694,1.0,4/13,12.16%,MID2;IFITM3;TRIM14;TRIM62
prerank,vasculogenesis (GO:0001570),-0.41476500690941637,-1.3220577459865401,0.1062992125984252,0.4285303802427152,1.0,9/32,5.68%,CAV1;NOTCH1;TGFBR2;RASIP1;KDR;RAMP2;SOX17;TGFB1;VEGFA
prerank,organic acid transport (GO:0015849),0.339886533436537,1.3214967210518074,0.06962025316455696,0.5701512578244095,1.0,21/94,11.57%,SLC7A11;SLC13A3;SLC6A12;SLC43A1;SLC7A2;SLC6A13;NCOA2;SFXN5;ABCC2;ACSL1;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A10;NCOA1;SLC10A1;SLC25A47;SLC1A5;SLC38A3;SLC46A1
prerank,renal absorption (GO:0070293),-0.5573189199324903,-1.3214805595811074,0.16755793226381463,0.42913425696786606,1.0,6/10,35.98%,KCNQ1;KLHL3;SLC15A2;HAS2;HYAL2;WNK4
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3346828290511995,-1.321115603416262,0.06613226452905811,0.42932765290599656,1.0,22/107,8.87%,ATP13A5;CAV1;SLC39A10;TPT1;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;MT2A;TMEM165;ATP2C1;SLC39A8;ATP2A3;ATP1B1;EDN1;STIM2;CCL15;SLC10A7
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3820802864080602,-1.3208134327660832,0.08082706766917293,0.4286596872354603,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3820802864080602,-1.3208134327660832,0.08082706766917293,0.4286596872354603,1.0,29/51,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,anterior/posterior pattern specification (GO:0009952),0.382473150280649,1.3207642759576406,0.09001956947162426,0.5703152795125089,1.0,11/53,9.95%,BMP2;WLS;HOXC4;HOXB3;HOXC5;HES3;HOXC9;TGFBR1;HES5;HOXB9;HOXC6
prerank,positive regulation of cation channel activity (GO:2001259),-0.40146782080738574,-1.320653223764662,0.10093457943925234,0.42834626512079277,1.0,14/40,25.04%,TMSB4X;SHANK3;CALM1;HTT;JPH2;AKAP6;GSTM2;CALM3;PKD2;KCNIP2;CTSS;CCL2;CASQ1;ATPSCKMT
prerank,cGMP-mediated signaling (GO:0019934),0.5341831560908787,1.3201117691092878,0.15570175438596492,0.5702735258996466,1.0,1/13,0.05%,IRAG1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5683701757918985,1.319696978780963,0.16377171215880892,0.5696371656718848,1.0,3/10,5.49%,HECW2;ATP1A2;HECW1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3360645082912573,-1.3191794433612376,0.05973025048169557,0.4311479903241374,1.0,18/91,7.01%,ABCG2;SLC39A10;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1B;MT1F;ATOX1;TFRC;MT2A;APP;SLC39A8;SLC40A1;ATP6V0A2;FTL
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.42732103062486,1.319027698263277,0.12422360248447205,0.5697736103311214,1.0,14/34,18.84%,GRID2;MPP2;GABRA2;NLGN3;MAPK8IP2;GABRA5;CHRNA4;GRIN2A;DRD2;GABRG1;GABRG3;GRIN2B;GABRG2;RAB3GAP1
prerank,basement membrane organization (GO:0071711),0.5259830731539643,1.3188025662180367,0.1600877192982456,0.5686264260397113,1.0,3/14,2.52%,FLRT2;NID2;NID1
prerank,sprouting angiogenesis (GO:0002040),0.38289118749182677,1.318095575305381,0.12757201646090535,0.5686851368229817,1.0,6/51,2.72%,CCBE1;ROBO1;NRP1;SEMA5A;RECK;VEGFB
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.48240154514911365,-1.3180719002264434,0.12386156648451731,0.4331811386989094,1.0,4/18,6.15%,CTNNA1;MFHAS1;CHP1;UFM1
prerank,calcium ion transport (GO:0006816),0.3340656056537047,1.3180257349381408,0.07171314741035857,0.5671968489621352,1.0,23/113,9.64%,NALCN;SLC24A3;SLC8A1;CACNA1E;CYP27B1;ITPR1;SLC24A5;ANK2;GRIN3A;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;ORAI2;CACNA1I;TRPM5;TRPA1;CACNA1G;CACNB2;SLC24A4;SLC24A2;CHRNA4
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.48823080076004616,1.3172385336395513,0.14444444444444443,0.5676418643249452,1.0,4/16,2.64%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.35343848847257225,-1.3163310760137956,0.07272727272727272,0.4365996373616829,1.0,20/70,14.41%,HIPK1;DAB2IP;NGF;CRADD;TGFB1;TGFB2;RNF41;GABARAP;CASP8;TLR3;TNFRSF1B;RIPK1;BAX;FAS;INHBA;CIB1;BCL2L1;BAK1;TNFRSF1A;JAK2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5010277489853817,1.315324115316897,0.15982721382289417,0.5708968020999972,1.0,2/17,1.65%,CAMK1D;DAPK2
prerank,vascular transport (GO:0010232),0.3478255778379285,1.3152669234567143,0.05410821643286573,0.5693361676301333,1.0,16/81,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.33429020338418164,-1.3150328255687056,0.06297709923664122,0.43899652180025495,1.0,33/101,17.09%,THBS1;VIM;RPL26;NFKBIA;KLF4;EEF2;NIBAN1;RPS4X;TGFB1;MSN;EZR;PRKDC;CASP8;AKT1;PERP;PTTG1IP;ATG7;RPS27L;EIF3D;INHBA;LARP4B;CIRBP;UPF3A;SOX4;BAK1;FMR1;VPS11;ERBB2;NR1H2;HSP90AA1;IST1;PCIF1;BAD
prerank,entry into host (GO:0044409),-0.5131368661130012,-1.3150313022755287,0.16428571428571428,0.43827685537107425,1.0,8/13,35.14%,CDH1;PPIA;MET;CBLL1;CTNNB1;SRC;CBL;ITGAV
prerank,positive regulation of cell communication (GO:0010647),0.44577805722384223,1.3144441897736567,0.11967545638945233,0.569810344712428,1.0,10/28,19.21%,WLS;CLSTN2;RIMS1;GRIK2;SYT1;GATA3;DLG4;HCRT;RIMS2;LGI1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4039184402988418,1.3144123588863503,0.11814345991561181,0.5682203306021237,1.0,11/40,12.50%,ARHGAP6;LPAR1;NTRK3;KIT;PDGFRA;GPR55;PDGFRB;ANG;GNA15;ITK;FGFR1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.439983804136812,-1.3141369044633293,0.1375,0.4396916347262906,1.0,10/24,24.12%,ACKR3;TPT1;CD44;CD74;BCL2L1;CCAR2;KDM1A;TAF9;TRIAP1;SNAI2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5403301738748352,-1.3141061581010223,0.1391465677179963,0.4390535443690045,1.0,11/11,46.01%,CYC1;UQCRQ;UQCRB;UQCR11;UQCRH;UQCC3;UQCRFS1;UQCRC1;UQCRC2;CYCS;UQCR10
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5301688301647275,-1.3135754347342805,0.14594594594594595,0.4396041777686696,1.0,4/12,17.16%,NOTCH1;CCN3;HDAC4;XBP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4857300861284208,1.3125716752099068,0.1463963963963964,0.5714257199715537,1.0,2/17,2.65%,BMP6;PRKCA
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4785578219453869,-1.3125046099225075,0.14516129032258066,0.4415463548735806,1.0,7/18,26.19%,JAM2;SLC39A8;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.32653066681674114,-1.3123000875443949,0.06276150627615062,0.44133237785768537,1.0,34/100,21.46%,CBFA2T3;RACK1;RNF144B;SMAD7;HSP90AB1;RPL11;GABARAP;SH3RF2;N4BP1;GIPC1;USP7;TRIB2;PABIR1;CAMLG;FOXF2;TRIB1;DDRGK1;VCP;USP5;BAG5;UBXN1;RBX1;SDCBP;HECTD1;UFL1;HSPA1A;CCAR2;RNF19A;ELOB;MAP1A;KEAP1;TRIB3;HSPA1B;TAF9
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4871609927096658,1.311589734052028,0.15124153498871332,0.5723458910401579,1.0,3/18,0.98%,IL34;PTN;DAAM2
prerank,regulation of viral genome replication (GO:0045069),-0.36970103774782387,-1.3115487283709928,0.09622641509433963,0.44234823263353973,1.0,15/56,16.17%,IFIH1;ADAR;PPIA;CNOT7;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;STAU1;MAVS;NR5A2;OAS2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5409782371286659,1.31149456480526,0.18509615384615385,0.5709545525361697,1.0,6/11,17.38%,LEPROT;SNX33;TAX1BP3;ACTN2;LEPROTL1;GOPC
prerank,regulation of protein kinase C signaling (GO:0090036),0.5103643276443641,1.3114824310781314,0.15856236786469344,0.56933599590576,1.0,3/14,4.33%,ADGRV1;DGKD;GPD1L
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3582552898615841,-1.3109500231017472,0.07156673114119923,0.44312537548028247,1.0,34/67,35.74%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CHUK;TAP2;CYBB;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;CD36;PSMC6;PSMD6;PSMA8;NCF1;SEC22B;IKBKG;PSMD2;ITGAV;PSMB2;SNAP23
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.35040625201304976,-1.3109036902906044,0.07509881422924901,0.4425119829791201,1.0,29/72,25.40%,SHANK3;KANK3;CYRIB;SLIT2;HSPA8;PFDN5;KANK4;SSH2;HIP1R;STMN2;PFN1;SPEF1;CIB1;APOE;KATNB1;PIK3CA;SMAD4;CRYAB;ARHGEF2;TPX2;SHANK1;CDH5;APC2;PFDN6;CAMSAP3;PRKCD;PFDN4;STMN1;TREM2
prerank,inorganic cation transmembrane transport (GO:0098662),0.2979248060935956,1.310456225918702,0.027833001988071572,0.5704332044071617,1.0,40/268,10.31%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ATP6V0A4;SCN7A;SLC6A12;SLC6A9;SLC8A1;SLC6A13;SLC24A5;SCN3B;SLC30A10;ABCB8;TRPM3;P2RX4;ATP2A2;TRPM1;CCDC51;SCN3A;SLC39A6;SLC36A2;KCND2;SLC9A7;TRPM5;KCNJ16;TRPA1;ASIC2;SCN2A;CACNA1G;KCND1;SLC24A4;SLC24A2;SLC41A1;SLC6A11;SLC6A1;DMAC2L;ATP6V1H;KCNJ14
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5582749827051372,-1.3103193671818867,0.15505226480836237,0.44322907150089147,1.0,1/10,0.35%,CAV1
prerank,synaptic vesicle cycle (GO:0099504),0.42943069356283814,1.310093055807491,0.145748987854251,0.5696092576346625,1.0,9/30,16.13%,RIMS1;SYNDIG1;CPLX2;SNAP25;OTOF;NLGN1;BRSK1;SNAPIN;PLD2
prerank,acylglycerol metabolic process (GO:0006639),-0.4002205651763945,-1.3100052964386726,0.1007905138339921,0.4432373176248153,1.0,8/37,12.33%,ABHD2;CAV1;DGKH;SEL1L;MGLL;PNPLA2;PLAAT3;APOE
prerank,regulation of protein kinase B signaling (GO:0051896),0.3080248151082155,1.3097930912317008,0.041044776119402986,0.568734738171961,1.0,36/193,10.35%,TCF7L2;PIK3R1;AREG;NTRK3;FGFR2;SEMA5A;NRG1;MAGI2;KL;PPARA;KIT;PDGFRA;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;IRS2;AXL;RTN4;MYORG;IAPP;PDGFRB;CALCR;RRAS;THPO;TGFBR1;IGF2;ERBB3;IL18;FGFR4;GATA3;MYDGF;ERBB4;PTEN
prerank,response to unfolded protein (GO:0006986),-0.3808414884644644,-1.3091166888907968,0.08118081180811808,0.4447226232686151,1.0,21/48,22.97%,DAB2IP;HSP90AB1;HSPA8;RHBDD1;HSPB1;BAX;DNAJA1;HSPD1;HSPA5;BAK1;ERP44;HSPA4;HSPB8;HSP90AA1;HSPA1A;HSPA9;HSPE1;TMBIM6;HSPA1B;DNAJB1;PTPN1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5080058998497478,1.3091158567150967,0.1580135440180587,0.5689850057407447,1.0,2/15,5.39%,IGF1;PRKN
prerank,ceramide catabolic process (GO:0046514),-0.5106360861965791,-1.3089116226385116,0.13904761904761906,0.4444746883460294,1.0,8/14,26.89%,ACER2;HEXA;ASAH2;ACER3;NEU3;NEU1;NEU2;NAGA
prerank,positive regulation of response to wounding (GO:1903036),-0.4421237864669193,-1.3086862549034926,0.11724137931034483,0.4442220418401497,1.0,5/24,3.46%,OCLN;ACTG1;SCARF1;PTK2;ANXA1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.43557217402982196,-1.30851017496738,0.13403880070546736,0.4439390458219849,1.0,8/26,15.84%,FOXP1;NCOR1;ZBTB7A;HEYL;KANK2;SMARCA4;VPS11;STRN3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43312735786561507,-1.3082496600434865,0.12126865671641791,0.44388204120824165,1.0,13/25,30.77%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B;HMGB2;ANKRD54;ABCB10
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5214626749017056,-1.3077983053123488,0.1571969696969697,0.44431852025357144,1.0,5/12,25.76%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.4008487523473263,-1.307693908698345,0.1018867924528302,0.4438305978580086,1.0,14/35,17.48%,TEK;ESAM;BAIAP2L1;PTK2B;F11R;ARHGDIA;BCAS3;ARHGDIB;ABI3;ABL2;CSF1R;HRAS;RAPGEF3;HCK
prerank,iron ion transmembrane transport (GO:0034755),-0.5614476041105613,-1.3074760763684659,0.17247386759581881,0.4436629435759763,1.0,6/10,35.33%,SLC39A8;SLC40A1;SLC25A28;ABCB6;SLC11A2;ABCB7
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.41298017796047154,1.3070362133733529,0.12190082644628099,0.5729398238414248,1.0,6/35,6.78%,ACSS3;HMGCLL1;PAM;ALOX12;GGT7;SCD5
prerank,regulation of stem cell proliferation (GO:0072091),0.49233193208238335,1.306726835710258,0.17582417582417584,0.5721228936966418,1.0,2/17,1.53%,FBLN1;GJA1
prerank,negative regulation of receptor binding (GO:1900121),-0.5554831555188923,-1.3067044601086995,0.14766355140186915,0.44487411552262757,1.0,3/10,6.17%,B2M;ADAM15;ATP2A3
prerank,regulation of response to external stimulus (GO:0032101),-0.32071578814300516,-1.3067004632315218,0.04781704781704782,0.44418430511499124,1.0,31/121,18.31%,FOXP1;CAV1;TMSB4X;SEMA7A;CD55;CYRIB;ANXA1;MGLL;CALM1;IL1R1;BRD4;GATA6;N4BP1;CASP8;PSMA6;ERAP1;BCL6;ACE2;TIRAP;LRP8;DHX58;PIK3AP1;SAMHD1;BCL6B;JAK2;TRIM5;NOD2;UFL1;RELA;HCK;DAGLB
prerank,regulation of intracellular signal transduction (GO:1902531),-0.27503304995452094,-1.3065246130041628,0.008908685968819599,0.44388275753407413,1.0,108/420,18.68%,ARHGAP31;TEK;CHN2;VWF;SGMS1;PPP1R13B;TMSB4X;MCF2L;ARHGEF3;NET1;PLCG2;RHOJ;FGF1;PIP5K1B;OPHN1;RASGRF2;NFKBIA;ARAP3;HIPK1;STARD13;ARHGAP23;MAPK3;STARD8;ARHGAP17;ARHGAP26;PPP1R16B;DAB2IP;RICTOR;PHF20;TMBIM4;ARAP2;RPL11;RNF41;ARHGAP1;ARHGDIA;TRIO;PDE2A;RAC1;CMKLR1;ING5;ARHGDIB;MINK1;CHN1;MOB3B;CRK;VEGFA;ARHGAP25;SOS2;TAOK3;EZR;PRKAR2B;MYOC;USP7;RASSF2;BCR;HSPB1;RAD1;DYRK2;AKT1;NOP2;ITSN1;PIP4P1;RHOT1;MAPKAP1;CSNK2B;MTA2;RHOB;PREX1;RHOT2;MBD3;TAOK2;GMIP;AKAP6;ULK4;ABR;SPHK2;TRAF1;ARHGEF5;TBCK;FBXL2;NUAK1;ARHGEF18;SLC15A2;RAD9B;SMYD2;EGFR;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;UFL1;SLC15A4;PIK3R2;RBBP4;RAD17;DDIT4;PRKAR2A;RELA;ARHGEF12;ARHGEF17;L3MBTL1;CHD4;ARHGEF4;ARHGEF2;ECT2;CHEK1
prerank,positive regulation of biosynthetic process (GO:0009891),0.39913866464631365,1.3049777043225699,0.1108695652173913,0.5751429260815261,1.0,6/40,3.98%,WNT4;ZBTB20;PPARA;SLC5A3;LARP6;CREB3L1
prerank,sphingolipid catabolic process (GO:0030149),-0.5035825374943932,-1.3046157161771204,0.14944649446494465,0.4476449348413987,1.0,5/15,12.89%,ACER2;ASAH2;SMPDL3A;SGPL1;ACER3
prerank,heart process (GO:0003015),0.5119930903042741,1.3041546875764294,0.15935334872979215,0.5757135757643209,1.0,3/14,4.22%,SGCZ;SGCD;TNNI3
prerank,RNA export from nucleus (GO:0006405),-0.32531242739087673,-1.3040395621996115,0.06203007518796992,0.44830733840290965,1.0,49/100,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;HNRNPA1;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,regulation of T cell chemotaxis (GO:0010819),-0.5486437050241388,-1.3039285100565388,0.13451327433628318,0.447829335583205,1.0,2/11,4.91%,WNK1;ADAM10
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5483353970640781,-1.3037256958451633,0.1621129326047359,0.44758518632860433,1.0,4/10,22.09%,LBP;TIRAP;NINJ1;PTPN22
prerank,positive regulation of histone acetylation (GO:0035066),-0.44542926485186174,-1.303705449124783,0.12932604735883424,0.44692639392658406,1.0,7/23,15.00%,RPS6KA5;MAPK3;PPARGC1A;TADA2B;WBP2;SPHK2;SMAD4
prerank,osteoclast differentiation (GO:0030316),-0.44863725111686026,-1.3035650653842576,0.1297709923664122,0.4465587442449243,1.0,8/22,15.34%,FOXP1;ANXA2;OSTM1;TNFRSF11A;GLO1;CSF1R;GAB2;EPHA2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.38716319112838327,-1.3033918848245543,0.12110091743119267,0.4462836736626322,1.0,24/43,32.39%,BRCC3;TAOK3;FOXN3;UIMC1;PABIR1;BABAM1;TAOK2;CDC14B;HUS1;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;INTS3;CDK1;CDC6;TICRR
prerank,positive regulation of protein secretion (GO:0050714),0.36034862670189155,1.3024871681885295,0.08982035928143713,0.5787253141600897,1.0,4/69,0.72%,IGF1;BMP6;TCF7L2;WLS
prerank,glycolytic process (GO:0006096),-0.42848313845671615,-1.3024677886329903,0.12593984962406016,0.4478691419034981,1.0,11/28,23.23%,GPI;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;PGAM1;PGAM4;PFKL;ENO1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.5151885386754491,-1.3021125818626897,0.1534195933456562,0.44807003275655133,1.0,3/13,14.53%,MID2;TRIM28;TRIM5
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3179399200819752,1.3019588296633846,0.058365758754863814,0.5785165417393655,1.0,27/150,8.96%,ENPP1;PPM1E;ERRFI1;PID1;PTPN13;LDLRAD4;NTRK3;FBLN1;PRKAG2;PDPK1;DEPTOR;LYN;SFRP1;GPD1L;PMEPA1;PRKN;CEP85;GSTP1;NLRP12;PLPP3;SIRT2;IBTK;MEN1;CEP43;TRIM27;NLRP2B;PPP1R15B
prerank,regulation of cell cycle (GO:0051726),-0.28491768878107887,-1.3019585295344747,0.016359918200409,0.44771716745845275,1.0,81/271,21.50%,MECOM;PPP1R13B;CDK6;APBB2;AFAP1L2;THBS1;TTC28;NOTCH1;RACK1;JUND;CDC14A;IQGAP1;FAP;NEK7;DAB2IP;MAP3K20;HSP90AB1;CDKN1B;RPRD1B;TGFB1;TGFB2;RPL23;RPS15A;ADAM10;PKD1;CTBP1;RARA;GATA6;HCFC1;RGCC;RASSF1;PLAGL1;SIPA1;ASAH2;PIM3;RB1;JUNB;PHACTR4;RHOB;PES1;INHBA;MAEA;CDK4;CRLF3;GADD45G;GRK5;CDK10;CDC14B;RPS6KA2;HRAS;DHCR24;RNF20;SDCBP;GAS2L1;UHMK1;MADD;CDKN1A;CSNK2A1;CSNK2A2;LIN54;RBBP4;ANKRD17;FBXL3;TSC2;CDKN2C;L3MBTL1;MAPK12;CHEK1;CDK5RAP3;GADD45A;TTLL12;CCND1;SRA1;SOX9;TSPYL2;PTPRK;WDR12;FGF10;ZBTB49;TBRG4;PKD2
prerank,Rap protein signal transduction (GO:0032486),-0.5588512266101067,-1.301329110060068,0.16448598130841122,0.448521600737593,1.0,4/10,8.12%,RAP1A;RAP1B;RAPGEF1;PLK2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32631090723574235,1.301089751042583,0.058,0.5791857377239503,1.0,18/129,8.56%,RNF220;LGR4;LRRK1;WLS;DAAM2;FGFR2;LYPD6;SEMA5A;TBL1XR1;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1
prerank,negative regulation of cellular process (GO:0048523),-0.2704775763201391,-1.3010055026897651,0.004424778761061947,0.448546223241538,1.0,116/521,15.00%,ZBTB7C;PODXL;PTPN14;PPP1R13B;CDK6;ITGA1;APBB2;JAM2;CTTNBP2NL;IGFBP7;NOS3;PTPRJ;CD34;SERTAD2;IGFBP6;NOTCH1;CBFA2T3;OSGIN2;RACK1;PTK2B;BMPR2;SH3BP4;KLF4;FHL1;CCN3;TBX1;ETS1;SOX17;DAB2IP;FERMT2;SLIT2;NPR1;NGF;ADAM15;CDKN1B;TGFB1;LPCAT3;REST;APP;TGFB2;RNF41;COL18A1;PLXNA4;ARHGDIA;TES;PLPP1;ADAM10;CYP1B1;ING5;ARHGDIB;CTBP1;IGFBP3;TGFBI;DYSF;SMAD6;CNOT7;AQP11;PPP2R1A;WNT9A;NOTCH4;IFITM1;ACTN1;PDE8A;TGFB3;TNFRSF21;CD9;TNFRSF1B;RGCC;DUS2;ADGRG1;SRSF6;NDUFA13;BCL6;SIPA1;KANK2;SOX7;WARS1;CSNK2B;RB1;WFDC1;SPEF1;RHOB;WNT11;MYBL1;PLXNA1;PLXND1;DIS3L2;INHBA;CCDC85B;GAS8;CRLF3;FRK;IMPACT;CIB1;FTH1;TMEM115;CDK10;SOX4;CCN5;FGF2;SPHK2;RPS6KA2;ABI1;HRAS;TMEM109;P3H2;SMARCA4;NDUFS3;CDKN2AIP;JAK2;BNIP3L;RAD18;SMYD2;STRN;OSGIN1;SMAD4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.38742735678852513,1.3000593206901925,0.1092436974789916,0.5802496772525292,1.0,10/46,11.33%,IGF1;TCF7L2;CCN4;PDGFRB;OGN;IL18;HES5;ANG;IL6R;PTGIR
prerank,ERBB2 signaling pathway (GO:0038128),0.41592158640302457,1.2994226006444425,0.147239263803681,0.580293186666523,1.0,7/31,9.82%,PIK3R1;NRG1;PRKCA;NRG4;NRG2;ERBB3;ERBB4
prerank,myotube cell development (GO:0014904),0.5394734551080126,1.2988914429222336,0.18329466357308585,0.5800660559639663,1.0,2/10,6.49%,IGF1;MYORG
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.43935094980542216,-1.2986233464379948,0.152014652014652,0.4537139966813239,1.0,8/24,15.22%,PTK2B;UBB;PKD1;CTSC;GPX1;PSMD14;APOE;ATP5IF1
prerank,DNA replication initiation (GO:0006270),0.40637415759690726,1.2984843914221915,0.13034188034188035,0.5795589177800486,1.0,14/37,23.13%,MCM3;ORC4;RPA2;MCM2;MCM8;ORC1;POLE4;RPA1;ORC3;ORC5;CDC7;PRIM1;PRIM2;MCM7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4427162754449365,1.29829610620821,0.16279069767441862,0.5784171115459341,1.0,4/24,2.62%,ERRFI1;VDR;CYP27B1;ROCK2
prerank,phospholipid biosynthetic process (GO:0008654),-0.399197423771975,-1.2977225936860908,0.11466165413533834,0.4552129069224697,1.0,13/36,27.46%,SGMS1;SGMS2;SPHK2;FAR1;MBOAT1;PCYT2;AGPAT5;NUS1;CPNE3;FDPS;DHDDS;IDI1;PIP5K1A
prerank,endothelial cell migration (GO:0043542),-0.401357862684712,-1.2969801927706823,0.11173184357541899,0.45625924565718096,1.0,16/37,16.32%,NOS3;ID1;DPP4;PXN;STARD13;CCN3;FAP;CYP1B1;VEGFA;GIPC1;SOX18;EMP2;PLXND1;FSTL1;PIK3CA;STAT1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5207136712790438,1.2969470993261305,0.17330210772833723,0.5805434181875667,1.0,1/13,0.08%,IGF1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.30856174953789073,-1.2966871548896404,0.048,0.45622579539091745,1.0,33/151,8.42%,MEF2C;FLT1;SEMA6A;RAP1A;EEF1A1;NOTCH1;TGFBR2;RACK1;BMPR2;MAP2K5;KDR;KLF4;MT1G;IQGAP1;RAMP2;RAPGEF1;TBX1;SMAD9;ANXA1;DAB2IP;SMAD7;CD44;TGFB1;PDE2A;LIMS1;VEGFA;SHC1;PDE8A;NR3C1;HSPB1;FLT4;STMN2;AKT1
prerank,positive regulation of neutrophil migration (GO:1902624),0.48950800450010956,1.2966265530493801,0.1729957805907173,0.5797740433745885,1.0,2/18,1.65%,CAMK1D;DAPK2
prerank,TOR signaling (GO:0031929),-0.42792297563019577,-1.296511917452334,0.15779092702169625,0.45596652663866105,1.0,14/26,30.72%,RICTOR;PRR5L;AKT1;MAPKAP1;RPS6KB2;RPS6;EIF4EBP1;MEAK7;SMG1;CCDC88A;RPTOR;CARD11;RPS6KB1;RHEBL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35010424367969745,1.295374630016582,0.1006036217303823,0.5815079039275702,1.0,13/77,7.96%,IGF1;TCF7L2;AR;BCL2;SH3RF1;PHIP;CFLAR;IL4;PRKN;GSTP1;SCG2;MAPK8IP2;TGFBR1
prerank,response to steroid hormone (GO:0048545),-0.41739292687824914,-1.2949781026549987,0.12075471698113208,0.4590599398770355,1.0,10/31,12.63%,ABHD2;CAV1;THBS1;ATP1A1;TGFB1;TGFB2;TGFB3;NR3C1;WBP2;ABCA2
prerank,muscle cell development (GO:0055001),0.42256136290090396,1.2945978340515987,0.14383561643835616,0.5819254266920305,1.0,6/30,3.63%,IGF1;SGCZ;SLC8A1;EFEMP2;ANK2;MEGF10
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.39379656193496737,1.294165619604617,0.12393162393162394,0.5814329541640064,1.0,4/37,6.04%,ADCY7;PPARA;TICAM1;ABCD2
prerank,transport across blood-brain barrier (GO:0150104),0.3424237195965334,1.2940115779057084,0.08216432865731463,0.580227181808872,1.0,16/83,5.34%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC6A9;SLC16A12;LRP1;SLC7A2;SLC6A13;SLC2A13;SLC5A3;LEPR;ABCC2;SLC29A1;SLC22A3;SLC38A1
prerank,regulation of plasminogen activation (GO:0010755),0.5247348495951862,1.293881709147241,0.19381443298969073,0.579062072659594,1.0,3/12,5.80%,CLEC3B;SERPINE2;SERPINE1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.515998166627984,1.2932014479369798,0.17209302325581396,0.5792072886097317,1.0,2/12,1.22%,PIK3R1;BCL2L11
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.41818050067286555,1.2930046919926939,0.13524590163934427,0.5781484875360201,1.0,7/33,10.35%,IGF1;PIK3R1;MYO16;SIRT2;ERBB3;GATA3;PTEN
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.48708108729857663,-1.2923636333078565,0.14690265486725665,0.4648782264145137,1.0,4/16,24.19%,CLDN5;CLDN11;CLDN10;CLDN1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4335227429106049,1.2917987022261075,0.16263736263736264,0.5797502568558396,1.0,8/27,14.15%,LPAR1;GPR55;GPR174;GRM1;LPAR4;C3AR1;GNA15;DRD2
prerank,intestinal absorption (GO:0050892),-0.5220602490432201,-1.2917587336980452,0.18382352941176472,0.46557841599041777,1.0,3/13,5.13%,F11R;TJP2;KCNQ1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.43407802537347145,1.2912878004133475,0.16335540838852097,0.5795730149892986,1.0,6/24,9.57%,ADAMTS12;TRPS1;LOXL2;TGFBR1;SCIN;SOX5
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.41808852856429224,1.291054183322996,0.12967032967032968,0.5786428995214932,1.0,8/31,9.35%,TGFBR3;FGFR2;NRG1;TNNC1;TNNI3;TGFBR1;RBPJ;BMPR1A
prerank,programmed necrotic cell death (GO:0097300),-0.4724051533738435,-1.291027182119027,0.16727941176470587,0.46668518289547484,1.0,7/18,16.20%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,B cell differentiation (GO:0030183),-0.37878825198000776,-1.2908497155861134,0.11,0.4664258939077249,1.0,23/46,33.99%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;IRF2BP2;HDAC4;HHEX;CLCF1;ITGA4;TCF3;KLF6;JAK3;ADGRG3;DCAF1;NFAM1;HDAC5;PTPN2;SYVN1;LYL1;BLNK;CR2;MS4A1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.45988701325663806,-1.2907691802198284,0.13980582524271845,0.465915567670109,1.0,6/20,18.22%,CDK6;PTK2B;ZBTB16;CIB1;LDB1;HSPA9
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4877595116113619,-1.2905823609668652,0.15653775322283608,0.4656774530478615,1.0,8/16,28.36%,SCARB1;MFSD2A;PNPLA2;NR1H2;DAGLB;CNEP1R1;SREBF1;SLC27A1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3028570897383381,1.2905657412959992,0.05273833671399594,0.5783778277974071,1.0,33/199,10.70%,ALDH1A1;ROBO1;LGR4;BMP2;PLCL1;LDLRAD4;NOVA1;BMP5;GJA1;ADAMTS5;TBX18;ROCK2;LRP4;WWC1;SFRP1;MCC;ACTN3;IL4;ADM;NLRP12;PLCL2;NPTN;FOXA2;LOXL2;ACOT11;DOCK7;RBPJ;SFMBT1;GATA3;HOXC10;BBS2;PTEN;RPS6KA6
prerank,blood vessel diameter maintenance (GO:0097746),-0.3944613481465461,-1.2904797809338415,0.12406015037593984,0.46523433268970865,1.0,9/34,19.56%,EDNRA;NOS3;KLF2;NPR1;EDN1;ACE2;ACE;GCLM;GCLC
prerank,glucose import (GO:0046323),-0.5118959075956675,-1.2903886045546444,0.1794425087108014,0.46473163201894574,1.0,6/13,28.36%,SLC2A1;RAB4B;SLC2A3;SLC2A4;SLC2A10;SLC27A1
prerank,regulation of tube diameter (GO:0035296),-0.5023760356378659,-1.2901949570196205,0.1537037037037037,0.4638089074567569,1.0,7/13,22.68%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),-0.5023760356378659,-1.2901949570196205,0.1537037037037037,0.4638089074567569,1.0,7/13,22.68%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,regulation of chromatin binding (GO:0035561),-0.5531162293308624,-1.289612919239554,0.1693121693121693,0.4645791506786206,1.0,6/10,36.33%,HMBOX1;WAPL;DTX3L;BTAF1;PARP9;MED25
prerank,adipose tissue development (GO:0060612),-0.539079439396321,-1.289473732701223,0.1586998087954111,0.4642119861188576,1.0,4/11,6.33%,SPTLC2;NAMPT;LRP5;PGRMC2
prerank,positive regulation of cellular component organization (GO:0051130),-0.32198752757981164,-1.288968517414571,0.08531746031746032,0.464858355356872,1.0,32/107,12.88%,SHANK3;IGF1R;ATP10A;GPC3;NEDD4L;RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;TGFB2;CD151;VEGFA;TGFB3;PLEKHM2;GPX1;BAX;INSR;TAL1;WARS1;ADD1;FLOT1;RB1;DCTN1;TIRAP;VCP;CAMK1;SURF4;APOE;BAK1;SYK
prerank,regulation of cellular pH (GO:0030641),-0.42333537930527015,-1.2888737307592677,0.13805970149253732,0.46437629682799303,1.0,12/29,28.72%,SLC4A10;SLC9A2;CHP1;ATP5F1B;SLC4A8;SLC4A2;SLC9B1;ATP6AP1;SLC9A5;SLC9A4;SLC4A3;SLC26A6
prerank,regulation of defense response to virus by host (GO:0050691),-0.42091208263853114,-1.2885735547964081,0.14652014652014653,0.46442449257923873,1.0,17/30,31.99%,DHX9;ZDHHC1;MAVS;AIM2;TNFAIP3;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;IFNLR1;MUL1;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,blood vessel morphogenesis (GO:0048514),0.37249447351166787,1.2883932171571542,0.10020040080160321,0.5822871836796487,1.0,10/54,8.08%,CCBE1;LAMA1;TGFBR3;NRP1;TNNI3;TGFBR3L;GLMN;ADM;TGFBR1;RBPJ
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5122431411519691,-1.2883012039669548,0.16266173752310537,0.4643985879882744,1.0,9/13,34.79%,SVIP;UBE2G2;BCAP31;DERL2;ERLEC1;EDEM2;BRSK2;EDEM1;OS9
prerank,response to interleukin-6 (GO:0070741),0.5466072578311161,1.2881659417388462,0.19126819126819128,0.5813238864636205,1.0,4/10,6.59%,PID1;PTGIS;PTPRT;FOXA2
prerank,gastrulation (GO:0007369),-0.4979743919443981,-1.2880075040311456,0.14571948998178508,0.4644208458808879,1.0,5/15,24.81%,GPC3;LRP5;TASOR;SMAD2;MKKS
prerank,mRNA export from nucleus (GO:0006406),-0.3209117257711881,-1.2879211667930806,0.08076923076923077,0.46397319943748866,1.0,50/102,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;ENY2;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;DDX19A;NUP88;NUP214
prerank,histone H2A ubiquitination (GO:0033522),0.47627863169886947,1.2876974740897567,0.1843220338983051,0.5810493732529496,1.0,3/17,5.21%,BCOR;DDB2;RNF2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4824572202807582,1.2864295135750903,0.1531322505800464,0.5828396183170794,1.0,2/17,0.36%,ROBO1;NRP1
prerank,reticulophagy (GO:0061709),-0.5243181067507189,-1.286416781064761,0.1921641791044776,0.466970064671617,1.0,5/12,19.01%,UFM1;DDRGK1;UFL1;UFC1;UBA5
prerank,regulation of membrane depolarization (GO:0003254),-0.4612051525098571,-1.286401860370357,0.18198529411764705,0.4663165024634224,1.0,4/18,3.59%,NEDD4L;FHL1;CAMK2D;SMAD7
prerank,phospholipid translocation (GO:0045332),-0.4251913130420241,-1.28609283643038,0.15748031496062992,0.46637161312859593,1.0,8/28,8.51%,ANO6;ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;MFSD2A;ATP9B
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.37010781900037515,-1.2852456132817003,0.1111111111111111,0.4676998313224493,1.0,26/50,30.92%,THBS1;MAP2K5;KLF4;RPS6KA3;NGF;CD44;VEGFA;GPX1;AKT1;BEX3;DHCR24;CSNK2A1;IGBP1;SFN;TRIAP1;CARD16;PLAUR;XIAP;YWHAE;PARK7;LAMTOR5;DNAJB6;SRC;RPS6KA1;PAK2;AQP1
prerank,cGMP biosynthetic process (GO:0006182),-0.5434423715574406,-1.285174613726191,0.1828793774319066,0.46718425902442395,1.0,4/10,15.32%,NPR1;GUCY1B1;GUCY1A1;GUCY2C
prerank,cell junction assembly (GO:0034329),-0.3261043022580646,-1.2847404340531998,0.07707509881422925,0.4675862215533746,1.0,15/100,4.86%,FN1;PKP4;ACTB;SHANK3;DNM3;ITGA6;CLDN5;LIMS2;CDH1;SPOCK2;ACTG1;OPHN1;FERMT2;SDK1;LIMS1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5308988073382646,-1.284677866998162,0.1763668430335097,0.46701974296936544,1.0,7/11,25.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,response to ionizing radiation (GO:0010212),-0.34095237676861967,-1.2844960242750645,0.1007905138339921,0.4667514651078364,1.0,35/70,32.43%,NET1;ANXA1;BRCC3;EEF1D;UIMC1;RAD1;BABAM1;RHOB;MTA1;RAD9B;AEN;HUS1;RAD9A;CDKN1A;BABAM2;ECT2;GADD45A;BRAT1;IKBIP;CLOCK;RHNO1;COP1;MRNIP;DCUN1D3;SMPD1;FANCD2;RAD51AP1;LIG4;TNKS1BP1;RNF8;SWI5;MYC;INTS3;TICRR;FIGNL1
prerank,potassium ion transmembrane transport (GO:0071805),0.3175208132090411,1.284260664204858,0.08884297520661157,0.5869277826195461,1.0,32/135,17.85%,SLC1A3;KCNK2;KCNT2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;KCND2;SLC9A7;KCNJ16;KCNJ3;KCND1;SLC24A4;SLC24A2;KCNJ5;KCNJ14;KCNK10;ATP1A3;SLC12A3;KCNH7;ATP1B3;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5
prerank,positive regulation of cell killing (GO:0031343),-0.5133206576872426,-1.2842339580037192,0.16152450090744103,0.46670731261636944,1.0,5/13,30.85%,RAC1;FZD7;SYK;NOX1;NOS2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.34645776390952204,-1.2840298273040696,0.09108910891089109,0.4665298273834974,1.0,23/72,22.81%,ACER2;RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLK2;BAX;PLAGL1;PCBP4;RPS27L;E2F1;SOX4;CDKN1A;E2F4;GADD45A;SFN;CNOT11;E2F7;CNOT3;TRIAP1;PLK3;SESN2
prerank,Ras protein signal transduction (GO:0007265),-0.3083010942555175,-1.2834612544523931,0.06679389312977099,0.4672165664696361,1.0,43/137,16.94%,PLCE1;RREB1;RAP1A;RASGRP3;ARHGEF3;EPS8;RAP1B;RAPGEF1;SHOC2;EPS8L2;ARHGAP1;ARHGDIA;RAC1;SHTN1;RALB;ARHGDIB;SHC1;ADGRG1;KRAS;USP8;RIT1;RASSF1;GRAP;PLK2;TRIM28;RB1;GDI1;PHACTR4;RHOB;CFL1;RTKN;NF1;DBNL;FGF2;GNB1;HRAS;NTN1;CELSR1;LIMK1;RGL2;CDKN1A;NCKAP1;RAPGEF3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4909821305801098,1.2832985361148321,0.18816067653276955,0.5879554003095624,1.0,3/16,1.69%,BMP2;SALL1;GDNF
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.36670943736216743,-1.2830203844540105,0.11284046692607004,0.4675475522203116,1.0,17/57,17.57%,MAP3K5;NOD1;ARL6IP5;REST;TNFSF10;CASP8;PPM1F;PERP;NDUFA13;CTSD;SOX7;BAK1;SYK;AIM2;BCAP31;BAD;FOXL2
prerank,phosphorylation (GO:0016310),-0.2736264860780682,-1.282851470918199,0.012987012987012988,0.46721992045467914,1.0,105/385,18.84%,PRKCH;ERG;CDK6;MAP3K5;RPS6KA5;DGKH;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;BMX;NEK7;CAMK2D;HK1;MAP3K1;MAP3K20;FNIP2;TGFB1;APP;TGFB2;FAM20A;CSNK1G2;ADAM10;PRKCZ;CTBP1;IGFBP3;MINK1;TAOK3;NRBP1;IKBKB;RARA;PRKDC;BCR;SRPK1;TRIB2;STK25;PLK2;DYRK2;AKT1;INSR;MAP3K11;CDC42BPB;TRIB1;PIM3;LMTK2;WNT11;TOLLIP;CAMK1;CDK4;TAOK2;FRK;LIMD1;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;YWHAZ;PRKCE;CDK10;PPP3CB;PNKP;SPHK2;SYK;FASTK;CDKL4;TBCK;NUAK1;CERKL;NUAK2;JAK2;ERBB2;PIK3CA;PRKAG1;COQ8A;LMTK3;LIMK1;NEK3;STK38L;STK26;CDK13;CSNK2A1;PGK1;MAP3K9;JAK3;HCK;DGKZ;RET;CHUK;POMK;MAP3K6;TXK;CHEK1;NADK;FAM20B
prerank,regulation of protein localization to membrane (GO:1905475),0.4322226920312663,1.2823002146681535,0.17835671342685372,0.5889380882005396,1.0,8/28,10.06%,GPC6;AR;SLC5A3;GPC4;GPC2;PRKN;STX7;GPC5
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3248519641865798,-1.2820755149273266,0.07429718875502007,0.4685072352209062,1.0,27/98,17.44%,SLCO1C1;THBS1;TGFBR2;NFKBIA;PPARD;KLF4;TGFB1;RNF41;ANXA2;VEGFA;ACLY;CHCHD2;RIPK1;AKT1;INSR;IFNAR1;ACE2;INHBA;APOE;AGPAT1;FMR1;RAB1A;CDKN1A;NR1H2;GREM1;CBR1;NSF
prerank,positive regulation of chemokine production (GO:0032722),-0.37939833204513235,-1.281984978016381,0.12260536398467432,0.46801480897352493,1.0,11/44,15.55%,APP;IL33;TLR3;TWIST1;TIRAP;CD74;MAVS;TLR4;SYK;CSF1R;IL17RA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5431455333532359,-1.281737725735704,0.17669172932330826,0.46790060208234907,1.0,5/11,24.58%,ITM2A;BACE2;ABCA2;NECAB3;NECAB2
prerank,regulated exocytosis (GO:0045055),-0.2987486622037217,-1.28173190942671,0.04430379746835443,0.4672265695829225,1.0,38/173,12.98%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;ARHGAP17;CYRIB;VEGFC;CALM1;VAMP7;TGFB1;APP;TGFB2;LHFPL2;FAM3C;CD109;RAB11FIP1;VEGFA;PSAP;STX1A;WDR1;ISLR;ACTN1;TGFB3;CD9;QSOX1;PDGFA;PCDH7;VCL;RAB11B;VEGFD;PPP3CB;SYT2;CDC37L1;CYB5R1
prerank,axonal transport of mitochondrion (GO:0019896),-0.5319986751509889,-1.281716076923238,0.1720226843100189,0.46658622892461704,1.0,4/11,16.25%,TRAK1;NEFL;TRAK2;OPA1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3395391147721521,-1.2817005188532908,0.094,0.46594942239176695,1.0,17/75,10.11%,TEK;CLDN5;SEMA6A;THBS1;KLF4;COL4A2;DAB2IP;NPR1;TGFB2;STAB1;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,regulation of secretion (GO:0051046),0.5255661478991093,1.2807007469009295,0.18640350877192982,0.5916265411200158,1.0,4/13,8.27%,NRG1;OPRK1;SCIN;ERBB3
prerank,regulation of NMDA receptor activity (GO:2000310),0.4235296542847335,1.2803659098704234,0.14042553191489363,0.5909273984229848,1.0,13/32,14.41%,SLC6A9;GRIA4;DLG2;DAPK1;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.494863789245872,-1.279649771814983,0.1736745886654479,0.4703688517907367,1.0,8/15,30.80%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.273033132158438,-1.279391076683962,0.012244897959183673,0.4703152243820857,1.0,84/348,15.87%,TEK;PECAM1;CAV1;SLCO3A1;RAP1A;RPS6KA5;PTPRJ;CCND3;PLCG2;IL15;FGF1;RACK1;PTK2B;LIMCH1;BMPR2;LIMK2;KDR;MAPK3;IQGAP1;TFRC;PTK2;NIBAN1;TBX1;VEGFC;CSPG4;CARD14;NGF;CD44;HSP90AB1;CALM1;FNIP2;TGFB1;APP;TGFB2;FAM20A;RAC1;PPIA;RALB;CD81;VEGFA;PDE8A;TGFB3;RASSF2;RIPK1;KRAS;FLT4;AKT1;INSR;PDGFC;PDGFA;FLOT1;FAS;CSNK2B;DDRGK1;LRP8;CD74;CAMK1;INHBA;TAOK2;CIB1;VEGFD;MTCP1;CALM3;ACVR1;MAVS;FGF2;FMR1;CSF1R;ENG;PIK3R3;HRAS;INHBB;JAK2;SDCBP;EGFR;LCP2;MMD;ERBB2;PRKAG1;SMAD4;CAB39;BCAR3;CX3CR1;CDKN1A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.5459567606914212,-1.2783222569607227,0.1776937618147448,0.4722802927784395,1.0,3/10,14.68%,MAP2K5;KLF4;SIGIRR
prerank,regulation of cell development (GO:0060284),-0.39123019789707564,-1.2768098369631027,0.15060240963855423,0.47516625136621526,1.0,11/36,15.81%,FOXO1;HDAC9;BHLHE40;HEYL;RPS19;AKT1;PRUNE1;YTHDF2;HES1;HEY1;CX3CR1
prerank,negative regulation of lyase activity (GO:0051350),0.4818678059994475,1.2766667530424805,0.17889908256880735,0.5991603092710345,1.0,4/16,17.13%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,regulation of developmental growth (GO:0048638),0.42386619969233613,1.2766249601420596,0.15565031982942432,0.5976909925546238,1.0,7/29,10.84%,IGF1;STAT5B;OLFM1;GHR;SIX4;NRCAM;MUSK
prerank,selective autophagy (GO:0061912),-0.3572529866881229,-1.2765008022004682,0.1087378640776699,0.475248259492709,1.0,17/56,19.74%,VIM;MAP1LC3B;UBB;DYNC1LI2;UBC;RPS27A;UFM1;DDRGK1;RAB7A;KLHL3;PHB2;DYNC1LI1;UFL1;AMBRA1;UFC1;UBA5;DYNLL2
prerank,T cell proliferation (GO:0042098),-0.5138665992197545,-1.2762781939955454,0.19469026548672566,0.4750738485847459,1.0,11/13,37.82%,CTPS1;MSN;PPP3CB;PIK3CG;RASGRP1;LILRB1;DOCK8;CADM1;LMBR1L;SLC11A1;CRTAM
prerank,regulation of cell division (GO:0051302),-0.3439526092432609,-1.2761482171052665,0.1095890410958904,0.47470684396619584,1.0,35/72,31.40%,MLLT3;FGF1;RACK1;RAB11A;CALM1;ZFYVE26;PLK2;TAL1;PRDM15;CIB1;CALM3;BCL2L1;RAB11FIP3;CETN2;KLHL9;KLHL21;PIN1;CDK2AP2;PRPF40A;SFN;KIF18B;TLE6;KIF13A;PLK3;PLK5;MYO19;SETD2;CSPP1;ENTR1;HTR2B;PLK1;MYC;DLL1;AURKA;PIK3R4
prerank,regulation of cell differentiation (GO:0045595),-0.3012662921985877,-1.2760575641100609,0.06097560975609756,0.474246959622472,1.0,39/148,16.55%,SLC6A6;CDK6;SMOC1;SPOCK2;DDX5;LTBP4;KLF4;PTK2;TBX1;RPS6KA3;SMAD7;NGF;HSP90AB1;DDX17;SIX1;TGFB1;REST;PPP2R1A;UQCC2;NOTCH4;ATF4;CBFB;PHLDB1;BCL6;MCRIP1;EMP2;CAMK1;NF1;OCIAD1;ZFHX2;BCL6B;HEY1;SRF;FLOT2;YWHAG;ZFHX3;GREM1;YWHAH;PDCD2
prerank,lymphocyte proliferation (GO:0046651),-0.4351151754810351,-1.2759787267943976,0.1577981651376147,0.4737620682409864,1.0,5/22,12.38%,MEF2C;CTPS1;MSN;HSPD1;PPP3CB
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.37332133765710823,-1.2752731199117349,0.1276595744680851,0.47474274021470964,1.0,13/47,17.01%,NFKBIA;KLF4;RPL10;FOXO3;TGFB1;APP;EDN1;AKT1;INHBA;APOE;RBM4B;NR1H2;PCIF1
prerank,regulation of lamellipodium organization (GO:1902743),-0.5036696652442019,-1.275095969427384,0.166351606805293,0.4744718498936516,1.0,9/14,38.26%,CD44;RAC1;EPHA2;DMTN;CARMIL1;CDC42;CAPZB;TWF2;VIL1
prerank,vitamin D metabolic process (GO:0042359),0.5097599721572278,1.2742242901656193,0.18318965517241378,0.6024968745422125,1.0,2/13,1.77%,VDR;CYP27B1
prerank,regulation of protein catabolic process (GO:0042176),-0.32179176031827333,-1.2740132711578773,0.09240246406570841,0.47649738615344844,1.0,29/99,19.76%,WWP1;GPC3;EEF1A1;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;EGLN2;IDE;PLK2;NDUFA13;ATG7;VCP;RAB7A;OAZ2;ITCH;SMURF1;EGFR;SNF8;TNFAIP3;CSNK2A1;FZR1;NSF;AGAP2;GFAP;PIN1;SNX3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5363919887405532,-1.2735116762644527,0.18806509945750452,0.4770837844249823,1.0,3/10,8.42%,CTTNBP2NL;THBS1;AKT1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4778005532373659,-1.272812668327006,0.18618042226487524,0.4780737140285199,1.0,12/15,42.57%,NLRC5;CNOT7;YTHDF2;SAMHD1;TTLL12;PTPN2;MUL1;YTHDF3;USP18;OAS3;CACTIN;STAT2
prerank,glycogen biosynthetic process (GO:0005978),-0.5136873759596705,-1.272733744809058,0.1797153024911032,0.47689578513993397,1.0,5/12,27.20%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,glucan biosynthetic process (GO:0009250),-0.5136873759596705,-1.272733744809058,0.1797153024911032,0.47689578513993397,1.0,5/12,27.20%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5037271144570135,-1.2716489438560237,0.17794970986460348,0.4787847014637636,1.0,3/13,5.34%,RREB1;SIX1;SOX13
prerank,natural killer cell mediated immunity (GO:0002228),-0.47699794665325695,-1.2714191670132007,0.18679245283018867,0.47873008621610685,1.0,4/15,19.41%,LYST;PLEKHM2;TUBB4B;ARL8B
prerank,protein localization to cell periphery (GO:1990778),-0.30820784379812466,-1.2709055192173586,0.04572564612326044,0.47925965760527983,1.0,48/133,21.37%,CAV1;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;AP4M1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,heart looping (GO:0001947),-0.38652254069840797,-1.2705936099687192,0.1442687747035573,0.4793568054970767,1.0,11/39,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.35936043309338567,-1.2700416338899294,0.14211438474870017,0.4800732657139632,1.0,25/56,25.76%,CCND3;RAB11A;ANXA1;BRD4;RGCC;ANAPC11;AKT1;RB1;LSM11;CDK4;RCC2;PHB2;EGFR;ANAPC7;CDC27;ANKRD17;CCND1;FGF10;EIF4G1;LSM10;DTL;HYAL1;AIF1;RPTOR;RDX
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4464427295350957,-1.2699067821173544,0.15970961887477314,0.47971343703769,1.0,6/19,16.48%,CSGALNACT1;EXTL3;NDST1;NDST3;HS3ST3B1;XYLT2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5143669436685457,-1.268870954300842,0.15798922800718132,0.4816517598301043,1.0,8/12,35.15%,DKC1;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;CCT6A
prerank,mitochondrial fusion (GO:0008053),-0.4660207493747569,-1.2687433653605942,0.16998191681735986,0.48125528204232393,1.0,12/18,41.33%,MIEF1;BAX;CHCHD3;MIEF2;OPA1;FIS1;MFF;THG1L;MIGA1;STOML2;GDAP1;MFN1
prerank,regulation of ATP metabolic process (GO:1903578),-0.354456913762105,-1.2684036288190115,0.13636363636363635,0.48142937096561367,1.0,23/54,27.54%,ZBTB7A;UQCC2;NUP93;NDC1;NUP54;SPHK2;NUP188;NUP155;RANBP2;PRKAG1;ATP5IF1;NUP37;JMJD8;SLC25A33;FIS1;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,glutathione biosynthetic process (GO:0006750),-0.53177894192393,-1.2682895023569765,0.1875,0.4810311065021993,1.0,6/11,29.73%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2
prerank,pulmonary valve development (GO:0003177),-0.4650789492821818,-1.2680427208471605,0.1488970588235294,0.4809740300093679,1.0,12/18,14.52%,NOS3;NOTCH1;BMPR2;SLIT2;TGFB2;STRA6;HEYL;SMAD6;TNFRSF1B;NFATC1;TNFRSF1A;HEY1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.32264804338114517,-1.2679591274045976,0.09001956947162426,0.4805310648964527,1.0,26/94,16.82%,RAB11A;DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CEP162;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;CC2D2A;HAUS1;NDE1;CETN2;CEP72;KIF24;YWHAG;HSP90AA1;CEP41;TMEM67
prerank,anion transmembrane transport (GO:0098656),0.35767360222227784,1.2676915783053266,0.12371134020618557,0.6185870764651914,1.0,11/67,7.31%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;SLC7A2;SLC6A13;SLC13A4;MFSD12;SLC25A13;SLC25A42;SLC25A10
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.29689710990644236,-1.267655742467888,0.05432595573440644,0.4806044166875333,1.0,57/175,24.36%,TMSB4X;PTK2B;ACTN4;NFKBIA;TNFRSF11B;FOXO3;RPS3;DAB2IP;CARD14;LIMS1;IKBKB;TNFRSF21;PSMA6;TNFRSF1B;RIPK1;NPNT;YBX3;TNFRSF11A;PSMB5;AKT1;CCL15;DHX9;PSMC4;PSMC5;CIB1;PSMD14;COMMD7;EDA2R;TRAF1;TNFRSF1A;AIM2;JAK2;PSMD8;TNFSF13;PSMD11;STAT1;PSMB4;PSMD12;PSMC1;RELA;CHUK;ARHGEF2;HAS2;LTBR;PSMA1;ADAMTS7;PSMB1;PSMC3;TXNDC17;PSMA4;TNFSF13B;PSMA2;HYAL1;TNFRSF9;TNFRSF12A;TRAF6;CCL2
prerank,retinoic acid metabolic process (GO:0042573),0.48906510585833973,1.267509066112031,0.17123287671232876,0.6174435488874243,1.0,1/14,0.56%,ALDH1A2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.4025215792312893,-1.2674572111987235,0.14311270125223613,0.48045552685956183,1.0,15/33,28.16%,PTPRJ;RPS3;CD81;EZR;RC3H1;DUSP3;NECTIN2;RELA;DGKZ;LAPTM5;PRKD2;PTPN22;BCL10;PTPN2;CARD11
prerank,response to calcium ion (GO:0051592),-0.3178992749797846,-1.2669683043716524,0.09109730848861283,0.4810121124643339,1.0,21/102,14.41%,MEF2C;CAV1;ITPKB;CLIC4;THBS1;PLCG2;TRPC3;MEF2A;IQGAP1;CAMK2D;CALM1;ITPR3;CARF;CPNE8;ADD1;SLC25A12;CALM3;HOMER1;SYT2;PEF1;CASQ2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4392802221401807,-1.2668992183188363,0.16967509025270758,0.4805301457227379,1.0,12/22,30.15%,DDX5;RPS15;RPL23;UBB;RPS20;RPS7;CDK5RAP3;MSX1;SPRED3;PMAIP1;RPL37;SPRED1
prerank,endothelial cell differentiation (GO:0045446),-0.5038975430060947,-1.2667682747127915,0.1879432624113475,0.48015927942194836,1.0,5/12,12.73%,TIE1;BMPR2;KDR;SOX18;FSTL1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4108704335249609,1.266518213186422,0.1504237288135593,0.6185345905322449,1.0,8/33,9.13%,TCF7L2;SEMA5A;PPARA;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,regulation of RNA metabolic process (GO:0051252),-0.34943281654872504,-1.266381917986107,0.10721247563352826,0.48052968996577095,1.0,15/59,13.27%,AHNAK;NOVA2;AHNAK2;MBNL1;HNRNPLL;RBM20;PTBP3;ZNF326;TNFRSF1B;RC3H1;FUS;PCBP4;YTHDF2;CLK1;FASTK
prerank,regulation of MAPK cascade (GO:0043408),0.308587307930726,1.2663184788082595,0.08082706766917293,0.6174399763591315,1.0,26/157,9.40%,IGF1;EPHA7;TGFBR3;NRK;BMP2;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;ROCK2;RIT2;WWC1;LYN;GSTP1;IAPP;EPHB1;RRAS;TNIK;THPO;SOX2;IGF2;RYK;EPHA8;MYDGF
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.4361419759689944,-1.2662305801235767,0.1510791366906475,0.4802201327921617,1.0,3/22,4.03%,IL15;SLC7A5;TGFB1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5240498204591117,-1.26617293583391,0.19099099099099098,0.4796928256842505,1.0,8/11,37.52%,JAK2;STAT1;IL6ST;IL12RB2;STAT4;IL27RA;CANX;IL12A
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4271993484921174,-1.2661077247386452,0.16536964980544747,0.4791986156567413,1.0,4/24,7.84%,DACH1;BMPR2;RPS3;ERCC1
prerank,cellular response to type I interferon (GO:0071357),-0.38113439469941507,-1.2659773187551162,0.14177693761814744,0.4781638037952418,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,type I interferon signaling pathway (GO:0060337),-0.38113439469941507,-1.2659773187551162,0.14177693761814744,0.4781638037952418,1.0,24/41,39.84%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;STAT1;IRF8;RSAD2;PSMB8;EGR1;IP6K2;ISG20;IRF6;XAF1;IRF3;IFNAR2;IRF2;TYK2;OAS3;IRF5
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.39285134502517133,-1.2659343908309049,0.13409961685823754,0.47762175437842386,1.0,13/34,16.64%,TEK;FLT1;PTK2B;PTK2;DAB2IP;TNFAIP8L3;TGFB1;PIK3IP1;FGF2;PIK3R3;NOD2;PIK3R2;AMBRA1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.467123957299013,-1.2654032375180553,0.17889087656529518,0.47825481602510317,1.0,7/17,15.49%,ARL6IP5;TGFB2;MID1;TAOK3;STK25;TAOK2;NOD2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.43670396466598166,-1.2653940355823676,0.16541353383458646,0.47761672526813054,1.0,4/22,10.02%,B2M;CD55;CYRIB;HSPD1
prerank,positive regulation of axonogenesis (GO:0050772),0.38801238651990755,1.265333523706919,0.13184584178498987,0.6185682511905637,1.0,3/43,0.57%,PLXNA2;ROBO1;ROBO2
prerank,regulation of filopodium assembly (GO:0051489),0.40043917388238487,1.2652234750969389,0.1317365269461078,0.6172592534231814,1.0,7/38,7.72%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.42915537444135354,-1.2645560372241167,0.1645101663585952,0.4788787551749033,1.0,7/23,4.89%,THBS1;MAPK3;PTK2;STK10;SLIT2;MSN;CMKLR1
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.36238643914288593,-1.2641730899601018,0.15689981096408318,0.4791972764415896,1.0,10/49,11.58%,MEF2C;THBS1;TNRC6C;KMT2C;RBBP5;CBFB;MYL9;H3-3A;KMT2D;CIB1
prerank,negative regulation of neuron projection development (GO:0010977),0.3638219767754444,1.2635921846881228,0.13742071881606766,0.6202347802797393,1.0,14/56,12.61%,LPAR1;LRP4;SEMA3A;MCF2;RTN4;RAB29;DPYSL3;BCL11A;NLGN1;STX1B;DCC;PTEN;NGFR;CBFA2T2
prerank,mitotic recombination (GO:0006312),0.4833354880398026,1.263547705837764,0.19325842696629214,0.6187922649207858,1.0,6/15,18.37%,DMC1;GEN1;TEP1;SMC6;SMC5;NSMCE2
prerank,negative regulation of catalytic activity (GO:0043086),-0.42342294222275406,-1.2632864523973877,0.16911764705882354,0.48061641055981374,1.0,7/24,17.61%,NOTCH1;NES;IFIT1;ATP5IF1;APBA3;CCAR2;NOSIP
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4038073330852622,-1.262972172967719,0.1586452762923351,0.48074262871700024,1.0,20/32,34.14%,BRCC3;TAOK3;FOXN3;UIMC1;BABAM1;TAOK2;CDC14B;CDKN1A;FZR1;BABAM2;CHEK1;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;PLK1;CDK1;TICRR;CLSPN
prerank,mRNA transport (GO:0051028),-0.31559368195817306,-1.2629027125204588,0.09055118110236221,0.480264651156698,1.0,49/101,34.81%,HNRNPA2B1;SRSF2;SRSF5;NUP93;SRSF6;NDC1;HHEX;NUP54;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;RANBP2;CHTOP;ALYREF;AGFG1;NUP37;DDX39B;SMG7;CASC3;THOC6;CPSF4;NUP160;DDX39A;NCBP2;SMG1;EIF4E;NUP43;SEH1L;SEC13;NUP107;NUP42;THOC7;NUP98;SRSF9;GLE1;UPF1;SMG6;U2AF1L4;RAE1;SRSF1;UPF3B;RBM15B;NUP88;NUP214
prerank,protein modification process (GO:0036211),-0.3342728894312317,-1.2628761950670837,0.09423076923076923,0.47967110997131307,1.0,23/76,19.46%,ST3GAL6;ST8SIA4;MANBA;PLOD2;WWP2;PRKDC;MSRA;CSNK1G3;UBE2L6;CPE;ATG3;ABL2;STK38;MMP15;ICMT;FBXL2;LOX;YES1;PHEX;MCRS1;FBXW2;UBL5;LCMT1
prerank,negative regulation of ossification (GO:0030279),0.4267163258585224,1.262558963988832,0.1722689075630252,0.6199417063239396,1.0,5/23,4.24%,ENPP1;BCOR;AHSG;LRP4;SFRP1
prerank,response to histamine (GO:0034776),0.5307922449638619,1.2624758798735143,0.2081447963800905,0.6185642733684065,1.0,7/10,25.54%,GABRB3;HRH1;DRD2;GABRB1;GABRG2;GABRB2;DRD3
prerank,phosphatidylserine metabolic process (GO:0006658),0.4080084662292243,1.2622148886699474,0.17834394904458598,0.6177460481257896,1.0,4/32,3.11%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4749021668516271,-1.2621042634143254,0.17896678966789667,0.48083601346119564,1.0,11/17,34.05%,COX4I1;COX7C;COX6B1;COX15;COX6C;NDUFA4;COX10;COX8A;COX4I2;COX7A2L;COX5B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.49607385536083426,-1.261472245364676,0.17472118959107807,0.48172114314167186,1.0,4/14,10.20%,LIMS2;LIMS1;EMP2;PHACTR4
prerank,inhibitory synapse assembly (GO:1904862),0.506343688268856,1.261205461263184,0.19915254237288135,0.6189062748738584,1.0,2/11,5.56%,GABRA2;GABRB3
prerank,amino acid transmembrane transport (GO:0003333),0.3750287413766039,1.2606950444347682,0.1557377049180328,0.6187750231716455,1.0,8/45,7.15%,SLC7A11;SLC6A13;SLC22A4;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC25A13
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4851456664730477,-1.2605043359754142,0.18968692449355432,0.48332704261340736,1.0,4/14,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,regulation of neurogenesis (GO:0050767),-0.353798074096833,-1.2598819139588693,0.12156862745098039,0.4842311944773778,1.0,13/55,15.81%,B2M;NOTCH1;TGM2;REST;BHLHE40;HEYL;FAIM;PRUNE1;YTHDF2;PCM1;HES1;HEY1;CX3CR1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.49871518135712734,-1.259880551235032,0.17985611510791366,0.4835821332060729,1.0,4/13,15.00%,NOTCH1;TGFBR2;CPE;SMAD4
prerank,mesenchymal cell differentiation (GO:0048762),0.36841674733301577,1.2597511654600926,0.1288981288981289,0.6198452850005678,1.0,11/51,8.08%,TGFBR3;WNT4;BMP2;FGFR2;ROCK2;RANBP3L;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,male gonad development (GO:0008584),0.39689964763465213,1.259741896905727,0.15644820295983086,0.6183266654528662,1.0,7/34,9.13%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5284441513733535,-1.2596383730424372,0.20384615384615384,0.48349123473343314,1.0,3/11,6.53%,RACK1;REST;ATF4
prerank,glycoprotein biosynthetic process (GO:0009101),0.3447374123943884,1.259389001948009,0.11220472440944881,0.6177939896294615,1.0,12/79,5.53%,IGF1;B3GALT1;CHST8;GAL3ST3;GAL3ST2;B3GALNT1;ST6GALNAC1;ST3GAL5;B3GNT7;ST8SIA1;ALG5;FUT4
prerank,hyaluronan metabolic process (GO:0030212),0.4371180816677144,1.2593073510203252,0.19037199124726478,0.6164520411662165,1.0,3/23,1.32%,CEMIP;SPAM1;HYAL3
prerank,cellular response to drug (GO:0035690),-0.4202564107867232,-1.2592098012257595,0.15939278937381404,0.4839685872397152,1.0,7/25,8.70%,MEF2C;ACER2;TFRC;REST;KCNQ1;PPM1F;RBM22
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.395084847762743,1.259152152651616,0.171875,0.6153238732241568,1.0,11/37,12.33%,IFT81;DYNLL1;DYNC2I2;DYNC2H1;IFT122;DYNC2LI1;IFT140;IFT74;KIF3C;KIF3A;IFT43
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3671044116623079,-1.2589659013842454,0.15678776290630975,0.4838650816416653,1.0,13/48,11.58%,LIMS2;RREB1;DOCK1;FERMT2;RAC1;LIMS1;NEDD9;CRK;MYOC;PRKDC;S100A10;CAPRIN1;CIB1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3121060551516601,-1.2589434538431459,0.08333333333333333,0.4832492548307777,1.0,31/108,19.57%,CAV1;NXN;RPS3;SMAD7;HSP90AB1;FKBP1A;IVNS1ABP;UBB;CHP1;SH3RF2;N4BP1;DCUN1D1;FBXO4;AKT1;DNAJA1;CAMLG;FOXF2;FAM107A;PTTG1IP;BAG5;UBXN1;SOX4;SPRTN;PRMT3;TNFAIP3;UFL1;HSP90AA1;HSPA1A;CDK5RAP3;USP4;LAPTM5
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3381819107706526,-1.2585939769703083,0.1130952380952381,0.4834513737424905,1.0,17/71,11.24%,FAP;CAPN2;RNF41;CTSZ;UBB;UBC;RPS27A;CTSO;RHBDD1;CTSC;CASP8;PSMA6;IDE;USP9X;CTSF;VCP;CTSB
prerank,calcium ion import across plasma membrane (GO:0098703),0.4891775352863884,1.2584036542543853,0.19444444444444445,0.6157881623343945,1.0,3/14,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3532347607550081,-1.2583830349320648,0.1237721021611002,0.4833336271281102,1.0,25/52,28.98%,PPP1R13B;ABLIM3;PPP3CC;CASP8;SAE1;BBC3;YWHAZ;E2F1;VPS11;YWHAG;CSNK2A2;YWHAH;BAD;UBL5;SFN;FZD5;NPEPPS;MICALL2;YWHAB;YWHAE;UBE2J2;ATG13;NMT1;PMAIP1;YWHAQ
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3321595571694429,-1.257509570698176,0.08527131782945736,0.4847340131565187,1.0,26/80,17.57%,MAP3K5;THBS1;NOD1;MAP2K5;ARL6IP5;KLF4;RPS6KA3;NGF;CD44;REST;TNFSF10;VEGFA;PPM1F;GPX1;AKT1;NDUFA13;CTSD;SOX7;BEX3;SYK;DHCR24;BCAP31;CSNK2A1;IGBP1;BAD;FOXL2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5095997992016488,-1.2571885835511694,0.18063314711359404,0.4848751510676968,1.0,8/12,32.17%,SEC63;HSPA5;SEC61B;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3804276375474225,1.257059129021803,0.16344086021505377,0.6178516920877425,1.0,10/41,15.68%,IL34;AREG;TGFA;STAP1;ERBB3;DOK7;DLG4;BTC;GPRC5B;FCGR1A
prerank,aminoglycan biosynthetic process (GO:0006023),0.3691155409885883,1.257056236890164,0.12350597609561753,0.6163418533783016,1.0,18/49,18.11%,GPC6;B3GALT1;B3GALNT1;GPC4;GPC2;B3GNT7;PXYLP1;GPC5;B3GALT2;HS2ST1;HS6ST2;B3GALT5;HS3ST6;HS3ST5;HSPG2;B4GAT1;B3GNT6;B4GALT7
prerank,ventricular septum development (GO:0003281),0.39115391158596113,1.2568854489560444,0.14376321353065538,0.615233220232569,1.0,4/37,0.61%,ROBO1;TGFBR3;ROBO2;SALL1
prerank,regulation of necroptotic process (GO:0060544),-0.426770197162562,-1.256735255883799,0.16888045540796964,0.48536606385448217,1.0,10/23,18.57%,CASP8;RIPK1;YBX3;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1;ARHGEF2
prerank,leukocyte tethering or rolling (GO:0050901),-0.4635080904622009,-1.256717486292819,0.18928571428571428,0.4847577472770922,1.0,11/17,43.59%,JAM2;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7;ADD2;ROCK1;TNF;GCNT1;SELE
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.345273178784606,1.2566401572456072,0.11787819253438114,0.6144205473363459,1.0,14/69,11.07%,IGF1;PIK3R1;PLCL1;PDGFRA;MYO16;IRS2;PLCL2;PDGFRB;SIRT2;PLCH1;ERBB3;GATA3;PTEN;PLCD4
prerank,monocyte chemotaxis (GO:0002548),-0.400872086936147,-1.2559565703142475,0.15469613259668508,0.48604964259518574,1.0,5/32,8.73%,FLT1;ANXA1;RPS19;TNFRSF11A;CCL15
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.37228577716081496,1.255852993849692,0.16182572614107885,0.615065072960256,1.0,3/45,1.32%,BMP6;BMP2;BMP5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3118660860676934,1.2557424818614038,0.07905138339920949,0.6138678699784539,1.0,23/121,14.31%,IGF1;BMP6;IL31RA;NRP1;IL34;KIT;TNK2;LYN;GHR;IL4;IGF2;ERBB3;IL18;HES5;ERBB4;CNTF;IL6R;PIBF1;TEC;DOK7;DLG4;TSLP;GPRC5B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44507724237971424,1.2553555336567863,0.19101123595505617,0.6133894127685281,1.0,2/21,1.99%,SAMD4A;TUT4
prerank,positive regulation of transport (GO:0051050),-0.3289142575426465,-1.2549433157684948,0.10196078431372549,0.48793204446481836,1.0,23/85,15.09%,ACTB;GPC3;IL15;NEDD4L;ANXA1;RAB27A;ANXA2;CHP1;CD151;HIP1R;GATA2;BAX;PLAA;FLOT1;FCER1G;APOE;BAK1;FMR1;CAPN10;TUB;MLC1;LMAN2;CHCHD10
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.43774996747628914,-1.2548165104707474,0.16666666666666666,0.48759346550161103,1.0,6/21,12.56%,PDE4D;NT5E;PDE2A;NT5C1A;NUDT4;HINT1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.40565511800023646,-1.2545730703948172,0.18130841121495328,0.4875170359437094,1.0,3/30,1.42%,PPP1R13B;ACER2;DDX5
prerank,estrogen metabolic process (GO:0008210),-0.4745923580582173,-1.2544016842389778,0.2,0.4872709183746563,1.0,4/15,18.42%,SULT1A1;CYP1B1;HSD17B10;HSD17B2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4097036720020478,-1.2532250046936362,0.18908382066276802,0.4895143883081252,1.0,8/29,8.84%,SHANK3;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1
prerank,gland development (GO:0048732),0.3659357603081065,1.252758573891478,0.13980582524271845,0.618837978594509,1.0,11/59,7.96%,TGFBR3;WNT4;SALL1;TBX3;FGFR2;NRG1;GLI2;DKK3;SOX2;CITED2;TGFBR1
prerank,mesenchyme morphogenesis (GO:0072132),-0.4576246772863164,-1.2526342810226483,0.19708029197080293,0.4902647731927338,1.0,10/17,19.37%,NOS3;NOTCH1;TGFB2;TBX2;HEYL;ACVR1;ENG;HEY1;SMAD2;SOX9
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.37044861260854867,-1.2521137978288117,0.14579439252336449,0.49095425161650563,1.0,10/43,6.98%,DDX5;PPARD;KLF4;FOXO3;ETS1;TGFB1;REST;TGFB2;GATA2;NR3C1
prerank,regulation of inflammatory response (GO:0050727),-0.2906005087203446,-1.2517293439300525,0.059574468085106386,0.49134466207225613,1.0,49/190,20.25%,TEK;FOXP1;TMSB4X;SEMA7A;IL15;NFKBIA;PPARD;KLF4;CCN3;ETS1;ANXA1;MGLL;LPCAT3;APP;MFHAS1;PDE2A;IL1R1;IL33;GPR4;BRD4;TLR3;PSMA6;NFKBIZ;TNFRSF1B;RIPK1;BCL6;DHX9;RB1;ACE2;PIK3AP1;APOE;TLR4;TNFRSF1A;FEM1A;BCL6B;JAK2;NOD2;IL17RA;TNFAIP3;UFL1;RELA;HCK;NINJ1;DAGLB;PTGER4;CD200;METRNL;CASP1;GGT1
prerank,regulation of programmed cell death (GO:0043067),-0.29610209247211355,-1.2514595327579974,0.07028112449799197,0.49138595242105076,1.0,39/161,16.67%,MECOM;PPP1R13B;ACER2;TPT1;TGM2;ACTN4;RPS3;ZBTB7A;CRADD;IGFBP3;TMEM219;ANP32A;ACTN1;DCPS;TOX3;RIPK1;BAX;AKT1;PERP;BCL6;KANK2;FAS;HIP1;VCP;LRP8;CTSB;RTKN;PSMC5;HTATIP2;ACER3;JAK2;BNIP3L;OSGIN1;MADD;PTPN6;STK26;LGALS1;STAT1;HSP90AA1
prerank,glutamate receptor signaling pathway (GO:0007215),0.39590352413744695,1.251314603508202,0.15565031982942432,0.6212787478559271,1.0,14/37,18.62%,GRIA4;GRID2;GRIN3A;TRPM1;GRIK2;GRM1;GRIK1;CDK5R1;GRIA3;GRM4;GRIN2A;CLN3;GRIN2B;HOMER2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.4903024301220391,-1.250862531418516,0.1797153024911032,0.4922653668891673,1.0,10/14,34.09%,RPL35;PES1;URB1;RPL7;WDR12;FTSJ3;RPF2;ZNHIT6;DDX18;ZNHIT3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4143751438289085,-1.2504717632630247,0.1615798922800718,0.49255181916803864,1.0,10/25,19.15%,CAV1;CXADR;CAMK2D;CALM1;JUP;CTNNA3;CALM3;DSG2;DSP;CACNA1C
prerank,positive regulation of hormone secretion (GO:0046887),-0.4634842802300511,-1.2503735244103942,0.17495395948434622,0.49215458446019916,1.0,14/17,51.99%,VAMP7;EDN1;SPP1;RASL10B;EDN3;C1QTNF3;HFE;VAMP8;TFR2;CYP19A1;HCAR2;NMB;SOX11;GRP
prerank,regulation of cardiac conduction (GO:1903779),0.35964648858740544,1.2498740692673371,0.1422680412371134,0.6235020746093264,1.0,10/54,6.07%,ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;ATP2A2;FXYD1;ASPH
prerank,regulation of extracellular matrix organization (GO:1903053),0.47893909909682414,1.2489713613783955,0.18502202643171806,0.6243910656732844,1.0,6/15,8.80%,DDR2;LRP1;EFEMP2;DDR1;AEBP1;FGFR4
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4937329187865991,-1.248967777120396,0.21772639691714837,0.4949377470513762,1.0,7/14,33.13%,HTT;PRKAR2B;PRKAR2A;RAPGEF2;PKIG;PKIB;ADRB2
prerank,cation transport (GO:0006812),-0.291017476791585,-1.248766528475665,0.055449330783938815,0.4947345398399051,1.0,19/167,5.23%,SLC47A1;PIEZO2;ANO6;SLC6A6;SLC12A2;KCNK5;ANO1;KCNJ2;NEDD4L;SLC9B2;SLC7A1;TRPM7;ABCC9;TRPM6;PIEZO1;SLC5A6;SLC38A5;SLC1A1;CHP1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4642333497974592,-1.248715941344407,0.20297951582867785,0.4942178991353826,1.0,9/16,28.86%,RB1;POGZ;BOD1;RAD21;NIPBL;REC8;SGO1;DSCC1;NAA50
prerank,outflow tract septum morphogenesis (GO:0003148),0.44096398759383865,1.248671591448834,0.18543046357615894,0.6236844029942391,1.0,4/24,1.11%,ROBO1;NRP1;ROBO2;FGFR2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4213030766966633,1.2480773357965955,0.19690265486725664,0.623725863995745,1.0,5/26,8.87%,LGR4;SMPDL3B;LRRC14;NLRP2B;GPR108
prerank,actin filament network formation (GO:0051639),-0.5255256359421141,-1.247929986506167,0.19926873857404023,0.495449555968635,1.0,3/11,6.61%,COBL;PLS3;ACTN1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5134465423868378,1.2478454418193516,0.21861471861471862,0.6228364235110225,1.0,4/10,12.64%,STAT5B;LYN;GHR;PRLR
prerank,embryonic organ development (GO:0048568),0.35982527826773736,1.2477783086498597,0.1214574898785425,0.6215248314381958,1.0,15/61,9.35%,COL13A1;SALL1;FGFR2;GDNF;RARB;TEAD1;KIT;GLI2;GLI3;PBX4;IFT122;KMT2A;RBPJ;GATA3;BMPR1A
prerank,positive regulation of peptidase activity (GO:0010952),-0.44265053881388555,-1.2472668615816025,0.1773049645390071,0.49643344901053216,1.0,7/20,18.46%,NDUFA13;PSENEN;DDRGK1;VCP;APH1A;VSIR;MAPK12
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4051530622746117,1.2470269302708383,0.16733870967741934,0.6220362554402984,1.0,8/31,11.03%,FGFR2;HOXC4;PDGFRA;HOXB3;HOXC9;TGFBR1;HOXB9;FUZ
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.40887792825811625,-1.246855733284822,0.16727941176470587,0.4967818570224461,1.0,9/25,17.25%,ZNF326;ZMYND11;HMGN1;TSFM;LDB1;ALYREF;CCNK;DDX39B;CCAR2
prerank,UV protection (GO:0009650),-0.527207276576438,-1.2464270708956806,0.19402985074626866,0.4971457191308223,1.0,2/10,8.01%,SCARA3;GPX1
prerank,positive regulation of cellular process (GO:0048522),-0.25718511471744515,-1.2457067993594881,0.009009009009009009,0.49830181945480007,1.0,122/565,15.78%,FN1;KITLG;LEF1;CAV1;SLC6A6;FLT1;FRMD5;IGF1R;CLDN5;ACER2;LBP;THBS1;PTPRJ;NOTCH1;PARD3;IL15;DPP4;NAMPT;TRPC3;FGF1;TGFBR2;LRP5;PTK2B;TGM2;LIFR;ACTN4;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;RPS6KA3;VEGFC;ETS1;HSP90AB1;CDKN1B;RPRD1B;TGFB1;CNBP;TGFB2;RAB27A;TBX2;RPL23;RAC1;RPS15A;DNAJA2;ADAM10;CD81;RPS19;VEGFA;CNOT7;S100B;AQP11;ACLY;RARA;SHC1;GATA2;MFSD2A;TGFB3;HCFC1;TNFRSF1B;ADGRG1;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;PABIR1;MMP14;AKT1;INSR;FZD7;TAL1;NOP2;PDGFC;PDGFA;LAMC2;FLOT1;EMP2;FCER1G;DDRGK1;H3-3A;CDK4;KMT2D;S100A13;AKAP6;CIB1;VEGFD;FAM98A;GRK5;TLR4;SOX4;FXN;FGF2;HES1;RPS6;ACER3;AGPAT1;FMR1;CSF1R;CAPN10;HRAS;TUB;CDKN2AIP;MLC1;SDCBP;RAD18;EGFR;CHTOP;LMAN2;SRF;ERBB2;GAB2;CLCF1;TNFSF13;PTPN6;ZFHX3;NSMCE4A;CDK13
prerank,extracellular transport (GO:0006858),-0.5059926839823993,-1.2456231334291783,0.19784172661870503,0.49781275775258815,1.0,8/12,27.29%,WWP2;ARRDC1;TSG101;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,V(D)J recombination (GO:0033151),-0.5113963022148431,-1.2454386896090688,0.212406015037594,0.4976197843195582,1.0,5/11,28.60%,PRKDC;TCF3;DCAF1;LIG4;HMGB2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3950129228158588,1.245378282130971,0.16182572614107885,0.6249486755742013,1.0,7/34,9.25%,IGF1;TGFA;PHIP;PDGFRB;CDC23;IGF2;CDC16
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3162166423986302,-1.2452567680729525,0.09375,0.4974361877550154,1.0,34/93,27.00%,CAV1;DMD;RACK1;TFRC;PDE4D;SMAD7;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;RASSF2;PPM1F;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;DDIT4;NCK1;HCLS1;PRKD2;PDCD10;EIF4G1;DMTN;NCK2;RPTOR;PARK7;TXN;TNKS1BP1
prerank,receptor internalization (GO:0031623),-0.3658140626361379,-1.2448460862599795,0.13953488372093023,0.49778798783012423,1.0,9/44,9.89%,CAV1;DNM3;ACKR3;RAMP2;TFRC;CD81;CD9;AP2M1;FCER1G
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3543532418777126,-1.2446864055674436,0.14149139579349904,0.4975515199814156,1.0,13/55,12.16%,CAV1;RACK1;RPS3;TPD52L1;DAB2IP;CRADD;TNFSF10;ING5;RIPK1;BAX;FAS;BBC3;BCL2L1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5122638141400286,1.2444587381723167,0.20353982300884957,0.6259204302616578,1.0,4/10,18.79%,KIT;LYN;BTLA;FGR
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.48679401926303767,1.2442503702675314,0.19693654266958424,0.6250639339204878,1.0,4/15,14.06%,SH3D19;SNX33;SNX9;NRDC
prerank,inositol lipid-mediated signaling (GO:0048017),0.36459875452969226,1.244216249609907,0.14680851063829786,0.6236837702629593,1.0,8/50,7.70%,IGF1;PIK3R1;PLCL1;PDGFRA;IRS2;PLCL2;PDGFRB;PLCH1
prerank,regulation of isotype switching (GO:0045191),0.49239918401152005,1.2441757110461258,0.2151029748283753,0.6223415166446238,1.0,7/14,16.52%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B;PARP3
prerank,alpha-amino acid metabolic process (GO:1901605),0.37375206956899865,1.2438595232913392,0.18619246861924685,0.6216934395117361,1.0,19/45,23.74%,ASPA;ALDH18A1;SLC25A13;KMO;GLUL;GLS2;FOLH1;MTHFD1;ASS1;DDAH2;ASPG;NOX4;GPT2;GOT1;GOT2;MMUT;KYAT1;CBS;MTHFR
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.38656039012808546,-1.24380426559488,0.17286245353159851,0.4990887359172865,1.0,12/36,12.82%,MEF2C;THBS1;NOTCH1;DAB2IP;SLIT2;TGFB1;PTPRM;RGCC;JUP;CSNK2B;APOE;FGF2
prerank,early endosome to late endosome transport (GO:0045022),-0.4470849216781998,-1.243343337429408,0.1875,0.49960338464089216,1.0,6/20,15.29%,EEA1;EMP2;LMTK2;KIF16B;RAB7A;SNF8
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5211859900811135,-1.2430152582898024,0.21511627906976744,0.4996903847350447,1.0,7/11,19.37%,TGFBR2;LRP5;TBX1;PDGFA;CTNNBIP1;STAT1;SOX9
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.42315527981391965,-1.242718619067368,0.1875,0.49982267570330496,1.0,14/23,27.65%,UBB;UBC;RPS27A;CUL4A;COPS6;COPS5;RBX1;CETN2;COPS7A;COPS4;COPS7B;XPC;GPS1;RAD23B
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4518555901343133,1.2426901655556473,0.19736842105263158,0.6233711926260865,1.0,5/18,11.12%,SLC2A13;ROCK2;LRRTM3;CASP3;CHRNA7
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.477644498551043,-1.2421341641018866,0.20074349442379183,0.5006012741009741,1.0,11/14,26.68%,DAB2IP;BAX;DDRGK1;HSPA5;BAK1;COPS5;UFL1;TMEM33;BFAR;PTPN1;FICD
prerank,protein mannosylation (GO:0035268),0.4376023664671703,1.2421088551417534,0.20044543429844097,0.6235664229793899,1.0,9/22,19.50%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;DPY19L1;B4GAT1;DPM1;DPY19L4
prerank,regulation of monocyte differentiation (GO:0045655),-0.48255002731466223,-1.2418251524112618,0.20545454545454545,0.5007496332813297,1.0,4/14,10.73%,FOXP1;CDK6;CTNNBIP1;CD74
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3845550380567897,-1.2411574110226977,0.17712177121771217,0.5016552236278458,1.0,13/38,16.67%,CAV1;CD34;KLF2;KLF4;HSP90AB1;RAC1;EDN1;AKT1;INSR;TLR4;JAK2;CX3CR1;HSP90AA1
prerank,regulation of protein transport (GO:0051223),-0.4167247549175068,-1.2406076254949217,0.18164435946462715,0.5023101817042847,1.0,14/27,31.46%,HSPA8;WWP2;CHP1;PPM1F;DNAJA1;NDEL1;SNX3;PTPN1;RHBDF2;NDFIP2;P3H1;ATP13A2;NDFIP1;SNX12
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3968814031324811,1.2399901081962126,0.20833333333333334,0.6276666208961688,1.0,9/29,13.61%,LDLRAD4;BMP5;SFRP1;FOXA2;GATA3;PTEN;FUZ;ZNF750;NKX2-1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5151249436565034,1.2398945227910825,0.22706422018348624,0.6249873995432926,1.0,2/12,4.89%,FHL2;ACTN3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5151249436565034,1.2398945227910825,0.22706422018348624,0.6249873995432926,1.0,2/12,4.89%,FHL2;ACTN3
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3892921134474976,1.2395630808208922,0.18240343347639484,0.6244542853928654,1.0,4/36,6.45%,NRP1;AREG;TGFA;NLGN3
prerank,regulation of fat cell differentiation (GO:0045598),0.33767917144349957,1.2395524554957853,0.13709677419354838,0.6230501580487662,1.0,11/74,9.32%,RORA;ENPP1;BMP2;RUNX1T1;SMAD3;SFRP1;CEBPB;MEDAG;SIRT2;GATA3;FTO
prerank,regulation of interleukin-10 production (GO:0032653),-0.36841473737042035,-1.239371466135048,0.15779467680608364,0.5047286625692485,1.0,11/44,17.47%,CD34;PLCG2;PRKCZ;TNFRSF21;TRIB2;HSPD1;TLR4;SYK;NOD2;VSIR;JAK3
prerank,cellular response to nutrient levels (GO:0031669),-0.340741387061086,-1.2393641423109683,0.12678936605316973,0.5041046368509371,1.0,28/62,25.23%,BMPR2;FOXO1;KCNB1;MAP1LC3B;HSPA8;RALB;MFSD2A;FAM107A;ATG7;MAP1LC3A;INHBB;GAS2L1;STK26;RRAGD;XBP1;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;EIF4G1;CD68;RRAGC;NUPR2;CDKN2B;RPTOR;SREBF1
prerank,negative regulation of MAPK cascade (GO:0043409),-0.3201923170480795,-1.239178096600162,0.11267605633802817,0.503926012301697,1.0,31/87,27.93%,CAV1;SEMA6A;PTPRJ;FOXO1;DAB2IP;PPIA;PEBP1;EZR;PRDM15;UCHL1;NF1;STK38;DUSP3;APOE;TLR4;SMAD4;PIK3R2;IGBP1;SPRY1;CDK5RAP3;PIN1;PTPN1;DUSP4;PRKCD;SPRED3;PPEF2;SMPD1;SPRY4;DUSP6;PTPN2;DUSP1
prerank,regulation of cytokinesis (GO:0032465),-0.3258405868608575,-1.2391274597698245,0.13229571984435798,0.5034382937578621,1.0,39/78,32.09%,PKP4;RAB11A;CDC14A;CALM1;GIPC1;ZFYVE26;PLK2;KIF23;CALM3;BCL2L1;PRKCE;CDC14B;RAB11FIP3;CETN2;KLHL9;ECT2;KLHL21;PIN1;PRPF40A;E2F7;KIF13A;PLK3;CDC42;CIT;VPS4A;PLK5;MYO19;SETD2;RACGAP1;CENPV;CSPP1;ENTR1;PLK1;AURKA;RHOA;PIK3R4;CDC6;E2F8;OPN1MW
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.4712605027280731,1.239086271349324,0.22026431718061673,0.6228375208330886,1.0,3/16,3.98%,WNT4;LARP6;CREB3L1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5215400143302495,-1.2388828319073093,0.18996415770609318,0.5033944999659831,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,cellular response to inorganic substance (GO:0071241),-0.4227475950597891,-1.2385606849003095,0.2018867924528302,0.5035233187321875,1.0,3/21,4.92%,MTR;FOXO1;GUCY1B1
prerank,regulation of translation (GO:0006417),-0.2904700829858174,-1.2385217522008607,0.07039337474120083,0.502991633769792,1.0,52/173,23.02%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;RPS6KA3;RPL10;FOXO3;RPS3;IGFBP5;APP;EIF4G3;EIF5B;CNOT7;PRKDC;HSPB1;GAPDH;NCL;DHX9;RPL13A;CAPRIN1;RPS27L;EIF3D;LARP4B;IMPACT;CIRBP;UPF3A;SOX4;TSFM;FMR1;RBM4B;ERBB2;PCIF1;LSM14A;GIGYF2;EIF5;ZCCHC4;TYMS;PAIP2B;SYNCRIP;EIF1;RPL5;YTHDF1;LTN1;PAIP1;EIF4G1;EIF4A2;NCBP2;PYM1;MRPL13
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3267031766042832,-1.2381064227706755,0.13813229571984437,0.5034459698513659,1.0,25/76,21.43%,CBFA2T3;RACK1;PTK2;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;SMURF1;RBX1;HECTD1;HSPA1A;CDK5RAP3;RNF19A;ELOB;LAPTM5;CCDC22;KEAP1;TRIB3;HSPA1B
prerank,positive regulation of T cell proliferation (GO:0042102),0.3544223402523353,1.237538842102603,0.17842323651452283,0.625652665779827,1.0,6/55,8.31%,IGF1;IGFBP2;IL4;CD274;IGF2;IL18
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.31052334765678147,-1.2372693537577362,0.104,0.5048407130921133,1.0,30/113,14.34%,ESR1;RASIP1;RAP1B;RACK1;UNC13B;TFRC;PIEZO1;RPS3;GBP5;DAB2IP;FERMT2;FNIP2;TGFB1;VEGFA;ERCC1;CUL4A;BAX;TAL1;GTF2H3;WARS1;CHD1L;TIRAP;VCP;PSMC4;PSMC5;TLR4;BAK1;SYK;SLF1;RBX1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.40795225639262367,-1.2365156941221631,0.1776061776061776,0.5059867509441359,1.0,8/25,28.45%,BRD4;ZMYND11;NELFE;LDB1;CDK13;EAPP;ELL;RNF8
prerank,striated muscle tissue development (GO:0014706),-0.4006340523953637,-1.2360443548632005,0.16380952380952382,0.506550835355988,1.0,8/29,4.68%,MEF2C;CAV1;PGM5;MYL6;BMPR2;SIX1;TBX2;NDUFV2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5272643112485192,-1.2356817061327434,0.22282608695652173,0.5067567148649855,1.0,4/10,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,regulation of cellular component movement (GO:0051270),0.3633201396273757,1.2343777848220723,0.14225053078556263,0.632746335801639,1.0,12/49,9.82%,TGFBR3;MYCBP2;NRG1;ROCK2;LYN;NRG4;NRG2;TGFBR1;ZSWIM5;MEMO1;ERBB3;ERBB4
prerank,protein localization to plasma membrane (GO:0072659),-0.30132223290178123,-1.2342912508123816,0.08686868686868687,0.5094937982571389,1.0,46/129,21.37%,BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;GORASP2;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;TMEM88;FLOT2;EPHA2;TSPAN17;PACSIN1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;FYB2;EHD3;RAPGEF2;ZDHHC23;KCNB2
prerank,regulation of mitotic nuclear division (GO:0007088),0.3502287928950503,1.2340247675765998,0.1554192229038855,0.6322398045763722,1.0,12/55,13.30%,IGF1;AURKAIP1;TGFA;PHIP;CUL9;PDGFRB;IGF2;BORA;TOM1L2;TOM1L1;OBSL1;BTC
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3285889009407372,-1.2338049213725377,0.138,0.5100858000960292,1.0,17/75,11.10%,MEF2C;ACTB;PARD3;OPHN1;MEF2A;KLF7;APP;SHTN1;MINK1;S100B;MFSD2A;BTBD3;RB1;S100A6;RAB8A;LMTK2;TAOK2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5364872706132373,1.2337906560269694,0.24008810572687225,0.6314515529555208,1.0,3/10,6.09%,ENPP1;ERRFI1;NLRP12
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4721227042373698,1.2334800691500751,0.1958041958041958,0.6308171340978768,1.0,3/15,6.00%,ALDH4A1;PRODH;GGT7
prerank,regulation of transforming growth factor beta production (GO:0071634),0.43487058868802864,1.2327340776196298,0.19912472647702406,0.6313260401242363,1.0,3/18,5.04%,LTBP1;SMAD3;LRRC32
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4311168869296827,-1.2323028528232258,0.19782214156079855,0.5130970674084692,1.0,3/20,7.21%,ANO6;THBS1;RGCC
prerank,actin filament depolymerization (GO:0030042),0.518637597012446,1.2322460485385622,0.2205240174672489,0.631243830108403,1.0,1/11,0.13%,MICAL3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3886987111597275,1.2318522701659291,0.17429193899782136,0.630825746296105,1.0,6/34,4.22%,SLC8A1;ANK2;PRKACA;P2RX4;ATP2A2;TNNI3
prerank,regulation of cell population proliferation (GO:0042127),-0.24938526403851194,-1.2312884195356282,0.013452914798206279,0.5149355966312161,1.0,155/691,16.42%,FN1;KITLG;LEF1;ZBTB7C;PTPN14;FLT1;IGF1R;CDK6;CLDN5;ITGA1;ACER2;IGFBP7;THBS1;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;BMPR2;LIFR;SH3BP4;JUND;KDR;KLF4;EGLN3;STX3;TFRC;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;ETS1;DAB2IP;NGF;SIX1;CDKN1B;RPRD1B;TGFB1;CNBP;REST;APP;TGFB2;RNF41;COL18A1;TBX2;RPL23;RPS15A;DNAJA2;TES;PLPP1;LIMS1;ADAM10;CYP1B1;ING5;CTBP1;IGFBP3;CD81;SMAD6;VEGFA;CNOT7;S100B;AQP11;JAG2;RBFOX2;WNT9A;RARA;IFITM1;SHC1;TGFB3;PRKDC;RGCC;ADGRG1;JUP;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;HDAC4;AKT1;INSR;BCL6;NOP2;KANK2;SOX7;PDGFC;PDGFA;WARS1;LAMC2;HHEX;CSNK2B;EMP2;DDRGK1;ACE2;JUNB;DIS3L2;INHBA;CDK4;GAS8;KMT2D;S100A13;FRK;CIB1;VEGFD;FTH1;TMEM115;FAM98A;GRK5;CDK10;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;ENG;RPS6KA2;ABI1;HRAS;NUAK1;P3H2;STAT5A;EID2;BCL6B;JAK2;SDCBP;SMYD2;EGFR;CHTOP;ERBB2;STRN;GAB2;OSGIN1;CLCF1;TNFSF13;PTPN6;CDK13;CDKN1A;CSNK2A1;NPR3;SMARCA2;UFL1;STAT1;GREM1;RBBP4
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4702074599471125,1.2312631436425316,0.19831223628691982,0.6309994762560903,1.0,3/18,4.13%,CAMK1D;PTN;LYN
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.45033234910737663,-1.2311806470954083,0.2261682242990654,0.5145735703390678,1.0,2/18,0.48%,OCLN;SLC2A1
prerank,positive regulation of cell growth (GO:0030307),-0.314807239224083,-1.2307143263276574,0.12301587301587301,0.5150577506262801,1.0,40/96,25.08%,SEMA7A;NEDD4L;RPS6KA3;ITSN2;NGF;TGFB2;SHTN1;ADAM10;MFSD2A;EDN1;PABIR1;MMP14;AKT1;PLAA;H3-3A;AKAP6;CIB1;DBNL;DBN1;SYT2;FXN;SMURF1;CDKN2AIP;NTN1;SDCBP;EGFR;ERBB2;LIMK1;CSNK2A1;DERL2;SLC25A33;BRAT1;UNC13A;ADNP2;DDX49;EIF4G1;HYAL1;CDC42;ZFYVE27;RPTOR
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.31754028991759237,-1.2301794008652795,0.14345114345114346,0.515807403375937,1.0,24/87,14.95%,ESAM;EPS8;PTK2B;F11R;IQGAP1;ARHGAP17;RICTOR;ARHGDIA;RAC1;ARHGDIB;CRK;HIP1R;EZR;ABI3;PDGFA;FAM107A;RHOB;ABL2;TAOK2;CDK10;CSF1R;ARHGEF5;CELSR1;PIK3CA
prerank,response to growth factor (GO:0070848),-0.3654953438758133,-1.2300175188952418,0.16085271317829458,0.515558165182227,1.0,12/41,15.34%,TGFBR2;RACK1;BMPR2;MAP2K5;KLF4;GATA6;SHC1;AKT1;CIB1;ACVR1;ERBB2;EPHA2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.40054305091514397,-1.2299715377474607,0.20441988950276244,0.5150321500867339,1.0,4/27,3.29%,UTRN;NEDD4L;FXYD5;CAMK2D
prerank,embryonic heart tube development (GO:0035050),-0.47735200501401864,-1.229396849511539,0.2116788321167883,0.5157918279308036,1.0,5/14,12.83%,SOX17;TBX2;SOX18;ACVR1;HES1
prerank,postsynaptic membrane organization (GO:0001941),0.4655632415412644,1.2292366924092286,0.23311546840958605,0.6348845849126652,1.0,8/17,13.19%,NRXN1;LRP4;NLGN2;NLGN3;NLGN1;MUSK;CHRNB1;DLG4
prerank,T cell differentiation in thymus (GO:0033077),0.4847138330041949,1.2291263884093677,0.21656050955414013,0.6337781732936653,1.0,6/14,22.28%,GLI3;CCR6;FADD;RABL3;SHH;ZFP36L2
prerank,regulation of acute inflammatory response (GO:0002673),0.448428443800115,1.2283209001624134,0.23311546840958605,0.634509510306653,1.0,5/18,16.60%,IL4;GSTP1;OSMR;PTGES;KLKB1
prerank,regulation of spindle organization (GO:0090224),0.440082134888668,1.2281993043852775,0.20125786163522014,0.633377120370971,1.0,7/18,19.01%,GNAI1;MAP9;BORA;FSD1;PARP3;NUMA1;NUP62
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4315580082003145,-1.2281869581544242,0.20599250936329588,0.5181190549524296,1.0,7/21,14.97%,ACTG1;LIMCH1;PEAK1;PTK2;VCL;DUSP3;LDB1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.43157968482200726,-1.228052830539109,0.18198198198198198,0.5178200008031346,1.0,8/22,22.43%,ESR1;MED24;PSMC4;PSMC5;SRF;MED14;PSMC3;MED13
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40116825099144793,-1.2277222279993902,0.18689788053949905,0.5180227759660844,1.0,10/28,23.92%,OCLN;RPS3;RAC1;SLAIN2;DCTN1;MET;HSPA1A;ARL2;HSPA1B;CLIP1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3947891224418013,-1.227668778879389,0.18714555765595464,0.5175280680363514,1.0,12/31,20.35%,MEF2C;CDON;CTNNA1;MEF2A;BOC;HDAC9;CAMK1;SPAG9;SRF;TCF3;MAPK12;MAPK11
prerank,positive regulation of type 2 immune response (GO:0002830),-0.47900364822160385,-1.2276057722547775,0.2036036036036036,0.517037405629274,1.0,7/14,18.62%,PRKCZ;CD81;RARA;DENND1B;CD74;NOD2;RSAD2
prerank,protein localization to mitochondrion (GO:0070585),-0.5203630220842391,-1.227598308459667,0.2072072072072072,0.5164238495047961,1.0,3/11,8.98%,HK1;AKT1;DNAJA1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3670500579157909,-1.227562499070778,0.14785992217898833,0.5158695544527625,1.0,11/42,14.82%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,cardiocyte differentiation (GO:0035051),0.5292970622714481,1.2275127117691507,0.22580645161290322,0.6338488922179993,1.0,2/10,1.40%,BMP2;NRG1
prerank,negative regulation of immune response (GO:0050777),0.29986071066309566,1.2274501351612157,0.10588235294117647,0.6326095656233047,1.0,21/154,11.33%,ADCY7;ADCY2;ADCY1;ADCY5;GPHB5;HTR7;PRKACA;LYN;PTGDR;ADM;MC5R;IAPP;CALCR;SIRT2;TRIM27;HRH2;GLP2R;RNF26;ADCY8;HTR4;PTGIR
prerank,ameboidal-type cell migration (GO:0001667),-0.3552606490117386,-1.2270947695693692,0.16535433070866143,0.5163731300995746,1.0,14/51,12.52%,SEMA6A;SEMA3C;GPC3;SEMA7A;CCN3;TBX1;PDLIM1;AMOT;AKT1;SEMA3G;PHACTR4;FAT2;PKN3;SGPL1
prerank,intermediate filament organization (GO:0045109),-0.4540484906738698,-1.226392580403815,0.2198581560283688,0.5174908900699059,1.0,6/17,22.79%,VIM;NEFL;MTM1;DSP;GFAP;KLHL24
prerank,regulation of exit from mitosis (GO:0007096),-0.36893398619492057,-1.2263386065403394,0.16698292220113853,0.5169906533453931,1.0,12/38,16.23%,CDC14A;ZW10;UBB;UBC;RPS27A;ANAPC15;RGCC;ANAPC11;CDC14B;PHB2;ANAPC7;CDC27
prerank,regulation of interleukin-13 production (GO:0032656),-0.492176333724847,-1.2262202119195689,0.21731123388581952,0.5166360104128669,1.0,5/13,12.85%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.49260130427818544,1.2254475189605711,0.21875,0.6365340485810899,1.0,5/13,14.73%,PDPK1;AKT3;IGF2;FGFR1;SIRT6
prerank,cellular response to starvation (GO:0009267),-0.2897294713734591,-1.2251788756162976,0.08316831683168317,0.5185822923458621,1.0,51/147,25.89%,MAP3K5;BMPR2;FOXO1;MAPK3;FOXO3;DAPL1;MAP1LC3B;ATP6V0B;HSPA8;RALB;GABARAP;ATF4;MFSD2A;FAS;ATP6V0C;ATG7;HSPA5;XPR1;IMPACT;MAP1LC3A;NUAK1;INHBB;NUAK2;LAMTOR2;GAS2L1;PRKAG1;ATP6V1G1;STK26;CDKN1A;RRAGD;XBP1;HNRNPA1;ASNS;WIPI2;RIPOR1;RRAGA;KLF10;TFEB;VPS41;RRAGC;SESN2;BRSK2;NUPR2;SIK1;CASTOR2;RPTOR;GABARAPL1;SREBF1;ATP6V0D1;SEH1L;SEC13
prerank,nucleoside catabolic process (GO:0009164),-0.5068609172371319,-1.2246331305188562,0.22522522522522523,0.5192989912163362,1.0,4/11,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.505926713080134,-1.2242591824979645,0.2247191011235955,0.5196354899795588,1.0,5/11,16.40%,EGLN3;EGLN2;EGLN1;P3H2;CRTAP
prerank,ERAD pathway (GO:0036503),-0.32250851845718137,-1.2242224721344968,0.12475247524752475,0.5191036079167052,1.0,36/83,31.16%,SEL1L;TRIM25;RHBDD1;FBXO17;DNAJB12;MAN1B1;ERLIN2;RNF185;UBE2G2;VCP;HSPA5;UBXN8;FAF2;RNF5;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;ERLEC1;TMEM129;TMUB2;SGTB;TMUB1;BRSK2;FBXO6;UBE2J2;UBE4A;FBXO2;STT3B;UBQLN2;DERL1;PSMC6;EDEM1;SYVN1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5130421000337602,-1.2241662287027724,0.23290203327171904,0.5186203866839142,1.0,7/11,29.30%,CASP8;RIPK1;YBX3;PELI1;ARHGEF2;SLC25A4;FZD9
prerank,negative regulation of protein transport (GO:0051224),-0.41160628197384447,-1.224070456442048,0.2028985507246377,0.5182232164194396,1.0,12/25,31.77%,WWP2;PPM1F;DPH3;APOE;RSAD2;SNX3;CSK;RHBDF2;NDFIP2;NDFIP1;SNX12;HMGCR
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.32226694809261613,1.2238018781849378,0.13976377952755906,0.6394858424161795,1.0,7/86,4.95%,IGF1;BMP6;EPHA7;NRP1;TNK2;SFRP1;GHR
prerank,regulation of stem cell population maintenance (GO:2000036),0.45538395049597324,1.2237240403724545,0.2330508474576271,0.6382903099105142,1.0,5/18,15.40%,PTN;TAF6L;LOXL2;TAF5L;NCOA3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.37798007452396154,-1.2233688400905915,0.18317757009345795,0.5192486814495342,1.0,14/35,18.39%,MEF2C;CAV1;FLT1;THBS1;CAV2;PTPRM;ATP5F1A;RGCC;NF1;APOE;ATP5IF1;STAT1;DLL4;KRIT1
prerank,response to thyroid hormone (GO:0097066),-0.4762407767905021,-1.222848736610783,0.22306238185255198,0.5199926654020124,1.0,5/13,25.76%,LMO2;CTSB;GAS2L1;CTSS;RDX
prerank,ERBB signaling pathway (GO:0038127),0.34132090458997366,1.2227125530199665,0.15476190476190477,0.6396326660460817,1.0,10/64,4.45%,PIK3R1;AREG;NRG1;PDPK1;PRKCA;SLC30A10;DGKD;TGFA;NRG4;NRG2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.5095066277463144,-1.2224523832144087,0.20761245674740483,0.5203383531251705,1.0,5/11,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,cell part morphogenesis (GO:0032990),0.4931621844612778,1.2223374951140191,0.2511520737327189,0.6392899354534418,1.0,3/13,10.46%,PID1;NUBPL;PNPT1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5255871456339754,-1.2214559195151797,0.2530329289428076,0.5222354071298522,1.0,7/10,31.14%,VEGFA;FZD3;DISC1;CX3CR1;KDM1A;CTNNB1;SMARCD3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4504897176788032,-1.221426989201585,0.24125230202578268,0.5216744576242939,1.0,5/17,12.88%,SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3704114311850443,1.2214198888651282,0.17611336032388664,0.6403030583726264,1.0,9/43,11.20%,IGF1;GJA1;CCN4;PDGFRB;IL18;DNMT1;HES5;BMPR1A;IL6R
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4823694052906366,1.2212101793198533,0.2202247191011236,0.6394274968762416,1.0,5/14,11.03%,SULF1;SULF2;CREB3L1;GATA3;FUZ
prerank,response to lipopolysaccharide (GO:0032496),-0.2906622074155684,-1.2211922558545492,0.1,0.521649431939528,1.0,56/138,34.11%,FOXP1;MEF2C;LBP;NOS3;VIM;SCARB1;RPS6KA3;DAB2IP;GCH1;MAPKAPK3;SMAD6;TNFRSF1B;OTUD5;TNFRSF11A;PLAA;IFNAR1;TRIB1;TIRAP;GGT5;TLR4;JAK2;NOD2;TNFAIP3;CX3CR1;TAB2;RELA;XBP1;PELI1;CASP1;GGT1;LGALS9;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SELP;SHPK;NOCT;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;NOS2;RHOA;CD14;LY96;NLRP3;TNIP2;SRR;NOS1;CXCL5;SLC11A1
prerank,aorta morphogenesis (GO:0035909),0.4518729030265944,1.2210915655937578,0.2214765100671141,0.6383492909322329,1.0,7/17,11.84%,LRP1;EFEMP2;MYLK;PDGFRB;RBPJ;BMPR1A;ADAMTS9
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5001316882462721,1.2208683190633614,0.23736263736263735,0.6375346729787381,1.0,3/12,8.25%,IGF1;IRS2;IGF2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5244216817394338,-1.2205104781304235,0.21808510638297873,0.5227309448620726,1.0,7/10,31.46%,WWP2;PPM1F;DNAJA1;SNX3;NDFIP2;NDFIP1;SNX12
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5284223381291623,1.220248367521826,0.24724061810154527,0.6377987470441002,1.0,4/10,23.19%,IL4I1;KYNU;PCBD1;KYAT1
prerank,negative regulation of cell differentiation (GO:0045596),0.2915442229096228,1.2200983169674338,0.12617702448210924,0.6368327452009556,1.0,27/181,9.13%,RORA;ENPP1;ADGRV1;ADAMTS12;RUNX1T1;LDLRAD4;TBX3;BMP5;ABCA1;CNTN4;PPARA;SMAD3;RANBP3L;SFRP1;HOXB8;HES3;DTX1;FOXA2;SIRT2;MEN1;SOX2;TGFBR1;ABCA5;IGF2;HES5;NPHP3;GATA3
prerank,activation of phospholipase C activity (GO:0007202),0.4095378309821804,1.2195633869665226,0.20316027088036118,0.6369269304179035,1.0,3/29,2.42%,ARHGAP6;LPAR1;GPR55
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5013684994942362,-1.2195063732430467,0.2119089316987741,0.5245195147463227,1.0,7/12,34.16%,GCLM;CNDP2;GCLC;GGT1;GGCT;MGST2;BDH2
prerank,neuron migration (GO:0001764),0.3613466842670245,1.219414459132518,0.16317991631799164,0.635990480770622,1.0,11/48,13.82%,AUTS2;NRP1;SEMA3A;GPM6A;SH3RF1;ASTN2;NRCAM;CDK5R1;LRP12;FGFR1;TUBGCP2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3820055728314397,1.2192781328281805,0.19753086419753085,0.6349841231308951,1.0,8/37,10.35%,IGF1;GJA1;EFEMP2;TAFA5;DNMT1;BMPR1A;SOD2;PTEN
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3082270138211686,-1.2191347544905877,0.10141987829614604,0.5247760556924862,1.0,46/98,32.82%,RAB11A;DCTN2;SMC4;ZW10;CHMP2B;KIF23;CSNK2B;RB1;DIS3L2;POGZ;CSNK2A1;CSNK2A2;SMC2;KIF18A;CHMP2A;BOD1;RAD21;KNSTRN;NCAPH;KIF18B;NIPBL;NSL1;NDC80;KIF22;NCAPG;REC8;SPDL1;CDCA8;CEP55;VPS4A;KMT5A;SEH1L;SGO1;EML3;NCAPH2;CHMP7;NAA50;TUBG2;TTN;PLK1;CDK1;NCAPD2;PSRC1;CHMP4B;CHMP4A;ESPL1
prerank,calcium ion import into cytosol (GO:1902656),0.4645150105240824,1.21884043319019,0.21982758620689655,0.6347325453482139,1.0,3/15,8.94%,SLC8A1;CACNA2D1;SLC24A2
prerank,supramolecular fiber organization (GO:0097435),-0.2611806440210716,-1.2185604378622457,0.044642857142857144,0.5256272137841029,1.0,71/333,12.53%,SHROOM4;COL25A1;PGM5;ITGA6;MYO1D;TLL1;B2M;TSPAN5;COL12A1;TMOD3;COL5A2;VIM;COL6A2;ARHGAP17;COL3A1;TNXB;PLOD2;COL4A2;CD2AP;ITGB4;HSP90AB1;MYH11;MPRIP;APP;TGFB2;COL18A1;FKBP1A;UBB;COL4A1;RAC1;ADAM10;CYP1B1;CHP1;CD151;LAMA3;UBC;RPS27A;TGFBI;COL6A1;ARHGAP25;BACE1;HIP1R;ACTN1;LMOD1;FLII;NEFL;COLGALT2;SLAIN2;RIPK1;MFGE8;STMN2;TMOD1;UBE2L6;CST3;PSENEN;LAMC2;USP9X;EMP2;H3-3A;TSPAN14;HIP1;DCTN1;COL5A3;RHOB;TRPV4;NF1;CIB1;PCM1;DBN1;PLOD3;KATNB1
prerank,positive regulation of immune effector process (GO:0002699),-0.3962753886254825,-1.2185175087967393,0.21897810218978103,0.5250882013137321,1.0,8/27,20.27%,LBP;PTPRJ;CD81;RPS19;DHX58;ANKRD17;XBP1;LGALS9
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.44128142165984874,-1.2182325654112744,0.20961538461538462,0.5251113747929442,1.0,9/19,23.08%,PLCE1;PPP3CC;EDN1;NFATC1;INPP5A;PPP3CB;ADGRB2;NFATC3;NMUR2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4927550696124361,1.2181927867941718,0.23820224719101124,0.6350818384322654,1.0,3/13,8.25%,IGF1;IRS2;IGF2
prerank,response to UV (GO:0009411),-0.3116903596011798,-1.2179191586438192,0.13972055888223553,0.52524270183378,1.0,28/95,23.42%,SCARA3;RPL26;MAP4K3;USP1;RHBDD1;ATF4;N4BP1;GPX1;YY1;AKT1;CIRBP;SPRTN;BAK1;FMR1;EGFR;RELA;CCAR2;KDM1A;POLK;ERCC4;CCND1;COPS9;PTPRK;UBE2B;RHNO1;TRIAP1;DTL;PRKCD
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.40976933710967905,1.2178205938792632,0.21691973969631237,0.6348042497828158,1.0,4/23,7.40%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,positive regulation of sodium ion transport (GO:0010765),0.4981261080576086,1.2177897203325427,0.23660714285714285,0.6335533287914916,1.0,2/12,4.33%,SCN3B;GPD1L
prerank,response to glucose (GO:0009749),0.36954298118235906,1.2174442371854806,0.1845841784989858,0.6331106749501209,1.0,6/46,5.80%,TCF7L2;ZBTB20;PRKACA;NKX6-1;IRS2;PDK3
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4320995140385746,-1.217431786099886,0.20149253731343283,0.5258799104318471,1.0,6/19,19.08%,HK1;AKT1;ARL2BP;HSPA5;CHCHD10;ARL2
prerank,protein O-linked mannosylation (GO:0035269),0.45153244903720235,1.2174016102811893,0.22298850574712645,0.6318668998789647,1.0,7/18,17.56%,TMTC1;TMTC3;TMTC4;CRPPA;POMT2;B4GAT1;DPM1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5046502811782769,-1.2170299870693204,0.21693121693121692,0.5262108753889368,1.0,5/11,24.98%,F11R;TJP2;RAB1A;RAPGEF2;TJP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4511373190868593,1.2168571598984852,0.21308016877637131,0.6318969831226222,1.0,10/18,13.19%,NRXN1;RIMS1;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,regulation of immune response (GO:0050776),-0.2899163096112355,-1.216699608431938,0.11181434599156118,0.5263608927036004,1.0,26/135,15.46%,FOXP1;CXADR;B2M;CD34;IL15;CLEC2D;COL3A1;TGFB2;FKBP1A;CD81;IFITM1;DENND1B;N4BP1;CASP8;ERAP1;PVR;BCL6;TIRAP;LRP8;DHX58;ICAM2;SYK;SAMHD1;JAML;NECTIN2;ITGA4
prerank,positive regulation of neuron differentiation (GO:0045666),0.3764777763157313,1.2159120288364527,0.1791044776119403,0.6330368081629982,1.0,10/40,14.31%,TCF4;BMP2;ZEB1;BRINP1;BRINP3;NRCAM;KCTD11;FGFR1;BRINP2;GPRC5B
prerank,growth hormone receptor signaling pathway (GO:0060396),0.47458297188417736,1.2155098726909563,0.23376623376623376,0.6327122188745211,1.0,4/14,4.95%,PIK3R1;STAT5B;LYN;GHR
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.45213743562412634,1.2152272437012677,0.2159090909090909,0.6321294745884436,1.0,2/17,2.58%,PLA2G5;PLA2G4A
prerank,peptidyl-proline modification (GO:0018208),-0.40879747202542716,-1.2148170704448895,0.1956124314442413,0.5304393083622684,1.0,11/25,25.21%,FKBP5;FKBP1A;PPIA;PPIC;P3H2;PPIG;PIN1;NTMT1;FKBP4;PPIB;PPID
prerank,membrane organization (GO:0061024),-0.2726641587227702,-1.214709693265953,0.06479481641468683,0.5300760646176855,1.0,63/227,22.03%,CERT1;ACTB;DNM3;SPTBN1;ACTG1;FNBP1L;TFRC;MYOF;FZD4;EPN1;VAMP7;LPCAT3;ATP2C1;UBB;IGF2R;HSPA8;CHP1;UBC;RPS27A;NAPA;DYSF;HIP1R;REPS2;CHMP2B;A4GALT;NUP93;ARPC5;AP2M1;ITSN1;PIK3C2A;HIP1;FCHO2;SGIP1;TOR1AIP1;SYT2;ACTR3;TMEM43;MITD1;EPN2;NPC1;NUP155;WASL;EGFR;AP2A1;AGFG1;SLC2A8;OPA1;SYNJ1;RABEP1;REEP4;VTI1B;DNM1;CHMP2A;TOR1AIP2;CTTN;SNX3;PACSIN2;DNM2;TMEM33;TIMM50;LPCAT2;CLTA;GLTP
prerank,BMP signaling pathway (GO:0030509),0.33918526300953233,1.2144907342079354,0.1740041928721174,0.6327313225723558,1.0,5/62,2.77%,BMP6;TGFBR3;BMP2;BMP5;SMAD3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.31395818897764444,-1.214365944720049,0.148,0.5303270279501797,1.0,34/88,27.47%,FBXO17;PSMA6;CUL4A;PSMB5;FBXO4;PSMC4;PSMC5;FBXL14;PSMD14;FBXW5;FBXL7;FBXL2;RBX1;PSMD8;PSMD11;CCNF;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;CUL1;DMAC2;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;FBXL18;FBXO6;PSMB8;FBXO38;FBXL8;FBXO2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5005421664195168,-1.2143534707440296,0.2271062271062271,0.5297352196092425,1.0,2/11,3.73%,RREB1;CD44
prerank,positive regulation of neurogenesis (GO:0050769),0.3389162783232618,1.2142559168241862,0.16176470588235295,0.6320085841762616,1.0,17/68,14.58%,PLXNA2;ROBO1;ROBO2;PTPRD;SERPINF1;NPTN;IL1RAPL1;CUX1;CDKL3;CUX2;PLXNB2;NGFR;OBSL1;CAPRIN2;AMIGO1;DRD2;MAP6
prerank,response to fatty acid (GO:0070542),0.4548474129255878,1.2140138436434689,0.22413793103448276,0.6313906295711506,1.0,4/17,5.80%,PID1;PDK4;GLDC;PDK3
prerank,sympathetic nervous system development (GO:0048485),0.47498833651463923,1.213985563383579,0.23580786026200873,0.630134504552056,1.0,3/15,2.89%,NRP1;GDNF;SEMA3A
prerank,sulfur compound catabolic process (GO:0044273),0.3732806108597523,1.2137226511269898,0.18875502008032127,0.6296243712002669,1.0,8/38,7.32%,FMOD;DCN;OMD;GNS;LUM;GGT7;GALNS;OGN
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.4670796476747201,1.213481199595099,0.24561403508771928,0.6289071548200295,1.0,4/15,6.18%,TNK2;DGKD;AAK1;SNAP91
prerank,amino acid import (GO:0043090),-0.41911273671575344,-1.2134237074693628,0.22007042253521128,0.5314078515584493,1.0,7/21,5.92%,SLC47A1;SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC1A1;SLC25A38
prerank,apoptotic process (GO:0006915),-0.2776791497282212,-1.2133161121494507,0.08928571428571429,0.5310356958832525,1.0,56/203,20.16%,SEMA6A;TGFBR2;PTK2B;NFKBIA;PPARD;FOXO1;EGLN3;FAP;TBX1;ADAM15;RFK;APP;PPIA;MAGI3;ZBTB16;DPF2;PPP2R1A;CASP7;TNFRSF21;CASP8;RIPK1;GAPDH;DDX41;BAX;AKT1;PLAGL1;MAL;FAS;HSPD1;HIP1;RHOB;TNFAIP1;PAEP;TAOK2;PRUNE2;CIB1;BBC3;BCL2L1;PRKCE;BAK1;DHCR24;JAK2;MRPS30;PIK3CA;NCKAP1;DDIT4;BAD;TSC2;TRAIP;CHEK1;MAGEH1;GADD45A;ARHGEF6;BIK;BRAT1;CASP1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5128706508705118,-1.2125890317522914,0.23703703703703705,0.5322182679139379,1.0,2/11,2.58%,NOTCH1;FOXO1
prerank,embryonic digit morphogenesis (GO:0042733),0.4566192795878503,1.212442466339816,0.23157894736842105,0.630324151526604,1.0,3/18,3.86%,SALL1;TBX3;GLI3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5161184416135495,1.2123532306550306,0.2543103448275862,0.6292455996196914,1.0,3/11,5.13%,STAP1;TICAM1;CAMK4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.4301227941688639,-1.2122561186435081,0.2153558052434457,0.5324233061742373,1.0,7/20,17.07%,TGFB1;ADAM10;RHBDD1;MBTPS2;PSENEN;APH1A;RELA
prerank,calcium ion import (GO:0070509),0.3963578766769355,1.212241857768717,0.20607375271149675,0.6282373516643194,1.0,7/28,7.60%,SLC8A1;CACNA1E;ATP2A2;CACNA1I;MICU3;CACNA1G;CACNB2
prerank,inorganic anion transport (GO:0015698),-0.34404388390797613,-1.2122020309798263,0.17073170731707318,0.5319162368483141,1.0,7/53,2.99%,SLC4A10;ANO6;SLC26A7;CLIC4;ANO1;CLIC1;CLIC5
prerank,skin development (GO:0043588),-0.33209896127802974,-1.2119906572783792,0.15913555992141454,0.5317556400431029,1.0,18/65,16.29%,ITGA6;CLIC4;LSR;COL5A2;COL3A1;ANXA1;ITGB4;PKD1;GATA6;BCR;PDGFA;COL5A3;DHCR24;HRNR;OPN3;EPHA2;MET;DSP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5066410073669508,-1.211948384969847,0.2407079646017699,0.5312249558274434,1.0,3/11,3.59%,RIN3;CCN3;SLIT2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.42947495148499987,-1.2119187821915924,0.22467771639042358,0.5306618811997693,1.0,12/18,35.86%,MANBA;FBXO17;SAMHD1;OGA;FBXO6;NEU2;NAGA;FBXO2;STT3B;FUCA1;AOAH;NEU4
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.27974444540046844,-1.2113347788623565,0.08196721311475409,0.5315059351470764,1.0,65/184,26.50%,CDC14A;DCTN2;TUBA1A;CEP164;ZW10;UBB;PKD1;UBC;RPS27A;PPP2R1A;PRKAR2B;CEP192;CEP57;ANAPC15;PSMA6;RGCC;ANAPC11;PSMB5;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PSMC4;PSMC5;PCM1;TUBB4B;PSMD14;E2F1;CDC14B;HAUS1;NDE1;PSMD8;CETN2;CEP72;YWHAG;PTPN6;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;HSP90AA1;CEP41;FZR1;CUL1;TPX2;PSMA1;ANAPC2;PSMB1;PSMC3;TUBA4A;CENPF;PSMA4;PSMA2;ANLN;PSMB8;HAUS4;RIOK2;YWHAE;CEP63;NEDD1;PLK5;XPC
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3645960089509191,-1.211325025026709,0.1889908256880734,0.530919689219534,1.0,13/39,18.07%,UTRN;NEDD4L;FXYD5;FHL1;WWP2;RIPK1;TRPC6;HOMER1;SPHK2;PHB2;CACNA1D;YWHAH;SCN2B
prerank,chloride transmembrane transport (GO:1902476),0.3596765930903599,1.2106695068169433,0.19,0.6309471546393881,1.0,16/48,14.70%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;GABRB3;ANO3;GABRR2;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.38517728327457645,-1.2104462034373369,0.17973231357552583,0.5324426039955941,1.0,9/31,12.32%,SHANK3;SIPA1L1;ABI3;CAPRIN1;LRP8;CFL1;DBNL;DBN1;SRCIN1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3191597289076106,-1.2102153507388556,0.15430861723446893,0.532437873406063,1.0,27/78,24.42%,CAV1;CBFA2T3;RACK1;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;VCP;USP5;BCAP31;RBX1;SGTA;HECTD1;FZR1;HSPA1A;RNF19A;ELOB;KEAP1;TRIB3;HSPA1B;PLK3;RAD23A;COP1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.44027159205891364,-1.210141486809787,0.21968365553602812,0.531990377022773,1.0,11/18,35.15%,CHP1;DKC1;CCT2;CCT3;CCT8;CCT7;TREM2;PTP4A3;WRAP53;CCT4;CCT6A
prerank,actin filament organization (GO:0007015),-0.2884281786263478,-1.2099851037862992,0.09563409563409564,0.5317456820803413,1.0,53/151,26.41%,NEBL;SHROOM4;MYO1D;BAIAP2L1;TMOD3;COBL;EPS8;VILL;ARHGAP17;PLS3;CD2AP;MPRIP;RAC1;NEDD9;ARHGAP25;HIP1R;ACTN1;LMOD1;FLII;TMOD1;EMP2;HIP1;RHOB;TRPV4;DBN1;ABI1;WASL;GAS2L1;SHROOM1;SHROOM3;TPM3;MYO1F;MARCKSL1;ARHGEF2;CAPG;TPM2;TPM4;RND2;TLE6;GAS2;AVIL;DMTN;CARMIL1;RFLNB;CORO7;AIF1;CDC42;MCU;ELMO3;INPPL1;MYO7A;TMOD2;MYO19
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.33979092568251346,-1.2099100368046634,0.15576923076923077,0.5313334020363,1.0,20/57,19.30%,BRCC3;TAOK3;FOXN3;PRKDC;UIMC1;BABAM1;RPS27L;TAOK2;CDC14B;RAD9B;HUS1;EME2;RAD9A;CDKN1A;RAD17;FZR1;BABAM2;CHEK1;CDK5RAP3;CCND1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2543258918676953,-1.2096651873419293,0.05172413793103448,0.5312846636926453,1.0,89/417,14.15%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;HMBOX1;ID3;PPARD;NCOR1;FOXO1;KLF4;DAB2IP;ZBTB7A;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;TWIST1;TRIM28;HHEX;SOX18;RB1;ZC3H8;FOXP2;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;CIART;MTERF3;PHF12;EPC1;MLX;PHB2;SMARCA4;EID2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.37334358890293157,1.2096066781567145,0.17647058823529413,0.6325397814999549,1.0,8/39,10.14%,STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3715416539817137,-1.2091602837046673,0.2084130019120459,0.5319656818441686,1.0,14/37,21.54%,CAV1;RACK1;RPS3;UBB;BAX;SFPQ;BBC3;BCL2L1;RPS7;BCAP31;BAD;MSX1;NCK1;FIS1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.31197225663637396,-1.209019229989385,0.1350293542074364,0.5316809263015394,1.0,26/88,15.29%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;VEGFA;RGCC;ERCC1;BAX;TAL1;PFN1;WARS1;FLOT1;SYNPO;TIRAP;VCP;RAB7A;BAK1;SLX4;SYK;SLF1;SDCBP;TSG101;LIMK1;SNF8
prerank,renal filtration (GO:0097205),0.5153284078098146,1.2086518791457512,0.2570093457943925,0.6337022715283064,1.0,5/10,15.04%,SULF1;SULF2;JCHAIN;TBC1D8B;MYO1E
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4346117864703756,-1.2083341928173905,0.24150268336314848,0.5327477870719324,1.0,5/19,12.43%,LBP;TIRAP;PIK3AP1;PRKCE;TLR4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.48408964447501107,-1.2081846641207148,0.22522522522522523,0.5325052435080984,1.0,4/14,8.25%,RFK;PAICS;ADSS2;IMPDH1
prerank,positive regulation of transferase activity (GO:0051347),0.29591965853960744,1.2080930978908841,0.1233140655105973,0.6338685020245935,1.0,37/142,13.39%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;LMO4;DDR1;MAPKAPK5;AXL;PDGFRB;EPHB1;IGF2;ERBB3;RYK;FGFR4;EPHA8;RFC5;PABPN1;ERBB4;EPHA5;TOPORS;ALK;MUSK;HNRNPD;CHRNA7;MST1R;DCUN1D4;MERTK;FGFR1;NBN;ROR1;EPHA1;SERINC1;PARN
prerank,development of primary male sexual characteristics (GO:0046546),0.37994895995584643,1.2075244783986143,0.1936842105263158,0.634124936944718,1.0,7/34,9.13%,WNT4;AR;KIT;CSDE1;SIX4;ADAM21;GATA3
prerank,import into cell (GO:0098657),0.36097333912015594,1.207498933934674,0.19874476987447698,0.6329085898626372,1.0,9/41,8.62%,SLC1A3;ATP1A2;SLC6A13;SLC22A4;SLC5A3;SLC29A1;SLC38A1;SNAP25;GLUL
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3309050757746237,-1.2071924869504016,0.1627450980392157,0.5344181901270173,1.0,32/60,37.81%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;RGCC;FBXO4;PNKP;FGF2;DKC1;CCT2;GREM1;HSP90AA1;CCT3;HNRNPA1;CCT8;PRKD2;RFC3;RFC2;CCT7;DSCC1;CTNNB1;CHTF18;MYC;PKIB;WRAP53;CCT4;MAP2K7;CCT6A;MAPK15;NVL;GRHL2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.39447356192491023,-1.2069731257580576,0.23595505617977527,0.5343318021243139,1.0,7/30,15.49%,CD34;PLCG2;PRKCZ;HSPD1;TLR4;SYK;NOD2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5019524471662308,1.2068463365538398,0.2654462242562929,0.6333333039812951,1.0,1/10,0.47%,ATP1A2
prerank,mesoderm development (GO:0007498),-0.4444252990088742,-1.2068133828043326,0.210727969348659,0.5340657906147703,1.0,13/18,31.82%,TIE1;TBX1;BMX;MESD;VEGFA;FOXC2;JAK2;HCK;BTK;MEST;GDF11;TCF15;TBX6
prerank,negative regulation of synaptic transmission (GO:0050805),0.4212811822794026,1.2065996835351744,0.2411504424778761,0.6326978886679894,1.0,12/23,25.67%,TMEM25;SLC24A2;PTEN;DRD2;SYT11;ACHE;PRRT1;GRIK3;STXBP1;SHANK2;DRD3;SLC24A1
prerank,histone H4-K16 acetylation (GO:0043984),-0.43052282875751446,-1.2064911491212589,0.2222222222222222,0.534322071111682,1.0,5/19,8.18%,MSL2;PHF20;JADE2;HCFC1;KANSL2
prerank,response to organophosphorus (GO:0046683),-0.4619017369774615,-1.206056701319666,0.23826714801444043,0.5347822332632617,1.0,7/16,23.08%,TRPC3;ABCC9;TRIM16;NDUFS4;STAT1;TYMS;RFC3
prerank,cortical cytoskeleton organization (GO:0030865),0.3773994636810685,1.2058604613330266,0.2076271186440678,0.6332981963718809,1.0,12/41,15.56%,EPB41L3;ROCK2;RHOH;RHOBTB1;FMNL3;FHOD3;NLGN1;RHOBTB3;RHOF;LLGL1;RND1;RHOQ
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.42029170154694695,-1.2058362460104868,0.21390374331550802,0.5346879179983461,1.0,9/22,17.81%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;GTF2H4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.369708183324677,-1.2056260320510603,0.17286245353159851,0.5345819745076748,1.0,10/35,19.52%,HMBOX1;MAPK3;NEK7;HNRNPA2B1;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,cardiac cell development (GO:0055006),-0.5042970406234453,-1.205049875169149,0.22142857142857142,0.5353413015936521,1.0,4/11,5.68%,CXADR;NOTCH1;MYH11;VEGFA
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.48199664159875855,-1.2046916795871574,0.24057450628366248,0.5355920202410172,1.0,3/12,2.73%,PODXL;PROM1;IQGAP1
prerank,extracellular matrix assembly (GO:0085029),-0.4063512694546207,-1.2044999995372934,0.2176360225140713,0.5354670418028561,1.0,7/23,11.70%,RAMP2;TNXB;MYH11;TGFB1;NTN4;QSOX1;HAS1
prerank,negative regulation of calcium ion transport (GO:0051926),0.4500643993242283,1.2044558770598497,0.24774774774774774,0.635758152456176,1.0,2/15,7.92%,ATP1A2;TRIM27
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4899096031995406,-1.2042007797602132,0.25444839857651247,0.5355899610620865,1.0,5/11,19.77%,DHX9;WTIP;LIMD1;FMR1;PUM2
prerank,xenobiotic transport (GO:0042908),-0.4373824676155174,-1.2040536657948642,0.2302025782688766,0.5353082372767459,1.0,3/17,1.79%,ABCG2;SLC47A1;SLC7A5
prerank,ventricular septum morphogenesis (GO:0060412),0.40036902163102794,1.2038598370405877,0.21951219512195122,0.6359754616428136,1.0,3/27,0.57%,ROBO1;TGFBR3;ROBO2
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.517509759250279,-1.2038405322709131,0.23163841807909605,0.5351918543708742,1.0,4/10,19.17%,LRCH1;AKT1;WASL;CD200
prerank,cardiac ventricle development (GO:0003231),-0.42451116854052406,-1.2038115757762358,0.20419847328244276,0.5346370467015777,1.0,10/20,17.87%,NOTCH1;PDE2A;STRA6;HEYL;HES1;ENG;HEY1;HECTD1;TMEM65;DLL4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3314663959479208,-1.2035442985877984,0.18055555555555555,0.5347251400108983,1.0,25/65,25.25%,FHL1;PSMA6;PSMB5;PABIR1;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;CHEK1;CDK5RAP3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;VPS4A;PSMB8
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4338605143487691,1.2033094072011095,0.2538293216630197,0.6360989112196106,1.0,2/21,2.62%,ERRFI1;ROCK2
prerank,metanephric mesenchyme development (GO:0072075),0.5003532690731389,1.2032379654646832,0.2657952069716776,0.6349750473413743,1.0,2/10,7.46%,WNT4;SIX4
prerank,response to interferon-alpha (GO:0035455),-0.4591875520886941,-1.203132766710047,0.2513863216266174,0.535121761254301,1.0,5/16,9.14%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4407650260329976,1.202696443704607,0.22198275862068967,0.6351185345295344,1.0,3/19,3.98%,WNT4;LARP6;CREB3L1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2852919653547068,-1.2022662809072127,0.11156186612576065,0.5365974514584373,1.0,33/151,14.67%,TEK;BMPER;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;SHC1;PDE8A;NPNT;FLT4;TNFRSF11A;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;APOE;FGF2;CSF1R;HRAS;PHB2;EGFR
prerank,leukotriene metabolic process (GO:0006691),0.4331831236687075,1.2019455877675465,0.23605150214592274,0.6359050349233883,1.0,4/19,7.34%,PLA2G5;ALOX12;PLA2G4A;DPEP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.49141270037245144,1.2015751787917996,0.26282051282051283,0.6355899331307101,1.0,3/12,8.54%,BMP2;SERPINE2;HES5
prerank,regulation of endopeptidase activity (GO:0052548),0.33582842408418606,1.2015521398210434,0.17391304347826086,0.6343790053366639,1.0,9/59,7.69%,TIMP3;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4;PSMA3
prerank,meiosis I (GO:0007127),0.4087037442172097,1.2014087408110263,0.21174004192872117,0.6334368234123329,1.0,4/23,7.98%,BCL2L11;MEIKIN;HSF2BP;ZSCAN21
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.43226605235915144,1.2012394121773058,0.24951267056530213,0.6326200862497551,1.0,3/20,13.45%,WNT4;CRY1;EP300
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4478326245443224,1.2010888770820591,0.2374727668845316,0.631773322819978,1.0,3/17,3.98%,WNT4;LARP6;CREB3L1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.40257301586342664,-1.2010708314281073,0.21960072595281308,0.5389392816063212,1.0,5/25,8.00%,CAV1;TMTC2;TRPM7;FAM20A;JPH2
prerank,membrane protein proteolysis (GO:0033619),-0.3627053295613818,-1.200974042042022,0.19165085388994307,0.5385703122463312,1.0,12/37,17.85%,BACE2;TGFB1;ADAM10;BACE1;RHBDD1;ADAM19;ERAP1;MBTPS2;PSENEN;APH1A;RELA;RET
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.33520535653416317,1.200867086147474,0.17219917012448133,0.6310826750366322,1.0,7/65,2.77%,LTBP1;FBN1;LDLRAD4;FBN2;PPARA;PDPK1;SMAD3
prerank,mitochondrion distribution (GO:0048311),-0.4906620950211985,-1.2007755483394522,0.2518939393939394,0.5384744959195921,1.0,4/12,15.08%,TRAK1;MEF2A;TRAK2;MTM1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3261583300834829,-1.200474651254603,0.16205533596837945,0.53862111323737,1.0,18/63,23.82%,MEF2C;IL15;SLC7A1;TFRC;ANXA1;CD38;CD81;TIRAP;CD74;CLCF1;JAK3;CD320;NCK1;FGF10;IL6ST;TNFSF13B;NCK2;AIF1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3539216011002017,-1.200452530509679,0.18832391713747645,0.5380752100646373,1.0,17/44,27.93%,PTPRJ;DAB2IP;AIDA;DNAJA1;UCHL1;NF1;STK38;APOE;SPRY1;CDK5RAP3;PTPN22;PTPN1;PRKCD;SMPD1;SPRY4;PDCD4;DUSP1
prerank,fluid transport (GO:0042044),-0.48148148148148145,-1.1997562458349649,0.26425855513307983,0.5391821624211848,1.0,9/12,51.88%,AQP11;AQP4;SLC26A6;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.3020860545673467,-1.1994677727403253,0.1448692152917505,0.5392861760839753,1.0,28/104,19.30%,ACTB;CCND3;LRP5;DAB2IP;CALM1;CDKN1B;HTT;RALB;TRIB2;AKT1;CCNG2;TRIB1;RB1;CAMK1;CIB1;MTCP1;CALM3;CSF1R;TSG101;SNF8;CAB39;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4069253128709446,-1.199025076146824,0.22794117647058823,0.5397767856840816,1.0,11/24,11.89%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10;DUSP3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4525823286162022,1.1984939420200107,0.24622030237580994,0.6359510110656802,1.0,2/17,0.68%,ATP1A2;AR
prerank,cellular component assembly (GO:0022607),-0.2655096548065341,-1.1982364587502696,0.06652806652806653,0.5411021911589525,1.0,53/253,16.42%,ACTB;OCLN;SLC2A1;LIMS2;BAIAP2L1;PARVB;SPTBN1;ACTG1;PARD3;RHOJ;EPS8;PTK2B;OPHN1;PLS3;FERMT2;CD2AP;TGFB1;ZW10;RAC1;LIMS1;GORASP2;RP1;NEDD9;PPARGC1A;PPP2R1A;TAPBP;REPS2;EZR;STK25;QSOX1;PDGFA;ADD1;FAS;FAM107A;CEP290;SPEF1;CD74;GAS8;TEAD2;YTHDF2;HAS1;VMP1;YWHAZ;HES1;TRAF1;CDAN1;WASL;MDN1;CHCHD10;SHROOM1;SKAP2;NCKAP1;RBBP4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3893825087312305,-1.197739515498816,0.21235521235521235,0.5416514078968775,1.0,12/29,20.30%,NAPA;RAB6B;GOSR1;COPG1;COPB2;COG8;COG3;GOLGA5;COG5;VTI1B;NSF;COG2
prerank,cellular glucose homeostasis (GO:0001678),-0.36192478171478554,-1.1975295094255363,0.19517102615694165,0.5415812628817898,1.0,9/41,5.37%,IGF1R;RACK1;UNC13B;LRRC8D;FOXO1;HK1;KCNB1;PPARGC1A;FOXK1
prerank,iron ion transport (GO:0006826),0.35305633499315986,1.197323260806034,0.20556745182012848,0.6376611489872187,1.0,4/47,1.49%,CP;STEAP3;ATP6V0A4;HEPH
prerank,heart morphogenesis (GO:0003007),0.3554033315113091,1.1969144036330683,0.20335429769392033,0.6375010576354787,1.0,7/50,5.18%,TGFBR3;FLRT2;BMP2;TBX3;CHD7;OLFM1;DLC1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3256288819283384,-1.1968572635774541,0.15120967741935484,0.5426562877109653,1.0,25/67,26.20%,PODXL;CAV1;ATP8B1;TBC1D8;PPP1R16B;IFT20;RAC1;TBC1D1;TBC1D22A;ATG3;FMR1;TBC1D9B;EPHA2;TBC1D2;RABEP2;DCDC2;TBC1D15;DMTN;FSCN1;CDC42;ODAD3;MYO10;TBC1D17;RDX;CDKL5
prerank,erythrocyte development (GO:0048821),-0.517368210507289,-1.196383543980394,0.2504604051565378,0.5431801175257474,1.0,5/10,32.94%,ZBTB7A;ALAS2;DMTN;ABCB10;LYAR
prerank,positive regulation of protein export from nucleus (GO:0046827),0.457403136621713,1.1963752063549162,0.24180327868852458,0.6375738675123315,1.0,5/15,17.96%,TCF7L2;XPO4;EMD;BAG3;TP53
prerank,neuron projection morphogenesis (GO:0048812),0.29284498455511804,1.19631477432463,0.12966601178781925,0.6364725215229983,1.0,28/137,10.85%,NRK;EPB41L3;FGFR2;CNTN4;CNTNAP2;LRP4;GPM6A;FLRT1;DOCK10;CTNNA2;SLITRK4;MYO16;SRGAP2;CTNND2;EPHB1;ALCAM;GAS7;TNIK;NLGN1;MAPK8IP2;DOCK7;NRCAM;RYK;RAB10;DCC;FARP1;PTEN;BRSK1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4280783672527346,-1.1962241194387417,0.23564356435643563,0.5429676114394211,1.0,8/20,13.09%,SHANK3;CAPRIN1;LRP8;CAMK1;DBNL;DBN1;APOE;FMR1
prerank,acylglycerol homeostasis (GO:0055090),0.43133492946310753,1.1952226325100406,0.24036281179138322,0.6381075125178947,1.0,3/20,11.15%,RORA;IL18;PLA2G12B
prerank,membrane assembly (GO:0071709),0.38399680343979264,1.195151262801053,0.232409381663113,0.6370552867015364,1.0,11/34,11.05%,NRXN1;LRP4;PTPRD;UBXN2B;NLGN2;NLGN3;UBXN2A;IL1RAPL1;NLGN1;PTEN;TLCD2
prerank,carboxylic acid transport (GO:0046942),0.3494957975206763,1.1949973600757822,0.2,0.6362131108422278,1.0,13/55,11.30%,SLC13A3;SLC6A12;SLC6A9;SLC16A12;SLC6A13;SLC17A1;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC1A5;SLC38A3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.3021763171102977,-1.1949095260740117,0.1378640776699029,0.5456097852680156,1.0,30/101,15.49%,FLT1;CCND3;FGF1;CCNY;TPD52L1;DAB2IP;FERMT2;CALM1;TGFB1;RALB;PKD1;PIK3R6;VEGFA;RGCC;EDN1;AKT1;PDGFC;PDGFA;TCIM;CAMK1;CIB1;MTCP1;CALM3;FGF2;CSF1R;HRAS;EGFR;ERBB2;CAB39;NOD2
prerank,regulation of fatty acid oxidation (GO:0046320),0.4575847132714982,1.1948982269114061,0.23949579831932774,0.63522414276611,1.0,3/16,3.91%,PPARA;PRKAG2;PDK4
prerank,regulation of hemopoiesis (GO:1903706),0.508912921454871,1.1946446750478397,0.2549019607843137,0.6346851173831922,1.0,2/10,9.16%,PTN;PRKCB
prerank,positive regulation of signaling (GO:0023056),0.3802086288971705,1.1946081450609636,0.1927710843373494,0.6335583389647026,1.0,12/37,19.21%,WLS;CLSTN2;RIMS1;GRIK2;RAB29;SYT1;GATA3;DLG4;HCRT;VAMP3;RIMS2;LGI1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3824636202055243,1.1945047237633866,0.2231578947368421,0.6325818873816899,1.0,5/35,4.77%,PLXNA2;NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.41234070790344857,1.1944496262646926,0.2444933920704846,0.6314894341783253,1.0,2/24,0.26%,AUTS2;PIK3R1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.5102180927133318,-1.1940819411316208,0.2724014336917563,0.5470780457767531,1.0,6/10,32.30%,REL;YY1;RELB;LILRB1;PTPRS;NLRC3
prerank,chloride transport (GO:0006821),-0.31231025489483083,-1.1938152927946744,0.15368852459016394,0.5471759156518804,1.0,10/74,4.60%,SLC4A10;ANO6;SLC12A7;SLC26A7;CLIC4;SLC12A2;ANO1;CLIC1;CLIC5;SLC1A1
prerank,actin polymerization or depolymerization (GO:0008154),0.3546717495887047,1.1936676074497685,0.2123015873015873,0.6322525737468396,1.0,3/50,0.25%,MICAL3;SVIL;ARHGAP6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.33778568537440484,-1.1932725691975963,0.18181818181818182,0.5478613699328495,1.0,18/54,22.12%,TAX1BP1;RACK1;HIPK1;IKBKB;CASP8;RIPK1;SYK;TRAF1;TNFRSF1A;MADD;TNFAIP3;HSPA1A;CHUK;TRAIP;LAPTM5;CASP1;HSPA1B;CCDC3
prerank,L-glutamate transmembrane transport (GO:0015813),0.510739094642466,1.193133237623581,0.2781456953642384,0.6323887746500474,1.0,2/10,7.15%,SLC1A3;SLC25A13
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.45431247830926236,1.1927373524246494,0.2511111111111111,0.6309971827069158,1.0,3/16,5.18%,ARHGAP6;PHLDB2;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.45431247830926236,1.1927373524246494,0.2511111111111111,0.6309971827069158,1.0,3/16,5.18%,ARHGAP6;PHLDB2;DLC1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2957338121753733,-1.1926113898741209,0.12727272727272726,0.5487885628350614,1.0,41/107,23.34%,MAP3K5;THBS1;RASGRF2;NIBAN1;SEL1L;DAB2IP;TMEM259;GORASP2;RHBDD1;UFM1;ATP2A3;ATF4;MBTPS2;DNAJB12;BAX;FLOT1;DDRGK1;RNF185;VCP;HSPA5;BBC3;BAK1;RNF5;ERP44;BCAP31;UFL1;PIK3R2;UFC1;CDK5RAP3;UBA5;ERLEC1;CREB3L2;NCK1;TMEM33;PDIA4;TRIB3;SELENOK;THBS4;ERO1A;ATF3;BRSK2
prerank,tRNA export from nucleus (GO:0006409),-0.3785041955828291,-1.1925886497260165,0.21335807050092764,0.5476211358938454,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3785041955828291,-1.1925886497260165,0.21335807050092764,0.5476211358938454,1.0,17/32,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4850369061572759,-1.1922656297319256,0.24770642201834864,0.5477813298508758,1.0,3/12,3.87%,PTPRJ;F3;IFT20
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.430885364056554,1.1922480831057884,0.2703962703962704,0.6310452304788903,1.0,10/20,23.08%,HENMT1;AGO4;SNIP1;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;DICER1
prerank,L-amino acid transport (GO:0015807),0.3965648122709072,1.1920939869915796,0.21940928270042195,0.6302498599128409,1.0,10/28,15.98%,SLC1A3;SLC7A2;SLC36A2;SLC7A9;SLC25A13;SLC38A3;CTNS;SLC1A2;SLC7A3;SLC25A18
prerank,histone H4-K8 acetylation (GO:0043982),-0.45463685028492096,-1.1920445570684433,0.2537037037037037,0.5471253807793675,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,histone H4-K5 acetylation (GO:0043981),-0.45463685028492096,-1.1920445570684433,0.2537037037037037,0.5471253807793675,1.0,4/15,8.18%,PHF20;JADE2;HCFC1;KANSL2
prerank,amyloid-beta metabolic process (GO:0050435),-0.4423801455023465,-1.1919527409148707,0.2587800369685767,0.5467466220013915,1.0,6/16,14.31%,BACE2;BACE1;IDE;PSENEN;ACE;APH1A
prerank,sensory perception of chemical stimulus (GO:0007606),0.4635638297269457,1.1914779490034253,0.2632794457274827,0.6305882096736027,1.0,4/15,14.15%,OMP;SLC24A4;UBR3;DRD2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.42853674968917943,-1.191475504852199,0.23076923076923078,0.547335498591431,1.0,3/21,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45870172587495994,1.191071003779966,0.24528301886792453,0.6304024482689636,1.0,7/15,16.40%,NLGN2;NLGN1;CNTNAP4;BAIAP3;DRD2;ADRA1A;CLN3
prerank,regulation of cell motility (GO:2000145),-0.2904390711679273,-1.1908153393701926,0.12474437627811862,0.5484898900309864,1.0,34/121,14.97%,TMSB4X;FRMD5;CDK6;SPOCK2;FGF1;CYRIB;TGFB1;PLXNA4;RAC1;CAVIN1;ROBO4;MINK1;AMOT;DIAPH1;CRK;CCDC125;SPATA13;ABI3;AKT1;TWIST1;TMSB10;RHOB;PLXNA1;PLXND1;ABL2;RCC2;SRCIN1;FGF2;CSF1R;NTN1;EGFR;ERBB2;OSGIN1;LDB1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3915080645469416,-1.190600844501947,0.20670391061452514,0.5484400011204005,1.0,15/29,34.63%,CAV1;THBS1;TNFSF10;RIPK1;INHBA;PPP2R1B;RET;LTBR;TNFRSF12A;BCL10;PMAIP1;PAK2;HYAL2;HTRA2;TNFSF12
prerank,regulation of dephosphorylation (GO:0035303),-0.44653643103868706,-1.1905790008645247,0.2381818181818182,0.5478939345137751,1.0,8/15,30.99%,PPP1R16B;IGBP1;PPP1R16A;SMG7;CDK5RAP3;MTMR2;SRC;SMG6
prerank,positive regulation of gene expression (GO:0010628),-0.25017719592177357,-1.1905522368905632,0.05508474576271186,0.547371717467806,1.0,87/442,13.26%,FN1;LEF1;MEF2C;ACTB;OCLN;CLDN5;THBS1;NOS3;CD34;TNRC6C;NOTCH1;DDX5;ACTG1;PLCG2;VIM;IL15;RPL26;FGF1;F3;KLF4;MAPK3;EEF2;RAMP2;TFRC;NIBAN1;RPS4X;RPS3;ETS1;NGF;RPL11;HNRNPLL;TGFB1;RBM20;APP;RAB27A;MSN;RPL23;SMO;PDE2A;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;EZR;ATF4;ADAM19;GATA2;PRKDC;LURAP1;TLR3;HCFC1;RGCC;RIPK1;KRAS;GAPDH;PPM1F;AKT1;RBM22;TWIST1;WARS1;FLOT1;DDRGK1;WNT11;RPS27L;GABPA;EIF3D;CD74;INHBA;LARP4B;S100A13;WBP2;CIRBP;FAM98A;SERPINB9;UPF3A;E2F1;RPS7;TLR4;SOX4;FGF2;SPHK2;AGPAT1;FMR1;PIK3R3
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3173419425629582,-1.1904951552146235,0.17045454545454544,0.546921031459039,1.0,13/70,6.61%,FN1;TEK;MEF2C;PARVB;PXN;OPHN1;PEAK1;LAMA5;FERMT2;RAC1;NTN4;ATF4;ACTN1
prerank,cellular response to heat (GO:0034605),-0.3715907392051557,-1.1903591547165981,0.20149253731343283,0.5466106915126165,1.0,9/35,10.66%,THBS1;ANO1;FGF1;HSP90AB1;CLPB;HSBP1;TCIM;VCP;TRPV4
prerank,muscle organ development (GO:0007517),0.34538626133127776,1.1902866487999235,0.19591836734693877,0.6312578678125463,1.0,7/54,4.40%,IGF1;LAMA2;VAMP5;ITGA11;SGCD;SGCE;EVC
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.25999915297897186,1.19028003744528,0.08646616541353383,0.6300759142557165,1.0,71/390,12.96%,COL4A6;IGF1;EPHA7;PIK3R1;IL31RA;NRP1;FLRT2;ATP6V0A4;NTRK3;DDR2;ANGPT2;FGFR2;SULF1;NRG1;SULF2;KL;KIT;EFS;PDGFRA;MTSS1;EPHA3;TNK2;ROCK2;EPHA6;VEGFB;FLRT1;PDK4;PTPRT;STAP1;PHIP;LYN;DDR1;EFNA3;GHR;IRS2;AXL;SHC4;CASP3;PDGFRB;SIRT2;EPHB1;POLR1G;PDGFD;IGF2;ERBB3;RYK;POLR2G;FGFR4;CDK5R1;SH2D2A;EPHA8;AHI1;SH2D6;ERBB4;ESRP1;EPHA5;ATP6V1H;ALK;BRK1;MUSK;MST1R;NGFR;MERTK;GFRA2;ANKS1B;FGFR1;PRLR;KALRN;ROR1;EPHA1;BCAR1
prerank,pinocytosis (GO:0006907),0.5018582796544551,1.1894438597740284,0.2733333333333333,0.6310634296582264,1.0,2/10,2.92%,AHSG;SNX33
prerank,acute inflammatory response (GO:0002526),-0.4044032069491116,-1.1888783473023177,0.22043010752688172,0.5497409969932583,1.0,3/23,2.55%,ANO6;LBP;F3
prerank,lipid translocation (GO:0034204),-0.4178297458879449,-1.1888471854608393,0.23946360153256704,0.5492240556545045,1.0,6/21,8.51%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A;ATP9B
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.47589451164618274,-1.1886248249974183,0.2527881040892193,0.5491900130573161,1.0,2/12,9.23%,CD44;FLOT1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3004712200186877,-1.1884067903098898,0.15606936416184972,0.5491185455670369,1.0,27/110,12.88%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;HSPA8;RALB;PRKCZ;NAPA;VEGFA;HCFC1;AIDA;SVIP;KIF9;BAX;TAL1;WARS1;RB1;TIRAP;VCP;HSPA5;NCLN;IMPACT;APOE;BAK1;SYK
prerank,positive regulation of protein binding (GO:0032092),-0.33298559020048235,-1.1883771134441141,0.17543859649122806,0.548593987902384,1.0,13/56,9.23%,CAV1;CLDN5;B2M;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;IDE;NMD3;ADD1;FLOT1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.43507210992852396,1.1879192437888557,0.25158562367864695,0.6336702588570743,1.0,3/18,5.08%,FBN1;GPR55;IL4
prerank,heterochromatin organization (GO:0070828),-0.46274805669286656,-1.1878020466929655,0.2857142857142857,0.5493976488863749,1.0,2/14,4.27%,MECOM;PRDM16
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.3855757601356794,-1.187354002550991,0.23551401869158878,0.5498768729780814,1.0,19/30,39.34%,CAV1;PRKCZ;PPP2R1A;SRCIN1;PTPN6;CADM4;PRKCD;DMTN;PTPN2;PARP14;MVP;HYAL2;NF2;SH3BP5;NTF3;PPP2CA;INPP5F;SFRP2;SOCS3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3373231338104433,1.1870576486670525,0.18126272912423624,0.6346567396003608,1.0,4/56,1.32%,BMP6;BMP2;LDLRAD4;BMP5
prerank,negative regulation of cell motility (GO:2000146),0.3033851501088362,1.1864004598495035,0.16733870967741934,0.6351036786565728,1.0,28/108,14.26%,ROBO1;LDLRAD4;PODN;FBLN1;SULF1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;SPOCK3;DLC1;SRGAP3;SRGAP2;SERPINE1;DPYSL3;CITED2;GATA3;PTEN;FUZ;AFDN;NGFR;EPHA1;NAV3;NKX2-1;DRD2;ARPIN
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2802352504633354,-1.1859277600684266,0.12317327766179541,0.5528453710328572,1.0,49/158,21.16%,NOD1;TFRC;MID2;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;RIPK1;EEF1D;GAPDH;PLK2;TRIM14;TIRAP;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;TNFRSF1A;TRIM68;TRIM5;NOD2;TMEM101;LGALS1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3502890155209478,-1.1852420076614283,0.20323741007194246,0.5539675043704393,1.0,10/41,12.17%,SLC12A7;SLC12A2;KCNJ2;ABCC9;ATP1A1;KCNJ10;ATP1B1;KCNJ8;KCNK9;KCNJ15
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.3160826536698261,-1.1842478849106548,0.17996289424860853,0.5559527589556998,1.0,29/74,25.25%,NOTCH1;EGLN3;UBB;UBC;RPS27A;VEGFA;PSMA6;EGLN2;PSMB5;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;HIF1AN;PSMB8
prerank,ganglion development (GO:0061548),0.4942155378497499,1.1834241277460409,0.2962138084632517,0.6414445297699796,1.0,3/11,7.40%,NRP1;SEMA3A;UNC5C
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.3189724762267991,-1.1832582903545197,0.17702448210922786,0.5579101378844099,1.0,27/72,26.38%,CARD14;REL;TLR3;PSMA6;PSMB5;AKT1;RELB;TIRAP;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;TRAF6;PSMB8;CARD10
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4185386405177104,1.1830876534879966,0.2375,0.6410574928565053,1.0,4/21,2.62%,ENPP1;BCOR;AHSG;ROCK2
prerank,histone H3-K36 demethylation (GO:0070544),0.49448134737889904,1.1830537673322774,0.28085106382978725,0.6399385001460789,1.0,6/10,26.08%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,cell-cell junction organization (GO:0045216),-0.3121237133376664,-1.1820335490434213,0.1889763779527559,0.5603874328495168,1.0,19/79,10.88%,PKP4;OCLN;CLDN5;LIMS2;CXADR;CDH1;CTNNA1;TJP2;TGFB1;TGFB2;SDK1;LIMS1;CDH4;TGFB3;JUP;GJC1;PVR;TRPV4;CDH6
prerank,positive regulation of myelination (GO:0031643),-0.4875674835448819,-1.1819724606778155,0.26607142857142857,0.5599406293596382,1.0,2/11,7.20%,PARD3;TNFRSF1B
prerank,positive regulation of T cell activation (GO:0050870),-0.32135579213419385,-1.1818713178809799,0.16569200779727095,0.5595788714499657,1.0,17/62,24.36%,IL15;SLC7A1;TFRC;CYRIB;ANXA1;CD81;HSPD1;FLOT2;NOD2;XBP1;JAK3;LGALS9;NCK1;IL6ST;NCK2;AIF1;CCL2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.40661684994224556,-1.1815666582178392,0.2169811320754717,0.5597218271948126,1.0,8/22,25.57%,BRD4;HMGN1;ALYREF;CDK13;CCNK;DDX39B;EAPP;ELL
prerank,response to interleukin-4 (GO:0070670),-0.500536458116221,-1.1814828549946328,0.2490974729241877,0.5593129677715479,1.0,5/10,27.84%,LEF1;XBP1;JAK3;SHPK;TCF7
prerank,protein localization to synapse (GO:0035418),0.49237260293781593,1.1813024468154716,0.3108695652173913,0.6432659513619688,1.0,5/12,17.07%,NRXN1;NLGN2;NLGN1;DLG4;ZDHHC15
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.4452477417152138,-1.1812679809836835,0.2572992700729927,0.5592241982879335,1.0,3/15,12.49%,ENTPD1;ENTPD7;ENTPD6
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2913360969362028,1.1811990645673556,0.14738805970149255,0.6423171908708981,1.0,14/132,6.12%,IGF1;SH3D19;ZBTB20;PPARA;DCN;TRIM38;SNX33;PIM2;PFKFB4;TICAM1;IRS2;DAPK1;ABCD2;LIN28B
prerank,cellular protein modification process (GO:0006464),-0.23345195343390682,-1.1811380609228508,0.02088167053364269,0.5589460244040196,1.0,217/983,17.51%,FN1;PTPRB;PRKCH;ST3GAL6;PTPRG;ERG;ST3GAL4;PTPN14;CDK6;MAP3K5;ST8SIA4;CTTNBP2NL;IGFBP7;THBS1;GPC3;RPS6KA5;PTPRJ;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;RAB11A;BMPR2;TGM2;PEAK1;LIMK2;HIPK1;NLK;MAPK3;EGLN3;WNK1;LMO7;MANBA;STK10;BMX;COL3A1;NEK7;CAMK2D;PLOD2;ANXA1;MAP3K1;MAP3K20;SOCS2;IGFBP5;FNIP2;TGFB1;APP;TGFB2;RBBP5;FAM20A;SUMF2;KLHL5;WWP2;CSNK1G2;MSLN;ADAM10;SPARCL1;PRKCZ;CTDSP1;CTBP1;PTPRM;IGFBP3;MINK1;SSH2;DCAF6;ZBTB16;PPP3CC;RHBDD1;TAOK3;NRBP1;PTP4A2;PPP2R1A;KLHL2;IKBKB;RARA;ST8SIA6;PRKDC;FBXO17;BCR;MSRA;MGAT1;NUCB1;PSMA6;CSNK1G3;SRPK1;PPP2R5A;DCUN1D1;PPM1F;WSB2;TRIB2;STK25;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;PLK2;UBE2L6;DYRK2;AKT1;INSR;CST3;MAP3K11;SPP1;CDC42BPB;CPE;PNPLA2;ATG3;TRIB1;PIM3;ART3;PPP1CB;ATG7;RAB8A;LMTK2;ASB8;COPS6;WNT11;UBE2F;DAD1;PSMC4;CAMK1;WDTC1;CDK4;ABL2;TAOK2;PSMC5;FRK;STK36;FBXL14;VRK1;RAB11B;PPP2R1B;STK38;CHRDL1;GRK5;ACVR1;MMP15;PKN3;PPP5C;PSMD14;YWHAZ;FBXW5;FBXW10;APOE;PRKCE;CDK10;PPP3CB;ICMT;FSTL1;PPP2R2A;SYK;COPS5;KLHL3;FBXL7;CDC14B;FASTK;SUMF1;PIGT;ST6GALNAC2;CDKL4;TBCK;SERP2;FBXL2;NUAK1;NPC1;LOX;NUAK2;FUCA2;CISH;FEM1A;PTPN12;RBX1;RAB1A;JAK2;F13A1;COG3;PSMD8;ERBB2;PRKAG1;COQ8A;WSB1;MTM1;LMTK3;PARP2;GLRX;LIMK1;NEK3;PTPN6;PSMD11;YES1;CCNF;STK38L;STK26;CDK13;UCHL3;CSNK2A1;LGALS1;UFL1;DSP;PSMB4;PSMD12;PSMC1;PHEX;FBXL3;FBXL16;F5;PPP2R5E;GAN;CTH;RCE1;MAP3K9;JAK3;HCK;CUL1;MCRS1
prerank,protein localization to vacuole (GO:0072665),-0.4686722539077686,-1.1806694358122993,0.2569832402234637,0.5595612950547099,1.0,4/13,14.70%,SH3BP4;CD81;GLMP;MFSD1
prerank,positive regulation of translation (GO:0045727),-0.3028847749518881,-1.1805992331956947,0.174,0.5591371657790205,1.0,29/94,17.01%,THBS1;VIM;RPL26;EEF2;NIBAN1;RPS4X;RPS9;CNBP;UQCC2;PKM;PRKDC;YBX3;DHX9;RPS27L;EIF3D;LARP4B;RPS6KB2;YTHDF2;CIRBP;UPF3A;SOX4;FMR1;COA3;TRMT10C;UHMK1;ERBB2;RPUSD4;FASTKD3;PCIF1
prerank,regulation of cellular senescence (GO:2000772),-0.3892804432984942,-1.180415255386579,0.24763705103969755,0.5590158321363844,1.0,6/28,9.25%,CDK6;B2M;MAP3K3;ABI3;TWIST1;YPEL3
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.44555649107943096,-1.180293094765441,0.2552083333333333,0.5581151369460188,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.44555649107943096,-1.180293094765441,0.2552083333333333,0.5581151369460188,1.0,11/15,38.38%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,protein secretion (GO:0009306),0.3401440908260119,1.1800969512363675,0.1891891891891892,0.643986876445624,1.0,13/56,16.10%,WLS;STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2;CYB5R4;COPG2;PORCN;SVBP
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4337800849901262,1.1800283054602811,0.2700892857142857,0.6429516420488434,1.0,2/18,1.22%,PIK3R1;BCL2L11
prerank,atrioventricular valve development (GO:0003171),-0.45244339270599127,-1.179915870709113,0.2788104089219331,0.5584307588790486,1.0,5/14,5.49%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL
prerank,cell-cell junction assembly (GO:0007043),0.33611369617830106,1.1798652134279635,0.20208333333333334,0.6421422662399807,1.0,14/63,6.72%,EPB41L3;TLN2;GJB6;GJA1;CDH8;PRKCA;CDH18;DCHS1;ARVCF;CTNND2;CDH11;CDH20;CDH19;CDH7
prerank,regulation of cell-cell adhesion (GO:0022407),-0.35862993604638843,-1.1796149858396934,0.2189922480620155,0.5586002964481785,1.0,8/39,5.31%,PTPRG;PODXL;CDH1;DPP4;PTK2;SMAD7;TGFB1;MINK1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.445266679020457,1.1789901514648555,0.25,0.6431645261134872,1.0,5/16,14.46%,SHLD2;UBQLN4;RADX;SMCHD1;RIF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.30684787257267004,-1.1787227041154504,0.1867704280155642,0.5603208907523234,1.0,27/85,21.45%,CBFA2T3;RACK1;RNF144B;DAB2IP;TMEM259;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;RNF185;VCP;USP5;PSMC5;FMR1;RBX1;HECTD1;HSPA1A;RNF19A;OSBPL7;ELOB;KEAP1;TRIB3;HSPA1B;PSMC3
prerank,mesenchyme development (GO:0060485),0.457284139617552,1.1786547843435466,0.2577777777777778,0.6428914048583855,1.0,3/15,7.96%,BMP2;FGFR2;TGFBR1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.338287320788037,-1.1785077395119063,0.23214285714285715,0.5602649149232832,1.0,23/49,31.18%,MANBA;DAB2IP;MTREX;FBXO17;IDE;RIPK1;DENND3;PPP1R8;UBE2G2;RNF5;UBE2G1;OGA;DNASE1L2;RNASEH2C;DFFB;FBXO6;NEU2;FBXO2;STT3B;MAGEC2;XRN2;ISG20;SIDT2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.35950542214503245,-1.1781691921068995,0.21115537848605578,0.5604599721861305,1.0,7/39,7.21%,TEK;ANO6;THBS1;KDR;RAMP2;GATA2;RGCC
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4441032244929075,-1.1781118549382812,0.2427007299270073,0.5599951453056569,1.0,3/16,5.28%,MEF2C;BOC;IGFBP3
prerank,negative regulation of nuclear division (GO:0051784),0.4943962401482538,1.1778066966166456,0.2945054945054945,0.6439378459016792,1.0,4/11,16.62%,AURKAIP1;TOM1L2;TOM1L1;FBXO5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4520042257604784,1.1776273007595155,0.26666666666666666,0.6431958025185475,1.0,3/15,7.03%,MOXD1;SAT1;TPH2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4484309896634788,1.1772506437629469,0.2603938730853392,0.6430087363661259,1.0,11/17,23.41%,VIRMA;ZC3H3;CPEB3;CPSF7;CCNT1;CDK9;CPEB1;HSF1;CPSF6;NUDT21;CTR9
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.47328045167746213,-1.1772412371572882,0.2914485165794066,0.5615537980072104,1.0,2/12,5.01%,SORBS1;PRKCZ
prerank,mitotic cell cycle phase transition (GO:0044772),-0.2699242247079806,-1.1770365861669914,0.1341991341991342,0.5614481850722586,1.0,68/203,25.79%,CDK6;CCND3;EPS8;CCNY;DCTN2;TPD52L1;TUBA1A;CDKN1B;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CUL4A;PLK2;NES;CEP70;DCTN3;CCNG2;RB1;PPP1CB;CEP290;CNTRL;DCTN1;INHBA;E2F3;CDK4;CRLF3;PPP1R12B;PCM1;TUBB4B;ACVR1;E2F1;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CCNF;CDKN1A;ANAPC7;CDC27;HSP90AA1;CEP41;FBXL3;CUL1;CHMP2A;CDKN2C;CCND1;LCMT1;RCC1;DNM2;PPP2R2D;TUBA4A;EIF4EBP1;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;EIF4E;SPDYA;HAUS4;YWHAE;CEP63;NEDD1
prerank,anion transport (GO:0006820),-0.3733440153848132,-1.1764693264188033,0.2236842105263158,0.5622718483251263,1.0,5/33,2.31%,ABCG2;SLC26A7;SLCO2B1;LRRC8C;LRRC8D
prerank,granulocyte chemotaxis (GO:0071621),-0.33504280779479145,-1.176373605226589,0.19525547445255476,0.5618834010446158,1.0,10/55,14.21%,BSG;CXADR;ANXA1;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4382147527755212,-1.176316085150955,0.2815533980582524,0.5614364714212684,1.0,3/16,5.34%,RREB1;SIX1;SOX13
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4646989070807951,-1.1762079653198232,0.2639138240574506,0.5610956710369559,1.0,6/13,26.94%,ELOVL7;ELOVL5;TECRL;ELOVL1;HACD4;HACD2
prerank,regulation of gene expression (GO:0010468),-0.23362136521917787,-1.1754354948815127,0.017817371937639197,0.56247782608264,1.0,174/903,14.99%,BNC2;FN1;LEF1;FOXP1;MEF2C;PRDM6;OCLN;CDK6;CLDN5;AHNAK;APBB2;RREB1;CDH1;NOS3;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;ACTG1;PLCG2;NOVA2;RPL6;SLC7A5;FGF1;AHNAK2;MBNL1;RACK1;HMG20B;KDR;JMJD1C;F3;KLF4;NLK;MAPK3;RAMP2;TFRC;RPS3;ETS1;SOX17;NGF;VSX1;RPL11;SIX1;HNRNPLL;TGFB1;RBM20;CNBP;REST;APP;TGFB2;RAB27A;TRRAP;AFF4;MSN;RPL23;SMO;PDE2A;NFYA;ZNF431;CRIP1;REL;WWP2;ASCC2;PPARGC1B;LIMS1;ADAM10;PFDN5;FOXD1;RLIM;PRDM2;PPARGC1A;BHLHE40;MYOM1;SOX13;SLC39A8;IL33;VEGFA;CNOT7;ACTA2;PTBP3;PPP2R1A;TAPBP;PRDM4;EZR;ATF4;ADAM19;FOXN3;ZNF326;GATA2;CASP8;NR3C1;TLR3;HCFC1;NFKBIZ;RGCC;KRAS;UBAP2;PPM1F;ATP1B1;YBX3;RC3H1;GPX1;NR2C2;YY1;HDAC4;ATXN1L;AKT1;SPIN1;INSR;FZD7;BCL6;FUS;SOX7;PCBP4;TWIST1;WARS1;TRIM14;SOX18;RB1;ESRRA;TDRD7;DDRGK1;ACE2;PRRX2;WNT11;MYBL1;HNRNPDL;GABPA;WTIP;CD74;INHBA;MTA1;CDK4;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;YTHDF2;FAM98A;SERPINB9;E2F1;RPS7;ZNF423;APOE;CLK1;TLR4;SOX4;HINT1;TOB2;FGF2;TSKU;ENG;PIK3R3;FASTK;PHF12;BTN3A3;HRAS;POGZ;HCFC2;MLX;TRIM68;RNF20;CAVIN4;BCL6B;NR5A2;HEY1;TRIM5;HNRNPK;LDB1;FLOT2;PRKAG1
prerank,tRNA transport (GO:0051031),-0.3641081691693747,-1.1752711098120034,0.21915285451197053,0.5623043448352117,1.0,17/35,34.81%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;RAE1;NUP88;NUP214
prerank,T cell activation involved in immune response (GO:0002286),-0.4691224159191128,-1.1748733582891548,0.2772808586762075,0.5627531091044342,1.0,10/12,50.21%,FCER1G;CD74;ICAM1;LILRB1;SLC11A1;LCP1;ITGAL;F2RL1;IFNK;TNFSF18
prerank,mononuclear cell differentiation (GO:1903131),0.40234635338715785,1.1742862388810373,0.24342105263157895,0.6495047475788129,1.0,4/24,5.75%,IL31RA;LYN;IL4;AXL
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5008576921383046,-1.1739650739578134,0.2914485165794066,0.5644397674271696,1.0,4/10,10.66%,UBB;UBC;RPS27A;DIS3L2
prerank,potassium ion homeostasis (GO:0055075),-0.4018017523998916,-1.1736451165294086,0.24866785079928952,0.5646556345969509,1.0,5/23,7.63%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.42478686975626134,-1.1736332739864281,0.25555555555555554,0.5640973494068562,1.0,2/20,0.35%,PLCE1;CAV1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.31591813572908395,-1.1730748057800544,0.19961977186311788,0.5648915879713193,1.0,20/73,11.91%,ACER2;NOD1;RACK1;F3;EGLN3;NGF;CRADD;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;BAX;FAS;HSPD1;HIP1;VCP;RPS27L;BEX3;BBC3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.321632308330049,-1.1730563358792943,0.1791907514450867,0.5643462146307668,1.0,25/70,23.10%,LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,transition metal ion homeostasis (GO:0055076),0.39662284816555554,1.1728332276823814,0.2374429223744292,0.6521989480562207,1.0,4/28,5.39%,CP;HEPH;NEO1;PRKN
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4188497103209622,1.172517349760827,0.23655913978494625,0.6518664104857592,1.0,1/20,0.08%,IGF1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5013603712613881,-1.1721451497301898,0.2798573975044563,0.5659912359435237,1.0,3/10,3.71%,RAP1A;RAPGEF1;NGF
prerank,regulation of mitochondrial fusion (GO:0010635),0.4963980978350825,1.1717404520041508,0.2924731182795699,0.6526330498550009,1.0,3/11,5.39%,PID1;OMA1;PRKN
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4441211330100026,1.17121346117843,0.25854700854700857,0.6527856567149454,1.0,4/16,7.92%,NRP1;PDGFRA;PDGFRB;PDGFD
prerank,defense response to protozoan (GO:0042832),-0.46996122934915646,-1.170503313445863,0.2905525846702317,0.5695362388377256,1.0,9/12,45.74%,LYST;GBP7;GBP4;CD40;SLC11A1;BATF;PF4;MYD88;IRF4
prerank,response to insulin (GO:0032868),0.31713827865691074,1.169958653045898,0.19222903885480572,0.6549172022255024,1.0,12/80,10.59%,ENPP1;PIK3R1;TBC1D4;PDPK1;MYO5A;IRS2;RAB10;PDE3B;C2CD5;INSIG2;PRKCI;LPIN3
prerank,histone monoubiquitination (GO:0010390),0.4065485846601159,1.168867748517907,0.24528301886792453,0.6565519714251388,1.0,12/24,27.46%,BCOR;DDB2;RNF2;SKP1;TRIM37;WAC;PAF1;KDM2B;CTR9;RNF168;RYBP;LEO1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.37807708792150363,-1.1688176606367813,0.25411334552102377,0.5731335891002652,1.0,9/27,19.15%,CAV1;PDE4D;CAMK2D;JUP;CTNNA3;DSG2;SRI;DSP;CACNA1C
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.468195580952108,-1.1687064796943984,0.26523297491039427,0.5728218576909536,1.0,4/12,12.83%,NOTCH1;REST;YTHDF2;HES1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4273263042433203,-1.168459861120381,0.24329159212880144,0.5728435191730734,1.0,4/17,13.51%,CD55;TLR4;IL18BP;BTN3A3
prerank,negative regulation of secretion by cell (GO:1903531),-0.3564321080031863,-1.168342280745401,0.22770398481973433,0.5724946150688471,1.0,7/38,13.25%,STXBP6;NOTCH1;ANXA1;TNFRSF1B;DPH3;APOE;TNFRSF1A
prerank,tRNA aminoacylation (GO:0043039),-0.364418577574461,-1.1681602674090752,0.24067164179104478,0.5723654236570519,1.0,17/37,30.44%,SARS1;QRSL1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;GATC;FARS2;FARSB;IARS1;GATB;GARS1;KARS1;NARS1;IARS2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.47360594099636,-1.1679497945266675,0.2920353982300885,0.5722828682160548,1.0,2/11,6.77%,MAPK3;USP7
prerank,hepaticobiliary system development (GO:0061008),0.42075076069037853,1.167660545581901,0.2832618025751073,0.6584658263436693,1.0,5/20,11.25%,TGFBR3;WNT4;CITED2;PRKCSH;ARID5B
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.40742165222360727,-1.1676242488755768,0.24680073126142596,0.5725306572217871,1.0,9/22,16.40%,CALM1;VEGFA;RASSF2;PDGFC;PDGFA;TAOK2;CALM3;ACE;GREM1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.4302732334358041,-1.16737733909034,0.28468468468468466,0.5725358982584898,1.0,11/17,29.30%,BAX;BBC3;BCL2L1;BAK1;BAD;SFN;TIMM50;GGCT;FIS1;MFF;FZD9
prerank,integrin-mediated signaling pathway (GO:0007229),-0.31056979498918547,-1.1665524753910363,0.19373776908023482,0.5739432332062268,1.0,13/73,5.29%,FN1;SEMA7A;DOCK1;PTK2B;PTK2;COL3A1;LAMA5;FERMT2;ITGB4;ADAM15;ADAM10;NEDD9;LAMA3
prerank,organelle transport along microtubule (GO:0072384),-0.3729503640833245,-1.1660617322112723,0.23552894211576847,0.5745449131234115,1.0,11/31,14.39%,TRAK1;UBB;HTT;TRAK2;BORCS5;RHOT1;COPG1;RHOT2;NDE1;NDEL1;RAB1A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.41941448438761775,1.1658905699132007,0.2689655172413793,0.6619707650765224,1.0,1/21,0.08%,IGF1
prerank,cell-matrix adhesion (GO:0007160),-0.2974437246370707,-1.1654097184817307,0.20119521912350596,0.5755226489972245,1.0,23/95,12.81%,FN1;ITGA1;THSD1;CD34;SORBS1;PEAK1;COL3A1;FERMT2;ITGB4;CD44;ADAM15;RAC1;MSLN;PKD1;BCAM;ACTN1;BCR;NPNT;VCL;EMP2;TAOK2;RCC2;ITGA7
prerank,purine-containing compound salvage (GO:0043101),0.4714073964915897,1.1648374895790135,0.2850467289719626,0.6635461863901335,1.0,2/12,6.90%,AMPD3;GMPR
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.42088342921284516,1.1642395877815004,0.28444444444444444,0.663941346819739,1.0,2/19,0.65%,CAMK1D;IL34
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.32498821588430277,-1.1641337720393743,0.22304832713754646,0.5781466102104719,1.0,16/59,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3846881909586999,-1.1637024947108858,0.23863636363636365,0.5786429427268323,1.0,8/26,15.09%,REST;PPIA;ATF4;PDE8A;HSPB1;AKT1;BAG5;GPR37L1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3963588085653682,-1.1634815240457541,0.26003824091778205,0.5785781785223023,1.0,7/22,17.53%,LBP;DAB2IP;MFHAS1;FLOT1;TIRAP;TNFAIP3;NINJ1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4049759764457511,-1.1634633132930832,0.26045627376425856,0.5780270801843169,1.0,6/21,8.83%,BACE2;ADAM10;BACE1;ADAM19;ERAP1;PSENEN
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4182377719867634,-1.1630165285173462,0.25925925925925924,0.5786408480255721,1.0,7/18,21.90%,SEC14L1;RNF125;DHX58;USP15;ANKRD17;PUM2;ZCCHC3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4708972944409481,-1.1627512038264518,0.2784090909090909,0.5786679720322276,1.0,5/13,13.01%,IFIH1;DHX9;CD74;MAVS;AGPAT1
prerank,establishment of protein localization to membrane (GO:0090150),-0.3112545385715672,-1.1626848656060822,0.21637426900584794,0.5782676098874806,1.0,17/66,14.67%,PARD3;RAB11A;GORASP2;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;RAB11B;ZDHHC1;ICMT;ARL6;NPC1;ZDHHC20;SDCBP;EGFR
prerank,muscle cell differentiation (GO:0042692),-0.3735531983732716,-1.1626680034209422,0.23452157598499063,0.5777167448874391,1.0,6/32,2.95%,MEF2C;NEBL;MRTFB;SYNE1;DMD;TBX1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4341096634646643,-1.1625246570632832,0.2864963503649635,0.5774951276115879,1.0,7/17,27.17%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22;PTPN2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4463689587975398,1.1625157169608875,0.2853932584269663,0.6672218632497204,1.0,2/15,2.06%,ADGRV1;KIT
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.36045166817849206,-1.1624471055014731,0.23076923076923078,0.5771194377053507,1.0,10/33,18.08%,PLCG2;CDKN1B;PKD1;DDRGK1;TCIM;E2F1;PHB2;PTPN6;CDKN1A;GLI1
prerank,vesicle transport along actin filament (GO:0030050),-0.42557366259014306,-1.1623807325560256,0.26515151515151514,0.5767070934636824,1.0,3/19,2.18%,MYO1D;FNBP1L;ACTN4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3464786360290402,1.16233881519365,0.24180327868852458,0.666498735398784,1.0,7/46,5.19%,PIK3R1;NRP1;ATRNL1;LAMC3;ANTXR1;RADIL;SRGAP2
prerank,neutrophil migration (GO:1990266),-0.32952194497170273,-1.1623140733534312,0.20186915887850468,0.5762885820269263,1.0,10/58,14.21%,PECAM1;BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,proteoglycan biosynthetic process (GO:0030166),0.3818183806434021,1.1622293940868424,0.25396825396825395,0.6655982350305414,1.0,4/31,4.91%,IGF1;CHST8;GAL3ST3;PXYLP1
prerank,acidic amino acid transport (GO:0015800),0.4401803824555431,1.1621955571264222,0.2888402625820569,0.6645048468316693,1.0,3/17,1.59%,SLC1A3;GJA1;SLC6A13
prerank,water transport (GO:0006833),-0.4638418079096045,-1.161857834450861,0.2749529190207156,0.5767952442529322,1.0,9/12,53.64%,AQP11;AQP4;AQP1;AQP9;AQP6;CFTR;PDPN;AQP7;SLC5A1
prerank,actin crosslink formation (GO:0051764),-0.47401402114409874,-1.1613566402763675,0.27495621716287216,0.5775002390896119,1.0,5/12,23.82%,BAIAP2L1;EPS8;GAS2L1;GAS2;AIF1
prerank,positive regulation of DNA binding (GO:0043388),0.3740692462940168,1.1607689031697408,0.25949367088607594,0.6670032908076368,1.0,5/31,9.13%,IGF1;PRKN;SIRT2;PINX1;GATA3
prerank,neuron projection regeneration (GO:0031102),0.5019588497358571,1.1605021696932554,0.29345372460496616,0.6664930525406484,1.0,2/10,5.48%,PTN;NREP
prerank,cellular response to amino acid stimulus (GO:0071230),-0.36255103866623284,-1.1604848421590166,0.24708171206225682,0.5790528594517275,1.0,19/33,36.47%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;RRAGA;RRAGC;SESN2;CASTOR2;NSMF;RPTOR;LAMTOR5;SESN1;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5;FYN
prerank,telomere maintenance (GO:0000723),0.33978514631439494,1.160153509467982,0.21085594989561587,0.6661871380214783,1.0,21/50,21.95%,STN1;BLM;RPA2;TEP1;NBN;ATM;RIF1;RPA1;SMC6;PARP3;PARP1;SP100;SMC5;POLD4;NSMCE2;POLD1;RTEL1;PCNA;POLD3;POLD2;DCLRE1B
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49118555609032344,1.1599911275650725,0.27069351230425054,0.6654170719601576,1.0,2/11,0.54%,TGFBR3;BMP2
prerank,regulation of dopamine secretion (GO:0014059),0.3974816441564844,1.159853417990322,0.24008810572687225,0.6645948379230899,1.0,9/25,18.07%,GDNF;PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,lysosome localization (GO:0032418),-0.3554977447199558,-1.1596707492280545,0.2553191489361702,0.5804568823225479,1.0,20/37,31.97%,PLEKHM1;PLEKHM2;BORCS5;PIP4P1;S100A13;FAM98A;NDEL1;SPAG9;VPS33A;ARL8B;TFEB;MILR1;BORCS6;PIK3CG;MYH9;KXD1;KIF5B;VPS33B;RAB3A;LAMTOR1
prerank,regulation of lipid kinase activity (GO:0043550),0.4785277662840238,1.1596068620073927,0.30454545454545456,0.6640465599065908,1.0,1/11,0.26%,PIK3R1
prerank,cellular response to interleukin-1 (GO:0071347),-0.28301041676133143,-1.1593755756812256,0.18426103646833014,0.5806120380580182,1.0,46/143,24.36%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;DAB2IP;MAP3K3;UBB;UBC;RPS27A;IL1R1;IKBKB;PSMA6;MAP3K8;RC3H1;PSMB5;CCL15;TOLLIP;PSMC4;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PELI1;IRAK4;SOX9;HAS2;MAPK11;PSMA1;ADAMTS7;PSMB1;PSMC3;PSMA4;PSMA2;HYAL1;TRAF6;CCL2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.479582880943731,1.1586086269563134,0.2974828375286041,0.6654281909547538,1.0,3/12,6.04%,PPARA;IRS2;ABCD2
prerank,B cell proliferation (GO:0042100),-0.4277431400142534,-1.1583450691477275,0.2594594594594595,0.5826026504793345,1.0,3/17,10.02%,MEF2C;CTPS1;HSPD1
prerank,endothelial tube morphogenesis (GO:0061154),-0.5066532866519957,-1.1582730970247306,0.3013182674199623,0.5821962105402825,1.0,7/10,31.13%,STARD13;CSNK2B;RHOB;PRKD2;CTNNB1;ACVRL1;RHOA
prerank,organic hydroxy compound transport (GO:0015850),-0.35498108993069005,-1.1581387617346923,0.25287356321839083,0.5819481900432771,1.0,5/36,5.09%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1;STRA6
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4071678692550146,-1.1580953756949828,0.275390625,0.5814633594735141,1.0,3/21,2.33%,CAV1;PLTP;NFKBIA
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2485211392689064,-1.1579953123227622,0.09473684210526316,0.5811067188159573,1.0,67/348,13.26%,FN1;LEF1;MEF2C;OCLN;CLDN5;NOS3;CD34;TNRC6C;NOTCH1;ACTG1;PLCG2;FGF1;MAP2K5;F3;KLF2;KLF4;MAPK3;RAMP2;TFRC;RPS3;ETS1;NGF;RPL11;TGFB1;APP;RAB27A;MSN;RPL23;SMO;PDE2A;ANXA2;LIMS1;FOXD1;PPARGC1A;MYOM1;IL33;VEGFA;ACTA2;MPHOSPH8;EZR;ATF4;ADAM19;GATA2;TLR3;HCFC1;RGCC;KRAS;PPM1F;AKT1;INSR;TWIST1;WARS1;TRIM28;DDRGK1;WNT11;GABPA;CD74;INHBA;FAM98A;SERPINB9;E2F1;RPS7;TLR4;ITCH;FGF2;FMR1;PIK3R3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.46960130795941374,1.1577269897364726,0.3073394495412844,0.6665865155763343,1.0,3/13,9.35%,BMP6;TGFBR1;BMPR1A
prerank,nuclear membrane reassembly (GO:0031468),-0.32904994198697995,-1.157602088490687,0.21973929236499068,0.5814612968048155,1.0,29/54,32.17%,LBR;PPP2R1A;CHMP2B;CC2D1B;NUP93;NDC1;VRK1;PPP2R2A;NUP188;NUP155;NUP37;IST1;REEP4;CHMP2A;RANGAP1;RCC1;NUP160;VPS4A;NUP43;SEH1L;SEC13;NUP107;NUP98;CHMP7;CDK1;BANF1;UBE2I;CHMP4B;CHMP4A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3849614180828723,-1.1574896330032005,0.2611218568665377,0.581181549629805,1.0,7/26,11.07%,ADIPOR2;ADIPOR1;ERLIN2;ELOVL5;ACADL;WDTC1;ACADVL
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4526884705483577,-1.1571992726919034,0.2755474452554745,0.5813105115982874,1.0,5/13,33.43%,ABL2;NOD2;ECSIT;ABL1;HP
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.34858995579368907,-1.1571723576676702,0.23684210526315788,0.5807953624964671,1.0,18/41,27.54%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.49188481419778696,-1.1570573646355926,0.29908256880733947,0.5805136776852352,1.0,2/11,3.46%,MEF2C;ANXA1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.37702630115277447,1.1563857932922232,0.2853982300884956,0.6689002486018644,1.0,6/30,6.87%,TGFBR3;SMAD3;DKK3;TGFBR3L;NREP;SMURF2
prerank,negative regulation of cell migration (GO:0030336),0.2870594207481814,1.1558607809734567,0.19096509240246407,0.6690203730336729,1.0,19/137,5.80%,ROBO1;LDLRAD4;PODN;SULF1;PHLDB2;LRP1;GJA1;MAGI2;MITF;RECK;RAP2A;PTPRT;SFRP1;MCC;IL4;DLC1;SRGAP3;SRGAP2;SERPINE1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.48236049492392746,1.1555826424255913,0.3073286052009456,0.6685675051145519,1.0,6/10,22.71%,CRY1;RPA2;THOC1;ETAA1;WDR76;RFWD3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3719825101931468,-1.1554439165496948,0.24950884086444008,0.58413273157144,1.0,13/30,24.03%,FLT1;MLLT3;KDR;TGFB1;FLT4;INHBA;CSF1R;ACE;UFL1;HOXB4;ARMC6;MLF1;PLD4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3515619521587446,1.1553093292455072,0.2464065708418891,0.668160190200559,1.0,4/46,2.77%,TCF7L2;PIK3R1;ZIC1;SMAD3
prerank,regulation of protein kinase A signaling (GO:0010738),0.4244240758513321,1.1549515484590074,0.28159645232815966,0.6679254701242893,1.0,3/20,6.91%,ADGRV1;IAPP;CALCR
prerank,positive regulation of T cell migration (GO:2000406),-0.41141576775857924,-1.1548440288738455,0.25274725274725274,0.5850976359930621,1.0,3/20,4.91%,WNK1;APP;ADAM10
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24009859794147048,-1.154509951560969,0.07692307692307693,0.5853459177291828,1.0,121/497,18.45%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;ATP8B1;RPS6KA5;NOTCH1;CBFA2T3;ID1;ZHX3;RACK1;HMBOX1;BMPR2;ID3;PPARD;NCOR1;FOXO1;KLF4;RPS3;DAB2IP;ZBTB7A;IGFBP5;CDKN1B;TGFB1;REST;KDM5C;PRDM16;TBX2;HDAC9;HSPA8;WWP2;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;HEYL;ZBTB16;DPF2;CNOT7;MPHOSPH8;DPF3;RBFOX2;RARA;GATA6;SHC1;FOXN3;NR3C1;CBX5;GAPDH;PPM1F;CIC;UIMC1;HDAC4;ZMYND11;NDUFA13;BCL6;SOX7;NCL;TWIST1;TRIM28;HHEX;SOX18;DBI;RB1;ZC3H8;FOXP2;RPL13A;CAPRIN1;WNT11;ZBTB18;CCDC85B;SP3;SFPQ;LIMD1;PHC1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;HES1;FMR1;CIART;MTERF3;PHF12;CDAN1;EPC1;MLX;PHB2;SMARCA4;EID2;HEY1;LDB1;SMAD4;CDKN1A;ZFPM2;SMARCA2;NR1H2;RAD17;PCIF1;RELA;LSM14A;GIGYF2;CCAR2;KDM1A;FOXL2;WAPL;SCML2;SMAD2;CRYAB;ZNF568;L3MBTL1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.41935443376414205,1.1541198629428526,0.27111111111111114,0.6689460905978526,1.0,4/20,6.24%,SULF1;SULF2;CREB3L1;NPTN
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3834164793508936,1.1537434515052658,0.26593406593406593,0.6687530982837931,1.0,14/29,23.08%,TUT4;SMAD3;AGO4;LIN28B;SNIP1;METTL3;DROSHA;AGO3;AGO1;AGO2;MRPL44;ZC3H7B;PUS10;DICER1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.34687525431837113,1.1537021194637282,0.25,0.667678826625066,1.0,10/46,7.83%,ATP1A2;NRXN1;GRM1;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;GRIK1;MAPK8IP2
prerank,positive regulation of cytokine production (GO:0001819),-0.25309854998979886,-1.1535894348979296,0.10905349794238683,0.5871007192420449,1.0,114/292,32.07%,FOXP1;AFAP1L2;LBP;CD34;SPTBN1;PLCG2;IL15;SLC7A5;NOD1;IFIH1;F3;PDE4D;CYRIB;RPS3;ANXA1;GBP5;TGFB1;APP;PRKCZ;CYP1B1;IL1R1;LRRFIP1;IL33;RARA;ATF4;PRKDC;LURAP1;TLR3;RGCC;RIPK1;GAPDH;DDX41;FLT4;DHX9;TWIST1;FLOT1;FCER1G;HSPD1;TIRAP;DHX58;PAEP;CD74;S100A13;MAVS;TLR4;SPHK2;SYK;AGPAT1;POLR3E;CSF1R;RAB1A;POLR3A;NOD2;IL17RA;POU2F2;HSPA1A;RELA;XBP1;ARHGEF2;CGAS;TXK;PTGER4;CD200;LAPTM5;LGALS9;MAPK11;FZD5;IL6ST;HSPA1B;PRKD2;C3;PTPN22;POLR3B;PIK3CG;ZFPM1;AIF1;HILPDA;IL12RB2;TRAF6;BCL10;NFAM1;TMEM106A;PARK7;LAMTOR5;SOD1;CTNNB1;RASGRP1;CARD11;LILRB1;CD86;C1QTNF4;MRE11;NOX1;TLR6;POLR1C;POLR2F;EGR1;HTR2B;LY9;HYAL2;TLR1;SCRIB;NOS2;PLCB1;MBP;TLR5;PQBP1;TYROBP;POLR2L;CD14;CADM1;SLAMF6;KAT2A;NLRP3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4514680660214027,-1.153370934389694,0.2821969696969697,0.5870385278256853,1.0,5/13,16.25%,UBB;NEFL;RHOT1;RHOT2;OPA1
prerank,regulation of viral life cycle (GO:1903900),-0.40291949107697483,-1.1531214108069028,0.26579925650557623,0.5870610967193438,1.0,8/21,15.28%,TRIM25;PPIA;TRIM14;TRIM62;TRIM68;TSG101;TRIM5;NECTIN2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.39402269946970114,1.1526565650057456,0.2631578947368421,0.6691202409226246,1.0,11/26,13.19%,NRXN1;RIMS1;TMEM25;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.25073806969947837,-1.1520986710226437,0.11618257261410789,0.5890694352656745,1.0,75/327,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;ACTN4;JMJD1C;NLK;SOX17;VSX1;SIX1;CNBP;REST;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4750420595911199,-1.1520514104829807,0.28284671532846717,0.5886196565660436,1.0,2/12,4.03%,PTPN14;TGFB1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.40137036439384377,-1.1518838154971225,0.2622309197651663,0.5884626935357161,1.0,13/22,39.25%,CHP1;UFM1;GDI1;RANGAP1;RAB23;DMTN;PARK7;BARD1;INSIG1;SIAH3;APOD;CABP1;INPP5K
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3963811753516968,1.1512812732337483,0.2754880694143167,0.671577683892933,1.0,4/24,4.77%,NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,miRNA metabolic process (GO:0010586),0.41673564827488396,1.15077258921257,0.28893905191873587,0.6717854133017028,1.0,7/20,16.05%,TUT4;LIN28B;KHSRP;XPO5;PARN;BCDIN3D;DROSHA
prerank,mitochondrial protein processing (GO:0034982),0.48731263383332113,1.1507267170710902,0.31026785714285715,0.6707162166693829,1.0,5/11,20.83%,OMA1;IMMP1L;YME1L1;PMPCA;AFG3L2
prerank,T cell migration (GO:0072678),-0.4563691582777276,-1.1506963008691902,0.29464285714285715,0.5909238605689265,1.0,3/13,4.35%,SLC12A2;S1PR1;MSN
prerank,aggrephagy (GO:0035973),-0.38274566367173374,-1.1506143362602959,0.27735849056603773,0.5905782788398476,1.0,5/27,5.40%,VIM;UBB;DYNC1LI2;UBC;RPS27A
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2649418571656058,-1.1505281214137166,0.15353535353535352,0.5902106460059408,1.0,26/182,6.75%,FOXP1;MEF2C;OCLN;CLDN5;CD34;TNRC6C;ESR1;NOTCH1;SLC7A5;RACK1;RIN3;KDR;KLF4;HSP90AB1;TGFB1;REST;APP;TGFB2;SMO;REL;WWP2;ADAM10;VEGFA;CNOT7;ANKRD13A;GATA2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3764625292674965,-1.1505061733460644,0.2777777777777778,0.5896779196951605,1.0,7/29,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,cellular response to unfolded protein (GO:0034620),-0.3796409847363187,-1.1501721681222885,0.2572463768115942,0.5899246213329967,1.0,13/26,22.97%,DAB2IP;HSPA8;RHBDD1;BAX;HSPD1;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,RNA destabilization (GO:0050779),0.42070783931156686,1.1500796405340243,0.291220556745182,0.6712580059748712,1.0,7/18,15.77%,ROCK2;LIN28B;FTO;RIDA;METTL16;RBM24;METTL3
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3129148622907535,-1.1493476003340963,0.21333333333333335,0.5914358501036183,1.0,34/66,31.36%,CDH1;LIMK2;TFRC;FERMT2;TGFB1;JUP;NMD3;AKT1;RBM22;TRIM28;MAVS;DKC1;CCT2;PIK3R2;CCT3;MCRS1;ECT2;CDK5RAP3;ZPR1;CCT8;MEPCE;HCLS1;SESN2;PRKCD;DTX3L;CCT7;PARK7;CARD10;LAMTOR5;HDAC3;PLK1;HYAL2;PARP9;CDK1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3466625320850001,-1.1493172209309603,0.25842696629213485,0.5909431272393092,1.0,18/41,27.54%,ZBTB7A;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4547984430372146,-1.1493015641276203,0.2676056338028169,0.5904038651449379,1.0,5/13,18.68%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,Notch signaling involved in heart development (GO:0061314),-0.481051412822582,-1.149270750476545,0.3022452504317789,0.5898871419540825,1.0,5/11,24.12%,NOTCH1;HEYL;HEY1;DLL4;SNAI2
prerank,regulation of microtubule-based process (GO:0032886),0.3674285948789225,1.1491441649950958,0.23157894736842105,0.6726016369000797,1.0,9/36,14.58%,PHLDB2;EPHA3;ATF5;KLHL42;MEMO1;BICD1;MAP10;MAPT;MAP6
prerank,ruffle organization (GO:0031529),-0.43655962505515017,-1.1491019108083604,0.2980599647266314,0.5897620906214807,1.0,11/16,39.25%,RAC1;CSF1R;CARMIL1;AIF1;PIP5K1A;PLEK;TPM1;LIMA1;CYFIP1;PLEKHA1;INPP5K
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4624931153552142,-1.1488291167672922,0.29349736379613356,0.5898831763394099,1.0,7/13,31.01%,CD81;BCAP31;TMEM30A;EDEM2;SEC16B;TMEM30B;EDEM1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.35599577393553783,1.1486620685573699,0.2650862068965517,0.6726264467853399,1.0,8/37,7.72%,TENM3;GRID2;DCHS1;PTPRD;TENM2;IL1RAPL1;ALCAM;NLGN1
prerank,regulation of heart contraction (GO:0008016),0.30109193072974433,1.148327530762239,0.22614107883817428,0.6723210310837648,1.0,12/90,6.07%,CELF2;ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;DMPK;CORIN;P2RX4;ATP2A2;FXYD1;ASPH
prerank,myelin assembly (GO:0032288),0.4935466099073943,1.147969475908912,0.3108108108108108,0.6720768446176842,1.0,1/10,0.51%,EPB41L3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3981732144554828,1.1479622026822567,0.29978118161925604,0.6709480221152754,1.0,3/25,9.13%,IGF1;NSD1;GATA3
prerank,skeletal muscle organ development (GO:0060538),-0.37936781914690965,-1.1479218700811553,0.2616279069767442,0.5916289070622006,1.0,5/26,5.09%,MEF2C;CAV1;MYL6;SIX1;STRA6
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3399604919850868,-1.147834887685162,0.24615384615384617,0.5912548528406468,1.0,7/41,9.23%,PODXL;PIEZO1;SMAD7;CD44;ADAM19;DENND6A;FLOT1
prerank,positive chemotaxis (GO:0050918),0.43786383933512624,1.147814695356711,0.2980132450331126,0.6701543586760608,1.0,3/17,7.30%,NRP1;SEMA5A;SCG2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.315204986484694,-1.1476608857711932,0.25333333333333335,0.5911165777895009,1.0,21/66,15.49%,FLT1;MAP3K5;FGF1;RPS3;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;TAOK3;EDN1;TNFRSF11A;MAP3K11;PDGFC;PDGFA;FGF2;ARHGEF5;HRAS;EGFR;ERBB2;NOD2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4618037210145684,-1.1473918110408219,0.29444444444444445,0.5912190046064223,1.0,1/13,0.49%,TMSB4X
prerank,regulation of neuron death (GO:1901214),-0.30088632109633245,-1.1466943871776596,0.22916666666666666,0.5923976149498791,1.0,12/82,8.42%,MEF2C;MAP3K5;CD34;EGLN3;REST;CTSZ;UBB;PPARGC1A;CHP1;TNFRSF1B;EGLN2;AKT1
prerank,melanosome transport (GO:0032402),-0.415461568960918,-1.146603323753685,0.2727272727272727,0.5915071579448112,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,pigment granule transport (GO:0051904),-0.415461568960918,-1.146603323753685,0.2727272727272727,0.5915071579448112,1.0,6/18,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.45388269321608854,-1.1463123834891757,0.296229802513465,0.5916983303705751,1.0,2/13,5.01%,SORBS1;PRKCZ
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4131887999487912,1.1462123048055393,0.28693790149892934,0.6731982960743051,1.0,6/19,9.82%,TGFBR3;FGFR2;TGFBR1;RBPJ;BMPR1A;ERBB4
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3351373935104621,-1.14585927647897,0.2366412213740458,0.5922837881359263,1.0,25/48,35.33%,ZBTB7A;PRDM16;NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;PRKAG1;NUP37;JMJD8;RUBCNL;NUP160;PGAM1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;NOS2;RAE1;NUP88;NUP214;GCGR
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.44597188780434216,-1.145809574903498,0.30566037735849055,0.5918126105689887,1.0,5/14,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;NUDT18
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.28416132843457087,-1.1449918480859687,0.20650095602294455,0.5932582375011588,1.0,35/119,17.68%,ITPKB;EFR3B;PLCG2;PIP5K1B;BMX;SOCS2;PI4K2A;INPP5D;PIK3R6;PIGL;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIK3C2A;PIGF;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;PIK3R3;PITPNM1;IP6K1;CISH;PIGC;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.3114115019995276,-1.1444361784647286,0.2300556586270872,0.5940344287181023,1.0,29/62,34.81%,TGFB1;NUP93;DHX9;NDC1;NUP54;H3-3A;WTIP;LIMD1;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2341815608276522,1.1443643292097294,0.0748663101604278,0.6768424274444648,1.0,100/834,9.65%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;WWC1;TFCP2;ZEB2;PHIP;SP7;TFDP1;PHOX2A;CEBPB;IL4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;GABPB1;GABPB2;FOXA2;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;KMT2A;NFIX;RARG;SOX2;CITED2;ZSCAN21;RBPJ;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;ATOH8;CREB3;CREB3L4;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;AHI1;HOXC10;HDAC8
prerank,cellular copper ion homeostasis (GO:0006878),-0.4439816106434563,-1.1442731426719461,0.30514705882352944,0.5938491335073246,1.0,3/14,4.11%,ATOX1;MT2A;APP
prerank,protein localization to membrane (GO:0072657),-0.2625659211895558,-1.1439904689068683,0.16108786610878661,0.5939545812859071,1.0,57/187,19.66%,CAV1;SHANK3;BSG;RAP1A;CDH1;TSPAN5;SPTBN1;EFR3B;RAB11A;AGRN;F11R;RAMP2;EHD4;KCNB1;RAB8B;FERMT2;PACS1;CD81;IKBKB;EZR;EHD2;JUP;ATP1B1;NDC1;CPE;FLOT1;NUP54;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;RAB11B;SLMAP;TNFRSF1A;SMURF1;NPC1;NUP155;AP4M1;TMEM88;FLOT2;EPHA2;ITGA4;TSPAN17;PACSIN1;NRXN2;RABEP1;RAB40B;PIGW;PRAM1;RAMP1;EHD1;PLEKHF1;RAB32;FYB2;EHD3
prerank,sterol transport (GO:0015918),-0.4049530250565758,-1.1439258074184686,0.27624309392265195,0.5935552052101383,1.0,9/19,36.09%,CAV1;NPC1;LCAT;MSR1;CD36;OSBPL2;OSBPL5;ARV1;LDLR
prerank,regulation of aerobic respiration (GO:1903715),-0.4407633207087742,-1.1439174001187924,0.2908745247148289,0.592996704680742,1.0,4/15,10.41%,CBFA2T3;UQCC2;IDE;VCP
prerank,regulation of vasculogenesis (GO:2001212),-0.4376361413165524,-1.1432390808365274,0.29464285714285715,0.5941476699801648,1.0,6/14,14.52%,RAP1A;CD34;KDR;EMP2;TMEM100;HEY1
prerank,organelle organization (GO:0006996),-0.2438536778448291,-1.14310271313489,0.1111111111111111,0.5939121826303245,1.0,98/388,20.30%,PLCE1;FGD5;CAV1;CXADR;SYNE1;SEMA6A;NOS3;ATP8B1;VPS13D;FNBP1L;ARAP3;CAV2;SNX11;PI4K2A;ZW10;BCAS3;PPIA;HTT;GORASP2;BRWD3;NEDD9;PPARGC1A;DIAPH1;RAB18;FAM174B;FGD6;MICAL2;TTC17;PDZD8;CHMP2B;CHCHD2;ATP5F1B;HCFC1;PLEKHM2;MREG;ATL3;TRIP11;SPTSSB;KIF9;SIPA1;ATL2;CDC42BPB;RHOT1;ESRRA;SIPA1L3;PLAAT3;TRAPPC11;MIEF2;GABPA;WTIP;RHOT2;BAG5;CFL1;SURF4;LIMD1;YTHDF2;RAB7A;VMP1;AGTPBP1;MTFR1;APOE;FAF2;PHB2;WASL;MAST4;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;CHCHD10;NIPSNAP2;NECTIN2;TNFAIP3;ADCK1;OPA1;HPS3;PACSIN1;HSD17B10;RANBP10;CHMP2A;SLC25A33;TMED1;PLEKHF1;TOR1AIP2;RAB32;PRPF40A;PACSIN3;IQCG;TMED5;PACSIN2;FGD2;PTCD2;STRIP2;ATP8B2;COG2
prerank,regulation of histone modification (GO:0031056),0.44998102247481664,1.142672563494626,0.30303030303030304,0.6800010679882474,1.0,6/13,18.13%,AKAP8L;IGF2;SETD5;CDK9;AKAP8;UBE2N
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.4042426181996429,-1.1423322275824874,0.27476635514018694,0.5953180089067185,1.0,8/20,18.19%,CASP8;RIPK1;FLOT1;SDCBP;FLOT2;MLKL;HSP90AA1;PELI1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.26927055047285775,-1.1420871405874706,0.17782426778242677,0.5953141305243641,1.0,60/159,26.08%,STXBP6;DMD;PXN;POMP;RPL38;HSP90AB1;TGFB1;FKBP1A;HIP1R;NUP93;AP2M1;DNAJB12;DHX9;NDC1;PIK3C2A;IMMP2L;CSNK2B;HSPD1;HIP1;FCHO2;SGIP1;TTC12;HIGD2A;CHCHD4;HSPA4;POGZ;ARL6;CCT2;EID2;CASQ2;SMAD4;GPX4;PSMD11;SRP19;HSP90AA1;HSPA1A;PTGES3L;CHMP2A;SMAD2;ARL2;HIGD1A;NCK1;HIGD1B;CLTA;PFDN6;CENPF;NSG2;NCK2;ANLN;PSMG2;CENPA;CASQ1;SMAD1;MKKS;EIF4B;TBCE;EPS15;CLTB;EIF4H;NUP107
prerank,autonomic nervous system development (GO:0048483),0.42365126346387144,1.1420166288417497,0.2993492407809111,0.6805292842942728,1.0,6/17,11.99%,NRP1;GDNF;SEMA3A;PHOX2A;GATA3;EDNRB
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3567525904148338,-1.1417864974408338,0.271484375,0.5955356902298333,1.0,11/34,28.61%,SLC7A5;GPI;SPHK2;PHB2;CLCF1;NOD2;XBP1;LAPTM5;PTPN22;STX4;CD86
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.33590398266173815,-1.1414827122451798,0.26153846153846155,0.5956861671562113,1.0,20/46,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5042681395932717,1.141387698594595,0.2962085308056872,0.6798063311125363,1.0,10/10,49.60%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5042681395932717,1.141387698594595,0.2962085308056872,0.6798063311125363,1.0,10/10,49.60%,TULP1;CEP250;RPE65;GRM6;CNGB1;CACNA1F;GNAT2;CACNA2D4;REEP6;GNAT1
prerank,liver development (GO:0001889),0.3701310289324697,1.1407803813718949,0.27896995708154504,0.6802221309088221,1.0,7/32,11.25%,TGFBR3;WNT4;CEBPB;CITED2;NPHP3;PRKCSH;ARID5B
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.334674215576426,1.1407064358227161,0.25833333333333336,0.6792587125560897,1.0,8/51,7.54%,NRK;EPB41L3;CNTNAP2;GPM6A;MYO16;SRGAP2;GAS7;TNIK
prerank,negative regulation of DNA recombination (GO:0045910),0.347584733843507,1.1406341799128412,0.2886178861788618,0.6783083776942138,1.0,14/43,21.74%,SHLD2;UBQLN4;POLR2G;RADX;BLM;SMCHD1;DAXX;RIF1;PARP3;POLR2D;RTEL1;POLR2K;ZRANB3;FBH1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.31043601582042873,-1.1403758673215194,0.2411764705882353,0.5978304344571903,1.0,22/67,17.48%,TEK;FLT1;IGF1R;IL15;PTK2B;KDR;MAPK3;PTK2;BMX;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4224141668000945,-1.1403728701863103,0.2694300518134715,0.5972655084966897,1.0,4/16,12.33%,NOS3;GUCY1B1;GUCY1A1;APOE
prerank,ncRNA export from nucleus (GO:0097064),-0.35249785849367826,-1.1403655143329898,0.2701688555347092,0.5967071739660733,1.0,16/36,27.54%,NUP93;NDC1;NUP54;NUP188;NUP155;RANBP2;NUP37;NUP160;NCBP2;NUP43;SEH1L;SEC13;NUP107;NUP42;NPM1;NUP98
prerank,protein stabilization (GO:0050821),-0.26334254550932057,-1.140175471043229,0.1786407766990291,0.596620601524151,1.0,57/168,23.42%,NLK;SEL1L;SOX17;SMAD7;HSP90AB1;RPL11;RPL23;PPARGC1A;CHP1;HIP1R;USP7;RASSF2;HCFC1;GAPDH;ATP1B1;COA8;GLMP;PFN1;CAMLG;IFT46;FLOT1;USP9X;LAMP1;HSPD1;HIP1;BAG5;NCLN;RPS7;SOX4;CDC37L1;PHB2;CCT2;COG3;MFSD1;TMEM88;FLOT2;HYPK;CDKN1A;CRTAP;HSP90AA1;CCT3;HSPA1A;CRYAB;TBL1X;PIN1;CCT8;MSX1;UBE2B;RPL5;ATP1B2;HSPA1B;TAF9;PDCD10;BAG1;WNT10B;PPIB;PRKCD
prerank,regulation of glycolytic process (GO:0006110),0.3164881633689937,1.1401525390872334,0.24672489082969432,0.6784142952181875,1.0,6/68,4.89%,IGF1;ZBTB20;PPARA;PRKAG2;PFKFB4;ACTN3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.47437231842597694,-1.1398497697748575,0.3126177024482109,0.5968473199923365,1.0,4/11,29.90%,AKAP6;KCNIP2;TREM2;RNF207
prerank,visual system development (GO:0150063),-0.3461658986570156,-1.1398005357408587,0.2519230769230769,0.59639526897702,1.0,12/37,21.55%,SMOC1;HIPK1;TGFB2;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1;ADAMTS18;C1QA;BMPR1B;C3
prerank,relaxation of cardiac muscle (GO:0055119),0.44890774324875127,1.1394945561657432,0.3163716814159292,0.6790048573741878,1.0,3/13,3.80%,ATP1A2;SLC8A1;P2RX4
prerank,negative regulation of histone methylation (GO:0031061),0.4810671968477429,1.1394441187507482,0.29978586723768735,0.6780065378216552,1.0,5/10,24.81%,BCOR;DNMT1;MTF2;DNMT3B;WDR5
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2729328934977147,-1.1388759156952477,0.18674698795180722,0.5982249628257388,1.0,37/153,16.04%,PRKCH;RPS6KA5;TGFBR2;HIPK1;NLK;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;RIPK1;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;CAB39;STK38L;CSNK2A1;CSNK2A2
prerank,response to hexose (GO:0009746),0.39816347725547574,1.138709767545743,0.3028322440087146,0.678759264001753,1.0,2/25,5.54%,TCF7L2;IRS2
prerank,regulation of microtubule polymerization (GO:0031113),-0.3441306336448815,-1.1385311081868386,0.2693032015065913,0.5985217977503546,1.0,13/40,25.22%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;PRUNE1;MET;ARL2;CDH5;CAMSAP3;CLIP1;STMN1
prerank,macrophage migration (GO:1905517),0.45394748951173425,1.1385224065508612,0.3108695652173913,0.6781105730290299,1.0,4/13,19.87%,P2RX4;EDNRB;CKLF;TAFA4
prerank,electron transport chain (GO:0022900),-0.43413123823662114,-1.1380418549922982,0.2967032967032967,0.5991781475912407,1.0,7/15,20.24%,PDIA5;ENOX2;PPARGC1A;ETFB;ETFDH;CYB561;SDHB
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33171561797734084,-1.1377497537286048,0.2411764705882353,0.5993455722693296,1.0,12/45,10.94%,PLCE1;RPS6KA5;GAB1;PTK2B;IQGAP1;PTK2;TGFB1;REPS2;SHC1;AKT1;PIK3C2A;KIF16B
prerank,mitotic nuclear division (GO:0140014),-0.30646791682762226,-1.1376737075474104,0.24848484848484848,0.598978500093524,1.0,29/71,32.82%,EPS8;RAB11A;SMC4;ZW10;CEP192;NDE1;NDEL1;LSM14A;KIF18A;CHMP2A;MISP;TPX2;KNSTRN;PPP2R2D;KIF18B;NSL1;NDC80;SPICE1;CDCA8;SGO1;KIFC2;CHMP7;TUBG2;KIF11;PLK1;BCCIP;RHOA;CHMP4B;ESPL1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3723044271403626,-1.1376636245587366,0.27239488117001825,0.5984276912634435,1.0,7/27,15.87%,DACH1;HMBOX1;BMPR2;RGCC;PDGFA;FGF2;CDKN1A
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.39905156861785374,-1.137533258176443,0.2846441947565543,0.598186488584657,1.0,11/21,24.83%,TGM2;MCUB;PDZD8;MCUR1;BCAP31;RAP1GDS1;MICU2;FIS1;SMDT1;MCU;SLC8B1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.42047448030344026,-1.1374617623462264,0.2944550669216061,0.5977943374389164,1.0,11/17,34.49%,PPIA;HSPB1;AKT1;BAG5;SFPQ;TREM2;SOD1;P4HB;VNN1;HTRA2;MAPK7
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3076728385978183,1.1372481404547232,0.2551440329218107,0.680305935737474,1.0,14/74,10.35%,BMP2;LDLRAD4;BMP5;PHLDB2;EPHA3;SMAD3;SFRP1;OLFM1;AXIN2;FOXA2;LOXL2;TGFBR1;GATA3;PTEN
prerank,actin filament bundle assembly (GO:0051017),-0.3598915767501988,-1.1371701691848106,0.28654970760233917,0.5979416059234682,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3269971493716502,1.1371320218567371,0.2478448275862069,0.6795289423582193,1.0,16/57,14.41%,GRIA4;DLG2;SHISA9;DLGAP1;DAPK1;NLGN2;CACNG4;CAMK2B;NLGN1;MAPK8IP2;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1
prerank,regulation of interleukin-17 production (GO:0032660),-0.3617358262081545,-1.1366771866820624,0.2572463768115942,0.5986430636887834,1.0,6/31,17.36%,IL15;SLC7A5;TGFB1;TLR4;NOD2;VSIR
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.4051938382109107,-1.1365486845182393,0.2859778597785978,0.5984058312137261,1.0,7/21,26.41%,GPI;HK1;PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,defense response to tumor cell (GO:0002357),0.47875327031031323,1.1360415140433107,0.30752688172043013,0.6811442917880978,1.0,3/10,5.99%,RBMS3;DLEC1;DAPK1
prerank,positive regulation of DNA replication (GO:0045740),0.4363869664526878,1.1360316556441055,0.3081896551724138,0.6800512066334952,1.0,4/16,7.91%,GLI2;STN1;ATAD5;BRPF3
prerank,regulation of vacuole organization (GO:0044088),-0.4029635800375762,-1.1353560564671246,0.2859744990892532,0.6007950674575143,1.0,7/20,23.23%,IFT20;ANXA2;TBC1D12;MTM1;LAPTM4B;ADPRH;ENO1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.24729463017067724,-1.1350210882436351,0.12164948453608247,0.6010636051380892,1.0,56/308,13.01%,PRKCH;LEF1;CAV1;ADIPOR2;IGF1R;RREB1;LBP;IL15;TGFBR2;BMPR2;GATM;TFRC;FERMT2;NPR1;VAMP7;SIX1;TGFB1;REST;TGFB2;PRDM16;SMO;PPARGC1B;CMKLR1;FOXD1;PPARGC1A;ADIPOR1;ZBTB16;IL33;RPS19;VEGFA;UCP2;KDM3A;TGFB3;LURAP1;RGCC;GAPDH;TRIM16;NR2C2;PDGFC;TWIST1;FLOT1;DECR1;FABP5;GRB10;ACADL;INHBA;CFL1;EBF2;S100A13;GADD45G;ACVR1;APOE;FGF2;TSKU;SYK;AGPAT1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.40029423938156417,1.135013334453259,0.30465116279069765,0.6814971355430082,1.0,4/21,2.64%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,negative regulation of phosphorylation (GO:0042326),0.3052812501543353,1.1346654935884803,0.2399193548387097,0.6812383863570869,1.0,17/85,10.46%,PID1;PTPN13;NTRK3;FBLN1;PPARA;STAP1;LYN;ACTN3;DYNLL1;PRKN;IRS2;PLPP3;IBTK;MEN1;PPP1R15B;PTEN;ANKLE2
prerank,negative regulation of receptor internalization (GO:0002091),-0.45673080755325424,-1.1344561708379162,0.2893772893772894,0.6018688401506058,1.0,6/12,29.01%,RIN3;ANKRD13A;SDCBP;NECAB2;MTMR2;UBQLN2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.34863524819206293,1.134160048245691,0.26666666666666666,0.6813665088557496,1.0,2/38,2.65%,BMP6;PRKCA
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.47532310508337083,1.1337368196391293,0.3076923076923077,0.6813373034607639,1.0,4/10,25.79%,PRKN;AOC3;HDAC6;SNCA
prerank,nuclear migration (GO:0007097),0.44837301283351605,1.1336289244340858,0.3217391304347826,0.6805208276816677,1.0,3/13,7.84%,CLMN;SYNE2;DOCK7
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4615722010309488,1.1333244589115365,0.29385964912280704,0.6802338229463523,1.0,5/13,13.22%,HYAL3;CACNA1I;SYT1;CACNA1G;SCAMP5
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3445058871939732,-1.1332501272836644,0.2965779467680608,0.6043757010626345,1.0,12/44,23.65%,BAIAP2L1;PTK2B;LMOD1;PFN1;PRKCE;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;CARMIL1;NCK2
prerank,regulation of fibrinolysis (GO:0051917),-0.45823035454778344,-1.1331995876182346,0.3127413127413127,0.6039244517145396,1.0,3/13,2.94%,THBS1;THBD;FAP
prerank,actin filament bundle organization (GO:0061572),-0.35745681603890117,-1.1327273227076242,0.2874015748031496,0.6044946623885684,1.0,7/33,9.68%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,positive regulation of stem cell differentiation (GO:2000738),0.42449077553353565,1.1325469661360397,0.2948717948717949,0.6811379524953833,1.0,5/16,14.52%,PTN;SP7;SOX5;LTBP3;RBM24
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.45335396093252056,-1.1324571417182874,0.31835205992509363,0.6045836469180629,1.0,6/13,31.82%,SMUG1;UPP2;NT5C;NEIL1;TDG;DCTPP1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3827111590888953,-1.132119232073633,0.29444444444444445,0.6048826683338553,1.0,4/23,5.35%,TMSB4X;CCN3;HDAC7;ADIPOR1
prerank,regulation of RNA splicing (GO:0043484),-0.303558096998765,-1.131942515515888,0.23391812865497075,0.6047783445578004,1.0,20/69,20.37%,AHNAK;AHNAK2;MBNL1;HNRNPLL;RBM20;QKI;RPS13;PTBP3;ZNF326;SRPK1;FUS;RBM22;JMJD6;CLK1;FASTK;HNRNPK;HSPA1A;RPS26;ZPR1;TMBIM6
prerank,cellular response to oxidative stress (GO:0034599),-0.27914920529258735,-1.1318266814113591,0.21181262729124237,0.6044923824840228,1.0,53/118,33.91%,PXN;FOXO1;MAPK3;FOXO3;RPS3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;AKT1;STX2;ETV5;EGFR;VKORC1L1;GSR;HSPA1A;CCS;CHUK;CYBB;PTPRK;GPX8;KEAP1;HSPA1B;PKD2;ADNP2;ERO1A;SESN2;SRXN1;PRKCD;NUDT2;AIF1;GPX3;PARK7;STX4;CAMKK2;SOD1;RAD52;ROMO1;ATP13A2;RBM11;TPM1;ABL1;MAPK9;ANKRD2;FOS;NCF1;SLC4A11;JUN;HTRA2
prerank,regulation of transferase activity (GO:0051338),-0.41035667476018056,-1.1317887475690074,0.27906976744186046,0.6040220694514843,1.0,9/17,17.07%,HMBOX1;NLRC5;SPTSSB;EMP2;PPP1R3F;BAG5;FEM1A;LDB1;JMJD8
prerank,neutrophil chemotaxis (GO:0030593),-0.3243821780411636,-1.1317286372119226,0.26142595978062155,0.6035945226604006,1.0,9/53,14.21%,BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK;JAML
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3167558288638685,1.1316665859839536,0.24634655532359082,0.6823043983877947,1.0,8/65,7.16%,RORA;EPAS1;PTGIS;MDM2;SFRP1;KCND2;SIRT2;SCN2A
prerank,positive regulation of cell population proliferation (GO:0008284),-0.23895225900802375,-1.1314218720478906,0.11739130434782609,0.6037707569656521,1.0,100/423,16.40%,FN1;PRKCH;KITLG;LEF1;FOXP1;MEF2C;FLT1;IGF1R;CDK6;CLDN5;ACER2;THBS1;NOTCH1;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;LIFR;KDR;STX3;PTK2;TBX1;TBC1D8;RPS4X;RPS9;VEGFC;RPRD1B;TGFB1;CNBP;TGFB2;MAP3K3;TBX2;RPL23;RPS15A;DNAJA2;ADAM10;CD81;VEGFA;CNOT7;S100B;AQP11;RARA;SHC1;TGFB3;KRAS;EDN1;FLT4;S1PR3;TNFRSF11A;NDUFS4;NES;HDAC4;AKT1;INSR;NOP2;DHX9;PDGFC;PDGFA;LAMC2;EMP2;S100A6;DDRGK1;CD74;CDK4;KMT2D;S100A13;CIB1;VEGFD;FAM98A;GRK5;E2F1;SOX4;FXN;FGF2;HES1;RPS6;ACER3;CSF1R;HRAS;SAAL1;SDCBP;EGFR;CHTOP;ERBB2;GAB2;CLCF1;TNFSF13;NOD2;PTPN6;CDK13;CDKN1A;BMI1;CSNK2A1;ZFPM2;UFL1;STAT1;GREM1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2796905896757566,1.130558936814374,0.21721311475409835,0.6840731632908792,1.0,31/140,14.15%,LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;GPR55;CACNA2D1;P2RX4;TRPM1;GPR174;CCR6;GRM1;ACKR4;ACKR2;CCR10;PTGDR;NPTN;IAPP;CALCR;LPAR4;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;GNA15;DLG4;P2RY1;CXCR4;DRD2
prerank,chromatin remodeling at centromere (GO:0031055),-0.35844949185371866,-1.1304195509244572,0.2894248608534323,0.6056853001340662,1.0,17/31,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.37449927960142304,1.1301681353232385,0.2809917355371901,0.683988044008523,1.0,6/28,13.17%,ADCY1;PTN;CYP46A1;ADCY8;CHRNA7;ZDHHC2
prerank,response to estradiol (GO:0032355),-0.36170291419441225,-1.1301010708219883,0.291044776119403,0.6059427775068122,1.0,11/31,20.25%,ESR1;ANXA1;SOCS2;TGFB1;NRIP1;GGT5;LCOR;EGFR;STRN3;FAM210B;GGT1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.44033891201327224,-1.129925739671698,0.3157894736842105,0.6058167470725202,1.0,5/14,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,carbohydrate transport (GO:0008643),-0.4766578140998549,-1.1294185096406426,0.29831144465290804,0.6065450075996508,1.0,8/11,43.32%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2915721999164765,-1.1293732936770544,0.21595330739299612,0.6061014817342553,1.0,20/90,12.88%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;KDM3A;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4541166591768561,-1.1292225842791614,0.3155963302752294,0.6059319125952056,1.0,7/13,31.36%,CD81;GCC2;TMEM30A;BRSK2;SEC16B;TMEM30B;INSIG1
prerank,eye development (GO:0001654),0.33094154943034315,1.1282551455212533,0.2723404255319149,0.6879431383572381,1.0,5/54,3.95%,LAMA1;FBN1;FBN2;SH3PXD2B;PBX4
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.43857718160098874,-1.1281416886918874,0.31053604436229204,0.6080842263513281,1.0,7/14,27.93%,PPM1F;PPP5C;PPP2R2A;NCK1;PPP2R2D;PPP1CA;DUSP1
prerank,regulation of striated muscle contraction (GO:0006942),0.3814506961538165,1.1278784706849398,0.2951167728237792,0.6878302770523448,1.0,5/27,8.07%,ATP1A2;ANK2;PRKACA;P2RX4;TNNI1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.28183792661133933,-1.1278768741974232,0.2274436090225564,0.6081655139221513,1.0,40/109,25.25%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2891541062733282,-1.1278324384427356,0.22023809523809523,0.6077114916006457,1.0,23/88,14.08%,TEK;CAV1;THBS1;NRP2;TIE1;BMPR2;KDR;CAV2;F3;VEGFC;PPP1R16B;PTPRM;VEGFA;ATP5F1A;RGCC;FLT4;AKT1;NF1;VEGFD;APOE;FGF2;EMC10;STAT5A
prerank,positive regulation of cholesterol transport (GO:0032376),-0.36846391791667676,-1.1277131817454267,0.29558541266794625,0.6074262584858979,1.0,4/27,4.05%,CAV1;PLTP;NFKBIA;LPCAT3
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26897574926942647,-1.1276241282390518,0.17805383022774326,0.6070842093209728,1.0,24/141,7.35%,MEF2C;ACTB;RAP1A;CDH1;ESR1;RAP1B;TGM2;ARL6IP5;CTNNA1;RAPGEF1;ATP1A1;IGFBP5;TGFB1;MSN;PDE2A;SLC1A1;KCNQ1;CYP1B1;DIAPH1;NRIP1;CASP7;EZR;NR3C1;JUP
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.46664044721123776,1.1275170735177196,0.32045454545454544,0.6876214846043895,1.0,2/12,2.16%,ADAMTS12;DCN
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4619755760998341,-1.1275084304848637,0.31860036832412525,0.6068096360459476,1.0,2/12,4.12%,MBNL1;TGFB2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3401355471262898,-1.1272901675748053,0.28820116054158607,0.606804809061905,1.0,10/39,14.39%,MYO1D;FNBP1L;TRAK1;ACTN4;HTT;TRAK2;NDE1;NDEL1;WASL;RAB1A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.38750362476866773,1.127289152680737,0.29490022172949004,0.6870369278188908,1.0,10/25,17.29%,B3GALT1;B3GALNT1;B3GNT7;NDST4;FUT9;B3GALT2;HS2ST1;B3GALT5;B4GAT1;B3GNT6
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4656031562179304,1.1269508967058033,0.32662192393736017,0.6867908861599114,1.0,7/12,23.37%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,response to amino acid (GO:0043200),-0.3551354337096704,-1.1267132134324225,0.2647058823529412,0.6076471974950546,1.0,19/31,35.88%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;TMBIM6;RRAGA;RRAGC;SESN2;MEAK7;NSMF;RPTOR;GRIN1;LAMTOR5;CPEB4;LAMTOR1;LAMTOR3;GLRA1;IPO5
prerank,T cell mediated immunity (GO:0002456),-0.4537242726016857,-1.126691646559626,0.31636363636363635,0.6071432732429927,1.0,3/13,13.51%,CD55;EMP2;BTN3A3
prerank,relaxation of muscle (GO:0090075),0.44071486604731647,1.1263727318585355,0.31798245614035087,0.6872394008431709,1.0,3/13,3.80%,ATP1A2;SLC8A1;P2RX4
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2906534872663195,-1.126275133009698,0.2219959266802444,0.6076328509694545,1.0,33/88,24.29%,PTPRB;CAV1;LRP5;DAB2IP;CDKN1B;ADAR;PPIA;CHP1;DBNDD2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;DUSP3;SRCIN1;YWHAG;CDKN1A;UBASH3B;TSC2;CDK5RAP3;GADD45A;DTNBP1;SFN;TRIB3;PTPRO;PTPRQ;PTPN1;CDKN1C;DBNDD1
prerank,positive regulation of lipid storage (GO:0010884),-0.3999854928608995,-1.12583391122435,0.2885375494071146,0.6081447582221893,1.0,6/21,24.15%,SCARB1;PLIN3;EHD1;MSR1;C3;HILPDA
prerank,protein K63-linked deubiquitination (GO:0070536),-0.3549054228379469,-1.1256178958127663,0.2922201138519924,0.6081260606364816,1.0,9/31,17.16%,BRCC3;USP7;OTUD5;USP8;UIMC1;BABAM1;PSMD14;TNFAIP3;BABAM2
prerank,positive regulation of cell cycle (GO:0045787),-0.3091175817383578,-1.1253724637577667,0.23846153846153847,0.6081780240840795,1.0,26/62,26.08%,CCND3;CCNY;CDKN1B;APP;TGFB2;RPS15A;PKD1;RARA;HCFC1;RGCC;AKT1;TAL1;CDK4;DUSP3;EGFR;ANKRD17;USP22;ASNS;CHEK1;CCND1;PKD2;EIF4EBP1;RAD23A;EIF4E;SPDYA;TTL
prerank,actomyosin structure organization (GO:0031032),-0.3011175754169734,-1.124464286251325,0.2490272373540856,0.6098496476459196,1.0,16/75,11.22%,FRMD5;PGM5;TMOD3;SORBS1;F11R;PDLIM1;EPB41L4A;WDR1;LMOD1;FLII;FAM171A1;TMOD1;CDC42BPB;EPB41L5;TNFAIP1;FHDC1
prerank,response to amino acid starvation (GO:1990928),-0.30195547098248954,-1.1241985444911982,0.24517374517374518,0.6099399130056002,1.0,23/72,27.36%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.39283611595420714,1.1240318836368985,0.2853828306264501,0.6920256120378553,1.0,4/26,3.41%,GDNF;VDR;CYP27B1;POR
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4643057922304302,1.1230029690315377,0.3456521739130435,0.6936159248507745,1.0,2/11,2.65%,IL34;PRKCA
prerank,aortic valve development (GO:0003176),0.350824718384489,1.122601802160927,0.31211498973305957,0.6935946253171953,1.0,4/34,2.62%,ROBO1;BMP2;ROBO2;ROCK2
prerank,lipoprotein transport (GO:0042953),0.47526769983054473,1.1225862708979462,0.3273942093541203,0.6925340565342836,1.0,5/10,18.81%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,cellular response to amino acid starvation (GO:0034198),-0.3028172889684127,-1.1224925465342168,0.24277456647398843,0.6136630331581022,1.0,23/71,27.36%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;ATP6V1G1;CDKN1A;RRAGD;RRAGA;TFEB;RRAGC;SESN2;CASTOR2;RPTOR;ATP6V0D1;SEH1L;SEC13;LAMTOR5;SESN1
prerank,protein autoubiquitination (GO:0051865),0.3160792190308136,1.1224117528841882,0.26883910386965376,0.6918491054842738,1.0,7/61,7.72%,RNF220;SH3RF3;SH3RF1;DDB2;MDM2;PRKN;RNF181
prerank,nucleic acid-templated transcription (GO:0097659),-0.3357285488889147,-1.1220974337975596,0.2800751879699248,0.614094114966244,1.0,20/42,32.33%,MEF2A;NR4A2;PTMA;XAB2;PPP5C;E2F1;RNPS1;EPC1;POLR3A;MED20;PWP1;RRAGC;MLF1;HOXD3;TAF1B;POLR2F;POLR2L;POLR2I;POLR2C;TERT
prerank,RNA metabolic process (GO:0016070),0.2765663529770378,1.1220160934193182,0.22265625,0.6917772585777143,1.0,46/127,25.34%,CELF2;ATXN1;NOVA1;RBMS1;ADARB2;HNRNPUL1;AGO4;DHX8;MPHOSPH10;RBM5;POLR2G;PCBP3;FTO;BICD1;PABPN1;PNPT1;RNASE4;HNRNPD;NOL9;THOC1;PARN;METTL3;DROSHA;RNASEL;POLR2D;RNASEH1;PAPOLA;AGO3;HNRNPF;AGO1;POLR2K;AGO2;RNASE3;DDX24;TENT2;MRPL44;RNASEH2B;ATXN2;DICER1;SETX;POLR2B;RBM39;WTAP;FASTKD1;CLP1;RNGTT
prerank,response to UV-A (GO:0070141),-0.43162643080783974,-1.1220016972780051,0.3108348134991119,0.6137741617130766,1.0,8/14,35.91%,AKT1;EGFR;OPN3;CCND1;PPID;MMP3;MMP1;CERS1
prerank,tRNA metabolic process (GO:0006399),-0.4179755071834528,-1.1216640704620258,0.3076923076923077,0.614041860159383,1.0,10/17,39.35%,SARS1;FARS2;TRPT1;RPP21;ADAT1;KARS1;AARS1;THG1L;YARS2;RPP30
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.343267737790064,1.1212042870068777,0.2733050847457627,0.6927493481062712,1.0,3/40,5.39%,IGF1;BCL2L11;PRKN
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2870018084931929,-1.1206909190106706,0.2396039603960396,0.6158623189839433,1.0,27/95,15.00%,CAV1;THBS1;LTBP4;TGFBR2;SMAD7;ZBTB7A;HSP90AB1;TGFB1;FKBP1A;PRDM16;UBB;UBC;RPS27A;CD109;SMAD6;GIPC1;ASPN;IL17RD;HTRA3;HTRA4;SKIL;RNF111;ENG;SMURF1;EID2;SDCBP;SMAD4
prerank,protein localization to cell surface (GO:0034394),-0.3702118894197951,-1.120221632191236,0.2919020715630885,0.6164331695250302,1.0,11/26,21.91%,MESD;JAM3;RIC3;VCL;EMP2;WNT11;SMURF1;USP4;PTPRK;FGF10;PTPRU
prerank,regulation of cell cycle process (GO:0010564),-0.2779362296913038,-1.119951636720966,0.22453222453222454,0.6165387940476578,1.0,42/104,31.40%,RAB11A;CAV2;CALM1;RPRD1B;ZFYVE26;PLK2;YTHDF2;CALM3;BCL2L1;RAB11FIP3;CETN2;CDK13;CSNK2A1;CSNK2A2;MAD1L1;L3MBTL1;KLHL9;ECT2;CHEK1;KLHL21;SOX9;PIN1;PRPF40A;RCC1;KNSTRN;MKI67;KIF13A;PLK3;CDC42;CDKN2B;DCUN1D3;PLK5;TTL;MYO19;SETD2;RACGAP1;CTNNB1;ENTR1;KIF11;PLK1;AURKA;PIK3R4
prerank,striated muscle cell differentiation (GO:0051146),0.42188699734137064,1.119756949927321,0.31222707423580787,0.6953813501709338,1.0,2/16,1.40%,BMP2;NRG1
prerank,protein ADP-ribosylation (GO:0006471),0.374715447894919,1.1197264336680794,0.30269058295964124,0.6943543102276463,1.0,14/28,24.81%,PARP16;SIRT2;PARP11;PARP12;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8
prerank,response to organic cyclic compound (GO:0014070),-0.31725294815731275,-1.11932803617778,0.2756052141527002,0.6175205621032882,1.0,12/52,12.63%,ESR1;ARL6IP5;ANXA1;SOCS2;IGFBP5;TGFB1;SLC1A1;CYP1B1;TLR3;SPP1;GGT5;ABCA2
prerank,toxin transport (GO:1901998),0.47326694806572367,1.1192606784561003,0.3271889400921659,0.694382551037144,1.0,3/10,6.61%,ANTXR1;SLC22A3;RAB29
prerank,regulation of macrophage activation (GO:0043030),-0.3559082995444691,-1.1191655970868488,0.312621359223301,0.6173672453468797,1.0,8/30,12.43%,LBP;THBS1;MFHAS1;IL33;GPR137B;HSPD1;CD74;TLR4
prerank,catecholamine metabolic process (GO:0006584),0.4361706664112037,1.1190029922028712,0.3268398268398268,0.6939624455910215,1.0,3/14,14.15%,PRKN;COMT;DRD2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.3201873341277521,-1.1189794431969318,0.27756653992395436,0.617302828842888,1.0,9/47,8.42%,RREB1;LRP5;PPARD;SIX1;CMKLR1;SOX13;ZBTB16;CDS1;AKT1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2233355234369965,-1.1189772525709274,0.07517084282460136,0.6167458304957895,1.0,155/807,14.63%,KLF12;MECOM;LEF1;FOXP1;ELK3;MEF2C;CAV1;PRDM6;DACH1;WWP1;RREB1;ATP8B1;RPS6KA5;ESR1;NOTCH1;DDX5;RPS14;CBFA2T3;ID1;ZHX3;NEDD4L;HMBOX1;ID3;MAP2K5;PPARD;NCOR1;MEF2A;KLF2;FOXO1;KLF4;RPL10;FOXO3;DAB2IP;SMAD7;ZBTB7A;IRF2BPL;CDKN1B;KLF7;FNIP2;TGFB1;CNBP;REST;KDM5C;PRDM16;TBX2;RPL23;UBB;PDE2A;ZNF431;HDAC9;HSPA8;WWP2;NR4A2;LIMS1;PFDN5;SARS1;KCTD1;FOXD1;RLIM;PRDM2;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;UBC;RPS27A;HEYL;ZBTB16;LRRFIP1;DPF2;IL33;VEGFA;CNOT7;MPHOSPH8;DPF3;NRIP1;RBFOX2;RARA;NOTCH4;EZR;GATA6;ATF4;SHC1;FOXN3;CBFB;KLF8;NR3C1;MXD4;HCFC1;CBX5;PPM1F;CIC;EDN1;UIMC1;IRF2BP2;MOSPD1;HDGF;NR2C2;YY1;HDAC4;ZMYND11;NDUFA13;BCL6;KANK2;SOX7;TWIST1;MAF1;TRIM28;USP9X;HHEX;HSBP1;SOX18;RB1;MXD1;ZC3H8;FOXP2;MTA2;WNT11;SKIL;FOXC2;ZBTB18;CCDC85B;MTA1;SP3;SFPQ;FRK;LIMD1;TCF25;PHC1;IMPACT;HIVEP1;CIPC;E2F1;ZNF423;COMMD7;POU2F1;MIER2;HES1;CIART;MTERF3;LCOR;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;EID2;BCL6B;SDCBP;HEY1;SMYD2;ETV5
prerank,negative regulation of insulin secretion (GO:0046676),-0.4126112398413385,-1.118951160222763,0.30782918149466193,0.6162502063652039,1.0,6/17,13.84%,CCN3;KCNB1;KLF7;REST;PIM3;INHBB
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4564166088451862,1.1187721156830983,0.3163972286374134,0.6934642232947612,1.0,3/11,8.22%,CACNA2D1;CACNB2;CACNB1
prerank,establishment of protein localization to organelle (GO:0072594),-0.3005769448991168,-1.1184574778607417,0.24214417744916822,0.6169148084162287,1.0,23/72,26.55%,RAB11A;HK1;NUP93;AKT1;LAMP1;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;TNPO3;RPAIN;TSPAN17;TSC2;NXT2;CD68;TNPO2;NEURL1B;FAM53A;SEC13;NUP107;IPO13
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.38620504855268,-1.1184115034082573,0.31379962192816635,0.6164708327678251,1.0,8/21,22.33%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;APC2;CAMSAP3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4208893577851244,-1.1180657482546246,0.3079710144927536,0.6167728509404241,1.0,3/16,6.13%,CAV1;ADIPOR1;PPP2R1A
prerank,cardiac muscle cell development (GO:0055013),0.3919350081132245,1.1180276046077138,0.32264957264957267,0.694331892751547,1.0,9/20,14.84%,SLC8A1;PDGFRA;CSRP3;FHOD3;PDGFRB;ALPK3;OBSL1;PDLIM5;MYLK3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3510054398003703,-1.117909799303224,0.2987012987012987,0.6165765972777512,1.0,9/32,19.52%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.32258342997794165,-1.1178282191718523,0.2734375,0.6162232292472988,1.0,19/53,25.25%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;BCKDK;PSMB8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3580869869727717,-1.1173668479489782,0.3142329020332717,0.6168248156418613,1.0,6/28,8.37%,DAB2IP;NGF;CRADD;GABARAP;CASP8;BAX
prerank,regulation of protein kinase activity (GO:0045859),-0.27748467336893634,-1.1171694193288624,0.23837209302325582,0.6167914030364843,1.0,42/106,27.63%,PLCE1;RAP1A;PTK2B;IQGAP1;PTK2;PPIA;CHP1;DBNDD2;RASSF2;HSPB1;PPM1F;TRIB2;AKT1;WARS1;TRIB1;RB1;NF1;SMG8;LCP2;MMD;PRKAG1;YWHAG;CDKN1A;TAB2;UBASH3B;AGAP2;TSC2;ECT2;DTNBP1;TSPYL2;SFN;RAPGEF2;TRIB3;DBNDD1;MRNIP;SPDYA;PARK7;MMD2;CAMKK2;SOD1;RTRAF;ADCYAP1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.27285330365948,-1.1170874816181193,0.23540856031128404,0.6164398317784605,1.0,56/125,33.64%,DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;PLK2;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;MAD1L1;KIF18A;RANGAP1;DYNLL2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;SETD2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;TACC3;ESPL1;ITGB3BP;CDC20;BUB1
prerank,positive regulation of MAPK cascade (GO:0043410),0.255796319545267,1.1170006454913495,0.21825396825396826,0.6957907926695821,1.0,35/245,10.09%,IGF1;ROBO1;NRP1;BMP2;IL34;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;PLA2G5;PDGFRA;GPR55;ROCK2;PRKCA;SLC30A10;RIT2;WWC1;MAP3K12;IAPP;PDGFRB;CALCR;THPO;SOX2;PDGFD;IGF2;RYK;KLHDC10;FGFR4;EPHA8;MYDGF;ERBB4;CCL25;ADRA1D
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4511687193745808,1.1168710420617889,0.3356009070294785,0.6950376999684397,1.0,2/11,4.13%,PRKCA;LYN
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.41048152136040517,1.1165449469994522,0.3230769230769231,0.6947764446234521,1.0,9/19,17.48%,PTPRD;IL1RAPL1;CUX1;CAMK2B;CDKL3;CUX2;OBSL1;CAPRIN2;CUL7
prerank,positive regulation of chemotaxis (GO:0050921),0.34616295931962354,1.1164979231207914,0.2938689217758985,0.6937947818374103,1.0,5/43,3.80%,NRP1;PTN;NTRK3;SEMA5A;P2RX4
prerank,establishment of melanosome localization (GO:0032401),-0.3993837339791281,-1.1163256275494355,0.31560283687943264,0.6178137784596631,1.0,6/19,13.87%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.43382048901595327,-1.1162537708711169,0.333955223880597,0.6174186040995394,1.0,3/13,7.75%,PRR5L;CNOT7;RC3H1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.27935611260582793,1.1162079045357929,0.23434343434343435,0.6934025050606297,1.0,24/122,11.58%,IGF1;PRR16;AR;SAMD4A;SLC6A9;GLI2;LARP6;STN1;IL4;IRS2;NLRP12;PDGFRB;ATAD5;BRPF3;IGF2;CPEB3;FGFR4;EIF3C;PLD1;PLXNB2;HNRNPD;PIWIL2;FXR2;HSPH1
prerank,organelle assembly (GO:0070925),-0.23766912544283889,-1.1159640877284032,0.16483516483516483,0.6176052796144815,1.0,93/384,19.97%,ABLIM1;ABCC4;PGM5;EXOC4;CD34;TMOD3;NOTCH1;EXOC6;FNBP1L;RAB11A;RPS23;CDC14A;NCOR1;EHD4;NEK7;RPS3;RAB8B;MAP1LC3B;IFT20;CEP164;GORASP2;ABLIM3;ATXN2L;PKD1;CHMP2B;GABARAP;EHD2;LMOD1;CEP162;FLII;CDS2;RC3H1;CDS1;TMOD1;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;ATG3;SYNPO;ATG7;RAB8A;CEP290;DHX37;EXOC1;FHDC1;LIMD1;STK36;YTHDF2;RAB7A;DBNL;CIRBP;PCM1;VMP1;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;VPS36;MAP1LC3A;POGZ;ARL6;RFX2;RAB11FIP3;RAB1A;TSG101;GOLGA8B;CCDC28B;KIF24;SNF8;DNAH5;HPS1;EMC6;AMBRA1;CEP41;TMEM67;IST1;LSM14A;MAPRE2;CHMP2A;E2F4;EHD1;SPAG16;RAB32;TMEM231;EHD3;DYNLL2;WIPI2;RCC1
prerank,chromatin remodeling (GO:0006338),-0.2813369487579795,-1.1158467145612372,0.2376237623762376,0.6173633642119963,1.0,38/100,32.40%,ACTB;ESR1;ZBTB7A;KDM5C;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;MBD3;GATAD1;SATB2;HCFC2;SMARCA4;GATAD2B;SMARCA2;RBBP4;KDM6A;CHD4;SOX9;SMARCC1;POLE3;EZH1;HDAC5;RUVBL1;NPM1;CHRAC1;SMARCD2;SMARCA5;MYC;MYSM1;SMARCD3;NPM3;KAT2A;HNRNPC
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.23265873227316658,1.1153913498750727,0.15313653136531366,0.6944232047597648,1.0,77/572,9.65%,BMP6;TCF7L2;FHL2;LDB2;BMP2;SALL1;AR;ATXN1;TBX3;GLIS3;MXI1;FGFR2;NR2F2;BCOR;ZEB1;TBL1XR1;VDR;RARB;TRPS1;PPARA;ZHX2;GLI2;MITF;PRDM5;SMAD3;TFEC;KDM1B;NKX6-1;TBX21;MDM2;GLI3;WWC1;TENM2;ZEB2;UXT;FNIP1;AEBP1;FOSB;ZMYM5;CEBPB;IL4;RNF2;JAZF1;PRKN;SUMO1;LIN37;HDAC10;ZHX1;LOXL2;SMURF2;SIRT2;CUX1;MEN1;MBD2;NFIX;CRY1;BCL11A;RARG;SOX2;TRIM27;CITED2;RBPJ;NSD1;IGF2;FOXD3;HES5;MIER3;CPEB3;ATN1;BRMS1L;BRMS1;GLIS1;GATA3;CTCF;KCNIP3;CUX2;HDAC8
prerank,positive regulation of secretion by cell (GO:1903532),0.30833205591566387,1.1151650110072937,0.26804123711340205,0.6939344129669581,1.0,5/70,4.15%,IGF1;BMP6;BMP2;P2RX4;CADPS
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3045077242647038,1.1146594905058573,0.26848249027237353,0.694163873333632,1.0,13/72,9.40%,IGF1;PIK3R1;NTRK3;KIT;DCN;PDGFRA;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF
prerank,negative regulation of complement activation (GO:0045916),-0.4716964554937531,-1.1143967904271328,0.3246753246753247,0.6202835944886819,1.0,1/10,1.66%,CD55
prerank,protein localization to cell junction (GO:1902414),-0.38604129313517743,-1.1140761814409543,0.2796934865900383,0.6205422081720927,1.0,4/22,4.07%,HEG1;TJP2;FERMT2;JAM3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.32890002291739845,1.1137336340258777,0.29958677685950413,0.6954901492617562,1.0,6/52,3.15%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3;GNAI1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.42670334689561185,1.113354243298481,0.3165137614678899,0.695383304422945,1.0,7/16,16.52%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,centromere complex assembly (GO:0034508),-0.3460923986049803,-1.1133276173915996,0.2980769230769231,0.6217911100173356,1.0,19/36,34.42%,POGZ;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPF;CENPA;CENPO;RUVBL1;NPM1;CENPV;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4148416354822321,1.1124560066296465,0.30444444444444446,0.6966736810146079,1.0,3/17,4.33%,SCN3B;ANK2;GPD1L
prerank,cardiac muscle cell action potential (GO:0086001),0.3682891814071271,1.1124462298668296,0.2908704883227176,0.6956169202968393,1.0,5/30,3.32%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.39100727113524375,-1.112403610316811,0.32432432432432434,0.6234716705672974,1.0,9/20,25.21%,FKBP5;FKBP1A;PPIA;PPIC;PPIG;PIN1;FKBP4;PPIB;PPID
prerank,protein acylation (GO:0043543),-0.3398309313509244,-1.111647194244137,0.27204502814258913,0.6247925727618642,1.0,18/38,32.61%,FOXO1;ING5;ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;CLOCK;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;NAT9;NAA80;KAT2A;CREBBP
prerank,2-oxoglutarate metabolic process (GO:0006103),0.43976218221686975,1.1115753790474008,0.3276955602536998,0.6967850580438231,1.0,6/13,21.85%,ADHFE1;PHYH;D2HGDH;GPT2;GOT1;GOT2
prerank,organic substance transport (GO:0071702),-0.27348133701466387,-1.1115444986469913,0.23983739837398374,0.624495349830933,1.0,21/121,12.95%,ABCG2;SLC47A1;SLCO2A1;PLTP;ATP8A1;SLCO2B1;ARL6IP5;RAMP2;CUBN;CHMP2B;MFSD2A;ABCG1;SPNS2;NDC1;CHKA;ARRDC1;CEP290;RUFY1;RAB7A;ABCA2;MFSD2B
prerank,sensory perception of sound (GO:0007605),0.2943967613199675,1.1112767754041222,0.25103734439834025,0.6964906217461908,1.0,9/88,6.54%,ADGRV1;CEMIP;ATP6V0A4;KIT;OTOS;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,protein targeting (GO:0006605),-0.2752533092602816,-1.1109490420389951,0.26429980276134124,0.62544059661664,1.0,26/118,14.46%,RASSF9;PARD3;TRAK1;RPL11;AQP11;GABARAP;GIPC1;TRAK2;SPCS1;HACL1;ATG3;NACA;SEC63;ZDHHC9;TAOK2;TIMM17A;AKAP6;ZDHHC1;KATNB1;ICMT;TOMM22;ARL6;BCAP31;ZDHHC20;AP4M1;SDCBP
prerank,lymphocyte differentiation (GO:0030098),-0.30034250933897605,-1.110935800636663,0.27647058823529413,0.6249092651416789,1.0,25/68,25.77%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;JAG2;HDAC4;HHEX;RELB;LFNG;SOX4;CLCF1;ITGA4;TCF3;KLF6;GPR89B;GPR89A;JAK3;DLL4;ADGRG3;PTPN22;DCAF1;TOX;NFAM1;HDAC5
prerank,regulation of cell communication (GO:0010646),-0.34873040125266935,-1.1103769337525495,0.2827324478178368,0.6257809713728459,1.0,16/35,23.07%,CXADR;IGFBP7;CAMK2D;ANXA1;MGLL;SOCS2;CRK;NCLN;GRK5;CASQ2;SRI;YWHAG;TSPYL2;VEPH1;PTPN1;GJA5
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.41342488225744967,-1.110064764744586,0.32181818181818184,0.6260042677581011,1.0,3/17,6.91%,CAV1;KLF7;APOLD1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.23880151428204047,-1.1096662842341454,0.16977225672877846,0.6264453104524648,1.0,81/366,17.62%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;JMJD1C;NLK;RPL10;FOXO3;SOX17;VSX1;SIX1;CNBP;REST;APP;TRRAP;NFYA;ZNF431;ASCC2;PPARGC1B;PFDN5;PRDM2;PPARGC1A;BHLHE40;SOX13;SLC39A8;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;NR2C2;ATXN1L;SPIN1;INSR;FZD7;FUS;SOX7;PDGFA;SOX18;RB1;ESRRA;PRRX2;MYBL1;WTIP;SP3;SOX12;KMT2D;SFPQ;LIMD1;TEAD2;E2F1;ZNF423;SOX4;HINT1;ENG;PHF12;HCFC2;MLX;RNF20;NR5A2;RBM4B;LDB1;ZFHX3;SOX6;DRAP1;CELSR2;SMARCA2;LIN54;SAP30L;TCF3;ANKRD17;PCIF1;RELA;ZNF22;CCAR2;BRCA2;SP1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4464851362331993,-1.1094462527861326,0.35231316725978645,0.6264781843278717,1.0,2/11,2.04%,MLLT3;RSPO3
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2857964804063279,1.1092407648037954,0.2543689320388349,0.7006485879638391,1.0,14/118,5.49%,SH3D19;HECW2;PID1;ADGRB3;LRRC4C;FGFR2;PHLDB2;GDNF;KIF13B;RAP2A;PHIP;SFRP1;ZMYM6;HECW1
prerank,glial cell development (GO:0021782),-0.3740869764525667,-1.1089531090406752,0.33587786259541985,0.6271520576357265,1.0,6/25,15.54%,CDK6;APP;NF1;SOX4;NRROS;EIF2B3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3401527131509529,-1.1087611428841087,0.30303030303030304,0.6270927465493099,1.0,13/38,19.50%,THBS1;NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;MADD;TNFAIP3;ARHGEF2;FAIM2
prerank,protein localization to condensed chromosome (GO:1903083),-0.4522579330917613,-1.1086024729931176,0.34900542495479203,0.626977674842251,1.0,6/12,31.36%,ZW10;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3993744358099966,-1.1081518484410597,0.3180987202925046,0.6275975541159696,1.0,6/18,4.23%,TEK;ADGRG6;NOTCH1;S1PR1;TGFB2;FKBP1A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.37973349812956547,-1.1081250646180343,0.3357798165137615,0.6271141772680777,1.0,10/25,21.50%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.22968145716583296,-1.108083613282802,0.14385150812064965,0.6266509045830424,1.0,118/509,17.11%,FN1;KITLG;TEK;VWF;CAV1;FLT1;IGF1R;NR3C2;THBS1;PTPRJ;GAB1;ESR1;PLCG2;FGF1;NOD1;RACK1;TGM2;ACTN4;KDR;CAV2;F3;IQGAP1;RPS15;TFRC;PTK2;MID2;TBX1;RPS3;DAB2IP;FERMT2;RICTOR;TRIM25;TNFAIP8L3;HSP90AB1;TGFB1;APP;TGFB2;ATP2C1;FKBP1A;MAP3K3;RPL23;MFHAS1;RAC1;REL;LIMS1;TNFSF10;VEGFA;S100B;IKBKB;BRD4;MYOC;SHC1;LURAP1;CASP8;TLR3;RIPK1;EEF1D;GAPDH;FLT4;PLK2;BAX;INSR;PDGFC;PDGFA;TRIM14;RPS20;HIP1;JCAD;TIRAP;TCIM;WNT11;DHX58;CD74;S100A13;PIK3AP1;BBC3;PPP5C;TRIM62;BCL2L1;MAVS;TLR4;MIB2;FGF2;EDA2R;SPHK2;ENG;TNFRSF1A;USP15;HRAS;PHB2;TRIM68;BCAP31;LAMTOR2;JAK2;TRIM5;EGFR;ERBB2;STRN;GAB2;PIK3CA;GPR37L1;NOD2;PTPN6;BCAR3;TMEM101;CX3CR1;MET;LGALS1;PIK3R2;RRAGD;HSP90AA1;ANKRD17;MIER1;TAB2;JMJD8;RELA;BAD;GPR89A
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.35997318501416337,1.107966989561253,0.3037974683544304,0.7028918445073544,1.0,4/32,6.91%,CEMIP;PDPK1;P2RX4;CALCR
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.3057195032960086,-1.107651303133343,0.2962226640159046,0.6271510058648898,1.0,24/62,25.92%,ACKR3;TPT1;PPIA;HSPB1;YBX3;AKT1;NDUFA13;DNAJA1;PTTG1IP;BAG5;BCL2L1;NDUFS3;OPA1;HSPA1A;XBP1;CCAR2;ARHGEF2;MCL1;TMBIM6;ENO1;SNAI2;HYOU1;PLAUR;PARK7
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.44709011434220114,-1.1075153878060577,0.333955223880597,0.626931220903774,1.0,2/12,4.11%,JAM2;APP
prerank,cellular response to cytokine stimulus (GO:0071345),-0.23377086725410992,-1.1074732381822736,0.16702819956616052,0.626476410123014,1.0,113/416,20.73%,FN1;LEF1;ST3GAL6;PTPN14;SLC12A2;LBP;PTPRJ;VIM;LIFR;LRCH1;MAOA;F3;FOXO1;MT1X;WNK1;STX3;RAPGEF1;LAMA5;FOXO3;RPS3;S1PR1;IRAK2;ANXA1;GBP5;DAB2IP;SOCS2;CDKN1B;MT2A;TGFB1;UBB;PDE2A;HSPA8;INPP5D;UBC;RPS27A;IL1R1;CRK;VEGFA;GBP7;STX1A;IKBKB;SHC1;TNFRSF21;TNFRSF1B;RIPK1;GAPDH;NPNT;YBX3;RC3H1;IL20RB;IFITM2;AKT1;NDUFA13;BCL6;CCL15;DHX9;ASAH2;TWIST1;IFNAR1;IFIT1;JUNB;RPL13A;UBE2G2;LRP8;GRB10;ABL2;AKAP6;CIB1;YWHAZ;BCL2L1;TLR4;POU2F1;FGF2;SYK;IL18BP;CSF1R;TNFRSF1A;AIM2;STAT5A;PTPN12;JAK2;F13A1;SIGIRR;GAB2;PIK3CA;CLCF1;PTPN6;NDN;CDKN1A;STAT1;HSP90AA1;RELA;XBP1;IFNGR1;JAK3;HCK;CHUK;SLA;IRF8;AQP4;ARHGEF2;IRAK4;IL3RA;CCND1;SOX9;SYNCRIP;MCL1;CASP1;HAS2;LGALS9;MAPK11;CSF2RB;IL10RB
prerank,artery morphogenesis (GO:0048844),-0.3569632762444659,-1.1074033757063422,0.3224043715846995,0.6261082070783088,1.0,11/30,13.24%,NOTCH1;BMPR2;TBX1;SMAD7;TGFB2;TBX2;STRA6;VEGFA;NF1;HES1;ENG
prerank,cellular response to interleukin-12 (GO:0071349),-0.32176766842139964,-1.1073210307498536,0.29411764705882354,0.6257870480621698,1.0,20/48,30.96%,RAP1B;HNRNPA2B1;MSN;ANXA2;PPIA;PITPNA;TALDO1;HNRNPDL;CFL1;JAK2;HSPA9;IL12RB2;CDC42;STAT4;SOD1;GSTO1;PDCD4;P4HB;PAK2;PLCB1
prerank,aminoglycan metabolic process (GO:0006022),0.46583798560565337,1.106993486085519,0.3626373626373626,0.7042746276999939,1.0,4/10,21.64%,GAL3ST3;B4GALT7;B3GAT1;B3GALT6
prerank,response to cytokine (GO:0034097),-0.26488484626296094,-1.106694092062633,0.24716981132075472,0.6267300988832128,1.0,47/141,21.46%,LEF1;PTPN14;MAP4K3;LIFR;COL3A1;IRAK2;ANXA1;GCH1;MAPKAPK3;APP;ADAR;REL;ADAM10;IL1R1;IFITM1;IFITM3;CASP8;RIPK1;TNFRSF11A;HDAC4;IFITM2;ASAH2;RELB;CD74;GGT5;AKAP6;TRIM56;BCL2L1;IL18BP;CSF1R;PTPN12;JAK2;SIGIRR;SRF;TIMP2;PTPN6;STAT1;IGBP1;RELA;JAK3;MCL1;CASP1;GGT1;LGALS9;HCLS1;IL6ST;TAF9
prerank,positive regulation of binding (GO:0051099),-0.28580263312699894,-1.1063724582116388,0.2774566473988439,0.6269637065617348,1.0,18/84,9.23%,CAV1;CLDN5;B2M;HMBOX1;NGF;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;RARA;IDE;NMD3;DPH3;DHX9;ADD1;FLOT1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3514938190057773,-1.1063597509554934,0.3196078431372549,0.6264414589162336,1.0,11/33,17.07%,KLF4;FOXO3;ETS1;TGFB1;TGFB2;GATA2;NR3C1;FGF2;SMARCA4;SRF;RELA
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.47547824467955796,-1.106247522449584,0.3181818181818182,0.626176412786951,1.0,4/11,7.38%,SCARA3;CASP8;TLR3;RIPK1
prerank,photoreceptor cell development (GO:0042461),-0.43370348040089934,-1.106164396395665,0.3339253996447602,0.6258445538976101,1.0,7/14,25.81%,RP1;VEGFA;MFSD2A;CEP290;CDHR1;ARL3;MYO7A
prerank,dendrite morphogenesis (GO:0048813),0.3544277486633935,1.105908909178465,0.3185483870967742,0.7059809549623371,1.0,12/35,14.58%,PTN;LRP4;DOCK10;CTNNA2;CTNND2;EPHB1;MAPK8IP2;FARP1;PTEN;CHRNA7;DLG4;MAP6
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.41448562099768627,-1.1058073960621682,0.3128491620111732,0.626220583151718,1.0,9/17,31.36%,ZW10;RB1;KNL1;MTBP;BOD1;SPDL1;CENPA;BUB3;CDK1
prerank,positive regulation of hemostasis (GO:1900048),-0.4733213223120516,-1.1056393478136983,0.3333333333333333,0.6255735542905428,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,positive regulation of coagulation (GO:0050820),-0.4733213223120516,-1.1056393478136983,0.3333333333333333,0.6255735542905428,1.0,3/10,9.15%,ST3GAL4;THBS1;ENPP4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.38944049064754005,1.1056220432973936,0.3482905982905983,0.7045786285481183,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.38944049064754005,1.1056220432973936,0.3482905982905983,0.7045786285481183,1.0,4/21,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,epithelial structure maintenance (GO:0010669),-0.4637540431255501,-1.1053804139763996,0.344106463878327,0.6256526449646885,1.0,5/11,36.09%,CXADR;NOD2;MUC13;PIWIL4;MUC6
prerank,ephrin receptor signaling pathway (GO:0048013),-0.29352240764071663,-1.1051537419932693,0.29568788501026694,0.6256756106466048,1.0,27/82,19.46%,ACTB;ARHGEF28;ACTG1;SIPA1L1;ARPC1B;PTK2;RAC1;CHN1;CRK;ARPC5;AP2M1;ANKS1A;PSENEN;ITSN1;ACTR3;HRAS;WASL;APH1A;SDCBP;AP2A1;EPHA2;YES1;DNM1;EPHB6;EFNB3;RASA1;EFNB1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3568900980593997,-1.1050657899781213,0.31876138433515483,0.6253359392402498,1.0,7/30,7.38%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4496542903142906,1.1048490615407303,0.34801762114537443,0.7055537105770396,1.0,1/12,0.69%,AKR1B1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.38555505185198735,-1.103605013807476,0.3339622641509434,0.6285128784046512,1.0,4/21,3.86%,MEF2C;ITGA1;HSP90AB1;CALM1
prerank,adherens junction organization (GO:0034332),-0.31806893172723455,-1.1035554501380944,0.3145009416195857,0.6280945452386031,1.0,12/48,10.88%,ACTB;CDH1;CTNNA1;RAMP2;FERMT2;SMAD7;JAM3;CDH4;JUP;PVR;VCL;CDH6
prerank,regulation of cilium movement (GO:0003352),0.462847434908686,1.103315495630396,0.367170626349892,0.7085188863473452,1.0,3/10,11.52%,CFAP43;CCDC65;DNAH11
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.43108274831522686,-1.1031143489108615,0.34790528233151186,0.6286393467717933,1.0,2/14,4.89%,THBS1;CMKLR1
prerank,linoleic acid metabolic process (GO:0043651),0.4180047248245962,1.1031063452483525,0.31237322515212984,0.707965675515873,1.0,3/17,6.08%,ALOX12;ACSL1;GSTP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.34586877374807473,-1.1030411036832206,0.3162878787878788,0.628296287630024,1.0,7/33,9.62%,MEF2C;PRKG1;IGFBP5;CDKN1B;IGFBP3;TGFB3;TRIB1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4103270069622774,1.1030001669656146,0.32494279176201374,0.7071606783658839,1.0,2/18,3.59%,IL4I1;TBX21
prerank,epithelial cell migration (GO:0010631),-0.33786364172275063,-1.1026214880386704,0.3172541743970315,0.6288568735486227,1.0,14/37,16.32%,NOS3;DPP4;PXN;STARD13;FAP;CYP1B1;GIPC1;KANK2;FAT2;PLXND1;PKN3;FSTL1;PIK3CA;STAT1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4402259389720541,-1.1023856210903944,0.35658914728682173,0.6288600230906304,1.0,6/12,20.02%,MAOA;AMD1;OAZ2;DDC;SMS;SRM
prerank,protein deubiquitination (GO:0016579),-0.24717445807048688,-1.102186418954556,0.21473684210526317,0.6288065764194506,1.0,65/242,21.45%,ACTB;ESR1;IFIH1;NFKBIA;MINDY2;SMAD7;MINDY1;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;ENY2;BABAM1;RHOT1;USP9X;OTUB1;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;PSMB1;PSMC3
prerank,cellular iron ion homeostasis (GO:0006879),0.3121938026120188,1.1021837682092737,0.2921108742004264,0.7081704212213068,1.0,3/55,1.49%,BMP6;CP;HEPH
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3860778897570882,-1.1021767809297858,0.3258003766478343,0.6282850178014787,1.0,8/22,30.30%,SLC7A5;TNFRSF1B;SPHK2;NOD2;LAPTM5;BTK;LILRB1;TRPM4
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4416618010910095,-1.1020628713234581,0.336996336996337,0.6280260133482501,1.0,10/12,52.61%,SLC11A1;IL12RB1;ZBTB1;CARD9;IL23A;IL23R;IL12B;CCR2;CLEC6A;IL1B
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.38081063432735623,-1.1017519110791616,0.33882783882783885,0.6282942657795629,1.0,10/22,28.29%,NOP14;RPS21;ERI1;PES1;URB1;EXOSC8;WDR12;ABT1;FTSJ3;EXOSC9
prerank,B cell receptor signaling pathway (GO:0050853),-0.3527306157522676,-1.1016253491521772,0.32149532710280376,0.6280525209713224,1.0,5/32,8.37%,MEF2C;PLCG2;BMX;CD38;BAX
prerank,skeletal muscle tissue development (GO:0007519),-0.34178982167091443,-1.1015221350483728,0.3069679849340866,0.6277686872724588,1.0,5/32,3.90%,MEF2C;CAV1;MYL6;CAV2;SIX1
prerank,apoptotic cell clearance (GO:0043277),0.3594414487490247,1.1015206813889094,0.30927835051546393,0.7088253498174389,1.0,7/30,8.10%,LRP1;XKR4;MEGF10;RHOH;XKR6;RHOBTB1;TXNDC5
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.48021223040446986,-1.1013973924577942,0.3613595706618962,0.6275209001213023,1.0,3/10,11.37%,ESR1;PSMC4;PSMC5
prerank,positive regulation of macrophage migration (GO:1905523),-0.39334996058868243,-1.101346272577863,0.33519553072625696,0.6270959122799538,1.0,4/19,4.89%,THBS1;MAPK3;PTK2;CMKLR1
prerank,neuromuscular process (GO:0050905),0.41149701934440885,1.1008735980988003,0.34273318872017355,0.7093185344990727,1.0,3/16,2.31%,MYCBP2;NRXN1;CHRNA1
prerank,brain development (GO:0007420),0.27303802665190735,1.099989474746914,0.26145038167938933,0.7106052828627757,1.0,25/136,14.10%,EPHA7;ARNT2;ROBO2;ATXN1;CNTN4;ZIC1;AFF2;CNTNAP2;PBX4;CTNNA2;SPEF2;HES5;CDK5R1;BBS2;PTEN;EML1;EEF1AKMT4-ECE2;PLXNB2;CTNS;PHF8;NKX2-1;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3291095403034171,1.0994235967957717,0.31941544885177453,0.71107406323657,1.0,5/43,7.92%,IGF1;IL4;GSTP1;CD274;TRIM27
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.24950891436025635,-1.0993937651687435,0.23408624229979466,0.6314378509322556,1.0,61/208,21.16%,ESR1;PLCG2;NOD1;TFRC;MID2;DAB2IP;TRIM25;ATP2C1;FKBP1A;MAP3K3;REL;TNFSF10;S100B;IKBKB;BRD4;LURAP1;CASP8;HSPB1;RIPK1;EEF1D;GAPDH;PLK2;ZMYND11;CARD19;TRIM14;TIRAP;MAPKBP1;CD74;S100A13;PPP5C;TRIM62;MAVS;MIB2;EDA2R;SPHK2;TRAF1;TNFRSF1A;TRIM68;TRIM5;NOD2;TNFAIP3;TMEM101;LGALS1;UFL1;STAT1;ANKRD17;MIER1;TAB2;JMJD8;RELA;GPR89A;CHUK;PELI1;ECT2;IRAK4;CCDC22;CASP1;LTBR;LGALS9;TSPAN6;CANT1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.35345037790656286,1.0993918699274363,0.3060428849902534,0.7101025288227981,1.0,5/31,7.73%,IL4I1;LYN;CEBPB;GLMN;CD274
prerank,cellular respiration (GO:0045333),-0.3321627500992426,-1.0992518895449375,0.3089108910891089,0.6312299040342091,1.0,15/41,22.14%,ATP5F1D;PPARGC1A;NDUFS4;COX15;MTFR1;SURF1;ETFB;ETFDH;UQCRB;COX10;UQCRH;LYRM7;SDHB;SDHAF4;MTFR2
prerank,Wnt signaling pathway (GO:0016055),-0.2812652904645747,-1.0992062236897024,0.27346938775510204,0.6308136485300503,1.0,19/92,10.46%,LEF1;NXN;PLCG2;LRP5;FZD6;FZD4;FERMT2;UBB;NR4A2;CSNK1G2;UBC;RPS27A;WNT9A;CSNK1G3;FZD3;FZD7;CPE;DIXDC1;WNT11
prerank,nitrogen compound transport (GO:0071705),0.26952134328461314,1.099083310976117,0.255859375,0.7098585890057334,1.0,14/141,6.25%,SLC7A11;SLC6A12;SLC43A1;TXNIP;SLC7A2;SLC6A13;SLC22A4;SLC35F3;LRP1B;ABCC2;SLC22A3;SLC38A1;SLC36A2;SLC7A9
prerank,fatty acid oxidation (GO:0019395),-0.30871476646664225,-1.098986822114607,0.2971887550200803,0.6308091824727801,1.0,15/57,18.03%,ADIPOR2;PPARD;ACAD11;PPARGC1A;ADIPOR1;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;ECI1;MECR;HSD17B10
prerank,protein neddylation (GO:0045116),-0.4336433067721367,-1.0974296769841025,0.3415929203539823,0.6340580624716008,1.0,4/13,14.34%,DCUN1D5;DCUN1D1;UBE2F;RBX1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.32066139116733583,-1.0973023033744544,0.2980392156862745,0.6338554526355915,1.0,23/47,31.23%,THBS1;PLCG2;TGFBR2;TGFB1;RNF41;RAB27A;RIPK1;ACE2;TLR4;SYK;CDKN1A;CBR1;GADD45A;PRKCD;DCXR;GRIN1;SOD1;CD36;TLR6;XDH;ROMO1;DHRS4;TYROBP
prerank,mesoderm formation (GO:0001707),-0.40375715933974843,-1.0971724712854027,0.34709193245778613,0.6336306296422235,1.0,4/17,19.70%,BMPR2;ITGB4;SMAD2;ITGB3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4678092549874635,-1.0971431189530283,0.3594306049822064,0.6331494165156939,1.0,3/10,13.09%,CALM1;CALM3;FMR1
prerank,carnitine shuttle (GO:0006853),0.4576420181966297,1.097098990797493,0.33649289099526064,0.7139845389561107,1.0,4/11,16.74%,PRKAG2;CPT2;ACACA;PRKAB2
prerank,glucose transmembrane transport (GO:1904659),-0.39836294602871614,-1.0965692785172847,0.34501845018450183,0.6340330805887204,1.0,9/18,28.76%,SLC2A1;PPARD;RAB4B;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,negative regulation of cellular protein localization (GO:1903828),0.3467659514826432,1.0963002670198596,0.3325892857142857,0.7149580851431652,1.0,9/34,13.81%,ROCK2;LEPROT;SNX33;UBXN2B;TAX1BP3;LZTFL1;ACTN2;LEPROTL1;MAPT
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.32698157829293706,1.0960094913484004,0.32382892057026474,0.7146565232201658,1.0,8/44,9.74%,CYP7B1;PRKAG2;ALOX12;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1
prerank,mitochondrial translation (GO:0032543),-0.27374263619652045,-1.095878188642113,0.2581967213114754,0.6352420124743511,1.0,42/104,30.44%,QRSL1;MRPL52;PTCD3;MRPL51;MRPL38;LARS2;MRPL28;MRPL43;TSFM;GATC;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;GATB;NDUFA7;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2;IARS2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.32123750723159267,-1.0957582285978051,0.301556420233463,0.6349933119102452,1.0,5/47,1.44%,STXBP6;EXOC4;SPTBN1;EXOC6;EXOC6B
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.36437499145224583,-1.0955292803194083,0.338768115942029,0.6350527001215786,1.0,8/24,22.57%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A
prerank,regulation of ERAD pathway (GO:1904292),-0.45881502067809476,-1.0954886817118474,0.3493761140819964,0.6346211204698278,1.0,4/11,11.64%,TMEM259;AQP11;RNF185;UBXN1
prerank,negative regulation of wound healing (GO:0061045),-0.35992386252973235,-1.0951919358944384,0.330188679245283,0.6348533078312167,1.0,8/28,12.82%,SLC12A2;CD34;THBD;CD109;CRK;EDN1;APOE;FGF2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2878336972754801,1.0944834972248743,0.2815734989648033,0.7176092455715344,1.0,12/86,9.35%,BMP6;BMP2;SULF1;BMP5;ZEB2;UBE2O;MEN1;CITED2;TGFBR1;RBPJ;HES5;BMPR1A
prerank,acylglycerol biosynthetic process (GO:0046463),0.3836277374842709,1.0943756857411504,0.3572984749455338,0.7168480535000441,1.0,8/23,16.49%,AGMO;PLA2G4A;MOGAT3;LPIN3;ANG;MOGAT2;DGAT2;LPIN1
prerank,mitotic DNA replication (GO:1902969),0.4675030178156116,1.0942975777530064,0.3488372093023256,0.7160104462359487,1.0,2/10,10.38%,MCM3;MCM2
prerank,response to estrogen (GO:0043627),-0.348083969608057,-1.0941526642798227,0.33459357277882795,0.636866939401509,1.0,11/31,12.06%,CAV1;ESR1;TRIM25;RBBP5;BCAS3;RARA;PELP1;KMT2D;NCOA4;WBP2;SERPINB9
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34515018340408193,-1.094128449084165,0.33214285714285713,0.636392088630492,1.0,13/31,22.97%,DAB2IP;HSPA8;RHBDD1;DNAJB12;BAX;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1
prerank,ion transport (GO:0006811),0.27838498891473346,1.0939699371043594,0.27800829875518673,0.7158113795471933,1.0,24/111,13.15%,SLC1A3;SLC24A3;SLC8A1;SLC24A5;SLC17A1;CNGB3;VDAC2;TRPM3;CHRNB4;GLRB;SLC20A2;SLC26A1;SLC36A2;SLC9A7;TRPA1;SLC25A10;SLC24A4;SLC24A2;CHRNA4;CHRNA7;CTNS;SLC12A3;CHRNB1;SLC1A2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2905099218975914,-1.0939655305528413,0.28053435114503816,0.6362827548502897,1.0,27/73,29.98%,CAV1;TFRC;NGF;CD44;HSP90AB1;FNIP2;TGFB1;APP;VEGFA;AKT1;CAMK1;MTCP1;EGFR;BCAR3;HSP90AA1;RAPGEF3;HCLS1;PRKD2;PDCD10;EIF4G1;RPTOR;PARK7;TXN;TNKS1BP1;SH2D3C;TERF2IP;IRGM
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34337344243830564,1.0937146619512665,0.31263383297644537,0.7154173949158408,1.0,18/40,23.90%,GEN1;SETMAR;BLM;MCM9;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;POLD1;RTEL1;DONSON;PCNA;ZRANB3;FBH1;RFWD3;TIMELESS
prerank,morphogenesis of an epithelium (GO:0002009),-0.3718815231025624,-1.0935740594259242,0.3522504892367906,0.6367138899317671,1.0,5/25,9.38%,ACTB;ACTG1;LAMA5;LAMA3;VCL
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.28365248847283203,-1.093445239906673,0.26900584795321636,0.6364976688037098,1.0,29/82,26.11%,DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;CEP70;DCTN3;CEP290;CNTRL;DCTN1;PCM1;TUBB4B;HAUS1;NDE1;CETN2;CEP72;YWHAG;HSP90AA1;CEP41;TPX2;TUBA4A;CENPF;HAUS4;YWHAE;CEP63;NEDD1;NEK10
prerank,neural crest cell migration (GO:0001755),0.34475599028307435,1.0931310803448027,0.32978723404255317,0.7158614154518111,1.0,6/36,4.77%,NRP1;SEMA5A;GDNF;SEMA3A;RADIL;SEMA3D
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.32131467841729505,1.0928087824132555,0.2937365010799136,0.715660972742548,1.0,3/51,0.54%,GREM2;FBN1;BMP2
prerank,fatty acid beta-oxidation (GO:0006635),-0.31155528356131684,-1.0926293718750817,0.30228136882129275,0.6380163242148005,1.0,15/51,18.03%,PPARD;ACAD11;ACAA2;ACOX3;ECHS1;DECR1;ACADL;ACADVL;CROT;ETFB;ETFDH;ECI1;ACOT8;MECR;HSD17B10
prerank,regulation of cytoplasmic translation (GO:2000765),-0.422241877680411,-1.0926243066076957,0.35855855855855856,0.6374872635544058,1.0,5/14,13.09%,CNBP;PKM;YBX3;DHX9;FMR1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.33668758885960665,1.0925270464394183,0.3188720173535792,0.7152553246786015,1.0,7/40,7.96%,TCF7L2;BMP2;SMAD3;OLFM1;AXIN2;LOXL2;TGFBR1
prerank,steroid metabolic process (GO:0008202),0.29623462211078583,1.0923015554319677,0.3216494845360825,0.7148236425033072,1.0,7/72,5.87%,CYP7B1;VDR;CYP27B1;CYP27A1;BAAT;CYP2A6;MSMO1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3859419737076134,1.0922754421562904,0.3530751708428246,0.7138135084234559,1.0,4/23,8.22%,ATP1A2;ANK2;CACNA2D1;CACNB1
prerank,regulation of cytokine production (GO:0001817),-0.26856916991396435,-1.0922476518627686,0.2757936507936508,0.6378442538634738,1.0,25/126,14.93%,FOXP1;AFAP1L2;RPS6KA5;IL15;SRGN;IFIH1;ANXA1;HDAC9;IL33;N4BP1;LURAP1;CASP8;TNFRSF1B;RGCC;GAPDH;BCL6;FLOT1;ACE2;S100A13;TRIM56;PLD3;AGPAT1;BTN3A3;BCL6B;NLRP4
prerank,myeloid cell development (GO:0061515),-0.39857543122836053,-1.0922454928432102,0.3488372093023256,0.6373123634879261,1.0,3/18,4.62%,FOXP1;APP;ANXA2
prerank,blood vessel endothelial cell migration (GO:0043534),0.3889734329352816,1.0922078026804987,0.35714285714285715,0.7129396551348769,1.0,2/22,0.36%,ROBO1;NRP1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3084781058829006,-1.0920167058761787,0.2796934865900383,0.6373401848586117,1.0,20/55,23.10%,FHL1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;AVEN;FBXL7;RBX1;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;CUL1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3502529233179369,-1.091925633734755,0.31985294117647056,0.6370144079491574,1.0,11/30,19.50%,NOS3;TNFSF10;CASP8;RIPK1;FAIM;GPX1;FAS;BCL2L1;TNFAIP3;ARHGEF2;FAIM2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4350851136724053,-1.0918898509280233,0.3466424682395644,0.6365694995539192,1.0,2/13,1.71%,DDX5;RPL26
prerank,membrane lipid metabolic process (GO:0006643),-0.37971542344977277,-1.0916238689983369,0.32514177693761814,0.636715528603191,1.0,6/22,13.77%,ST3GAL6;CYP1B1;SPTLC1;B4GALT4;SPHK2;CERKL
prerank,regulation of platelet aggregation (GO:0090330),0.41483504952496275,1.0909503676816101,0.35,0.7151100652463321,1.0,4/17,4.13%,SERPINE2;ALOX12;PRKCA;LYN
prerank,regulation of mRNA catabolic process (GO:0061013),-0.26696583384371747,-1.0909039194537042,0.26990291262135924,0.6379713162514558,1.0,42/121,25.93%,VIM;UBB;HSPA8;PRR5L;UBC;RPS27A;CNOT7;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;PCBP4;PSMC4;PSMC5;YTHDF2;PSMD14;YWHAZ;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;HSPA1A;EXOSC8;PUM2;SERBP1;PSMA1;YTHDF1;PSMB1;PSMC3;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB;PSMB8;PABPC1;DIS3
prerank,protein complex oligomerization (GO:0051259),-0.27867192598990814,-1.0908945723451957,0.282,0.6374554835209466,1.0,29/85,26.10%,LRRC8C;LRRC8D;EHD4;MAT2A;AQP11;ATL3;FUS;ATL2;KCNC3;PRMT8;JMJD6;HOMER1;OPA1;NINJ1;CHMP2A;POLQ;EHD1;TRMT61B;ECT2;EHD3;PKD2;UPB1;LRRC8A;CLDN1;BCL10;ALAD;MCU;RNF112;ZNHIT6
prerank,lipid droplet organization (GO:0034389),-0.3766181666864096,-1.0908722092649925,0.32228360957642727,0.6369761096878753,1.0,5/22,12.75%,PPIA;RAB18;CDS2;CDS1;FAF2
prerank,positive regulation of TOR signaling (GO:0032008),-0.32386697709791973,-1.0908211756695156,0.32514177693761814,0.6365773142023362,1.0,18/40,32.32%,RICTOR;GPR137B;PIP4P1;LAMTOR2;PIK3CA;RRAGD;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SIK3;SEC13;LAMTOR5;HDAC3;LAMTOR1;LAMTOR3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.27690382564352434,1.090721727542437,0.28793774319066145,0.7146356023617576,1.0,13/117,8.24%,IGF1;ALDH1A2;PPARA;ALDH4A1;ALOX12;ABAT;PCCA;ACADSB;BAAT;CPT1C;MSMO1;ACOT11;PDZD11
prerank,actin filament-based transport (GO:0099515),-0.38680703209275813,-1.0905732146972484,0.3606870229007634,0.6366420576306696,1.0,3/21,2.18%,MYO1D;FNBP1L;ACTN4
prerank,icosanoid secretion (GO:0032309),-0.44122025084033023,-1.0904496663311638,0.35664335664335667,0.6364217197466339,1.0,2/12,3.46%,ABCC4;ANXA1
prerank,inorganic anion transmembrane transport (GO:0098661),0.3111197933139554,1.090418403121852,0.3004032258064516,0.7144353335277455,1.0,20/63,15.96%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;SLC20A2;GABRB3;ANO3;GABRR2;SLC25A10;GABRA5;CLCN1;SLC6A1;SLC12A3;GLRA3;ANO5;GABRB1;GABRG1;SLC25A30;GABRG3
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3527248270818648,-1.0899217280207634,0.32592592592592595,0.6367063211637303,1.0,16/29,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3527248270818648,-1.0899217280207634,0.32592592592592595,0.6367063211637303,1.0,16/29,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4052204959770279,-1.0896299978621518,0.3302919708029197,0.6369114329141979,1.0,4/17,6.78%,MEF2C;PRKG1;CDKN1B;TGFB3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.47251415439914624,-1.0895744217111931,0.39641434262948205,0.6365213862170427,1.0,6/10,19.37%,TGFBR2;LRP5;TBX1;PDGFA;STAT1;SOX9
prerank,negative regulation of anoikis (GO:2000811),-0.42834505828305547,-1.089411413784516,0.3727598566308244,0.6364043075950194,1.0,3/14,2.88%,CAV1;NOTCH1;PTK2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3592437446475437,-1.0893017254823734,0.33088235294117646,0.6361442196619623,1.0,12/26,31.48%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;PKD2;ERO1A;SLC8B1;HTR2B;LETM1;HTR2C
prerank,positive regulation of vasculogenesis (GO:2001214),-0.46166274126716805,-1.0891832100904368,0.35664335664335667,0.6359169982453539,1.0,3/10,2.36%,RAP1A;CD34;KDR
prerank,Golgi to lysosome transport (GO:0090160),-0.4551132751902735,-1.0887017174001448,0.37657657657657656,0.6365250775155031,1.0,5/11,19.66%,LAMP1;CCDC91;AP4M1;LAPTM5;EHD3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26002879117027217,1.0886049578613475,0.26204238921001927,0.7180271741320138,1.0,22/170,9.44%,IGF1;NELL1;NOVA1;SLC8A1;C1D;GDNF;TRIM38;AFF2;PRDM5;ROCK2;AFF1;ZNF462;ZNF513;PRDM9;IGF2BP2;SOX2;TRIM27;STX1B;PCBP3;FUBP1;NPAT;CTCF
prerank,stabilization of membrane potential (GO:0030322),0.4216712759293976,1.0885831943781956,0.3537117903930131,0.7170383767338007,1.0,1/16,0.14%,KCNK2
prerank,genitalia development (GO:0048806),0.4576225418017964,1.088488258636346,0.37554585152838427,0.7162739135602528,1.0,2/12,2.66%,TBX3;CHD7
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.2271756989428005,-1.0884580120705951,0.1943231441048035,0.6365750406534263,1.0,111/476,18.22%,MECOM;LEF1;MEF2C;MAP3K5;AFAP1L2;RREB1;CDH1;MLLT3;ESR1;NOTCH1;FLI1;LRP5;PPARD;KLF2;FOXO1;KLF4;ELF1;TBX1;FZD4;FOXO3;ETS1;SOX17;SIX1;TGFB1;CNBP;REST;PRDM16;NFYA;PPARGC1A;ING5;FOXK1;CD38;ZBTB16;ACTA2;IKBKB;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;KDM3A;TGFB3;HCFC1;TRIM16;MED24;HDAC4;AKT1;SPIN1;FZD7;ENY2;TAL1;SPP1;MAP3K2;TRIM28;NFATC1;HHEX;SOX18;FOXF2;ARID1A;JMJD6;CEP290;ZIC3;WNT11;MYBL1;CD74;FOXC2;INHBA;SP3;ILF2;CRLF3;PSMC5;WBP2;TEAD2;ACVR1;TRIM56;E2F1;ZNF423;APOE;PPP3CB;SOX4;FGF2;HES1;RNF111;EPC1;SMARCA4;RNF20;NR5A2;HEY1;EGFR;SMAD4;ZFHX3;RAI1;SMARCA2;NR1H2;STAT1;YWHAH;TCF3;KLF6;ETS2;ZBTB48;RELA;MED14;USP22;BRCA2;FOXL2;SP1;RET;CHUK;GLI1;SMAD2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.34981885529065493,1.0883218644146166,0.3232104121475054,0.7156411779283068,1.0,2/32,0.26%,AUTS2;PIK3R1
prerank,regulation of cellular respiration (GO:0043457),-0.40983046826971625,-1.088194507849798,0.3409090909090909,0.6366839149859922,1.0,5/17,10.41%,CBFA2T3;PRDM16;IDE;IFNAR1;VCP
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4487646265218732,-1.0878122893467894,0.36531365313653136,0.6365686418014501,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,cellular response to interleukin-2 (GO:0071352),-0.4487646265218732,-1.0878122893467894,0.36531365313653136,0.6365686418014501,1.0,5/11,17.47%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.4528707316637498,-1.087730988579402,0.3609022556390977,0.6362586741414673,1.0,4/11,14.12%,ITPKB;IPMK;FGF2;IP6K1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.44220975291427084,-1.087413184966657,0.3732638888888889,0.6364528025837339,1.0,4/12,22.83%,ACLY;ACO1;IDH3A;ACO2
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.33022240460611163,-1.087303080687143,0.3272058823529412,0.6362334645885267,1.0,17/36,31.42%,MAP3K20;RAD1;E2F1;RAD9B;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;DNA2;ATRIP;PRPF19;CDC5L;CDC6
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.32754864062240957,-1.0872032681647636,0.3370577281191806,0.6359321185429139,1.0,6/39,3.29%,UTRN;DMD;NEDD4L;FXYD5;WNK1;CAMK2D
prerank,carnitine metabolic process (GO:0009437),0.4431411553997904,1.086919033292479,0.35079726651480636,0.7182319772139906,1.0,3/12,6.82%,BBOX1;CPT1C;CPT2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.29092428451136676,-1.0868965759372584,0.28542094455852157,0.6361430636003133,1.0,14/75,12.33%,HEG1;PTPRJ;LRP5;RASIP1;DAB2IP;CDKN1B;PRKAR2B;AKT1;HHEX;RB1;UCHL1;NF1;STK38;APOE
prerank,regulation of lamellipodium assembly (GO:0010591),0.3474456476626244,1.086688102595338,0.34177215189873417,0.717810182749629,1.0,2/34,0.26%,AUTS2;PIK3R1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.29976192324553946,-1.0866373588391656,0.3148148148148148,0.6362506298780418,1.0,21/61,25.43%,CDK6;CDKN1B;CUL4A;PLK2;MAP3K11;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;RCC1;EIF4EBP1;PLK3;EIF4E;SPDYA
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.43856433681183793,-1.0862762368985563,0.3619047619047619,0.6365676863696439,1.0,7/12,37.34%,MAD1L1;BOD1;NDC80;RMDN1;SEH1L;NUF2;KIF2C
prerank,COPII-coated vesicle budding (GO:0090114),0.297925113309264,1.086263938850533,0.3141683778234086,0.7178299255217176,1.0,17/68,17.90%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SCAP;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20;GOSR2;MIA3
prerank,regulation of autophagosome maturation (GO:1901096),0.4330576574304223,1.086112182185206,0.38924731182795697,0.7171415203930506,1.0,4/13,16.40%,PHF23;UBQLN4;CLEC16A;CLN3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3137794072753948,-1.0860068770274964,0.3146067415730337,0.6366832178316851,1.0,12/50,19.30%,ACTB;CCND3;HSP90AB1;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,cellular response to sterol (GO:0036315),0.43209057484047764,1.085650476944408,0.3506787330316742,0.7172798169440316,1.0,3/13,9.54%,RORA;INSIG2;GRAMD1B
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25557330437758363,-1.0849142730614725,0.258130081300813,0.6387937195848074,1.0,48/163,23.10%,MEF2C;PTPRJ;PLCG2;WNK1;PDE4D;BMX;INPP5D;CD38;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;SYK;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;SPG21;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;BTK;LAT2;PTPN22;CSK;PSMA4;PSMA2
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.28939707329417047,-1.0846714464473712,0.3207920792079208,0.6388817899494231,1.0,14/75,12.17%,SLC12A7;SLC9A2;SLC12A2;SLC39A10;KCNJ2;ABCC9;ATP1A1;SLC39A8;KCNJ10;ATP1B1;TRPV4;KCNJ8;KCNK9;KCNJ15
prerank,cellular response to calcium ion (GO:0071277),-0.29023439690810643,-1.084226780874165,0.33727810650887574,0.6394676844833989,1.0,9/67,6.89%,MEF2C;ITPKB;CLIC4;PLCG2;MEF2A;IQGAP1;CAMK2D;CARF;CPNE8
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.30140015807624204,-1.084144063419111,0.3198458574181118,0.6391553150268212,1.0,24/57,28.77%,KDR;HTT;TNFSF10;PPARGC1A;MIEF1;HIP1R;BAX;MIEF2;BBC3;BAK1;CHCHD10;ADCK1;BAD;BIK;FIS1;MCU;PLAUR;TREM2;PARK7;CAMKK2;HRK;MFF;MUL1;PMAIP1
prerank,positive regulation of protein transport (GO:0051222),-0.2903078546548588,-1.0841414467489547,0.3,0.638634824746379,1.0,19/67,13.54%,RACK1;UNC13B;CD2AP;TGFB1;TGFB2;ATP2C1;BCAS3;PPIA;PRR5L;CHP1;MYOM1;EZR;TGFB3;ABCG1;CEP290;EXOC1;PCM1;OAZ2;ARHGEF5
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3593696811069723,1.0841151335151014,0.34623655913978496,0.7201922247416335,1.0,3/27,2.19%,IGF1;DDR2;PDGFRA
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3551864852104601,-1.0838662914422406,0.3443223443223443,0.6388260287525485,1.0,4/30,4.40%,CHST11;CSGALNACT1;CSPG4;HEXA
prerank,positive regulation of organelle organization (GO:0010638),-0.33937608066458447,-1.0838551936950596,0.3415559772296015,0.6383301188539594,1.0,12/32,26.71%,SORBS3;ANXA1;ANXA2;PPARGC1A;ATL3;SURF4;SHCBP1L;SYNJ1;RAB3GAP2;DOC2B;TREM2;LIG4
prerank,regulation of gene silencing by RNA (GO:0060966),-0.3128005686523815,-1.0837183155373074,0.32015065913371,0.6376245605386434,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.3128005686523815,-1.0837183155373074,0.32015065913371,0.6376245605386434,1.0,25/50,34.81%,NUP93;NDC1;NUP54;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;SEC13;NUP107;NUP42;NUP98;POLR2F;POLR2L;POLR2I;RAE1;POLR2C;NUP88;NUP214
prerank,defense response to bacterium (GO:0042742),-0.27250953669417827,-1.0833662307416363,0.2891089108910891,0.6379722687581707,1.0,21/105,16.68%,LBP;NOD1;RPL30;RPL39;STAB1;LYST;RPS19;GBP7;SHC1;TLR3;FCER1G;PGLYRP1;TIRAP;MAVS;TLR4;SYK;RAB1A;CFP;NOD2;OAS2;ANKRD17
prerank,cellular response to estrogen stimulus (GO:0071391),0.421670539356856,1.0831284272411588,0.3656884875846501,0.7216692433304828,1.0,3/14,4.24%,AR;OCSTAMP;SFRP1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2457012040546441,-1.0829799958494033,0.2231578947368421,0.6383858063517855,1.0,47/214,15.56%,FN1;TEK;BMPER;SEMA6A;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;DAB2IP;FERMT2;TNFAIP8L3;CD44;TGFB1;APP;MFHAS1;PRKCZ;EZR;SHC1;PDE8A;NPNT;FLT4;CCL15;PDGFC;PDGFA;TIRAP;CD74;CIB1;DUSP3;YWHAZ;APOE;TLR4;FGF2;SYK;STYX;CSF1R;ARHGEF5;HRAS;PHB2;EGFR;ERBB2;SMAD4;EPHA2;NOD2;PTPN6
prerank,regulation of cellular localization (GO:0060341),0.32189736447721234,1.0829251806641904,0.30831643002028397,0.7211628196185934,1.0,14/46,17.74%,ADCY5;WWC1;STXBP4;LYN;PRKN;FOXA2;DVL3;EPHA5;BRSK1;PARD6G;CDK16;TRIM46;NUMA1;PARP1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.2500944989922947,-1.082226390914885,0.2632612966601179,0.6397414969104932,1.0,45/190,17.07%,CAV1;TMSB4X;THBS1;PTPRJ;ESR1;RACK1;SH3BP4;CCN3;PDE4D;CYRIB;DAB2IP;CD2AP;SLIT2;PDE2A;HDAC7;ADIPOR1;PEBP1;ARHGAP25;PIK3IP1;CASP8;RIPK1;ZMYND11;AKT1;NDUFA13;TWIST1;CARD19;PRDM15;TNFAIP8L1;MAPKBP1;WTIP;EPM2A;NF1;LIMD1;CIB1;DUSP3;BCL2L1;NDUFS3;EPHA2;PHLPP2;TNFAIP3;PIK3R2;STAT1;PHLDA3;DDIT4;RELA
prerank,positive regulation of viral genome replication (GO:0045070),-0.3502128016348899,-1.0820680224257169,0.3513011152416357,0.6396020579626128,1.0,8/29,15.00%,ADAR;PPIA;CNOT7;SRPK1;IFIT1;STAU1;NR5A2;TOP2A
prerank,metal ion export (GO:0070839),0.35200446041245337,1.0819177219711418,0.3946784922394678,0.7226173017337204,1.0,2/31,0.47%,KCNT2;ATP1A2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.23345068269874528,-1.081571647408631,0.21700223713646533,0.6403099147561976,1.0,76/351,16.42%,ZBTB7C;PTPN14;CDK6;ITGA1;B2M;IGFBP7;NOS3;PTPRJ;IGFBP6;NOTCH1;CBFA2T3;PTK2B;BMPR2;SH3BP4;KLF4;CCN3;FAP;ETS1;DAB2IP;NGF;IGFBP5;CDKN1B;TGFB1;REST;APP;TGFB2;RNF41;COL18A1;TES;PLPP1;CYP1B1;ING5;CTBP1;IGFBP3;SMAD6;CNOT7;AQP11;WNT9A;IFITM1;GATA6;GATA2;TGFB3;RGCC;ADGRG1;KANK2;SOX7;WARS1;TRIB1;CSNK2B;DIS3L2;CTNNBIP1;INHBA;E2F3;GAS8;NF1;FRK;CIB1;FTH1;TMEM115;E2F1;CDK10;SOX4;HES1;RPS6KA2;ABI1;HRAS;P3H2;JAK2;SMYD2;STRN;PTPN6;TNFAIP3;CDKN1A;SMARCA2;GREM1;RBBP4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.42470414575788107,1.0814580344536229,0.34989200863930886,0.7227671938525029,1.0,4/15,8.80%,DDR2;LRP1;DDR1;FGFR4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.35051413153101474,1.0812384290657082,0.34274193548387094,0.722284220101826,1.0,5/32,6.61%,ZBTB20;PPARA;PRKAG2;PDK4;ASXL3
prerank,regulation of cell adhesion (GO:0030155),-0.2630909743208261,-1.080897992913296,0.30168776371308015,0.6413493896823375,1.0,24/129,11.53%,PKP4;PODXL;FRMD5;PTPRJ;PTK2B;TGM2;STX3;PTK2;PLXNA4;ARHGDIA;ADAM10;ARHGDIB;MINK1;TGFBI;VEGFA;PPP2R1A;GPR4;ADGRG1;SIPA1;PPP1CB;PLXNA1;PLXND1;ABL2;YTHDF2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.31536088228197257,-1.0806727910788263,0.3176043557168784,0.6413943256892422,1.0,24/48,38.45%,SLC7A5;PDE4D;CYRIB;IL1R1;TLR3;HSPD1;TLR4;TXK;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;IL12RB1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3393526105471131,-1.0803679888258528,0.3412844036697248,0.6416513693300091,1.0,6/33,5.35%,PTPRG;THBS1;DAB2IP;SLIT2;PTPRM;ADIPOR1
prerank,histone H3 acetylation (GO:0043966),-0.32892747023251984,-1.0802839815009355,0.32447817836812143,0.6413277618938421,1.0,15/40,28.48%,LEF1;JADE2;ING5;TRIM16;NAA60;LDB1;BRCA2;TADA3;BRPF1;TAF9;POLE3;KAT6B;SPI1;TAF10;TAF5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4652116068324584,-1.0802743642526325,0.3853564547206166,0.640839299460217,1.0,7/10,40.10%,SVIP;UBE2G2;DERL2;ERLEC1;INSIG1;OS9;UBAC2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3703839119729525,-1.0801078434896434,0.3400735294117647,0.6407471076195759,1.0,13/24,31.99%,ZDHHC1;MAVS;AIM2;STAT1;HSP90AA1;CGAS;PTPN22;DTX3L;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,positive regulation of endocytosis (GO:0045807),-0.3111138628236035,-1.079863912932208,0.30495049504950494,0.6408248158147445,1.0,9/45,12.33%,ANO6;B2M;GPC3;NEDD4L;CD151;FLOT1;HIP1;SGIP1;APOE
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.32641717603115317,1.0798602821587038,0.3646055437100213,0.7247429583126374,1.0,6/43,7.40%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3571237540730515,-1.079512486585303,0.3391472868217054,0.6411971352941577,1.0,10/24,20.37%,RACK1;LPCAT3;AQP11;UBXN1;BCL2L1;OPA1;NR1H2;HSPA1A;XBP1;TMBIM6
prerank,positive regulation of developmental process (GO:0051094),0.26135391903477107,1.0793563152700874,0.2819548872180451,0.7249694873477499,1.0,25/164,10.29%,BMP2;AR;PTN;BMP5;PHLDB2;GJA1;NRXN1;GDNF;GRIP1;DCN;SHLD2;CEBPB;PRKN;RTN4;FOXA2;SMURF2;CAMK2B;NLGN1;KMT5C;CPEB3;DVL3;BMPR1A;SOX5;ALK;PAXIP1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4508745699480484,-1.0793230413750214,0.35701598579040855,0.6411419215017092,1.0,3/11,8.34%,TPK1;CTPS2;SLC19A3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.35853305904837346,1.0792776109913578,0.3325635103926097,0.7241574063289817,1.0,5/30,7.25%,ROBO1;LPAR1;GPR55;GPR174;LPAR4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4673269908775477,-1.0789494344082413,0.38571428571428573,0.6415531718803307,1.0,1/10,0.23%,ANO6
prerank,cellular response to ATP (GO:0071318),0.42307297362789736,1.0788883493686814,0.34841628959276016,0.7241199240863598,1.0,5/14,24.01%,P2RX4;HSP90B1;P2RY1;TAF1;RYR3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3655472095947595,-1.0787193454101565,0.36229205175600737,0.641574501238162,1.0,13/26,29.22%,KLF2;KLF4;HSP90AB1;EDN1;AKT1;INSR;TLR4;HSP90AA1;DDAH1;PKD2;TMEM106A;CD36;TLR6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.2537549674264784,-1.0784242442025223,0.2589641434262948,0.6417186684509761,1.0,55/148,28.92%,PPP1R13B;HIPK1;RPS15;RICTOR;PHF20;RPL11;RPL23;ING5;USP7;RAD1;DYRK2;AKT1;NOP2;PIP4P1;MAPKAP1;CSNK2B;RPS20;MTA2;MBD3;NUAK1;RAD9B;SMYD2;PRKAG1;HUS1;RPA3;RAD9A;CSNK2A1;CSNK2A2;RBBP4;RAD17;L3MBTL1;CHD4;CHEK1;CDK5RAP3;PIN1;TPX2;MAPK11;RPL5;BRPF1;TAF9;RHNO1;PLK3;RFC3;RFC2;EXO1;KMT5A;RPF2;DNA2;BARD1;ATRIP;TAF4;TAF10;TAF5;RPL37;MRE11
prerank,regulation of cartilage development (GO:0061035),0.3989718129830802,1.0784166406786402,0.36225596529284165,0.724312946824331,1.0,4/18,9.57%,BMP2;TRPS1;SCIN;SOX5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3804976575014849,1.0781960002998616,0.37336244541484714,0.7237937528325856,1.0,2/23,2.08%,CEMIP;PRKAG2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.31642915773326347,-1.0780671614316186,0.3176470588235294,0.6420943026377672,1.0,14/48,14.62%,DMD;PTK2B;PDE4D;CAMK2D;CALM1;FKBP1A;DIAPH1;JPH2;JPH4;AKAP6;GSTM2;CALM3;CASQ2;SRI
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3529959491616794,-1.0774284032704724,0.3795620437956204,0.6430928476017784,1.0,13/27,30.15%,DDX5;CD44;TWIST1;PTTG1IP;CD74;SMYD2;KDM1A;MSX1;SPRED3;SNAI2;KMT5A;PMAIP1;SPRED1
prerank,RNA interference (GO:0016246),0.3984888657115068,1.077095745342317,0.3493150684931507,0.72559369801695,1.0,9/17,25.23%,HENMT1;AGO4;DROSHA;AGO3;AGO1;AGO2;MRPL44;DICER1;CLP1
prerank,protein deacylation (GO:0035601),0.37777533521144635,1.0766001749160568,0.33548387096774196,0.7258777109117748,1.0,7/23,17.95%,NOTUM;HDAC10;SIRT2;ABHD10;SIRT6;HDAC1;ABHD17C
prerank,vasoconstriction (GO:0042310),-0.4417262529551445,-1.0765655745081428,0.3736059479553903,0.6446814624810537,1.0,4/11,9.34%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,action potential (GO:0001508),0.32530432415458155,1.076490144619397,0.32708333333333334,0.7251199199218545,1.0,10/44,11.72%,SCN7A;SCN3B;CHRNA1;SCN3A;CACNA1I;KCND2;SCN2A;CACNA1G;CHRNA4;GNA15
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36816235575224143,-1.076191077547532,0.34600760456273766,0.6451016894200097,1.0,11/24,29.31%,DAB2IP;HHEX;GRB10;EPN2;TMEM204;ITGB3;CADM4;PRKD2;PTPN1;PDCD6;ITGA5
prerank,mitochondrial translational elongation (GO:0070125),-0.277706177636363,-1.0761148013865849,0.3206751054852321,0.6447694892960892,1.0,36/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;TSFM;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;TUFM;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.31441827817570034,-1.0758837559734715,0.3238095238095238,0.6448046622990193,1.0,18/50,25.25%,PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8
prerank,nucleoside salvage (GO:0043174),-0.46350137722338075,-1.0754773100118205,0.37722419928825623,0.6452651172804842,1.0,9/10,51.45%,UPP2;TK2;UPP1;DCK;UCK2;TK1;UCKL1;UCK1;HPRT1
prerank,cytoplasmic translational initiation (GO:0002183),-0.3924857619344074,-1.0752993166617546,0.3553113553113553,0.6452190590606083,1.0,9/17,25.69%,EIF3D;EIF3I;EIF4A1;EIF2B3;EIF5;EIF4G1;EIF4A2;EIF4B;EIF4H
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4116682084258434,-1.0752930750406984,0.3671586715867159,0.6447199856972196,1.0,10/15,35.38%,SEL1L;VCP;FAF2;SEC61B;DERL2;TMEM129;DERL1;SYVN1;OS9;AUP1
prerank,ear morphogenesis (GO:0042471),0.3951432328630125,1.0752645787548742,0.3774403470715835,0.7272517097042625,1.0,3/20,2.66%,FGFR2;ZIC1;CHD7
prerank,pulmonary valve morphogenesis (GO:0003184),-0.39842628478916675,-1.0749901545612892,0.3448275862068966,0.6449951953531732,1.0,8/17,9.30%,NOS3;NOTCH1;SLIT2;TGFB2;STRA6;HEYL;SMAD6;NFATC1
prerank,copper ion transport (GO:0006825),0.4463972182577963,1.074838299710235,0.38461538461538464,0.7272812403789001,1.0,2/11,6.74%,STEAP3;SLC31A2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.43059787250450854,-1.0748113433322373,0.3769230769230769,0.6449274866983005,1.0,4/13,16.28%,LPCAT3;AQP11;MBTPS2;NR1H2
prerank,aortic valve morphogenesis (GO:0003180),-0.3480269185624903,-1.0744985210192652,0.361003861003861,0.645201175035007,1.0,10/30,9.65%,NOS3;TIE1;NOTCH1;SLIT2;TGFB1;HEYL;SMAD6;TWIST1;NFATC1;RB1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4058298883135093,-1.0743467209420905,0.3572744014732965,0.6450584413445439,1.0,4/15,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.42265259369871505,1.074187123526473,0.3744394618834081,0.7280151413968986,1.0,5/13,9.82%,TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,female gonad development (GO:0008585),0.3815071912824842,1.0741672694716995,0.3492063492063492,0.7270555989649854,1.0,5/19,11.50%,NR2F2;KIT;CEBPB;ANG;EIF2B5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.441118443873062,-1.0741034379480014,0.3726937269372694,0.6452036948923331,1.0,6/12,22.04%,RPL26;CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,regulation of phosphate metabolic process (GO:0019220),0.41329406608309616,1.0736252589485051,0.375,0.7274129429695009,1.0,3/16,7.11%,SRPX2;IL4;SIRT2
prerank,spinal cord development (GO:0021510),-0.4417345176637659,-1.073612605957375,0.39015151515151514,0.6458708337836762,1.0,7/12,21.50%,VIT;PKD1;SOX12;NF1;SOX4;ZPR1;PKD2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3679041379777364,1.0735327114920392,0.3504273504273504,0.7266417328499561,1.0,9/25,18.84%,GRID2;MPP2;NLGN3;MAPK8IP2;CHRNA4;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,MAPK cascade (GO:0000165),-0.23566169836039086,-1.0730733722710253,0.2691511387163561,0.6466864872176987,1.0,86/295,21.45%,KITLG;TEK;MEF2C;SHANK3;MAP3K5;RASAL2;RASGRP3;SPTBN1;FGF1;RASGRF2;KDR;MEF2A;MAPK3;PTK2;RGL1;SHOC2;DAB2IP;MAP3K20;CALM1;TGFB1;MAP3K3;UBB;MINK1;UBC;RPS27A;PEBP1;TAOK3;IKBKB;SHC1;PSMA6;NEFL;MAP3K8;KRAS;PSMB5;SPTAN1;PDGFA;IL17RD;PPP1CB;PSMC4;ZDHHC9;TAOK2;NF1;PSMC5;PPP5C;PSMD14;BCL2L1;ICMT;FGF2;HRAS;LYPLA1;LAMTOR2;RBX1;JAK2;EGFR;PSMD8;ERBB2;PIK3CA;RGL2;PSMD11;MET;PIK3R2;PSMB4;PSMD12;PSMC1;RCE1;JAK3;CUL1;RGL3;RET;CHUK;MAPK12;FGF9;PTGER4;RASA1;ARL2;IL3RA;SOX9;RASGRP4;LGALS9;MAPK11;CSF2RB;PSMA1;FGF10;RAPGEF2;PSMB1;PSMC3
prerank,melanosome localization (GO:0032400),-0.375829139301348,-1.072926011004806,0.3664259927797834,0.6465393795890652,1.0,7/21,16.80%,RAB11A;RAB27A;MREG;MLPH;RAB11B;ARL6;VPS33A
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.43448732398282913,1.0722447193713949,0.3654708520179372,0.728975557938463,1.0,4/12,18.38%,BLM;NUGGC;NBN;WRNIP1
prerank,mitotic spindle organization (GO:0007052),-0.2546345547945533,-1.0718814111449848,0.27920792079207923,0.6485752433129938,1.0,60/153,31.13%,RAB11A;DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;CEP192;PLK2;KIF23;VCP;RCC2;NDE1;NDEL1;RANBP2;KNL1;DYNC1LI1;CENPU;NUP37;LSM14A;MAD1L1;KIF18A;MISP;RANGAP1;DYNLL2;TPX2;RCC1;CENPI;NUP160;NSL1;NDC80;CENPN;CENPF;RMDN1;SPICE1;CLIP1;SPDL1;CENPA;EFHC2;CDCA8;STMN1;TBCE;NUP43;SEH1L;CENPO;SGO1;SEC13;NUP107;KIFC2;BIRC5;WDR62;NUP98;XPO1;TUBG2;KIF11;BUB3;PLK1;BCCIP;NUF2;AURKA;RHOA
prerank,protein kinase B signaling (GO:0043491),0.3770695544534108,1.0714663170193706,0.37142857142857144,0.7300176561707974,1.0,1/23,0.08%,IGF1
prerank,regulation of protein secretion (GO:0050708),-0.26194852421197584,-1.071309611735276,0.3065134099616858,0.6494277435439355,1.0,19/119,8.64%,ITPR2;SLC2A1;RAP1A;SLC12A2;DPP4;UNC13B;KCNB1;CD2AP;ITPR3;TGFB1;TGFB2;PPIA;MYOM1;STX1A;UQCC2;EZR;TGFB3;DPH3;ABCG1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3471679459456845,-1.0712999842501632,0.34448818897637795,0.648932416053958,1.0,8/29,17.77%,MEF2C;TFRC;CD38;CD81;TIRAP;CD74;CLCF1;CD320
prerank,regulation of cell death (GO:0010941),-0.2744384602673839,-1.0712192894309525,0.33530571992110453,0.6486032119052882,1.0,30/94,22.04%,ACER2;CCN3;FERMT2;CDKN1B;CTSZ;UBB;CHP1;PDE8A;TNFRSF1B;DUS2;SRSF6;SPEF1;WNT11;IMPACT;SOX4;CCN5;FGF2;ACER3;DHCR24;TMEM109;BNIP3L;RAD18;HSPA1A;CHMP2A;CRYAB;NCK1;HSPA1B;ADNP2;SNCG;EIF4G1
prerank,regulation of cellular response to stress (GO:0080135),-0.26535278338738233,-1.071109524389309,0.31390977443609025,0.6483535020496163,1.0,44/115,27.54%,MAPK3;CAMK2D;HSP90AB1;HSPA8;ATF4;CHCHD2;NUP93;MBTPS2;NDC1;HSBP1;NUP54;BAG5;NUP188;NUAK1;HSPB8;NUP155;RANBP2;RPA3;NUP37;HSP90AA1;HSPA1A;CCAR2;CRYAB;AMFR;MCL1;FKBP4;HSPA1B;NUP160;EIF4G1;DNAJB1;BAG1;ATF3;RSL1D1;SMG1;RPTOR;NUP43;SEH1L;YWHAE;SEC13;NUP107;NUP42;CAMK2G;NPM1;NUP98
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33591796958363607,-1.0710492885431422,0.3534971644612476,0.647973580045113,1.0,10/35,18.62%,ITGA1;HSP90AB1;CALM1;FKBP1A;HTT;CSNK2B;CALM3;NUAK1;BOD1;PPP6R3
prerank,cellular response to glucose starvation (GO:0042149),-0.3158895276799084,-1.0709222222352601,0.32879377431906615,0.6477836732164182,1.0,18/41,33.29%,FOXO3;ATF4;HSPA5;IMPACT;NUAK1;NUAK2;PRKAG1;XBP1;HNRNPA1;ASNS;SESN2;BRSK2;SIK1;SESN1;PMAIP1;CPEB4;PIK3R4;ATG14
prerank,regulation of BMP signaling pathway (GO:0030510),-0.2826038691235785,-1.0708134647314977,0.3258003766478343,0.6475424498993226,1.0,21/73,21.17%,CRIM1;BMPER;NOTCH1;BMPR2;SMAD9;SMAD7;FOXD1;SMAD6;HTRA3;SKIL;ZNF423;FSTL1;ENG;SMURF1;SMAD4;GREM1;SMAD2;SKI;BMPR1B;BAMBI;CDH5
prerank,Golgi organization (GO:0007030),-0.26624627137530293,-1.0707528006465972,0.30115830115830117,0.6471839779348275,1.0,52/112,31.50%,SYNE1;ATP8B1;PI4K2A;ZW10;BCAS3;HTT;GORASP2;FAM174B;PLEKHM2;ATL3;TRIP11;STK25;ATL2;TRAPPC11;BAG5;FHDC1;SURF4;VRK1;VMP1;YWHAZ;RAB1A;COG3;GOLGA5;GOLGA8B;LMAN2;GCC2;VTI1B;TMED1;TMED5;ATP8B2;COG2;PDCD10;STX5;PLK3;LMAN2L;RAB43;CDC42;GOLPH3;GOLPH3L;PLK5;TMED3;GOLGB1;SEC16B;DNAJC28;STX16;ATP8B4;SPTBN5;DYM;VAMP4;TRAPPC12;CDK1;HACE1
prerank,mesonephros development (GO:0001823),-0.44879994249049426,-1.070480121211711,0.39626168224299063,0.6473567990277899,1.0,2/11,5.53%,FGF1;ZBTB16
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.30089343102545196,1.0693105508917329,0.33468559837728196,0.7345635697222002,1.0,9/59,7.85%,ROBO1;ROBO2;SDK2;TENM3;CNTN4;PTPRT;KIRREL3;NPTN;TRO
prerank,postreplication repair (GO:0006301),-0.31219871786473685,-1.0691192951549093,0.33988212180746563,0.6501899167353218,1.0,16/45,25.72%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RAD18;RPA3;POLK;UBE2B;DTL;RFC3;RFC2;NSMCE1
prerank,pentose-phosphate shunt (GO:0006098),-0.4468700540865823,-1.0687456098044716,0.3872113676731794,0.6506155583918678,1.0,5/11,26.41%,PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,regulation of sodium ion transport (GO:0002028),0.34026325924916934,1.0686862591330302,0.36554621848739494,0.735132630512442,1.0,15/34,24.30%,SCN3B;NKAIN2;P2RX4;GPD1L;NKAIN3;DRD2;WNK3;NEDD4;FGF12;PER1;ATP2B4;DLG1;SCN5A;RANGRF;CNKSR3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3845031307868806,1.068195491339258,0.3656387665198238,0.7353354476790618,1.0,8/19,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,catecholamine biosynthetic process (GO:0042423),-0.42805288499544086,-1.0679289422838578,0.3795066413662239,0.6521030779499748,1.0,3/11,12.38%,GCH1;TGFB2;DDC
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.32279432779280937,-1.067758292498071,0.3428030303030303,0.6520074018743859,1.0,15/39,24.24%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4;RFC3;RFC2;FAN1
prerank,copper ion homeostasis (GO:0055070),-0.3919174411949309,-1.0674620929776824,0.35793357933579334,0.6522072646812828,1.0,3/17,4.11%,ATOX1;MT2A;APP
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4420353281915617,-1.067373775505214,0.39365671641791045,0.6518992889844688,1.0,2/12,8.53%,IGF1R;INSR
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.44526111538817836,-1.067118105969516,0.37906137184115524,0.6519883261243443,1.0,4/11,7.87%,MAP3K5;ARL6IP5;CYP1B1;STK25
prerank,peptidyl-serine modification (GO:0018209),-0.2521162806591547,-1.0670264073868632,0.281437125748503,0.6517124520740754,1.0,39/166,16.57%,PRKCH;RPS6KA5;TGFBR2;HIPK1;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;CSNK1G2;PRKCZ;PKD1;IKBKB;PRKDC;CSNK1G3;PLK2;DYRK2;AKT1;VRK3;STK32B;LMTK2;CAMK1;ULK3;RPS6KB2;VRK1;STK38;HPF1;POGLUT1;PKN3;PRKCE;RPS6KA2;MAST4;UHMK1;PARP2;CAB39;STK38L;CSNK2A1;CSNK2A2;POGLUT3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.38264765781576204,1.066908235388126,0.39414414414414417,0.7376373713125052,1.0,5/20,9.75%,BCL2;IL4;CASP3;ERBB3;DCC
prerank,negative regulation of mRNA processing (GO:0050686),-0.4058012127856476,-1.0665762048844722,0.3799621928166352,0.6523060294947529,1.0,5/15,13.94%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,lung epithelium development (GO:0060428),0.44864379257524334,1.0663475214085993,0.3782051282051282,0.7380202852061525,1.0,1/10,0.46%,ERRFI1
prerank,negative regulation of protein modification process (GO:0031400),-0.2828649834128525,-1.0663049285614812,0.3353658536585366,0.652489624591585,1.0,19/79,12.51%,OCLN;DMD;NIBAN1;PPP1R16B;DAB2IP;SLIT2;TGFB1;MFHAS1;PPIA;PRR5L;CHP1;IGFBP3;PRKDC;WARS1;DBI;PPP1R8;IMPACT;CIB1;PNKP
prerank,negative regulation of cellular component movement (GO:0051271),0.4128665601722953,1.0662816311463563,0.4077079107505071,0.7371451366366335,1.0,4/15,9.13%,TGFBR3;FBLN1;SPOCK3;GATA3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.27487030227186027,-1.0662311717603672,0.3194444444444444,0.6521682929846158,1.0,20/94,12.65%,PPP1R13B;MAP3K5;DDX5;ARL6IP5;DAB2IP;FNIP2;CRIP1;CYP1B1;ATP2A3;ATF4;PRKDC;TNFRSF1B;PPM1F;CUL4A;BAX;BBC3;BCL2L1;E2F1;HINT1;BAK1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2715212095743619,-1.0660670748456194,0.31906614785992216,0.6520355484565982,1.0,30/104,21.87%,ST3GAL6;ST3GAL4;CHST11;CSGALNACT1;SLC26A2;CSPG4;TPK1;MAT2A;GGTA1;CDO1;SLC10A7;GSTA4;B4GALT4;GGT5;GSTM2;GSTA3;SLC35B3;SLC35D2;GSTM1;GSTO2;CTH;GCLM;MGST3;CNDP2;GCLC;GGT1;B3GNT3;GSTK1;GGCT;CHPF
prerank,cellular response to pH (GO:0071467),-0.3924610740383282,-1.0660546466928276,0.3719298245614035,0.6515620408901812,1.0,5/17,26.90%,CHP1;IMPACT;RAB11B;HYAL1;RAB11FIP5
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3038868160008886,-1.065272563838489,0.35902255639097747,0.6528777471678855,1.0,23/49,35.65%,ACER2;MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;GADD45A;E2F7;CLOCK;RHNO1;TRIAP1;SESN2;FBXO6;CEP63;ATRIP;PRPF19;CDC5L;ABL1;CLSPN;MAD2L2;BATF
prerank,positive regulation of autophagy (GO:0010508),-0.2785764798464831,-1.0650007162809023,0.354,0.6530601784419384,1.0,24/81,22.81%,SH3BP4;KDR;FOXO1;MID2;FOXO3;HTT;SVIP;PLK2;SCOC;TRIM14;PIK3C2A;EPM2A;PHB2;TRIM68;BNIP3L;TRIM5;UFL1;BAD;TSC2;PLEKHF1;TMEM59;TFEB;PLK3;SESN2
prerank,mitotic metaphase plate congression (GO:0007080),-0.3004189660590246,-1.0649359842733068,0.35946462715105165,0.6527244773701033,1.0,22/51,32.17%,RAB11A;DCTN2;ZW10;CHMP2B;MAD1L1;KIF18A;CHMP2A;BOD1;NDC80;RMDN1;KIF22;SPDL1;CDCA8;CEP55;VPS4A;SEH1L;EML3;CHMP7;NUF2;PSRC1;CHMP4B;CHMP4A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.35620504546397996,1.0648351953767363,0.3485838779956427,0.7398638330620845,1.0,5/27,7.15%,SLC1A3;SLC6A9;SLC7A2;SLC38A1;SLC25A13
prerank,respiratory system development (GO:0060541),0.3476392896350117,1.0648007177181535,0.3609341825902335,0.7389340042366375,1.0,8/32,13.61%,FGFR2;GLI2;CHD7;SPEF2;LOXL3;NPHP3;SMCHD1;NKX2-1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3903422738725934,-1.0642919190755125,0.36617100371747213,0.6538060248555171,1.0,5/17,10.56%,NOTCH3;NOTCH1;HEYL;NOTCH4;PLXND1
prerank,lysine catabolic process (GO:0006554),-0.43513495278327363,-1.0641771748680746,0.3855855855855856,0.6530913826846366,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,lysine metabolic process (GO:0006553),-0.43513495278327363,-1.0641771748680746,0.3855855855855856,0.6530913826846366,1.0,5/12,19.23%,DLD;HYKK;OGDH;DLST;AASS
prerank,thyroid hormone generation (GO:0006590),0.4593119219572862,1.064144456979721,0.3940677966101695,0.7395587195025866,1.0,2/10,5.83%,DIO2;CPQ
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.204602512672046,-1.064135064173312,0.14182692307692307,0.6526801570430817,1.0,337/1646,18.51%,BNC2;KLF12;MECOM;LEF1;FOXP1;ELK3;ERG;ZBTB7C;MEF2C;DACH1;MAP3K5;APBB2;AFAP1L2;WWP1;RREB1;TBX15;NR3C2;CDH1;ATP8B1;MLLT3;RPS6KA5;ESR1;KLF3;NOTCH1;DDX5;CBFA2T3;ID1;RPL6;ZHX3;FLI1;DACH2;CDK17;LRP5;TEAD4;HMBOX1;TRAK1;ID3;JUND;PPARD;JMJD1C;NCOR1;MEF2A;KLF2;FOXO1;KLF4;NLK;ELF1;ZBTB46;TBX1;SMAD9;FZD4;ZSCAN29;RPS6KA3;CAMK2D;FOXO3;ETS1;SOX17;DAB2IP;BRD3;SMAD7;ZBTB7A;PHF20;IRF2BPL;VSX1;DDX17;SIX1;CDKN1B;KLF7;TGFB1;LHX6;CNBP;REST;KDM5C;PRDM16;TRRAP;TBX2;ARID3B;NFYA;ZNF431;REL;HDAC9;HSPA8;WWP2;NR4A2;CARF;ASCC2;PPARGC1B;LIMS1;PFDN5;KCTD1;FOXD1;RLIM;CTDSP1;TFCP2L1;BRWD3;PRDM2;PPARGC1A;ING5;CTBP1;PHC2;BHLHE40;SOX13;FOXK1;CD38;SLC39A8;HEYL;ZBTB16;LRRFIP1;DPF2;BRD9;CRK;SMAD6;VEGFA;CNOT7;ACTA2;MPHOSPH8;DPF3;AEBP2;USF2;PPP2R1A;IKBKB;RBFOX2;RARA;NOTCH4;BRD4;GATA6;ATF4;SHC1;FOXN3;KDM3A;ZNF326;CBFB;GATA2;TGFB3;KLF8;SAFB;NR3C1;MXD4;HCFC1;ZNF276;TOX3;CBX5;ANXA4;FOXQ1;CC2D1B;PPM1F;CIC;UIMC1;IRF2BP2;HDGF;TRIM16;MED24;NR2C2;YY1;HDAC4;ATXN1L;ZMYND11;AKT1;PLAGL1;SPIN1;INSR;FZD7;NDUFA13;ENY2;BCL6;FUS;TAL1;NOP2;SOX7;MKX;DHX9;SPP1;TWIST1;MED27;MAP3K2;TRIM28;NFATC1;BAZ1A;HHEX;PRDM15;RELB;SOX18;FOXF2;RB1;SP110;ESRRA;MXD1;ARID1A;JMJD6;ZC3H8;HSPD1;CEP290;JUNB;ZIC3;FOXP2;ZFP14;PRRX2;TCIM;WNT11;MYBL1;GABPA;WTIP;CD74;MED6;FOXC2;ZBTB18;INHBA;TADA2B;E2F3;CCDC85B;EBF2;SP3;ILF2;CRLF3;SOX12;KMT2D;SFPQ;PSMC5;LIMD1;HTATIP2;PHC1;WBP2;TEAD2;HIVEP1;ZNF83;OLIG1;IFRD1;ACVR1;TRIM56;CIPC;TOX2;MED29;ZFHX2;E2F1;ZNF423;APOE;PPP3CB;COMMD7;SOX4;HINT1;ZNF471;ABCA2;TSFM;POU2F1;FGF2;HES1;RNF111;SATB2;ZMIZ2;PLAGL2;GRHL1;ZNF367;TOX4;ENG;CIART;MTERF3;LCOR;ZNF569;PHF12;EPC1;HCFC2;MLX;PHB2;SMARCA4;STAT5A;MRGBP;EID2;RFX2;RNF20;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;ERBB2;PURG;IRF9;HNRNPK;LDB1;SMAD4;ETV4;SNF8;ZFHX3;SOX6;RFX5;CDKN1A;RAI1;DRAP1;ZFPM2;CELSR2;SMARCA2;POU2F2;LIN54;NR1H2;STAT1;SAP30L;ZNF76;YWHAH;TCF3;GMEB2;CCNK;KLF6;ZNF319;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;RELA;ZNF22;CCAR2;KDM1A;MED14;USP22;BRCA2;FOXL2;NR6A1;SP1;MED20;SCML2;DRGX;RET;ARID4B;CHUK;FOXP4;GLI1;E2F4;SMAD2;MED8;CRYAB;ZNF568;L3MBTL1;CHD4;PHF5A;IRF8
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.39168632508109436,1.0634226542028749,0.34065934065934067,0.7404259280111806,1.0,5/19,15.92%,AR;NAB2;ICE1;TENM1;ICE2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3540625152271961,-1.06257009673328,0.36311787072243346,0.656036049356061,1.0,4/25,6.52%,TGFB2;FKBP1A;CHP1;SH3RF2
prerank,zinc ion transmembrane transport (GO:0071577),-0.3692788708142155,-1.0625054539830148,0.3508771929824561,0.6556844935420651,1.0,6/22,14.06%,SLC39A10;SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,receptor signaling pathway via STAT (GO:0097696),0.36595288219168687,1.0624333059837159,0.35344827586206895,0.7420871205539039,1.0,4/25,7.59%,IL31RA;STAT5B;GHR;THPO
prerank,cell projection organization (GO:0030030),-0.3428613481729219,-1.062367868799723,0.3775700934579439,0.6555306169929638,1.0,10/30,25.35%,PARVB;RHOJ;RAC1;PDGFA;NCKAP1;CAPG;PACSIN2;ATP1B2;CDC42;KIF17
prerank,positive regulation of metabolic process (GO:0009893),-0.26726230632832604,-1.0620778556249793,0.32490272373540857,0.6557531940833473,1.0,23/103,13.01%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;CMKLR1;PPARGC1A;ADIPOR1;VEGFA;UCP2;ACLY;KDM3A;INSR;PDGFC;DECR1;FABP5;GRB10;ACADL;EBF2;GADD45G;SYK;AGPAT1
prerank,cilium assembly (GO:0060271),-0.23297960305960796,-1.0619746808157922,0.2936344969199179,0.6554966559203312,1.0,70/296,19.74%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;DCTN2;EHD4;RAB8B;TUBA1A;IFT20;CEP164;RP1;ABLIM3;PKD1;PPP2R1A;PRKAR2B;CEP192;EHD2;CEP57;CEP162;TRIP11;CEP70;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;DCTN3;RAB8A;CEP290;CNTRL;DCTN1;EXOC1;GAS8;FHDC1;STK36;PCM1;TUBB4B;CC2D2A;ACTR3;POC1B;CDC14B;HAUS1;ARL6;NDE1;RFX2;RAB11FIP3;RAB1A;CETN2;CEP72;CCDC28B;KIF24;YWHAG;DNAH5;HSP90AA1;CEP41;TMEM67;E2F4;EHD1;RPGRIP1;SPAG16;TMEM231;EHD3;IFT27;DYNLL2
prerank,cellular sodium ion homeostasis (GO:0006883),0.40018492834294583,1.0616104219588598,0.38137472283813745,0.7432266245893744,1.0,2/15,1.17%,ATP1A2;SLC8A1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.21329388029379642,1.0615913590552575,0.21228070175438596,0.7422593770107112,1.0,119/1082,9.65%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;WNT4;IL31RA;ARNT2;LDB2;BMP2;SALL1;PID1;AR;CDK8;TBX3;GLIS3;EPAS1;HLF;FGFR2;NFIA;NR2F2;BMP5;TBL1XR1;GDNF;VDR;RARB;NCOA2;ZIC1;TEAD1;PPARA;HOXC4;GLI2;DCN;MITF;NFAT5;IL4I1;SMAD3;CREB5;TFEC;KDM1B;STAT5B;NKX6-1;HOXB3;PIM2;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;GLI3;TFCP2;ZEB2;PBX4;PHIP;SFRP1;SP7;TFDP1;PHOX2A;CEBPB;MAP3K12;IL4;CAMK4;PRKN;ZNF513;MLLT10;HNF4G;SERPINE1;MAML3;BCL2L12;TAF6L;ATF5;ZNF318;GABPB1;GABPB2;FOXA2;TRIP4;ASXL3;ZNF296;PCGF5;SIRT2;LHX4;MEN1;TP53INP2;SIX4;KMT2A;NFIX;RARG;SOX2;CITED2;TGFBR1;ZSCAN21;RBPJ;NSD1;IGF2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;CXXC1;ATOH8;BLM;CREB3;CREB3L4;GLIS1;GATA3;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;AHI1;HOXC10;HDAC8
prerank,negative regulation of cell activation (GO:0050866),-0.40171316743621294,-1.0612729026028684,0.3970037453183521,0.6567394997202384,1.0,4/14,12.33%,NOS3;THBD;PDGFA;APOE
prerank,positive regulation of cell cycle process (GO:0090068),0.2803903674900079,1.0612316152084726,0.3379174852652259,0.7421592505898694,1.0,17/91,15.13%,IGF1;SVIL;TGFA;PHIP;UBXN2B;PDGFRB;GEN1;SIRT2;IGF2;MAP10;CDC25B;AURKC;BTC;DRD2;SPAST;RANBP1;USP19
prerank,oligosaccharide metabolic process (GO:0009311),0.3199940430163278,1.0610705773933715,0.35435992578849723,0.741600749653435,1.0,15/46,14.75%,B3GALT1;ST6GALNAC5;GAL3ST3;AMY1A;AMY1B;AMY1C;ST8SIA1;FUT4;ST6GALNAC6;FUT9;ST8SIA2;B3GALT2;B3GALT5;GLA;ST8SIA5
prerank,cellular response to UV (GO:0034644),-0.28207921025581273,-1.0609597925154302,0.33858267716535434,0.6570332139183255,1.0,31/76,30.92%,RPL26;CRIP1;RHBDD1;ATF4;N4BP1;ERCC1;YY1;IMPACT;BAK1;FMR1;OPN3;CDKN1A;KDM1A;POLK;CHEK1;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;HYAL1;PRKCD;CARD16;PPID;SMPD1;XPC;NPM1;MMP3;MYC;HYAL2;AQP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42465504852546654,-1.0608193182696153,0.3733826247689464,0.6568364307045478,1.0,6/13,20.61%,PPARD;REST;SRF;RELA;SOX9;NFATC3
prerank,Fc receptor signaling pathway (GO:0038093),-0.26465481834628624,-1.0601913770110696,0.3238095238095238,0.6579189126078694,1.0,40/110,25.25%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PSMD14;PPP3CB;SYK;LCP2;PSMD8;GAB2;PIK3CA;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;NFATC3;PSMA1;PSMB1;PSMC3;BTK;LAT2;PSMA4;PSMA2;TRAF6;BCL10;PSMB8
prerank,regulation of cytoskeleton organization (GO:0051493),-0.26408585334122964,-1.0601870161797202,0.31411530815109345,0.6574205821859352,1.0,20/108,11.10%,CLIC4;SORBS3;F11R;MAPK3;IQGAP1;PTK2;ARHGAP17;CAPN2;RICTOR;RAC1;DIAPH1;CRK;HIP1R;EZR;PHLDB1;PDGFA;FAM107A;SPEF1;RHOB;TAOK2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40251708936312397,-1.0598476950285194,0.4109090909090909,0.6577278669468462,1.0,6/15,15.81%,TMSB4X;KDR;VEGFA;HSPB1;FGF2;MET
prerank,cellular response to hormone stimulus (GO:0032870),0.2909251750107906,1.059604102428882,0.341130604288499,0.7444462185040176,1.0,8/69,4.95%,ATP1A2;ROBO2;AR;OCSTAMP;NCOA2;STAT5B;SFRP1;GHR
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4572128115930502,1.0594355786687144,0.38461538461538464,0.7438345291961095,1.0,5/10,23.08%,HENMT1;DROSHA;AGO2;MRPL44;DICER1
prerank,nucleotide-excision repair (GO:0006289),-0.26668977672213046,-1.0593602830839592,0.33727810650887574,0.6584297360628641,1.0,48/101,34.22%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;CHD1L;COPS6;XAB2;HMGN1;PNKP;SLX4;COPS5;RNF111;RBX1;XRCC1;CETN2;HUS1;RPA3;BRCA2;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;RAD23A;COPS4;RFC2;COPS7B;FAN1;POLL;XPC;GPS1;LIG4;RAD23B;POLR2F;AQR;POLB;PRPF19;POLR2L;POLR2I;POLR2C;POLE;SLC30A9;POLA1
prerank,vitamin transport (GO:0051180),-0.34173331910942306,-1.0590314464154251,0.3946869070208729,0.6587481059385991,1.0,7/29,17.77%,ABCG2;SLC5A6;CUBN;SLC52A3;SLC2A8;SLC52A2;CD320
prerank,icosanoid biosynthetic process (GO:0046456),0.45913329875818276,1.058312030971666,0.4269406392694064,0.7456743431143955,1.0,2/10,2.58%,PLA2G5;PLA2G4A
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2078288335195886,1.0581718605729138,0.18430034129692832,0.7450169186706302,1.0,194/1668,9.68%,IGF1;AUTS2;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;FHL2;ZBTB20;LDB2;BMP2;MAF;SALL1;PID1;AR;CDK8;ATXN1;TBX3;GLIS3;EPAS1;HLF;MXI1;FGFR2;NFIA;NR2F2;BCOR;BMP5;ZEB1;TBL1XR1;HIVEP2;GDNF;VDR;RBAK;RARB;TRPS1;NCOA2;ZIC1;TEAD1;PRRX1;PPARA;KIT;HOXC4;ZHX2;GLI2;DCN;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;IL4I1;SMAD3;CREB5;TFEC;KDM1B;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TGFA;TBX21;ZNF462;CSRP3;KLF15;AKAP8L;MDM2;GLI3;WWC1;VRTN;TENM2;TFCP2;ZEB2;PBX4;CREB3L1;UXT;PHIP;FNIP1;SP7;TFDP1;KDM7A;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CAMTA1;ZMYM5;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;IL4;GTF2H2;RNF2;SOX21;JAZF1;PRKN;ZNF292;ZNF513;HES3;SUMO1;ZKSCAN7;MNAT1;MLLT10;HNF4G;LIN37;MED12L;SERPINE1;MAML3;AGO4;HOXC9;BCL2L12;TAF6L;ATF5;HDAC10;BBX;GABPB1;GABPB2;ZNF394;BAZ1B;FOXA2;ASXL3;ZHX1;ZNF296;LOXL2;DMRTA2;SMURF2;SP5;PCGF5;SIRT2;CUX1;LHX4;MEN1;MBD2;DMTF1;ZNF697;SIX4;KMT2A;NFIX;KTI12;CRY1;BCL11A;HTATSF1;TNRC6A;RFX7;RARG;SOX2;TRIM27;CITED2;ZSCAN21;RBPJ;NSD1;IGF2;PPM1D;SAFB2;IL18;SENP1;RGMA;KAT8;FOXD3;NCOA1;HES5;MIER3;ZBTB45;CPEB3;ATN1;ATOH8;CREB3;CREB3L4;BRMS1L;BRMS1;GLIS1;GATA3;PRKCB;DVL3;BMPR1A;NPAT;MLXIP;MYDGF;CTCF;KCNIP3;CUX2;SOX5;AHI1;HOXC10;BRWD1;VGLL3;HDAC8;PCGF6
prerank,response to reactive oxygen species (GO:0000302),-0.3001647928630376,-1.057946286879373,0.3463035019455253,0.6608656635099153,1.0,26/54,33.74%,PXN;MAPK3;RPS3;STK25;COA8;GPX1;AKT1;APOE;EGFR;STK26;CHUK;PTPRK;PKD2;PDCD10;PLK3;HYAL1;CAMKK2;SOD1;ROMO1;HYAL2;TPM1;MAPK9;HP;FOS;NCF1;JUN
prerank,endoderm development (GO:0007492),-0.43047128325080425,-1.0579357197778552,0.4168126094570928,0.6603801798821303,1.0,8/13,38.75%,SOX17;SOX7;KIF16B;DUSP4;DUSP1;TBX20;DUSP5;DUSP2
prerank,positive regulation of macroautophagy (GO:0016239),-0.30838116464651555,-1.0578653371261388,0.32677165354330706,0.6600756611737412,1.0,12/48,18.97%,SPTLC2;VPS13D;KDR;HTT;RALB;SPTLC1;SCOC;EPM2A;HSPB8;BNIP3L;TSC2;RAB3GAP2
prerank,translesion synthesis (GO:0019985),-0.31908477892029063,-1.0577039942139692,0.3596153846153846,0.6599639885734444,1.0,15/42,24.18%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;REV3L;USP43;RPA3;POLDIP2;POLK;DTL;RFC3;RFC2
prerank,membrane fusion (GO:0061025),-0.3325725210634197,-1.0569545135536915,0.378698224852071,0.6612867565838572,1.0,11/33,20.37%,DNM3;MYOF;CHP1;NAPA;DYSF;OPA1;RABEP1;VTI1B;NSF;DNM1;DNM2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.4013868931519732,1.056861729040851,0.4053398058252427,0.747370694990079,1.0,3/17,4.89%,PID1;PPARA;ACTN3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3772703768754422,-1.0567904995703994,0.4098671726755218,0.6611927454509307,1.0,3/20,1.47%,SEMA6A;SEMA3C;SEMA7A
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.22780353972530137,-1.0566942353492061,0.29213483146067415,0.6608990545235484,1.0,106/336,27.26%,FOXP1;ACER2;FOXO1;MAPK3;PAXX;DCUN1D5;RPS3;FNIP2;RBBP5;TRRAP;CRIP1;MTREX;TAOK3;SUSD6;CBX1;PRKDC;TNFRSF1B;CBX5;ERCC1;RAD1;CUL4A;YY1;USP3;BAX;DYRK2;BCL6;GTF2H3;TRIM28;OTUB1;CHD1L;FAM111A;HERC2;VCP;TAOK2;CIB1;HPF1;BCL2L1;E2F1;PNKP;SPRTN;BAK1;SLX4;FMR1;SAMHD1;RAD9B;CDKN2AIP;SLF1;RAD18;TOP2A;PARP2;HUS1;EPHA2;NSMCE4A;RAD9A;RPAIN;CDKN1A;UFL1;CCNK;RAD17;PWWP3A;BABAM2;WDR48;GTF2H4;POLQ;POLK;TRAIP;MAPK12;CGAS;ZBTB40;CHEK1;ERCC4;GADD45A;CCND1;BRAT1;MCL1;UBE2B;SFN;UBA1;CHCHD6;NIPBL;TAF9;PLK3;CCDC13;DTL;EID3;RFC3;POLE3;NUPR2;DTX3L;ASH2L;RFC2;FAN1;EXO1;MRNIP;FBXO6;ALKBH7;XIAP;SPDYA;CEP63;PARK7;PLK5;XPC;RAD51AP1;KIN;SLF2;NPM1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.37102180758096615,-1.0565264001402197,0.38267148014440433,0.6608387626989409,1.0,8/20,22.16%,TGM2;CAMK2D;BAX;BAK1;BCAP31;RAP1GDS1;FIS1;SELENOK
prerank,B cell mediated immunity (GO:0019724),-0.46086188357107316,-1.0562401337686116,0.3985102420856611,0.6610585885348453,1.0,8/10,52.33%,FCER1G;CD74;TLR8;FCGR2B;CARD9;SLA2;MSH2;CD19
prerank,glycoprotein metabolic process (GO:0009100),-0.2967352644161384,-1.0562296200412475,0.3607843137254902,0.6605750523193324,1.0,9/53,9.28%,ST3GAL4;ST6GALNAC3;ST8SIA4;MANBA;GANC;ST8SIA6;FBXO17;MAN1B1;FUT8
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.41470063535058566,-1.0561902097091689,0.387434554973822,0.6601551643407367,1.0,5/13,6.44%,TGFBR2;KDR;COL4A1;VEGFA;NOTCH4
prerank,vesicle coating (GO:0006901),0.29863804076215406,1.0560272993793398,0.3594080338266385,0.7464221179052236,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,COPII vesicle coating (GO:0048208),0.29863804076215406,1.0560272993793398,0.3594080338266385,0.7464221179052236,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29863804076215406,1.0560272993793398,0.3594080338266385,0.7464221179052236,1.0,14/61,15.54%,AREG;SEC24D;TGFA;TRAPPC6B;SCFD1;GOLGA2;TMED10;SEC24A;TRAPPC3;SEC31A;SEC23A;GRIA1;SAR1B;TBC1D20
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.351562079068239,1.055724313300289,0.39823008849557523,0.7461473827637107,1.0,7/29,14.52%,GDNF;TENT5A;AXIN2;DHX34;TENT5B;NBAS;RBM24
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.43265491805669287,-1.0551714969112573,0.3788706739526412,0.6621674323414302,1.0,5/12,20.94%,DMD;WNK1;ATP1B1;GLRX;ATP1B2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22895103524687824,-1.0551698414006065,0.30869565217391304,0.6616658362183497,1.0,89/314,23.28%,WWP1;NEDD4L;SEL1L;TRIM25;UBB;ZNRF1;WWP2;UBC;RPS27A;FBXO17;ANAPC15;PSMA6;ANAPC11;CUL4A;DNAJB12;PSMB5;FBXO4;NHLRC3;KCTD5;MAN1B1;PLAA;RB1;ERLIN2;RNF185;UCHL1;UBE2G2;VCP;TNFAIP1;PSMC4;MTA1;MAEA;HSPA5;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;UBXN8;ITCH;FAF2;RNF5;FBXL7;SMURF1;FBXL2;SEC61B;FEM1A;RBX1;UBE2G1;SGTA;PSMD8;PSMD11;CCNF;RNF121;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;TMEM67;FBXL3;FZR1;FBXL16;CUL1;DMAC2;DERL2;PELI1;ZSWIM8;TBL1X;AMFR;KCTD2;TMEM129;UBE2B;PSMA1;ZFAND2B;TMUB2;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;LTN1;SGTB;PSMA4;PCNP;FBXL19;PSMA2;FBXL18;TMUB1
prerank,endoplasmic reticulum organization (GO:0007029),-0.285082244430748,-1.055030928099697,0.3501006036217304,0.6614997546003103,1.0,25/72,27.69%,CAV2;LPCAT3;APP;SHTN1;RAB18;STX1A;ATL3;SPTSSB;ATL2;SEC61B;DOP1B;SGTA;LMAN2;REEP4;RTN3;TOR1AIP2;TMEM33;TLE6;STX5;LMAN2L;RNF112;UBE2J2;SEC16B;TRAM1;SEC61A1
prerank,digestive tract morphogenesis (GO:0048546),0.41634771122850595,1.0550055725521243,0.4065934065934066,0.7469721624490003,1.0,2/14,2.19%,FGFR2;PDGFRA
prerank,sterol metabolic process (GO:0016125),0.2972868175957385,1.0549559780224025,0.3282608695652174,0.7460949963992537,1.0,10/60,9.74%,CYP7B1;ABCA1;PRKAG2;CYP27A1;IL4;MSMO1;ABCA5;INSIG2;SCAP;CYP46A1
prerank,epithelium development (GO:0060429),0.2673320339441624,1.0548776659922743,0.33657587548638135,0.7452812673579677,1.0,7/107,2.41%,WNT4;ERRFI1;BMP2;ALDH1A2;SALL1;FGFR2;DLX3
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3996303273222801,-1.054753528292417,0.3862815884476534,0.6616414173923895,1.0,7/16,26.83%,GPR137B;PIP4P1;RRAGD;RRAGA;SEH1L;SIK3;LAMTOR5
prerank,response to interferon-gamma (GO:0034341),-0.28589545160533264,-1.0546438140210634,0.3425414364640884,0.6614077145718338,1.0,17/67,20.27%,GBP5;GCH1;GBP7;IFITM1;IFITM3;GAPDH;IFITM2;CCL15;RPL13A;CD74;TLR4;STAT1;IRF8;AQP4;SYNCRIP;CASP1;LGALS9
prerank,sensory perception of mechanical stimulus (GO:0050954),0.27923962106471484,1.0543897310697867,0.3604887983706721,0.745562927109723,1.0,9/85,6.54%,ADGRV1;CEMIP;ATP6V0A4;OTOS;P2RX4;ALDH7A1;COL4A3;PCDH15;EYA1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.31960779972901276,-1.054211934745544,0.3664825046040516,0.6619728029256041,1.0,12/41,14.52%,MEF2C;NOTCH1;TGFBR2;SMAD7;TGFB1;TGFB2;FKBP1A;HEYL;CPE;SOX4;ENG;HEY1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3112365972870442,-1.054122822111753,0.3754646840148699,0.6616887959658801,1.0,9/44,13.50%,ANO6;KCNJ2;WNK1;KCNQ1;KCNJ10;ATP1B1;AKAP6;KCNJ15;GNB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38082365296583126,-1.053711722097617,0.37777777777777777,0.6621850748281775,1.0,4/18,7.38%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3186531520410322,-1.0532283510486422,0.3890977443609023,0.6628411391686531,1.0,18/38,34.42%,H3-3A;MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;ASF1B;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.27393121407260723,-1.0528269519691833,0.3522267206477733,0.6633011071509223,1.0,29/79,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,negative regulation of developmental process (GO:0051093),-0.28204824618445834,-1.0526879759805554,0.3365570599613153,0.6631451907805804,1.0,13/69,8.73%,CDK6;NOS3;NOTCH1;TFRC;TBX1;ARHGEF15;KLF7;TGFB1;TBX2;VAT1;NOTCH4;RC3H1;CST3
prerank,negative regulation of cellular component organization (GO:0051129),0.287609614679627,1.0523886703010632,0.3582089552238806,0.7498272493363983,1.0,5/74,3.69%,BMP6;AR;EPHA3;SNX33;DNAJB8
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3536745873256094,-1.0523310909955617,0.38095238095238093,0.6634873484916514,1.0,7/26,15.37%,NEDD4L;FHL1;WWP2;ATP1B1;CASQ2;CACNA1D;CAB39
prerank,myoblast fusion (GO:0007520),0.4283265089936658,1.0522864652603126,0.3870967741935484,0.7490861178730183,1.0,3/12,5.49%,ADGRB3;ADAMTS5;ADAM12
prerank,cellular glucan metabolic process (GO:0006073),0.4439931166409613,1.0521624253534845,0.4182242990654206,0.7483852211278662,1.0,2/11,2.55%,PRKAG2;PHKA1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2748949766772075,-1.0520270882040517,0.34279918864097364,0.6632494235052603,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2748949766772075,-1.0520270882040517,0.34279918864097364,0.6632494235052603,1.0,29/78,27.31%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;CTSD;KIF23;DCTN3;CTSF;FCER1G;DCTN1;CD74;RAB7A;KIF26A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;CTSS;ACTR1B;SEC13;DCTN4;RACGAP1;AP2A2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28576610484160847,1.0519440606832637,0.35039370078740156,0.7479378179193945,1.0,7/78,2.58%,PIK3R1;PID1;AR;LRP1;DPP10;PDPK1;EPHA3
prerank,cardiac muscle cell differentiation (GO:0055007),0.3716466368461027,1.0515090591199545,0.35824175824175825,0.7479997722990881,1.0,3/21,1.40%,BMP2;SLC8A1;NRG1
prerank,negative regulation of neuron death (GO:1901215),-0.26684690118895055,-1.051383814094861,0.3413654618473896,0.6643465902394982,1.0,13/93,8.42%,MEF2C;CD34;PTK2B;NGF;SIX1;REST;PPARGC1A;ATF4;TGFB3;TOX3;TNFRSF1B;FOXQ1;AKT1
prerank,response to purine-containing compound (GO:0014074),-0.3923812544362867,-1.0511840708322389,0.3985102420856611,0.6643398053195545,1.0,3/17,8.10%,TRPC3;ABCC9;NDUFS4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.45826652464792966,1.0509307126521008,0.4008714596949891,0.7484805381018416,1.0,7/10,25.79%,KLF15;NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.39399371696357677,-1.050912126971697,0.39705882352941174,0.664452061226725,1.0,7/15,28.92%,RAD9B;HUS1;EME2;RAD9A;RAD17;FANCD2;MRE11
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2785142958485156,-1.0508615015916656,0.37065637065637064,0.6640780416821872,1.0,24/72,24.21%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;COPS6;XAB2;HMGN1;COPS5;RBX1;XRCC1;RPA3;TCEA1;GTF2H4;POLK;ERCC4;COPS7A;RFC3;COPS4;RFC2;COPS7B
prerank,regulation of organelle assembly (GO:1902115),-0.2814445508516174,-1.0508280403515844,0.353515625,0.6636563558946729,1.0,29/72,29.03%,TBC1D8;IFT20;MSN;ATXN2L;TBC1D1;TBC1D12;EZR;TBC1D22A;PLK2;KIF9;ATG3;TBC1D9B;TSG101;VPS11;HCK;TBC1D2;RABEP2;ADPRH;DCDC2;TBC1D15;SPICE1;ODAD3;TBC1D17;RDX;CDKL5;NPM1;TBC1D5;UBQLN2;STAM
prerank,dopamine metabolic process (GO:0042417),-0.37180068222715773,-1.0508055706202306,0.37967914438502676,0.6632051839261757,1.0,3/18,4.12%,MAOA;GCH1;TGFB2
prerank,regulation of interleukin-1 production (GO:0032652),-0.4056253446756456,-1.0507257899188105,0.43653846153846154,0.6629017412505058,1.0,2/15,3.46%,FOXP1;ANXA1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3438454435245333,1.0505926796062597,0.375,0.7483793807065235,1.0,4/33,6.76%,IGF1;OMA1;PRKN;IAPP
prerank,regulation of cation channel activity (GO:2001257),0.27156420296108374,1.0505680454569615,0.34496919917864477,0.7474338382064395,1.0,23/89,15.09%,FGF14;GRIA4;ANK2;PRKACA;DLG2;SHISA9;DAPK1;NLGN2;CACNG4;CAMK2B;CACNB4;CACNB2;NLGN1;MAPK8IP2;CACNB1;LRRC7;GRIA3;ACTN2;DLG4;GRIN2A;GRIA1;JPH1;KCNS1
prerank,neutral amino acid transport (GO:0015804),0.3523760209881202,1.0504549722692884,0.39215686274509803,0.74669388895197,1.0,9/28,13.29%,SLC6A9;SLC43A1;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;CTNS;SLC38A6
prerank,negative regulation of double-strand break repair (GO:2000780),0.3433995320269289,1.0497508652914054,0.4021276595744681,0.7475237210686271,1.0,7/30,14.46%,SHLD2;UBQLN4;TRIP12;RADX;OTUB2;SMCHD1;RIF1
prerank,proton transmembrane transport (GO:1902600),0.33149858290358875,1.0494251045938918,0.3658008658008658,0.7474366150354288,1.0,7/36,12.33%,ATP1A2;ATP6V0A4;SLC36A2;DMAC2L;ATP6V1H;SLC46A1;ATP1A3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3272324142195306,-1.0493910941736315,0.3754646840148699,0.6656535672273448,1.0,9/35,14.41%,CAV1;NOTCH1;NLK;CYP1B1;ADIPOR1;CRLF3;OCIAD1;HES1;JAK2
prerank,regulation of neuron migration (GO:2001222),-0.3501292849444753,-1.0493557802643192,0.3822975517890772,0.665255148627323,1.0,11/26,20.92%,SEMA6A;COL3A1;DAB2IP;SHTN1;ADGRG1;PLAA;ULK4;NEXMIF;ARHGEF2;NIPBL;RAPGEF2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.27686110212390547,-1.0493281987842302,0.35195530726256985,0.6648178592957901,1.0,27/75,32.52%,GPCPD1;DGKH;PLCB3;PIGL;PIGF;CSF1R;FAR1;PLA1A;PIGC;ENPP6;SYNJ1;PIGW;LCAT;GDE1;CPNE3;PLA2G4F;ACP6;PIP5K1A;PLA2G4B;PLEK;PLA2G7;PLCB1;PIGM;CPNE7;SERINC5;ABHD6;PLCB2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3359870806468545,-1.0491554175556437,0.3984375,0.6647164564097227,1.0,15/32,26.21%,ITGA1;PPP1R16B;HSP90AB1;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,receptor-mediated endocytosis (GO:0006898),-0.2577885379016396,-1.0489136589645653,0.33263598326359833,0.6648088254354991,1.0,23/132,12.88%,CAV1;DNM3;ACKR3;FNBP1L;SCARB1;SCARF1;CAV2;RAMP2;TFRC;ARHGAP27;CUBN;STAB1;IGF2R;CD81;HIP1R;CD9;AP2M1;INSR;FCER1G;FCHO2;SGIP1;APOE;SYK
prerank,cellular response to leucine starvation (GO:1990253),-0.44516604181281333,-1.0488808837064085,0.4168126094570928,0.6643968224782681,1.0,7/10,45.48%,IMPACT;RRAGD;SESN2;SESN1;GCN1;SESN3;LARS1
prerank,regulation of T cell differentiation (GO:0045580),0.3329542614775171,1.0485184124569737,0.3710691823899371,0.74868778623065,1.0,7/33,15.77%,TBX21;RHOH;IL4;CAMK4;GATA3;CLPTM1;METTL3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4124353583926471,-1.0480669843597277,0.39814814814814814,0.6659136068051307,1.0,6/13,25.98%,DAB2IP;HHEX;EPN2;CADM4;PTPN1;PDCD6
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29376683713722757,1.047951206968018,0.37888198757763975,0.749148748026874,1.0,7/68,7.30%,ENPP1;AMPD3;TPST1;ACSM5;BAAT;SULT6B1;ACOT11
prerank,stem cell differentiation (GO:0048863),0.32692936747213214,1.0477235816893378,0.37199124726477023,0.7488170983797505,1.0,6/39,5.29%,FGFR2;KIT;GPM6A;SFRP1;SP7;SOX21
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.24389647933140185,-1.0476761167054973,0.33805668016194335,0.6663356834296604,1.0,46/166,18.30%,THBS1;SORBS1;VIM;RPL26;SCARB1;KLF2;KLF4;EEF2;NIBAN1;RPS4X;HSP90AB1;PPARGC1A;CHP1;GIPC1;MFSD2A;PRKDC;RGCC;EDN1;NMD3;DYRK2;AKT1;INSR;DHX9;ELOVL5;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;TLR4;SOX4;FGF2;FMR1;PAOX;EGFR;ERBB2;LDB1;OPN3;STAR;BCAR3;NR1H2;HSP90AA1;PCIF1;SP1;GLI1;ZCCHC4
prerank,negative regulation of protein catabolic process (GO:0042177),0.32165876686233824,1.0474843432928929,0.36554621848739494,0.7484453699348101,1.0,13/40,21.65%,NELL1;TIMP3;SIRT2;TIMP4;FMN2;PRKCG;SF3B3;CYP51A1;SNRNP70;IRAK3;AZIN2;RGP1;TIMP1
prerank,phospholipid catabolic process (GO:0009395),-0.358953670403439,-1.0474832358800468,0.3947858472998138,0.6662779422949564,1.0,8/24,28.84%,GPCPD1;SMPDL3A;ENPP6;GDE1;PLA2G4F;ENPP2;SMPD1;PLA2G4B
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3927064299914696,1.047465050988391,0.3969957081545064,0.7475064164013884,1.0,5/18,7.72%,NRXN1;NLGN2;NLGN3;CACNG4;NLGN1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.33347916670573413,1.0474557539172806,0.3699788583509514,0.7465423402408674,1.0,5/39,2.15%,NRP1;BMP2;SALL1;GDNF;GLI2
prerank,chromatin organization (GO:0006325),-0.2552483563577682,-1.047089845332602,0.36645962732919257,0.6667349652766374,1.0,48/132,31.95%,MECOM;ESR1;ZBTB7A;KDM5C;PRDM16;SAFB;HCFC1;HDAC4;BAZ1A;CHD1L;RB1;ARID1A;MTA2;TADA2B;HMGN1;GATAD1;SATB2;CDAN1;HCFC2;SMARCA4;HMGN2;SMARCA2;RBBP4;PWWP3A;KDM6A;L3MBTL1;SOX9;SETDB1;SMARCC1;EZH1;PHF19;HDAC5;FAM50A;SETD2;CHD1;RUVBL1;NPM1;CHRAC1;SPI1;SMARCD2;HMGB2;SMARCA5;HDAC3;MYC;MYSM1;SMARCD3;NPM3;KAT2A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.4068752306815525,1.0467313245717011,0.39954853273137697,0.7473867789620574,1.0,8/15,25.72%,TRPM1;GRM1;GRM4;HOMER2;GRIK3;DAGLA;GRM5;GRM8
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.36257156953358455,1.0465432011815397,0.4049586776859504,0.7468669374839393,1.0,3/21,9.35%,BMP6;TGFBR1;BMPR1A
prerank,RNA splicing (GO:0008380),-0.26448802711145397,-1.0458440231271724,0.3645224171539961,0.6692075443425748,1.0,27/95,19.99%,MBNL1;IVNS1ABP;PPARGC1A;PRPF8;SRSF2;PPP2R1A;SNRNP48;SRPK1;DHX15;FUS;SNRPD3;U2AF1;SFPQ;RNPS1;ZRSR2;SRSF4;MAGOH;DDX23;SF3A3;DDX39B;CCAR2;SCAF11;PPIG;SNRPG;PDCD7;LSM1;SYNCRIP
prerank,glucose homeostasis (GO:0042593),-0.2755301195431985,-1.0457208408283507,0.36016096579476864,0.6690369989049971,1.0,11/83,5.37%,ADIPOR2;IGF1R;LRRC8D;FOXO1;HK1;KCNB1;BACE2;KLF7;PPARGC1A;ADIPOR1;FOXK1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.2978063160581177,-1.0454206350874409,0.3709090909090909,0.6692771893917131,1.0,12/54,15.37%,CAV1;KCNJ2;NEDD4L;FHL1;WWP2;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1;CACNA1D;CAB39
prerank,regulation of sequestering of triglyceride (GO:0010889),0.40833902886108314,1.0453082526205886,0.42355371900826444,0.7490931908631393,1.0,2/15,3.11%,PPARA;OSBPL8
prerank,regulation of postsynapse organization (GO:0099175),-0.3426612820411322,-1.0452824046406277,0.37988826815642457,0.6691493953552615,1.0,6/28,12.62%,SHANK3;SIPA1L1;ABI3;CFL1;SRCIN1;HOMER1
prerank,nucleotide biosynthetic process (GO:0009165),-0.381897247950201,-1.0452192464613106,0.39713774597495527,0.6687862427504088,1.0,5/18,13.47%,ME1;PRPS2;PRPS1;PRPS1L1;RRM1
prerank,protein sumoylation (GO:0016925),-0.30089669211649606,-1.045149739417211,0.3821292775665399,0.6684593181637815,1.0,25/49,34.81%,IFIH1;STX1A;NUP93;NDC1;TRIM28;NUP54;SAE1;NUP188;SUMO3;NUP155;RANBP2;NUP37;UBA2;RANGAP1;NUP160;NUP43;SEH1L;NUP107;NUP42;NUP98;TRPM4;UBE2I;RAE1;NUP88;NUP214
prerank,neural crest cell development (GO:0014032),0.31997442073285204,1.0450434039451675,0.40444444444444444,0.7488371424901512,1.0,6/44,4.77%,SEMA5A;NRG1;GDNF;SEMA3A;RADIL;SEMA3D
prerank,cognition (GO:0050890),-0.3101900076923762,-1.044964148499511,0.3898305084745763,0.66841477798158,1.0,9/42,11.33%,ST3GAL4;SHROOM4;APP;DGCR2;STRA6;CHMP2B;MFSD2A;FAM107A;NF1
prerank,lymphocyte mediated immunity (GO:0002449),-0.4211836288451122,-1.0448541640387918,0.4099264705882353,0.6681878842385688,1.0,2/12,13.51%,CD55;BTN3A3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.27504808402451225,-1.0447416162573846,0.37425742574257426,0.667949457200558,1.0,38/84,34.73%,UBB;UBC;RPS27A;ANAPC15;PSMA6;ANAPC11;PSMB5;RB1;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;BUB3;PSMC6;PLK1;AURKA;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;CUL3;PSMD2;UBE2C
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.42371810019586253,-1.0444820545000744,0.4198895027624309,0.6680875430641683,1.0,6/12,25.17%,ERLIN2;ACADL;WDTC1;ACADVL;TRIB3;APOC1
prerank,snRNA metabolic process (GO:0016073),-0.3875225664879172,-1.0444700807766962,0.4025974025974026,0.6676294326222758,1.0,9/17,31.56%,MTREX;INTS8;INTS1;RBM7;MEPCE;INTS12;INTS2;INTS3;ZCCHC8
prerank,determination of bilateral symmetry (GO:0009855),-0.35504861774996455,-1.044332595758852,0.4247787610619469,0.6674926161267757,1.0,9/24,24.81%,NOTCH1;TBX1;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3898252067466206,1.0441257481387618,0.4212678936605317,0.7502038858342903,1.0,7/20,12.73%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,cell differentiation in spinal cord (GO:0021515),-0.4470900696189642,-1.044054996626941,0.4090121317157712,0.6677330181483451,1.0,3/10,15.70%,SOX13;SOX4;SOX6
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.26761228806933507,1.0439706291328714,0.3701550387596899,0.7496085960893791,1.0,17/100,10.90%,IGF1;PIK3R1;PTPN13;NTRK3;KIT;DCN;PDGFRA;PIP4K2A;LYN;IRS2;PDGFRB;PDGFD;ERBB3;IL18;MYDGF;PTEN;PIP4K2B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4435008778898767,1.0439621143999724,0.4164859002169197,0.74865059359348,1.0,1/10,0.35%,NELL1
prerank,regulation of insulin secretion (GO:0050796),0.27249806139588145,1.043602996234824,0.3736951983298539,0.748613862222698,1.0,15/101,7.62%,TCF7L2;ADCY5;RAPGEF4;CACNA1E;ITPR1;PRKCA;STXBP4;SFRP1;FAM3D;PRKN;IRS2;NLGN2;FOXA2;SNAP25;TM7SF3
prerank,neuron projection development (GO:0031175),0.2533726514612126,1.0435636658217053,0.34714003944773175,0.7477382101975598,1.0,33/168,13.81%,ADGRV1;NRK;EPB41L3;GDNF;CNTN4;CNTNAP2;GPM6A;DOCK10;GPRIN2;LYN;GPRIN1;MYO16;SRGAP2;CTNND2;TBC1D24;EPHB1;GAS7;TNIK;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;PTEN;LRP12;RASGRF1;SNAPIN;ATXN10;DLG4;CDK16;MAPT
prerank,regulation of signal transduction (GO:0009966),0.24474001921090635,1.0434555349994261,0.34593572778827975,0.7470402686310132,1.0,22/190,8.27%,RORA;IGFBP2;GRK3;FGFR2;SEMA5A;GPHB5;SULF1;GDNF;IFT81;ZIC1;DHRS3;KCTD8;RGS20;TSPAN15;SENP2;NLRP12;DTX1;YJEFN3;FRMPD1;TULP3;MAPK8IP2;ERBB3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3847091072001271,-1.043428172675864,0.3875685557586837,0.6687966511322944,1.0,3/17,3.86%,ITGA1;HSP90AB1;CALM1
prerank,cell projection assembly (GO:0030031),-0.36013902354367483,-1.043376001841914,0.4,0.6684389711890717,1.0,4/22,8.93%,PARVB;RHOJ;RAC1;PDGFA
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4003908371916381,1.043277489059273,0.39732142857142855,0.7465106385554816,1.0,3/17,4.01%,NRP1;NTRK3;STAP1
prerank,cellular response to peptide (GO:1901653),0.2974896982438006,1.0432288847672164,0.3551587301587302,0.7456552579928304,1.0,5/56,3.85%,IGF1;LRP1;GJA1;CACNA2D1;MDM2
prerank,calcium ion transmembrane transport (GO:0070588),0.2805926956121781,1.0431509195768882,0.38461538461538464,0.744881329658035,1.0,16/86,9.82%,NALCN;SLC24A3;SLC8A1;SLC24A5;CACNA2D1;TRPM3;P2RX4;ATP2A2;TRPM1;TRPM5;TRPA1;MICU3;CACNA1G;SLC24A4;SLC24A2;PARL
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3299431571634468,-1.0427491570118768,0.40630797773654914,0.6695334096317789,1.0,13/32,21.54%,BAX;ATG3;HSPD1;BBC3;BCL2L1;BAK1;BAD;CCAR2;BIK;SFN;TIMM50;GGCT;FIS1
prerank,aminoglycan catabolic process (GO:0006026),0.3557340150232537,1.042677115904734,0.3919491525423729,0.7451196778233989,1.0,4/28,4.99%,GPC6;GPC4;GPC2;GNS
prerank,protein depolymerization (GO:0051261),0.34444420934387765,1.042463818252437,0.38784067085953877,0.7447241000080643,1.0,2/27,3.06%,MICAL3;NCKAP5
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3331708367236488,-1.0421928927539748,0.3850267379679144,0.6703539989501217,1.0,14/28,31.04%,MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;CLOCK;RHNO1;FBXO6;CEP63;ATRIP;PRPF19;CDC5L
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4142417168071439,-1.042112337439354,0.40574506283662476,0.6700574441103243,1.0,4/13,7.63%,SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,membrane lipid catabolic process (GO:0046466),-0.44233938065412015,-1.0416762289875783,0.41947565543071164,0.6705995551575363,1.0,8/10,36.21%,CYP1B1;SGPL1;ENPP2;NAGA;MGST2;SMPD2;FUCA1;PDXDC1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35208676684709517,1.0412726933717984,0.4232456140350877,0.7468649145367982,1.0,3/28,2.77%,PIK3R1;ZIC1;SMAD3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4507662477896716,1.0411552854398296,0.4021505376344086,0.746204637806437,1.0,2/10,6.13%,BMP6;PLG
prerank,protein autophosphorylation (GO:0046777),0.2521826067832464,1.0410980550717777,0.383587786259542,0.7453767548423875,1.0,35/157,13.16%,DDR2;FGFR2;DAPK2;STK17B;KIT;PDGFRA;PDPK1;PIM2;LYN;DDR1;AAK1;MAPKAPK5;MAP3K12;CAMK4;DAPK1;PDGFRB;EPHB1;CAMK2B;TNIK;MAK;FGFR4;STK33;EPHA8;ERBB4;ALK;MEX3B;MAP3K10;MUSK;EEF2K;ITK;FGFR1;TEC;EPHA1;ULK2;ATM
prerank,regulation of translational initiation (GO:0006446),-0.2867969833093688,-1.0401417023834223,0.382,0.6738580657307931,1.0,33/63,33.70%,EIF4G3;EIF5B;ATF4;HSPB1;RPS6KB2;IMPACT;YTHDF2;FMR1;UHMK1;EIF5;PAIP2B;EIF1;NCK1;YTHDF1;PAIP1;EIF4G1;EIF4A2;EIF4EBP1;NCBP2;ATF3;NCK2;EIF4B;EIF4H;PAIP2;NPM1;BOLL;RPS6KB1;GLE1;YTHDF3;MIF4GD;MTIF2;CTIF;CCL5
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.34025240432632037,1.0397946167585836,0.4004329004329004,0.7477270961045231,1.0,6/30,7.51%,GJA1;SCN3B;ANK2;CACNA2D1;GPD1L;CACNA1G
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4414661047742095,-1.0395083265963547,0.42342342342342343,0.6749092066760155,1.0,5/10,30.78%,ST6GAL1;AMDHD2;RENBP;GNPDA1;GNE
prerank,sodium ion export across plasma membrane (GO:0036376),0.41535175112894196,1.0392296288293794,0.405152224824356,0.7481514091239061,1.0,3/13,14.06%,ATP1A2;ATP1A3;ATP1B3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3530781360857387,-1.039202982118045,0.4111969111969112,0.6751585298704382,1.0,3/24,3.59%,ANO6;CCN3;SLIT2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.36777335637844677,-1.038842007608884,0.40860215053763443,0.6755895775633484,1.0,5/20,7.63%,SLC12A2;KCNJ2;NEDD4L;ATP1A1;ATP1B1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.37094330611655246,-1.0388223783913249,0.40225563909774437,0.6751420724027504,1.0,4/18,9.68%,ANXA1;REST;NR3C1;FAM107A
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2819898190942257,1.0381447662346133,0.4178794178794179,0.7498067880710481,1.0,11/84,11.37%,IGF1;SAMD4A;DAPK1;RTN4;IGF2BP2;NANOS3;CPEB3;DDX6;RIDA;CHRNA7;FXR2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3761418599866355,1.0378975119177107,0.4205020920502092,0.7494398642688072,1.0,6/21,16.03%,BCL2L11;CREB3L1;PRKN;CREB3;TXNDC12;DDIT3
prerank,lipoprotein localization (GO:0044872),0.4266615841024048,1.0372759538366692,0.39823008849557523,0.7500114345662942,1.0,5/11,18.81%,LRP1;PRKCB;MIA3;UNC119B;PPARG
prerank,cellular response to hexose stimulus (GO:0071331),-0.35569726209342,-1.0368184325101935,0.424812030075188,0.679606134413696,1.0,4/23,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3552387805456677,-1.0367937820791957,0.4125230202578269,0.6791722524592766,1.0,6/23,13.50%,TGM2;MAPK3;KCNQ1;ATF4;GABPA;GNB1
prerank,steroid biosynthetic process (GO:0006694),0.29909360980839506,1.0367206957931776,0.39789473684210525,0.7504135341075179,1.0,10/56,12.64%,CYP7B1;PRKAG2;HSD11B2;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1;OSBP;PRLR
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2980311887962882,-1.0364558146767704,0.3962962962962963,0.6794861521682536,1.0,13/45,12.22%,FN1;CDK6;DAB2IP;NDUFS4;DHX9;PDGFC;PDGFA;S100A6;CD74;CDK4;NF1;FTH1;E2F1
prerank,vasodilation (GO:0042311),-0.4180401157719641,-1.0356537161710755,0.4288224956063269,0.6809692395350416,1.0,2/13,2.57%,NOS3;KLF2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.38356423421867936,-1.0356252269254187,0.42752293577981654,0.6805386544803482,1.0,7/17,19.84%,SEL1L;RHBDD1;VCP;FAF2;SEC61B;DERL2;TMEM129
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.45421797866837654,-1.0353686729231024,0.43345323741007197,0.6806897456133563,1.0,2/10,3.51%,SEMA6A;DAB2IP
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.39417179044925893,1.0345750605417712,0.4240506329113924,0.7547230397392299,1.0,4/15,8.91%,DAAM2;ZNRF3;SFRP1;NPHP3
prerank,positive regulation of B cell activation (GO:0050871),-0.2959722221004061,-1.0343968275191175,0.39539347408829173,0.682523257386707,1.0,13/50,17.77%,MEF2C;TFRC;CD38;CD81;MMP14;PPP2R3C;TIRAP;CD74;SYK;CLCF1;NOD2;XBP1;CD320
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.25294544777393396,1.034396795040107,0.374749498997996,0.7542268325520284,1.0,29/142,15.37%,ATP1A2;LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;PRKACA;SMAD3;CCR6;ACKR4;ACKR2;CCR10;PTGDR;NPTN;IAPP;CALCR;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;DLG4;P2RY1;CXCR4;DRD2;HCRTR1;TRPC1;ADRA1A
prerank,regulation of macrophage differentiation (GO:0045649),0.39689350058916306,1.0343390789786922,0.4074074074074074,0.7534110142554526,1.0,2/15,2.65%,IL34;PRKCA
prerank,neurogenesis (GO:0022008),-0.3063181910654902,-1.0340885182259119,0.41818181818181815,0.6827527094340151,1.0,7/43,7.22%,CDK6;TRAK1;ANXA1;SIX1;TGFB2;TRAK2;BTBD3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4241798482169647,-1.0338733863812841,0.43243243243243246,0.682740253076107,1.0,3/12,7.75%,ELF1;CBFB;RC3H1
prerank,transepithelial transport (GO:0070633),-0.40044578933961683,-1.0334939227762638,0.43040293040293043,0.6832147735951849,1.0,4/15,4.60%,ABCG2;CXADR;SLC12A2;SLC1A1
prerank,protein modification by small protein removal (GO:0070646),-0.23017561039915208,-1.0334938757157903,0.35429769392033544,0.6827178901234793,1.0,100/252,32.49%,ACTB;ESR1;IFIH1;NFKBIA;SMAD7;TRRAP;EIF3F;UBB;USP1;USP46;FOXK1;UBC;RPS27A;IL33;BRCC3;USP7;PSMA6;HCFC1;RIPK1;OTUD5;USP8;UIMC1;PSMB5;YY1;USP3;BABAM1;RHOT1;USP9X;OTUB1;COPS6;UCHL1;VCP;PSMC4;TADA2B;USP5;PSMC5;PSMD14;COPS5;USP15;PSMD8;SMAD4;PSMD11;TNFAIP3;UCHL3;PSMB4;PSMD12;PSMC1;BABAM2;WDR48;USP22;RCE1;MCRS1;SMAD2;USPL1;USP4;USP49;SNX3;USP38;KEAP1;JOSD1;PSMA1;TADA3;COPS7A;PSMB1;PSMC3;PSMA4;PSMA2;INO80D;RAD23A;COPS4;COPS7B;TRAF6;SENP5;TFPT;SMAD1;PSMB8;GPS1;RUVBL1;RAD23B;BARD1;USP14;TAF10;STAM2;JOSD2;FOXO4;STAM;POLB;USP35;PSMC6;MYC;MYSM1;FOXK2;RHOA;CDK1;PSMD6;KAT2A;NLRP3;PSMA8;USP12;TNIP2
prerank,secretion (GO:0046903),0.40287947444686306,1.033248784855379,0.4013452914798206,0.755274928773694,1.0,6/14,18.68%,SLC22A4;RIMS1;PRKCI;FBLN5;GUCA1B;SLC22A2
prerank,response to glucocorticoid (GO:0051384),-0.34056668727362704,-1.033134034560104,0.3908918406072106,0.6831360469041483,1.0,5/26,9.68%,ANXA1;SLIT2;REST;NR3C1;FAM107A
prerank,post-translational protein modification (GO:0043687),-0.22258458181260052,-1.0330508090741672,0.34375,0.6828426073740528,1.0,101/332,25.25%,FN1;IGFBP7;GPC3;RAB11A;LMO7;SOCS2;IGFBP5;APP;RBBP5;SUMF2;KLHL5;MSLN;ADAM10;SPARCL1;IGFBP3;DCAF6;ZBTB16;RHBDD1;PTP4A2;KLHL2;FBXO17;NUCB1;PSMA6;DCUN1D1;WSB2;QSOX1;MFGE8;CUL4A;PSMB5;FBXO4;CST3;SPP1;PNPLA2;RAB8A;ASB8;COPS6;UBE2F;PSMC4;WDTC1;PSMC5;FBXL14;RAB11B;CHRDL1;PSMD14;FBXW5;FBXW10;APOE;ICMT;FSTL1;COPS5;KLHL3;FBXL7;SUMF1;FUCA2;CISH;FEM1A;RBX1;RAB1A;PSMD8;WSB1;PSMD11;CCNF;UCHL3;LGALS1;PSMB4;PSMD12;PSMC1;FBXL3;FBXL16;F5;GAN;CUL1;FBXW2;KLHL9;KLHL21;ELOB;PRSS23;CCDC22;KEAP1;KCTD7;PSMA1;COPS7A;VWA1;PSMB1;PSMC3;C3;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18;COPS4;COPS7B;COP1;FBXO6;EVA1A;TULP4;KCTD6;DCUN1D3;PSMB8
prerank,regulation of telomerase activity (GO:0051972),-0.3006215232344691,-1.0327444932767806,0.4,0.683120628116915,1.0,24/45,37.81%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;PNKP;DKC1;CCT2;GREM1;HSP90AA1;ERCC4;CTNNB1;SRC;MYC;PKIB;SMG6;PIF1;WRAP53;CCT4;MAP2K7;CERS1;MAPK15;NVL;GRHL2
prerank,cellular response to lectin (GO:1990858),-0.2607992076737232,-1.0327185915928976,0.3937621832358674,0.682191928603112,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2607992076737232,-1.0327185915928976,0.3937621832358674,0.682191928603112,1.0,48/104,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3022735793022333,1.0326579329161507,0.390495867768595,0.7557443448083129,1.0,7/52,8.30%,CELF2;RBFOX1;NOVA1;SRSF12;KHDRBS1;CELF4;RBM5
prerank,regulation of mitotic cell cycle (GO:0007346),-0.24070844435569966,-1.0325515627134223,0.36610878661087864,0.6820805678152285,1.0,53/171,24.01%,AFAP1L2;TTC28;CAV2;IQGAP1;NEK7;CDKN1B;TGFB1;APP;ANAPC15;PSMA6;ANAPC11;PSMB5;TAL1;ASAH2;PIM3;RB1;PSMC4;MAEA;PSMC5;DUSP3;PSMD14;CDK10;RNF20;SDCBP;PSMD8;PSMD11;CDK13;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;USP22;CUL1;L3MBTL1;ASNS;CDK5RAP3;TTLL12;SRA1;PIN1;RCC1;PSMA1;MKI67;ANAPC2;PSMB1;PSMC3;EIF4EBP1;PSMA4;PSMA2;BTG3;SIK1;CDKN1C
prerank,connective tissue development (GO:0061448),-0.31770083566198193,-1.0312219339839488,0.4049429657794677,0.6848551729159146,1.0,9/35,9.90%,SPTLC2;NAMPT;LRP5;CD44;PKD1;ZBTB16;PGRMC2;TRIP11;DDRGK1
prerank,response to sterol (GO:0036314),0.429905634817864,1.0310415061272653,0.41517857142857145,0.7590682135057542,1.0,1/11,0.19%,RORA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2743814232773184,1.0309544167687805,0.3709677419354839,0.7583363058219474,1.0,6/80,3.90%,AUTS2;PIK3R1;NRP1;DOCK11;GPM6A;TENM2
prerank,regulation of acrosome reaction (GO:0060046),-0.4408164285770566,-1.030915781009897,0.43486238532110094,0.6850893837480438,1.0,7/10,54.41%,CACNA1H;PLCB1;GLRA1;SERPINA10;FAM170B;PRSS37;PLA2G10
prerank,positive regulation of dendrite development (GO:1900006),0.4398646335760823,1.030801513216055,0.4153846153846154,0.7577471358369997,1.0,2/10,1.32%,PTN;BMP5
prerank,positive regulation of stress fiber assembly (GO:0051496),0.31109057366462245,1.0305146084463785,0.40973630831643004,0.7574905922581694,1.0,5/44,4.24%,PPM1E;NRP1;LPAR1;ROCK2;SFRP1
prerank,triglyceride homeostasis (GO:0070328),0.352004502010104,1.030495815943322,0.4233409610983982,0.7565912216292595,1.0,5/26,17.54%,RORA;IL18;PLA2G12B;DGAT2;MLXIPL
prerank,positive regulation of intracellular transport (GO:0032388),-0.313555103723379,-1.0303923367597019,0.412573673870334,0.6858579327859792,1.0,12/38,22.40%,BCAS3;PRR5L;EHD2;CEP290;PCM1;OAZ2;CAPN10;MLC1;EHD1;RIPOR1;PDCD10;PLK3
prerank,regulation of B cell proliferation (GO:0030888),-0.30141032309947663,-1.0303352458550623,0.386,0.6855188041218352,1.0,8/44,10.73%,MEF2C;TFRC;CD38;CD81;TNFRSF21;RC3H1;TIRAP;CD74
prerank,sarcomere organization (GO:0045214),0.34040505348382966,1.0300422712558752,0.41002277904328016,0.7568032149710099,1.0,8/27,14.84%,CSRP3;FHOD3;SIX4;CSRP2;ACTN2;SYNPO2L;TNNT3;MYLK3
prerank,protein polyglutamylation (GO:0018095),0.4290121435958397,1.0296876978014615,0.44206008583690987,0.7567722663933173,1.0,2/11,5.52%,TTLL11;TTLL9
prerank,erythrocyte differentiation (GO:0030218),-0.30627972604044656,-1.0291456721396777,0.441340782122905,0.6878736212610487,1.0,21/44,27.17%,RPS14;MFHAS1;RPS19;VEGFA;SLC25A38;TAL1;INHBA;JAK2;ATP5IF1;UFL1;JAK3;HSPA9;CDK5RAP3;UBA5;ALAS2;HCLS1;ZFPM1;DMTN;ACIN1;INHA;PTPN2
prerank,alanine transport (GO:0032328),-0.44728501402964804,-1.0289499897951926,0.4791666666666667,0.6878600723749653,1.0,1/10,0.38%,SLC6A6
prerank,extracellular matrix disassembly (GO:0022617),-0.29097986534969367,-1.0282249208824081,0.4074074074074074,0.6891221136878672,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.40413239331113404,-1.0281506521976802,0.44343065693430656,0.6887947863150743,1.0,2/13,6.72%,TGFBR2;CBFB
prerank,defense response to fungus (GO:0050832),-0.3778001884539484,-1.0279512838169191,0.4306049822064057,0.6887945920119276,1.0,5/17,24.55%,PLCG2;GAPDH;CX3CR1;FAM3A;BCL10
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2791282865511109,-1.027874516239779,0.41254752851711024,0.6884696152026955,1.0,8/67,6.37%,ITPR2;SLC2A1;RAP1A;DPP4;KCNB1;ITPR3;STX1A;UQCC2
prerank,cardiolipin metabolic process (GO:0032048),0.4104622956735482,1.0274271211184707,0.4488888888888889,0.7616508237801121,1.0,2/13,2.58%,PLA2G5;PLA2G4A
prerank,regulation of mRNA metabolic process (GO:1903311),-0.4285628537568876,-1.027190428192866,0.43672014260249553,0.6896922613689405,1.0,3/11,8.77%,SAFB;SRPK1;DHX9
prerank,glycine transport (GO:0015816),0.43788732981386164,1.02708084112369,0.40764331210191085,0.761574964923402,1.0,2/10,5.51%,SLC6A9;SLC36A2
prerank,regulation of protein localization to centrosome (GO:1904779),0.43364961252273243,1.0270682960444708,0.40948275862068967,0.7606509123075504,1.0,4/10,20.12%,UBXN2B;BICD1;NUP62;APC
prerank,mammary gland epithelium development (GO:0061180),0.4005212891028106,1.0270352725737697,0.4164859002169197,0.7597826575067168,1.0,1/14,0.32%,WNT4
prerank,protein polymerization (GO:0051258),-0.29234871260162804,-1.02673761312616,0.41379310344827586,0.6903482667100541,1.0,21/55,24.74%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;TRPV4;PREX1;ARL6;WASL;JAK2;CASQ2;WASHC5;GPX4;CHMP2A;PIN1;MSRB2;MICALL2;CORO7;AIF1;CASQ1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4189649441421388,-1.026644187834439,0.46409807355516636,0.6900729231212096,1.0,7/11,50.06%,NFKBIZ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3158985764117597,-1.026283509882861,0.3829787234042553,0.6904423977985562,1.0,12/37,19.11%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3839343458047221,-1.026048426029393,0.42418426103646834,0.6905557246836187,1.0,13/16,47.79%,TNFRSF21;TRIB2;VSIR;JAK3;LILRB1;DLL1;TYROBP;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,androgen receptor signaling pathway (GO:0030521),-0.43123542400993103,-1.0258309114969615,0.4336917562724014,0.6906279541520329,1.0,5/11,9.87%,DDX5;DDX17;PLPP1;KDM3A;ARID1A
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2673901815138213,1.0256934389932058,0.40078585461689586,0.7622796236865288,1.0,24/95,16.23%,CEMIP;GPC6;FMOD;UST;DCN;GPC4;GPC2;B3GNT7;PXYLP1;OMD;LUM;OGN;GPC5;DSE;CHST1;HS2ST1;HS6ST2;VCAN;CHSY3;HS3ST6;HS3ST5;HSPG2;CHSY1;ST3GAL1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.25816061956621045,-1.0254872934764088,0.4065040650406504,0.6909692410585121,1.0,16/96,8.37%,MEF2C;PTK2B;EGLN3;FOXO3;KCNB1;NGF;SIX1;TGFB2;PPARGC1A;BACE1;ATF4;TGFB3;TOX3;EGLN2;FOXQ1;BAX
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3636866875718508,1.0254822132366674,0.40625,0.761863394175088,1.0,2/23,1.40%,IGF1;NRG1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3692302967181318,1.025456162129408,0.425764192139738,0.7609853854477066,1.0,2/20,9.74%,AKR1B1;CYP46A1
prerank,generation of neurons (GO:0048699),0.24345647731811307,1.0250884687462392,0.40304182509505704,0.7610236147453553,1.0,32/190,14.23%,AUTS2;WNT4;NRP1;SEMA3A;GPM6A;ARTN;PTPRD;SH3RF1;ASTN2;HES3;CASP3;IL1RAPL1;LHX4;SIX4;DOCK7;NRCAM;HES5;RYK;ATOH8;CDK5R1;FUT9;EML1;PLXNB2;BRSK1;LRP12;FZD10;FGFR1;YAP1;MAPT;TUBGCP2;TAFA1;WNT6
prerank,positive regulation of dendrite extension (GO:1903861),-0.3772142358274312,-1.0248610696921239,0.42391304347826086,0.692022111355795,1.0,5/17,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.25859251300720837,-1.0248358509047046,0.41568627450980394,0.6915915318778041,1.0,48/105,36.47%,RPS6KA5;PLCG2;IKBKB;PSMA6;KRAS;PSMB5;RELB;FCER1G;PSMC4;ICAM2;PSMC5;PSMD14;SYK;HRAS;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PSMA1;PSMB1;PSMC3;PSMA4;NRAS;PSMA2;PRKCD;TRAF6;BCL10;PSMB8;CARD11;SRC;PSMC6;PAK2;TYROBP;PSMD6;PSMA8;CREBBP;MUC1;IKBKG;PSMD2;MUC13;PSMB2;MUC6;FYN
prerank,sensory perception of pain (GO:0019233),0.36857730201006467,1.024570634539353,0.4043956043956044,0.761372305031334,1.0,6/21,17.41%,P2RX4;OPRK1;TRPA1;CHRNA4;PTGES;SCN9A
prerank,cellular component disassembly (GO:0022411),-0.29081316835995324,-1.024468461755787,0.4074074074074074,0.6920097713332817,1.0,9/53,9.23%,TLL1;BSG;CAPN2;CD44;ADAM15;ADAM10;KIF9;MMP14;FLOT1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.22369353524207522,-1.0240158834216206,0.3794466403162055,0.692625649594969,1.0,108/264,35.00%,DDX5;NOVA2;HNRNPA2B1;DDX17;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;DCPS;SRPK1;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;SMN1;CDK13;EFTUD2;SF3A3;DDX20;DDX39B;PCBP1;GTF2F1;HNRNPA1;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;TGS1;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;CLNS1A;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;SNUPN;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,exit from mitosis (GO:0010458),-0.4207340956853468,-1.023850201314914,0.4573055028462998,0.6925738144777922,1.0,7/12,36.63%,EPS8;CHMP2A;PPP2R2D;CHMP7;CHMP4B;UBE2C;SIRT7
prerank,cellular response to nitrogen compound (GO:1901699),0.3707011092424181,1.0237911669843793,0.40772532188841204,0.7624195715529314,1.0,7/20,23.90%,ROCK2;BLM;DAXX;EPG5;ATP2B4;HSF1;TIMELESS
prerank,regulation of coagulation (GO:0050818),-0.42853275439899324,-1.0235063406514182,0.4448462929475588,0.6928755989801949,1.0,1/11,0.35%,CAV1
prerank,cation transmembrane transport (GO:0098655),0.31262999606160713,1.023414285385113,0.4066390041493776,0.76238830630914,1.0,8/44,7.08%,ATP1A2;SLC6A9;SLC7A2;TRPM3;TRPM1;MFSD12;TRPM5;ASIC2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2685619698041942,-1.0233863067774884,0.4076923076923077,0.6926746900981618,1.0,25/80,18.30%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;PRKDC;ABCG1;RPS27L;EIF3D;LARP4B;CIRBP;UPF3A;SOX4;ABCA2;SPHK2;FMR1;TNFRSF1A;ERBB2;PCIF1;RELA;IFNGR1;SP1;ZCCHC4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.27857547047367237,-1.0232146639558006,0.4166666666666667,0.6926066614460873,1.0,27/65,30.03%,ITGA1;AFAP1L2;PTPRJ;DAB2IP;EPN1;MVB12B;HIP1R;AKT1;HIP1;DUSP3;SHKBP1;PTPN12;TSG101;EGFR;BCAR3;NEU3;SPRY1;RHBDF2;CDC42;CCDC88A;PLAUR;EPS15;PTPN2;STAM2;STAM;MVP;ARAP1
prerank,negative regulation of heart contraction (GO:0045822),0.42324339296863506,1.0231259767436462,0.4264069264069264,0.7621681560545258,1.0,1/11,0.47%,ATP1A2
prerank,regulation of dendrite extension (GO:1903859),-0.3705548626902329,-1.0228331130210377,0.44223826714801445,0.6930126412631495,1.0,5/18,13.59%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,negative regulation of cilium assembly (GO:1902018),-0.42137297869598,-1.022466319481963,0.45540796963946867,0.6934091090235093,1.0,3/12,12.34%,LIMK2;MAP4;CDK10
prerank,regulation of steroid metabolic process (GO:0019218),0.3526037825947972,1.0224524216073236,0.4055793991416309,0.7630228517391188,1.0,1/23,0.19%,RORA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.29415276933969275,-1.0223698711828484,0.414,0.6931312774265286,1.0,14/51,10.46%,SORBS3;PXN;LIMCH1;ARHGEF15;FERMT2;RAC1;MYOC;TGFB3;RGCC;PPM1F;PFN1;SYNPO;S100A10;WNT11
prerank,central nervous system development (GO:0007417),0.23350983239692122,1.0219397820620264,0.3837638376383764,0.7633731241013281,1.0,45/250,14.10%,EPHA7;ARNT2;ROBO2;ATXN1;TBX3;CHST8;CNTN4;ZIC1;AFF2;CNTNAP2;CHD7;PBX4;PRKN;GSTP1;ASIC2;LOXL3;GRIK1;ADGRA2;SCIN;NRCAM;HES5;ATN1;CDK5R1;AHI1;PTEN;ZIC4;ANKLE2;EML1;EEF1AKMT4-ECE2;RPS6KA6;PLXNB2;CTNS;EIF2B5;PHF8;COX7B;PAX8;GBA2;VCAN;NKX2-1;CNTN6;POU6F2;TUBGCP2;CXCR4;GRIN2A;AMIGO1
prerank,cellular response to gamma radiation (GO:0071480),-0.3721418912092961,-1.0218585614360363,0.4423791821561338,0.6938604834442066,1.0,6/17,18.35%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB
prerank,RNA transport (GO:0050658),-0.2720003549552771,-1.0218457914231223,0.40118577075098816,0.6934076404224857,1.0,22/71,22.46%,TGFBR2;HNRNPA2B1;SRSF2;SRSF5;SRSF6;FLOT1;U2AF1;ZC3H11A;RNPS1;NUP188;FMR1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;DDX39B;HNRNPA1;CASC3;THOC6;DDX39A;NCBP2
prerank,positive regulation of axon extension (GO:0045773),0.3591206110482335,1.0215321160763031,0.4020618556701031,0.7634049679271026,1.0,2/22,1.18%,NRP1;SEMA5A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.36993068953590647,-1.0215224629152,0.43097014925373134,0.6936957844826755,1.0,6/18,19.51%,RAP1A;RAP1B;SLC4A8;FMR1;RIMS4;DTNBP1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4441919904473626,-1.0213718280266113,0.4404332129963899,0.6935779947921644,1.0,4/10,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,endomembrane system organization (GO:0010256),-0.23962490677758347,-1.021066323158087,0.38445378151260506,0.693864801956148,1.0,45/178,20.30%,SYNE1;ATP8B1;SPTBN1;SRGN;CAV2;MYOF;PI4K2A;ZW10;BCAS3;HTT;GORASP2;DYSF;FAM174B;CHMP2B;PLEKHM2;A4GALT;NUP93;USP8;ATL3;TRIP11;SPTSSB;ATL2;TRAPPC11;BAG5;SURF4;VMP1;ALS2CL;NUP155;RAB1A;DOP1B;COG3;GOLGA5;GOLGA8B;VPS11;LMAN2;WASHC5;LAPTM4B;REEP4;DNM1;TMED1;PLEKHF1;TOR1AIP2;TMED5;ATP8B2;COG2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2884918802695212,-1.0210310203275492,0.42778793418647165,0.6934738576690602,1.0,24/53,30.22%,OPHN1;DAB2IP;HSP90AB1;UBB;PKD1;GPX1;FOXF2;DDRGK1;PSMC5;PSMD14;APOE;FMR1;UFL1;OSBPL7;PSMC3;RAD23A;ALAD;TREM2;F8A1;RAD23B;USP14;XPO1;PSMC6;ECSCR
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.32041254220472837,-1.0207978780548503,0.4254545454545455,0.6935575960531088,1.0,14/34,27.93%,PTPRB;PTPRJ;DUSP3;PTPN12;PTPN6;UBASH3B;PTPRO;PTPRQ;PTPN22;PTPN1;DUSP4;DUSP6;PTPN2;DUSP1
prerank,regulation of response to oxidative stress (GO:1902882),0.425067517689143,1.0203514926662594,0.43946188340807174,0.7653666177437419,1.0,3/11,14.30%,PRKN;GGT7;STOX1
prerank,phospholipid homeostasis (GO:0055091),0.4145673961562658,1.0201975425236742,0.4427645788336933,0.7648232454931252,1.0,2/11,11.05%,ABCA1;TLCD2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3098100997358064,1.0200441366229829,0.4105263157894737,0.7642977009443338,1.0,4/41,7.92%,IGF1;IL4;GSTP1;TRIM27
prerank,lipoprotein catabolic process (GO:0042159),0.42086417122731384,1.020037967635588,0.4125560538116592,0.7633668692199582,1.0,1/11,0.50%,NOTUM
prerank,SNARE complex assembly (GO:0035493),-0.4353442665324977,-1.0200206992249876,0.44020797227036396,0.6949600961123771,1.0,1/10,1.02%,STXBP6
prerank,cardiac muscle cell contraction (GO:0086003),-0.36862862732527607,-1.0197598845085283,0.43795620437956206,0.6950700919450463,1.0,8/19,19.15%,KCNJ2;ATP1A1;CAMK2D;SCN1A;CACNA1D;PIK3CA;SCN2B;CACNA1C
prerank,positive regulation of heart rate (GO:0010460),0.3791161530785356,1.0196989974852722,0.4152542372881356,0.7632864674598522,1.0,5/17,10.72%,SCN3B;ATP2A2;ADM;ADRA1D;ADRA1B
prerank,sulfate transport (GO:0008272),-0.40737151181934333,-1.019537390782597,0.4236983842010772,0.6950944956433147,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2698376355284897,-1.0195000818226148,0.40784313725490196,0.6947088945958205,1.0,23/76,24.28%,TEK;SORBS3;BAIAP2L1;PTK2B;BCAS3;WDR1;LMOD1;EDN1;NES;PFN1;SYNPO;PRKCE;HRAS;LIMK1;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;HCLS1;CARMIL1;NCK2;CDC42
prerank,protein localization to centrosome (GO:0071539),-0.3783997010683008,-1.0192631687135791,0.42911153119092627,0.6947979082093687,1.0,4/17,11.72%,DCTN2;CEP192;NUDCD3;PCM1
prerank,regulation of synapse organization (GO:0050807),0.36568066470768157,1.0189846629153072,0.42735042735042733,0.764117026263966,1.0,10/26,17.95%,CTNNA2;SLITRK4;ARHGAP22;IL1RAPL1;CAMK2B;SETD5;PDLIM5;NEDD4;CLN3;ABHD17C
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32589643045934275,1.0181145700928018,0.4340425531914894,0.7654080644407188,1.0,3/33,2.65%,IL34;OCSTAMP;PRKCA
prerank,protein-DNA complex disassembly (GO:0032986),-0.3768540024939927,-1.0178596791117427,0.45108695652173914,0.6977026857551539,1.0,9/16,37.59%,RPL23;ARID1A;SMARCA4;SMARCC1;SMARCD2;MYC;SMARCD3;NFE2;HMGA1
prerank,ether lipid biosynthetic process (GO:0008611),0.43837847400367475,1.0174906359713638,0.43506493506493504,0.7660834245152994,1.0,2/10,2.58%,CHPT1;PLA2G4A
prerank,negative regulation of response to wounding (GO:1903035),-0.3669408232793638,-1.0173995172365629,0.4519056261343013,0.698325568135412,1.0,10/19,37.69%,CD109;CRK;FGF2;RTN4RL1;RTN4R;CERS2;ALOX5;PTPRS;KLK8;INPP5F
prerank,rRNA 3'-end processing (GO:0031125),-0.43327750725900416,-1.0170820627505266,0.4390681003584229,0.6985901604478199,1.0,3/10,17.09%,RPS21;ERI1;EXOSC8
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.34202668692415056,-1.0170700378010122,0.4220532319391635,0.6981272107052989,1.0,3/27,3.48%,CHST11;CSGALNACT1;CSPG4
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4264840583029413,-1.0166252992404934,0.47513812154696133,0.6987460788090296,1.0,6/11,22.33%,CCN3;JUP;VCL;DSP;THBS4;CAMSAP3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2542313316702957,-1.016529350394617,0.4329501915708812,0.6985032773898857,1.0,31/109,17.68%,PLCG2;PIP5K1B;BMX;PLCB3;PI4K2A;INPP5D;PIK3R6;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;PIP4P1;PIK3C2A;PLAAT3;PITPNM2;MBOAT7;RUFY1;PITPNM3;RAB4A;FGF2;CSF1R;PIK3R3;PITPNM1;PIK3CA;MTM1;SYNJ1;PIK3R2;FIG4;PIK3C2B;PIGW
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3095282345285047,-1.016484521401276,0.4331450094161959,0.6981230559837458,1.0,10/33,21.43%,FOXO3;ETS1;PRKDC;TAL1;INHBA;STAT1;HSPA1A;FAM210B;MAPK11;HSPA1B
prerank,N-glycan processing (GO:0006491),-0.3700925135423916,-1.0160690380083874,0.4525691699604743,0.6986197718899974,1.0,5/18,9.28%,ST8SIA4;GANC;ST8SIA6;MAN1B1;FUT8
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.24732574780951253,-1.0158628843444248,0.4101010101010101,0.6986415055738421,1.0,43/128,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,sodium ion homeostasis (GO:0055078),0.3544670464213188,1.0155415961141256,0.42528735632183906,0.7701208390858238,1.0,2/21,1.17%,ATP1A2;SLC8A1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3532516922676975,1.015422993303248,0.43073593073593075,0.7694768355674453,1.0,2/24,2.58%,PLA2G5;PLA2G4A
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3422358665942171,1.0153726422360232,0.43610547667342797,0.7686935696937303,1.0,3/25,5.41%,NRP1;AR;GLMN
prerank,regulation of DNA binding (GO:0051101),-0.3003510005131974,-1.014974386801812,0.43902439024390244,0.7002920832244716,1.0,15/44,19.98%,LEF1;NFKBIA;ZBTB7A;NGF;TGFB1;SMO;CSNK2B;E2F1;HES1;SUMO3;JAK2;KDM1A;MDFI;SKI;EDF1
prerank,cellular response to radiation (GO:0071478),-0.30021584561334186,-1.0146892278427126,0.4519774011299435,0.7005154868264155,1.0,21/40,32.43%,NET1;EEF1D;RAD1;RHOB;RAD9B;OPN3;HUS1;RAD9A;CDKN1A;ECT2;GADD45A;CLOCK;RHNO1;RAD51AP1;LIG4;TNKS1BP1;SWI5;RRH;OPN1MW3;OPN1MW;FIGNL1
prerank,mRNA polyadenylation (GO:0006378),0.3402004229596336,1.0145113496144413,0.4344086021505376,0.7689805098631728,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.3402004229596336,1.0145113496144413,0.4344086021505376,0.7689805098631728,1.0,15/26,28.42%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;TENT2;MTPAP;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,cellular response to organic substance (GO:0071310),0.2563592989925417,1.0144967958181996,0.41453831041257366,0.7680847859201804,1.0,19/116,9.35%,ROBO2;PID1;PTPN13;CLEC3B;NCOA2;NFAT5;SMAD3;STAT5B;SFRP1;GHR;NLRP12;IL1RAPL1;DPYSL3;TGFBR1;IL18;IL1RL2;NCOA1;PTPN4;BMPR1A
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.30067235645879586,-1.0141907125076428,0.45366795366795365,0.7012230471216365,1.0,18/45,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3210212703028855,-1.0140783440168621,0.44571428571428573,0.7009509907560313,1.0,17/35,30.10%,DAB2IP;MFHAS1;MINK1;VEGFA;EZR;ULK4;GADD45G;EMC10;GADD45A;LGALS9;PTPN22;TREM2;DUSP1;SPI1;RASGRP1;XDH;PJA2
prerank,spermatid development (GO:0007286),-0.32525823465353043,-1.0139514846219075,0.4398496240601504,0.700766189126327,1.0,11/32,28.45%,JAM2;CEP57;CIB1;TDRD5;RFX2;NECTIN2;IQCG;SYCP3;MKKS;CDYL;RNF8
prerank,replicative senescence (GO:0090399),0.40734710524506745,1.0138804130378334,0.44042553191489364,0.7686953036033781,1.0,4/12,17.96%,PLA2R1;SERPINE1;ATM;TP53
prerank,calcium ion homeostasis (GO:0055074),0.2634673063205065,1.0138667258591085,0.42535787321063395,0.767802096816926,1.0,14/95,8.94%,SLC24A3;SLC8A1;CYP27B1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2
prerank,axon development (GO:0061564),0.27321027284506233,1.0134951954902438,0.4090909090909091,0.7678350151252678,1.0,18/78,14.15%,FGFR2;SEMA5A;CNTN4;CTNNA2;SLITRK4;NREP;RTN4;DOCK7;NRCAM;RYK;RAB10;CDK5R1;DCC;BRSK1;LLGL1;MAPT;AMIGO1;DRD2
prerank,positive regulation of protein import (GO:1904591),0.336352077335111,1.0133497651311894,0.44776119402985076,0.7672647664432038,1.0,3/30,2.77%,PIK3R1;ZIC1;SMAD3
prerank,negative regulation of axonogenesis (GO:0050771),0.3423243102566141,1.0132731017891496,0.427061310782241,0.766523070690914,1.0,9/27,15.69%,LRP4;MCF2;RTN4;CDKL3;DCC;PTEN;NGFR;ULK2;TRIM46
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3696203129449348,-1.0131920327568449,0.4356060606060606,0.7016652488465681,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,glutathione derivative metabolic process (GO:1901685),-0.3696203129449348,-1.0131920327568449,0.4356060606060606,0.7016652488465681,1.0,14/20,38.99%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD;MGST1;HPGDS;GSTM4
prerank,positive regulation of reproductive process (GO:2000243),0.3317101815049869,1.0128857972884726,0.4276315789473684,0.766563469430159,1.0,5/31,7.11%,HYAL3;PRDM9;CFAP69;SMURF2;SIRT2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3710781424360054,1.012761812180957,0.448512585812357,0.7659403527588268,1.0,8/19,23.42%,AMPD3;GMPR;APRT;POLD1;POLD3;POLD2;AMPD2;DGUOK
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3397450051509921,-1.0127263893998424,0.44294003868471954,0.7022764921551764,1.0,9/24,20.01%,B2M;TAPBP;ERAP1;IDE;FCER1G;ACE;BCAP31;TAP2;SEC24B
prerank,histone H3-K4 methylation (GO:0051568),0.3413994940552102,1.0126629574145416,0.43655913978494626,0.7652663706817832,1.0,9/26,15.53%,WDR5B;PRDM9;SETMAR;MEN1;KMT2A;CXXC1;PAXIP1;DYDC2;WDR82
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3591043264489369,1.0125253289247702,0.43526785714285715,0.7646925781830013,1.0,2/22,2.05%,ZBTB20;PPARA
prerank,regulation of protein sumoylation (GO:0033233),-0.3834400530570564,-1.0121406608805437,0.4605263157894737,0.7031698375811368,1.0,9/17,32.73%,HDAC4;SAE1;UBA2;PARK7;CTNNB1;MUL1;CAPN3;EGR1;RASD2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3474611272550819,-1.0120832554233234,0.4450651769087523,0.7028014578610167,1.0,7/23,10.73%,DPP4;SLIT2;JAM3;RAC1;TIRAP;MOSPD2;CD74
prerank,cytoskeleton organization (GO:0007010),0.2556043853194284,1.0120115544893045,0.404296875,0.7650494211537232,1.0,19/114,10.68%,MICAL3;SH3D19;EPB41L3;RHOH;PHIP;FGD4;RHOBTB1;ZMYM6;ANK1;FMNL3;TNIK;FGD1;AJUBA;RHOBTB3;BRWD1;CAMSAP1;PRKCI;CECR2;MICAL1
prerank,second-messenger-mediated signaling (GO:0019932),0.26967021523545087,1.0119537263335945,0.40372670807453415,0.7642705646995972,1.0,13/82,10.25%,RCAN2;PDPK1;DGKD;P2RX4;CCR6;ACKR4;ACKR2;CCR10;CHRM3;HRH1;PPP1R9A;CCR9;MCTP2
prerank,actin filament polymerization (GO:0030041),-0.3268826618664935,-1.0118850980271359,0.4291044776119403,0.7027867881001599,1.0,14/29,23.82%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;PREX1;WASL;JAK2;WASHC5;MSRB2;MICALL2;CORO7;AIF1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3945747144712759,-1.0118292592336284,0.4364326375711575,0.7024168054831493,1.0,5/14,16.80%,UQCC2;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,Notch signaling pathway (GO:0007219),-0.2813080531149735,-1.011742956978171,0.4269230769230769,0.7021511668931152,1.0,17/59,16.32%,SORBS2;NOTCH3;NOTCH1;ADAM10;HEYL;JAG2;NOTCH4;DTX3;PSENEN;PLXND1;ZNF423;ITCH;HES1;APH1A;HEY1;DTX2;STAT1
prerank,negative regulation of chemokine production (GO:0032682),-0.3935601537581066,-1.0117148434925827,0.4388888888888889,0.7017306532636167,1.0,2/14,2.59%,MAP2K5;KLF4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.4208776358758368,1.0111729661832447,0.4416135881104034,0.7653235851449139,1.0,2/12,6.08%,AR;GSTP1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41121146145634807,1.0110944082964686,0.4314159292035398,0.764583300962751,1.0,5/12,17.90%,PPARA;FUT4;FUT9;ASS1;MIA3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.4158218209475306,-1.0106538077992926,0.46880570409982175,0.7037398590444733,1.0,3/12,8.25%,PAICS;ADSS2;IMPDH1
prerank,mitochondrial translational termination (GO:0070126),-0.25853379877535987,-1.0105067445059586,0.43209876543209874,0.703612274667935,1.0,34/88,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,protein localization to kinetochore (GO:0034501),-0.3985463058581864,-1.010170115247809,0.4690909090909091,0.7039330312503412,1.0,7/14,31.36%,ZW10;RCC2;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.32257230417164884,-1.0101372143442888,0.4549019607843137,0.703525086578089,1.0,11/28,26.04%,STMN2;PRUNE1;GAS2L1;MAP1B;MAPRE2;ARL2;MAP1A;FKBP4;CAMSAP3;STMN1;SKA3
prerank,regulation of mitochondrial translation (GO:0070129),-0.3526232342063075,-1.010043924497408,0.448692152917505,0.7032558364675005,1.0,6/21,16.80%,UQCC2;TSFM;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,regulation of transport (GO:0051049),0.3169371062050528,1.0100227468847933,0.4330543933054393,0.7664352728543969,1.0,5/36,5.39%,NRP1;LEPR;WWC1;SCFD1;PRKN
prerank,macromolecule catabolic process (GO:0009057),-0.3382179185018372,-1.0099151877420351,0.4599236641221374,0.7030831887067069,1.0,6/26,16.02%,TPP1;TGFB1;IDE;KIF16B;SMURF1;UCHL3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2628804338312407,-1.0098551951503543,0.4269005847953216,0.7027436731315939,1.0,20/84,14.96%,DDX5;NOVA2;MBNL1;ZBTB7A;DDX17;REST;QKI;RBFOX2;SRPK1;SRSF6;NCL;PCBP4;JMJD6;CIRBP;RNPS1;FMR1;SRSF4;SFSWAP;MAGOH;HNRNPK
prerank,negative regulation of gene expression (GO:0010629),-0.22163385149445947,-1.0098165579623775,0.4394904458598726,0.7023652406101055,1.0,73/302,20.37%,FOXP1;MEF2C;OCLN;CLDN5;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;SRGN;SLC7A5;RACK1;KDR;NCOR1;KLF4;RPS3;IGFBP5;TGFB1;REST;APP;TGFB2;SMO;REL;HDAC9;WWP2;ADAM10;RPS13;VEGFA;CNOT7;MPHOSPH8;AEBP2;PTBP3;N4BP1;GATA2;RGCC;GAPDH;YY1;NCL;RB1;DDRGK1;H3-3A;RPL13A;CAPRIN1;DIS3L2;YTHDF2;APOE;FGF2;FMR1;ENG;HRAS;EPC1;FLOT2;BMI1;TASOR;ATP2B1;RBBP4;RNH1;HSPA1A;PCIF1;LSM14A;GIGYF2;CNPY2;DLL4;RPS26;PTGER4;MSR1;LSM2;TYMS;PAIP2B;PTRH2;SYNCRIP;LGALS9;TMBIM6
prerank,dicarboxylic acid catabolic process (GO:0043649),0.40583154971407115,1.0096243473390973,0.4420131291028446,0.7665422492902018,1.0,3/13,8.62%,ASPA;DDO;GLUL
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3092871416265129,1.0095654138623675,0.4223194748358862,0.7657722396300591,1.0,14/44,16.37%,ROCK2;NANOS3;TNRC6A;CPEB3;POLR2G;FTO;RIDA;PNPT1;KHSRP;TNRC6B;METTL16;RBM24;METTL3;TOB1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3869030134418738,1.0095172932220573,0.43171806167400884,0.7649662065348452,1.0,3/16,5.08%,PID1;PPARA;IL4
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2638184137230521,-1.0089126876814145,0.45664739884393063,0.7041346738033084,1.0,31/80,27.62%,KLC1;ZW10;KDELR1;HTT;NAPA;TAPBP;ARF5;RAB6B;ATP9B;ERGIC1;KIF23;COPG1;SURF4;KIF26A;TMEM115;COPB2;RAB1A;COG3;LMAN2;NSF;KIF18A;KIF1C;USE1;KIF22;COPZ2;GOLPH3;GOLPH3L;TMED3;ARF3;RACGAP1;DNAJC28
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4074056393315211,1.0079016713132858,0.45617977528089887,0.768242777101287,1.0,3/13,8.31%,TICAM1;AXL;IL18
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3693024876606111,1.0074456884966425,0.4355179704016913,0.7685190373021676,1.0,3/19,6.04%,PPARA;IRS2;ABCD2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2899103653415464,-1.0072376309340576,0.437137330754352,0.7077745879299656,1.0,7/51,5.68%,ANO6;THBS1;MAPK3;PTK2;VEGFC;CMKLR1;VEGFA
prerank,macroautophagy (GO:0016236),-0.24523424014994363,-1.0070954878887326,0.4404040404040404,0.7076434475898616,1.0,36/118,21.48%,PLEKHM1;MAP1LC3B;VAMP7;CHMP2B;GABARAP;LIX1L;MTMR14;TECPR1;PLAA;ATG3;CSNK2B;ATG7;VCP;ULK3;KLHL3;TOMM22;MTERF3;VPS36;MAP1LC3A;PGAM5;TSG101;PRKAG1;SNF8;CSNK2A1;CSNK2A2;VPS16;AMBRA1;VPS33A;VTI1B;CHMP2A;ARL8B;DYNLL2;WIPI2;TOMM5;RUBCNL;VPS41
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3367163074706081,-1.0067777869658832,0.4567669172932331,0.7079720212586473,1.0,4/27,3.87%,VPS13D;VPS13A;GBP5;IFT20
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34180075006658855,-1.006065998818585,0.4550561797752809,0.7091793314050594,1.0,11/23,31.09%,HSP90AB1;NLRC5;JAK2;NR1H2;STAT1;IFNGR1;TXK;PTPN2;PARP14;IRGM;PARP9
prerank,DNA strand elongation (GO:0022616),0.3646035438623686,1.0057230269589008,0.4497716894977169,0.7719831496594763,1.0,8/18,23.13%,MCM3;GINS2;NBN;POLD3;MCMDC2;POLD2;DCLRE1B;MCM7
prerank,regulation of peptidase activity (GO:0052547),-0.3589118668947832,-1.005302705469573,0.4540337711069418,0.7105214798103654,1.0,3/19,8.73%,CAV1;NDUFA13;CST3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3830416544163697,-1.005210013405796,0.4612546125461255,0.7102359532907266,1.0,4/14,13.71%,NOS3;EDN1;ACE2;ACE
prerank,regulation of anoikis (GO:2000209),-0.3668320546416392,-1.004778775781824,0.46153846153846156,0.7108250653555368,1.0,3/19,2.88%,CAV1;NOTCH1;PTK2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.39730315537517574,1.0047358526417505,0.4482758620689655,0.7735333712358277,1.0,1/13,0.21%,ENPP1
prerank,protein dephosphorylation (GO:0006470),-0.24370361092726356,-1.0046122885779187,0.4603174603174603,0.7107479572574337,1.0,46/135,27.17%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;RPRD1B;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;PPP2R5E;UBASH3B;UBLCP1;DUSP11;PTPRK;NCK1;PPP2R2D;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;PPEF2;MTMR2;PPP2R5B;PDP1;RPRD1A;DUSP6;PTPN2
prerank,negative regulation of platelet activation (GO:0010544),-0.38140727671497454,-1.003806919055243,0.46825396825396826,0.7122027062731288,1.0,7/16,16.44%,NOS3;PRKG1;THBD;CD9;PDGFA;APOE;ADAMTS18
prerank,histone H4 deacetylation (GO:0070933),-0.4200809830201785,-1.0036644304535447,0.46619217081850534,0.7120708198372415,1.0,3/10,8.31%,REST;HDAC9;HDAC4
prerank,positive regulation by host of viral transcription (GO:0043923),-0.38407833803976843,-1.0035763811087264,0.474671669793621,0.7118063035421291,1.0,1/15,0.14%,LEF1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.3026741658952953,-1.0031125153098341,0.43423423423423424,0.7124383945048395,1.0,12/38,19.15%,CAV1;KCNJ2;CAMK2D;KCNQ1;JUP;CTNNA3;CACNA1D;DSG2;KCND3;DSP;SCN2B;CACNA1C
prerank,cilium organization (GO:0044782),-0.22983165360572205,-1.0030977766829914,0.46825396825396826,0.7119844071133463,1.0,49/209,19.78%,ABLIM1;ABCC4;EXOC4;NOTCH1;EXOC6;FNBP1L;RAB11A;CDC14A;EHD4;RAB8B;IFT20;CEP164;ABLIM3;PKD1;TTC17;EHD2;CEP162;BBIP1;INPP5E;NUDCD3;DISC1;TMEM237;CPLANE2;IFT46;RAB8A;CEP290;EXOC1;FHDC1;STK36;PCM1;CC2D2A;ACTR3;POC1B;CDC14B;ARL6;RFX2;RAB11FIP3;RAB1A;CCDC28B;KIF24;DNAH5;CEP41;TMEM67;EHD1;SPAG16;TMEM231;EHD3;DYNLL2;IQCG
prerank,telomere organization (GO:0032200),0.30667581247384285,1.0026743791728792,0.4288840262582057,0.7779281314016621,1.0,18/43,21.95%,STN1;BLM;RPA2;NBN;ATM;RIF1;RPA1;PARP3;PARP1;SP100;POLD4;POLD1;RTEL1;PCNA;POLD3;DOT1L;POLD2;DCLRE1B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3938133832598153,-1.002635590847847,0.47202797202797203,0.7126529375404733,1.0,10/14,37.20%,RPS3;CD81;NECTIN2;RELA;PRKD2;BCL10;CARD11;IKBKG;CD226;TESPA1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.32660047870458164,-1.0026130381334475,0.46525096525096526,0.7122150046494312,1.0,12/31,21.06%,CNOT7;DCPS;HBS1L;DIS3L2;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,Rho protein signal transduction (GO:0007266),-0.2910522607237298,-1.0025658400253288,0.4582560296846011,0.7118290540340879,1.0,16/53,15.29%,ARHGEF3;RHOJ;EPS8;EPS8L2;ARHGAP1;ARHGDIA;SHTN1;ARHGDIB;ADGRG1;PHACTR4;RHOB;CFL1;RTKN;NTN1;CELSR1;LIMK1
prerank,hexose transmembrane transport (GO:0008645),-0.34813910886960797,-1.0023768558363872,0.45569620253164556,0.7118124226886193,1.0,8/21,28.76%,SLC2A1;PPARD;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4022764687319268,-1.0019760596369607,0.45729537366548045,0.712259992107191,1.0,5/13,17.33%,CD44;TWIST1;PTTG1IP;CD74;KDM1A
prerank,positive regulation of vasoconstriction (GO:0045907),-0.395731422032787,-1.001909138077276,0.45588235294117646,0.7119299637780817,1.0,1/13,0.35%,CAV1
prerank,negative regulation of autophagy (GO:0010507),-0.28036559048528065,-1.001423622040417,0.43357933579335795,0.7126524897647554,1.0,19/54,25.40%,RASIP1;DAPL1;EIF4G3;FOXK1;QSOX1;AKT1;ATG7;PIK3CA;MET;TAB2;MCL1;RRAGA;EIF4G1;PTPN22;WDR6;SMG1;RUBCN;EIF4E;TREM2
prerank,regulation of cation transmembrane transport (GO:1904062),0.32177027829332694,1.0013463180782307,0.4357298474945534,0.7803242786403787,1.0,12/29,23.03%,KCNIP4;DPP10;KCNIP3;DPP6;WNK3;FGF12;ATP2B4;DLG1;PDZK1;KCNAB2;SCN5A;RANGRF
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4279051632480823,-1.0008806045828358,0.4805194805194805,0.7134601642173753,1.0,3/10,6.47%,OPHN1;MSN;EZR
prerank,nuclear transport (GO:0051169),-0.3751766174675172,-1.0008470523465993,0.4824399260628466,0.7130586557989563,1.0,11/16,39.93%,ANP32A;NXT2;PSIP1;NPM1;NUP98;XPO1;BANF1;RBM15B;RSRC1;HMGA1;NXT1
prerank,response to ATP (GO:0033198),-0.365658146394832,-1.0007572830419857,0.4635036496350365,0.7128173175285464,1.0,2/18,2.17%,TRPC3;ABCC9
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4175454512346509,-1.0005991346962146,0.4661508704061896,0.7127544087016455,1.0,5/11,12.53%,WDR1;STMN2;NES;TRPV4;KATNB1
prerank,negative regulation of cation channel activity (GO:2001258),-0.33644959476104697,-1.000553919192993,0.44770642201834865,0.7123944322017313,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3229850645210741,-1.000498319413629,0.44639376218323584,0.7120426756074677,1.0,11/32,25.22%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;FKBP4;CDH5;APC2;CAMSAP3;STMN1
prerank,regulation of phospholipase C activity (GO:1900274),0.3903632602305571,1.000235446639029,0.4331896551724138,0.7822326248748412,1.0,6/15,12.50%,NTRK3;KIT;PDGFRA;PDGFRB;BICD1;FGFR1
prerank,regulation of myoblast differentiation (GO:0045661),-0.3138131657539049,-1.0001425923108846,0.4373795761078998,0.7124386819931553,1.0,5/32,5.28%,MEF2C;NOTCH1;BOC;TGFB1;IGFBP3
prerank,positive regulation of cellular protein localization (GO:1903829),-0.26495302822892847,-1.0000926164247184,0.48148148148148145,0.7120788755995628,1.0,30/69,31.49%,LIMK2;STX3;TFRC;FERMT2;HSP90AB1;TGFB1;RIC3;GPR137B;AKT1;DDRGK1;GAS8;CDK5RAP3;MAP1A;NDC80;SESN2;MEAK7;DTX3L;NECAB2;CCDC88A;PARK7;CARD10;STX4;LAMTOR5;ENTR1;PLK1;PARP9;TRAPPC12;TYROBP;CDK1;PARD6A
prerank,negative regulation of nervous system development (GO:0051961),-0.3716200907526535,-0.9999326525521266,0.4612476370510397,0.7119719159756379,1.0,3/17,4.11%,B2M;NOTCH1;REST
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.4312960559576868,-0.9998816317098215,0.4629294755877034,0.7116275628692833,1.0,3/10,16.67%,HSP90AB1;RB1;HSP90AA1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.40374699133538866,0.9994708682666349,0.47191011235955055,0.7832601626386385,1.0,2/13,4.38%,PHF23;SCFD1
prerank,positive regulation of vascular permeability (GO:0043117),-0.40076039037291095,-0.9993251212081032,0.4672897196261682,0.7124882884258793,1.0,6/12,10.66%,OCLN;TJP2;TGFB1;PDE2A;VEGFA;TRPV4
prerank,positive regulation of protein kinase activity (GO:0045860),-0.2379716905689422,-0.9989485548588567,0.4306418219461698,0.7129042266365732,1.0,37/148,19.85%,RAP1A;TGFBR2;PTK2B;IQGAP1;PTK2;DAB2IP;HSP90AB1;CALM1;TGFB2;RALB;NEDD9;MINK1;VEGFA;TAOK3;RASSF2;INSR;EMP2;LRP8;CAMK1;TAOK2;CIB1;MTCP1;CALM3;SRCIN1;CSF1R;ACE;LCP2;MMD;PRKAG1;CAB39;CDKN1A;HSP90AA1;TAB2;AGAP2;ECT2;ITGB3;TPX2
prerank,protein glycosylation (GO:0006486),-0.24114755642342292,-0.9988318260582577,0.44763860369609854,0.7127046391781721,1.0,44/125,27.54%,ST3GAL6;ST3GAL4;EOGT;ST8SIA4;TRAK1;PLOD2;TMEM165;SLC39A8;AQP11;ST8SIA6;MGAT1;C1GALT1C1;GALNT10;FUT8;KRTCAP2;DAD1;POGLUT1;PLOD3;GFPT1;ST6GALNAC2;SERP2;NPC1;COG3;TMEM258;POMK;OGA;ALG9;NUS1;B3GNT3;B3GNT8;ALG12;MGAT5;ALG1;PGM3;LARGE1;MPI;GCNT4;POMGNT2;RPN2;ALG2;GALNT6;GALNT9;ALG3;STT3B
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3301845063996957,-0.9988036359955159,0.464354527938343,0.7122922651107222,1.0,11/29,21.06%,CNOT7;DCPS;HBS1L;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM7;LSM3
prerank,cellular metal ion homeostasis (GO:0006875),0.25689568477769215,0.9986754716449403,0.4439918533604888,0.7843099215836852,1.0,15/102,9.00%,ATP1A2;SLC24A3;SLC8A1;SLC24A5;ANK2;DMPK;ATP13A3;CSRP3;ATP2A2;TNNI3;NPTN;ATP13A4;SLC24A4;SLC24A2;SLC41A1
prerank,phosphate ion transport (GO:0006817),0.3855850942817496,0.9985962931410456,0.4838012958963283,0.7836097035112443,1.0,3/16,7.31%,SLC17A1;SLC20A2;SLC25A10
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2906871451777443,-0.9981983990115698,0.4598825831702544,0.7132224818619638,1.0,13/45,19.21%,DDX5;HNRNPLL;TGFB1;RBM20;RIPK1;NMD3;RBM22;ZC3H18;HRAS;EGFR;HSPA1A;RELA;ZPR1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3890380785181803,0.997962743014892,0.47404063205417607,0.7842691430822908,1.0,3/14,6.04%,PPARA;IRS2;ABCD2
prerank,positive regulation of RNA splicing (GO:0033120),0.3261240507720599,0.9976303700462545,0.4587737843551797,0.7841854737295504,1.0,4/29,7.63%,PIK3R1;DAZAP1;TRA2A;CELF4
prerank,cholesterol biosynthetic process (GO:0006695),-0.3171013768380596,-0.9975514301398098,0.4381139489194499,0.7143043047830521,1.0,14/31,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,outer dynein arm assembly (GO:0036158),-0.38513033004282493,-0.9971941821981822,0.4763572679509632,0.7147268396632347,1.0,8/14,34.95%,ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;DNAH17;DNAAF4;CCDC63
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.39494900992683235,-0.9971012632841796,0.45960502692998206,0.7144737700055102,1.0,6/13,27.90%,CHP1;UFM1;RANGAP1;RAB23;PARK7;BARD1
prerank,regulation of endocytic recycling (GO:2001135),-0.4173215929233742,-0.9966818084240778,0.46886446886446886,0.7150397408570185,1.0,4/11,18.42%,ARHGAP1;EHD2;RAB11B;EHD1
prerank,peptidyl-threonine modification (GO:0018210),-0.2728124673880017,-0.996496401542883,0.4425612052730697,0.715018917045298,1.0,16/66,16.04%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2809999097266653,0.9964935520917909,0.46169354838709675,0.7861357140109295,1.0,10/59,14.23%,ALDH1A2;CYP7B1;CYP27A1;ACSM5;BAAT;CYP46A1;NDUFAB1;OSBP;MCAT;ACACA
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4045534171033214,0.9961996511977109,0.4541577825159915,0.7859755825483721,1.0,2/13,1.64%,TBX3;PRICKLE1
prerank,regulation of MAP kinase activity (GO:0043405),-0.257337395621968,-0.9961343048336375,0.4437869822485207,0.7153655841610089,1.0,40/92,28.62%,FLT1;PTPRJ;FGF1;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;EDN1;TRIB2;PDGFC;PDGFA;TRIB1;UCHL1;NF1;STK38;APOE;FGF2;HRAS;TSG101;EGFR;ERBB2;SNF8;NOD2;SPRY1;CDK5RAP3;TRIB3;PDCD10;PTPN1;PIK3CG;PRKCD;PIK3R5;PPEF2;FGF18;NEK10;SMPD1;SPRY4;DUSP1;RASGRP1;CD24
prerank,leukotriene biosynthetic process (GO:0019370),0.38733301918540586,0.9961162127953616,0.46621621621621623,0.7852775111769812,1.0,3/14,6.00%,PLA2G5;PLA2G4A;GGT7
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4011922399599288,-0.9960619951347476,0.48484848484848486,0.7150638020580705,1.0,6/13,32.49%,IRAK2;PIK3AP1;IRAK4;TRAF6;PIK3R4;TNIP2
prerank,regulation of histone acetylation (GO:0035065),-0.31424315239785594,-0.9959859243241261,0.46946564885496184,0.7147601298334533,1.0,6/33,10.90%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;CAMK1;TADA2B
prerank,regulation of receptor internalization (GO:0002090),-0.31289859580653256,-0.9958987466654479,0.46153846153846156,0.7145195124529248,1.0,8/35,16.40%,RIN3;VEGFA;ANKRD13A;INSR;FLOT1;FMR1;SDCBP;GREM1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.37472225042066104,0.9952236692064537,0.45617977528089887,0.7865998358888268,1.0,4/17,13.62%,GJA1;THPO;LTBP3;N4BP2L2
prerank,endosome organization (GO:0007032),-0.30179003776607,-0.994825038701204,0.4666666666666667,0.7165781263729382,1.0,16/41,25.17%,PI4K2A;RAB27A;EEA1;CHMP2B;USP8;CLCN3;ALS2CL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;SNX3;ANXA8L1;ANXA8;PHETA2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4278408296463956,-0.9947657912893694,0.478584729981378,0.7162389539282107,1.0,3/10,7.75%,SMAD7;NFKBIZ;RC3H1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3840966501418612,-0.9947591486390293,0.45108695652173914,0.7157736610655464,1.0,5/14,14.03%,NT5E;UPP2;NT5C;NT5C1A;CAD
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23665811474891177,-0.9942589388499395,0.47780126849894294,0.716470242416238,1.0,49/144,23.42%,PPP1R13B;CDH1;KCNB1;TGFB1;BCAS3;PRR5L;ABLIM3;CHP1;MIEF1;CD81;PPP3CC;CASP8;JUP;RBM22;TRIM28;CEP290;MIEF2;CAMK1;CIB1;PCM1;SAE1;BBC3;YWHAZ;OAZ2;E2F1;MAVS;HRAS;VPS11;ERBB2;YWHAG;CSNK2A2;PIK3R2;YWHAH;RAPGEF3;BAD;TMEM30A;ECT2;UBL5;ZPR1;SFN;FZD5;RIPOR1;HCLS1;FIS1;PDCD10;NPEPPS;PLK3;MICALL2;PRKCD
prerank,lung development (GO:0030324),0.3210162417447701,0.9941745924677544,0.45841784989858014,0.7883262624312712,1.0,5/33,8.91%,ERRFI1;FGFR2;GLI2;LOXL3;NPHP3
prerank,T cell receptor signaling pathway (GO:0050852),-0.2411326316970553,-0.9938624122520716,0.48326359832635984,0.7169519230077707,1.0,41/138,23.10%,PTPRJ;PLCG2;WNK1;PDE4D;INPP5D;IKBKB;DENND1B;TNFRSF21;PSMA6;NFKBIZ;RC3H1;PSMB5;PSMC4;PSMC5;PSMD14;BTN3A3;LCP2;PSMD8;PIK3CA;EIF2B3;PSMD11;PIK3R2;PSMB4;PSMD12;PSMC1;TAB2;RELA;CUL1;CHUK;PRAM1;TXK;FYB2;NCK1;PSMA1;PSMB1;PSMC3;PRKD2;PTPN22;CSK;PSMA4;PSMA2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.42665815780500554,-0.9936974748390797,0.47601476014760147,0.7168751760997575,1.0,3/10,10.60%,SEC14L1;RNF125;DHX58
prerank,RNA processing (GO:0006396),0.2370494594665415,0.9935245624274129,0.46034816247582205,0.789046999327458,1.0,23/176,11.07%,CELF2;ATXN1;NOVA1;RBMS1;TUT4;AURKAIP1;PRKACA;SNRPN;ADARB2;AKAP8L;SNRPA1;RNPC3;HNRNPUL1;LIN28B;DHX8;MPHOSPH10;RBM5;SLU7;BICD1;PABPN1;HNRNPD;KHSRP;PIWIL2
prerank,organelle disassembly (GO:1903008),-0.31310250779235277,-0.9934133189705162,0.4635036496350365,0.7170236267998281,1.0,19/33,37.46%,KLC1;UFM1;KIF9;DDRGK1;VCP;VRK1;UFL1;UFC1;UBA5;STX5;PLK3;PLK5;KIF5B;CDK1;MTIF2;MCTS1;DYRK3;ULK1;PELO
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.416376033033366,-0.9932567767228424,0.4918032786885246,0.7169066567466317,1.0,7/11,30.55%,NDUFA13;TIMM29;TIMM13;TIMM10;TIMM8B;TIMM10B;ROMO1
prerank,protein localization to phagophore assembly site (GO:0034497),0.41739848892446607,0.9932495451501219,0.4889380530973451,0.7888103718956757,1.0,4/11,21.67%,WDR45B;WIPI1;ATG9A;WDR45
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.41114509152850764,0.9930498814165184,0.4718826405867971,0.7883903858188914,1.0,1/11,2.09%,PLA2G5
prerank,protein deneddylation (GO:0000338),-0.4199696557402874,-0.9927592199192364,0.47771836007130125,0.7175956164008367,1.0,6/10,26.57%,COPS6;COPS5;COPS7A;COPS4;COPS7B;GPS1
prerank,canonical Wnt signaling pathway (GO:0060070),0.27645466227134496,0.9927312325840062,0.45656565656565656,0.7883115518790025,1.0,16/68,15.79%,TCF7L2;WNT4;SFRP1;FRAT1;PLPP3;RARG;RYK;GATA3;DVL3;PTEN;FRZB;FZD10;WNT6;WNT5B;TCF7L1;PORCN
prerank,midbody abscission (GO:0061952),-0.36480185554361017,-0.9925409706333865,0.4891696750902527,0.7176537381132497,1.0,8/17,32.17%,CHMP2B;MITD1;CHMP2A;CEP55;VPS4A;CHMP7;CHMP4B;CHMP4A
prerank,protein hydroxylation (GO:0018126),-0.3722806649565051,-0.9923330490234648,0.4585635359116022,0.7176564165618269,1.0,7/15,29.09%,EGLN3;PLOD2;PLOD3;P3H2;HIF1AN;VPS33B;P3H1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.28033664024181243,-0.9921715741393468,0.45714285714285713,0.717541611039239,1.0,26/58,34.22%,PAXX;ZBTB7A;BRCC3;PRKDC;UIMC1;ERCC1;BABAM1;HERC2;PSMD14;DCLRE1C;CYREN;BABAM2;POLQ;ERCC4;POLL;LIG4;BARD1;RNF8;HMGB2;MRE11;POLB;PRPF19;NSD2;RAD50;ATP23;POLA1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.39521902297792744,0.9921320478230338,0.4631336405529954,0.788880428113368,1.0,4/13,8.69%,ALDH4A1;PRODH;GLUL;GLS2
prerank,iron ion homeostasis (GO:0055072),0.2824896361130357,0.9919437996526381,0.4638949671772429,0.7884104277633363,1.0,3/58,1.49%,BMP6;CP;HEPH
prerank,monocyte differentiation (GO:0030224),0.4269487029960923,0.9916218167223587,0.44976076555023925,0.7883076303992195,1.0,1/10,0.34%,IL31RA
prerank,aerobic respiration (GO:0009060),-0.35131673603598257,-0.9914795815316303,0.4807692307692308,0.7187047525399121,1.0,7/20,22.14%,ATP5F1D;MTFR1;SURF1;UQCRB;UQCRH;SDHB;MTFR2
prerank,response to peptide hormone (GO:0043434),0.3030174799709173,0.9909254601753594,0.4418103448275862,0.7892189463058483,1.0,4/43,3.15%,TGFBR3;ROCK2;STAT5B;GNAI1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4176398751506689,-0.9908769253354255,0.48375451263537905,0.7196703083171234,1.0,7/11,30.82%,MFHAS1;TIRAP;TNFAIP3;TREM2;TLR6;PJA2;TLR1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3735586112353971,0.9906953575138171,0.4841628959276018,0.7888738723737233,1.0,2/17,3.32%,ANK2;CACNA2D1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3772945966021735,-0.9906692408755904,0.49168207024029575,0.7196913132626526,1.0,2/15,6.27%,HMGCS2;ACLY
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2809965284094748,-0.9903418892264778,0.4625984251968504,0.7199829149570826,1.0,18/56,17.48%,TEK;FLT1;PTK2B;KDR;PTK2;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;JAK2;EGFR;ERBB2;PTPN6;JAK3;HCK
prerank,negative regulation of T cell differentiation (GO:0045581),0.4218579204089836,0.9902282391102771,0.4501108647450111,0.7891511876693449,1.0,2/10,11.79%,GLI3;LAG3
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3345725326798545,-0.9899588207877287,0.47176684881602915,0.7204463706479737,1.0,12/23,35.38%,SEL1L;VCP;SURF4;FAF2;SEC61B;DERL2;TMEM129;SEC13;DERL1;SYVN1;OS9;AUP1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.38279859986508463,-0.9899405166776201,0.4868651488616462,0.7200123499947515,1.0,6/15,27.77%,VCP;GSTO2;HNRNPA1;ATF3;MKNK2;GSTO1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.321809228647806,0.9899126960035546,0.4840085287846482,0.7890644002283479,1.0,9/32,16.19%,RIMS1;CHRNB4;CPLX2;STX1B;MCTP2;BAIAP3;SNAPIN;SYT11;HCRT
prerank,cellular response to purine-containing compound (GO:0071415),0.422772835256209,0.9897159125615917,0.4746136865342163,0.7886369156870325,1.0,1/10,1.17%,SLC8A1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.36666438865012246,-0.9891905962659383,0.4718045112781955,0.7212952494852533,1.0,2/16,8.53%,IGF1R;INSR
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2824090708301862,-0.9891268871096401,0.5019455252918288,0.720972824756118,1.0,19/51,32.07%,GBP5;APP;CASP8;HSPB1;TRIM16;S100A13;TLR4;AIM2;JAK2;NOD2;CASP1;LGALS9;FZD5;TMEM106A;CD36;TLR6;EGR1;TYROBP;NLRP3
prerank,positive regulation of exocytosis (GO:0045921),-0.3062226836464038,-0.9888395133985107,0.46771037181996084,0.7211759756430864,1.0,14/35,33.07%,RAB27A;RAB7A;SDCBP;TSG101;SNF8;CHMP2A;RAB2B;RAB3D;ATP6AP1;VPS4A;STAM;ATP13A2;RAB3A;RAB15
prerank,error-free translesion synthesis (GO:0070987),-0.34411599908621815,-0.9885619500189138,0.47244094488188976,0.7213638000806217,1.0,9/22,24.18%,UBB;UBC;RPS27A;VCP;SPRTN;RPA3;POLDIP2;RFC3;RFC2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3229464264300584,-0.9880790807444924,0.45387453874538747,0.7220607881444709,1.0,10/29,17.81%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;RPA3;GTF2H4
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22494254243321637,-0.9880490577018727,0.49469214437367304,0.7216605043559665,1.0,42/198,16.69%,PTPRB;PLCE1;ITPKB;PLCG2;LIMK2;GPI;MAPK3;PLCB3;HK1;TNFAIP8L3;CALM1;TGFB1;PLPP1;INPP5D;IPMK;PFKP;NT5C;AKT1;PLAA;PIP4P1;PLAAT3;TOLLIP;INPP5A;LIMD1;ISYNA1;DUSP3;PPP3CB;NUDT4;PNKP;GFPT1;SPHK2;AGPAT1;CERKL;IP6K1;PIK3CA;COQ8A;GPX4;PGK1;MINPP1;SYNJ1;DUSP23;IMPA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3891660875503745,0.9878249210332755,0.47533632286995514,0.7924830783767876,1.0,5/14,15.91%,SHLD2;KMT5C;PAXIP1;RIF1;KMT5B
prerank,positive regulation of response to external stimulus (GO:0032103),-0.24070549523620524,-0.9873300548747626,0.4881889763779528,0.7228786493172484,1.0,28/128,17.53%,THBS1;IL15;NFKBIA;SCARF1;STX3;THBD;ETS1;GBP5;TGFB1;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;PPM1F;DHX9;DHX58;TLR4;TNFRSF1A;USP15;FEM1A;AKIRIN2;IL17RA;SLC15A4;ANKRD17;NINJ1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4216101405204047,-0.9873209307485159,0.49429657794676807,0.7224212803821434,1.0,6/10,44.29%,CX3CR1;LGALS9;LILRB1;FCGR2B;CEACAM1;KLRD1
prerank,ncRNA metabolic process (GO:0034660),0.3078265737439138,0.9873023655307147,0.4605543710021322,0.7928856416661572,1.0,11/37,20.54%,TUT4;HENMT1;KHSRP;PIWIL2;XPO5;PARN;MAPT;BCDIN3D;DROSHA;NIFK;AGO2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39413004028691373,-0.9870226976651624,0.4990825688073395,0.7226466963340175,1.0,7/12,32.72%,ABCC9;KCNJ8;CACNA1H;PKD2;ABCC8;TRPM4;P2RX3
prerank,positive regulation of phagocytosis (GO:0050766),0.29885246679664096,0.98682959748936,0.4607218683651805,0.793213386870119,1.0,5/47,4.01%,CAMK1D;PLA2G5;AHSG;C4B;STAP1
prerank,regulation of cholesterol efflux (GO:0010874),-0.31601275294374276,-0.9864783079264088,0.4669187145557656,0.7234620556898265,1.0,6/30,12.63%,CAV1;PLTP;NFKBIA;NAXE;APOE;ABCA2
prerank,chromosome condensation (GO:0030261),-0.3043809039737674,-0.985976918612486,0.4699248120300752,0.7241706676853065,1.0,19/36,31.91%,SMC4;CSNK2B;RB1;TOP2A;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;DFFB;ACIN1;KMT5A;BANF2;NCAPH2;TTN;PLK1;CDK1;BANF1;NCAPD2
prerank,multivesicular body organization (GO:0036257),-0.31422328976567954,-0.9857129886480057,0.4779270633397313,0.7243443118879178,1.0,15/31,32.17%,RAB11A;RAB27A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3156743443344488,0.9852917709013135,0.49137931034482757,0.7962991546737722,1.0,4/32,5.80%,ARHGAP6;PHLDB2;DLC1;SERPINE1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.36670916491742905,-0.9850841507846232,0.48523985239852396,0.7253201353621509,1.0,4/16,11.45%,NT5E;UPP2;NT5C;NT5C1A
prerank,mitotic cytokinetic process (GO:1902410),-0.34635331435055816,-0.984763924455991,0.5017921146953405,0.7256424054595091,1.0,10/20,32.17%,CHMP2B;MITD1;CHMP2A;CNTROB;CEP55;VPS4A;CHMP7;RHOA;CHMP4B;CHMP4A
prerank,regulation of phosphorylation (GO:0042325),0.2468752227972515,0.9842153264600546,0.4749034749034749,0.7980067550801462,1.0,18/120,10.73%,NRP1;SRPX2;LDB2;AR;PRKAG2;STAP1;PHIP;LYN;FNIP1;IL4;DYNLL1;GLMN;SIRT2;NUP205;ANKLE2;ANG;NUP35;PLXNB2
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3742738625130436,-0.9839351169559797,0.4753787878787879,0.7271558252827035,1.0,6/15,22.20%,PDSS2;COQ6;NDUFA9;COQ8A;COQ7;UBIAD1
prerank,regulation of potassium ion transport (GO:0043266),0.3235404246672996,0.9835793852779589,0.5010893246187363,0.7987234660740645,1.0,7/31,14.15%,KCNIP4;DPP10;ANK2;KCNIP3;ACTN2;DPP6;DRD2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.41474451233715953,0.983455866468662,0.4696629213483146,0.7981479434945117,1.0,2/10,5.75%,LYN;AXL
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.40886194119482744,-0.9831441588470569,0.48201438848920863,0.7285604403702426,1.0,5/11,16.40%,MEF2C;TGFB1;FZD7;SOX6;GREM1
prerank,regulation of cholesterol esterification (GO:0010872),-0.4278815150546819,-0.9826464994248278,0.5187713310580204,0.7292442852147454,1.0,6/10,35.25%,ABCG1;APOE;ABCA2;APOC1;LAMTOR1;STARD4
prerank,regulation of cholesterol transport (GO:0032374),0.35689557480706513,0.9824891095989399,0.4666666666666667,0.7996834719557457,1.0,4/20,8.12%,LRP1;YJEFN3;ABCB4;ABCA5
prerank,mitotic cytokinesis (GO:0000281),-0.2838224151468896,-0.9823885316563536,0.4739776951672863,0.7293923040968272,1.0,24/47,33.50%,SPTBN1;USP8;KIF23;RHOB;RTKN;MITD1;SNX18;ECT2;RASA1;ANLN;CNTROB;CENPA;EFHC2;CIT;CEP55;STMN1;ARL3;RACGAP1;TRIM36;PLK1;CHMP4B;ESPL1;UNC119;STAMBP
prerank,maintenance of protein location in nucleus (GO:0051457),-0.34725260804334135,-0.982147249132149,0.4874274661508704,0.7294804831240043,1.0,8/20,31.63%,SYNE1;ARL2BP;CHCHD10;ARL2;RANGAP1;PARK7;BARD1;TAF3
prerank,potassium ion export across plasma membrane (GO:0097623),0.39054486416996115,0.9820735707351493,0.4762979683972912,0.7997334099273384,1.0,1/13,0.43%,KCNT2
prerank,dermatan sulfate metabolic process (GO:0030205),0.39849792466962436,0.9818684769405581,0.5,0.7993186436531184,1.0,7/13,23.37%,UST;DCN;DSE;VCAN;CHST14;DSEL;BCAN
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3352689905815863,-0.9815928607859427,0.458955223880597,0.7303009807173161,1.0,6/24,11.03%,NOTCH1;KLF2;VEGFA;ATF4;MBTPS2;HSPA5
prerank,protein modification by small protein conjugation (GO:0032446),-0.2082987335307896,-0.9813823597569384,0.5100222717149221,0.7302998441485172,1.0,92/361,20.48%,WWP1;NEDD4L;RACK1;IFIH1;LMO7;MSL2;DCUN1D5;RNF41;UBB;WWP2;RLIM;UBC;RPS27A;UFM1;KLHL2;STX1A;UBE2Q2;USP7;PRKDC;RNF38;DCUN1D1;NUP93;ANAPC11;TRIM47;CUL4A;FBXO4;DTX3;NDC1;TRIM28;TRIM14;USP9X;NUP54;ATG3;ARRDC1;HERC2;ATG7;DDRGK1;UBE2G2;VCP;UBE2F;TNFAIP1;USP5;SAE1;TRIM62;FBXW5;MIB2;ITCH;RNF111;NUP188;KLHL3;FBXL7;URM1;SMURF1;FBXL2;TRIM68;SUMO3;RNF20;NUP155;RBX1;UBE2G1;RAD18;TRIM5;RANBP2;VPS11;DTX2;CCNF;TSPAN17;ANAPC7;UCHL3;KCTD10;CDC27;UFL1;NUP37;FBXL3;UFC1;UBA2;GAN;CUL1;TRAIP;KLHL9;CDK5RAP3;ZSWIM8;KLHL21;UBA5;AMFR;RANGAP1;ELOB;TMEM129;CCDC22;KEAP1;UBE2B;UBA1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3284900076321655,-0.9813684377111318,0.4826254826254826,0.7298559513464177,1.0,10/24,26.62%,STMN2;TRPV4;KATNB1;KIF24;KIF18A;PIN1;KIF18B;NCKAP5L;STMN1;MAP7D3
prerank,cellular calcium ion homeostasis (GO:0006874),-0.23902906116317868,-0.9813501068134959,0.5009487666034156,0.7294237904798125,1.0,22/133,11.62%,ATP13A5;CAV1;TPT1;TRPC3;CAV2;MCUB;CAMK2D;TMEM165;ATP2C1;SLC35G1;ATP2A3;PDZD8;ATP1B1;EDN1;BAX;STIM2;CCL15;SLC10A7;TRPC6;TRPV4;TRPC4;ATP2B3
prerank,fatty acid elongation (GO:0030497),-0.39403329136499543,-0.9810147544031256,0.477859778597786,0.7297353548032544,1.0,5/13,26.94%,ELOVL7;ELOVL5;ELOVL1;HACD4;HACD2
prerank,import into nucleus (GO:0051170),-0.2658841422886887,-0.9808951715565397,0.47701149425287354,0.7295429767771736,1.0,24/73,26.55%,NUP93;AKT1;SNRPD3;PTTG1IP;E2F3;HTATIP2;SYK;NUP188;PHB2;NUP155;TNPO3;SMN1;RPAIN;DDX20;HNRNPA1;TSC2;SNRPG;NXT2;TNPO2;SNRPB;FAM53A;SEC13;NUP107;IPO13
prerank,protein-containing complex assembly (GO:0065003),-0.2181617375197024,-0.9801217340674153,0.5266666666666666,0.7308612235101141,1.0,62/259,20.01%,FN1;LEF1;ANO6;OCLN;SLC2A1;DMD;PARD3;PTK2B;TLE4;FERMT2;CD2AP;RBBP5;TRRAP;ZW10;CTSZ;ADAM10;PPARGC1A;NAPA;PYGO2;PPP2R1A;TAPBP;REPS2;TLE3;CTSC;CASP8;RIPK1;AP2M1;DNAJB12;DHX9;FAS;CSNK2B;CD74;KMT2D;TEAD2;DBNL;HES1;TRAF1;FBXL7;TNFRSF1A;AIM2;PEF1;SMARCA4;WASL;RBX1;RAB1A;MCFD2;MDN1;CHCHD10;SKAP2;TRAPPC5;OPA1;BAD;F5;NSF;CUL1;WIPF1;PPP6R3;CAPG;ELOB;SOX9;SHANK1;SEC24B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4215317563689006,-0.9799310277868739,0.5036101083032491,0.7308790127026703,1.0,2/10,4.11%,SHANK3;APP
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.32078454563698644,0.9798025201667897,0.47702407002188185,0.8036747757465653,1.0,2/32,2.26%,CEMIP;PDPK1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2550580117326262,0.9796807474466223,0.497029702970297,0.8030731526503464,1.0,10/98,5.39%,CEMIP;PIK3R1;LRP1;DPP10;PDPK1;EPHA3;SLC5A3;BCL2;TFDP1;PRKN
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.21202778444490666,-0.9795678895228529,0.5311827956989247,0.7312614674587543,1.0,39/291,11.49%,MEF2C;ACTB;RAP1A;LBP;ESR1;MTR;VIM;PXN;RAP1B;PTK2B;TGM2;SH3BP4;FOXO1;MAPK3;RAPGEF1;TBX1;FZD4;CAPN2;RPS3;DAB2IP;SLIT2;IGFBP5;PDE2A;GUCY1B1;KCNQ1;NRIP1;WNT9A;EZR;TNFRSF1B;AKT1;FZD7;NDUFA13;PLAA;TIRAP;VCP;WNT11;ABL2;AKAP6;IMPACT
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4021832174103266,-0.9791099780720273,0.5061946902654867,0.7318745429785439,1.0,4/12,12.26%,PROM1;VEGFA;CEP290;AGTPBP1
prerank,positive regulation of organelle assembly (GO:1902117),0.29383627267364254,0.9790747500947324,0.46611909650924027,0.803727196491556,1.0,13/44,24.31%,ASAP1;PIP4K2A;STX18;PIP4K2B;FUZ;LRSAM1;NUMA1;RAB3GAP1;NUP62;BBS4;G3BP1;PDCD6IP;CNOT2
prerank,carbohydrate biosynthetic process (GO:0016051),0.36177618425007724,0.978607076093645,0.4784394250513347,0.804011096907497,1.0,7/21,12.73%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,diacylglycerol metabolic process (GO:0046339),-0.3308096540978641,-0.9783835375313025,0.4747663551401869,0.7331234635276569,1.0,2/23,1.69%,PLCE1;DGKH
prerank,response to retinoic acid (GO:0032526),-0.27034271447731195,-0.978331805337376,0.5038167938931297,0.732772063468321,1.0,12/59,11.08%,ACER2;PTK2B;TBX1;FZD4;WNT9A;RARA;GATA6;TRIM16;FZD7;NDUFA13;WNT11;ABL2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4125587062782991,-0.9782511094400621,0.50187265917603,0.7324617803327956,1.0,2/11,5.35%,CAV1;ADIPOR1
prerank,cell cycle G2/M phase transition (GO:0044839),-0.23764538233717347,-0.9772111532561139,0.5101626016260162,0.7345125010144148,1.0,43/129,25.79%,CCNY;DCTN2;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP192;CEP57;NES;CEP70;DCTN3;PPP1CB;CEP290;CNTRL;DCTN1;PPP1R12B;PCM1;TUBB4B;PPP2R2A;FBXL7;HAUS1;NDE1;CETN2;CEP72;YWHAG;CDKN1A;HSP90AA1;CEP41;FBXL3;CUL1;LCMT1;DNM2;TUBA4A;PLK3;ARPP19;PPP1R12A;BRSK2;CDKN2B;HAUS4;YWHAE;CEP63;NEDD1
prerank,regulation of protein localization (GO:0032880),-0.2759273708700153,-0.9771683282237384,0.494140625,0.7341431640104651,1.0,19/58,19.70%,RACK1;TRIM25;HSP90AB1;FKBP1A;PLEKHM2;PPM1F;USP8;CTSD;TRIM14;CEP290;CAMK1;TRIM68;TRIM5;MMD;UFL1;HSP90AA1;KDM1A;TMEM231;ITGB3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31849603954341404,-0.976664029862035,0.5101663585951941,0.7348324371325878,1.0,8/30,13.98%,FOXP1;DDX5;NCOR1;ZBTB7A;HEYL;H3-3A;TRIM68;SMARCA4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3234112034196415,-0.9765260139388383,0.4782608695652174,0.7346757452715559,1.0,8/27,24.36%,CYRIB;ETS1;CD44;HSPD1;RELA;HAS2;TRAF6;CCL2
prerank,regulation of dendritic spine development (GO:0060998),-0.3509101382876939,-0.9764128920179587,0.5049701789264414,0.7344831453404083,1.0,5/19,13.09%,MEF2C;SHANK3;CAMK1;APOE;FMR1
prerank,myofibril assembly (GO:0030239),0.29689228805446405,0.9758366387903287,0.4955555555555556,0.8100726771742139,1.0,13/42,14.84%,PDGFRA;CSRP3;CFLAR;KLHL41;FHOD3;PDGFRB;SIX4;CSRP2;ACTN2;OBSL1;SYNPO2L;TNNT3;MYLK3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.4197943456766014,0.9756255011753017,0.48866498740554154,0.8096887542587785,1.0,2/10,5.49%,HECW2;HECW1
prerank,negative regulation of cell division (GO:0051782),0.4123685591270988,0.9754694085451157,0.5032537960954447,0.809175355843815,1.0,2/11,8.95%,TXNIP;BLM
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.31717540805831596,0.9752950883775701,0.49099099099099097,0.8087404773977449,1.0,7/31,10.17%,PARD3B;DLG2;RAP2A;ANK1;PDZD11;LRRC7;PRKCI
prerank,error-prone translesion synthesis (GO:0042276),-0.33807438429349457,-0.9752317084769737,0.48007246376811596,0.7367181791155398,1.0,8/21,24.18%,UBB;UBC;RPS27A;REV3L;RPA3;POLK;RFC3;RFC2
prerank,protein localization to nucleus (GO:0034504),-0.24617606798716207,-0.975168581391461,0.501953125,0.7363868825888731,1.0,30/102,26.55%,ZBTB7A;RPL11;SIX1;NUP93;AKT1;HHEX;PTTG1IP;ARL2BP;E2F3;TOR1AIP1;SYK;NUP188;PHB2;NUP155;TNPO3;CHCHD10;RPAIN;TSC2;TOR1AIP2;ARL2;MSX1;CNEP1R1;NXT2;TNPO2;YWHAE;FAM53A;SEC13;RPF2;NUP107;IPO13
prerank,protein maturation (GO:0051604),-0.25103446028275445,-0.9747746748436312,0.5128205128205128,0.7368430152268395,1.0,18/95,17.24%,TSPAN5;NNAT;SRGN;F3;ADAM10;BACE1;ADAM19;MMP14;PSENEN;CPE;HSPD1;TSPAN14;LMF2;NAA60;APH1A;TSPAN17;PHEX;CCS
prerank,regulation of blood circulation (GO:1903522),0.3036438517247705,0.9746490262499232,0.5073375262054507,0.809424242284751,1.0,3/34,5.75%,CELF2;DMPK;FXYD1
prerank,ganglioside metabolic process (GO:0001573),-0.3431407414295969,-0.9745426849329167,0.47418738049713194,0.7368766462161327,1.0,4/20,6.49%,ST6GALNAC3;ST8SIA4;HEXA;ST8SIA6
prerank,cardiac myofibril assembly (GO:0055003),0.3718025845519502,0.9743699739910561,0.4908256880733945,0.8092423362487887,1.0,6/15,14.84%,PDGFRA;CSRP3;FHOD3;PDGFRB;OBSL1;MYLK3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3840164306493219,-0.9743006541635673,0.4825174825174825,0.7369778146380721,1.0,9/14,20.07%,GAB1;KDR;VEGFC;VEGFA;FLT4;VEGFD;PIK3CA;PGF;NUS1
prerank,monoacylglycerol metabolic process (GO:0046462),0.3857148019798067,0.9742030814472323,0.4861407249466951,0.8087571339447808,1.0,4/13,14.54%,PLA2G4A;MOGAT3;MOGAT2;DGAT2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3724273026352827,-0.9741003159747815,0.49122807017543857,0.7369958998218129,1.0,4/15,16.28%,PPARD;PPARGC1A;ELOVL5;NR1H2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.34866502972052765,-0.9739707484572282,0.4937388193202147,0.7368532968941448,1.0,8/18,18.77%,DAB2IP;MSN;EZR;PTTG1IP;VPS11;HSP90AA1;ATRAID;CDK5RAP3
prerank,plasma membrane tubulation (GO:0097320),-0.38900314917546636,-0.9731569582423358,0.5080789946140036,0.7383465555290546,1.0,6/13,19.95%,FNBP1L;CAVIN2;EHD2;PACSIN1;PACSIN3;PACSIN2
prerank,epidermal cell differentiation (GO:0009913),-0.29339445560102906,-0.9727934821097907,0.5106796116504855,0.7387667084986503,1.0,13/41,27.73%,CLIC4;ANXA1;GATA6;BCR;OPN3;EPHA2;DSP;GLI1;EVPL;SCEL;CERS3;PIP5K1A;CTNNB1
prerank,dephosphorylation (GO:0016311),-0.23305066190702325,-0.9721062598788303,0.544,0.7399346530637754,1.0,51/147,28.27%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;PLPP1;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPP2R5A;PPM1F;NT5C;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PNKP;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;DUSP23;PPP2R5E;UBLCP1;DUSP11;PTPRK;PLPP2;TIMM50;PPP1CA;PTPRO;PTPRU;PTPN22;PPP1R12A;PPM1M;PTPN1;DUSP4;ACP6;PPEF2;SGPP1;MTMR2;THNSL2;PPP2R5B;PDP1;DUSP6;PLPP6;DUSP1;PPP4R1
prerank,epithelial cell differentiation (GO:0030855),-0.2523416856400372,-0.97193716077547,0.509765625,0.739844684547914,1.0,28/88,23.59%,KDR;TBX1;TPP1;ANXA1;SIX1;VEGFA;GATA6;ANXA4;AKT1;FZD7;TDRD7;TOLLIP;ACADVL;CTSB;CPT1A;FSTL1;TAGLN2;PGK1;CBR1;TAGLN;GLI1;E2F4;EDF1;GSTK1;E2F7;CNN3;CASP6;ANXA7
prerank,protein polyubiquitination (GO:0000209),-0.21231139346943015,-0.9716971941438928,0.5617021276595745,0.7399632471251284,1.0,84/297,23.17%,WWP1;NEDD4L;LMO7;RNF144B;HERC6;RNF41;UBB;ZNRF1;WWP2;RLIM;UBC;RPS27A;RNF125;UBE2Q2;CBFB;FBXO17;PSMA6;RNF114;ANAPC11;RC3H1;PSMB5;FBXO4;NHLRC3;UBE2L6;TRIM14;UBE2G2;PSMC4;PSMC5;FBXL14;TRIM56;PSMD14;TRIM62;FBXW5;UBE2Q1;FBXW10;MIB2;ITCH;RNF5;TRAF1;KLHL3;FBXL7;LNPEP;SMURF1;TRIM68;RNF20;RBX1;UBE2G1;TRIM5;PSMD8;WSB1;PSMD11;TNFAIP3;CCNF;ANAPC7;HECTD1;CDC27;PSMB4;PSMD12;PSMC1;FBXL3;FZR1;FBXL16;CUL1;ZNRF2;FBXW2;PELI1;RNF19A;AMFR;TMEM129;UBE2B;PSMA1;UBE3A;BLMH;ANAPC2;PSMB1;PSMC3;BFAR;NPEPPS;PSMA4;FBXO40;DTL;FBXL19;PSMA2;FBXL18
prerank,B cell homeostasis (GO:0001782),0.4131179545347108,0.9712420329693112,0.49002217294900224,0.8153415002376057,1.0,3/10,4.13%,DOCK11;DOCK10;LYN
prerank,negative regulation of glycolytic process (GO:0045820),-0.4179399536697251,-0.971204056810751,0.5270506108202443,0.7401619397953666,1.0,3/10,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4179399536697251,-0.971204056810751,0.5270506108202443,0.7401619397953666,1.0,3/10,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3593377555949249,-0.9711422768278428,0.4952919020715631,0.7398326538313406,1.0,2/17,0.97%,SLC9A2;SLC12A2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3830290145009543,-0.9711182493257614,0.501779359430605,0.7389449916751992,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,cellular response to interleukin-15 (GO:0071350),-0.3830290145009543,-0.9711182493257614,0.501779359430605,0.7389449916751992,1.0,4/13,17.47%,IL15;SHC1;STAT5A;JAK3
prerank,positive regulation of bone resorption (GO:0045780),-0.40836203562079454,-0.9708258017029555,0.5028571428571429,0.7391663912400315,1.0,4/11,12.88%,PLEKHM1;TNFRSF11A;SPP1;SYK
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3425342777417487,-0.9707931998183231,0.5009416195856874,0.7387752391343959,1.0,12/21,32.71%,COA8;COX15;TIMM21;COA3;SURF1;FASTKD3;COX10;SCO1;PET100;BCS1L;COA6;SCO2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.40608622744040823,-0.9704105484037491,0.5034965034965035,0.7391958172168785,1.0,3/11,26.35%,GPX1;GPX3;PRDX4
prerank,negative regulation of kinase activity (GO:0033673),0.27624715379671283,0.9701403774557753,0.5080645161290323,0.8171771728155498,1.0,9/62,7.92%,PPM1E;PRKAG2;PDPK1;DEPTOR;CEP85;IRS2;GSTP1;CEP43;TRIM27
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.33987029327984597,0.9699078475626176,0.5,0.8168646390030531,1.0,2/23,2.58%,PLA2G5;PLA2G4A
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.3135723986060973,-0.9698078955539661,0.49809160305343514,0.7401480979603422,1.0,2/29,1.00%,ANO6;JAM2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.39070973994901703,0.9697702530076309,0.497787610619469,0.816296324943881,1.0,3/12,8.12%,ABCA1;PPARA;ABCA5
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.37461591071415057,-0.96974400230694,0.5063752276867031,0.7398224651283497,1.0,4/15,15.55%,GBP5;TLR4;NOD2;IL17RA
prerank,activation of GTPase activity (GO:0090630),-0.2510701272694638,-0.9695026990927005,0.5217391304347826,0.7399227855094829,1.0,32/89,22.60%,ARHGAP42;SIPA1L1;SGSM2;RALGAPA2;TBC1D8;ARHGEF15;GRTP1;BCAS3;TBC1D1;ARHGAP25;CCDC125;TBC1D12;BCR;TBC1D22A;RALGAPB;SIPA1;SIPA1L3;GMIP;ABR;TBC1D9B;ARHGEF5;TBCK;EPHA2;TBC1D25;TBC1D2;ECT2;RANGAP1;APC2;ADPRH;RAP1GAP;TBC1D15;ARHGAP45
prerank,regulation of cell size (GO:0008361),0.33303324775085935,0.9694598798877734,0.5010752688172043,0.8161304003354366,1.0,4/23,10.35%,PRR16;DEPTOR;RARG;PTEN
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2767512118511746,-0.9692356649775328,0.4704761904761905,0.740108613093177,1.0,22/52,31.68%,EXTL3;PDIA5;TPP1;SHC1;HDGF;ADD1;DCTN1;HSPA5;ACADVL;GFPT1;XBP1;KLHDC3;TSPYL2;YIF1A;HYOU1;ATP6V0D1;PPP2R5B;PLA2G4B;ERN1;EDEM1;SYVN1;SRPRA
prerank,regulation of lipid metabolic process (GO:0019216),0.25523844517138317,0.9687621198860443,0.5019685039370079,0.8169371056302617,1.0,6/88,2.08%,RORA;TBL1XR1;CHD9;NCOA2;PPARA;PRKAG2
prerank,neuromuscular process controlling balance (GO:0050885),0.3943067383034763,0.9683392735273657,0.5033860045146726,0.8170535130981121,1.0,4/12,16.40%,NRXN1;PCDH15;CLRN1;CLN3
prerank,positive regulation of lipid localization (GO:1905954),0.42433525410755485,0.968323252275476,0.46206896551724136,0.8161893164047732,1.0,1/11,1.51%,LRP1
prerank,anterograde axonal transport (GO:0008089),-0.29337019658240526,-0.9682779292736321,0.5158878504672897,0.7419166027244765,1.0,7/37,9.75%,TRAK1;AP3M1;AP3B1;NEFL;TRAK2;HSPB1;KIF1B
prerank,wound healing (GO:0042060),0.2761517208279811,0.9680484991330082,0.5020161290322581,0.8159683980775227,1.0,6/62,4.25%,IGF1;NRG1;PDGFRA;SMAD3;PPL;CFLAR
prerank,spindle assembly (GO:0051225),-0.2618280452844512,-0.9672016538417338,0.5167652859960552,0.7439680068459826,1.0,22/67,31.13%,RAB11A;NCOR1;NEK7;RPS3;CEP192;HAUS1;GOLGA8B;LSM14A;MAPRE2;MISP;TPX2;RCC1;SPICE1;HAUS4;CEP63;KIFC2;SAC3D1;TUBGCP6;KIF11;HDAC3;BCCIP;RHOA
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.29043622982797057,-0.9670828349877351,0.4892367906066536,0.7437590529505521,1.0,13/42,24.18%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RPA3;POLK;DTL;RFC3;RFC2
prerank,intracellular protein transport (GO:0006886),-0.21193224508554526,-0.9670648023580992,0.5685483870967742,0.7433288565941036,1.0,99/304,27.42%,RASSF9;TRAK1;SGSM2;STX3;TBC1D8;GRTP1;RPL11;TGFB1;AP3B1;PKD1;CHP1;SYNRG;NAPA;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;GABARAP;GIPC1;TRAK2;TBC1D22A;NUP93;ARF5;AKT1;RAB6B;PTTG1IP;HERC2;CD74;E2F3;STX2;SURF4;AKAP6;RAB24;RAB7A;COPB2;KATNB1;ARL4A;SYK;NUP188;TBC1D9B;VPS36;TBCK;SMURF1;ARL6;PHB2;NUP155;RAB1A;AP4M1;TNPO3;AP2A1;SNF8;RPAIN;YWHAH;VPS33A;NSF;TBC1D25;CCHCR1;TSC2;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;ARL4C;RAB23;ADPRH;STX5;NXT2;CAMSAP3;KIF13A;TBC1D15;CACNG3;TNPO2;COPZ2;RAB43;STXBP2;TBC1D30;TBC1D17;FAM53A;SEC13;RAB5C;PDCD6;RTN2;NUP107;TMED3;NUP42;BCS1L;IPO13;STX4;ARF3;NPM1;TBC1D5
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2541895997625624,-0.9667705006332227,0.5354330708661418,0.743541602374871,1.0,32/80,30.24%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;FAM107A;PTTG1IP;MTA1;SPRTN;PEF1;RBX1;BMI1;KDM1A;CDK5RAP3;PIN1;LAPTM5;UBE3A;TRIB3;TRAF6;BCL10;DCUN1D3;XIAP;PDCD6;TSPYL5;NDFIP2;MAGEC2;DERL1;RPS2;HDAC3;PLK1
prerank,chemical homeostasis (GO:0048878),-0.26524694602634946,-0.9666347595416699,0.539651837524178,0.7433716313427033,1.0,14/61,19.63%,SLC4A10;NEDD4L;WNK1;AQP11;USF2;SLC4A8;ACOX3;PNPLA2;SLC4A2;KLHL3;TLCD3A;ADCK1;AQP4;ABHD8
prerank,positive regulation of cartilage development (GO:0061036),0.3617896759229333,0.9664230389931538,0.49445676274944567,0.8191464479012905,1.0,3/17,9.57%,BMP2;LOXL2;SOX5
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.36216286287379695,-0.9661876975931334,0.5185185185185185,0.743927994695591,1.0,9/17,35.13%,ALG9;NUS1;ALG12;ALG1;DHDDS;ALG2;ALG3;MPDU1;ALG6
prerank,folic acid metabolic process (GO:0046655),0.3542581295520403,0.9660499395742366,0.48623853211009177,0.8192301653903343,1.0,8/18,24.32%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,substrate-dependent cell migration (GO:0006929),0.3704119027413768,0.9658481232502133,0.47391304347826085,0.8188433258466797,1.0,2/14,1.80%,NRP1;ITGA11
prerank,positive regulation of telomere maintenance (GO:0032206),-0.30600215664504904,-0.965459023959241,0.5264150943396226,0.7451486645182572,1.0,6/31,12.82%,MAPK3;NEK7;HNRNPA2B1;ERCC1;PNKP;SLX4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.316307542050361,-0.9651454000598221,0.5,0.7454160097003627,1.0,11/28,23.34%,MAP3K5;DAB2IP;ATP2A3;ATF4;BAX;BBC3;BAK1;TRIB3;SELENOK;ERO1A;BRSK2
prerank,fibrinolysis (GO:0042730),0.37730850608220745,0.9646079369448591,0.49130434782608695,0.8210688593250033,1.0,2/13,6.13%,SERPINE1;PLG
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3834968332843497,0.964303503345116,0.5210970464135021,0.8208900502516603,1.0,4/13,13.17%,ADCY1;ADCY8;CHRNA7;ZDHHC2
prerank,chondrocyte differentiation (GO:0002062),0.3144231348451537,0.9642792975819144,0.4989059080962801,0.8200458675827301,1.0,3/32,1.48%,BMP2;SULF1;SULF2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2772940191200421,0.9642210792409717,0.5114345114345115,0.819294990614279,1.0,9/53,12.43%,HTR7;CHRM2;MC5R;CHRM3;HRH1;HRH2;HTR4;PTGIR;HTR5A
prerank,cellular response to virus (GO:0098586),-0.30947449745863986,-0.9635318715069668,0.5093984962406015,0.7487319995524957,1.0,16/30,37.52%,IFIH1;BAX;FMR1;POU2F2;HSP90AA1;CHUK;LGALS9;MAPK11;VWCE;IRGM;RIOK3;CCL5;IRF3;EIF5A;POU2AF1;IL12A
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2623151846782212,-0.9628144637580797,0.5584677419354839,0.7500028275976557,1.0,18/64,19.79%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;HACL1;ASAH2;ELOVL5;ACADL;GSTM2;CPT1A;ACSL5;FAAH;GPX4;ACOT8;ELOVL1;DAGLB;ACOT2
prerank,response to alcohol (GO:0097305),0.3232722411165684,0.9626738097535418,0.49464668094218417,0.8223018361784733,1.0,2/27,2.71%,TGFBR3;GRIN3A
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31440656052401716,0.9623284886270412,0.4989733059548255,0.8222238355153014,1.0,3/30,5.54%,IGF1;LYN;IRS2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3092443005830333,-0.9622695373066456,0.5115384615384615,0.7507736544160218,1.0,7/29,12.33%,SORBS1;SCARB1;CHP1;MFSD2A;AKT1;ELOVL5;APOE
prerank,RNA stabilization (GO:0043489),0.3118406461405884,0.9615999117929501,0.485838779956427,0.8231807719207257,1.0,7/33,14.52%,GDNF;TENT5A;AXIN2;PHAX;TENT5B;PARN;RBM24
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.34081121731000835,0.9614415657269909,0.49547511312217196,0.8226688460852195,1.0,1/22,0.29%,PPM1E
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3770335969806378,0.9606395974815238,0.5229759299781181,0.8238491659849957,1.0,1/14,1.34%,OCSTAMP
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2932285984837524,-0.960529688954616,0.5101289134438306,0.7543959949950972,1.0,5/36,5.70%,THBS1;DOCK1;VAMP7;RAC1;ARHGAP25
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2635909191255134,0.9604710381600644,0.5150905432595574,0.823385344144112,1.0,7/75,3.08%,NRP1;BMP2;SEMA5A;PDPK1;PRKCA;VEGFB;AKT3
prerank,synaptic vesicle endocytosis (GO:0048488),0.31007042831223236,0.9599156065077435,0.5211267605633803,0.8238189501505512,1.0,7/33,7.72%,DNAJC6;STON1;SNAP91;NLGN2;NLGN3;SYT1;NLGN1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.37805188953386343,-0.9598468113492113,0.5359223300970873,0.7555299456117639,1.0,8/14,31.13%,OPHN1;MSN;EZR;CAMSAP3;FSCN1;CDC42;SCRIB;RHOA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3421014579977784,0.9598045031212038,0.4791666666666667,0.822266102286991,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3421014579977784,0.9598045031212038,0.4791666666666667,0.822266102286991,1.0,10/20,20.96%,ACADSB;ALDH6A1;BCKDHB;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT2;BCAT1
prerank,positive regulation of histone modification (GO:0031058),-0.30094384520039064,-0.9597146044676135,0.5369003690036901,0.7553433367377436,1.0,8/33,17.33%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;TADA2B;FMR1;CHTOP;KDM1A
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.25339354800970293,-0.9592134137516954,0.5190380761523046,0.7560183509691888,1.0,21/79,19.31%,CRIM1;BMPER;THBS1;NOTCH1;BMPR2;SMAD9;DAB2IP;SMAD7;SLIT2;SMAD6;HHEX;HTRA3;SKIL;FGF2;SMURF1;EPN2;SMAD4;GREM1;SPRY1;SKI;BMPR1B
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3649302626926551,-0.9591476599250864,0.5208711433756806,0.7557067427295879,1.0,6/15,30.56%,RACK1;SPHK2;TNFRSF1A;PRKCD;ORMDL1;SMPD2
prerank,tRNA processing (GO:0008033),-0.26970922990186946,-0.9587086504644383,0.55,0.7562996021412564,1.0,24/61,29.51%,SARS1;THUMPD1;TRMT9B;QTRT2;URM1;TRMT10C;FARS2;TRDMT1;TRPT1;QTRT1;TSEN54;RPP21;CPSF4;TRMT6;AARS2;ANKRD16;RTCB;METTL1;ADAT1;ADAT2;RTRAF;CTU2;TSEN2;KARS1
prerank,positive regulation of T cell differentiation (GO:0045582),0.30310414843631667,0.9586088325613141,0.5130784708249497,0.8243147099642356,1.0,5/36,5.08%,GLI2;IL4I1;RHOH;GLI3;IL4
prerank,negative regulation of DNA replication (GO:0008156),-0.3849212904703375,-0.9585827532439086,0.5353356890459364,0.7561208664930478,1.0,4/13,19.59%,CDAN1;RAD17;WAPL;TSPYL2
prerank,establishment of skin barrier (GO:0061436),-0.3716406967695644,-0.9582734553408313,0.532967032967033,0.7559366644775417,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,regulation of water loss via skin (GO:0033561),-0.3716406967695644,-0.9582734553408313,0.532967032967033,0.7559366644775417,1.0,7/15,30.21%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.40985554135677454,-0.9578418715097172,0.5212014134275619,0.7564448718905233,1.0,3/10,6.57%,RACK1;KDR;MYOC
prerank,protein K48-linked ubiquitination (GO:0070936),-0.2675286123938744,-0.9576341026686296,0.5350194552529183,0.7564224230086793,1.0,26/54,35.80%,NEDD4L;ZNRF1;UBE2Q2;UBE2G2;ITCH;RNF5;KLHL3;RBX1;UBE2G1;TNFAIP3;PELI1;AMFR;UBE2B;UBE3A;BFAR;DTX3L;RNF187;FBXO38;RNF8;SYVN1;HACE1;UBE2T;CUL3;UBE2R2;UBE2C;RNF152
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.32919187766159974,0.9573340180318365,0.5116772823779193,0.8264866105441306,1.0,4/24,8.46%,PID1;LEPR;SLC25A13;NDUFS1
prerank,hippo signaling (GO:0035329),0.32069573684034663,0.9572254288984379,0.5134575569358178,0.8258798284588931,1.0,4/26,6.63%,TEAD1;DCHS1;WWC1;CASP3
prerank,negative regulation of protein secretion (GO:0050709),-0.29179611465926847,-0.9568260990731233,0.5276190476190477,0.757875412269954,1.0,10/38,19.17%,CCN3;KCNB1;REST;RAB11FIP1;DPH3;APOE;INHBB;RAB11FIP3;RSAD2;CD200
prerank,non-motile cilium assembly (GO:1905515),0.31811343791727986,0.9568250192899129,0.5224839400428265,0.8259746123897638,1.0,15/30,26.70%,TMEM17;TTC8;IFT122;C2CD3;FUZ;PIBF1;ARL13B;IFT88;IFT57;BBS4;TMEM107;TMEM80;CSNK1D;CEP250;CEP89
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3829467614710681,0.9567830718391505,0.5121412803532008,0.8251886950103918,1.0,2/13,3.42%,BCL2L11;VDAC2
prerank,cholesterol transport (GO:0030301),-0.28159881514587115,-0.9567477387477732,0.5333333333333333,0.7575727737677455,1.0,18/45,33.06%,CAV1;SCARB1;ABCG1;STARD5;APOE;TSKU;NPC1;STAR;LCAT;MSR1;SERAC1;APOC1;VPS4A;CD36;SOAT2;OSBPL2;OSBPL5;LIMA1
prerank,glutamate metabolic process (GO:0006536),0.35323759378488434,0.9564669622582538,0.5032119914346895,0.8250795851735251,1.0,5/19,11.17%,ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,mRNA metabolic process (GO:0016071),-0.24643106882209997,-0.9562529192582633,0.5480572597137015,0.7583092929447314,1.0,37/90,33.10%,DDX5;HNRNPA2B1;PPARGC1A;PRPF8;SRSF2;SRSF5;DHX15;SNRPD3;U2AF1;LSM11;DIS3L2;SFPQ;YTHDF2;SRSF4;SF3A3;RNH1;HSPA1A;SCAF11;SNRPG;LSM2;LSM3;TBRG4;HSPA1B;NCBP2;LSM10;SNRPB;SF3A1;SF3A2;KIN;HNRNPR;ERN1;SRSF9;LSM6;SRSF1;ZC3H12D;PCF11;DCP2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.31182306189772446,-0.9562203030608838,0.5204460966542751,0.7579132938253277,1.0,8/27,25.80%,CTPS1;CTPS2;RRM1;GLRX;GSR;TYMS;NME1;AK9
prerank,long-chain fatty acid import into cell (GO:0044539),-0.40551472330593996,-0.9561600671547805,0.5411985018726592,0.7575848149679812,1.0,6/10,30.00%,SLC2A1;SPX;SLC27A2;SLC27A1;CD36;RPS6KB1
prerank,macrophage differentiation (GO:0030225),0.3839128703722284,0.9556845500816511,0.48214285714285715,0.8261215861372351,1.0,1/13,0.34%,IL31RA
prerank,membrane repolarization (GO:0086009),-0.36892324931866044,-0.9556553846949112,0.518918918918919,0.7583049852961247,1.0,7/15,21.60%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;ATP1B2;KCNIP2
prerank,mRNA destabilization (GO:0061157),0.288667346357505,0.955570254374385,0.505091649694501,0.8255130466617648,1.0,9/38,15.77%,TUT4;ROCK2;CPEB3;FTO;RIDA;KHSRP;METTL16;RBM24;METTL3
prerank,negative regulation of T cell proliferation (GO:0042130),0.31809298135039343,0.9550612874726035,0.48717948717948717,0.8258685461240247,1.0,4/28,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.34600155956278517,0.9549530935334117,0.5086580086580087,0.8252480256798186,1.0,7/21,17.44%,SULF1;SULF2;HS6ST3;HS2ST1;HS6ST2;HS3ST5;HPSE
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.39447277465753106,-0.9549179991001814,0.5488029465930019,0.7595968353072856,1.0,4/12,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,cellular response to glucose stimulus (GO:0071333),-0.30679968410716085,-0.9548573111541795,0.5423728813559322,0.7592650751681138,1.0,4/30,3.44%,IGF1R;RACK1;UNC13B;KCNB1
prerank,cellular response to insulin stimulus (GO:0032869),-0.23359147932169588,-0.9546008509478671,0.5843137254901961,0.7594401548220092,1.0,22/124,10.84%,IGF1R;GAB1;SORBS1;NAMPT;GRB14;CAV2;FOXO1;RAB8B;ATP6V0B;HDAC9;ATP6V0A2;PKM;SHC1;PRKDC;IDE;AKT1;INSR;PIK3C2A;ATP6V0C;RAB8A;GRB10;FOXC2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.3929896144501524,-0.9545837786523732,0.5283687943262412,0.7590058337957213,1.0,3/11,7.75%,ANXA1;SMAD7;RC3H1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.4048249369739392,-0.9545403376469289,0.5435203094777563,0.7586338562743604,1.0,4/10,24.95%,TXN2;CTH;BLMH;MTRR
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3445019271887086,0.9542990339761251,0.5021739130434782,0.8259500676984559,1.0,4/19,10.17%,PARD3B;DLG2;LRRC7;PRKCI
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.4039253642733334,-0.9542184455668588,0.5519125683060109,0.7588906459131677,1.0,6/10,40.16%,MFSD2A;PHB2;MTMR2;GNB3;ABCA3;MTMR3
prerank,regulation of protein polymerization (GO:0032271),-0.2955662477295513,-0.9541969652665193,0.521505376344086,0.7584624406270832,1.0,13/35,23.65%,ESAM;PFN1;PRUNE1;DBNL;DBN1;HSP90AA1;RASA1;ARL2;CTTN;HCLS1;PLEKHG2;CAMSAP3;ARHGAP18
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3794498900622854,-0.9541711998859804,0.5350553505535055,0.7580539111542086,1.0,1/13,0.23%,ANO6
prerank,regulation of calcium ion transport (GO:0051924),0.26899073547736907,0.9536824845912207,0.5290322580645161,0.826547683397376,1.0,8/54,8.79%,ANK2;CACNA2D1;BCL2;P2RX4;MYLK;CAMK2B;CACNB2;SARAF
prerank,protein import into nucleus (GO:0006606),-0.2614896021623439,-0.9533847667240766,0.5487571701720841,0.759357229252542,1.0,22/66,26.55%,RPL23;NUP93;KPNA1;AKT1;NUP54;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;RANBP2;TNPO3;RPAIN;TSC2;KPNA4;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3555397749493524,-0.9530139597979901,0.5422138836772983,0.759705708014668,1.0,8/16,34.14%,RAD9B;HUS1;RAD9A;RAD17;DNA2;CDC6;TICRR;CLSPN
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2887576216312699,-0.9523987264065891,0.5219047619047619,0.7606695005461489,1.0,13/39,15.49%,NOS3;TSPAN5;NOTCH1;CCN3;TGFB2;NEPRO;JAG2;NOTCH4;TSPAN14;TM2D3;POGLUT1;EPN2;NOD2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3739973660322339,-0.9518499094662812,0.5479704797047971,0.7615252964012715,1.0,7/14,33.92%,CARD14;TLR3;TIRAP;TRAF6;CARD10;TLR6;TNFSF15
prerank,DNA methylation (GO:0006306),0.32778905010810083,0.9514892786802057,0.4829787234042553,0.8309855135804983,1.0,7/23,22.69%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP;ZFP57
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3633880174736711,-0.9513589606145482,0.5335753176043557,0.7622082630370326,1.0,4/15,14.84%,MVB12B;PTPN12;EGFR;ERBB2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3285262309508757,0.9513559488057954,0.5233853006681515,0.83044593038882,1.0,1/22,0.22%,ADGRV1
prerank,phosphatidic acid metabolic process (GO:0046473),0.2805751593166382,0.9513247589134973,0.5262054507337526,0.8296312622779289,1.0,12/48,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G6;PLA2G12A
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.37331151952834724,0.9511116435569005,0.4965986394557823,0.8292345142894219,1.0,2/14,7.96%,ADAMTS12;TGFBR1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.24841227161598928,-0.9510228304852871,0.563953488372093,0.7625392845709352,1.0,45/88,35.76%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;SPEF1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2;CDC42;PSMB8;VANGL2;AP2A2;PSMC6;WNT7A;RHOA;PARD6A;PSMD6;PSMA8;AP2B1;PKHD1;ROR2;PSMD2;PSMB2;CELSR3
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.28674787841742533,-0.9509483306739112,0.5384615384615384,0.7622457886639057,1.0,10/37,23.55%,ENTPD1;MTREX;PPP1R8;ENTPD7;ENTPD6;DNASE1L2;ENTPD2;RNASEH2C;NUDT18;DFFB
prerank,cortical actin cytoskeleton organization (GO:0030866),0.33986944536579805,0.9509217473087657,0.5206073752711496,0.8288637586371745,1.0,5/20,15.56%,ROCK2;FMNL3;FHOD3;LLGL1;RHOQ
prerank,plasma membrane organization (GO:0007009),-0.26333109371216773,-0.9507287851459324,0.5603960396039604,0.7622496997857314,1.0,9/61,7.53%,ANO6;SPTBN1;FNBP1L;AHNAK2;CAVIN2;MYOF;DYSF;EHD2;A4GALT
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3711215230028876,-0.9505612751801442,0.5228519195612431,0.7621837977336527,1.0,6/14,36.29%,YBX3;TIRAP;BOLL;HNRNPC;ANGEL2;DAZL
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2927026107321625,-0.9504011000499244,0.5264187866927593,0.7620890841754302,1.0,7/37,14.46%,RIN3;NCOR1;ANKRD13A;EDN1;APOE;ABCA2;SDCBP
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3555409383584869,-0.9503040306028258,0.5285451197053407,0.7618564510315856,1.0,2/16,3.35%,ST3GAL4;ETS1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.40553775766732036,-0.9499649838728156,0.5270758122743683,0.7617402262740371,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.40553775766732036,-0.9499649838728156,0.5270758122743683,0.7617402262740371,1.0,5/10,32.90%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,secondary palate development (GO:0062009),0.3770491458472652,0.9497247900180609,0.49448123620309054,0.8309083293993829,1.0,3/14,5.04%,TGFBR3;CHD7;LRRC32
prerank,neuron development (GO:0048666),0.23163721631110581,0.9497067021683703,0.5731462925851704,0.8300652962688576,1.0,30/141,13.81%,TENM3;GDNF;CNTN4;GLI2;CNTNAP2;GPM6A;GPRIN2;TENM2;PBX4;LYN;GPRIN1;TBC1D24;PPP1R9A;NLGN1;DOCK7;RYK;CDK5R1;EPHA8;CAMSAP1;EPHA5;ALK;ATP8A2;LRP12;RASGRF1;SNAPIN;ATXN10;GBA2;TENM1;CDK16;MAPT
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.34859329784249404,0.9496027309499248,0.5209713024282561,0.8294549789939819,1.0,3/19,6.59%,BMP6;PLG;FOXA2
prerank,regulation of neutrophil migration (GO:1902622),-0.4124226274056632,-0.9489123824394814,0.5348837209302325,0.7637338328145039,1.0,2/10,4.56%,JAM3;RAC1
prerank,cartilage development (GO:0051216),0.286875548059241,0.9486972863314627,0.5296703296703297,0.8307726517077034,1.0,4/49,1.48%,BMP2;SULF1;HYAL3;SULF2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3337892420307519,-0.9485195464428612,0.5284403669724771,0.7636920465738328,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3337892420307519,-0.9485195464428612,0.5284403669724771,0.7636920465738328,1.0,8/21,19.11%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,neural tube closure (GO:0001843),0.3027019885050318,0.9484000873118319,0.5472527472527473,0.8306362250169925,1.0,9/34,12.31%,PRICKLE1;LMO4;DLC1;IFT122;DVL3;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.36828312182547257,0.9483195392206119,0.532293986636971,0.829938036302292,1.0,3/15,5.95%,PPARA;IRS2;ADM
prerank,protein localization to chromatin (GO:0071168),-0.3451423539975481,-0.9483179212702737,0.5370018975332068,0.7636936454775618,1.0,8/18,30.24%,ESR1;TASOR;WAPL;RAD21;NIPBL;MRNIP;CHMP7;PLK1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2975065853177535,0.9480344355675269,0.5191873589164786,0.8297644675373798,1.0,5/38,6.94%,RORA;RHOH;GSTP1;NLRP12;TLE1
prerank,DNA alkylation (GO:0006305),0.3434228549611323,0.9475225586024447,0.48423423423423423,0.8292734802899877,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,DNA methylation or demethylation (GO:0044728),0.3434228549611323,0.9475225586024447,0.48423423423423423,0.8292734802899877,1.0,6/19,21.62%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.32493014463270486,-0.9468337409074037,0.5539033457249071,0.7662562108009837,1.0,6/23,15.00%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.32493014463270486,-0.9468337409074037,0.5539033457249071,0.7662562108009837,1.0,6/23,15.00%,THBS1;HSP90AB1;GIPC1;RNF111;SDCBP;SMAD4
prerank,vacuolar acidification (GO:0007035),0.33573792384312034,0.9467786055365444,0.49551569506726456,0.8302302742679355,1.0,5/21,17.07%,ATP6V0A4;ATP6V1H;DMXL1;CLN3;DMXL2
prerank,autophagy of nucleus (GO:0044804),0.36151814176404107,0.9466541139065303,0.5353982300884956,0.8296533570555862,1.0,7/16,21.67%,WDR45B;ATG12;WIPI1;ULK2;ATG9A;ATG5;WDR45
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.28318205851283046,-0.9464666412678411,0.573076923076923,0.7666302421537583,1.0,9/42,18.45%,ACTB;ARID1A;MTA2;MBD3;SMARCA4;GATAD2B;SMARCA2;RBBP4;CHD4
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4006143464225925,-0.9464361263081671,0.5480943738656987,0.7657561252311625,1.0,3/10,13.25%,RACK1;SPHK2;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4006143464225925,-0.9464361263081671,0.5480943738656987,0.7657561252311625,1.0,3/10,13.25%,RACK1;SPHK2;TNFRSF1A
prerank,nuclear export (GO:0051168),-0.250231752871683,-0.9462941554271959,0.5668549905838042,0.7656159373684028,1.0,24/80,22.46%,TGFB1;PKD1;CHP1;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;NUP188;SMURF1;SRSF4;MAGOH;NUP155;CHTOP;ALYREF;RITA1;DDX39B;HNRNPA1;CCHCR1;CASC3;THOC6;DDX39A;NCBP2
prerank,O-glycan processing (GO:0016266),-0.2611454178954965,-0.9462896489510854,0.5531914893617021,0.765157325600734,1.0,20/54,36.09%,ST3GAL4;ST6GAL1;C1GALT1C1;GALNT10;GXYLT1;ST6GALNAC2;B3GNT3;B3GNT8;GALNT5;GCNT4;GALNT6;GALNT9;GALNT1;B4GALT5;ST3GAL2;MUC1;ST6GALNAC4;MUC13;B3GNT2;MUC6
prerank,establishment of vesicle localization (GO:0051650),-0.3389897982476573,-0.9460616914621934,0.5592233009708738,0.7652055029443007,1.0,3/18,4.21%,RAB11A;LIMK2;RAB27A
prerank,tyrosine metabolic process (GO:0006570),0.4025582001695793,0.9456698633833847,0.5154867256637168,0.8311573372875583,1.0,2/11,14.41%,IL4I1;GSTZ1
prerank,megakaryocyte differentiation (GO:0030219),0.3813423335736076,0.9452898418496506,0.5022522522522522,0.8311633446939453,1.0,2/11,7.59%,KIT;THPO
prerank,negative regulation of cell projection organization (GO:0031345),0.27905669094227725,0.9451668517086691,0.5460674157303371,0.8306350392526031,1.0,11/48,17.48%,LPAR1;SEMA3A;RAB29;DPYSL3;STX1B;DCC;PTEN;CBFA2T2;DENND5A;PTPN9;GRIN2B
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.277252667843369,0.9451498068433369,0.5498981670061099,0.829802983826943,1.0,5/52,2.58%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3
prerank,motor neuron axon guidance (GO:0008045),-0.36047619193925917,-0.9449987760502274,0.5364485981308411,0.7671879815255302,1.0,5/15,14.21%,SLIT2;RAC1;CHN1;LAMC2;NTN1
prerank,DNA double-strand break processing (GO:0000729),0.3524893798852938,0.944870719237171,0.49892008639308855,0.8296629838462789,1.0,7/18,18.13%,RNF138;SETMAR;BLM;NBN;ATM;KAT5;UBE2N
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3876091140865718,-0.9447834780600688,0.5424610051993067,0.7672397436804433,1.0,5/12,16.40%,CCN3;SLIT2;AKT1;WASL;GREM1
prerank,translational termination (GO:0006415),-0.23852413483239693,-0.9443778439277284,0.5693877551020409,0.7677047463118463,1.0,34/95,29.61%,MRPL52;PTCD3;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;MRPS30;ERAL1;MRPL24;MRPS17;MRPL50;MRPL16;MRPL47;MRPL54;MRPS18C;MRPS18A;MRPL35;MRPS6;MRPL58;MRPL48;MRPL49;MRPL13;MRPL11;MRPL21;MRPL30;MRPS24;MRPL2;MRPL42;MRPL15;MRPL19;MRPS14;MRPS2
prerank,steroid hormone biosynthetic process (GO:0120178),0.31026513663414407,0.9442650948096561,0.5216450216450217,0.830261350925113,1.0,1/29,0.69%,AKR1B1
prerank,negative regulation of cartilage development (GO:0061037),0.37521668609838577,0.944253030737141,0.5405405405405406,0.8294191032253052,1.0,2/13,7.96%,ADAMTS12;TGFBR1
prerank,peptidyl-arginine modification (GO:0018195),-0.3651735895094294,-0.9441927890524785,0.5493716337522442,0.7676662762515963,1.0,3/15,10.12%,PRMT8;ART3;KRTCAP2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.28149377386949953,-0.9441282203925792,0.5540796963946869,0.7673661110797936,1.0,5/40,10.31%,LBP;RPL39;GBP7;PGLYRP1;TIRAP
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2099276668385455,-0.9439114105626959,0.6114519427402862,0.7673974636776504,1.0,98/241,35.00%,DDX5;NOVA2;HNRNPA2B1;CTNNBL1;HSPA8;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;RBM19;CPSF4;LSM3;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;GTF2F2;SNRPB2;HNRNPR;WBP11;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,pharyngeal system development (GO:0060037),0.3673705016499745,0.9429325692995535,0.5518763796909493,0.8318634875684991,1.0,5/15,9.35%,BMP5;SIX4;TGFBR1;GATA3;BMPR1A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3332539542069678,-0.9424921438151419,0.5561797752808989,0.7702634177291384,1.0,5/22,14.62%,AHNAK;DMD;CACNB3;FMR1;SRI
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2756176855098215,-0.942155198477116,0.55859375,0.7705959281163646,1.0,13/49,21.54%,SGMS1;CAV1;RACK1;BAX;NDUFA13;BBC3;BCL2L1;NDUFS3;BCAP31;BAD;PTPMT1;MCL1;FIS1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26316226560635125,-0.9417082119867859,0.5411985018726592,0.771143308503838,1.0,21/53,30.32%,DDX5;RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;FMR1;EGFR;NSMCE4A;BABAM2;CCAR2;MSX1;FGF10;PRKCD;SPRED3;NSMCE1;RNF8;PMAIP1;SPRED1;MYC
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.34063976212351643,-0.9412661168869874,0.5339622641509434,0.7717011287573049,1.0,6/18,17.16%,NOTCH1;CCN3;HDAC4;FZD7;SOX6;XBP1
prerank,T cell differentiation (GO:0030217),0.2919668552587863,0.940901021217597,0.53099173553719,0.8359746472677865,1.0,5/40,3.86%,KIT;CHD7;LEPR;RHOH;GLI3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3997245064183055,0.9406300663956062,0.5339578454332553,0.8357604135601855,1.0,3/11,7.11%,PTGIS;DLC1;SIRT2
prerank,protein targeting to membrane (GO:0006612),-0.24435632525983672,-0.9401845798258949,0.58203125,0.7737439407226503,1.0,34/83,32.23%,PARD3;RAB8B;AQP11;ATG3;NACA;SEC63;ZDHHC9;TAOK2;ZDHHC1;ICMT;ARL6;ZDHHC20;SDCBP;SGTA;SRP19;SSR2;ZDHHC23;FIS1;SGTB;ZDHHC12;ZDHHC3;ZDHHC18;TRAM1;SEC61A1;PEX14;GOLGA7B;NACAD;ZDHHC24;ABCD3;SRPRA;VPS37C;CHMP4B;CHMP4A;CHM
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3272980194858866,0.9396736005480492,0.5241228070175439,0.837271174373158,1.0,7/23,16.00%,GJA1;GDNF;SIX4;PAX8;SIRT6;WNT5B;LIF
prerank,regulation of platelet activation (GO:0010543),0.33287249849181455,0.9390536042751036,0.5169491525423728,0.8379445657517788,1.0,4/21,4.13%,PDGFRA;PLA2G4A;PRKCA;LYN
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.265029197686326,0.9389621735892435,0.5297872340425532,0.8372903935296808,1.0,9/59,11.39%,TCF7L2;CDK8;MITF;CEBPB;AGO4;TNRC6A;PPM1D;PTEN;TNRC6B
prerank,phasic smooth muscle contraction (GO:0014821),0.401400912838673,0.9384300203821214,0.5239179954441914,0.8377839727802728,1.0,3/10,14.15%,GDNF;EDNRB;DRD2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3145898298205559,0.9383226433351793,0.5202702702702703,0.8371750100093562,1.0,4/26,6.04%,PPARA;SLC5A3;SLC30A10;ABCD2
prerank,peptide metabolic process (GO:0006518),-0.24844840040936367,-0.9382813370864622,0.5769230769230769,0.7776489009923196,1.0,18/75,15.05%,DMD;TPP1;BACE2;BACE1;LTA4H;ERAP1;IDE;SPCS1;GPX1;GSTA4;CPE;CARNMT1;GSTM2;SEC11A;GSTA3;LNPEP;ACE;GSTM1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.36764344303978114,-0.9382138761115222,0.552,0.7773302888924241,1.0,6/15,25.02%,RAB18;ATL2;REEP4;RTN3;TMEM33;ZFYVE27
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.32545088319735166,-0.9380974676961891,0.5494505494505495,0.7771131426648527,1.0,8/22,25.25%,PSMA6;PSMB5;PSMB4;PSMA1;PSMB1;PSMA4;PSMA2;PSMB8
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3881719895502411,0.9373004963772028,0.5321888412017167,0.8387854954224606,1.0,3/11,10.18%,VCPIP1;RTN4;STX18
prerank,vasculature development (GO:0001944),0.35523061811935885,0.9372087178337903,0.5557986870897156,0.8381357880568486,1.0,3/16,6.77%,ERRFI1;PDGFRA;PDGFRB
prerank,T cell activation (GO:0042110),-0.2560861479344997,-0.9371618800535731,0.5867924528301887,0.7787554238010337,1.0,22/69,23.65%,CXADR;DPP4;CTPS1;CD44;FKBP1A;MSN;JAG2;CASP8;HSPD1;CD74;LFNG;PPP3CB;SOX4;JAML;GPR89B;GPR89A;DLL4;NCK1;PTPN22;ADA;PIK3CG;NCK2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.34601315852559145,0.9368780091715061,0.5440860215053763,0.8380499666392037,1.0,7/18,23.13%,MCM3;GINS2;PCNA;POLD3;MCMDC2;POLD2;MCM7
prerank,positive regulation of embryonic development (GO:0040019),0.3414735063376852,0.9368748454211664,0.5534591194968553,0.8371866418391909,1.0,2/19,6.59%,WNT4;FOXA2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2861433629353731,-0.936869225723277,0.5940409683426443,0.7789767763105221,1.0,16/36,31.99%,NLRC5;RIPK1;EDN1;CD74;MAVS;AGPAT1;HSPA1A;TXK;LAPTM5;CASP1;HSPA1B;PARP14;C1QTNF4;IRGM;PARP9;TRIM44
prerank,gene silencing by miRNA (GO:0035195),-0.2997503477907001,-0.9366377581269753,0.551660516605166,0.7790230194075068,1.0,6/32,11.40%,TNRC6C;ADAR;CNOT7;NOTCH4;WTIP;LIMD1
prerank,arachidonic acid metabolic process (GO:0019369),-0.2899463635134711,-0.9363679586138597,0.547486033519553,0.7791914530249046,1.0,10/35,18.31%,PTGDS;MGLL;EPHX1;CYP1B1;GPX1;PTGS1;FAAH;GPX4;CBR1;DAGLB
prerank,positive regulation of ion transport (GO:0043270),0.2781621395246327,0.9361593101847475,0.5495689655172413,0.8379935647809653,1.0,7/48,7.60%,GDNF;SCN3B;ANK2;P2RX4;GPD1L;MYLK;CACNB2
prerank,mRNA modification (GO:0016556),0.32671852056419276,0.9361197593897366,0.5516431924882629,0.83720587687934,1.0,7/22,18.64%,VIRMA;RPUSD2;METTL16;PUS7;METTL3;METTL8;PUS1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3969877253040225,-0.9360286346236082,0.5533088235294118,0.7795136070062535,1.0,5/10,15.15%,CALM1;CACNB3;CALM3;SRI;NIPSNAP2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.30978978517893346,0.9360185057931079,0.5405982905982906,0.8365837196154026,1.0,3/26,4.80%,ROCK2;LYN;EFNA3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24805612059022347,-0.9359663214155567,0.6004016064257028,0.7791696918997792,1.0,17/78,19.30%,ACTB;CCND3;CCNY;CDKN1B;PKD1;RGCC;AKT1;HHEX;CCNG2;EGFR;CCNF;CDKN1A;CCNK;CDKN2C;CDK5RAP3;GADD45A;CCND1
prerank,regulation of stem cell differentiation (GO:2000736),-0.24082167820773454,-0.9358792465905871,0.5777777777777777,0.7788999581109712,1.0,24/89,17.06%,NOTCH1;LMO2;CBFB;GATA2;PRKDC;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;OCIAD1;PSMD14;ITCH;HES1;SETD1A;PSMD8;LDB1;PSMD11;PSMB4;PSMD12;PSMC1;TCF3;HOXB4
prerank,negative regulation of transposition (GO:0010529),0.35286554339587367,0.9356608823610787,0.5407725321888412,0.8365857116292541,1.0,3/16,13.85%,TUT4;PIWIL2;TEX15
prerank,bile acid biosynthetic process (GO:0006699),0.3141335055377355,0.9356106636562006,0.5441176470588235,0.8358200965693244,1.0,5/24,12.39%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP
prerank,negative regulation of neuron differentiation (GO:0045665),0.32857660182660203,0.9355347809072029,0.5183673469387755,0.835138190695418,1.0,5/22,8.54%,CNTN4;HES3;DTX1;SOX2;HES5
prerank,excitatory postsynaptic potential (GO:0060079),0.3391311319310141,0.9353625110765734,0.5105042016806722,0.8347185013140992,1.0,7/19,18.84%,GRID2;MPP2;MAPK8IP2;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,fat cell differentiation (GO:0045444),0.2695815068539828,0.9353429506965345,0.533195020746888,0.8339123178727323,1.0,5/57,6.13%,TCF7L2;PID1;OSBPL8;SENP2;ATF5
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3084973647708677,0.9347006548567073,0.5331905781584583,0.834588414304369,1.0,7/30,13.61%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.29896168334572526,-0.9343053423668354,0.5531914893617021,0.781996970177168,1.0,13/30,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3432538222757482,0.9342084749591539,0.546485260770975,0.8349376840158479,1.0,9/18,23.74%,ASPA;SLC25A13;FOLH1;MTHFD1;ASS1;ASPG;GOT1;GOT2;MTHFR
prerank,negative regulation of cellular senescence (GO:2000773),-0.37469692490280904,-0.9335203263453902,0.5467889908256881,0.7832923749108641,1.0,3/13,8.99%,CDK6;MAP3K3;TWIST1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3122379825643151,-0.9330543390726891,0.5582255083179297,0.78386640113823,1.0,7/25,17.50%,AFAP1L2;HIP1R;AKT1;HIP1;SHKBP1;BCAR3;NEU3
prerank,regulation of phagocytosis (GO:0050764),0.2735222589423665,0.9327201825764264,0.5765199161425576,0.8376015061363292,1.0,4/53,2.10%,CAMK1D;PRTN3;PLA2G5;AHSG
prerank,triglyceride metabolic process (GO:0006641),0.2763283713380102,0.9324866820917138,0.5551181102362205,0.8372785286764378,1.0,9/48,16.49%,AGMO;APOH;APOBR;MOGAT3;LPIN3;MOGAT2;DGAT2;FABP4;LPIN1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.29150734603511647,-0.9316336893079952,0.5616942909760589,0.7866322849657124,1.0,10/33,19.01%,ESR1;DDX5;UFM1;CBFB;DDRGK1;H3-3A;TRIM68;UFL1;KDM1A;UBA5
prerank,negative regulation of histone modification (GO:0031057),-0.3609987232941555,-0.930859002426313,0.5817490494296578,0.7878930130978119,1.0,4/14,19.23%,CTBP1;TWIST1;SPHK2;AASS
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.37996328635156507,0.9305462672291052,0.5307377049180327,0.8410682889193618,1.0,2/12,3.27%,DOCK11;DOCK10
prerank,actin filament capping (GO:0051693),0.3466114102001977,0.9304081823158081,0.5196687370600414,0.839673748631375,1.0,1/18,0.16%,SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.3466114102001977,0.9304081823158081,0.5196687370600414,0.839673748631375,1.0,1/18,0.16%,SVIL
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.37025405999526895,-0.9302211631130137,0.579136690647482,0.7889014995191229,1.0,4/13,20.19%,CYRIB;PVR;NECTIN2;MR1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3849899426640927,0.9300457282098248,0.5488888888888889,0.8397196179001506,1.0,3/11,9.11%,NOVA1;IGF2BP2;PCBP3
prerank,synaptic vesicle localization (GO:0097479),0.37312182959481055,0.9300198590612833,0.5578093306288032,0.8389114634298815,1.0,5/13,16.28%,KIF5C;SYNDIG1;NLGN1;SNAPIN;TMEM230
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4024180023083169,0.9298953031845165,0.5418502202643172,0.8383244137895877,1.0,3/10,11.47%,ZEB2;MFSD12;CTNS
prerank,phagosome-lysosome fusion (GO:0090385),0.4096699277854485,0.9289143259355694,0.5152838427947598,0.8398430159403135,1.0,4/10,19.23%,PLA2G5;RAB20;CLN3;RAB7B
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2882662765470895,-0.9286865207537006,0.5701107011070111,0.7918811238238044,1.0,8/36,16.26%,CAV1;TRPC3;STIM2;TRPC6;ORAI1;SPHK2;CACNA1D;ATP2B1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.2792934229132934,-0.9281132840252555,0.5875706214689266,0.7927597655103906,1.0,5/42,11.58%,ACKR3;PTK2B;WNK1;CCL15;CIB1
prerank,GTP metabolic process (GO:0046039),-0.3547683183922863,-0.9279233701986263,0.5549348230912476,0.7927013885990628,1.0,4/15,21.31%,IMPDH1;ENTPD7;OPA1;RAB23
prerank,establishment of spindle localization (GO:0051293),-0.36242085362780996,-0.9277415738668923,0.5685185185185185,0.7926458227535262,1.0,5/14,36.29%,MAP4;CFL1;TLE6;ESPL1;NLRP5
prerank,negative regulation of secretion (GO:0051048),0.4009219347455177,0.927093744965308,0.5526315789473685,0.8433602806691678,1.0,2/10,8.27%,NRG1;ERBB3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.35813382126297383,-0.9270528312179933,0.5495495495495496,0.7937532284900094,1.0,7/14,30.94%,CAV1;NOTCH4;SPRY1;SPRED3;XDH;SPRED1;DLL1
prerank,histone acetylation (GO:0016573),-0.2501281602489182,-0.9261740094291485,0.5953757225433526,0.7952809347027994,1.0,21/69,28.86%,LEF1;PHF20;TRRAP;JADE2;ING5;TRIM16;EPC1;NAA60;MRGBP;BRCA2;EP400;TADA3;BRPF1;TAF9;POLE3;RUVBL1;KAT6B;SPI1;TAF10;TAF5;NAA50
prerank,cellular protein localization (GO:0034613),-0.20340222764096294,-0.9259234479571475,0.7204968944099379,0.7953778366319196,1.0,81/285,22.58%,OCLN;ESAM;DMD;ID1;SGSM2;STX3;TBC1D8;GRTP1;MESD;FERMT2;JAM3;AP3B1;RIC3;SYNRG;NAPA;AMOT;TBC1D1;RAB18;FAM91A1;TBC1D12;STX1A;TBC1D22A;ARF5;RAB6B;ITSN1;CPLANE2;CPE;HHEX;VCL;HERC2;EMP2;WNT11;CD74;STX2;GAS8;RAB24;COPB2;ARL4A;TBC1D9B;TBCK;SMURF1;ARL6;LAMTOR2;RAB1A;CEP68;AP4M1;CELSR1;COG3;EGFR;AP2A1;RRAGD;YWHAH;PACSIN1;VPS33A;NSF;TBC1D25;TBC1D2;EHD1;ARHGEF2;VPS29;TMED1;USP4;RAB3GAP2;RAB32;CTTN;LAPTM5;IFT27;TMED5;WIPI2;PTPRK;FGF10;RRAGA;NIPBL;ARL4C;RAB23;ADPRH;PTPRU;STX5;KIF13A;RRAGC;TBC1D15
prerank,central nervous system neuron axonogenesis (GO:0021955),0.38076442973789515,0.9258275345971045,0.5401301518438177,0.8455576745169759,1.0,3/12,10.35%,MYCBP2;EPHB1;PTEN
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3077761133311212,-0.9257636107600031,0.5610200364298725,0.7952579090235262,1.0,4/25,4.89%,PLCG2;TMBIM4;HTT;CMKLR1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3167784749331667,-0.9254477268107083,0.5749063670411985,0.795515951457914,1.0,3/25,5.31%,MEF2C;SHANK3;MINK1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.3824320217616154,0.9251095909665126,0.5582959641255605,0.846483444433059,1.0,3/12,6.74%,RIMS1;UNC13C;SYT1
prerank,regulation of endocytosis (GO:0030100),-0.25642130576332267,-0.9250615149933695,0.5881188118811881,0.7958822546598873,1.0,23/61,26.21%,GPC3;NEDD4L;OPHN1;CD151;HIP1R;FLOT1;HIP1;RAB4B;ABL2;RUFY1;RAB4A;APOE;PACSIN1;TSC2;PACSIN3;PACSIN2;PTPN1;RUBCN;ZFYVE16;CBLL1;MTMR2;RAB5C;SMPD1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.25799424307059377,-0.9247782652348266,0.5831775700934579,0.7960515850186743,1.0,27/56,33.50%,SPTBN1;USP8;KIF23;DCTN3;RHOB;RTKN;MITD1;SNX18;IST1;ECT2;RASA1;ANLN;CENPA;EFHC2;CIT;CEP55;VPS4A;STMN1;ARL3;RACGAP1;TRIM36;PLK1;RHOA;CHMP4B;ESPL1;UNC119;STAMBP
prerank,innate immune response in mucosa (GO:0002227),0.4020604749751613,0.924476303254154,0.5369127516778524,0.847087893282858,1.0,2/10,5.47%,IL4;BPIFB1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.30628260146891134,0.9242346495967366,0.5734989648033126,0.8467948715881775,1.0,4/26,6.54%,EYA2;GDNF;BCL2;EYA1
prerank,regulation of autophagy (GO:0010506),-0.21023888727609968,-0.9237569936937365,0.6549586776859504,0.7978145679821712,1.0,62/216,25.40%,ACER2;EXOC4;EEF1A1;RASIP1;SH3BP4;FOXO1;MID2;FOXO3;DAPL1;ATP6V0B;EIF4G3;FOXK1;PSAP;ATP6V0A2;GPR137B;HSPB1;GAPDH;SVIP;PLK2;AKT1;TRIM14;PIK3C2A;ATP6V0C;RAB8A;UCHL1;EXOC1;ABL2;FBXL2;TRIM68;LAMTOR2;TRIM5;PRKAG1;ATP6V1G1;MET;CSNK2A2;UFL1;PIK3R2;RRAGD;TAB2;BAD;VPS29;GFAP;PLEKHF1;OSBPL7;TMEM59;MCL1;KEAP1;FZD5;RRAGA;TFEB;TRIB3;EIF4G1;PTPN22;RRAGC;TPCN2;WDR6;RUBCN;EIF4E;RPTOR;SREBF1;ATP6V0D1;TREM2
prerank,cellular response to interleukin-6 (GO:0071354),0.3121680066987981,0.9235315472040677,0.5496031746031746,0.8476538327426523,1.0,3/26,3.92%,PID1;PTGIS;PTPRT
prerank,pore complex assembly (GO:0046931),-0.3343918756754394,-0.9232733207224703,0.536283185840708,0.7984712538455248,1.0,4/19,9.18%,ANO6;ADAM10;NUP93;NDC1
prerank,tRNA wobble base modification (GO:0002097),-0.3580482167411919,-0.922979736718607,0.5663551401869159,0.798647595212908,1.0,5/14,28.07%,DPH3;TRMT9B;URM1;ADAT2;CTU2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.39970312379924,-0.922616344073458,0.5684007707129094,0.799022517598758,1.0,3/10,6.42%,ACTN4;TBX1;RARA
prerank,histone modification (GO:0016570),0.23948567617377975,0.922361463788763,0.610337972166998,0.8495901309640979,1.0,23/109,15.47%,EYA2;TBL1XR1;PRDM5;MAP3K12;TAF6L;HDAC10;BAZ1B;EYA1;SIRT2;ATXN7;NSD1;KAT8;MIER3;BRMS1L;BRMS1;EHMT2;NEK11;AURKC;NSD3;EP300;EZH2;KAT5;PADI1
prerank,DNA duplex unwinding (GO:0032508),-0.26623513487591655,-0.9222857850593233,0.575,0.7992990183402535,1.0,12/50,17.81%,ANXA1;UBB;UBC;RPS27A;CUL4A;GTF2H3;DHX9;CHD1L;RBX1;CETN2;ASCC3;GTF2H4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.32637662194360595,-0.9220501881479981,0.5748175182481752,0.7993847955084477,1.0,8/20,17.16%,NOTCH1;SMAD9;CARF;VEGFA;ATF4;SMAD4;RELA;XBP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.36223668777619067,-0.9219220916989306,0.5766283524904214,0.7992047559838765,1.0,3/13,4.55%,STX3;HSP90AB1;RIC3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3186008690116078,-0.9217511501194054,0.5755813953488372,0.7990982810576368,1.0,7/23,22.39%,FAR2;ELOVL7;ELOVL5;ACSL5;FAR1;ELOVL1;ACSF3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3460038030995481,0.9207567018355378,0.5328798185941043,0.8526554975170844,1.0,5/17,15.86%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.30315999317730397,0.9206700658525011,0.5699152542372882,0.8519954076933751,1.0,3/29,4.95%,IL31RA;STAT5B;GHR
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.28088118553078456,-0.9201270796917514,0.5988483685220729,0.8022737891792008,1.0,8/38,13.71%,CAV1;APP;NEDD9;SHC1;LRP8;SRCIN1;CSF1R;ACE
prerank,cytosolic transport (GO:0016482),-0.23488420688962786,-0.9197296989711541,0.6245059288537549,0.8027191686854572,1.0,40/108,29.97%,MYO1D;VPS13A;VPS53;EEA1;RAB6B;TMEM87B;HEATR5A;GOSR1;LAMP1;EMP2;LMTK2;DCTN1;KIF16B;RAB7A;CCDC91;DOP1B;AP4M1;SPAG9;AP2A1;SNF8;GCC2;VTI1B;TBC1D23;VPS29;LAPTM5;EHD3;STX5;VPS54;CORO7;PHETA2;TBC1D17;EPS15;SNX2;TBC1D5;PREPL;ERC1;STX16;HEATR5B;RAB6A;AP1G1
prerank,calcineurin-mediated signaling (GO:0097720),-0.3919580286280969,-0.9196968715839597,0.5608856088560885,0.8018568405624252,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3919580286280969,-0.9196968715839597,0.5608856088560885,0.8018568405624252,1.0,5/10,20.61%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,protein targeting to mitochondrion (GO:0006626),-0.2608660041394576,-0.9191599551582852,0.6280834914611005,0.8025975961918256,1.0,19/52,28.18%,NDUFA13;IMMP2L;HSPD1;TIMM17A;TIMM21;TIMM29;TOMM22;CHCHD4;HSPA4;BCAP31;HSP90AA1;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,cytosolic calcium ion transport (GO:0060401),-0.30538880331316176,-0.9188585925607216,0.6049382716049383,0.802773731965328,1.0,15/28,24.61%,MCUB;ITPR3;SLC35G1;ATP2A3;MCUR1;JPH2;JPH4;CACNB3;ATP2B3;ATP2B1;MICU2;CACNA1C;JPH3;SMDT1;MCU
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2810159738086753,0.9178152211027693,0.597165991902834,0.8581427900497002,1.0,18/40,22.71%,CRY1;RADX;RPA2;FXR2;ANKLE1;MAPT;IER3;CDK9;FBXO5;ETAA1;UBE2N;WRNIP1;ARMT1;WDR76;NEK4;NPAS2;UBE2V2;RFWD3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2934043252147056,0.9177831144159396,0.5732484076433121,0.8573536492233084,1.0,6/33,11.17%,ALDH4A1;ALDH18A1;PRODH;GLUL;GLS2;FPGS
prerank,protein K11-linked ubiquitination (GO:0070979),0.31075817210822154,0.9177162371112625,0.5787321063394683,0.8566444720171895,1.0,9/27,19.60%,PRKN;ANAPC1;UBE2E3;CDC23;CDC16;RNF26;UBE2E2;ANAPC5;CDC26
prerank,peptide hormone secretion (GO:0030072),-0.3076824063079646,-0.9172554383385356,0.5862708719851577,0.8058992756564323,1.0,16/26,45.50%,LTBP4;ANXA1;EDN1;RAB1A;PARK7;CAMK2G;ADCYAP1;SNX19;EXOC3L1;VIP;EDN3;SLC30A8;FAM3B;NEUROD1;IL6;GAL
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.35472126225004286,-0.9164821623086347,0.5646630236794171,0.8072088690787803,1.0,3/15,12.70%,ARPC1B;ARPC5;ACTR3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3056654905227393,-0.9162220713432988,0.5908256880733945,0.807342110773011,1.0,8/26,19.90%,SHANK3;ACTG1;RAC1;PFN1;SYNPO;LIMK1;PTGER4;SHANK1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3181146345053309,-0.9161537796419479,0.5850467289719626,0.8070181087575248,1.0,7/21,20.67%,RPL11;RPL23;RPS7;CDC14B;RAB1A;FZR1;RPL5
prerank,thymus development (GO:0048538),-0.368395735288906,-0.9161296990262465,0.5842911877394636,0.8065979974756015,1.0,5/13,27.09%,TBX1;SIX1;HES1;FGF10;SOD1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3137026095167317,-0.9155397454952741,0.5780346820809249,0.8074124757144825,1.0,11/24,31.12%,KDR;CYRIB;MIEF1;MIEF2;INF2;FIS1;MCU;MYO19;MFF;MUL1;AURKA
prerank,eye photoreceptor cell development (GO:0042462),-0.3503336682242738,-0.915526904640332,0.5737122557726465,0.8069697121510335,1.0,4/15,18.66%,RP1;VEGFA;CEP290;RPGRIP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2907938115445153,0.9155233256519946,0.5895196506550219,0.8610452838525419,1.0,5/39,9.92%,TCF7L2;IRS2;NLGN2;TM7SF3;AIMP1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.27176876952629564,0.9148336818519615,0.5817805383022774,0.861757701873738,1.0,11/46,20.28%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G12A
prerank,actin nucleation (GO:0045010),-0.3220025993459202,-0.9146431213713381,0.5911602209944752,0.808488917748214,1.0,4/21,12.70%,ARPC1B;LMOD1;ARPC5;ACTR3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3356069969963039,-0.9142802304383032,0.5792452830188679,0.8087932689539673,1.0,2/18,0.53%,MEF2C;FLT1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3563966833471806,-0.9140531949622313,0.5776965265082267,0.8088032565336596,1.0,1/15,0.12%,PRKCH
prerank,glycine metabolic process (GO:0006544),0.38003456323872226,0.913151515855306,0.5548523206751055,0.8648699669804458,1.0,3/12,9.74%,GLDC;BAAT;RIDA
prerank,regulation of cellular metabolic process (GO:0031323),0.2720457319395577,0.9131378135037083,0.5688259109311741,0.8640360686920533,1.0,5/45,5.80%,PID1;PPARA;PDK4;PRKN;PDK3
prerank,negative regulation of ion transport (GO:0043271),-0.3053875154101754,-0.9125469809850099,0.5886654478976234,0.8116883553077459,1.0,13/24,39.25%,PTK2B;WNK1;CASQ2;PACSIN3;LILRB1;NOS1;CD33;WNK4;HRH3;ADRA2A;VIP;GPM6B;INPP5K
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.332735626162101,-0.9122003898900829,0.6112115732368897,0.812015825903136,1.0,7/19,29.11%,GPX1;ACOX1;GPX3;PARK7;PRDX4;SOD1;NOX1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.37687527462180653,0.9115033832024798,0.5412844036697247,0.8670492546350791,1.0,11/11,62.34%,PKD1L3;LPO;RTP2;PKD2L1;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;RTP4
prerank,protein palmitoylation (GO:0018345),-0.2911771780166693,-0.911344034732565,0.5895117540687161,0.8134228390011531,1.0,13/30,31.18%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;SELENOK;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,transferrin transport (GO:0033572),-0.28421618105944096,-0.9106770579712231,0.5934489402697495,0.8145308580495441,1.0,8/33,11.50%,TFRC;ATP6V0B;ARHGAP1;ATP6V0A2;ATP6V0C;LMTK2;REP15;RAB11B
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.2952701250832892,-0.910621903115068,0.5984555984555985,0.8141705188545041,1.0,6/29,6.37%,LEF1;TLE4;RBBP5;TRRAP;PYGO2;TLE3
prerank,negative regulation of hemostasis (GO:1900047),0.37284866345822865,0.9103922403083862,0.5739130434782609,0.8688886933942004,1.0,3/12,5.80%,SERPINE2;APOH;SERPINE1
prerank,negative regulation of leukocyte migration (GO:0002686),0.39257266266851576,0.9100461764542775,0.5553097345132744,0.8688775598955376,1.0,1/10,1.32%,BMP5
prerank,mitotic chromosome condensation (GO:0007076),-0.30319574403653804,-0.9099316362702132,0.5841209829867675,0.8151755679389102,1.0,14/26,31.91%,SMC4;CSNK2B;RB1;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;KMT5A;NCAPH2;TTN;PLK1;CDK1;NCAPD2
prerank,response to light stimulus (GO:0009416),0.2635056715676154,0.909643111100894,0.6030042918454935,0.8690018803723811,1.0,7/55,7.62%,GPR88;DDB2;TRPM1;GTF2H2;COPS3;MEN1;CRY1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.39462876137468306,-0.9093348842891649,0.5985663082437276,0.8160601754211417,1.0,6/10,25.77%,CAMK1;SPHK2;SMAD4;RAPGEF3;CHEK1;HDAC5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.36808914186531455,-0.9090208386876394,0.5732600732600732,0.8162781344325071,1.0,7/12,39.25%,REST;PSMC3;POU2F3;CCL5;JUN;CCL4;INPP5K
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3317097729960123,-0.9088394521934215,0.5894160583941606,0.8162080657793349,1.0,11/18,39.04%,ESR1;NRIP1;LCOR;EGFR;FAM210B;SSTR2;POU4F1;RAMP3;GPER1;CRHBP;SSTR1
prerank,regulation of cell morphogenesis (GO:0022604),0.29926443976069594,0.9087227910486857,0.6090712742980562,0.8702751383799903,1.0,3/30,5.12%,SH3D19;PHIP;ZMYM6
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3672528341797096,0.9085192636705173,0.5589519650655022,0.8699247516902002,1.0,3/13,5.08%,PID1;PPARA;IL4
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3419685331590291,-0.9081899135398153,0.5790408525754884,0.8171681037961978,1.0,3/16,4.12%,NOTCH1;BMPR2;TGFB2
prerank,homologous chromosome segregation (GO:0045143),0.32126194941209196,0.9080228179805953,0.5794183445190156,0.8702602002572202,1.0,3/20,10.93%,MEIKIN;PRDM9;FMN2
prerank,maturation of 5.8S rRNA (GO:0000460),0.3331239562431262,0.9078700634257099,0.5436681222707423,0.8697256727603043,1.0,2/17,1.51%,MPHOSPH6;C1D
prerank,respiratory electron transport chain (GO:0022904),-0.3437794840126494,-0.907839296909686,0.5736842105263158,0.8174866384732236,1.0,7/14,26.95%,PPARGC1A;SLC25A12;ETFB;ETFDH;SDHB;SLC25A22;ETFRF1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.34794538519523516,-0.9076603366536619,0.5848375451263538,0.817385923738486,1.0,4/15,5.68%,KDR;F3;VEGFC;VEGFA
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33753789178549576,0.9072830360701682,0.5767441860465117,0.8702345075679679,1.0,5/18,11.56%,PRDM9;SETMAR;KMT2A;SETD7;EHMT2
prerank,smoothened signaling pathway (GO:0007224),0.2967038848173565,0.9072415918233253,0.6194503171247357,0.8694633962850485,1.0,11/32,19.76%,TMEM17;GLI2;GLI3;GPC2;HES5;MAP3K10;EVC2;ARL13B;SHH;DISP3;DISP2
prerank,regulation of protein import into nucleus (GO:0042306),0.2880605020965184,0.9071818413461273,0.5849462365591398,0.8687519284804115,1.0,3/36,2.77%,PIK3R1;ZIC1;SMAD3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.310315331699988,0.9070684663522453,0.5678733031674208,0.8681588120900765,1.0,8/23,12.64%,KIT;GHR;IL4;HES5;ERBB4;OCIAD2;PIBF1;PRLR
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.3190301148172265,-0.9067033936670237,0.6033834586466166,0.8190586736728548,1.0,9/22,20.92%,RAP1A;RAPGEF1;NGF;STMN2;AKT1;CIB1;KIDINS220;EHD1;RAPGEF2
prerank,bile acid metabolic process (GO:0008206),0.3004922481761063,0.9067032534400036,0.5720338983050848,0.8681766821396573,1.0,6/27,13.34%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP;GBA2
prerank,histone methylation (GO:0016571),0.3031859509576448,0.9066328743844437,0.5822510822510822,0.8674950855677813,1.0,6/26,14.58%,NSD1;SMYD1;SMYD3;EHMT2;NSD3;EZH2
prerank,regulation of T cell proliferation (GO:0042129),-0.24542708568004645,-0.906581239681704,0.6424474187380497,0.8188550644784733,1.0,6/61,7.20%,IL15;SLC7A1;TFRC;ANXA1;TNFRSF21;TNFRSF1B
prerank,glutathione metabolic process (GO:0006749),-0.2828559373534478,-0.9062690970347063,0.6273764258555133,0.8190831752356301,1.0,16/38,27.09%,GPX1;GSTA4;GGT5;GSTM2;GSTA3;GSTM1;GSR;GCLM;CNDP2;GCLC;GGT1;GSTK1;GGCT;GSTM5;PARK7;SOD1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3326143161265188,-0.9061365149607983,0.5953654188948306,0.8188891201900054,1.0,3/18,6.47%,CD34;HDAC7;EZR
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.30759789070932264,-0.9060886935288489,0.6096718480138169,0.8180390036098022,1.0,9/22,31.18%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.30759789070932264,-0.9060886935288489,0.6096718480138169,0.8180390036098022,1.0,9/22,31.18%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.33020727381536397,-0.9059401809338888,0.6014760147601476,0.8178997876364104,1.0,8/20,24.55%,LBP;TGFB1;PRKCE;TLR4;HCK;PTPN22;CCL2;BCL10
prerank,body fluid secretion (GO:0007589),0.34099306972848115,0.9058254266624755,0.5863539445628998,0.868517446596334,1.0,5/15,18.68%,SLC22A4;ERBB4;PRLR;GUCA1B;SLC22A2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.30900742743082876,-0.9053987396029125,0.6045627376425855,0.8185939266341641,1.0,6/23,10.91%,MINDY2;MINDY1;OTUD5;USP8;OTUB1;USP5
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.22480501569267514,-0.9049265017003595,0.674,0.8191457050852354,1.0,30/124,16.47%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;NFATC1;WNT11;PSMC4;PSMC5;PSMD14;PPP3CB;GNB1;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.2692784382995972,-0.9047241511121249,0.6242884250474383,0.8191329485409276,1.0,21/45,37.12%,RPL10;FOXO3;APP;RC3H1;TDRD7;RBM4B;PCIF1;PUM2;ZC3H7A;MEX3D;EIF4E;RBM3;METTL18;ZC3H10;PARP9;ATG14;NANOS1;LARP4;CYFIP1;TRIM71;EIF2A
prerank,negative regulation of blood coagulation (GO:0030195),-0.2739630485106248,-0.9045758738911552,0.5992366412213741,0.8189954122571469,1.0,6/38,8.93%,NOS3;CD34;F3;THBD;EDN1;PDGFA
prerank,transition metal ion transport (GO:0000041),0.2841685043648762,0.9039352842719067,0.5931477516059958,0.8721085970943646,1.0,4/35,6.74%,CP;HEPH;SLC30A10;SLC31A2
prerank,synaptic vesicle exocytosis (GO:0016079),0.2761971952173721,0.9036873488128935,0.5909090909090909,0.8717989914782239,1.0,9/40,13.07%,RIMS1;UNC13C;SYT1;CPLX2;SNAP25;OTOF;STX1B;SNAPIN;SNAP47
prerank,cell junction maintenance (GO:0034331),0.36600433479745587,0.9035809228793621,0.569593147751606,0.8711791717403475,1.0,3/14,10.74%,PRTN3;NLGN2;CBLN2
prerank,peptide catabolic process (GO:0043171),-0.3115808401975605,-0.9035030946069322,0.6209964412811388,0.8208423120238897,1.0,7/23,13.71%,TPP1;LTA4H;ERAP1;IDE;GGT5;LNPEP;ACE
prerank,negative regulation of lipid storage (GO:0010888),0.3206146199632654,0.9034740096597289,0.5835010060362174,0.8705696323343367,1.0,3/19,3.11%,ABCA1;PPARA;OSBPL8
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.39461204726555554,0.9031782727421777,0.5686274509803921,0.8704105655207001,1.0,2/10,2.55%,SERPINE2;ALOX12
prerank,protein-containing complex subunit organization (GO:0043933),0.23065039829962822,0.9026335197522164,0.6747967479674797,0.8708075086726647,1.0,27/109,15.17%,TEAD1;MITF;RIMS1;MDM2;IL1RAP;JCHAIN;MAGI1;MNAT1;SLC7A9;GPAA1;FANCC;PPIH;TUBGCP4;KMT2A;HES5;KNTC1;NUP205;LPXN;NUP35;SNX9;LAMC1;LLGL1;DLG4;YAP1;TUBGCP2;TRAF2;GEMIN5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.31427424966779444,-0.9024134122174546,0.6142595978062158,0.8228077421281358,1.0,6/22,22.09%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22
prerank,regulation of catabolic process (GO:0009894),-0.3307510351829507,-0.902362511674873,0.5885826771653543,0.8224575940680604,1.0,2/18,2.94%,NEDD4L;FAP
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3580074722864739,-0.902346090084155,0.5918367346938775,0.8220118233258695,1.0,3/13,6.47%,OPHN1;MSN;EZR
prerank,regulation of vasoconstriction (GO:0019229),-0.291664478991347,-0.9022014595570886,0.575812274368231,0.8218670620698214,1.0,5/27,16.26%,CAV1;BMPR2;ACE2;ACE;ATP2B1
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2534092069637775,-0.9019769008213964,0.6390532544378699,0.8219169484562038,1.0,14/54,16.48%,GPC3;AGRN;HS3ST3A1;HEXA;NDST1;HS3ST1;IDUA;HAS1;SDC3;SGSH;HS3ST3B1;SLC35D2;GUSB;XYLT2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.26663271447716064,-0.9019504754347825,0.621031746031746,0.8215039967531079,1.0,10/40,16.40%,B2M;ANXA2;VEGFA;INSR;HIP1;SGIP1;FMR1;WASL;HNRNPK;GREM1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2530382955607565,0.901897906520573,0.5870020964360587,0.8716742380742948,1.0,9/60,11.39%,TCF7L2;CDK8;CEBPB;AGO4;TNRC6A;PPM1D;PAXIP1;PTEN;TNRC6B
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3177560861377493,0.9018857482296821,0.5695652173913044,0.8708516520949244,1.0,2/21,3.32%,ANK2;CACNA2D1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3331061612059565,-0.9018772279646402,0.6245283018867924,0.8211893106524252,1.0,4/17,7.32%,KCNB1;RAB27A;STX1A;SLC4A8
prerank,cilium movement (GO:0003341),-0.2597881779624572,-0.9018754459650554,0.620817843866171,0.820719805335201,1.0,28/47,44.25%,SPEF1;ODAD1;GAS8;DNAH5;CABYR;CFAP251;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;ZBBX;SPA17;DNAH17;CFAP70;CFAP206;DNAAF4;CCDC63;CFAP91;TEKT5;CFAP54;DNAH1;RSPH6A;DNHD1;DNAAF1;DNAI3;RSPH4A
prerank,negative regulation of developmental growth (GO:0048640),0.29979351932728854,0.9015438783054037,0.603448275862069,0.8707855495589553,1.0,9/30,15.83%,WWC1;RTN4;CDKL3;DCC;BBS2;PTEN;ULK2;TRIM46;NKD1
prerank,cellular amide metabolic process (GO:0043603),0.23304943823859006,0.901061068765272,0.6601307189542484,0.8710143516865365,1.0,22/102,16.99%,PCCA;ACSM5;CPZ;AEBP1;BAAT;CPXM1;DNPEP;PLPP3;ACOT11;PDZD11;ALDH1L1;NSMAF;FPGS;SLC46A1;THOP1;MTHFD1;PLAAT5;ACSL6;MTHFD1L;ST3GAL1;ACBD6;MCCC2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.35411436227362325,0.9009414503352676,0.5730088495575221,0.8704655876129813,1.0,3/14,14.06%,ANK2;ACTN2;ATP1B3
prerank,determination of left/right symmetry (GO:0007368),-0.2765250752835681,-0.9008854568716305,0.6418439716312057,0.8224241244671324,1.0,10/36,24.81%,NOTCH1;TBX1;SMO;ZIC3;ARL6;DNAH5;PKD2;ODAD2;ODAD3;MKKS
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2116228264507121,-0.900770659404262,0.744140625,0.8222130077687972,1.0,48/172,21.70%,PLCG2;DGKH;PIP5K1B;BMX;TAMM41;PI4K2A;LPCAT3;INPP5D;PIK3R6;MFSD2A;CDS2;CDS1;MTMR14;MTMR12;CDIPT;INPP5E;CHKA;PIK3C2A;CSNK2B;PITPNM2;MBOAT7;RUFY1;CEPT1;PITPNM3;RAB4A;FGF2;AGPAT1;PIK3R3;PITPNM1;FAR1;PIK3CA;MTM1;CSNK2A1;CSNK2A2;PCYT2;SYNJ1;PIK3R2;FIG4;PIK3C2B;DGKZ;LCAT;GPD1;ABHD8;AGPAT5;CPNE3;PCYT1A;CHAT;LPCAT2
prerank,primary neural tube formation (GO:0014020),0.2941828929046861,0.9007192861928308,0.6158940397350994,0.8701320072545278,1.0,8/30,12.31%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.30308707333117496,0.90037080320895,0.6255506607929515,0.8701134009255388,1.0,5/27,8.31%,ABCA1;PPARA;PLA2G5;ABCA5;IL18
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33910977747066195,0.9001883087992386,0.5886075949367089,0.8696902793741731,1.0,3/16,7.63%,DAZAP1;TRA2A;CELF4
prerank,regulation of mast cell activation (GO:0033003),0.3900746358339004,0.9000940530286764,0.578088578088578,0.8690683475313797,1.0,4/10,16.35%,LYN;CD300LF;TSLP;CRLF2
prerank,calcium import into the mitochondrion (GO:0036444),-0.3913108505517708,-0.9000137314219857,0.5892857142857143,0.8233363747677489,1.0,5/10,24.61%,MCUB;MCUR1;MICU2;SMDT1;MCU
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.34117712296864255,-0.8998910223830865,0.5977653631284916,0.8231190463323079,1.0,4/16,7.53%,ST6GALNAC3;ST8SIA4;ST8SIA6;A4GALT
prerank,ATP transport (GO:0015867),0.3901213045413128,0.8996112737168945,0.5436241610738255,0.8693007408327034,1.0,3/10,15.52%,SLC25A42;SLC25A24;CD47
prerank,regulation of interleukin-1 beta production (GO:0032651),0.25638406328260577,0.8995564374092574,0.645021645021645,0.8685828063483825,1.0,6/66,8.44%,IGF1;ORM2;GSTP1;NLRP12;GSDMD;NLRP2B
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3887128860031629,-0.8990958644109143,0.5925925925925926,0.824371629939114,1.0,5/10,32.73%,HDAC4;SAE1;UBA2;MUL1;RASD2
prerank,protein transport (GO:0015031),0.19870948919978912,0.8986279766976963,0.7839851024208566,0.8699185411868978,1.0,74/332,18.12%,WLS;VAMP5;STEAP3;ATP6V0A4;TBC1D4;TANGO2;RABGAP1L;TXNIP;LRP1;ABCA1;ARCN1;LRP1B;SNX33;RAB3C;SCFD1;MON1A;VPS26B;SYNDIG1;RAB5B;RAB29;SCG2;TBC1D2B;STX1B;RAB10;PRKCB;TMED10;SLU7;CHMP1A;ATP6V1H;STX7;LTBP2;BBS2;SEC31A;SNX9;TBC1D10C;EIF2D;KIF3A;HSP90B1;NGFR;DNAJC27;OPTN;STXBP3;TBC1D8B;STX12;SCAMP2;SYS1;SCAMP5;RPGR;RUNDC1;RAB38;SAR1B;ATP6V1B2;SCFD2;COPG2;TBC1D10A;ARRDC2;RAB20;ARL1;SCG5;TMED9;AFM;LRSAM1;SVBP;SNX8;TBC1D9;RAB19;RABL3;SGSM3;TRIM23;COPZ1;EVI5;MIA3;VLDLR;SNX6
prerank,regulation of chromosome segregation (GO:0051983),-0.3330232483436537,-0.898605776782916,0.6,0.8249146869074621,1.0,11/16,42.40%,RAD18;CSNK2A1;CSNK2A2;PUM2;MKI67;CDC6;BUB1;KIF2C;IHO1;AURKB;RMI2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38638803555377244,0.8984092075023704,0.5856236786469344,0.8695707111561576,1.0,2/10,11.79%,SEMA5A;ACTN2
prerank,tube closure (GO:0060606),0.2892992630759034,0.8983350939172304,0.6209150326797386,0.8688927137328217,1.0,8/31,12.31%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.26122550647067333,-0.898264447572723,0.6425925925925926,0.8252104843050266,1.0,16/46,28.18%,HK1;AKT1;HSPD1;TIMM17A;TIMM21;TOMM22;CHCHD4;BCAP31;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,regulation of interferon-gamma production (GO:0032649),-0.24150759798971264,-0.8979414416603089,0.6517690875232774,0.8254559857373773,1.0,32/71,40.25%,SLC7A5;PDE4D;CYRIB;IL1R1;RARA;TLR3;HSPD1;INHBA;TLR4;VSIR;TXK;LAPTM5;LGALS9;FZD5;PTPN22;ZFPM1;IL12RB2;INHA;RASGRP1;LILRB1;SCRIB;CD14;SLAMF6;SLC11A1;TLR8;CD226;IL12A;CRTAM;PDCD1LG2;IL12RB1;ISL1;NR1H4
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3699057165203302,-0.8978212694239707,0.5922509225092251,0.825258429055139,1.0,5/11,25.89%,MSN;EZR;VPS11;RDX;MTMR2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3157265607549364,-0.8978075906214883,0.6263940520446096,0.8248181717284904,1.0,1/21,0.35%,CAV1
prerank,positive regulation of viral life cycle (GO:1903902),-0.3058010490529044,-0.8974290643201007,0.5909090909090909,0.8251454986923948,1.0,9/22,27.99%,CHMP2B;CD74;FMR1;TSG101;LGALS1;CHMP2A;LGALS9;VPS4A;P4HB
prerank,proteasomal protein catabolic process (GO:0010498),-0.20620122419910825,-0.8973351354830735,0.7553191489361702,0.8248959952540967,1.0,56/201,24.42%,WWP1;NEDD4L;SEL1L;RNF41;ZNRF1;WWP2;RHBDD1;PSMA6;CUL4A;DNAJB12;PSMB5;NHLRC3;KCTD5;PLAA;RNF185;UCHL1;VCP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;UBXN1;PSMD14;FBXW5;ITCH;RNF5;SMURF1;RBX1;UBE2G1;PSMD8;PSMD11;KCTD10;PSMB4;PSMD12;PSMC1;PELI1;ZSWIM8;TBL1X;ERLEC1;KCTD2;UBE2B;PSMA1;ZFAND2B;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;PCNP;FBXL19;PSMA2;BRSK2;RAD23A;RNF187;COP1
prerank,nucleotide metabolic process (GO:0009117),-0.3048821333797723,-0.8967298708653235,0.6201834862385321,0.8257072666682334,1.0,14/23,48.53%,ME1;CTPS2;NMNAT3;PARK7;NMNAT2;FHIT;CMPK2;DCK;ENPP3;DCTD;AK7;NUDT5;AK4;AK1
prerank,positive regulation of neuron death (GO:1901216),-0.2637591388447242,-0.8966589019449245,0.6524163568773235,0.8253830508369715,1.0,11/46,17.02%,MAP3K5;FOXO3;REST;TGFB2;BACE1;ATF4;BAX;NF1;TLR4;C1QA;DDIT4
prerank,establishment of spindle orientation (GO:0051294),-0.28987066284433827,-0.8964685306548126,0.63003663003663,0.8253322083993215,1.0,10/28,24.32%,MAP4;ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.303384748701459,-0.8964066864901497,0.6259541984732825,0.8250000720967993,1.0,7/24,16.42%,MPHOSPH8;AEBP2;H3-3A;EPC1;BMI1;TASOR;RBBP4
prerank,proteasome assembly (GO:0043248),-0.36724434329320377,-0.8959368307472229,0.6067019400352733,0.8255655116157594,1.0,3/11,24.05%,POMP;PSMD11;PSMG2
prerank,DNA recombination (GO:0006310),0.2785734655203223,0.8959323168162328,0.5974842767295597,0.8736153521724501,1.0,7/37,14.57%,DMC1;HDAC10;GEN1;BLM;RAD51C;RAD51B;RPA1
prerank,neurotrophin signaling pathway (GO:0038179),-0.30798430324968584,-0.8957023737720872,0.6252220248667851,0.825604189695082,1.0,3/21,3.71%,RAP1A;RAPGEF1;NGF
prerank,negative regulation of cell aging (GO:0090344),-0.33632280318913077,-0.8956987515170758,0.614963503649635,0.8251424830939919,1.0,3/16,8.99%,CDK6;MAP3K3;TWIST1
prerank,protein localization to chromosome (GO:0034502),-0.2759528788340949,-0.895585631497756,0.6155339805825243,0.8249182747508407,1.0,13/34,30.24%,ESR1;TPP1;RB1;SLF1;WAPL;BOD1;RAD21;CENPA;MRNIP;SLF2;CHMP7;TERF2IP;PLK1
prerank,polyol biosynthetic process (GO:0046173),-0.3355400118655571,-0.8955634540130838,0.6120527306967984,0.8244946753184065,1.0,6/16,14.12%,ITPKB;IPMK;ISYNA1;FGF2;ACER3;IP6K1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3460523711853957,-0.89528774161881,0.6019230769230769,0.8246258174097761,1.0,3/15,11.72%,DCTN2;CEP192;PCM1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.23062129816251142,-0.895225806048334,0.7252964426877471,0.8242862846073489,1.0,39/91,34.73%,CDKN1B;ANAPC15;PSMA6;ANAPC11;PSMB5;TCIM;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;CDKN1A;ANAPC7;CDC27;PSMB4;PSMD12;PSMC1;FZR1;CUL1;PSMA1;ANAPC2;PSMB1;PSMC3;PSMA4;PSMA2;PSMB8;TRIM39;NEK10;XPC;BUB3;PSMC6;PLK1;CDK1;PSMD6;PSMA8;ANAPC10;CDC20;PSMD2;UBE2C
prerank,positive regulation of protein acetylation (GO:1901985),-0.36274481662512864,-0.8948275920587078,0.6172839506172839,0.824625820380477,1.0,3/12,16.94%,DIP2B;CAMK1;RAPGEF3
prerank,cellular response to osmotic stress (GO:0071470),-0.31636745723460225,-0.8947836742094812,0.6103202846975089,0.8242502205620408,1.0,10/21,33.55%,LRRC8D;YBX3;TRPV4;CAB39;ARHGEF2;PKD2;CAPN3;LRRC8E;AQP1;SLC4A11
prerank,lipid biosynthetic process (GO:0008610),0.24204656272444675,0.8945389868489961,0.6571428571428571,0.8760004493524252,1.0,15/77,17.28%,PAM;ACSM5;ACSL1;SCD5;NDUFAB1;PRLR;GNPAT;MCAT;ACSL6;ACACA;FADS1;SCD;OLAH;ACSS2;CYP51A1
prerank,nuclear membrane disassembly (GO:0051081),0.3490240681328036,0.8944289857530061,0.579520697167756,0.8754128034956823,1.0,3/14,9.16%,PRKCA;AKAP8L;PRKCB
prerank,keratan sulfate metabolic process (GO:0042339),0.2915630864971549,0.8942244787297474,0.6206185567010309,0.8750161145508596,1.0,13/31,19.34%,FMOD;B3GNT7;OMD;GNS;LUM;GALNS;OGN;CHST1;GLB1;ST3GAL1;B4GAT1;CHST2;B4GALT6
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.35503760855203315,0.8942192156477666,0.5759493670886076,0.8741844235195135,1.0,2/13,5.13%,GLI2;CAMK4
prerank,positive regulation of nervous system process (GO:0031646),-0.3253419434365527,-0.8941736029928599,0.6203007518796992,0.8250981481848133,1.0,3/18,7.20%,PARD3;UNC13B;TNFRSF1B
prerank,regulation of neurotransmitter transport (GO:0051588),0.33730068457353723,0.8940833058258663,0.5755693581780539,0.8736510161276948,1.0,4/16,10.25%,RIMS1;CHRNB4;CPLX2;MCTP2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3125791945386724,0.8937222092492433,0.5864978902953587,0.8736316898590927,1.0,6/24,9.13%,SEMA5A;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,chromosome organization (GO:0051276),-0.22468315494432337,-0.8935981381049807,0.6955645161290323,0.8258300235942583,1.0,42/99,30.77%,ZBTB7A;UBB;UBC;RPS27A;SAFB;CUL4A;HHEX;H3-3A;COPS6;HMGN1;GATAD1;COPS5;CDAN1;SMARCA4;NUP155;RBX1;CETN2;LDB1;TOP2A;HMGN2;PWWP3A;L3MBTL1;COPS7A;NDC80;POLE3;COPS4;COPS7B;EZH1;CDCA8;PHF19;HDAC5;FAM50A;XPC;GPS1;LIG4;CENPV;RAD23B;TOP2B;HMGB2;HDAC3;MYC;NUF2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2667991416097653,-0.8933722197311743,0.642578125,0.8258410380939823,1.0,12/41,18.31%,MGLL;EPHX1;CYP1B1;GPX1;ELOVL5;GSTM2;PTGS1;FAAH;GPX4;ACOT8;ELOVL1;DAGLB
prerank,positive regulation of leukocyte migration (GO:0002687),0.30514535500440565,0.8932634178099192,0.5901639344262295,0.873875520783293,1.0,2/27,5.08%,PTN;IL4
prerank,cellular response to superoxide (GO:0071451),-0.3755294210263941,-0.8929774812503838,0.6162162162162163,0.8262358809070162,1.0,1/10,1.10%,NOS3
prerank,triglyceride catabolic process (GO:0019433),-0.32240742775982106,-0.8928377507447898,0.5932539682539683,0.8260687969035351,1.0,2/19,10.36%,PNPLA2;FABP5
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3206807969935368,0.892538961435832,0.5995717344753747,0.8746880270660609,1.0,6/19,16.91%,CHRNB4;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;ACHE
prerank,mRNA splice site selection (GO:0006376),0.2993583588674729,0.8913577207813923,0.6247191011235955,0.8765357810605635,1.0,4/30,9.28%,CELF2;SRSF12;CELF4;SLU7
prerank,brain morphogenesis (GO:0048854),0.36824551872833045,0.891329965478759,0.6031390134529148,0.8757675924787885,1.0,4/12,10.35%,CTNNA2;SPEF2;BBS2;PTEN
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2812528955411985,0.8911844067145954,0.5977777777777777,0.8752373373322423,1.0,3/33,3.55%,AREG;DGKD;TGFA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2071560663050091,-0.8908869253308682,0.7732793522267206,0.8298624605806018,1.0,58/173,27.34%,SPTBN1;CD55;DCTN2;VAMP7;ZW10;KDELR1;CTSZ;DYNC1LI2;NAPA;NRBP1;CTSC;ATL3;TRIP11;SPTAN1;ATL2;ERGIC1;GOSR1;DCTN3;COPG1;TRAPPC11;DCTN1;TMEM115;COPB2;COG8;PEF1;BCAP31;RAB1A;MCFD2;COG3;LMAN2;DYNC1LI1;COG5;TRAPPC5;F5;VTI1B;NSF;TMED1;DYNLL2;TMED5;SEC24B;COG2;TRAPPC2L;TRAPPC2;USE1;TEX261;STX5;YIF1A;LMAN2L;COPZ2;HYOU1;CNIH2;SEC13;PDCD6;TMED3;DCTN4;GOLGB1;F8;SEC16B
prerank,sensory organ development (GO:0007423),-0.2568028810209846,-0.8906161991443922,0.6330645161290323,0.8299567492863652,1.0,9/51,11.80%,SMOC1;HIPK1;TGFB2;STRA6;RAB18;FREM2;SIPA1L3;SMG9;CHRDL1
prerank,detection of calcium ion (GO:0005513),-0.35374809979040334,-0.8904203904209809,0.610236220472441,0.8298934659453137,1.0,4/13,21.60%,CALM1;CALM3;CASQ2;KCNIP2
prerank,positive regulation of ATPase activity (GO:0032781),-0.26759861473930635,-0.8901744467371947,0.6320939334637965,0.8299507149448011,1.0,12/41,22.07%,ATP1B1;DHX9;PFN1;VMP1;TOR1AIP1;DNAJC9;CHTOP;TOR1AIP2;DYNLL2;FGF10;ATP1B2;DNAJB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.29142318567389214,0.8887987487857975,0.6171548117154811,0.8798131868788583,1.0,27/27,70.91%,NYNRIN;RNASE4;PARN;RNASEH1;NHP2;DICER1;ZC3H12B;TOE1;XRN1;LACTB2;POP1;CPSF3;ZC3H12A;POP7;RNASE1;ZC3H12C;SLFN14;RNASE6;TRIR;KHNYN;NUDT16;RPP30;CSTF3;PDE12;PCF11;ZC3H12D;ERN1
prerank,epidermis development (GO:0008544),0.25516169696489926,0.8887584358968393,0.6348547717842323,0.8790600688961784,1.0,3/56,3.83%,SVEP1;FGFR2;ATP2A2
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.35110366259387116,-0.8887511549629368,0.5965909090909091,0.8325257852928821,1.0,5/13,20.48%,ATG7;SAE1;UBA2;UBA5;UBA1
prerank,histone deacetylation (GO:0016575),0.2683435979731523,0.8884941202924429,0.6475583864118896,0.878791147833369,1.0,8/43,9.65%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1;HDAC8
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2510082813109743,0.888298267416635,0.673036093418259,0.8783901879750408,1.0,8/63,8.57%,NELL1;TIMP3;LEPR;BCL2;DAP;SIRT2;TIMP4;GOLGA2
prerank,regulation of axon extension (GO:0030516),-0.27166294587767154,-0.8881658339027717,0.6615678776290631,0.8333137775745194,1.0,22/37,37.62%,SEMA7A;SHTN1;DIP2B;SEMA3G;DBNL;DBN1;APOE;NTN1;LIMK1;CTTN;DNM2;RTN4R;ZFYVE27;CDKL5;ISLR2;PTPRS;ABL1;MAP3K13;MAG;RNF6;L1CAM;TWF2
prerank,replication fork processing (GO:0031297),0.2783704860550791,0.8880978159248072,0.6147186147186147,0.8779844083639595,1.0,15/38,22.71%,ZGRF1;GEN1;SETMAR;BLM;FANCM;THOC1;CENPS;CDK9;ETAA1;SMARCAL1;RTEL1;PCNA;ZRANB3;FBH1;RFWD3
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.35676676731718526,-0.8879850978370872,0.6238532110091743,0.8332293434379358,1.0,4/12,17.76%,PTK2B;DIAPH1;CASQ2;UBASH3B
prerank,embryonic limb morphogenesis (GO:0030326),0.2821961042700199,0.8862283383415145,0.6356107660455487,0.8814312305687576,1.0,4/34,7.78%,SALL1;TBX3;GLI3;RARG
prerank,response to gamma radiation (GO:0010332),-0.29501853448900234,-0.8858380506465012,0.6382575757575758,0.8373910169039457,1.0,11/24,30.32%,RPL26;MAP3K20;HRAS;TMEM109;KDM1A;CRYAB;DCUN1D3;FANCD2;LIG4;TSPYL5;MYC
prerank,polyamine metabolic process (GO:0006595),-0.34429555046032595,-0.8858192790558751,0.6245421245421245,0.8369627426332246,1.0,6/13,23.30%,AMD1;OAZ2;PAOX;SMS;SRM;DHPS
prerank,positive regulation of isotype switching (GO:0045830),0.34450436476172996,0.8855836806965545,0.6049661399548533,0.8820647942769337,1.0,6/15,15.91%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B
prerank,protein-DNA complex assembly (GO:0065004),0.22691580825095478,0.8854024142738914,0.7098765432098766,0.8816256555341175,1.0,26/116,19.03%,TCF4;DMC1;MCM3;ORC4;DDB2;GTF2H2;MNAT1;PSMA3;PSMF1;RPA2;MCM2;CCNH;MCM8;PSME3;ORC1;DAXX;SPTY2D1;RPA1;PSMD1;PSMB9;SART3;ORC3;PARP1;PSMD13;NAP1L2;ORC5
prerank,regulation of mRNA stability (GO:0043488),-0.21277599511527265,-0.8852153473317826,0.7782258064516129,0.8377903424928778,1.0,46/145,24.02%,VIM;UBB;HSPA8;UBC;RPS27A;ANP32A;PSMA6;HSPB1;RC3H1;PSMB5;AKT1;FUS;PCBP4;PSMC4;PSMC5;YTHDF2;CIRBP;PSMD14;YWHAZ;E2F1;FMR1;PSMD8;TNFSF13;PSMD11;PSMB4;PSMD12;PSMC1;FASTKD3;HSPA1A;EXOSC8;GIGYF2;TENT5D;PUM2;SERBP1;PSMA1;YTHDF1;TBRG4;MEX3D;PSMB1;PSMC3;PAIP1;EIF4G1;PSMA4;PSMA2;PRKCD;YWHAB
prerank,multivesicular body assembly (GO:0036258),-0.28404580342489044,-0.8851613385039194,0.6673114119922631,0.8374119973458877,1.0,14/30,32.17%,RAB11A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;CHMP7;STAM;VPS37C;CHMP4B;CHMP4A
prerank,negative regulation of proteolysis (GO:0045861),0.28508438297887734,0.8850748616230769,0.6299559471365639,0.8815147732243982,1.0,3/34,7.28%,TIMP3;SERPINE2;TIMP4
prerank,regulation of trophoblast cell migration (GO:1901163),0.33747837476654685,0.8849800131604809,0.6081081081081081,0.8809102579046468,1.0,5/14,21.65%,GJA1;SMURF2;SYDE1;AGO2;TIMP1
prerank,protein deacetylation (GO:0006476),0.27348939084700014,0.8845718091539039,0.6483050847457628,0.8809945998363,1.0,7/41,9.10%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1
prerank,mRNA 3'-end processing (GO:0031124),-0.23147498927871385,-0.8843230371278267,0.6884615384615385,0.8387329092086738,1.0,24/78,26.92%,RPRD1B;APP;SRSF2;SRSF5;SRSF6;U2AF1;LSM11;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;PAPOLG;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;PABPC1;THOC7;RPRD1A
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2997741888704589,-0.8843146451843894,0.6291512915129152,0.8382816473153785,1.0,9/25,21.17%,NOTCH1;BMPR2;FOXD1;ZNF423;ENG;SMAD4;SMAD2;BMPR1B;CDH5
prerank,axonal transport (GO:0098930),-0.27487135813897556,-0.8842192757481819,0.6620825147347741,0.8379893154869712,1.0,17/36,38.38%,AP3M1;AP3B1;NEFL;KIF1B;DCTN1;OPA1;DTNBP1;AP3M2;SOD1;DST;BLOC1S2;BLOC1S6;AP3D1;AP3S1;BLOC1S1;AP3B2;BLOC1S4
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3196491364423618,-0.8840636835405928,0.6547406082289803,0.8378434164604447,1.0,3/18,4.11%,CCN3;KCNB1;REST
prerank,peptidyl-lysine trimethylation (GO:0018023),0.30114830115668945,0.8838100649511912,0.6264236902050114,0.8819156163657697,1.0,10/26,23.41%,PRDM9;KMT2A;KMT5C;SETD5;WDR82;KMT5B;VCPKMT;SETD4;SUV39H2;CTR9
prerank,ganglioside biosynthetic process (GO:0001574),-0.3386941214302738,-0.8837779351059435,0.6367112810707457,0.837965280626429,1.0,3/15,6.49%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,negative regulation of protein depolymerization (GO:1901880),0.3030834064153063,0.8835603947712241,0.6107660455486542,0.8816607886626693,1.0,4/24,13.49%,PLEKHH2;ATXN7;CAMSAP1;NAV3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24950110746114695,-0.8834555587794894,0.6978131212723658,0.838167370967167,1.0,13/55,19.26%,THBS1;TGFBR2;RNF41;RAC1;CYP1B1;RIPK1;ACE2;SPHK2;CDKN1A;COQ7;CBR1;SLC25A33;GADD45A
prerank,response to muscle stretch (GO:0035994),0.3481394456287777,0.8828489266161686,0.5895691609977324,0.8824552539514131,1.0,2/15,3.68%,SLC8A1;CSRP3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3491376751651165,-0.8827430306041785,0.631578947368421,0.8392090395607211,1.0,5/13,20.44%,PRPF8;DDX20;USP4;LSM2;CD2BP2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.28442124727409535,-0.88243752900207,0.6641929499072357,0.8393678205040223,1.0,20/29,45.89%,CYRIB;PVR;LAMP1;NECTIN2;SPI1;RASGRP1;AP1G1;NOS2;TYROBP;CADM1;SLAMF6;CD226;IL12A;CRTAM;IL12RB1;IL23A;KLRD1;CD160;KLRK1;IL23R
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.23150784828868554,0.8821301009877088,0.6754966887417219,0.8832268831139449,1.0,16/88,13.18%,SH3D19;DNAJC6;SORCS1;AP4B1;MYO5A;SCFD1;ACBD3;GBF1;ARFGEF2;TXNDC5;RAB10;CCDC93;SCAMP2;VPS35L;SYS1;LLGL1
prerank,regulation of mRNA processing (GO:0050684),-0.2788708632264976,-0.8821081277534114,0.6453488372093024,0.8395829036738885,1.0,8/32,20.74%,QKI;SAFB;SRPK1;DHX9;JMJD6;HNRNPK;PTCD2;CPSF4
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23838946694100663,-0.8810395607547422,0.6991869918699187,0.8413122400139029,1.0,8/75,8.48%,PLCE1;RGS3;RGS5;MGLL;CALM1;GIT2;EDN1;RGS6
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3549687046445346,-0.8804842222248155,0.6163636363636363,0.8419927155274105,1.0,5/12,39.15%,TMEM165;VPS33A;CCDC115;GRN;TMEM199
prerank,regulation of chemotaxis (GO:0050920),0.2929350107078473,0.880424862916464,0.6291666666666667,0.8861822992430978,1.0,6/30,8.14%,MYCBP2;PDGFRA;P2RX4;PDGFRB;ZSWIM5;ADGRA2
prerank,cell-cell junction maintenance (GO:0045217),0.372723443392339,0.8803790401596777,0.5969498910675382,0.8854448677242109,1.0,2/11,6.25%,PRTN3;NLGN2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3773442772399519,-0.8803265529234103,0.6324324324324324,0.8418593239656335,1.0,4/10,22.04%,DBI;APOE;TMEM30A;TRIAP1
prerank,vesicle transport along microtubule (GO:0047496),-0.2992311664544546,-0.8801406837733324,0.647495361781076,0.841770268387384,1.0,8/23,22.37%,TRAK1;HTT;TRAK2;NDE1;NDEL1;RAB1A;KIF1C;KIF13A
prerank,negative regulation of response to external stimulus (GO:0032102),0.2272113673965548,0.8797663503783199,0.7070707070707071,0.8859837759597581,1.0,14/105,10.35%,RORA;GRID2;PPARA;PTGIS;CTNNA2;IL4;SERPINE1;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6;PTEN
prerank,superoxide metabolic process (GO:0006801),-0.2865550888630633,-0.8796867770777487,0.6483931947069943,0.8422950986392018,1.0,5/29,12.83%,SH3PXD2A;NOS3;NCF2;PREX1;NRROS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3612235187730921,-0.879638663899809,0.6194852941176471,0.8419257237912907,1.0,6/12,29.22%,PLCG2;RAB27A;TLR4;GRIN1;CD36;TLR6
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.3664566808016452,0.879498528411343,0.5866666666666667,0.885771432136051,1.0,2/10,1.77%,VDR;CYP27B1
prerank,epiboly involved in wound healing (GO:0090505),-0.3353165487685337,-0.8794023873368996,0.6365313653136532,0.8419556924241193,1.0,9/16,40.94%,CD44;CD151;MRTFA;PDCD10;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29364335610013925,-0.8792725989460841,0.620754716981132,0.8417556039140789,1.0,10/24,29.93%,UBB;UBC;RPS27A;XRCC1;RPA3;POLK;RFC3;RFC2;LIG4;POLB
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2922204624390135,0.8783983687108283,0.6258351893095768,0.8874250617459966,1.0,7/26,13.76%,ADCY5;STXBP4;FOXA2;EPHA5;ADCY8;BAIAP3;CDK16
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3333414432651103,-0.8783926356420706,0.6214689265536724,0.843067299947985,1.0,7/15,25.40%,APP;PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,fatty acid catabolic process (GO:0009062),-0.23942440684830776,-0.877987064213356,0.7082494969818913,0.8434303816678513,1.0,15/67,18.03%,ABHD2;PPARD;ACAD11;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;FAAH;ECI1;ACOT8;MECR;HSD17B10
prerank,dendritic spine organization (GO:0097061),-0.2926620512248594,-0.8778970083214778,0.6163021868787276,0.8431456045810389,1.0,2/26,0.55%,SHANK3;IGF1R
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.21746081782615875,0.8773608724985147,0.7132075471698113,0.8889137194005409,1.0,15/138,8.77%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;RARG;RBPJ;POLR2G
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.323642622974059,-0.8770594493036827,0.6409774436090225,0.844422455840109,1.0,1/17,0.23%,ANO6
prerank,regulation of actin filament-based process (GO:0032970),0.24116029008147297,0.8767262694559056,0.6826347305389222,0.8894763972287947,1.0,16/70,15.56%,LRP1;ARHGEF19;EPHA3;ROCK2;RHOH;RHOBTB1;DLC1;PDGFRB;RHOBTB3;EPHA5;GRHL3;RHOF;FZD10;RND1;PAK1;RHOQ
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32535945250204035,0.8758452081733689,0.6335403726708074,0.8905807470393162,1.0,15/15,67.49%,NYNRIN;RNASEH1;DICER1;ZC3H12B;LACTB2;POP1;ZC3H12A;POP7;ZC3H12C;SLFN14;KHNYN;NUDT16;RPP30;ZC3H12D;RPP40
prerank,negative regulation of axon extension (GO:0030517),-0.28101864877560917,-0.8756981321798748,0.67984934086629,0.8466714875008428,1.0,5/30,9.74%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G
prerank,keratinocyte differentiation (GO:0030216),-0.28483343864925,-0.8754737222510263,0.6423220973782772,0.84668659734174,1.0,10/29,27.46%,CLIC4;ANXA1;BCR;OPN3;EPHA2;DSP;EVPL;SCEL;CERS3;PIP5K1A
prerank,icosanoid metabolic process (GO:0006690),-0.26212137098889843,-0.875394643565353,0.6476014760147601,0.8463847304797631,1.0,12/40,20.25%,MGLL;EPHX1;CYP1B1;LTA4H;GPX1;PON3;GGT5;PTGS1;FAAH;GPX4;DAGLB;GGT1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3364887295961869,-0.875361059398179,0.6326164874551972,0.8459858743161311,1.0,9/15,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;CCT4;CCT6A;NOP10
prerank,carboxylic acid metabolic process (GO:0019752),-0.2751868827249629,-0.8753527866912871,0.6737967914438503,0.8455359651696878,1.0,5/33,10.82%,SLC2A1;CSGALNACT1;ST6GAL1;PON3;CARNMT1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.31942503112776616,-0.8750554527324406,0.6514285714285715,0.8456577848903114,1.0,4/18,11.00%,PPIA;HSPB1;AKT1;BAG5
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3691169842610719,-0.8748084113158232,0.6243478260869565,0.8456638898573717,1.0,8/10,43.57%,PPP2R1A;PTPN2;PARP14;NF2;PPP2CA;INPP5F;SOCS3;SH2B3
prerank,regulation of protein targeting to membrane (GO:0090313),-0.28383712615129003,-0.8747984889076486,0.6596558317399618,0.8452149084089848,1.0,8/28,14.84%,KCNB1;CHP1;MIEF1;GDI1;MIEF2;CIB1;HRAS;ERBB2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.28780918523896004,-0.8745544984142646,0.6423357664233577,0.8452339391893908,1.0,6/26,15.59%,TRIB1;DHX58;MAPKBP1;ITCH;SIGIRR;TNFAIP3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3015944658154042,0.8742071324314273,0.6142241379310345,0.8934640441783412,1.0,1/24,0.15%,EPHA7
prerank,positive regulation of insulin secretion (GO:0032024),0.27859040337862473,0.8742000385636013,0.6636971046770601,0.8926454719718127,1.0,6/36,10.91%,TCF7L2;IRS2;NLGN2;TM7SF3;ADCY8;BAIAP3
prerank,regulation of primary metabolic process (GO:0080090),-0.2130418435873356,-0.873841976417017,0.7628865979381443,0.8461874589441171,1.0,43/126,28.06%,PPARD;NCOR1;TNFAIP8L3;NFYA;PLPP1;ADIPOR1;PSAP;PSMA6;PSMB5;LACTB;PSMC4;PSMC5;PSMD14;OAZ2;APOE;PSMD8;TM7SF2;PSMD11;SC5D;PSMB4;PSMD12;PSMC1;NQO1;SP1;TBL1X;TGS1;EDF1;HELZ2;PSMA1;RUBCNL;OPA3;PSMB1;PSMC3;FDPS;PSMA4;PSMA2;SREBF1;PSMB8;LSS;SIN3B;IDI1;NFYB;CERS2
prerank,lipoprotein biosynthetic process (GO:0042158),0.3696799468679084,0.8732660417512318,0.5949074074074074,0.8938579485944167,1.0,4/11,15.79%,WDR45B;WIPI1;ATG10;PORCN
prerank,organonitrogen compound catabolic process (GO:1901565),0.2548914190498276,0.8724846082214222,0.6934156378600823,0.894714205882194,1.0,10/57,10.88%,PLA2G5;PLA2G4A;IL4I1;CPQ;CLPX;ANPEP;ENPEP;RIDA;NAALADL1;TRHDE
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.35496036258249175,-0.8724251714738102,0.6339622641509434,0.8486391256090554,1.0,5/12,36.09%,TLR4;NOD2;SOX9;MUC13;MUC6
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23663722025992753,0.8720605636774336,0.6820083682008368,0.894844441921199,1.0,16/76,14.15%,LPAR1;GPR55;GPR174;GRM1;CHRM2;OPRK1;HRH1;LPAR4;NMBR;ADRA1D;C3AR1;ADRA1B;GNA15;ACTN2;P2RY1;DRD2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2994008665699393,-0.8718837008359387,0.6366782006920415,0.8492635575841636,1.0,2/23,0.97%,SLC12A7;SLC12A2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.31670631480356237,0.8718671239358012,0.6339869281045751,0.8944308438460427,1.0,3/19,7.44%,ASPA;ALDH7A1;DDO
prerank,acute-phase response (GO:0006953),0.36050719340148674,0.8714554718905719,0.6216216216216216,0.8945065589226785,1.0,3/12,11.20%,AHSG;CEBPB;IL6R
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2507323852389862,0.8713709635996173,0.6733067729083665,0.8938480542697275,1.0,17/52,21.85%,ALDH18A1;ADHFE1;PHYH;D2HGDH;ALDH1L1;FPGS;MDH2;SLC46A1;SDHA;MTHFD1;ASS1;MTHFD1L;GPT2;ALDH5A1;GOT1;SLC19A1;GOT2
prerank,methylguanosine-cap decapping (GO:0110156),-0.3784512716713583,-0.8709853928890987,0.6527272727272727,0.8506012586025783,1.0,5/10,19.92%,DCPS;PNRC2;EDC4;DCP1B;LSM1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3685430743349433,-0.8706954449534571,0.6391752577319587,0.8502532604364985,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3685430743349433,-0.8706954449534571,0.6391752577319587,0.8502532604364985,1.0,2/11,6.44%,TNRC6C;NOTCH4
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.34664253288393954,-0.8705594130730087,0.6350626118067979,0.8500760743308883,1.0,4/13,12.88%,CD81;CD9;FCER1G;SYK
prerank,cellular response to retinoic acid (GO:0071300),0.2686135414609988,0.8703152794703111,0.6416666666666667,0.8952424176358532,1.0,11/42,14.80%,PTK7;EPHA3;LYN;ZNF35;BRINP1;BRINP3;FZD10;BRINP2;ATM;WNT6;WNT5B
prerank,ovarian follicle development (GO:0001541),0.3420529642930282,0.8702860321730618,0.6114790286975718,0.8944717868657487,1.0,5/13,15.91%,KIT;CEBPB;ANG;EIF2B5;EIF2B2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3612825444747456,0.8700696695247121,0.6285714285714286,0.8941078061745874,1.0,5/12,20.74%,NINL;BICD1;KIF3A;BBS4;CCDC68
prerank,limb morphogenesis (GO:0035108),0.314772124019037,0.8696987180524733,0.6353711790393013,0.8941276291196877,1.0,2/20,3.86%,TBX3;GLI3
prerank,regulation of myelination (GO:0031641),-0.29518479066404923,-0.8695552627072753,0.6501831501831502,0.8517122507880924,1.0,4/25,7.20%,JAM2;PARD3;TNFRSF21;TNFRSF1B
prerank,positive regulation of tissue remodeling (GO:0034105),0.35939586239691607,0.8694556607495856,0.6129032258064516,0.8938041583084162,1.0,2/10,8.31%,ROCK2;IL18
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.37718366553923377,0.8693680845928204,0.6162046908315565,0.8931522807891754,1.0,5/10,23.00%,CPEB3;CPEB1;PAF1;HSF1;NUDT21
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.312375650624952,-0.8690025040708378,0.6566037735849056,0.8523398622881309,1.0,6/18,19.19%,ACTB;SPTBN1;MMP14;ABCA2;VTI1B;MISP
prerank,regulation of centriole replication (GO:0046599),0.3213379784362051,0.8686181524602455,0.6430205949656751,0.8939819233020617,1.0,8/17,23.01%,MDM1;CEP295NL;ALMS1;NUP62;TRIM37;CEP295;CEP76;KAT2B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3176038330469102,0.8685446592515191,0.6188436830835118,0.893316404174007,1.0,9/20,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,regulation of lipid storage (GO:0010883),-0.30072700889823206,-0.8684671985039685,0.6589595375722543,0.8529459634342753,1.0,13/22,44.34%,NFKBIA;ITGB3;C3;HILPDA;ALKBH7;PTPN2;MEST;IKBKE;ITGAV;PLIN5;TNF;IL6;LPL
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3071882299980801,-0.8684212578026118,0.6299065420560748,0.8525703368347319,1.0,5/20,16.01%,FAR2;ACLY;PPT2;FAR1;SLC25A1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.34615181995208744,-0.8680315604992845,0.6502732240437158,0.8529292530682445,1.0,2/13,2.97%,NOP14;RPS21
prerank,blood circulation (GO:0008015),0.25451381996743455,0.8679887613690899,0.6829787234042554,0.8936711363025973,1.0,6/49,5.85%,SGCZ;HTR7;SGCD;ROCK2;TNNI3;COL4A3
prerank,gluconeogenesis (GO:0006094),-0.2659359658580318,-0.8679504283661118,0.6786389413988658,0.8526208088534006,1.0,8/39,16.11%,GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1
prerank,motile cilium assembly (GO:0044458),0.3517487407607743,0.8678399584020762,0.6145124716553289,0.8931806674518958,1.0,4/12,22.14%,DNAAF3;BBOF1;RSPH9;CCDC39
prerank,regulation of urine volume (GO:0035809),-0.3717898941600887,-0.8677969319044098,0.6586715867158671,0.8524562210185571,1.0,6/10,39.25%,NPR1;NPR3;HAS2;HYAL2;TFAP2B;INPP5K
prerank,glucose metabolic process (GO:0006006),-0.24122834878941618,-0.8676279157452218,0.6992337164750958,0.8523138332286919,1.0,11/58,16.93%,LRP5;PPARD;GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;SLC25A1;PGK1;GALM
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.29483826138188396,-0.8675954421061187,0.6609848484848485,0.8519018605810222,1.0,6/22,25.84%,ATF4;NCL;SMARCA4;ERBB2;PWP1;UTP15
prerank,negative regulation of cell cycle process (GO:0010948),0.24702398966259467,0.8674018581113813,0.6818181818181818,0.8933052427114628,1.0,18/61,20.86%,AURKAIP1;UXT;TFDP1;L3MBTL2;RNF2;APAF1;TOM1L2;PCGF6;EHMT2;TOM1L1;PPP1R10;EZH2;FBXO5;ZFYVE19;YAF2;CDC7;MGA;PCGF2
prerank,regulation of tissue remodeling (GO:0034103),0.31774011109799194,0.8672193575349135,0.6175869120654397,0.8928652837308785,1.0,3/18,8.31%,DDR2;LEPR;IL18
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3264850194271611,0.8671456950109047,0.6383442265795207,0.8921815440508554,1.0,3/16,18.26%,PRKCA;PDE6G;MRAP2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3323821431308219,0.8663116714628649,0.6702586206896551,0.893201161151655,1.0,2/16,5.08%,LRP1;IL4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.26596413813567055,-0.866113979064986,0.6660447761194029,0.8544370132268211,1.0,18/37,30.24%,PARD3;SMAD7;CALM1;TGFB1;APP;CALM3;CAB39;DDIT4;CADM4;EIF4G1;DMTN;SPRED3;PPEF2;RPTOR;TNKS1BP1;IRGM;SPRED1;PLK1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.36144791598484544,-0.865991574602958,0.6289752650176679,0.8542133783703473,1.0,4/11,21.38%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,dendritic spine morphogenesis (GO:0060997),0.33606087645501914,0.8657767286837178,0.5995850622406639,0.8935248723127871,1.0,5/15,13.19%,DOCK10;CTNND2;EPHB1;PTEN;DLG4
prerank,calcium ion transport into cytosol (GO:0060402),0.30768926789688983,0.8656418345269978,0.6359550561797753,0.8929981161348094,1.0,7/21,17.48%,SLC8A1;CACNA2D1;TRPM1;GRIN2A;JPH1;ADRA1A;GRIN2B
prerank,negative regulation of cell cycle (GO:0045786),0.24062284202520562,0.8656117040443376,0.7172557172557172,0.8922293975280237,1.0,11/73,10.49%,BMP2;NR2F2;SMAD3;BRINP1;BRINP3;MEN1;NLRP2B;GATA3;CHMP1A;PTEN;HPGD
prerank,peripheral nervous system development (GO:0007422),0.2967498148711957,0.8652800144831171,0.6241299303944315,0.8921320123901275,1.0,5/23,10.55%,GDNF;ARTN;ASIC2;ERBB3;NFASC
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.22726385720524855,-0.865167593809201,0.7480769230769231,0.8553521686774237,1.0,28/85,23.10%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD3;FZD7;PFN1;WNT11;PSMC4;PSMC5;PSMD14;SMURF1;CELSR1;PSMD8;AP2A1;PSMD11;CELSR2;PSMB4;PSMD12;PSMC1;PSMA1;FZD5;PSMB1;PSMC3;PSMA4;PSMA2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3150838690817558,0.8646869160198448,0.6330472103004292,0.8925289506083017,1.0,2/19,2.64%,PTGFR;PRKACA
prerank,metanephros development (GO:0001656),0.2879316588316161,0.8639726637185399,0.6365638766519823,0.8932491983079047,1.0,2/26,1.69%,ROBO2;GDNF
prerank,proteolysis (GO:0006508),-0.19490275972129867,-0.8635556554942172,0.8620689655172413,0.8581422502273356,1.0,43/252,13.71%,DPP4;SRGN;F3;FAP;TPP1;CAPN2;BACE2;CTSZ;ADAM10;CTSO;BACE1;CASP7;ADAM19;CTSC;CASP8;PSMA6;ERAP1;IDE;SPCS1;PRCP;CAPN15;PSMB5;LACTB;MMP14;CTSD;PSENEN;CPE;CTSF;HTRA3;CAPN5;FAM111A;HTRA4;LRP8;PSMC4;GGT5;CTSB;MMP15;DPP8;SPRTN;CAPN10;LNPEP;FBXL2;ACE
prerank,modulation by host of symbiont process (GO:0051851),-0.27474166068376515,-0.8633605581633138,0.6489563567362429,0.858063053125976,1.0,14/31,36.85%,LEF1;REST;SMARCA4;CX3CR1;SP1;NAPEPLD;CHD1;POU2F3;AQP1;CCL5;JUN;SAP30;HPN;CCL4
prerank,positive regulation of chromatin organization (GO:1905269),-0.35181673327836105,-0.8632377754669729,0.6497277676950998,0.8578203739378012,1.0,3/12,16.98%,TAL1;H3-3A;MIER1
prerank,DNA replication (GO:0006260),0.22355524734080018,0.8625136946455613,0.7469635627530364,0.8955242159728618,1.0,29/105,21.08%,RBMS1;MCM3;ORC4;TOP1;TOP3A;TOP1MT;BLM;RPA2;RFC5;MCM2;MCM9;MCM8;ORC1;NBN;ATM;RPA1;KAT5;BRIP1;ORC3;POLD4;WRNIP1;ORC5;POLD1;DONSON;SET;CDC7;DUT;RFC1;NT5M
prerank,P-body assembly (GO:0033962),-0.3475315103657607,-0.8621611923919874,0.6605839416058394,0.8595440966616106,1.0,4/12,21.06%,RC3H1;LIMD1;LSM14A;LSM3
prerank,quinone biosynthetic process (GO:1901663),-0.3324574387493572,-0.8618329457655494,0.6779026217228464,0.8597253104151208,1.0,5/14,22.20%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,positive regulation of cellular respiration (GO:1901857),-0.3655720006894225,-0.8616188866749097,0.65587734241908,0.8596698218199439,1.0,5/11,27.00%,IFNAR1;VCP;IL10RB;PARK7;IFNLR1
prerank,myeloid dendritic cell activation (GO:0001773),0.35269772238829733,0.8611796656965122,0.6247288503253796,0.8975166497106646,1.0,3/12,12.82%,IL4;CAMK4;DOCK2
prerank,glycerol metabolic process (GO:0006071),0.3692293828098977,0.8605527819315734,0.6200873362445415,0.8980383266498353,1.0,7/10,29.58%,GOT1;COQ3;GK;PDXP;ANGPTL3;COQ2;TKFC
prerank,negative regulation of hormone secretion (GO:0046888),0.36294081706410386,0.8592030352092801,0.6344827586206897,0.9000309384554619,1.0,1/10,1.53%,GJA1
prerank,smooth muscle contraction (GO:0006939),0.3414989828051119,0.8591190359828604,0.6615720524017468,0.8993915067559894,1.0,3/14,6.27%,SLC8A1;ROCK2;MYLK
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.32642781691828093,-0.8590121644975658,0.6534839924670434,0.8644844646895481,1.0,5/15,18.42%,EHD2;FLOT1;CAMK1;RAPGEF3;EHD1
prerank,Golgi localization (GO:0051645),-0.3596399386478429,-0.8581867788133644,0.6372007366482505,0.8655739147829565,1.0,6/11,24.28%,STK25;COPG1;YWHAZ;RIPOR1;PDCD10;CDC42
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3201203129030943,-0.8579579047824387,0.6788321167883211,0.8655702918300755,1.0,11/16,38.50%,SLX4;TOP2A;EME2;ERCC4;TOP2B;MEIOB;RMI1;MSH4;CENPX;EME1;SHOC1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.31384840825928273,0.8571897024314231,0.6369294605809128,0.9026622638440832,1.0,4/19,9.13%,RHOH;IL4;AXL;GATA3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.326178604709602,0.856365991964938,0.6487068965517241,0.9035760512230723,1.0,7/15,23.93%,CASP3;NGFR;BCAR1;FRS2;SORT1;NTRK2;BDNF
prerank,DNA conformation change (GO:0071103),0.32862775176976267,0.8560423712600621,0.6197802197802198,0.9034502946792612,1.0,3/17,8.02%,TOP1;TOP3A;TOP1MT
prerank,negative regulation of coagulation (GO:0050819),0.3373859112598464,0.855964899254268,0.6290672451193059,0.9027926484696791,1.0,3/14,5.80%,SERPINE2;APOH;SERPINE1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.291402967704526,-0.8559045930809471,0.6648745519713262,0.869175786303549,1.0,13/23,30.55%,BAX;NDUFA13;TIMM29;TOMM22;HSPA4;HSP90AA1;BAD;TIMM13;TIMM10;TIMM8B;TIMM10B;PMAIP1;ROMO1
prerank,negative regulation of protein processing (GO:0010955),-0.34342828871367626,-0.8557383151860438,0.6710280373831776,0.8690229464332583,1.0,2/12,4.45%,THBS1;CTSZ
prerank,double-strand break repair (GO:0006302),-0.20389614264010072,-0.8550018680820057,0.8181818181818182,0.8700345816164323,1.0,57/158,30.52%,PAXX;BRCC3;PRKDC;ZFYVE26;UIMC1;ERCC1;YY1;BABAM1;HERC2;VCP;MTA1;SFPQ;CIB1;UBXN1;HPF1;PPP5C;PSMD14;SLX4;DCLRE1C;REV3L;SAMHD1;XRCC1;PARP2;HUS1;MMS22L;EME2;RPA3;CYREN;BABAM2;BRCA2;AP5Z1;HELQ;POLQ;RAD21;ERCC4;SFR1;DTX3L;FAN1;POLL;NSMCE1;DNA2;RAD51AP1;LIG4;TNKS1BP1;BARD1;RNF8;HMGB2;MRE11;SWI5;EXD2;POLB;SMARCA5;MEIOB;RMI1;RAD52;PRPF19;RECQL
prerank,protein localization to organelle (GO:0033365),-0.2092847600179816,-0.8549615363198253,0.7938144329896907,0.8696470850028316,1.0,33/133,22.43%,RAB11A;GBP5;ZBTB7A;IFT20;RPL11;SIX1;APP;STX1A;DHX9;DNAJA1;HHEX;LAMP1;DDRGK1;TOLLIP;TULP2;ZNF423;TOR1AIP1;SEC61B;TUB;ARL6;CEP68;COG3;SGTA;TSPAN17;GCC2;TMEM30A;EHD1;PACSIN2;MSX1;RIPOR1;CNEP1R1;STX5;CD68
prerank,organic cation transport (GO:0015695),0.30621997424236,0.8548349704055209,0.6388308977035491,0.904319535005834,1.0,4/20,9.42%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.25613394257141997,0.8544661547732835,0.7005988023952096,0.9042834864836063,1.0,6/46,10.70%,FBLN1;TIMP3;LYN;GSTP1;PTEN;RPS6KA6
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2972290901625336,0.8544461906489785,0.6323529411764706,0.9035119657733045,1.0,4/23,10.30%,CASP3;SETMAR;EXOG;CECR2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26303402098708856,0.8542698397876445,0.6791569086651054,0.9030915256939939,1.0,4/39,4.69%,PIK3R1;PIP4K2A;ITPKC;EFR3A
prerank,lipid droplet formation (GO:0140042),-0.3704456018453559,-0.8536835070567698,0.6446428571428572,0.8716664506648606,1.0,2/10,7.82%,CDS2;CDS1
prerank,negative regulation of bone remodeling (GO:0046851),-0.3560740350254217,-0.8535748482592806,0.6715063520871143,0.8714067446042285,1.0,4/11,17.76%,GPR137B;TNFAIP3;GREM1;UBASH3B
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32088093212491703,-0.8530345759983522,0.6799242424242424,0.8719761822331822,1.0,3/15,4.12%,STOX2;RICTOR;TGFB2
prerank,cellular response to light stimulus (GO:0071482),-0.23134206736918445,-0.8526256227564062,0.7167300380228137,0.8722987164045098,1.0,25/66,32.61%,RPL26;RHBDD1;ATF4;N4BP1;YY1;BAK1;FMR1;GNB1;OPN3;KDM1A;POLK;ERCC4;COPS9;PTPRK;RHNO1;TRIAP1;PRKCD;SMPD1;NPM1;MYC;AQP1;RRH;OPN1MW3;OPN1MW;CREBBP
prerank,steroid catabolic process (GO:0006706),0.3603895298228876,0.8526012968424691,0.6253041362530414,0.9058599638393224,1.0,1/10,1.77%,CYP27B1
prerank,microglial cell activation (GO:0001774),-0.2954250031516039,-0.8520670081974069,0.6988416988416989,0.8728801037381388,1.0,14/21,46.27%,APP;JAK2;CX3CR1;C1QA;IFNGR1;AIF1;TREM2;TYROBP;GRN;ITGB2;C5AR1;TNF;CX3CL1;CLU
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3221983535174848,0.8518993898818049,0.6279569892473118,0.9065524373016141,1.0,2/15,1.77%,VDR;CYP27B1
prerank,regulation of RNA export from nucleus (GO:0046831),0.3527055592656152,0.8518747106622149,0.6291390728476821,0.9057959633819633,1.0,2/11,7.13%,AKAP8L;KHDRBS1
prerank,prostanoid biosynthetic process (GO:0046457),-0.32700921045563514,-0.8515702439676748,0.6826568265682657,0.8734005978273329,1.0,5/15,18.31%,PTGDS;EDN1;CD74;PTGS1;DAGLB
prerank,DNA metabolic process (GO:0006259),0.19196740359245257,0.8511299829724854,0.8727598566308243,0.9064970320779825,1.0,69/270,21.96%,TCF7L2;DMC1;MCM3;ORC4;DDB2;MPG;STN1;AXIN2;SUMO1;MNAT1;TOP1;TOP3A;GEN1;FANCC;SETMAR;MEN1;KMT5C;TOP1MT;DNMT1;BLM;RPA2;RFC5;CHRNA4;MCM2;RAD51C;MCM8;RAD51B;ORC1;NBN;POLE4;ATM;CENPS;RIF1;RPA1;SMARCB1;KAT5;ENDOV;KMT5B;PDS5A;PARP4;NUDT1;PARP3;BACH1;POLI;INIP;ORC3;PARP1;SP100;UBE2N;POLD4;RNASEH1;ORC5;SMARCAL1;PDS5B;POLD1;RTEL1;CDC7;PCNA;POLD3;DOT1L;RFC1;PRIM1;ZRANB3;GLRX2;TOP3B;POLD2;PRIM2;DCLRE1B;UBE2V2
prerank,heterocycle biosynthetic process (GO:0018130),0.33536024386067603,0.8510377637619237,0.6460554371002132,0.9058983568061468,1.0,1/14,2.11%,MOCS2
prerank,response to tumor necrosis factor (GO:0034612),0.22616707320129328,0.8503041408981631,0.746268656716418,0.9066018309248457,1.0,11/91,10.34%,ADAMTS12;PID1;HYAL3;OCSTAMP;SFRP1;GGT7;CXCL16;CASP3;GATA3;CCL25;YTHDC2
prerank,DNA geometric change (GO:0032392),-0.28760189951626053,-0.8496763188936408,0.7181467181467182,0.8766389005271195,1.0,11/24,35.58%,HNRNPA2B1;ANXA1;DHX9;ASCC3;DNA2;HMGB2;MRE11;RECQL;PIF1;RAD50;HMGB3
prerank,microtubule depolymerization (GO:0007019),-0.30666421552836587,-0.8484879989823071,0.672316384180791,0.8784935193766915,1.0,7/17,25.22%,STMN2;KATNB1;KIF24;KIF18A;KIF18B;NCKAP5L;STMN1
prerank,histone H2A acetylation (GO:0043968),-0.3158537020472813,-0.8483283930471172,0.6854130052724078,0.8783067665593857,1.0,4/16,18.10%,TRRAP;SPHK2;EPC1;EP400
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.32551342245164294,-0.8482689497318142,0.6666666666666666,0.8779441625452462,1.0,3/15,5.68%,SIX1;SMO;VEGFA
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.331520334206412,0.8481704210430634,0.6491228070175439,0.9102490996511641,1.0,2/13,3.63%,PARP16;PTGIS
prerank,regulation of nervous system development (GO:0051960),0.26921519976485503,0.8478343119898081,0.6975806451612904,0.9101608202663815,1.0,6/37,8.91%,PTN;HES3;SIRT2;DOCK7;HES5;NPHP3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2211374937297174,-0.8476131228348488,0.7613168724279835,0.878757897841757,1.0,22/83,22.69%,CDK6;CDK17;CDKN1B;BRD4;CUL4A;PLK2;RB1;INHBA;E2F3;CDK4;CRLF3;ACVR1;E2F1;CDKN1A;CUL1;CDKN2C;CCND1;TYMS;RCC1;EIF4EBP1;PLK3;CDK15
prerank,regulation of viral transcription (GO:0046782),-0.25549170133245824,-0.8472182360504085,0.7126213592233009,0.8790512130579878,1.0,6/39,12.16%,MID2;IFITM3;DHX9;TRIM14;NELFE;TRIM62
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.21541333611328528,-0.8470387631144923,0.7829457364341085,0.8789276905705817,1.0,33/95,32.49%,MEF2C;LBP;VIM;CYRIB;DAB2IP;TNFRSF1B;PLAA;TIRAP;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;CASP1;FZD5;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20550589444234726,0.846598952831035,0.8403041825095057,0.9119756167750911,1.0,18/166,9.27%,RORA;AR;TBL1XR1;VDR;RARB;TEAD1;PPARA;POLR1A;GTF2H2;MNAT1;HNF4G;MAML3;HDAC10;POLR1G;RARG;RBPJ;POLR2G;POLR1B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.36759613198466723,0.8465296491253506,0.6397379912663755,0.9112901369519651,1.0,4/10,17.96%,RPS6KA6;KAT5;SP100;TP53
prerank,regulation of protein neddylation (GO:2000434),-0.3606248937457432,-0.8463727308918262,0.6530612244897959,0.8797494707162092,1.0,6/10,25.13%,DCUN1D5;RPL11;DCUN1D1;COPS9;RPL5;DCUN1D3
prerank,histone exchange (GO:0043486),-0.2574304008684365,-0.8460998047126199,0.7191011235955056,0.8797895357449869,1.0,17/37,34.42%,MIS18BP1;KNL1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;RUVBL1;NPM1;RNF8;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,sensory perception of light stimulus (GO:0050953),0.224301631444211,0.8457447923671436,0.7777777777777778,0.912097077706386,1.0,19/87,18.98%,ADGRV1;DHRS3;TRPM1;PCDH15;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;CLRN1;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,regulation of TORC1 signaling (GO:1903432),-0.26984609699769924,-0.845602755764768,0.7198443579766537,0.8802849481295502,1.0,11/33,27.36%,GPR137B;PIP4P1;RRAGD;RRAGA;RRAGC;SESN2;CASTOR2;SEH1L;SIK3;LAMTOR5;SESN1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3318509195102998,0.845542365620787,0.6415094339622641,0.9116966394426511,1.0,4/14,12.52%,CREB3L1;PRKN;CREB3;TXNDC12
prerank,protein alkylation (GO:0008213),-0.29365050754015987,-0.8454798491815259,0.6916058394160584,0.8800473944680944,1.0,6/22,19.46%,PRMT8;SNRPD3;FAM98A;EEF2KMT;PRMT3;LCMT1
prerank,regulation of cellular protein localization (GO:1903827),0.25809055064740827,0.8453621556809835,0.7098121085594989,0.911275266906636,1.0,7/45,10.06%,GPC6;GPC4;GPC2;VCPIP1;GBF1;DVL3;GPC5
prerank,zinc ion transport (GO:0006829),-0.29469860122781444,-0.845232028095635,0.6910112359550562,0.8800600756956571,1.0,5/21,14.06%,SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2889368650875918,-0.8443402933651851,0.6745886654478976,0.8812738434957759,1.0,10/22,38.63%,GATA2;NES;KDM1A;DLL4;SHCBP1;TOX;FZD9;RASSF10;TRIM71;PROX1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.22621266214348523,-0.8438121353324992,0.763671875,0.881856172851821,1.0,8/69,7.54%,MEF2C;PTK2B;NGF;SIX1;PPARGC1A;TGFB3;TOX3;FOXQ1
prerank,mRNA processing (GO:0006397),-0.1843739582029017,-0.8437693695205725,0.9227642276422764,0.8814623776048314,1.0,111/287,35.00%,DDX5;NOVA2;HNRNPA2B1;RPRD1B;CTNNBL1;HSPA8;PPARGC1A;PRPF8;SRSF2;MTREX;DNAJC8;SRSF5;SNRNP48;SNRPA;SNRPC;ISY1;DDX41;SRSF6;DHX15;FUS;RBM22;GTF2H3;DHX9;SNRPD3;U2AF1;XAB2;SFPQ;ZC3H11A;RNPS1;RBM6;ZRSR2;SRSF4;MAGOH;RBM4B;DDX23;CHTOP;HNRNPK;ALYREF;EFTUD2;SF3A3;DDX39B;PCBP1;GTF2F1;HNRNPA1;GTF2H4;SCAF11;PHF5A;SNRPG;PNN;PDCD7;UBL5;LSM2;CASC3;USP49;CHERP;PRPF40A;SYNCRIP;LSM7;CD2BP2;THOC6;RBM19;CPSF4;LSM3;TBRG4;SRRM2;DDX39A;NCBP2;RBM17;RBM14;CSTF2T;SNRPB;SF3A1;PABPC1;SF3A2;THOC7;RPRD1A;KIN;GTF2F2;SNRPB2;HNRNPR;WBP11;ERN1;POLR2F;AQR;SRSF9;LSM6;PRPF19;HNRNPA3;CDC5L;HNRNPH3;PQBP1;POLR2L;ESS2;ZCCHC8;U2AF1L4;POLR2I;SNRNP25;POLR2C;HNRNPC;SF3B5;SRSF1;PCF11;UPF3B;WBP4;RBM15B;TRA2B;RSRC1;HNRNPM;HNRNPH1;SMNDC1;PUF60
prerank,regulation of axon regeneration (GO:0048679),0.3487471049251524,0.8435942840870455,0.6554054054054054,0.9140483394447821,1.0,1/12,0.72%,PTN
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2232597048336881,-0.8428802540661432,0.7793240556660039,0.8826728135072356,1.0,26/76,30.06%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;HDAC4;FAM107A;PTTG1IP;SAE1;SPRTN;UBA2;WDR48;CDK5RAP3;LAPTM5;UBE3A;TRAF6;BCL10;DCUN1D3;XIAP;TSPYL5;NDFIP2;MUL1;DERL1;HDAC3
prerank,cellular response to hypoxia (GO:0071456),-0.20685167718786449,-0.8427046924825922,0.8326996197718631,0.8825301551160608,1.0,41/126,25.45%,EGLN3;UBB;UBC;RPS27A;VEGFA;ACAA2;GATA6;PSMA6;RGCC;EGLN2;PSMB5;TWIST1;PSMC4;EGLN1;PSMC5;LIMD1;PSMD14;RBX1;BNIP3L;PSMD8;PSMD11;PGK1;PSMB4;PSMD12;PSMC1;BAD;ELOB;HIGD1A;PSMA1;PSMB1;PSMC3;NPEPPS;PLK3;PSMA4;PSMA2;HILPDA;HYOU1;HIF1AN;CARD16;PSMB8;ANGPT4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.27516731250372484,-0.8426291587290425,0.7104761904761905,0.882212922412347,1.0,15/26,30.83%,CDK6;RARA;GPR137B;TLR3;C1QC;INHBA;TLR4;TCTA;ZFPM1;INHA;PTPN2;LILRB3;CARTPT;MYC;LRRC17
prerank,synaptic vesicle recycling (GO:0036465),0.27624486782687685,0.8421982692081288,0.673469387755102,0.9160884348754801,1.0,6/31,7.72%,STON1;NLGN2;TBC1D24;NLGN3;SYT1;NLGN1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.26656199505063893,-0.8421831583603208,0.6894639556377079,0.8825748891713826,1.0,2/30,2.11%,DACH1;BMPR2
prerank,negative regulation of locomotion (GO:0040013),-0.3436498914268675,-0.8415863044221534,0.7039848197343453,0.8832025789897368,1.0,4/12,11.89%,FRMD5;CRK;CCDC125;DUSP3
prerank,neuron differentiation (GO:0030182),0.2034163931623037,0.8413485908279625,0.8304093567251462,0.9170185516454681,1.0,20/165,10.85%,WNT4;TENM3;GLI2;PTPRD;TENM2;PBX4;PHOX2A;FOXA2;CASP3;IL1RAPL1;LHX4;TGFBR1;RYK;ATOH8;CDK5R1;EPHA5;ALK;FUT9;ATP8A2;BRSK1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2218204077390276,-0.8413000344398401,0.8003992015968064,0.8832767718957325,1.0,22/88,19.99%,RACK1;RPS3;DAB2IP;IGFBP5;CNOT7;GAPDH;EDN1;AKT1;CST3;NCL;RPL13A;CAPRIN1;APOE;FMR1;PCIF1;LSM14A;GIGYF2;ATRAID;CDK5RAP3;TYMS;PAIP2B;SYNCRIP
prerank,neuron fate commitment (GO:0048663),0.32661110701958945,0.8412828087349102,0.6666666666666666,0.9163514507399417,1.0,5/14,19.68%,TGFBR1;MYT1L;PAX6;SHH;POU3F2
prerank,endochondral bone morphogenesis (GO:0060350),-0.3509788134319001,-0.8412015216343374,0.643510054844607,0.8829978824535706,1.0,2/11,2.11%,MEF2C;BMPR2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.30433252185598986,0.8411294400705892,0.665948275862069,0.9158453210458902,1.0,9/20,20.54%,AGO4;HELZ;TNRC6A;AJUBA;TNRC6B;AGO3;CNOT8;AGO1;AGO2
prerank,neuron apoptotic process (GO:0051402),0.31457467658781085,0.8409240711294734,0.6794055201698513,0.9154165704077654,1.0,6/19,12.56%,BCL2;SCN2A;ERBB3;ATN1;NGFR;DIABLO
prerank,fatty acid transport (GO:0015908),-0.3112527524890646,-0.8402472808065622,0.6791744840525328,0.8843465286404921,1.0,4/17,12.33%,PPARD;MFSD2A;FABP5;APOE
prerank,myelination (GO:0042552),-0.2485238625346211,-0.8395520895085022,0.7536496350364964,0.885171844824729,1.0,11/46,16.05%,ADGRG6;PARD3;CMTM8;MYOC;TNFRSF21;MAL;NF1;PLLP;ACER3;MALL;MARVELD1
prerank,receptor recycling (GO:0001881),-0.36547990093042065,-0.8392376930422046,0.6766917293233082,0.8852926319454674,1.0,5/10,25.17%,LMTK2;REP15;RAB11B;EHD3;PHETA2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30125976914645436,-0.8386598252140351,0.6907407407407408,0.8859229749002827,1.0,4/18,12.01%,NUP93;ENY2;HHEX;ZC3H11A
prerank,protein ubiquitination (GO:0016567),0.17815779305700738,0.8385845202350114,0.9473684210526315,0.9194183120776752,1.0,90/471,18.13%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;EPAS1;PELI2;TRIM38;FBXO24;DTX4;SPSB1;BCL2;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;TRIP12;RNF43;PRKN;KLHL41;HECW1;UBE2O;RNF138;VCPIP1;CUL9;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;PSMA3;RNF181;KLHL25;TRIM27;CDC23;PSMF1;CUL2;CDC16;MGRN1;AKTIP;RNF26;TOPORS;UBR3;SPOP;MIB1;PPIL2;SIAH2;UNKL;FBXO7;THOP1;BTRC;RNF146;RNF217;PSME3;RNF122;TRIM63;SASH1;BIRC2;ARIH2;FBXO44;ASB1;RNF34;UBA6;UBE3C;PSMD1;TRAF2;UBE2E2;FBXO28;PSMB9;LRSAM1;HECTD2;SKP1;NEDD4;SKP2;KLHL22;FBXO31;HLTF;TRIM35;RNFT1;SPSB2;NFE2L2;CUL7;FBXO21;TRIM23;RNF13;PSMD13;PEX10;UBE2N
prerank,peptidyl-glutamic acid modification (GO:0018200),0.287638769982695,0.8381565339631689,0.6928251121076233,0.9194978549452822,1.0,3/24,5.52%,TTLL11;AGBL4;TTLL9
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.33869378177744136,-0.8380091482347912,0.6818181818181818,0.8866959152001705,1.0,2/12,4.91%,CTPS1;CTPS2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.2627949038400055,0.8379708233712727,0.718816067653277,0.9190684913750226,1.0,3/39,3.55%,ERRFI1;AREG;TGFA
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27848932584338504,0.8374265648557574,0.6848739495798319,0.9193553767263942,1.0,6/28,11.47%,PRKAG2;MITF;PDK4;MFSD12;FGFR4;CTNS
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2776490965534185,-0.8371570853869853,0.7158671586715867,0.8877954199721699,1.0,7/26,15.15%,FNBP1L;ITSN2;AP2M1;ITSN1;FCHO2;SGIP1;AP2A1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.28024835788454605,-0.836932867841408,0.7068345323741008,0.887734117946584,1.0,7/26,14.62%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,pyroptosis (GO:0070269),-0.3180388001623592,-0.8368697813540038,0.677536231884058,0.8873874077327492,1.0,5/15,25.40%,CASP8;DHX9;AIM2;CASP1;TREM2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.32238653153227925,0.836832017304382,0.6337719298245614,0.9197090272313904,1.0,3/15,5.39%,BCL2;MDM2;PRKN
prerank,intestinal lipid absorption (GO:0098856),-0.3473619600594772,-0.8368274878713758,0.6897810218978102,0.8869848590444586,1.0,7/11,52.95%,CD36;SOAT2;LIMA1;LDLR;AKR1C1;ABCG5;NPC1L1
prerank,protein trimerization (GO:0070206),0.32605055466469446,0.8367497500228456,0.6651982378854625,0.9182574317086636,1.0,6/14,23.64%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,protein homotrimerization (GO:0070207),0.32605055466469446,0.8367497500228456,0.6651982378854625,0.9182574317086636,1.0,6/14,23.64%,SLC1A5;PNPT1;SLC1A2;MIF;STEAP4;SCARA5
prerank,peptidyl-lysine modification (GO:0018205),-0.21105480517993,-0.8360323418193726,0.8264299802761341,0.8879273695102073,1.0,31/99,26.55%,NNAT;IFIH1;PLOD2;HDAC9;STX1A;NUP93;HDAC4;NDC1;TRIM28;NUP54;SAE1;PLOD3;NUP188;LOX;SUMO3;NUP155;RANBP2;NUP37;UBA2;CTH;USPL1;RANGAP1;NUP160;SENP5;ATPSCKMT;NUP43;SEH1L;PARK7;NUP107;NUP42;EEF1AKMT3
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.34417543172730575,0.8358274891866305,0.6711111111111111,0.9185081889086306,1.0,1/12,1.08%,FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.34417543172730575,0.8358274891866305,0.6711111111111111,0.9185081889086306,1.0,1/12,1.08%,FBLN1
prerank,ESCRT complex disassembly (GO:1904896),-0.3593888072848348,-0.835789369754717,0.701627486437613,0.8874237087417485,1.0,5/10,28.55%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.3593888072848348,-0.835789369754717,0.701627486437613,0.8874237087417485,1.0,5/10,28.55%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,regulation of multicellular organismal development (GO:2000026),0.28507925873262097,0.8348535211837488,0.6746203904555315,0.9196169034406249,1.0,3/25,9.13%,PTN;TRIP12;GATA3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.33555450164345024,-0.834514075710253,0.6825095057034221,0.8893198207871852,1.0,6/12,25.40%,PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,regulation of protein export from nucleus (GO:0046825),0.28993526195633457,0.834234597215277,0.6797520661157025,0.9200412597185136,1.0,1/23,0.18%,TCF7L2
prerank,DNA repair (GO:0006281),-0.18230143977359817,-0.8341274746328431,0.9260780287474333,0.8895686979697485,1.0,105/284,34.25%,TRRAP;UBB;USP1;ASCC2;UBC;RPS27A;BRCC3;SMUG1;PRKDC;UIMC1;ERCC1;RAD1;USP3;GTF2H3;BABAM1;TRIM28;CHD1L;FAM111A;HERC2;VCP;MTA1;CIB1;UBXN1;HPF1;PPP5C;PNKP;SPRTN;SLX4;DCLRE1C;RAD9B;RAD18;XRCC1;CETN2;PARP2;HUS1;EME2;RPA3;NSMCE4A;RAD9A;RPAIN;ASCC3;RAD17;PWWP3A;BABAM2;WDR48;BRCA2;GTF2H4;NEIL1;POLQ;POLK;TRAIP;CHEK1;RAD21;ERCC4;GADD45A;UBE2B;APEX2;RHNO1;EID3;RFC3;DTX3L;RAD23A;RFC2;FAN1;POLL;EXO1;FBXO6;NSMCE1;PARK7;DNA2;SETD2;TDG;XPC;FANCD2;RAD51AP1;LIG4;TNKS1BP1;NPM1;RAD23B;BARD1;ATRIP;RNF8;MRE11;EXD2;POLB;SMARCA5;RAD52;FAAP24;RECQL;UPF1;INTS3;PARP9;CDK1;NSD2;TICRR;UBE2T;ABL1;RAD50;NEIL3;POLE;SLC30A9;CENPX;MAD2L2;POLA1;FANCF
prerank,sterol biosynthetic process (GO:0016126),-0.2615821836562818,-0.8334056665404077,0.7189922480620154,0.890462256189257,1.0,15/33,31.77%,LBR;ACAA2;ACLY;DHCR24;TM7SF2;SC5D;CH25H;FDPS;LSS;PLPP6;IDI1;ACAT2;INSIG1;EBP;HMGCR
prerank,placenta development (GO:0001890),-0.3426815213565033,-0.8333826923991361,0.6861313868613139,0.8900254840749948,1.0,2/12,6.61%,PTK2;ADAM19
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3099634158975866,-0.8331902687421787,0.6975881261595547,0.8898957932543955,1.0,6/18,22.92%,RAB11A;BRD4;CDK4;RCC2;CCND1;DTL
prerank,positive regulation of secretion (GO:0051047),-0.33763468184154977,-0.8325229801476346,0.693050193050193,0.8906752645053201,1.0,2/11,17.16%,NPR1;XBP1
prerank,cholesterol homeostasis (GO:0042632),0.23542727911026537,0.8322032676796806,0.7367303609341825,0.9233008502594862,1.0,8/64,11.15%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.28107639738411316,0.83219047922319,0.6592427616926503,0.9225151613847836,1.0,7/28,16.52%,SHLD2;SETMAR;KMT5C;SMCHD1;RIF1;KMT5B;PARP3
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3175613822077249,-0.8321799581702637,0.7097902097902098,0.8908145861372062,1.0,4/15,11.97%,SMAD7;FKBP1A;CSNK2B;ACVR1
prerank,regulation of actomyosin structure organization (GO:0110020),0.335856051389348,0.8321625235877838,0.6309794988610479,0.9217616534214528,1.0,3/13,9.17%,ROCK2;ASAP3;ALMS1
prerank,regulation of macroautophagy (GO:0016241),-0.20718419139265154,-0.8320090424549371,0.8401559454191033,0.8906658535637026,1.0,37/105,32.32%,EXOC4;KDR;ATP6V0B;ATP6V0A2;GAPDH;QSOX1;AKT1;SCOC;ATP6V0C;UCHL1;EXOC1;EPM2A;LAMTOR2;BNIP3L;PIK3CA;PRKAG1;ATP6V1G1;RRAGD;TBC1D25;TSC2;RRAGA;RRAGC;SESN2;SMG1;RPTOR;ATP6V0D1;ATG13;LAMTOR5;SESN1;UBQLN2;ERN1;ATG101;ATP13A2;ATP6V0E2;ATP6V1C1;LAMTOR1;LAMTOR3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.35296824267330396,-0.8317674966659118,0.6883116883116883,0.8906344442986261,1.0,5/11,22.04%,CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,smooth muscle tissue development (GO:0048745),-0.357762193501202,-0.8315923594021307,0.6857142857142857,0.8904877853554795,1.0,4/10,13.24%,SMO;STRA6;NF1;ENG
prerank,glycoprotein catabolic process (GO:0006516),0.30401208873185964,0.8309822751300092,0.6666666666666666,0.9232590985478236,1.0,1/17,0.44%,ADAMTS12
prerank,response to organonitrogen compound (GO:0010243),-0.25391906300853584,-0.830651842659158,0.7554240631163708,0.8917342537966766,1.0,10/38,23.87%,SEL1L;RHBDD1;DNAJB12;RNF185;VCP;RNF5;ERLEC1;RRAGC;BRSK2;MEAK7
prerank,regulation of B cell differentiation (GO:0045577),-0.3056027103231898,-0.8304261301469031,0.6939890710382514,0.8916641433745149,1.0,7/17,26.70%,MMP14;PPP2R3C;INHBA;SYK;XBP1;BTK;INHA
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.27510619304914724,-0.8303045700999528,0.6923076923076923,0.8914184285479978,1.0,2/26,0.35%,ST3GAL6;ST3GAL4
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2398692112838304,-0.8294211549762367,0.7544910179640718,0.8925280108959854,1.0,16/48,25.40%,HSP90AB1;PFDN5;EDN1;APOE;INHBB;EGFR;FLOT2;CD84;AGAP2;CRYAB;PIN1;ITGB3;SNX3;PFDN6;PFDN4;TREM2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.23042528001706938,-0.8293780020453614,0.7781954887218046,0.8921302069937797,1.0,18/61,23.10%,CAV1;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;OAZ2;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;NQO1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2
prerank,negative regulation of transport (GO:0051051),0.2446306939753317,0.829056670394781,0.7366336633663366,0.9262496824833424,1.0,12/51,16.74%,NRG1;PRTN3;EPHA3;SNX33;PRKN;ERBB3;YRDC;PTEN;SCAMP5;SYT11;LRSAM1;TRAT1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.33413531712763844,-0.8289880615458518,0.7084870848708487,0.8923926905952316,1.0,4/13,14.89%,LAMP1;SPHK2;SYK;GAB2
prerank,organophosphate biosynthetic process (GO:0090407),-0.24927499397062067,-0.8284470670395727,0.7631067961165049,0.8928640564265073,1.0,7/37,16.18%,ITPKB;TPK1;IPMK;FGF2;IP6K1;MBOAT1;PCYT2
prerank,mitochondrion disassembly (GO:0061726),0.26525864047073366,0.8283301119660742,0.7352941176470589,0.926825481915609,1.0,12/34,21.67%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A;ATG5;USP30;WDR45
prerank,protein insertion into ER membrane (GO:0045048),-0.2528263426516364,-0.8277967614172995,0.7546816479400749,0.8935935169072906,1.0,13/37,29.07%,APP;STX1A;CAMLG;EMC10;SEC61B;SGTA;EMC6;EMC9;STX5;UBE2J2;EMC1;TRAM1;VAMP2
prerank,positive regulation of cell death (GO:0010942),-0.23298451863306435,-0.8276565991250506,0.7854251012145749,0.8933874171877669,1.0,4/59,3.91%,SLC6A6;MAP3K5;ACER2;CDKN1B
prerank,negative regulation of defense response (GO:0031348),0.22741132460432922,0.8276322797739398,0.7860082304526749,0.9273651943199213,1.0,10/77,10.16%,RORA;PPARA;PTGIS;IL4;NLRP12;SMPDL3B;SIRT2;GATA3;RNF26;TNFAIP6
prerank,androgen metabolic process (GO:0008209),-0.3002382653162566,-0.8275311969716138,0.7122302158273381,0.8931248012135408,1.0,12/18,53.04%,SPP1;HSD17B10;HSD17B7;SRD5A2;SRD5A3;HSD3B2;CYP19A1;DHRS9;SRD5A1;HSD17B6;HSD17B3;AKR1D1
prerank,positive regulation of lipid transport (GO:0032370),0.3323300645701155,0.8274414683404988,0.6688888888888889,0.9269437229746051,1.0,2/12,8.09%,LRP1;ABCB4
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21223604678710087,-0.8273809022426187,0.8317214700193424,0.8929384695504502,1.0,23/91,19.95%,RAB11A;OPHN1;SCARB1;MAPK3;RAB8B;HIP1R;USP7;CPLANE2;RAB8A;HIP1;RAB4B;ABL2;RAB11B;RUFY1;RAB4A;SYK;PACSIN1;LGI3;NSF;HCK;TSC2;PACSIN3;PACSIN2
prerank,regulation of humoral immune response (GO:0002920),-0.24543895444191552,-0.8272700516050381,0.7660818713450293,0.8926528534489186,1.0,8/44,16.97%,CD55;CD81;GATA6;C1QB;C1QC;PHB2;CFP;C1QA
prerank,phagolysosome assembly (GO:0001845),0.34708110107400847,0.8271009379342936,0.673728813559322,0.9267783413942444,1.0,4/12,19.23%,PLA2G5;RAB20;CLN3;RAB7B
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.26475796190533674,-0.8270506533522339,0.7432950191570882,0.8925633822760338,1.0,13/32,28.36%,LPCAT3;MFSD2A;CHKA;CSNK2B;CEPT1;CSNK2A1;CSNK2A2;LCAT;PCYT1A;CHAT;PEMT;LPIN2;SLC27A1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.30541253296496296,0.8268765616780036,0.6772151898734177,0.9264237209948216,1.0,16/16,69.49%,BLM;MCM2;RPA1;MCMDC2;MCM7;MCM6;MCM4;RECQL5;SSBP1;WRN;RECQL4;HMGA1;PURA;RAD51;TWNK;RECQL
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.335719712730411,-0.8266049893475449,0.6982142857142857,0.8928799417071408,1.0,2/12,12.38%,ANO1;PPP3CB
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3274562280024824,-0.8265609975940316,0.696798493408663,0.8924888619829229,1.0,7/13,35.13%,ALG9;ALG12;ALG1;ALG2;ALG3;MPDU1;ALG6
prerank,transcription by RNA polymerase II (GO:0006366),0.18423044634790356,0.8263812225408768,0.9397163120567376,0.9265977464915114,1.0,61/305,18.87%,RORA;MAF;AR;GLIS3;TBL1XR1;VDR;RARB;TEAD1;PRRX1;PPARA;TFCP2;TFDP1;PMF1;GTF2H2;MNAT1;HNF4G;MAML3;HSF2BP;HDAC10;DTX1;RPAP1;NFIX;FIP1L1;RARG;RBPJ;SNAPC3;POLR2G;SYMPK;SOX5;PHAX;PABPN1;CCNH;SNAPC1;MAML1;INTS7;ICE1;SCAF8;PGR;TAF5L;YAP1;INTS9;CPSF7;CCNT1;NRBF2;ICE2;PAX5;CDK9;HDAC1;PARP1;ESRRG;GTF2E2;MED4;POLR2D;GTF2B;TAF15;PAPOLA;ELOA;E2F2;PPARG;ELL2;TAF1C
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.28963729081558043,-0.8262141614315295,0.6967370441458733,0.8926336585044521,1.0,7/21,22.00%,SMO;GAS8;ULK3;STK36;TUBD1;GLI1;DCDC2
prerank,mitochondrial transcription (GO:0006390),-0.34677118935432016,-0.8259580832332998,0.7094339622641509,0.8926129371510474,1.0,2/10,18.64%,FOXO3;SLC25A33
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.33064485809320265,-0.8257358287263894,0.6994633273703041,0.8925417524387694,1.0,6/13,32.79%,JAK2;OAS2;STAT1;IL6ST;IL27RA;CANX
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.34690251720997345,-0.8251930311650812,0.6924460431654677,0.8930455103625768,1.0,1/10,0.70%,CSGALNACT1
prerank,histone ubiquitination (GO:0016574),-0.29074691370081407,-0.8251267906986276,0.6986027944111777,0.8926907927517262,1.0,8/21,29.68%,PHC1;RNF20;USP22;UBE2B;DTX3L;RNF40;RNF8;UHRF1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.28051967182362897,-0.8250422605736445,0.7134502923976608,0.8923736515403815,1.0,6/24,12.16%,TGFB1;ABI3;PPP2R5A;AP2M1;GDI1;BCL2L1
prerank,pre-replicative complex assembly (GO:0036388),-0.22565566236360982,-0.8249473929601654,0.7827715355805244,0.8920850313219434,1.0,20/64,25.25%,UBB;UBC;RPS27A;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMD11;PSMB4;PSMD12;PSMC1;PSMA1;PSMB1;PSMC3;PSMA4;PSMA2;MCM5;PSMB8
prerank,inner dynein arm assembly (GO:0036159),0.3486065779563144,0.8249360424123644,0.7168539325842697,0.9286321522899276,1.0,10/10,65.16%,CCDC39;CFAP73;CCDC40;DNAAF5;CFAP100;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4
prerank,tRNA modification (GO:0006400),-0.22987051614939413,-0.8247718466978353,0.8058252427184466,0.8919064108943383,1.0,21/62,28.53%,DUS2;THUMPD1;TRMT9B;QTRT2;URM1;TYW1;TRDMT1;QTRT1;TRMT61B;TRMT6;AARS2;TRMT44;TYW3;ANKRD16;PUSL1;WDR6;METTL1;ADAT2;CTU2;METTL2B;METTL2A
prerank,regulation of proteolysis (GO:0030162),-0.23758391902845888,-0.8247067262319707,0.7725563909774437,0.8915428481191262,1.0,10/48,17.09%,CAV1;LTBP4;CASP8;AKT1;PERP;CST3;ITCH;BAK1;IST1;BAD
prerank,regulation of hormone secretion (GO:0046883),-0.31695514092090926,-0.8243762803784846,0.7096774193548387,0.8916389539688043,1.0,2/15,7.67%,ANXA1;EDN1
prerank,serine family amino acid metabolic process (GO:0009069),-0.30776509264155416,-0.8241875640457486,0.6966490299823633,0.891485385774172,1.0,9/16,36.02%,SARS1;CDO1;SEPHS2;CTH;GCLC;THNSL2;SRR;SHMT2;DAO
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2731380745738248,-0.8236487057694063,0.7211895910780669,0.8919971593691123,1.0,1/27,0.10%,GPCPD1
prerank,negative regulation of neurogenesis (GO:0050768),-0.2572732508788474,-0.8236423320196008,0.7486136783733827,0.8915428349653202,1.0,7/34,11.72%,B2M;NOTCH1;REST;ARHGDIA;GDI1;NF1;PCM1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.30140813492615676,-0.8235665141206777,0.6979362101313321,0.8912228386116094,1.0,8/19,29.27%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;MPI;UAP1;GNPDA1
prerank,sterol homeostasis (GO:0055092),0.23307716613524732,0.8232245923561303,0.759656652360515,0.9311879530312007,1.0,8/65,11.15%,RORA;CYP7B1;ABCA1;ABCA5;IL18;FGFR4;GRAMD1B;PLA2G12B
prerank,peptidyl-lysine methylation (GO:0018022),0.2775778776561788,0.8229475019706636,0.7404921700223713,0.9309200856641813,1.0,5/26,11.56%,METTL21A;SMYD1;SETD7;SMYD3;EHMT2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.33797438318453155,-0.8223127317327731,0.6973451327433628,0.8929762221373779,1.0,8/12,40.57%,UPP2;TK2;CAD;UMPS;UPP1;DCK;UCK2;TK1
prerank,regulation of cholesterol storage (GO:0010885),-0.3165942237470287,-0.822299314998094,0.6895910780669146,0.892534036817802,1.0,6/15,19.06%,SCARB1;PPARD;ABCG1;NR1H2;EHD1;MSR1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.34753334731909113,-0.8219261100944034,0.6890459363957597,0.8926960966006451,1.0,5/10,29.12%,HOMER1;CD84;CASQ1;SLC8B1;GRAMD2A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.234891050836472,-0.821791494617063,0.7601547388781431,0.8924751543113628,1.0,20/51,35.15%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;CCT3;HNRNPA1;CCT8;CCT7;CTNNB1;SRC;PKIB;SMG6;PIF1;HNRNPC;DCP2;CCT4;MAP2K7;CCT6A
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.33402432193084586,-0.8217208924195887,0.6778398510242085,0.8921328577857313,1.0,3/12,12.63%,LPCAT3;MBTPS2;ABCA2
prerank,protein tetramerization (GO:0051262),-0.22430920809395413,-0.8215466371668707,0.8170731707317073,0.8919964315779823,1.0,16/67,22.31%,B2M;KCNJ2;GBP5;PKD1;KCNC3;GLS;HOMER1;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;FARSB;PKD2;ACOT13;UPB1
prerank,phospholipid dephosphorylation (GO:0046839),0.2587917529812345,0.8212186726121243,0.7468619246861925,0.9334426145881946,1.0,9/37,17.91%,MTMR7;PLPP3;PLPPR1;PTEN;PLPP4;MTMR10;PLPPR5;OCRL;MTMR9
prerank,negative regulation of T cell activation (GO:0050868),0.2583985518080479,0.8208438425881514,0.7346534653465346,0.9333190147903068,1.0,4/35,7.73%,IL4I1;CEBPB;GLMN;CD274
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.30155984507211864,-0.8206699850120756,0.710727969348659,0.8930491251816215,1.0,9/18,42.86%,ATF4;MAF1;ERBB2;UTP15;POLR2L;LYAR;SIRT7;FLNA;RASL11A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3305585326851395,0.8206407065122554,0.6995708154506438,0.9329036426651959,1.0,3/12,9.65%,AXIN2;CTCF;HDAC8
prerank,transcription by RNA polymerase III (GO:0006383),0.27444370511943983,0.8204527171632966,0.7222222222222222,0.9324781305999514,1.0,11/27,20.36%,SNAPC3;GTF3C3;GTF3C2;SNAPC1;GTF3C6;ICE1;GTF3C4;ICE2;POLR3H;POLR2K;POLR3GL
prerank,Golgi ribbon formation (GO:0090161),-0.3248646610902064,-0.8195217271778394,0.6936936936936937,0.8946065347304633,1.0,7/13,30.47%,TRIP11;FHDC1;GCC2;TMED5;GOLPH3;STX16;VAMP4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.29517977490073644,0.819295196673368,0.7125603864734299,0.933862999289773,1.0,2/20,5.49%,HECW2;HECW1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.31981700260955614,0.8187479181981718,0.6884210526315789,0.9340798338501737,1.0,2/16,6.06%,ANK2;GBF1
prerank,Golgi to endosome transport (GO:0006895),-0.31101736219564036,-0.818687447165581,0.7272727272727273,0.8956050318227973,1.0,5/16,15.15%,VPS13A;KIF16B;DOP1B;AP4M1;AP2A1
prerank,regulation of muscle contraction (GO:0006937),-0.2769347889737806,-0.8185286775090078,0.7121771217712177,0.8954147726634724,1.0,2/26,0.35%,PLCE1;CAV1
prerank,response to interleukin-1 (GO:0070555),0.22776291525196368,0.8184722688135593,0.7875,0.9337822079130913,1.0,5/73,4.24%,ADAMTS12;HYAL3;PRKCA;PTGIS;SFRP1
prerank,positive regulation of telomere capping (GO:1904355),-0.3024210560480577,-0.8182035003297451,0.6846846846846847,0.8955360430527665,1.0,2/17,3.11%,MAPK3;NEK7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3112530545057332,-0.817925859833907,0.7255985267034991,0.8950701271546474,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3112530545057332,-0.817925859833907,0.7255985267034991,0.8950701271546474,1.0,2/15,5.85%,TNRC6C;CNOT7
prerank,regulation of ion transport (GO:0043269),0.22133529740925367,0.8177260834776388,0.8080808080808081,0.9344005630317577,1.0,23/76,18.76%,GDNF;NKAIN2;P2RX4;PRKN;KCNJ16;SYT1;KCNJ3;NKAIN3;KCNJ5;CHRNA4;KCNJ14;SYT13;DRD2;KCNJ6;SYT11;SYT12;NEDD4;KCNJ9;VAMP3;PER1;SYT6;SNX6;HTR1A
prerank,reverse cholesterol transport (GO:0043691),-0.3244697950518388,-0.8176277336700162,0.7233676975945017,0.8951344384540809,1.0,4/13,18.26%,SCARB1;ABCG1;APOE;LCAT
prerank,histone mRNA catabolic process (GO:0071044),0.3121795516378623,0.8176118973443486,0.6742081447963801,0.9338062090810038,1.0,7/15,26.88%,TUT4;ATM;TENT2;MTPAP;SSB;TENT4B;XRN1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3354652266711551,-0.8174464164826183,0.7102966841186736,0.8949982785566962,1.0,3/12,5.68%,SIX1;SMO;VEGFA
prerank,cellular response to alkaloid (GO:0071312),0.30331428459923493,0.817256020955095,0.6778947368421052,0.9336673036449844,1.0,3/17,8.95%,SLC8A1;CASP3;BLM
prerank,photoperiodism (GO:0009648),-0.270054325340702,-0.8170208002575273,0.7300970873786408,0.8952830097107505,1.0,9/28,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;CLOCK;SIK1;FBXL8
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.24625211490558996,-0.8163461521285869,0.7628083491461101,0.8959980470977675,1.0,16/42,30.44%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.29856768005802214,-0.8156464568703815,0.7429643527204502,0.896762071617222,1.0,8/18,26.50%,COA8;TIMM21;COA3;SURF1;FASTKD3;SCO1;PET100;BCS1L
prerank,cholesterol efflux (GO:0033344),-0.29272361693132765,-0.815571081222319,0.7391304347826086,0.8964342369249846,1.0,5/20,13.92%,SCARB1;ABCG1;APOE;TSKU;NPC1
prerank,metal ion transport (GO:0030001),-0.21334903279014217,-0.8151288473877858,0.8394308943089431,0.8967460229377829,1.0,12/86,11.23%,CAV1;TPT1;TRPC3;TRPM7;RAMP2;ATP2C1;SLC39A8;ATP2A3;TRPV4;TRPC4;CACNB3;NIPAL3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.27992807226741956,0.8149386270794043,0.7057569296375267,0.9372566153262164,1.0,1/24,0.26%,CEMIP
prerank,regulation of neuron projection arborization (GO:0150011),0.31876015842699995,0.8149201710800014,0.7022727272727273,0.9364794503122906,1.0,4/15,16.77%,GRIP1;DVL3;DLG4;MYO9A
prerank,regulation of chromatin organization (GO:1902275),-0.3208151916843822,-0.8148525524158937,0.7240740740740741,0.8967542655817986,1.0,4/14,21.07%,MLLT3;HPF1;SETD1A;MKI67
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3215851368195848,-0.8147842183570463,0.7377049180327869,0.8964062660155999,1.0,4/14,12.36%,SEMA7A;PLCG2;CD74;MAVS
prerank,ubiquinone metabolic process (GO:0006743),-0.30857175216847643,-0.8147183360218273,0.7490774907749077,0.8960385499918776,1.0,5/15,22.20%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.26610641498773824,-0.8138621560514179,0.7302504816955684,0.8969837277569033,1.0,13/27,26.21%,PPP1R16B;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CNEP1R1;CDH5;PRKCD;NSMF;SMPD1
prerank,regulation of protein localization to cell surface (GO:2000008),0.2545554407007661,0.8133260702686259,0.7584745762711864,0.9386573214537207,1.0,5/33,6.06%,LEPROT;SNX33;GPD1L;TAX1BP3;GBF1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.24849278354796012,-0.8127317072656701,0.7793240556660039,0.8984316667356163,1.0,19/38,40.10%,PRPF8;SNRPC;SNRPD3;SMN1;DDX20;SNRPG;USP4;LSM2;TGS1;CD2BP2;SNRPB;CLNS1A;PRPF19;SNUPN;SRSF10;SNRPE;SNRPF;GEMIN2;PRPF6
prerank,glycogen catabolic process (GO:0005980),0.3081227080486984,0.8125472870803383,0.7040358744394619,0.939304916115183,1.0,3/15,11.57%,PHKA1;STBD1;PYGM
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2591173813999547,-0.8124660678102142,0.7589641434262948,0.8984278177800508,1.0,5/32,10.03%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.24788686611264568,-0.8122062288228581,0.7936802973977695,0.8984057061283457,1.0,7/38,13.50%,KCNJ2;FHL1;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1
prerank,activin receptor signaling pathway (GO:0032924),0.3088009201110658,0.8120864718026308,0.7149321266968326,0.9394150238247231,1.0,2/15,7.96%,SMAD3;TGFBR1
prerank,positive regulation of viral process (GO:0048524),-0.2240103186875447,-0.8118708341935057,0.7954110898661568,0.8984990502219908,1.0,21/60,32.29%,ADAR;PPIA;CNOT7;SRPK1;DHX9;IFIT1;RAB7A;NELFE;STAU1;NR5A2;GTF2F1;RAD23A;VPS4A;PPID;PABPC1;GTF2F2;POLR2F;POLR2L;KPNA6;POLR2I;POLR2C
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.314845117564159,-0.8116754774769394,0.7302158273381295,0.8983709693559917,1.0,6/15,32.30%,GBP5;TLR4;TREM2;CD36;TLR6;NLRC3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3375001401506362,-0.8115191832587461,0.7156133828996283,0.8981765380853948,1.0,3/12,11.05%,STX3;STX1A;STX2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.32378423704098175,-0.8113373938932811,0.7155635062611807,0.8980070042286092,1.0,5/12,26.03%,PRKDC;RPS27L;CCND1;PLK3;PLK5
prerank,GPI anchor biosynthetic process (GO:0006506),0.26034949129930485,0.8110426859286539,0.7447257383966245,0.9405294307843542,1.0,11/30,22.22%,GPAA1;PIGU;PIGH;PIGP;PIGX;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.26266478196631426,0.810662310376743,0.7345679012345679,0.9403934802619777,1.0,6/35,9.57%,TNK2;AAK1;IL4;SERPINE1;SNAP91;BICD1
prerank,carbohydrate homeostasis (GO:0033500),-0.2216952480478534,-0.8103962248714458,0.8226120857699805,0.8991042095880636,1.0,6/67,5.35%,ADIPOR2;IGF1R;KCNB1;BACE2;KLF7;ADIPOR1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.29823353111657486,-0.8095958367050101,0.7319391634980988,0.9000023235258249,1.0,6/18,18.31%,PTGDS;EDN1;CD74;PTGS1;CBR1;DAGLB
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.27383759076649766,-0.8092147867356829,0.7495395948434622,0.9002055280152539,1.0,9/23,24.32%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,microtubule-based transport (GO:0099111),-0.32656769897348054,-0.8091479007645755,0.7240773286467487,0.8998533842222523,1.0,6/12,27.29%,HTT;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,actin-myosin filament sliding (GO:0033275),-0.2458267656842686,-0.8086959336606983,0.7683823529411765,0.8996895083783542,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,muscle filament sliding (GO:0030049),-0.2458267656842686,-0.8086959336606983,0.7683823529411765,0.8996895083783542,1.0,3/38,1.74%,DMD;VIM;MYL6
prerank,RNA modification (GO:0009451),-0.23309835712671975,-0.8086325890393656,0.7882562277580071,0.8993305530983245,1.0,19/54,28.07%,ADAR;THUMPD1;NOP2;TRMT9B;JMJD6;QTRT2;URM1;TRDMT1;QTRT1;MEPCE;TRMT6;AARS2;ANKRD16;MRM2;METTL1;NSUN5;FTSJ3;ADAT2;CTU2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2666115872223123,-0.8078590616484591,0.7504761904761905,0.9002199356922075,1.0,5/25,9.05%,DMD;WNK1;ATP1B1;COA8;TRPC6
prerank,autophagosome assembly (GO:0000045),0.23842646424649172,0.8077610995359611,0.7635983263598326,0.9449654917077421,1.0,11/52,12.91%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.34618062811214034,-0.8069684578543278,0.7180385288966725,0.9012383505360233,1.0,6/10,29.22%,AKT1;TLR4;CD68;TREM2;CD36;TLR6
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.29526192259049117,-0.8066530428939076,0.7163120567375887,0.9013196795369304,1.0,10/18,35.68%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;DCP2;CCT4;CCT6A;NOP10
prerank,macrophage chemotaxis (GO:0048246),0.3475766633677124,0.8063340866500437,0.7170626349892009,0.9467361970530971,1.0,3/10,19.87%,EDNRB;CKLF;TAFA4
prerank,regulation of defense response to virus (GO:0050688),-0.31509304788291825,-0.8054205392503111,0.7246653919694073,0.9029709211269656,1.0,3/14,15.59%,DHX9;ITCH;TNFAIP3
prerank,hexose biosynthetic process (GO:0019319),0.24566462637851982,0.8050839223851075,0.7561475409836066,0.94820184921163,1.0,7/42,11.75%,AKR1B1;SLC25A13;SLC25A10;CRY1;ALDOB;MDH2;ENO2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.24103990561821093,0.8050128604401244,0.771255060728745,0.9475283281889135,1.0,4/48,8.44%,ROBO1;STAP1;GSTP1;NLRP2B
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.32341891133618433,0.8040365390238349,0.6828752642706131,0.9484654706870348,1.0,4/12,17.06%,SETMAR;STK33;ORC1;NAE1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.335196465457922,-0.8039086248895745,0.7198581560283688,0.9045913038583202,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.335196465457922,-0.8039086248895745,0.7198581560283688,0.9045913038583202,1.0,4/11,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2634278908703994,0.8038589773512185,0.7300215982721382,0.9479894387684844,1.0,6/32,10.75%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH
prerank,long-chain fatty acid transport (GO:0015909),0.26629550033147353,0.8034150121863425,0.7725321888412017,0.9479582509738311,1.0,9/30,18.81%,PRKAG2;ACSL1;ABCD2;CPT2;ACACA;FABP4;PRKAB2;SLC27A4;PPARG
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3388696495961817,-0.8033298320810738,0.7092592592592593,0.9050531658143778,1.0,5/10,27.12%,RCC2;ECT2;KNSTRN;CDC42;RACGAP1
prerank,neural tube development (GO:0021915),0.31318944089168416,0.8016877606638015,0.7027027027027027,0.9502392531853909,1.0,1/15,0.56%,ALDH1A2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.29752606097795337,-0.8009848700273642,0.7490842490842491,0.9084631592134753,1.0,6/17,17.87%,NOTCH1;TGFB1;HEYL;ACVR1;HEY1;DLL4
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.32332704003106283,-0.8009615647351547,0.7033582089552238,0.9080465529617907,1.0,3/13,9.35%,CSPG4;HEXA;IDUA
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2218672944303205,0.8008776765047431,0.8251028806584362,0.9509229876373613,1.0,4/72,3.04%,FLRT2;FGFR2;KL;FLRT1
prerank,protein processing (GO:0016485),-0.20213044715157474,-0.8004769973135751,0.8666666666666667,0.9083683737257136,1.0,25/102,24.34%,SRGN;F3;ADAM10;BACE1;ADAM19;SPCS1;MMP14;PSENEN;CPE;FAM111A;SEC11A;SPRTN;FXN;APH1A;PHEX;VSIR;RCE1;TMEM208;PRSS12;CASP1;GGT1;SEC11C;CTSS;PTCH1;MYRF
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.31227183100403955,-0.8004168833284896,0.740418118466899,0.9080023475403182,1.0,6/14,38.18%,FUS;WDR48;MRNIP;RAD51AP1;WRAP53;FANCB
prerank,protein O-linked glycosylation (GO:0006493),0.20930306952353187,0.7999979035658085,0.854251012145749,0.9516857677306384,1.0,9/96,7.81%,TMTC1;GALNTL6;GXYLT2;B3GNT7;B3GLCT;TMTC3;TMTC4;POGLUT2;CRPPA
prerank,apoptotic DNA fragmentation (GO:0006309),0.2998401900466355,0.7996984091749906,0.7166324435318275,0.9514189415969193,1.0,3/16,10.30%,CASP3;EXOG;CECR2
prerank,lipid catabolic process (GO:0016042),-0.28803033428112834,-0.7989848663429732,0.759493670886076,0.9099276456615152,1.0,6/18,33.37%,PLAAT3;ACADL;PLA1A;LIPH;HSD11B1;LIPE
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.31644167485866515,-0.7985278234065941,0.7571942446043165,0.9101991255757513,1.0,2/13,5.85%,TNRC6C;CNOT7
prerank,cholesterol metabolic process (GO:0008203),-0.21686273266283107,-0.7983217846338072,0.8306451612903226,0.9100695006753131,1.0,14/68,18.26%,PPARD;SCARF1;LBR;OSBPL1A;ACAA2;ACLY;ABCG1;PIP4P1;APOE;TSKU;DHCR24;TM7SF2;CH25H;LCAT
prerank,regulation of gastrulation (GO:0010470),0.31303314346125843,0.7982451979069334,0.7106382978723405,0.9531911552920483,1.0,2/14,6.59%,PHLDB2;FOXA2
prerank,rRNA methylation (GO:0031167),-0.275554648630081,-0.7976956663988889,0.7588785046728972,0.9106075218602439,1.0,8/22,28.38%,NOP2;EMG1;MRM3;ZCCHC4;MRM2;NSUN5;FTSJ3;MRM1
prerank,presynaptic endocytosis (GO:0140238),0.27794476328261725,0.7975676307001817,0.7505285412262156,0.9536109572507794,1.0,5/24,7.72%,STON1;NLGN2;NLGN3;SYT1;NLGN1
prerank,transport along microtubule (GO:0010970),-0.3197373000103726,-0.7974608890632244,0.7334593572778828,0.9105219895605138,1.0,3/13,9.41%,APP;BORCS5;COPG1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3031883732248862,-0.7974237578540755,0.7490842490842491,0.9101164859686005,1.0,10/15,35.80%,PLCG2;DDRGK1;PHB2;GLI1;NPM1;FAM83D;CUL3;KLHL18;DYRK3;CDC73
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.31709708183517527,-0.7972595035939457,0.7333333333333333,0.9099157557399805,1.0,5/13,29.66%,GLRX5;ISCA2;NFU1;ISCA1;CISD3
prerank,regulation of T cell migration (GO:2000404),-0.277315951449211,-0.797213185740615,0.7527675276752768,0.9095260584334016,1.0,2/18,4.11%,LRCH1;APP
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3345045799838997,0.7971246405238129,0.7256235827664399,0.9535645913335863,1.0,4/10,23.59%,DNMT1;RIF1;DNMT3B;SIRT1
prerank,regulation of B cell apoptotic process (GO:0002902),0.32533098700716,0.796243054705579,0.7242105263157895,0.9543070766420445,1.0,3/12,5.54%,LYN;FNIP1;IRS2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2974686944428103,-0.7962176934062689,0.7556390977443609,0.9106476150706815,1.0,10/16,33.40%,SNRPC;DCPS;RBM22;SFSWAP;DDX23;NCBP2;PSIP1;WBP11;SRSF1;WBP4
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3081288498052025,0.7956046788433101,0.7379310344827587,0.9546436623341905,1.0,5/15,15.51%,FGFR2;PDGFRA;TGFBR1;MTHFD1;MTHFD1L
prerank,pseudouridine synthesis (GO:0001522),0.3074103162093835,0.7952934935421634,0.7015945330296127,0.9543756920707906,1.0,5/13,22.80%,RPUSD2;PUS7;PUS1;NHP2;PUS10
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2531971697340859,0.7950597928242714,0.7609561752988048,0.9540003084013835,1.0,12/36,20.86%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2;EZH2;YAF2;CDC7;MGA;PCGF2
prerank,autophagosome organization (GO:1905037),0.2361936258552851,0.7949276458031113,0.7995867768595041,0.9534283230090542,1.0,11/50,12.91%,ATP2A2;WDR45B;UBXN2B;ATG12;WIPI1;UBXN2A;TP53INP2;TMEM41B;ATG16L2;STX12;ULK2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.29033473591659853,0.7947772926305873,0.728051391862955,0.9520783792113416,1.0,19/19,71.00%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.29033473591659853,0.7947772926305873,0.728051391862955,0.9520783792113416,1.0,19/19,71.00%,POLR2G;DAXX;POLR2D;POLR2K;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;POLR2J;TERF2;TERF1;POLR2A;POLR2C;POLR2I;POLR2L;POLR2F;TERF2IP
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.2960064688209631,0.7945303138827761,0.7270788912579957,0.9516977535902142,1.0,3/17,9.58%,NKX6-1;ATOH8;AHI1
prerank,regulation of B cell activation (GO:0050864),0.2767315653419027,0.7944117783790905,0.7270742358078602,0.9511036437229996,1.0,3/25,11.53%,IL4I1;IL4;AHR
prerank,secretory granule organization (GO:0033363),-0.33463245757977395,-0.7943999607834491,0.7211367673179396,0.9130665408297067,1.0,2/10,5.21%,SRGN;LYST
prerank,regulation of establishment of protein localization (GO:0070201),-0.3249388952929657,-0.7940330040607767,0.7634408602150538,0.9132175753793109,1.0,3/13,10.06%,CTSD;DNAJA1;CEP290
prerank,regulation of telomere capping (GO:1904353),-0.27167277598542733,-0.7939570407252546,0.7680890538033395,0.91288780135774,1.0,4/23,12.51%,MAPK3;NEK7;USP7;PNKP
prerank,sulfation (GO:0051923),0.32614952015885845,0.7934977174076548,0.7065217391304348,0.9518944981184002,1.0,2/11,7.11%,UST;SULT6B1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.251460450859631,-0.7933184904193163,0.7847619047619048,0.9134051602830687,1.0,14/31,34.73%,DCUN1D5;DCUN1D1;CDC14B;RAB1A;BMI1;FZR1;PIN1;TRIB3;DCUN1D3;MAGEC2;RPS2;PLK1;CDC20;UBE2C
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3431457713015315,0.7920423404129445,0.7209821428571429,0.9536827622461881,1.0,2/10,12.95%,KLF15;SETD5
prerank,regulation of Golgi organization (GO:1903358),-0.2956586025500645,-0.7919561466891789,0.775894538606403,0.9150917578558706,1.0,6/17,22.33%,MAPK3;ARMH3;EHD3;PDCD10;STX5;CAMSAP3
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20091403291288695,-0.7915227144482276,0.8934108527131783,0.9153148976610287,1.0,34/101,32.49%,MEF2C;LBP;VIM;DAB2IP;TGFB1;TNFRSF1B;PLAA;PRKCE;TLR4;NOD2;TNFAIP3;CX3CR1;RELA;XBP1;HCK;CASP1;PTPN22;CD68;TRAF6;CCL2;CARD16;BCL10;SHPK;PDCD4;LILRB1;HMGB2;CD86;IRGM;UPF1;RHOA;CD14;LY96;NLRP3;TNIP2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3342247725654988,0.791259800087315,0.6981981981981982,0.9542068295806919,1.0,5/11,17.96%,CREB3L1;CEBPB;ATF6;DDIT3;TP53
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3256076433292755,-0.7912437160532794,0.7404718693284936,0.9152794760569092,1.0,5/11,35.23%,NR4A2;LMX1A;WNT2;CTNNB1;LRP6
prerank,transcription by RNA polymerase I (GO:0006360),0.25458136509056284,0.7909071424982027,0.7451820128479657,0.9540261281217092,1.0,10/34,20.07%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1;TAF1C;TAF1;POLR2K
prerank,mucosal immune response (GO:0002385),0.31049591628067374,0.7908262209000668,0.7326086956521739,0.953368236647028,1.0,2/15,5.47%,IL4;BPIFB1
prerank,stem cell development (GO:0048864),0.30261579470087907,0.7904460131307065,0.7407407407407407,0.9532164779003195,1.0,1/16,1.40%,NRG1
prerank,regulation of exocytosis (GO:0017157),-0.22860345720286027,-0.7903999044211167,0.8305084745762712,0.9161330793936566,1.0,6/46,9.84%,STXBP6;ANXA1;RAB8B;RAB27A;CPLANE2;RAB8A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2812072090701252,0.7899056979566345,0.7505422993492408,0.9533553168195024,1.0,9/22,25.64%,NR2F2;MEN1;PTEN;IPO7;CDK5RAP1;APC;HEXIM1;LATS2;LATS1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.3357882952128922,-0.7893117061084546,0.7320490367775832,0.9173639846596275,1.0,2/10,4.54%,PDE4D;PDE2A
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2745237612613054,-0.7892098038712858,0.7695167286245354,0.9170575197279618,1.0,12/24,40.94%,CD44;CD151;MRTFA;PDCD10;ACVRL1;ITGA5;WNT7A;RHOA;TMEFF2;CEACAM1;FLNA;ARHGAP35
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.26384269941793204,-0.7891111530958476,0.7842778793418648,0.9167450194527055,1.0,10/28,23.65%,ESAM;WDR1;PFN1;DBNL;DBN1;RASA1;CTTN;HCLS1;PLEKHG2;ARHGAP18
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3378438181795571,0.7890007155130416,0.7216035634743875,0.954125036902464,1.0,4/10,13.70%,IL4;IL18;GATA3;TSLP
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.3373119040852903,0.7889151917912562,0.7268623024830699,0.9534560153734346,1.0,1/10,3.70%,SH3RF1
prerank,visual perception (GO:0007601),0.20899908796480646,0.7872243901570346,0.8672199170124482,0.9556181665733675,1.0,17/84,18.98%,ADGRV1;DHRS3;TRPM1;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;RPGR;RP2;COL11A1;MYO9A;ZIC2;PAX6;TULP1;COL1A1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.26178789528865387,0.7871801640682619,0.7657657657657657,0.9548891925592702,1.0,7/26,18.37%,HECW2;CDC23;CDC16;DLGAP5;FBXO5;ANAPC5;NSMCE2
prerank,regulation of TOR signaling (GO:0032006),-0.2123875637852749,-0.7863834405581576,0.8548707753479126,0.9205800038535933,1.0,26/67,35.32%,SH3BP4;RICTOR;TNFAIP8L1;EPM2A;TBCK;LAMTOR2;PIK3CA;RRAGD;DDIT4;TSC2;RRAGA;RRAGC;GOLPH3;RPTOR;SEH1L;TREM2;SEC13;PDCD6;LAMTOR5;FAM83D;HDAC3;LAMTOR1;LAMTOR3;PKHD1;DYRK3;TTI1
prerank,respiratory tube development (GO:0030323),0.2670408165369674,0.7862828819871264,0.7756813417190775,0.9556446557725338,1.0,4/28,8.91%,FGFR2;GLI2;LOXL3;NPHP3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.3321649443648251,-0.7862268746811831,0.7402135231316725,0.9203645716548852,1.0,3/10,16.40%,MAPK3;FAS;GREM1
prerank,epithelial cell development (GO:0002064),-0.27785777086266183,-0.7860738306476832,0.7745098039215687,0.9201338072246876,1.0,11/20,40.75%,ACTA2;SIPA1L3;WNT7A;RILPL1;PKHD1;POF1B;GRHL2;RILPL2;WNT7B;RAB25;ROS1
prerank,positive regulation of DNA repair (GO:0045739),-0.2289929802737134,-0.785941266188754,0.806949806949807,0.9199032750687026,1.0,10/46,17.16%,RPS3;BRCC3;UIMC1;DHX9;BABAM1;TRIM28;SLF1;XRCC1;EGFR;BABAM2
prerank,cobalamin metabolic process (GO:0009235),-0.2896500573549042,-0.785492764636687,0.7689243027888446,0.9201453094944944,1.0,4/17,17.77%,MTR;CUBN;MMADHC;CD320
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3016284053091803,0.7853201179855583,0.7217573221757322,0.9564912293926888,1.0,4/15,13.46%,UST;DCN;DSE;VCAN
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3091797628384564,-0.7853023492402076,0.7464028776978417,0.9199615805514043,1.0,1/13,0.21%,SLC4A10
prerank,negative regulation of macroautophagy (GO:0016242),0.2648823155365223,0.7851011063889936,0.7620087336244541,0.9560707391847394,1.0,3/26,4.38%,PHF23;UBQLN4;SCFD1
prerank,C-terminal protein amino acid modification (GO:0018410),0.32973245106994525,0.7845894855184862,0.7116279069767442,0.9561508277149051,1.0,3/11,10.81%,AGBL4;ATG12;FOLH1
prerank,camera-type eye morphogenesis (GO:0048593),0.3365070782576184,0.7839429890660377,0.7159353348729792,0.9564566180799889,1.0,2/10,6.38%,TENM3;IFT122
prerank,plasma membrane invagination (GO:0099024),-0.24940261741625797,-0.7839180229593522,0.7879341864716636,0.9215970822305165,1.0,8/29,24.28%,DOCK1;VAMP7;ARHGAP25;SNX18;MSR1;MYH9;AIF1;CDC42
prerank,early endosome to Golgi transport (GO:0034498),-0.3213417090379166,-0.7833435771612169,0.7580071174377224,0.921984960276837,1.0,5/11,29.68%,SURF4;EHD3;STX5;SNX2;RAB6A
prerank,"transcription, DNA-templated (GO:0006351)",-0.1790098204995645,-0.7829497551059552,0.9684684684684685,0.9221232630060149,1.0,35/207,17.81%,RREB1;MLLT3;DDX5;MEF2A;FOXO3;AFF4;IVNS1ABP;NFYA;NR4A2;PTMA;GTF3C5;GTF2E1;ATF4;CBFB;TRIP11;PIR;GTF2H3;XAB2;NELFE;PPP5C;E2F1;RNPS1;BTF3;EPC1;POLR3A;IRF9;SMN1;DRAP1;GMEB2;CCNK;XBP1;GTF2F1;TCEA1;MED20;GTF2H4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.26332634977227515,-0.7826836828763314,0.7636022514071295,0.9220588498030765,1.0,3/23,8.31%,CBFA2T3;NCOR1;HDAC4
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2533622766709496,0.7823127520065803,0.7541666666666667,0.9584674111117153,1.0,5/30,13.15%,VAMP5;RAB10;BBS2;OPTN;SYS1
prerank,endodermal cell fate commitment (GO:0001711),-0.339096346154513,-0.7822792049815069,0.7617328519855595,0.922199844683079,1.0,1/10,3.46%,SOX17
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3213691696681118,0.7817543301487232,0.7461368653421634,0.9586020314419315,1.0,3/12,10.16%,GPAA1;INSIG2;KDELR3
prerank,regulation of cellular catabolic process (GO:0031329),0.2245317601475364,0.7814300546404748,0.8478260869565217,0.9583556732750589,1.0,11/62,13.81%,DAPK2;ITPR1;PIP4K2A;PRKN;DAPK1;KAT8;RAB39B;PIP4K2B;ATM;EP300;MAPT
prerank,regulation of feeding behavior (GO:0060259),0.32601462485869204,0.7813181346630119,0.7466666666666667,0.9577465410615094,1.0,1/11,2.85%,LEPR
prerank,bone morphogenesis (GO:0060349),-0.3120466392793767,-0.7812312341439431,0.7763401109057301,0.9233628878657938,1.0,2/14,2.11%,LRP5;BMPR2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.19127823498241908,-0.7809727703844908,0.9274509803921569,0.9232927933282048,1.0,11/124,6.57%,FRY;FRYL;RAB11A;OPHN1;STX3;MAP4;APP;RAC1;PTPRM;TTC17;MYOC
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3008920162758197,-0.7807785814913587,0.7357798165137615,0.9231265514494987,1.0,4/14,17.22%,HSP90AB1;JAK2;STAT1;IFNGR1
prerank,positive regulation of DNA recombination (GO:0045911),0.2644259605571467,0.7802560735016894,0.7770419426048565,0.9587375739394888,1.0,7/27,17.74%,SHLD2;PRDM9;KMT5C;PAXIP1;RIF1;KMT5B;PARP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.32014828852123334,0.779651791335482,0.7204301075268817,0.9589556251962972,1.0,2/12,8.31%,STAP1;IL18
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.26414760734925397,-0.7795506868267744,0.791814946619217,0.9245083451124659,1.0,8/23,28.50%,RARA;INHBA;TLR4;VSIR;LAPTM5;LGALS9;INHA;LILRB1
prerank,nucleosome disassembly (GO:0006337),-0.30146228732864516,-0.7795192841074996,0.7751798561151079,0.9236215798159632,1.0,7/14,37.59%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,chromatin disassembly (GO:0031498),-0.30146228732864516,-0.7795192841074996,0.7751798561151079,0.9236215798159632,1.0,7/14,37.59%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.2978692573366352,-0.7789852906682068,0.7495621716287215,0.9239790719263293,1.0,6/15,17.33%,VEGFA;FZD3;DISC1;NF1;CX3CR1;KDM1A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3130723334245185,-0.7784956506278107,0.7402135231316725,0.9242213769926814,1.0,8/13,41.23%,ANAPC15;DYNC1LI1;LCMT1;NDC80;DUSP1;CCNB1;CDK5RAP2;PCID2
prerank,regulation of actin filament-based movement (GO:1903115),0.32664683416209045,0.7782074537230814,0.738562091503268,0.9604957223981485,1.0,2/10,10.22%,ANK2;PDE4B
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.30906011374610176,-0.7778120302158725,0.770949720670391,0.9247746394011703,1.0,3/13,21.31%,ENTPD7;OPA1;RAB23
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21263577440986697,0.7764190639172368,0.8536585365853658,0.962594846428977,1.0,8/72,10.64%,ENPP1;DCP1A;DDB2;GTF2H2;SETMAR;RPA2;RFC5;RNASE4
prerank,regulation of myoblast fusion (GO:1901739),0.3221566873105842,0.776240054916155,0.7303370786516854,0.9620899394753875,1.0,2/11,5.08%,CFLAR;IL4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2846532444673956,-0.7761913290960972,0.7704347826086957,0.9266748264822625,1.0,4/17,10.73%,CD44;TWIST1;PTTG1IP;CD74
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.33024289505029303,-0.7760431350525999,0.7482014388489209,0.9264214249333657,1.0,6/10,52.90%,USP7;GNMT;SIRT7;DGKQ;PDK2;FBP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.3150595627703995,-0.7756070684265833,0.7540394973070018,0.9265867689988646,1.0,4/12,24.67%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3370781346947237,-0.775382813861104,0.7614035087719299,0.9264653037732609,1.0,4/10,19.37%,ZBTB16;SOX6;BMPR1B;SOX9
prerank,cochlea morphogenesis (GO:0090103),0.33049933356599176,0.7752632123670086,0.7301587301587301,0.9629228727782777,1.0,1/10,2.25%,TBX18
prerank,response to axon injury (GO:0048678),0.29060155776887164,0.7752076961878959,0.7838427947598253,0.962230426185152,1.0,5/18,17.42%,P2RX4;NREP;DPYSL3;SARM1;FLRT3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.25678108345495665,-0.7751204194350045,0.7752380952380953,0.926385539309057,1.0,11/26,35.13%,ST3GAL4;ST8SIA6;RRM1;SCCPDH;LARGE1;GOLPH3;ALG2;B4GALT5;ST3GAL2;TPI1;ALG6
prerank,positive regulation of cell division (GO:0051781),0.24490540102122765,0.7750234867597284,0.8174273858921162,0.9617483233344564,1.0,2/38,1.11%,SVIL;FGFR2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2342611318722697,0.775021323211739,0.8298319327731093,0.9609633921420002,1.0,13/45,19.14%,AURKAIP1;SMAD3;BRINP1;BRINP3;TOM1L2;WEE2;TOM1L1;PRCC;BRINP2;ZWINT;TRIM35;FOXC1;ZWILCH
prerank,cellular response to UV-A (GO:0071492),-0.3205587872455646,-0.7740964924415628,0.7710196779964222,0.9274211178721559,1.0,8/11,50.01%,OPN3;PPID;MMP3;MMP1;CERS1;OPN5;MMP9;OPN1SW
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2782770780875953,-0.7739632228136255,0.7873563218390804,0.9271446455957858,1.0,8/20,23.71%,TGFB1;ABI3;PPP2R5A;AP2M1;BCL2L1;TMEM59;CSK;NUMB
prerank,nucleus organization (GO:0006997),-0.22489199645548702,-0.7738341230028314,0.8812615955473099,0.926884941632782,1.0,14/47,28.55%,SYNE1;RPS19;CHMP2B;NUP93;NDC1;NUP54;NUP155;REEP4;CHMP2A;CEP55;VPS4A;SEH1L;NUP98;CHMP7
prerank,regulation of lipase activity (GO:0060191),0.3113817565446671,0.7735761385489095,0.7405857740585774,0.9625101443447102,1.0,13/13,68.89%,PCSK6;SNCA;ANGPTL3;LIPC;LMF1;RHOC;APOA2;ANGPTL8;PCSK5;LPL;PLIN5;FURIN;RHOA
prerank,regulation of DNA repair (GO:0006282),-0.22812092389402655,-0.7734934137972093,0.8460076045627376,0.9269313238890323,1.0,7/44,9.21%,RPS3;USP1;BRCC3;UIMC1;DHX9;BABAM1;TRIM28
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3139157620932659,-0.7731977399279338,0.7837338262476895,0.9269043659700643,1.0,7/12,34.80%,SEPHS2;CTH;GGT1;SERINC3;SERINC5;SRR;PSAT1
prerank,alcohol catabolic process (GO:0046164),0.3267290984584328,0.7727856055109192,0.7247058823529412,0.9629924154399965,1.0,2/10,9.74%,CYP27A1;CYP46A1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.17800340091015188,-0.7718945444313274,0.9555084745762712,0.9283766621745402,1.0,45/193,21.57%,NEDD4L;RNF144B;TRIM25;UBB;RLIM;UBC;RPS27A;RNF125;ANAPC15;RNF114;ANAPC11;RC3H1;UBE2L6;ARRDC1;RNF185;UBE2G2;TOLLIP;FBXL14;PCYOX1;PSMD14;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;UBL7;PSMD11;ANAPC7;KCTD10;CDC27;FZR1;XBP1;RNF19A;AMFR;PCYOX1L;KEAP1;UBE2B;UBA1;ANAPC2;BFAR
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2087597196197522,-0.7718444670676821,0.8869047619047619,0.9279863126471447,1.0,22/70,28.84%,LPCAT3;MFSD2A;CHKA;DBI;CSNK2B;PLAAT3;MBOAT7;CEPT1;MBOAT1;CSNK2A1;CSNK2A2;NR1H2;LCAT;PCYT1A;CHAT;LPCAT2;PLA2G4F;ENPP2;PEMT;LPIN2;SLC27A1;PLA2G4B
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3191722409010852,-0.7714121478616011,0.7667910447761194,0.9281489256680701,1.0,5/11,28.99%,REST;STK26;PARK7;P4HB;MMP3
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.29362789985027726,-0.771351924924186,0.7803992740471869,0.9277749533545777,1.0,7/15,29.11%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2;ERN1
prerank,AMP metabolic process (GO:0046033),-0.30949756408279394,-0.7711370113618187,0.7730627306273062,0.9276201223891953,1.0,7/13,30.09%,NT5E;ADSS2;NT5C1A;ADSS1;NUDT2;AK9;XDH
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2929665603043789,0.7710124037513247,0.7744034707158352,0.9650908210640525,1.0,2/16,5.09%,LEPROT;VPS25
prerank,cellular response to leucine (GO:0071233),-0.331658271949669,-0.7707895703045426,0.776937618147448,0.9272101363341976,1.0,4/10,27.36%,RRAGD;SESN2;RPTOR;SESN1
prerank,response to leucine (GO:0043201),-0.331658271949669,-0.7707895703045426,0.776937618147448,0.9272101363341976,1.0,4/10,27.36%,RRAGD;SESN2;RPTOR;SESN1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.2478926845995017,-0.7698621806671049,0.8221343873517787,0.9280207120097943,1.0,10/30,25.82%,ABLIM3;SAE1;VPS11;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;UBE2J2;ATG13
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.21100812219647858,-0.7694732834001806,0.8576642335766423,0.9281058981331379,1.0,9/61,9.33%,RPS3;BRCC3;USP7;RGCC;UIMC1;DHX9;BABAM1;TRIM28;USP9X
prerank,inflammatory response (GO:0006954),0.18075451888094243,0.7684848043350623,0.9612244897959183,0.9682111789555155,1.0,20/195,10.66%,ADCY1;BMP2;PTGFR;HYAL3;SCUBE1;KIT;TPST1;CEBPB;IL4;PTGDR;ADM;PPBP;HRH1;SCG2;LOXL3;IL18;CCL25;TNFAIP6;C3AR1;ADCY8
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.32668365139263983,-0.7684640865772511,0.7530224525043178,0.9290379133661631,1.0,3/10,17.87%,NOTCH1;PHACTR4;DLL4
prerank,glycolipid biosynthetic process (GO:0009247),0.2370407343408469,0.7681174460525472,0.8138613861386138,0.9680241590044698,1.0,12/38,20.47%,ST6GALNAC5;ST3GAL5;ST8SIA1;PIGU;PIGH;PIGP;ST8SIA5;PGAP3;DPM1;PIGN;B4GALT6;MPPE1
prerank,Golgi inheritance (GO:0048313),-0.32068061498257555,-0.7678923998450168,0.7672413793103449,0.9293982734293894,1.0,7/11,26.03%,STK25;VRK1;YWHAZ;PDCD10;STX5;PLK3;PLK5
prerank,regulation of exosomal secretion (GO:1903541),-0.27853717913962256,-0.7673606210390365,0.7938517179023508,0.9296882418459,1.0,8/19,30.80%,RAB7A;SDCBP;TSG101;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2754492938139705,-0.7671312287361832,0.8022388059701493,0.929543803874299,1.0,8/19,33.91%,HTT;CSNK2A2;FZD5;SREBF1;PARK7;CAMKK2;ATP13A2;HTRA2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.25621322672276103,0.7665604023353934,0.7835497835497836,0.9697252657713094,1.0,5/25,12.48%,OMA1;ATXN3;UFD1;UGGT2;POMT2
prerank,prostaglandin metabolic process (GO:0006693),-0.2580670959533021,-0.765870599070525,0.8007736943907157,0.9308123829995402,1.0,7/26,18.31%,PTGDS;EDN1;PLAA;CD74;PTGS1;GSTM1;DAGLB
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2961532859190611,0.7657055508918273,0.7477876106194691,0.970241266848365,1.0,7/15,21.85%,TNRC6A;CPEB3;POLR2G;TNRC6B;TOB1;AGO2;TENT4A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31494749672329403,0.765321930464599,0.756578947368421,0.970059179754103,1.0,4/12,15.77%,PCGF5;SMCHD1;LRIF1;METTL3
prerank,glucan catabolic process (GO:0009251),0.2896359789139732,0.7651755447562244,0.7702702702702703,0.9694814232211814,1.0,3/15,11.57%,PHKA1;STBD1;PYGM
prerank,regulation of lymphocyte activation (GO:0051249),0.31268047708725677,0.7647126872783065,0.7422434367541766,0.9694096970903342,1.0,12/12,68.76%,PAG1;LCK;IKZF3;SIT1;CD4;CD19;THEMIS2;CRTAM;CCL5;DCAF15;KAT2A;LAT
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2514902475446935,-0.76373407534157,0.8107142857142857,0.9333311578489268,1.0,8/27,28.36%,CHKA;PLAAT3;CEPT1;PCYT2;NAPEPLD;SELENOI;LPIN2;SLC27A1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22944985018882286,-0.7636054456215589,0.8528301886792453,0.933042524226876,1.0,6/42,7.53%,ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;A4GALT
prerank,regulation of DNA replication (GO:0006275),0.2238735190216805,0.7634485011496313,0.8559837728194726,0.9705383197618778,1.0,12/49,20.32%,GLI2;STN1;USP37;ATAD5;BRPF3;BLM;EHMT2;PDS5A;FBXO5;ORC3;ORC5;PCNA
prerank,intracellular protein transmembrane transport (GO:0065002),-0.22517045322477616,-0.7628253112315386,0.8552123552123552,0.9336494385083913,1.0,14/42,30.55%,HSPD1;SEC63;HSPA5;TIMM17A;TIMM21;CHCHD4;SEC61B;TIMM50;ZFAND2B;RTN2;SEC61A1;PEX14;PEX6;ROMO1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3072783286824388,0.7625953914768066,0.7566371681415929,0.9710379950107887,1.0,4/12,20.13%,PRKCA;PRKCB;LPIN1;CCNB2
prerank,positive regulation of calcium ion import (GO:0090280),0.3142832404056749,0.7621770992653727,0.7466367713004485,0.9708661722782398,1.0,2/12,6.91%,PDGFRB;CALCR
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2476802597834344,-0.7620028263010378,0.8330170777988615,0.9343171369379736,1.0,9/28,24.32%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,regulation of histone deacetylation (GO:0031063),-0.3018889633433404,-0.7618972473849672,0.7879310344827586,0.9340177499082493,1.0,5/13,25.67%,CAMK2D;CTBP1;SPHK2;NIPBL;APLNR
prerank,response to UV-B (GO:0010224),0.3081493040851861,0.7616932947012002,0.7404921700223713,0.970770518850252,1.0,1/12,1.32%,HYAL3
prerank,regulation of cilium assembly (GO:1902017),-0.20911117434884033,-0.7615566915807691,0.8670756646216768,0.9340207638182826,1.0,19/62,27.42%,LIMK2;TBC1D8;IFT20;HTT;TBC1D1;TBC1D22A;ATG3;CDK10;TBC1D9B;TBC1D2;RABEP2;DCDC2;TBC1D15;ODAD3;CCDC88A;TBC1D30;TBC1D17;CDKL5;TBC1D5
prerank,autophagy of peroxisome (GO:0030242),-0.30740690673207627,-0.7615442513039391,0.7849264705882353,0.9335716813962596,1.0,1/12,3.68%,MAP1LC3B
prerank,positive regulation of protein deacetylation (GO:0090312),0.297137956106398,0.7615349773842331,0.7595238095238095,0.9702166570575113,1.0,3/14,11.00%,AKAP8L;BRMS1;SAP30BP
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3318677192654185,-0.7614944715239441,0.767175572519084,0.9331949800279467,1.0,4/10,17.06%,MLLT3;ACE;UFL1;HOXB4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23081098564349153,0.7607122253641,0.8588957055214724,0.9706973874955608,1.0,8/47,14.50%,WNT4;ROCK2;PTGIS;CRY1;KHSRP;ERLIN1;EP300;GLA
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3129182290109756,-0.7605831298082535,0.7792706333973128,0.9339404690859586,1.0,3/12,28.45%,NELFE;EAPP;RNF8
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19833077734251092,0.760429312994217,0.920892494929006,0.9703452386695632,1.0,23/95,18.39%,MCM3;RNF138;GEN1;POLN;GINS2;SWSAP1;BLM;RPA2;MCM2;MCM9;RAD51C;MCM8;RAD51B;FANCM;NBN;RPA1;SMC6;PARP1;SEM1;SMC5;UBE2N;NSMCE2;PALB2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3052808352961836,-0.7603878863132046,0.791814946619217,0.9337688956544377,1.0,2/13,8.14%,RPS15;NMD3
prerank,nucleosome assembly (GO:0006334),-0.24266488132357356,-0.7593398728516064,0.8314606741573034,0.9347412193429853,1.0,10/31,30.02%,H3-3A;NAA60;RBBP4;SOX9;NPM1;KAT6B;HMGB2;ANP32B;ASF1B;SMARCA5
prerank,microtubule anchoring at centrosome (GO:0034454),0.328888060424631,0.7589272633281868,0.737417943107221,0.9718395567836979,1.0,4/10,20.74%,NINL;KIF3A;BBS4;CCDC68
prerank,protein homotetramerization (GO:0051289),-0.218742789169293,-0.7589209995375954,0.8635477582846004,0.9348577376093169,1.0,12/49,22.31%,B2M;KCNJ2;GBP5;GLS;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;PKD2;ACOT13;UPB1
prerank,protein heterooligomerization (GO:0051291),-0.28440166762818314,-0.7588651921647354,0.7804878048780488,0.9344830110629969,1.0,8/17,36.06%,PKD1;MAT2A;FARSB;PKD2;GRIN1;KRT10;TMEM120B;TMEM120A
prerank,cellular response to misfolded protein (GO:0071218),-0.26710476020290563,-0.7588132688948871,0.8153564899451554,0.9340924007927504,1.0,4/20,12.80%,DNAJB12;RNF185;VCP;RNF5
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2505596009669013,0.7585677885826091,0.8117154811715481,0.9715720880018461,1.0,2/29,2.58%,PLA2G5;PLA2G4A
prerank,intracellular pH reduction (GO:0051452),-0.23592835779099813,-0.7584122517938042,0.8492366412213741,0.9341838610131429,1.0,8/33,17.11%,ATP6V0B;ATP6V0A2;CLCN3;ATP6V0C;RAB7A;ATP6V1G1;GPR89B;GPR89A
prerank,regulation of nuclear division (GO:0051783),-0.25938136222739866,-0.7578341729506513,0.805019305019305,0.9345176372523647,1.0,6/20,21.07%,CAV2;CDK13;L3MBTL1;PIN1;RCC1;MKI67
prerank,response to peptide (GO:1901652),0.24404988137956476,0.7578306328836205,0.7978494623655914,0.9719072203480364,1.0,5/33,11.50%,STAT5B;GNAI1;CALCR;CHRNA7;EIF2B5
prerank,antibacterial humoral response (GO:0019731),0.28461688001198066,0.7577422171359359,0.8034188034188035,0.9712385551165473,1.0,5/16,22.39%,JCHAIN;ANG;PLA2G6;RNASE3;SLPI
prerank,lymphocyte migration (GO:0072676),0.2430131146694235,0.756964494022876,0.8141592920353983,0.9716185234794126,1.0,5/32,10.73%,TBX21;CCR6;GATA3;CCL25;MYO1G
prerank,Rac protein signal transduction (GO:0016601),-0.27909777520100437,-0.7567946298121642,0.8109090909090909,0.9354425356695605,1.0,4/18,16.41%,EPS8;RAC1;DBNL;NCKAP1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.22052310859236163,0.7562651001981625,0.8481012658227848,0.971859305499827,1.0,3/52,2.63%,SAMD4A;TUT4;DCP1A
prerank,secondary alcohol metabolic process (GO:1902652),0.2273431912229292,0.7562155890675748,0.8589743589743589,0.9711667480641312,1.0,5/42,9.35%,ABCA1;CYP27A1;IL4;ABCA5;SCAP
prerank,atrial septum development (GO:0003283),-0.2962392776052446,-0.7559000736395843,0.7921146953405018,0.9361763741501357,1.0,2/13,4.12%,BMPR2;TGFB2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20236969764536777,-0.7555944814082695,0.9058380414312618,0.9361240901650516,1.0,25/68,29.81%,SLC2A1;MTR;SLC5A6;RFK;CUBN;TPK1;SLC19A3;SLC52A3;MMADHC;SLC2A3;SLC52A2;GSTO2;CD320;NNMT;MTHFS;MCCC1;CYB5R3;MTRR;AOX1;SLC25A19;GSTO1;PANK2;VNN1;SLC23A1;SLC23A2
prerank,neural crest cell differentiation (GO:0014033),-0.2831343631381006,-0.7549549519457542,0.8025830258302583,0.9365104635484987,1.0,1/18,0.31%,MEF2C
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3089604914346725,-0.7547540547924643,0.7862453531598513,0.936339673696458,1.0,2/12,8.12%,ZW10;PLK2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.263851513027651,0.7547268616652814,0.7895927601809954,0.9725942527841106,1.0,7/22,16.35%,KIT;GHR;HES5;ERBB4;OCIAD2;TSLP;CRLF2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.320568380924845,0.7546148911590447,0.7804347826086957,0.9719921411933663,1.0,4/11,17.96%,RPS6KA6;KAT5;SP100;TP53
prerank,peptidyl-lysine acetylation (GO:0018394),0.3196083354255587,0.7535593823850127,0.7368421052631579,0.9727501797812346,1.0,10/10,68.06%,EP300;KAT5;KAT2B;SIRT1;ESCO1;KAT7;BAG6;BLOC1S1;CREBBP;KAT2A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2667533411142544,-0.7534206978566573,0.835820895522388,0.9376716946610405,1.0,7/20,24.83%,MCUB;MCUR1;PHB2;MICU2;SMDT1;MCU;SLC8B1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2972843192307374,0.7532307039828436,0.7818181818181819,0.9724396890056612,1.0,4/14,23.28%,MOXD1;ACHE;SLC22A2;DAGLA
prerank,dendrite self-avoidance (GO:0070593),-0.282506960493165,-0.752841731415883,0.7992700729927007,0.9379858923004114,1.0,2/16,4.96%,BSG;ROBO4
prerank,cyclooxygenase pathway (GO:0019371),-0.3204178478142554,-0.7525707592290302,0.7860869565217391,0.9378893572473638,1.0,3/10,16.72%,PTGDS;PTGS1;CBR1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3049595715682913,-0.7515691701149916,0.7920433996383364,0.938726515527277,1.0,3/12,11.39%,PRPS2;PRPS1;PRPS1L1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.27315474855663274,-0.7513716758757665,0.8155339805825242,0.9385188506283818,1.0,6/18,26.94%,ELOVL7;ELOVL5;ACSL5;ELOVL1;ACSF3;HACD2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24337838543570361,-0.7511807299370552,0.8474903474903475,0.9383258655139012,1.0,13/29,35.68%,HSP90AB1;PPIA;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24679933827038375,-0.750909526323054,0.8367346938775511,0.9382338053985493,1.0,10/29,27.61%,ELOVL7;ACLY;ELOVL5;ACSL5;PPT2;SLC25A1;ELOVL1;ACSF3;HACD2;GCDH
prerank,positive regulation of mRNA processing (GO:0050685),0.2698874192749553,0.7506790177929817,0.8270833333333333,0.9753866542522992,1.0,3/21,7.63%,DAZAP1;TRA2A;CELF4
prerank,protein homooligomerization (GO:0051260),-0.1855274179411148,-0.7506771842982535,0.9490835030549898,0.9380583915907695,1.0,27/114,22.31%,B2M;KCNJ2;EHD4;GBP5;AQP11;ATL3;FUS;ATL2;PRMT8;JMJD6;GLS;SAMHD1;ALDH1A3;MLKL;CTH;NINJ1;HSD17B10;CHMP2A;POLQ;EHD1;AQP4;TRMT61B;ECT2;EHD3;PKD2;ACOT13;UPB1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.31668586009393784,0.7493073969075835,0.7794759825327511,0.9766070763237259,1.0,2/11,13.45%,CRY1;EP300
prerank,positive regulation of cytokinesis (GO:0032467),-0.23810537866808354,-0.7488368860783086,0.8557504873294347,0.9399759995752189,1.0,6/32,13.19%,PKP4;CDC14A;GIPC1;KIF23;PRKCE;CDC14B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.292364551935438,-0.7482958300250802,0.8178438661710037,0.9401822641010223,1.0,6/14,28.36%,CHKA;CEPT1;PCYT2;SELENOI;LPIN2;SLC27A1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29997859948499117,-0.7480846619906987,0.7933450087565674,0.939982829494505,1.0,5/12,25.67%,CTBP1;VEGFA;NIPBL;PRKD2;APLNR
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.23034961457836242,-0.7479105786147062,0.8736059479553904,0.9397802572650452,1.0,15/38,30.65%,PTPRJ;RACK1;AKT1;CIB1;EPHA2;PHLPP2;PHLDA3;TSC2;TRIB3;BANK1;PDCD6;PPP2R5B;MUL1;XDH;HYAL2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.269050686852508,0.7474341237774947,0.7777777777777778,0.9783903451763427,1.0,4/18,11.72%,CHRM2;CHRM3;CDK5R1;GNA15
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3011487427257787,-0.7471035343775938,0.802536231884058,0.9403414773202093,1.0,4/13,17.09%,CASP8;PERP;BAK1;BAD
prerank,protein lipidation (GO:0006497),0.21387700423574182,0.7467166032111374,0.9138655462184874,0.978617982449026,1.0,19/59,22.22%,WDR45B;ATG12;WIPI1;PIGU;GLUL;PIGH;PIGP;ATG10;ZDHHC2;PGAP3;PORCN;ZDHHC15;DPM1;PIGN;ZDHHC6;MPPE1;ATG5;WDR45;PIGB
prerank,regulation of chromosome organization (GO:0033044),-0.2585327658943505,-0.7467123835266186,0.8203125,0.9403829822705569,1.0,12/22,33.64%,RB1;SHCBP1L;WAPL;SMG1;LIG4;CENPV;TERF2IP;MYC;UPF1;SMG6;PIF1;BUB1
prerank,regulation of mitochondrion organization (GO:0010821),0.22410802391875542,0.7466123293618572,0.8663883089770354,0.977983731043289,1.0,8/47,14.30%,PID1;OMA1;PRKN;IAPP;PARL;EP300;MAPT;STOX1
prerank,rRNA transcription (GO:0009303),0.27833839331283805,0.7464681682504023,0.7932692307692307,0.977418504024099,1.0,6/17,14.66%,POLR1G;GTF3C3;ANG;GTF3C2;GTF3C6;GTF3C4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.30786115941912295,-0.7455315589705939,0.7723292469352014,0.9414201507291279,1.0,3/11,20.79%,NCL;SMARCA4;PWP1
prerank,snRNA transcription (GO:0009301),-0.20002634072562045,-0.7454295337831306,0.9235181644359465,0.9410970280296369,1.0,25/70,33.25%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;USPL1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,muscle cell migration (GO:0014812),-0.3175184852945031,-0.7444249879691838,0.8065099457504521,0.9419090852068719,1.0,2/10,3.90%,CCN3;SIX1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.246949284504358,-0.744067841728389,0.8391472868217055,0.9419015882072833,1.0,8/27,27.43%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;SIK1;FBXL8
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.1610562696863732,-0.7437475278862297,1.0,0.9418736253298071,1.0,80/341,23.10%,WWP1;NEDD4L;RNF144B;TRIM25;ZNRF1;WWP2;MVB12B;RLIM;RNF125;ANAPC15;PSMA6;RNF114;ANAPC11;RC3H1;CUL4A;PSMB5;NHLRC3;UBE2L6;KCTD5;PLAA;USP9X;ARRDC1;RNF185;UCHL1;UBE2G2;VCP;TOLLIP;TNFAIP1;PSMC4;MTA1;MAEA;PSMC5;FBXL14;UBXN1;PSMD14;FBXW5;ITCH;RNF5;RNF111;KLHL3;FBXL7;SMURF1;FEM1A;RNF20;RBX1;UBE2G1;TSG101;UBL7;PSMD8;PSMD11;TNFAIP3;ANAPC7;KCTD10;CDC27;PSMB4;PSMD12;PSMC1;FZR1;XBP1;PELI1;RNF19A;ZSWIM8;TBL1X;AMFR;KCTD2;KEAP1;UBE2B;UBA1;PSMA1;ZFAND2B;ANAPC2;CLOCK;PSMB1;PSMC3;BFAR;PSMA4;DTL;PCNP;FBXL19;PSMA2
prerank,C4-dicarboxylate transport (GO:0015740),-0.29215025082414203,-0.7421948275277064,0.8022388059701493,0.9433212544346393,1.0,3/14,10.97%,LRRC8D;SLC1A1;SLC25A12
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.315993833064502,0.7420512313333941,0.7690677966101694,0.9820247608058211,1.0,2/10,9.32%,MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.315993833064502,0.7420512313333941,0.7690677966101694,0.9820247608058211,1.0,2/10,9.32%,MPG;FTO
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2706776722544738,0.7415683832821746,0.8077803203661327,0.9819013645923724,1.0,6/17,22.16%,CTNNA2;GMFB;BRK1;FCHSD2;WASF1;ABI2
prerank,mitochondrial membrane organization (GO:0007006),-0.23333763021776496,-0.7409800638586753,0.8413926499032882,0.9443827402503218,1.0,12/32,28.77%,CHCHD3;BCL2L1;BAK1;OPA1;BAD;HSPA9;CHCHD6;TIMM50;SLC25A4;APOO;MICOS13;PMAIP1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2435566008572958,0.740964751129047,0.842741935483871,0.9819895332013048,1.0,10/31,18.84%,CACNA1I;SYT1;CACNA1G;SYT13;STXBP3;SCAMP5;SYT11;SYT12;SYT6;RAB3GAP1
prerank,negative regulation of transferase activity (GO:0051348),-0.23904831111554084,-0.7409133290551345,0.8571428571428571,0.9440193410662809,1.0,12/28,32.96%,SMAD7;CDKN1B;BAG5;LIMK1;ERCC4;EIF4A2;DTX3L;CDKN1C;PARK7;SRC;PIF1;ABL1
prerank,neuron projection organization (GO:0106027),-0.28360104228304356,-0.7408534097774742,0.8242753623188406,0.9436358592336526,1.0,3/15,10.22%,APP;INSR;DCTN1
prerank,phospholipid metabolic process (GO:0006644),0.20318132391861574,0.7407997828161829,0.9210526315789473,0.9814373171773535,1.0,11/71,14.65%,PLA2G5;PIP4K2A;PLA2G4A;PLPP3;PLPPR1;PLBD2;LGALS13;PIP4K2B;GNPAT;FADS1;PLPPR5
prerank,retinol metabolic process (GO:0042572),0.287985941525664,0.740417496573356,0.790948275862069,0.9811919092906686,1.0,1/14,2.06%,DHRS3
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3057375739636118,-0.7395899575424606,0.8122676579925651,0.9447403677164005,1.0,3/11,16.10%,TGFB2;SOX4;ZFPM2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.24407549243411042,-0.739260903105581,0.847985347985348,0.9446697368899732,1.0,13/28,44.22%,CYRIB;PRKDC;HSPD1;NOD2;FGF10;CCL2;TYROBP;TNIP2;IL12A;CCDC88B;TNFSF11;IL23A;IL6
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2588797869843508,0.7391020690477563,0.8316008316008316,0.9822054573359291,1.0,1/22,0.54%,BMP2
prerank,cellular senescence (GO:0090398),0.24922513064973165,0.7382485025155024,0.8183716075156576,0.9825972286314753,1.0,2/27,4.65%,TBX3;MAPKAPK5
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.28596196735111845,-0.7379239210668243,0.8357400722021661,0.9458929001325819,1.0,1/14,2.58%,ME1
prerank,tetrapyrrole metabolic process (GO:0033013),-0.26960130928415094,-0.7379090130381452,0.812375249500998,0.9454546863589586,1.0,2/18,4.06%,MTR;CUBN
prerank,melanosome organization (GO:0032438),-0.24425156800161535,-0.7377492638779095,0.8417132216014898,0.9451953957747233,1.0,15/26,38.38%,AP3B1;LYST;HPS1;RAB32;DTNBP1;KIF13A;ABCB6;AP1G1;BLOC1S2;BLOC1S6;AP3D1;SHROOM2;BLOC1S1;GPR143;BLOC1S4
prerank,negative regulation of endocytosis (GO:0045806),-0.24428027797992619,-0.7377294461467854,0.848314606741573,0.9447645477578905,1.0,2/24,4.56%,CAV1;RAC1
prerank,nuclear pore complex assembly (GO:0051292),0.30997069420370577,0.7373372169793863,0.7544642857142857,0.9830486268115266,1.0,4/10,17.18%,RTN4;NUP205;AHCTF1;TMEM170A
prerank,regulation of complement activation (GO:0030449),-0.2231316803494263,-0.7370256748802287,0.8871595330739299,0.9451536582581195,1.0,7/40,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,regulation of G0 to G1 transition (GO:0070316),0.23214246298437136,0.7368610023133355,0.8620689655172413,0.9829323808630487,1.0,7/38,11.56%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2
prerank,mesenchymal cell development (GO:0014031),-0.27006947132572473,-0.7352577333102639,0.8287292817679558,0.9467972502629434,1.0,7/18,30.12%,NOTCH1;HEYL;PEF1;SNAI2;SOX8;PDCD6;TBX20
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.20084080282533762,0.7351087146827872,0.9327902240325866,0.9844860211905976,1.0,16/73,15.82%,KDM1B;POLR1A;GLMN;BAZ1B;POLR1G;TRIM27;IGF2;PPM1D;DNMT1;POLR1B;CTCF;EP300;MYBBP1A;EZH2;MYO1C;MTF2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.20091784224843393,0.7341968886922942,0.9157894736842105,0.9848833419710177,1.0,23/80,19.23%,RAB9B;VPS26B;UBE2O;GBF1;RAB29;TRIM27;RHOBTB3;BAIAP3;TBC1D10C;PHETA1;VPS50;TBC1D10A;ARL1;TMED9;DENND5A;SNX8;SNX32;GOSR2;EVI5;VAMP3;SNX6;DENND2A;RAB7B
prerank,arachidonic acid secretion (GO:0050482),0.3048128914772906,0.733801244651803,0.7889908256880734,0.9838652719382989,1.0,1/10,2.09%,PLA2G5
prerank,arachidonate transport (GO:1903963),0.3048128914772906,0.733801244651803,0.7889908256880734,0.9838652719382989,1.0,1/10,2.09%,PLA2G5
prerank,negative regulation of translation (GO:0017148),0.19618866698521753,0.733508455204191,0.9457700650759219,0.9835050384938968,1.0,16/87,16.67%,SAMD4A;ROCK2;DAPK1;IGF2BP2;NANOS3;CPEB3;FTO;DDX6;RIDA;FXR2;METTL16;PUS7;RBM24;METTL3;TOB1;CPEB1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3192405902381698,-0.7330326228710119,0.8216911764705882,0.9490622641355194,1.0,5/10,30.37%,SMYD2;KMT5A;SETD2;METTL18;EEF1AKMT2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2959828987399771,-0.7329784528642985,0.8147512864493996,0.9486721561034936,1.0,2/12,7.90%,KLF2;TRIM16
prerank,neuron remodeling (GO:0016322),-0.30686825759252634,-0.7324661622837232,0.8203703703703704,0.9488125372432795,1.0,3/10,8.12%,SCARF1;APP;ANKS1A
prerank,tRNA wobble uridine modification (GO:0002098),-0.28532438711551505,-0.7320504655836086,0.8200371057513914,0.9488495569973332,1.0,3/14,13.54%,DPH3;TRMT9B;URM1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.23612718624113824,0.731989176515134,0.8528138528138528,0.9846899929487103,1.0,7/32,16.62%,CDK14;TFDP1;NPAT;ORC1;CDK16;BACH1;FBXO5
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.31626008114141796,-0.7316419930523669,0.7963963963963964,0.9488783090111305,1.0,2/10,11.03%,ATF4;HSPA5
prerank,fatty acid transmembrane transport (GO:1902001),0.2592784315494953,0.7315960973931601,0.8101851851851852,0.9844303345037859,1.0,3/19,6.82%,PRKAG2;ABCD2;CPT2
prerank,regulation of mitotic spindle organization (GO:0060236),0.23396022391374854,0.7310868666793184,0.8508403361344538,0.9843104468335595,1.0,9/35,19.01%,GNAI1;MAP9;BORA;CHMP1A;FSD1;PARP3;NUMA1;DRG1;NUP62
prerank,glycogen metabolic process (GO:0005977),0.24205337662021126,0.7305047056440426,0.8482758620689655,0.9843096382765316,1.0,4/27,11.57%,PRKAG2;PHKA1;STBD1;PYGM
prerank,mRNA methylation (GO:0080009),0.2814662927863087,0.7296883651316548,0.8325688073394495,0.9845785869974195,1.0,4/15,16.82%,VIRMA;METTL16;METTL3;METTL8
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2581057537116475,0.7295216744795938,0.8392484342379958,0.9840463502777963,1.0,6/22,13.81%,EFEMP2;AEBP1;CAMSAP1;CHRNA7;GBA2;MAPT
prerank,purine-containing compound biosynthetic process (GO:0072522),0.250204963758628,0.7293394955848711,0.8290993071593533,0.9835149471317354,1.0,3/25,6.90%,AMPD3;PRPSAP2;GMPR
prerank,protein acetylation (GO:0006473),-0.2295197618573547,-0.7287171185628607,0.8722222222222222,0.9518121593143569,1.0,11/30,36.55%,FOXO1;ING5;NAA60;CLOCK;DSCC1;NAT9;NAA50;NAA80;CREBBP;ESCO2;BLOC1S1
prerank,regulation of secretion by cell (GO:1903530),0.2126193071507743,0.7273476054407538,0.8876889848812095,0.9853436198229713,1.0,14/54,19.63%,RIMS1;RAB3C;CHRNB4;SYT1;CPLX2;RAB10;MCTP2;LLGL1;SCG5;HCRT;VAMP3;HTR1A;RIMS2;STXBP5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.24542066492020004,-0.7273289189328078,0.84,0.9529607124684764,1.0,4/25,12.34%,LIMK2;SLIT2;ABI3;CDK10
prerank,response to X-ray (GO:0010165),-0.2850524635655877,-0.7272197538264066,0.8195488721804511,0.9526268526345423,1.0,5/14,26.71%,ANXA1;BRCC3;IKBIP;NIPBL;LIG4
prerank,base conversion or substitution editing (GO:0016553),0.3090339711681814,0.7265637506971241,0.7925764192139738,0.985560538817255,1.0,1/11,3.36%,ADARB2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.26700684775570793,-0.7258749475822283,0.8403846153846154,0.9537213302334797,1.0,8/18,31.12%,KDR;MIEF1;MIEF2;FIS1;MCU;MFF;MUL1;AURKA
prerank,regulation of phosphatase activity (GO:0010921),0.2500358750645565,0.7245177054912412,0.8280254777070064,0.9874115609387418,1.0,1/24,0.54%,BMP2
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21825248994027108,-0.7244756835688206,0.8793418647166362,0.9548092849781062,1.0,11/40,18.64%,ARL6IP5;UBB;BAX;AKT1;VCP;BCL2L1;BAK1;ATP5IF1;TUSC2;BAD;SLC25A33
prerank,microtubule polymerization (GO:0046785),-0.2316679288333263,-0.724200434620686,0.8752362948960303,0.9546528724405168,1.0,9/28,29.62%,SLAIN2;TRPV4;NDE1;NDEL1;PIN1;TPX2;MAP7D3;TUBG2;TUBGCP6
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.26546774824971353,-0.7239641699989925,0.8410714285714286,0.9544484755392015,1.0,6/17,26.40%,CAMLG;EMC10;SGTA;EMC6;EMC9;EMC1
prerank,fatty acid metabolic process (GO:0006631),0.1826671870801432,0.7239395199455251,0.9766536964980544,0.9873338635694214,1.0,19/115,15.11%,PPARA;ALOX12;ACSM5;ACADSB;ACSL1;BAAT;CPT1C;MSMO1;ABCD2;CPT2;ACOT11;HPGD;LPIN3;NDUFAB1;GNPAT;MCAT;ACSL6;ACACA;NUDT19
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.303777283669857,-0.7236238203902605,0.8281535648994516,0.95438313977327,1.0,3/11,12.80%,RNF185;VCP;RNF5
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2712038718825925,0.7236039058949751,0.8246013667425968,0.9869951846558022,1.0,3/16,11.57%,PHKA1;STBD1;PYGM
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.29493755425827256,0.7234487226102274,0.7966101694915254,0.9864222243678659,1.0,4/13,16.35%,PTPRT;PIGU;TSLP;CRLF2
prerank,tRNA 5'-end processing (GO:0099116),-0.27321971835542846,-0.7228882036095806,0.849721706864564,0.9547413684839212,1.0,5/15,25.51%,RPP38;TRMT10C;HSD17B10;RPP21;RPP25L
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.26884154039246605,0.7202717519060388,0.8319148936170213,0.9895611648833571,1.0,2/18,3.41%,GDNF;POR
prerank,regulation of leukocyte activation (GO:0002694),-0.27657881122199235,-0.7202264826657133,0.8282097649186256,0.9572288626779797,1.0,8/14,36.97%,MFHAS1;GPR137B;CD74;CD200;SHPK;PJA2;CD33;GPER1
prerank,nuclear membrane organization (GO:0071763),0.2637039544529746,0.7201035363349043,0.8304347826086956,0.988971469899916,1.0,5/19,16.29%,AKAP8L;UBXN2B;UBXN2A;SPAST;EMD
prerank,protein autoprocessing (GO:0016540),-0.2668701538555444,-0.719945276740247,0.8423005565862709,0.9570667551171332,1.0,7/17,33.91%,FAM111A;SPRTN;FXN;CASP1;MYRF;PIDD1;HTRA2
prerank,RNA 3'-end processing (GO:0031123),-0.19253320690009568,-0.7198122576793979,0.9501915708812261,0.9567623818179666,1.0,20/69,26.92%,RPRD1B;SRSF2;SRSF5;SRSF6;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;THOC6;CPSF4;DDX39A;NCBP2;CSTF2T;THOC7;RPRD1A
prerank,protein import (GO:0017038),-0.18862242486426017,-0.7196797628935551,0.960820895522388,0.9564348461013138,1.0,23/84,26.55%,RAB8B;NUP93;AKT1;PTTG1IP;E2F3;APOE;SYK;NUP188;TOMM22;HSPA4;PHB2;NUP155;TNPO3;RPAIN;HSP90AA1;TSC2;FIS1;NXT2;TNPO2;FAM53A;SEC13;NUP107;IPO13
prerank,carboxylic acid catabolic process (GO:0046395),-0.295075615126121,-0.7191918783065023,0.8710865561694291,0.9565099447439535,1.0,6/12,29.27%,PON3;ACOT8;AMDHD2;RENBP;BCKDK;GNPDA1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.23813835982675655,-0.7189464811498473,0.8923076923076924,0.9563212440010632,1.0,11/27,27.05%,AKT1;DISC1;ULK4;HOMER1;NDEL1;MBOAT1;BRSK2;EFHC2;CCDC88A;TREM2;CAMK2G
prerank,central nervous system neuron development (GO:0021954),-0.27943827032651336,-0.7184334660484085,0.8485981308411215,0.9564306370797969,1.0,2/15,4.08%,HSP90AB1;LHX6
prerank,recombinational repair (GO:0000725),-0.19037769079939526,-0.7180590694481552,0.9427480916030534,0.9563570165246758,1.0,29/77,30.52%,ZFYVE26;YY1;SFPQ;PSMD14;SLX4;REV3L;SAMHD1;XRCC1;HUS1;MMS22L;RPA3;BRCA2;AP5Z1;HELQ;POLQ;ERCC4;SFR1;RHNO1;FAN1;POLL;NSMCE1;RAD51AP1;MRE11;SWI5;EXD2;MEIOB;RMI1;RAD52;RECQL
prerank,regulation of nervous system process (GO:0031644),-0.25672938378719223,-0.7179278875786546,0.8382899628252788,0.9560582026015098,1.0,2/18,4.11%,NOS3;APP
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2978642628896249,-0.7178669006140845,0.8423005565862709,0.9556770067755824,1.0,1/11,1.59%,PLCG2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.21568014003803448,-0.7171446149146441,0.9106796116504854,0.9560175269369463,1.0,7/41,13.50%,KCNJ2;KCNQ1;KCNJ10;ACE2;AKAP6;KCNJ15;GNB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.3006060690737302,0.716876309324952,0.7978021978021979,0.9921503987090715,1.0,2/11,11.53%,IL4I1;AHR
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27002141508790767,0.7159465765615602,0.8478747203579419,0.992489424205105,1.0,2/18,2.69%,PPARA;IL4I1
prerank,nuclear envelope organization (GO:0006998),-0.255238570111079,-0.7155560184108138,0.8766114180478821,0.9572238060438691,1.0,5/20,17.34%,NUP93;TOR1AIP1;TMEM43;NUP155;REEP4
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2568883335031068,-0.7155388962474275,0.866913123844732,0.956788291656432,1.0,7/19,32.17%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2170733139489609,0.7143920723962651,0.9004237288135594,0.9936322717953745,1.0,5/41,8.94%,SLC8A1;ITPR1;CACNA2D1;IBTK;SLC24A2
prerank,dendritic cell chemotaxis (GO:0002407),0.2788138305095864,0.7131656934155992,0.8247863247863247,0.9943299343221148,1.0,2/14,13.93%,CCR6;CXCR4
prerank,cytoplasmic microtubule organization (GO:0031122),-0.20219194476620989,-0.71316543525717,0.9291497975708503,0.9589256304037267,1.0,9/54,11.72%,RAB11A;LIMK2;CHP1;EZR;SLAIN2;DCTN1;TRPV4;CIB1;PCM1
prerank,kinetochore organization (GO:0051383),-0.2854417281417226,-0.712870825681729,0.8443223443223443,0.9587702284289875,1.0,6/13,34.34%,POGZ;NDC80;CENPF;CENPA;NUF2;CENPW
prerank,negative regulation of translational initiation (GO:0045947),-0.2842753281833684,-0.7127012509911177,0.8258527827648114,0.9584864466966413,1.0,4/13,26.81%,FMR1;PAIP2B;EIF4EBP1;PAIP2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.28097387316271893,0.7124457302046393,0.8165548098434005,0.9944082957267079,1.0,2/13,10.21%,NFAT5;FUT9
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.1917356375910866,0.7124320263988243,0.9340425531914893,0.9936503496048361,1.0,5/87,4.24%,FLRT2;FGFR2;KL;FLRT1;SFRP1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.264776734454865,0.7124234828838414,0.827433628318584,0.9921237360318829,1.0,5/17,16.35%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,cellular response to interleukin-7 (GO:0098761),0.264776734454865,0.7124234828838414,0.827433628318584,0.9921237360318829,1.0,5/17,16.35%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,regulation of immune effector process (GO:0002697),-0.21377572857256535,-0.7121963549120903,0.9105058365758755,0.9585373797508318,1.0,7/41,16.97%,CD55;CD81;C1QB;C1QC;PHB2;CFP;C1QA
prerank,oligodendrocyte differentiation (GO:0048709),-0.2542880541301541,-0.7118659310685936,0.8576998050682261,0.9584669025230912,1.0,7/19,25.38%,SOX13;EIF2B3;SOX6;SOX9;MYRF;SOX8;NSUN5
prerank,lipid homeostasis (GO:0055088),0.20477639124710323,0.7117890815610561,0.9083503054989817,0.9920658123043546,1.0,11/57,20.42%,ZBTB20;ABCA1;IRS2;ABCB4;TLCD2;DGAT2;ABHD5;MLXIPL;PPARG;POLD1;NR1D2
prerank,histone H3-K4 trimethylation (GO:0080182),0.29625872765268,0.7113326782537926,0.7925407925407926,0.9918283332887624,1.0,3/11,15.53%,PRDM9;KMT2A;WDR82
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.2735815135729648,-0.71078539622325,0.8276481149012568,0.9591476055627792,1.0,7/15,29.27%,AMDHD2;OGA;RENBP;LARGE1;CHST5;CHST3;GNPDA1
prerank,fatty acid biosynthetic process (GO:0006633),-0.19469508819103462,-0.7105725700555888,0.93713163064833,0.9589064024352433,1.0,10/63,17.96%,ABHD2;ELOVL7;LTA4H;ACLY;ASAH2;ELOVL5;TECRL;GPX4;XBP1;ELOVL1
prerank,embryonic axis specification (GO:0000578),0.27137112208566977,0.7097868442281972,0.8300653594771242,0.9928677805393298,1.0,2/15,7.51%,TBX3;CXXC4
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20624250902522573,-0.7096103448509021,0.9259927797833934,0.9594785894264946,1.0,8/49,11.49%,JAM3;PRKCZ;SMAD6;AIDA;SVIP;RPL13A;HSPA5;IMPACT
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.2906191945924445,0.7094052962649621,0.8373101952277657,0.9925281065851539,1.0,3/12,11.12%,ROCK2;TMED10;CHRNA7
prerank,regulation of gluconeogenesis (GO:0006111),-0.23175019166465582,-0.7092654676231223,0.8871595330739299,0.9594023927716986,1.0,12/27,43.02%,PPARGC1A;USP7;NNMT;ARPP19;SIK1;PTPN2;GNMT;SIRT7;DDB1;CLK2;C1QTNF3;ERFE
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.24596175619894237,-0.7086977779239906,0.8771929824561403,0.9594965302134152,1.0,8/23,26.03%,ZW10;PLK2;PABIR1;CHEK1;CDK5RAP3;PLK3;VPS4A;PLK5
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2464830105849133,-0.7081018919955231,0.8797127468581688,0.9596429838636599,1.0,9/22,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,autophagy of mitochondrion (GO:0000422),0.22054006913535962,0.7080326023628559,0.8997912317327766,0.9933816705894579,1.0,9/38,16.54%,WDR45B;PRKN;ATG12;WIPI1;FBXO7;ULK2;FUNDC1;FUNDC2;ATG9A
prerank,negative regulation of ATPase activity (GO:0032780),0.26950814798272227,0.7072964312626231,0.8122171945701357,0.9934814781404637,1.0,6/16,23.59%,TNNI3;TP53;PAM16;VCPKMT;PXK;SIRT1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.25641385463074706,-0.7069196300403096,0.8639705882352942,0.9603897838113421,1.0,10/18,39.61%,BCL2L1;BAK1;BAD;SLC25A4;ALKBH7;MUL1;PMAIP1;HEBP2;SLC25A31;PPIF
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2553000374830982,0.7068601127092864,0.853448275862069,0.9932476858443022,1.0,3/20,7.96%,EPAS1;PRKN;TGFBR1
prerank,regulation of autophagosome assembly (GO:2000785),0.22579221818767897,0.7066238041553843,0.8853503184713376,0.9927666117380773,1.0,3/33,4.38%,PIP4K2A;PHF23;SCFD1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.1967435113380989,0.7063168637468045,0.925343811394892,0.9923666178471008,1.0,12/68,14.53%,POLR1A;GTF2H2;MNAT1;FIP1L1;POLR1G;SYMPK;POLR1B;PABPN1;CCNH;SCAF8;TTF1;CPSF7
prerank,regulation of regulated secretory pathway (GO:1903305),0.22247636299516485,0.706223668465369,0.9018789144050104,0.9917122699701391,1.0,9/34,20.29%,RIMS1;SYT1;SYT13;SNAPIN;SYT11;SYT12;SYT6;RIMS2;UNC13D
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.1896145883072361,-0.7059012785375782,0.9619771863117871,0.96099122608854,1.0,24/69,33.25%,RPRD1B;GTF2E1;ZC3H8;INTS8;POU2F1;INTS1;POU2F2;CCNK;GTF2F1;SP1;TAF9;NCBP2;ELL;RPRD1A;GTF2F2;INTS12;TAF5;INTS2;POLR2F;INTS3;POLR2L;POLR2I;POLR2C;INTS14
prerank,stress granule assembly (GO:0034063),-0.2482833527069329,-0.7057032764815785,0.887378640776699,0.9607521077328673,1.0,6/20,20.99%,RPS23;ATXN2L;YTHDF2;CIRBP;LSM14A;YTHDF1
prerank,regulation of DNA recombination (GO:0000018),0.2313012699061845,0.7056903217046191,0.8805031446540881,0.9915537104130081,1.0,6/32,14.73%,SHLD2;IL4;BLM;RPA2;THOC1;SIRT6
prerank,chromatin assembly or disassembly (GO:0006333),-0.2942984707196599,-0.7055695566703781,0.8382899628252788,0.9604538984175902,1.0,3/11,16.42%,MTA2;CDAN1;RBBP4
prerank,positive regulation of vacuole organization (GO:0044090),0.29687482482305516,0.7037993590566874,0.7922374429223744,0.9929209332353618,1.0,4/10,18.84%,PIP4K2A;PIP4K2B;LRSAM1;RAB3GAP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2728607549041672,-0.7026198704811888,0.8633879781420765,0.9629468407819171,1.0,6/14,28.14%,TRPT1;TSEN54;CPSF4;RTCB;RTRAF;TSEN2
prerank,GPI anchor metabolic process (GO:0006505),0.23424153589724184,0.702331088482771,0.8842975206611571,0.9937894722473823,1.0,9/26,22.22%,PIGU;PIGH;PIGP;PGAP3;DPM1;PIGN;MPPE1;PGAP1;PIGB
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.24029834841021117,-0.7007885728274844,0.8761726078799249,0.9643545826452149,1.0,10/22,37.76%,FKBP1A;IKBKB;BOD1;MGAT5;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA;ROCK1
prerank,regulation of mast cell degranulation (GO:0043304),-0.27073711660794736,-0.700600441111549,0.8464285714285714,0.9640857917346181,1.0,6/14,24.01%,SPHK2;SYK;GAB2;CD84;LGALS9;STXBP2
prerank,regulation of cell projection organization (GO:0031344),-0.277673473907261,-0.7001213411781512,0.8560885608856088,0.9640766783945024,1.0,10/13,57.33%,MFSD2A;TREM2;ERMN;NTNG1;MOV10;SEMA4D;NTNG2;FAM110C;MACF1;CCL19
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.253658676604269,0.7000461582611623,0.8659574468085106,0.9955549825645578,1.0,6/20,18.26%,PID1;LZTFL1;SAPCD2;RHOQ;DAB2;MRAP2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.25134071457030754,-0.6996257819324887,0.8487084870848709,0.9641213708404899,1.0,3/20,8.25%,PAICS;ADSS2;IMPDH1
prerank,primary miRNA processing (GO:0031053),0.29478789301892633,0.6991968340254086,0.812933025404157,0.9956863502378044,1.0,5/10,22.80%,SMAD3;METTL3;DROSHA;MRPL44;PUS10
prerank,microtubule bundle formation (GO:0001578),-0.20744862244623308,-0.6988330075069027,0.9140767824497258,0.9644407957755162,1.0,13/42,32.27%,NAV1;RP1;CHP1;SPEF1;GAS8;GAS2L1;SPAG16;CLIP1;NCKAP5L;CAPN6;PLK1;PSRC1;CFAP206
prerank,histone H3-K9 demethylation (GO:0033169),-0.29243432620069376,-0.6986290781010405,0.8342541436464088,0.9641993429230958,1.0,2/11,6.71%,JMJD1C;KDM3A
prerank,RNA catabolic process (GO:0006401),-0.20365690771857403,-0.6985563168405207,0.9254032258064516,0.9638082341691447,1.0,18/46,33.10%,MTREX;PPP1R8;DIS3L2;YTHDF2;RNH1;HSPA1A;LSM2;ZPR1;RNASEH2C;HSPA1B;DNA2;ERN1;XRN2;LSM6;ISG20;SIDT2;ZC3H12D;DCP2
prerank,NAD biosynthetic process (GO:0009435),0.24592643812933662,0.698363126594782,0.8663697104677061,0.9958558747673022,1.0,3/20,10.07%,PARP16;PTGIS;KYNU
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23186349681608995,0.6979594737874455,0.8989473684210526,0.9955383711950159,1.0,8/29,16.40%,SHISA9;GRIK2;CAMK2B;SYP;ZDHHC2;DLG4;DRD2;CLN3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.29179596604265495,-0.6975119489425176,0.8512110726643599,0.9643469736200762,1.0,3/11,20.27%,CBFB;VSIR;LGALS9
prerank,synaptic vesicle membrane organization (GO:0048499),-0.26119570654502267,-0.6971939489853487,0.8705035971223022,0.9642046593269851,1.0,3/17,11.05%,STX3;STX1A;STX2
prerank,histone mRNA metabolic process (GO:0008334),-0.23049893617000256,-0.6964315411366747,0.8773234200743495,0.9644658950551837,1.0,8/27,24.84%,ERI1;SNRPD3;LSM11;SNRPG;LSM1;NCBP2;LSM10;SNRPB
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.2672701730204637,-0.695549185814447,0.8612099644128114,0.9648523581884684,1.0,3/14,16.01%,ACOX3;CROT;ACOT8
prerank,nuclear pore organization (GO:0006999),0.27361340894574426,0.6953935545912162,0.7966903073286052,0.9976067447562038,1.0,5/14,17.18%,RTN4;NUP205;NUP35;AHCTF1;TMEM170A
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2381760383103472,0.6953311361139668,0.8875,0.9969197243323631,1.0,5/23,17.91%,MTMR7;PTEN;MTMR10;OCRL;MTMR9
prerank,peroxisome organization (GO:0007031),-0.23319410088642306,-0.6949093885320905,0.8984674329501916,0.9650294365339797,1.0,11/25,33.99%,PLAAT3;ACOT8;FIS1;PEX11G;PEX11A;SEC16B;PEX14;MFF;PEX6;ABCD3;PEX7
prerank,negative regulation of phagocytosis (GO:0050765),0.26331149416148886,0.6940704541446537,0.8633405639913232,0.997519913148087,1.0,4/17,15.94%,PRTN3;CD300LF;CD47;SYT11
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.22237311910497443,-0.6940212428692755,0.9185606060606061,0.9654227735476837,1.0,3/32,4.11%,RPL10;FOXO3;APP
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2749355185276181,0.6939745650338468,0.8394004282655246,0.9968582051878961,1.0,5/13,23.00%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,positive regulation of double-strand break repair (GO:2000781),0.21563654092257933,0.6939435891308019,0.9189765458422174,0.9961345024114503,1.0,9/39,17.74%,SHLD2;SETMAR;KMT5C;FMN2;SMCHD1;RIF1;KMT5B;PARP3;PARP1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.2945707091021536,-0.6936291278087132,0.8460207612456747,0.965305990505217,1.0,2/10,17.36%,TLR4;VSIR
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.234434602762031,-0.6930285883314625,0.9131238447319778,0.9654381861398017,1.0,7/24,20.92%,PDE4D;PDE2A;PRKAR2B;PRKAR2A;CGAS;UBE2B;RAPGEF2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.2879098984338044,0.6928284811648013,0.8271334792122538,0.9964986395182335,1.0,3/11,18.41%,AXL;MERTK;CXCL12
prerank,protein kinase A signaling (GO:0010737),-0.2848610950204792,-0.6918500526645004,0.8670309653916212,0.9660677640673131,1.0,2/12,6.47%,MYOM1;EZR
prerank,mitochondrial transport (GO:0006839),0.2004950045816413,0.691803174642667,0.9399585921325052,0.9968749318357326,1.0,10/53,15.83%,AIP;BCL2;SLC25A13;MTX2;TOMM70;FBXO7;COX18;TIMM22;SLC25A24;MAIP1
prerank,histone H3 deacetylation (GO:0070932),-0.26006481357204814,-0.6917021000881987,0.874113475177305,0.9657615585763248,1.0,3/15,11.34%,HDAC9;HDAC4;SFPQ
prerank,central nervous system myelination (GO:0022010),0.2932260208679396,0.6911106513920736,0.8371040723981901,0.9968201723591025,1.0,4/11,19.34%,HES5;PTEN;TENM4;B4GALT6
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.28910621284428284,-0.6910020786713291,0.8438061041292639,0.9659451979180883,1.0,5/10,33.67%,EMC10;EMC6;EMC9;EMC1;EMC4
prerank,peptidyl-asparagine modification (GO:0018196),-0.22336079229140954,-0.6909265844678848,0.8996138996138996,0.9655688209103754,1.0,14/31,35.82%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2;MGAT5;HIF1AN;RPN2;STT3B;OSTC;NUDT14;RPN1;UGGT1
prerank,regulation of hippo signaling (GO:0035330),-0.2551642257314612,-0.6907531554951769,0.8574074074074074,0.9652787618681533,1.0,7/17,30.86%,MOB3B;WTIP;LIMD1;CIT;WWC2;MARK3;NF2
prerank,sensory perception of taste (GO:0050909),0.28922922420286207,0.6900042732274054,0.8380952380952381,0.9972387926655282,1.0,10/10,71.10%,ASIC2;TAS1R1;PKD1L3;PKD2L1;TAS1R3;GNAT3;ASIC1;TAS1R2;ASIC3;CD36
prerank,cellular lipid catabolic process (GO:0044242),-0.2296801445396367,-0.6899550967066838,0.8989169675090253,0.9655675092087947,1.0,9/27,29.73%,PPARD;CYP1B1;ACADL;FAAH;ACOT8;ENPP2;ACOX1;LPIN2;MGST2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.1879048208116341,-0.6881561456582649,0.9653179190751445,0.9667233859551762,1.0,18/62,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,regulation of protein acetylation (GO:1901983),-0.28029222960455974,-0.6879019774482992,0.8482142857142857,0.9665019780179812,1.0,4/12,29.01%,CAMK1;RAPGEF3;PARK7;TERF2IP
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24299184285880052,0.6876612300571426,0.8630434782608696,0.9989551398508761,1.0,4/20,11.12%,CHRM2;CHRM3;CDK5R1;CHRNA7
prerank,regulation of synapse maturation (GO:0090128),-0.2907677397935277,-0.6873842564601873,0.8375912408759124,0.9664934268307529,1.0,3/10,12.13%,ARHGEF15;DAB2IP;YWHAZ
prerank,mRNA stabilization (GO:0048255),0.2122819008871434,0.6870368428648267,0.9171974522292994,0.9988191108390744,1.0,3/40,5.19%,GDNF;TENT5A;AXIN2
prerank,neuron maturation (GO:0042551),-0.2435781759945571,-0.6868448343749751,0.8973384030418251,0.9665269677130581,1.0,3/18,8.12%,SCARF1;APP;ANKS1A
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2199555532362812,-0.6864832265102175,0.9089184060721063,0.9663964790164737,1.0,12/30,31.29%,ELOVL7;ELOVL5;TECRL;ELOVL1;ACOT2;HACD4;SLC27A2;ACOX1;HACD2;SLC27A6;ACOT1;ABCD3
prerank,regulation of calcium ion import (GO:0090279),0.23766663414455846,0.685604120029046,0.8400852878464818,0.9995163239185169,1.0,5/21,18.41%,PDGFRB;TRIM27;PLPP4;WNK3;CXCL12
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.2459622322470823,-0.6855667737082723,0.8763440860215054,0.9667775697996742,1.0,7/18,27.29%,CABYR;AQP4;ROPN1L;ADCY10;SPAG17;NEK10;SPA17
prerank,ether lipid metabolic process (GO:0046485),0.268748583154398,0.6850023015667152,0.8352402745995423,0.9993686908673364,1.0,1/14,1.30%,AGMO
prerank,DNA biosynthetic process (GO:0071897),-0.2583605819550069,-0.6839709893992192,0.88268156424581,0.9677269786515443,1.0,9/16,42.42%,PPIA;TYMS;RFC3;POLL;TERT;POLE;POLA1;POLH;WRN
prerank,protein methylation (GO:0006479),-0.20839047887930856,-0.6837630829227452,0.9349112426035503,0.9674807309207076,1.0,13/40,30.37%,PRMT8;SNRPD3;FAM98A;EEF2KMT;ICMT;PRMT3;LCMT1;NTMT1;SNRPB;ATPSCKMT;EEF1AKMT3;RAB6A;EEF1AKMT2
prerank,long-term memory (GO:0007616),0.2453806317970282,0.6831961830222456,0.8876889848812095,1.0,1.0,3/19,12.41%,CAMK4;CPEB3;RASGRF1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2217500814058493,-0.6831211504553097,0.9137931034482759,0.9675711341152989,1.0,6/30,14.58%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2
prerank,positive regulation of translational initiation (GO:0045948),0.2507207217144287,0.6824785867271258,0.8552631578947368,1.0,1.0,6/18,18.32%,KHDRBS1;POLR2G;EIF2B5;HABP4;CDC123;POLR2D
prerank,integrated stress response signaling (GO:0140467),-0.2680486845169814,-0.6824593773343199,0.8706739526411658,0.9677262628559153,1.0,3/14,11.49%,ATF4;HSPA5;IMPACT
prerank,covalent chromatin modification (GO:0016569),0.27122835131971446,0.6822243290382761,0.858139534883721,0.9998510534520995,1.0,4/14,17.00%,MBD2;AURKC;SETD5;HDAC1
prerank,intracellular lipid transport (GO:0032365),0.2433209101478951,0.682025532021791,0.858139534883721,0.999307583053112,1.0,3/21,6.82%,PRKAG2;ABCD2;CPT2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.27900802934871544,0.6817533951438153,0.8505747126436781,0.9988348773771137,1.0,4/11,26.29%,PARN;EXOSC3;EXOSC2;TENT4B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24198098759568393,-0.6806048776667714,0.8978102189781022,0.9689060370105591,1.0,4/21,12.21%,RAB11A;BRD4;CDK4;RCC2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.2771825921066482,-0.6802696741306888,0.8656195462478184,0.9678628205937896,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.2771825921066482,-0.6802696741306888,0.8656195462478184,0.9678628205937896,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.2771825921066482,-0.6802696741306888,0.8656195462478184,0.9678628205937896,1.0,4/12,16.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,cellular defense response (GO:0006968),-0.20467447931155355,-0.6798515105145356,0.9390962671905697,0.9677884969950431,1.0,3/40,5.78%,LBP;PTK2B;NCF2
prerank,long-term synaptic potentiation (GO:0060291),-0.2424548306455976,-0.6794581160155014,0.8994413407821229,0.9676761002964837,1.0,3/21,8.12%,PTK2B;PRKCZ;PLK2
prerank,protein import into peroxisome matrix (GO:0016558),0.2795982423101069,0.6787441158401255,0.8549107142857143,1.0,1.0,12/12,72.06%,PEX5L;PEX10;PEX2;PEX16;PEX5;PEX12;PEX1;PEX26;PEX13;PEX7;PEX6;PEX14
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.256268459703508,-0.6781842069767675,0.8658318425760286,0.9682897577200625,1.0,3/16,8.25%,PAICS;ADSS2;IMPDH1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2311624494757022,-0.6778698094587858,0.9310344827586207,0.9681015490465052,1.0,9/24,27.36%,FXN;GLRX5;ISCA2;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,nuclear body organization (GO:0030575),-0.2764140479197592,-0.677755891582414,0.8770053475935828,0.9677505780989685,1.0,4/12,19.88%,ETS1;USPL1;ZPR1;SERBP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.280519605244824,-0.6775701099252636,0.875,0.9674665566492864,1.0,5/11,33.91%,FAS;LGALS9;PLAUR;PARK7;HTRA2
prerank,axoneme assembly (GO:0035082),0.2194681795499499,0.6774948937309565,0.9125,1.0,1.0,3/30,6.91%,CFAP74;DNAAF3;CCDC65
prerank,regulation of lipid catabolic process (GO:0050994),0.2518997676317275,0.677389445510713,0.8923766816143498,1.0,1.0,19/19,74.84%,PDE3B;ALK;RARRES2;ANGPTL3;APOC3;SCT;LONP2;APOA2;IL1B;PRKAA1;HCAR2;ABCB11;TNF;ABCD1;CIDEA;ADRA2A;TYSND1;BSCL2;APOC1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2765385504101425,-0.6765145105305213,0.8918439716312057,0.9679407029742362,1.0,2/11,16.42%,H3-3A;RBBP4
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.25084812692775027,-0.6762891220085087,0.8852459016393442,0.9676779873295676,1.0,4/16,17.68%,PIGL;PIGF;PIGC;PIGW
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2299305436144096,0.6749939372004748,0.8643006263048016,1.0,1.0,6/23,19.07%,ALOX12;GSTP1;HPGD;FADS1;ELOVL6;PTGS2
prerank,histone lysine demethylation (GO:0070076),0.22421371326962913,0.6747748320303946,0.9125799573560768,1.0,1.0,7/25,18.71%,KDM1B;KDM7A;KDM2A;PHF8;HR;KDM4C;KDM5B
prerank,regulation of T cell mediated immunity (GO:0002709),-0.29275010071569396,-0.6742283429735828,0.8584558823529411,0.9688438551052778,1.0,1/10,7.20%,TNFRSF1B
prerank,B cell activation involved in immune response (GO:0002312),0.26718563626090774,0.6734727806752906,0.8475991649269311,1.0,1.0,13/13,73.30%,CD180;EXOSC3;RNF168;GPR183;CD40LG;GAPT;CD19;MSH2;BATF;MSH6;FCGR2B;RNF8;LIG4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2706686431804758,-0.6732065209589408,0.8908045977011494,0.9692475684800089,1.0,3/13,28.45%,NELFE;EAPP;RNF8
prerank,negative regulation of centrosome duplication (GO:0010826),-0.27524434993595626,-0.6730193833754817,0.8518518518518519,0.9689566534155539,1.0,7/11,38.30%,CCNF;TMEM67;RBM14;NPM1;KAT2A;CDK5RAP2;BRCA1
prerank,lymphocyte chemotaxis (GO:0048247),0.21289037826071075,0.6723036358870977,0.9110169491525424,1.0,1.0,3/34,9.84%,CYP7B1;CXCL16;CCL25
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.28532011146792813,0.6721523610373978,0.8588957055214724,1.0,1.0,6/11,28.42%,ZC3H3;PAPOLA;PAF1;ZFP36L1;LEO1;AHCYL1
prerank,regulation of embryonic development (GO:0045995),0.21684942394916257,0.6707638636122614,0.913135593220339,1.0,1.0,5/34,10.70%,PHLDB2;TRIP12;FOXA2;NPHP3;RPS6KA6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.2904700762688556,-0.6707637570187837,0.874113475177305,0.9703597164799488,1.0,4/10,29.31%,GRB10;ITGB3;PRKD2;ITGA5
prerank,modulation by host of viral genome replication (GO:0044827),0.26797531015688825,0.6700570745928787,0.8896103896103896,1.0,1.0,4/13,18.25%,PRKN;YTHDC2;TBC1D20;IFI27
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2690051301236757,0.6694844677619602,0.8565400843881856,1.0,1.0,4/12,16.03%,GOLGA2;PTEN;BTRC;SKP1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23853374814332284,0.6689498893539327,0.8769574944071589,1.0,1.0,6/22,16.08%,VPS25;VPS37D;UBAP1;TOM1L1;VPS37A;NEDD4
prerank,dendritic cell migration (GO:0036336),-0.24819087001886814,-0.6688253707337275,0.8863636363636364,0.971475290680256,1.0,1/16,1.78%,EPS8
prerank,epithelial cell morphogenesis (GO:0003382),0.2503854118442309,0.6686515769208452,0.861995753715499,1.0,1.0,2/17,9.02%,COL22A1;CNMD
prerank,negative regulation of TOR signaling (GO:0032007),0.2162325914280717,0.6683597414178265,0.945031712473573,1.0,1.0,3/36,4.65%,DEPTOR;FNIP1;MAPKAPK5
prerank,magnesium ion transport (GO:0015693),0.26762205489146607,0.6676068542530813,0.8752642706131079,1.0,1.0,4/12,20.75%,MAGT1;SLC41A1;TUSC3;NIPAL1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.20280478238308233,0.6675957865825535,0.9217758985200846,1.0,1.0,14/42,26.08%,SHLD2;UBQLN4;RADX;RPA2;SMCHD1;RIF1;SIRT6;PARP1;RTEL1;FBH1;WAS;TIMELESS;ARID2;PPP4C
prerank,regulation of microglial cell activation (GO:1903978),0.2561513741768836,0.6674988321191917,0.8611111111111112,0.9993369873491136,1.0,14/15,63.93%,STAP1;SYT11;TTBK1;SPHK1;MMP8;PTPRC;NR1D1;CCL3;CX3CL1;IL6;TAFA3;CST7;GRN;LDLR
prerank,glial cell differentiation (GO:0010001),-0.22144507549328257,-0.6667326603198537,0.9156862745098039,0.9727004696194882,1.0,7/28,24.59%,ADGRG6;SOX4;SOX9;FGF10;METRN;MYRF;SOX8
prerank,protein export from nucleus (GO:0006611),-0.21980046404871617,-0.6664638264977667,0.9141323792486583,0.9724690571171325,1.0,5/27,13.59%,TGFB1;PKD1;CHP1;STYX;SMURF1
prerank,histone H2B ubiquitination (GO:0033523),-0.28871431626416577,-0.6660946566220629,0.8706563706563707,0.9722952282587212,1.0,5/10,35.80%,RNF20;DTX3L;RNF40;RNF8;CDC73
prerank,chromatin assembly (GO:0031497),-0.20530129140921669,-0.665487745603746,0.9375,0.9723304187056362,1.0,13/38,30.02%,H3-3A;CDAN1;NAA60;LIN54;RBBP4;SOX9;POLE3;EZH1;NPM1;KAT6B;HMGB2;ANP32B;SMARCA5
prerank,regulation of microtubule nucleation (GO:0010968),-0.2822300223146648,-0.6647754787115474,0.8875219683655536,0.9724207912846936,1.0,3/10,21.43%,DCTN1;HSPA1A;HSPA1B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.24568337203863028,0.6647252572293588,0.9055441478439425,1.0,1.0,2/19,8.92%,STN1;PINX1
prerank,mitochondrial genome maintenance (GO:0000002),0.2824599004922338,0.6647082750412086,0.8673913043478261,1.0,1.0,4/11,17.74%,AKT3;TOP3A;SLC25A36;PARP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.21018026412947294,0.6636929809715475,0.9257731958762887,1.0,1.0,2/37,2.58%,PHLDB2;EPHA3
prerank,interstrand cross-link repair (GO:0036297),-0.19056120370765117,-0.662691350018735,0.9495145631067962,0.9735885826062272,1.0,27/53,39.24%,UBB;USP1;UBC;RPS27A;ERCC1;VCP;SLX4;DCLRE1C;RPA3;WDR48;ERCC4;FAN1;FANCD2;RAD51AP1;ATRIP;RNF8;FAAP24;UBE2T;NEIL3;CENPX;FANCF;MSH6;RAD51;UBA52;EME1;FANCB;XPA
prerank,7-methylguanosine mRNA capping (GO:0006370),0.21824119451930207,0.6620821715526349,0.9224489795918367,1.0,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,7-methylguanosine RNA capping (GO:0009452),0.21824119451930207,0.6620821715526349,0.9224489795918367,1.0,1.0,12/31,26.43%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2D;POLR2K;RNMT;POLR2B;ERCC2;RNGTT;RAMAC;ERCC3
prerank,regulation of keratinocyte migration (GO:0051547),-0.2715076915606292,-0.6619061636014663,0.8870967741935484,0.9737292550379621,1.0,4/12,28.39%,MAPRE2;IQSEC1;FGF10;EPB41L4B
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.20925055777911858,0.6618855772845612,0.934322033898305,0.9997116586068028,1.0,6/36,13.15%,VAMP5;RAB10;BBS2;AFDN;OPTN;SYS1
prerank,dorsal/ventral pattern formation (GO:0009953),0.24582871652434674,0.6617699629518182,0.8896396396396397,0.9990706415956108,1.0,3/20,9.35%,GLI2;SFRP1;BMPR1A
prerank,monosaccharide transmembrane transport (GO:0015749),0.2526221730498181,0.6614392824108402,0.8680851063829788,0.9986359150749451,1.0,1/16,2.70%,SLC5A3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22396766241181537,-0.6610740326159003,0.9379562043795621,0.9739034064847863,1.0,9/25,28.77%,TNFSF10;BAX;BBC3;BAD;BIK;PLAUR;HRK;MFF;PMAIP1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.26138087645274916,-0.659148262896294,0.8785046728971962,0.9748668281155083,1.0,4/14,32.33%,TPP1;BRCA2;TERF2IP;TERT
prerank,coenzyme A metabolic process (GO:0015936),-0.2589817229393902,-0.6585317307103459,0.9149797570850202,0.9749033653060887,1.0,4/14,29.04%,ACLY;CROT;SLC25A16;PANK2
prerank,spliceosomal complex assembly (GO:0000245),0.196925363231821,0.6580386134958227,0.9532520325203252,1.0,1.0,4/46,10.06%,CELF2;CELF4;RBM5;GCFC2
prerank,ncRNA transcription (GO:0098781),-0.259040495463691,-0.6577821752517291,0.8984509466437177,0.9750096149445386,1.0,4/13,20.05%,CAVIN1;SPIN1;USPL1;GTF3C1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.21821352695597787,0.6577412000458823,0.9315352697095436,1.0,1.0,8/31,18.33%,SHLD2;KMT5C;PAXIP1;TNFRSF4;RIF1;KMT5B;VAMP3;RBP4
prerank,cell differentiation in hindbrain (GO:0021533),0.2763788433290754,0.6575976101384804,0.8778280542986425,0.9997331500519331,1.0,1/11,1.54%,GRID2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.28608911527073067,-0.6574016083899549,0.8830409356725146,0.9748374354064214,1.0,5/10,24.31%,IMPACT;HSPA1A;NCK1;DNAJB1;HIF1AN
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.19068625363885222,-0.656614914258087,0.9643527204502814,0.9749493810809803,1.0,16/48,31.95%,ACTB;SERTAD2;ARID1A;WBP2;SPHK2;ZMIZ2;CDCA4;CHEK1;POLR1F;TAF1B;POLR1C;POLR2F;SMARCA5;POLR1H;POLR2L;KAT2A
prerank,phagosome acidification (GO:0090383),0.2250540324506719,0.6565741536145974,0.9082969432314411,0.9998653287032432,1.0,5/26,15.45%,ATP6V0A4;ATP6V1H;RAB38;ATP6V1B2;RAB20
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2583715379290346,-0.6565333402282653,0.8921933085501859,0.9745747205759833,1.0,10/14,52.61%,PAEP;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.2802806225889085,0.6564002544036129,0.8695652173913043,0.9992868045952868,1.0,1/10,1.51%,LRP1
prerank,protein N-linked glycosylation (GO:0006487),-0.17991579400878893,-0.6541620791536208,0.9815950920245399,0.9758309362101253,1.0,20/66,27.54%,TMEM165;ST6GAL1;SLC39A8;MGAT1;FUT8;KRTCAP2;DAD1;GFPT1;OST4;MCFD2;TMEM258;ALG9;ALG12;MGAT5;ALG1;PGM3;RPN2;ALG2;ALG3;STT3B
prerank,protein heterotetramerization (GO:0051290),-0.25942401294838,-0.65388181081268,0.9119266055045872,0.9755927720310759,1.0,5/13,31.76%,PKD1;FARSB;PKD2;GRIN1;KRT10
prerank,dopaminergic neuron differentiation (GO:0071542),0.24203449994980686,0.6531823873121845,0.8706896551724138,1.0,1.0,3/19,8.57%,PHOX2A;FOXA2;RYK
prerank,phagosome maturation (GO:0090382),-0.2036739971730101,-0.6529472786618087,0.9464627151051626,0.9757836585607016,1.0,12/35,31.21%,ATP6V0B;ATP6V0A2;MREG;ATP6V0C;RAB7A;ATP6V1G1;RAB32;RAB43;ATP6V0D1;CORO1A;ATP6V0E2;ATP6V1C1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.22760696814891304,-0.6521558354552288,0.9281663516068053,0.9759058932444624,1.0,4/22,17.36%,CBFB;BCL6;SOX12;VSIR
prerank,phosphate ion transmembrane transport (GO:0035435),0.2716219547448058,0.6518227301755302,0.8660714285714286,1.0,1.0,3/12,15.23%,SLC20A2;SLC25A10;SLC25A30
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.23943693770575658,-0.6517158822879012,0.914396887159533,0.9757636367383116,1.0,7/18,33.75%,JAK2;SMAD4;STAT1;IL6ST;SPI1;SRC;CBL
prerank,L-serine metabolic process (GO:0006563),0.2811950790861161,0.6511937214879181,0.8638392857142857,1.0,1.0,10/10,71.90%,PSPH;PHGDH;CBS;SHMT1;SDS;SHMT2;PSAT1;SRR;SERINC5;SERINC3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.1987032609033056,-0.651116319410275,0.9502982107355865,0.9757405832764726,1.0,12/38,25.82%,ABLIM3;SAE1;VPS11;ATP5IF1;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;SREBF1;UBE2J2;ATG13
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24594008256915117,-0.650927282967341,0.9056261343012704,0.9754351422543751,1.0,12/16,50.34%,CYRIB;LILRB1;IL12A;CEACAM1;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.24702350388233998,-0.6506852952506483,0.9147005444646098,0.9751586774927979,1.0,2/15,12.88%,CD55;SYK
prerank,zymogen activation (GO:0031638),-0.19881372394127536,-0.6499564947164256,0.9652509652509652,0.9752360663651198,1.0,10/39,20.25%,CASP8;MMP14;PERP;BAK1;PGK1;BAD;VSIR;PLAU;PRSS12;GGT1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.25887276736244924,0.649952904282944,0.8964059196617337,1.0,1.0,2/14,8.44%,GSTP1;NLRP2B
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.2760962748736969,-0.6498834372757452,0.9045871559633027,0.9748301410509996,1.0,2/10,12.33%,AKT1;PRKCE
prerank,mRNA catabolic process (GO:0006402),0.19677633233051883,0.6496700403313002,0.936734693877551,1.0,1.0,9/44,15.77%,TUT4;AGO4;DHX34;RIDA;PNPT1;METTL16;NBAS;NBDY;METTL3
prerank,regulation of DNA metabolic process (GO:0051052),0.19900599909982924,0.649630731256685,0.9648033126293996,1.0,1.0,12/44,19.43%,KDM1B;RADX;HDAC8;HNRNPD;TOM1L1;THOC1;NBN;STOX1;CDK9;UBE2N;WRNIP1;SMG5
prerank,retrograde axonal transport (GO:0008090),0.2464838935516468,0.6494842413718013,0.8920704845814978,0.9996295745433931,1.0,5/16,20.67%,DLG2;KIF1A;ACTR10;FBXW11;TMEM108
prerank,regulation of double-strand break repair (GO:2000779),0.19977768769720494,0.6494574526951454,0.9440860215053763,0.9989179976462886,1.0,5/39,10.93%,SHLD2;TRIP12;OTUB2;RPA2;FMN2
prerank,positive regulation of actin nucleation (GO:0051127),-0.2748024037787853,-0.6492347399261578,0.893581081081081,0.9748112128120385,1.0,1/11,1.61%,WASF2
prerank,superoxide anion generation (GO:0042554),0.25471451004051865,0.6482049813077391,0.8826086956521739,0.9992273345444357,1.0,1/13,2.55%,ALOX12
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.25875627833006887,0.6468345018347288,0.8677685950413223,0.9995258199385523,1.0,2/13,10.66%,CBLB;NUP35
prerank,RNA methylation (GO:0001510),0.1841575033083834,0.645805907616539,0.9794238683127572,0.9995818046986497,1.0,20/60,25.20%,VIRMA;FTSJ1;HENMT1;DIMT1;METTL16;NSUN6;MTERF4;METTL6;METTL3;BCDIN3D;METTL8;TFB1M;TARBP1;TRMT12;TRMT5;THUMPD2;RBM15;WTAP;BUD23;THUMPD3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.24306567857534647,0.6457665723258351,0.8924485125858124,0.9988863893104275,1.0,4/17,16.47%,SULF1;FSTL3;PCSK6;TWSG1
prerank,tRNA methylation (GO:0030488),0.20711860590146408,0.6454876962414202,0.9484978540772532,0.9983653370019223,1.0,11/34,23.45%,DALRD3;FTSJ1;NSUN6;METTL6;BCDIN3D;TARBP1;TRMT1L;TRMT12;PRORP;TRMT5;THUMPD2
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.17566509905007485,-0.6445059353912101,0.9844660194174757,0.9775844374248256,1.0,18/64,32.29%,MLLT3;AFF4;GTF2H3;NELFE;CDK13;CCNK;GTF2F1;TCEA1;GTF2H4;ELOB;NCBP2;ELL;SETD2;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,calcium-ion regulated exocytosis (GO:0017156),0.21890398713809053,0.6439574056345577,0.9319148936170213,0.9987953269679135,1.0,8/27,18.77%,RIMS1;SYT1;SCIN;SYT13;SYT11;SYT12;SYT6;RIMS2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.2730981672106452,0.6435425929581413,0.8837209302325582,0.998371399926778,1.0,10/10,72.71%,RYK;WNT3;WNT5A;FZD1;WNT3A;WNT1;WNT9B;LRP6;CTNNB1;WNT2
prerank,insulin secretion (GO:0030073),-0.2342964129482239,-0.6425086402856437,0.9296028880866426,0.9784320906056496,1.0,7/19,30.97%,ANXA1;RAB11B;PARK7;RAB11FIP5;CAMK2G;ADCYAP1;SNX19
prerank,negative regulation of catabolic process (GO:0009895),0.19253885567204326,0.641440882439549,0.9539748953974896,0.9991881152166737,1.0,12/47,20.26%,PPARA;ACTN3;SIRT2;PDE3B;ALK;FMN2;PRKCG;SF3B3;CYP51A1;NUPR1;IRAK3;AZIN2
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.26084866089870845,-0.6402373473908088,0.9177330895795247,0.9794173855244206,1.0,6/13,28.59%,OGA;RENBP;PGM3;LARGE1;CHST5;CHST3
prerank,RNA biosynthetic process (GO:0032774),0.20678277451263305,0.6392921821992139,0.9478260869565217,1.0,1.0,30/31,71.57%,TTF1;GTF2B;TCEA2;TAF7;PRIM1;PRIM2;SETX;BRF1;BRF2;TBPL1;RSF1;TAF13;TBPL2;ELL3;TAF6;PRMT5;POLA2;TTF2;POLR2A;TAF12;NAT14;NCOA6;TBP;POLA1;HELB;TERT;SMARCA5;TAF5;TAF10;TAF4
prerank,cell proliferation in forebrain (GO:0021846),-0.26538169443690085,-0.6391495076034849,0.9142857142857143,0.9796543817631194,1.0,4/10,31.10%,PCM1;NUMB;AKNA;WNT7A
prerank,negative regulation of hippo signaling (GO:0035331),0.2613388820183878,0.639000334978944,0.9047619047619048,0.9995779371456638,1.0,2/12,8.59%,WWC1;AJUBA
prerank,intracellular sterol transport (GO:0032366),0.2485815322469423,0.6385846291006114,0.8905263157894737,0.9991376569720445,1.0,3/13,14.37%,ABCA1;OSBP;RELCH
prerank,hexose metabolic process (GO:0019318),-0.19173287564432284,-0.6380878453274982,0.951310861423221,0.9798646488388587,1.0,15/39,36.94%,PPARD;HK1;PGM1;FUCA2;GALM;GALT;BRAT1;DCXR;FUCA1;ALDOA;HECTD4;ADPGK;GDPGP1;APOD;TFAP2B
prerank,DNA-dependent DNA replication (GO:0006261),-0.15480763111651086,-0.6374622863078825,1.0,0.9797676173126493,1.0,49/128,37.59%,UBB;UBC;RPS27A;PSMA6;PSMB5;BAZ1A;PSMC4;PSMC5;PSMD14;PNKP;REV3L;DDX23;PSMD8;RPA3;PSMD11;RPAIN;PSMB4;PSMD12;PSMC1;GINS3;PSMA1;PSMB1;PSMC3;PSMA4;RFC3;PSMA2;POLE3;MCM5;RFC2;PSMB8;DNA2;POLB;PSMC6;RECQL;TWNK;CDC6;PSMD6;PSMA8;HELB;POLE;POLA1;PSMD2;GINS4;PSMB2;RAD51;SIRT7;UBA52;PURA;HMGA1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.27460876700376036,-0.6340681283872523,0.9040139616055847,0.9814392462961257,1.0,4/10,27.86%,AIDA;DNAJA1;PTPN22;PDCD4
prerank,regulation of telomere maintenance (GO:0032204),-0.21035734897378217,-0.6338798136079439,0.9563567362428842,0.9810861570861608,1.0,11/26,33.31%,USP7;ERCC1;ERCC4;SMG1;MRE11;TERF2IP;MYC;UPF1;SMG6;PIF1;RAD50
prerank,somite development (GO:0061053),0.26462942781021837,0.6338119243093031,0.8833333333333333,1.0,1.0,4/11,18.67%,LOXL3;MTHFD1;PPP2R3A;SHH
prerank,protein import into peroxisome membrane (GO:0045046),0.21687696565132927,0.6337726048586172,0.9282608695652174,1.0,1.0,6/22,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX19;PEX2
prerank,protein oxidation (GO:0018158),0.25834327383350925,0.6336892880181214,0.8958333333333334,1.0,1.0,2/11,7.67%,LOXL2;LOXL3
prerank,lipid phosphorylation (GO:0046834),-0.27612532501759185,-0.6336862637619144,0.9058380414312618,0.9807567402772751,1.0,1/10,1.69%,DGKH
prerank,negative regulation of histone acetylation (GO:0035067),0.2704281946410507,0.6333170595008203,0.8766519823788547,0.9998600875957155,1.0,6/11,25.79%,NOC2L;THAP7;SET;TAF7;SIRT1;SNCA
prerank,regulation of immunoglobulin production (GO:0002637),-0.21425205629434427,-0.6327009987120562,0.9473684210526315,0.9809006746927617,1.0,4/23,17.16%,GPI;PHB2;CLCF1;XBP1
prerank,regulation of histone methylation (GO:0031060),-0.24899635050511193,-0.6322809547368103,0.9045801526717557,0.9807116255526718,1.0,4/13,22.14%,CHTOP;AASS;TTLL12;NNMT
prerank,urogenital system development (GO:0001655),-0.2636243903044703,-0.6322211585834339,0.912568306010929,0.9803102743339787,1.0,1/11,3.46%,ANXA1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.20975932679390613,0.6320256195054285,0.9308855291576674,0.999326023365526,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.20975932679390613,0.6320256195054285,0.9308855291576674,0.999326023365526,1.0,3/29,7.30%,ACSM5;BAAT;ACOT11
prerank,protein K63-linked ubiquitination (GO:0070534),-0.1878846526694652,-0.6312911036811096,0.9684418145956607,0.9804220998185145,1.0,11/41,21.57%,WWP2;TRIM56;ITCH;RNF5;TRAF1;UBE2G1;TRIM5;HECTD1;PELI1;UBE2B;BFAR
prerank,protein localization to cilium (GO:0061512),-0.20296453591309307,-0.6309862698495096,0.96875,0.9801615556248415,1.0,7/32,18.42%,IFT20;TULP2;ZNF423;TUB;ARL6;RABEP1;EHD1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.26658897771524515,-0.630061358049565,0.9052224371373307,0.9802526462306036,1.0,2/11,7.75%,TNFRSF21;RC3H1
prerank,regulation of centrosome cycle (GO:0046605),0.2284225657128212,0.6294861798598523,0.9295154185022027,1.0,1.0,3/21,9.48%,ATF5;GEN1;CHMP1A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.22801593044373314,0.6290760105193741,0.9225352112676056,0.9998158291382102,1.0,8/20,25.54%,ADRA1D;ADRA1B;DRD2;ADRA1A;ADRB3;LMBRD2;ADCY9;DRD3
prerank,nucleocytoplasmic transport (GO:0006913),-0.19062636167020558,-0.6286587337408803,0.9611451942740287,0.9806633398140505,1.0,22/40,40.18%,ANP32A;SNRPD3;HTATIP2;SMN1;RITA1;DDX20;HNRNPA1;SNRPG;NXT2;NCBP2;SNRPB;NPM1;NUP98;XPO1;RBM15B;RSRC1;SNUPN;SNRPE;SNRPF;GEMIN2;NXT1;NCBP1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.1846682295110849,-0.6275585813961247,0.9779559118236473,0.9808554642664519,1.0,3/42,5.67%,LBP;RPL30;RPS19
prerank,positive regulation of glucose metabolic process (GO:0010907),0.24901462461239018,0.6271851355293973,0.8900862068965517,1.0,1.0,2/14,5.54%,ACTN3;IRS2
prerank,male meiosis I (GO:0007141),0.23508341529424703,0.6269352563763552,0.9120879120879121,0.9997744887173955,1.0,3/16,15.05%,HSF2BP;ZSCAN21;BRDT
prerank,lysosome organization (GO:0007040),-0.19358178908977364,-0.6268925256653999,0.9537892791127541,0.9808055420392708,1.0,12/36,33.33%,TPP1;TMEM165;HPS1;VPS33A;TFEB;TPCN2;GNPTAB;MYO7A;ATP10B;CORO1A;LAMTOR1;MBTPS1
prerank,regulation of catecholamine secretion (GO:0050433),0.20992357201846107,0.6266354759009344,0.9659574468085106,0.9992627957718987,1.0,8/29,18.07%,PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,lipid modification (GO:0030258),0.19641119307266405,0.6256359475666168,0.9614604462474645,0.9992091162512835,1.0,8/37,17.59%,ALOX12;DGKD;PLPP3;PLPPR1;PLPP4;PLPPR5;PORCN;DGKI
prerank,eosinophil migration (GO:0072677),0.24372174786539405,0.6241114434516835,0.9151376146788991,0.9987668940553381,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.24372174786539405,0.6241114434516835,0.9151376146788991,0.9987668940553381,1.0,14/14,75.65%,SCG2;CCL13;CCL8;CCL24;CCL26;LGALS3;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL11;CCL5;CCL2
prerank,protein insertion into membrane (GO:0051205),-0.1969392299148053,-0.6232575070279505,0.9662921348314607,0.9823999687019608,1.0,13/32,38.30%,APP;STX1A;SEC61B;EGFR;SGTA;STX5;UBE2J2;TRAM1;VAMP2;CCDC47;RTP4;RTP3;VAPA
prerank,"base-excision repair, gap-filling (GO:0006287)",0.20026006835929344,0.6230220465684838,0.9691991786447639,0.9987058712113795,1.0,11/35,21.92%,MPG;RPA2;RFC5;RPA1;PARP1;POLD4;POLD1;PCNA;POLD3;RFC1;POLD2
prerank,axonemal dynein complex assembly (GO:0070286),0.20394196332481784,0.6210302372817098,0.951271186440678,0.9992114361813773,1.0,3/27,8.19%,DNAAF3;CCDC65;DNAL1
prerank,telomere maintenance via telomerase (GO:0007004),-0.20266087626961454,-0.6201660535055339,0.9613899613899614,0.9836934691678743,1.0,12/28,35.68%,HSP90AB1;DKC1;HSP90AA1;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.23016470387405363,-0.6185631566322833,0.9316546762589928,0.9841501989477318,1.0,12/16,51.84%,TNFRSF1B;FGF10;PTPN22;LST1;TNFSF8;IL12A;CD22;TNFSF9;IL12B;LGALS3;TNFSF18;SOX11
prerank,t-circle formation (GO:0090656),-0.2644342532150533,-0.6178423866737004,0.9294532627865961,0.9831959273783555,1.0,4/10,26.28%,ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2644342532150533,-0.6178423866737004,0.9294532627865961,0.9831959273783555,1.0,4/10,26.28%,ERCC1;SLX4;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2644342532150533,-0.6178423866737004,0.9294532627865961,0.9831959273783555,1.0,4/10,26.28%,ERCC1;SLX4;EXO1;DNA2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.20591009321220205,-0.6152740315969205,0.9601518026565465,0.9841244904386284,1.0,9/26,26.08%,APP;TAL1;DUSP3;HES1;USP22;ASNS;EIF4EBP1;EIF4E;TTL
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.22751636457206065,0.6152338575311294,0.9291845493562232,1.0,1.0,5/16,22.28%,CPEB3;KHSRP;RBM24;TARDBP;ZFP36L2
prerank,UV-damage excision repair (GO:0070914),0.2504631050665521,0.6133741934475441,0.9139784946236559,1.0,1.0,1/12,3.73%,DDB2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.23910386121049193,0.6129074146380576,0.9073684210526316,1.0,1.0,2/14,10.46%,EARS2;PNPT1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.25320703581072707,-0.6128863103964844,0.9365079365079365,0.9849229620800342,1.0,5/12,39.71%,STMN2;CDH5;STMN1;DYRK1A;MAP2
prerank,regulation of centrosome duplication (GO:0010824),-0.1976502440596938,-0.6118867403667535,0.9528130671506352,0.9849825930532641,1.0,6/29,18.15%,CHMP2B;PLK2;FBXW5;CCNF;TMEM67;CHMP2A
prerank,ncRNA catabolic process (GO:0034661),0.20215657276657312,0.6115782477417537,0.9518599562363238,1.0,1.0,2/28,6.12%,TUT4;LIN28B
prerank,positive regulation of rRNA processing (GO:2000234),0.2547702736630681,0.6111399796502549,0.8991228070175439,1.0,1.0,10/10,74.54%,DIMT1;HEATR1;BUD23;WDR75;WDR43;TRMT112;SIRT7;RIOK1;UTP15;RIOK2
prerank,detection of visible light (GO:0009584),0.23777021803140055,0.609772733092615,0.9383886255924171,1.0,1.0,1/16,3.53%,ABCA4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.23596698202892077,0.607486040098004,0.9180672268907563,1.0,1.0,5/14,23.00%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.21550034644236998,-0.6063263376866559,0.9581056466302368,0.9873568962555443,1.0,6/21,28.23%,PPARD;FAAH;ACOT8;LDHD;ACOX1;LPIN2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.20677932422817907,0.6059081847051997,0.9653679653679653,1.0,1.0,5/27,15.00%,NAT8;TAF6L;KAT8;EP300;KAT5
prerank,negative regulation of organelle assembly (GO:1902116),0.1888984776118166,0.6058803265069614,0.9622641509433962,1.0,1.0,11/35,23.78%,PHF23;SCFD1;MDM1;YAP1;TCHP;NBDY;NUPR1;TRIM37;FEZ1;KAT2B;TESK1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.20933876199128937,0.6051511039349566,0.9545454545454546,1.0,1.0,5/23,14.58%,KIF5C;DYNC1I1;CCDC186;KIF1A;MAP6
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.24448628700208475,-0.6050531120858527,0.9324817518248175,0.9875568025025868,1.0,10/12,53.99%,IL1R1;SLC11A1;IL12RB1;IL23A;IL23R;IL12B;XCL1;CCR2;IL1B;IL18R1
prerank,telomere maintenance via recombination (GO:0000722),0.2562587718298709,0.604317276733739,0.9181818181818182,1.0,1.0,4/11,18.37%,TEP1;SMC6;SMC5;NSMCE2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.2140139525764374,-0.6030106696840356,0.9721189591078067,0.9880485011609064,1.0,11/22,42.86%,NCOR1;PPP2R5A;CCDC3;APOC1;BSCL2;APOD;GPER1;ADRA2A;CEACAM1;CIDEA;TNF
prerank,central nervous system neuron differentiation (GO:0021953),-0.19406381670568285,-0.6021882909118935,0.9776951672862454,0.9880038599813404,1.0,18/33,39.97%,OPHN1;NR4A2;AGTPBP1;SOX4;FAIM2;TOX;CEND1;LMX1A;WNT2;CTNNB1;DRAXIN;LRP6;SPOCK1;NPY;PROX1;KNDC1;MAP2;ISL1
prerank,microtubule nucleation (GO:0007020),-0.21213082552272242,-0.6014981067206019,0.9593345656192237,0.9878786278135735,1.0,6/19,29.62%,SLAIN2;NDE1;NDEL1;TPX2;TUBG2;TUBGCP6
prerank,positive regulation of cell development (GO:0010720),-0.19485456741785984,-0.6014518888826461,0.978515625,0.987461415757119,1.0,8/31,26.71%,TGM2;FAIM;CX3CR1;BAD;NUMB;ATP6AP1;LRP2;LIG4
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.23335277310655783,0.6003934390846671,0.9348314606741573,1.0,1.0,1/17,1.91%,APOH
prerank,receptor catabolic process (GO:0032801),-0.204317533887825,-0.5998765790822529,0.9618320610687023,0.9877188084543781,1.0,5/24,15.15%,TGFB1;AP2M1;KIF16B;SMURF1;AP2A1
prerank,peroxisomal membrane transport (GO:0015919),0.19592288324614532,0.5997028863430508,0.9593147751605996,1.0,1.0,7/27,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,lipoxygenase pathway (GO:0019372),0.2356592317539603,0.5993186370315161,0.934640522875817,1.0,1.0,2/14,10.49%,ALOX12;HPGD
prerank,heterochromatin assembly (GO:0031507),0.21936099275591406,0.5952923619856719,0.9426048565121413,1.0,1.0,4/20,17.00%,SIRT2;MBD2;SMCHD1;HDAC1
prerank,negative regulation by host of viral process (GO:0044793),0.25329120966506424,0.5948185539133205,0.9072398190045249,1.0,1.0,1/10,5.39%,PRKN
prerank,microtubule anchoring (GO:0034453),0.24453093352090444,0.594107038095063,0.9140969162995595,1.0,1.0,3/12,15.97%,SAXO2;BICD1;DAG1
prerank,intracellular cholesterol transport (GO:0032367),0.2251693892340395,0.5936259835135457,0.944206008583691,1.0,1.0,4/15,18.17%,ABCA1;OSBP;RELCH;LDLRAP1
prerank,"phototransduction, visible light (GO:0007603)",-0.23348738360374946,-0.5935937861237394,0.9547920433996383,0.9900100636719273,1.0,3/14,21.20%,RP1;GNB1;GNA11
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.1916156517978327,-0.5933794252190995,0.9539347408829175,0.9896508997003345,1.0,5/27,22.09%,TLR4;PTPN6;TNFAIP3;CD200;PTPN22
prerank,protein prenylation (GO:0018342),-0.2557420785109099,-0.5927473846074683,0.931098696461825,0.9894755050920578,1.0,6/10,48.16%,RCE1;RABGGTB;CHM;RABGGTA;FNTB;AIPL1
prerank,regulation of intracellular transport (GO:0032386),0.18768154653758676,0.592577504144295,0.9836734693877551,1.0,1.0,5/38,13.05%,WWC1;SCFD1;ATP9A;DYNLT2B;RINT1
prerank,retinal metabolic process (GO:0042574),-0.24052873826704083,-0.5921468683804489,0.9432624113475178,0.9892889993135215,1.0,3/12,17.17%,CYP1B1;ALDH1A3;DHRS13
prerank,snRNA 3'-end processing (GO:0034472),-0.2139264714011581,-0.5918483553461847,0.9595588235294118,0.9889705736581514,1.0,8/19,36.70%,INTS8;INTS1;EXOSC8;INTS12;EXOSC9;INTS2;INTS14;USB1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.20409244395202275,-0.590595763951003,0.9624765478424016,0.989053633545501,1.0,8/21,27.85%,DUSP3;TNFAIP3;JAK3;LAPTM5;PTPN22;BANK1;LST1;LAX1
prerank,negative regulation of immune system process (GO:0002683),-0.22124401519674955,-0.5888515266957242,0.9552529182879378,0.98931615795431,1.0,3/16,19.37%,COL3A1;CD200;SOX9
prerank,gas transport (GO:0015669),-0.25544437767607925,-0.5878148277213273,0.9360902255639098,0.9893115605687074,1.0,5/10,41.43%,CYGB;MYC;AQP1;MB;NGB
prerank,cilium-dependent cell motility (GO:0060285),0.20575065085325284,0.5873397669908956,0.9571428571428572,1.0,1.0,2/22,6.91%,TEKT3;CCDC65
prerank,regulation of microtubule-based movement (GO:0060632),0.23910169878394338,0.587067861058117,0.9474835886214442,1.0,1.0,2/11,11.65%,CCDC65;DYNLT2B
prerank,negative regulation of cholesterol transport (GO:0032375),-0.25420139512521167,-0.5851425562097475,0.9585585585585585,0.9899554890870935,1.0,2/10,25.17%,ABCA2;APOC1
prerank,protein destabilization (GO:0031648),0.18144020377637574,0.5851323481347004,0.9763948497854077,1.0,1.0,8/32,20.06%,MDM2;PRKN;SENP2;BTRC;EP300;CTSH;FBXW11;PEX2
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.2162071560107668,-0.5846721995877803,0.9634369287020109,0.9896962212898139,1.0,9/16,41.34%,UQCC2;VCP;SLC25A33;COX7A2L;SHMT2;PDE12;PPIF;COX7A2;ABCD1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.24908840078889222,0.5838871869984774,0.9390519187358917,1.0,1.0,4/10,24.32%,MTHFD1;MTHFD1L;MTHFR;MTHFD2L
prerank,regulation of pseudopodium assembly (GO:0031272),-0.2506266052176434,-0.583765297513196,0.948905109489051,0.9891528615852577,1.0,4/10,37.25%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.2506266052176434,-0.583765297513196,0.948905109489051,0.9891528615852577,1.0,4/10,37.25%,CDC42EP3;CDC42;CDC42EP2;WASHC1
prerank,regulation of spindle assembly (GO:0090169),-0.19399258200351172,-0.5832986218075894,0.9758364312267658,0.9888795047145023,1.0,7/25,32.17%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,ncRNA 3'-end processing (GO:0043628),0.23123906651063006,0.5830077440459064,0.9323467230443975,1.0,1.0,7/14,26.40%,INTS6L;PTCD1;INTS7;TRNT1;SSB;INTS5;TOE1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.219150048076045,-0.5795988724932362,0.9747747747747748,0.9898826970030653,1.0,2/17,8.42%,MFSD2A;AKT1
prerank,nucleic acid metabolic process (GO:0090304),0.15874639240540087,0.578840511236595,0.9940476190476191,1.0,1.0,1/69,0.21%,ENPP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.18953057248790275,0.5785206086692302,0.9849785407725322,1.0,1.0,29/29,81.08%,PRDM9;SYCE2;P3H4;TEX11;MEI4;SYCE3;RNF212;KASH5;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;TERB2;HORMAD1;ANKRD31;RNF212B;TERB1;RAD21L1;IHO1;SIRT7;STAG3;TEX12;ZCWPW1;MEIOB;MAJIN;FANCD2;REC8;RAD21
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.22364823880933382,-0.5781948184153746,0.9688715953307393,0.9899522752144012,1.0,6/15,31.68%,SPCS1;RAB3GAP2;ZFAND2B;SEC61A1;EDEM1;SRPRA
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.22903909409263262,-0.5778671488799718,0.9544626593806922,0.9896463223602404,1.0,5/13,31.23%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2002601714263645,-0.57739148534611,0.9690522243713733,0.9893859633458303,1.0,8/22,29.76%,CDKN1B;INHBA;CDKN1A;CDKN2C;CDKN1C;CDKN2B;INHA;PLEK
prerank,mismatch repair (GO:0006298),0.19670657291444252,0.576887795950663,0.9678800856531049,1.0,1.0,11/27,23.97%,RPA2;MCM9;PMS2;RPA1;POLD4;POLD1;PCNA;POLD3;POLD2;PMS1;MUTYH
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.24916605793686364,-0.5765994811228209,0.9559082892416225,0.989246978679225,1.0,3/10,18.00%,DKC1;RPUSD4;RPUSD1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.24799568506383707,0.5750421435240358,0.9339407744874715,1.0,1.0,1/10,3.69%,DNAJB8
prerank,nucleosome organization (GO:0034728),0.165260670638222,0.5740615994911101,0.9877300613496932,1.0,1.0,16/55,23.18%,PRDM9;CTCF;ANP32E;MCM3AP;DAXX;SPTY2D1;SMARCB1;BRDT;SART3;SRCAP;NAP1L2;SET;PAF1;SMARCD1;BPTF;NASP
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.1900572343722933,-0.5734095899099312,0.9802867383512545,0.9899684581044322,1.0,5/25,18.15%,LYST;CHMP2B;VCP;LAPTM4B;CHMP2A
prerank,mitotic spindle assembly (GO:0090307),0.17474140763992227,0.5723333909906194,0.980276134122288,1.0,1.0,6/42,12.32%,STAG1;MAP9;GOLGA2;MAP10;PIBF1;AURKC
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.2450330223865137,-0.571588868029757,0.9476635514018692,0.990155827074708,1.0,9/10,59.89%,E2F7;E2F8;STOML2;DBF4;SSBP1;CDT1;INO80;WIZ;ATRX
prerank,piRNA metabolic process (GO:0034587),0.20772265930735428,0.5710476409160589,0.9646569646569647,1.0,1.0,3/19,13.85%,HENMT1;PIWIL2;TEX15
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.1934483327892545,-0.5709379959512403,0.9767441860465116,0.9899465368629282,1.0,6/25,19.92%,PRPF8;SRSF4;DDX23;SF3A3;SCAF11;LSM1
prerank,serine family amino acid catabolic process (GO:0009071),-0.24660963314346884,-0.5704853390610638,0.9478584729981379,0.9896525802272849,1.0,5/10,36.02%,DLD;AMT;THNSL2;SHMT2;DAO
prerank,homocysteine metabolic process (GO:0050667),-0.2350107194437222,-0.568671577488477,0.9532710280373832,0.9898469500738514,1.0,6/11,42.66%,CTH;BLMH;MTRR;MPST;TST;DPEP1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.21556661537937716,-0.5685993382857883,0.9667318982387475,0.989432478595142,1.0,3/16,16.01%,ACLY;PPT2;SLC25A1
prerank,negative regulation of signaling (GO:0023057),0.19906257844018813,0.5660794239979131,0.972457627118644,1.0,1.0,7/25,19.85%,NLRP12;ERBB3;OPTN;LIF;HHIP;TRAT1;SOCS5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.2363168465980417,0.5654421228947152,0.9265033407572383,1.0,1.0,10/10,76.38%,DLGAP1;DLGAP2;DLGAP3;CACNG5;NPTX2;NPTX1;AKAP9;NPTXR;DLGAP4;BEGAIN
prerank,rRNA modification (GO:0000154),-0.19919815241402855,-0.5654398339312021,0.977859778597786,0.9900169809915843,1.0,5/21,25.97%,THUMPD1;DKC1;ZCCHC4;MRM2;FTSJ3
prerank,positive regulation of receptor internalization (GO:0002092),0.20358135486618548,0.5638199146495045,0.961864406779661,1.0,1.0,2/22,9.58%,MAGI2;AHI1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.1989072437640809,0.5616409600402624,0.9568788501026694,1.0,1.0,10/24,28.22%,STN1;PINX1;PARP1;GNL3L;TNKS;TINF2;TENT4B;TNKS2;XRN1;NAT10
prerank,organophosphate catabolic process (GO:0046434),0.23520180779612068,0.5606273962695038,0.9313304721030042,1.0,1.0,11/11,76.50%,PLBD2;PLBD1;PDXP;ANGPTL3;PNLIPRP2;ABHD12;APOA2;LIPG;PON1;NUDT15;ENPP2
prerank,glycerolipid metabolic process (GO:0046486),-0.23231435565877845,-0.5597067560471162,0.9553903345724907,0.9914205949837418,1.0,11/11,76.79%,DGKZ;PIP5K1A;DGKB;DGKG;PGP;DGKQ;GAL3ST1;PDXP;PLA2G15;PNPLA3;DGKA
prerank,negative regulation of TORC1 signaling (GO:1904262),0.22820013811287576,0.5595899486180349,0.9385593220338984,1.0,1.0,13/13,77.20%,ITFG2;ATM;CASTOR1;DEPDC5;KPTN;SZT2;STK11;SPAAR;SESN3;RNF152;SESN1;CASTOR2;SESN2
prerank,coenzyme A biosynthetic process (GO:0015937),0.22854811374050596,0.5590404114174385,0.9612244897959183,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.22854811374050596,0.5590404114174385,0.9612244897959183,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.22854811374050596,0.5590404114174385,0.9612244897959183,1.0,1.0,11/11,77.16%,PANK3;PANK1;COASY;PPCDC;PANK4;ACAT1;PPCS;DCAKD;ACOT7;PANK2;SLC25A16
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.22704372569686532,-0.5556717302241166,0.950381679389313,0.992172519610305,1.0,4/12,24.94%,ELOVL5;ACOT8;ELOVL1;ACOX1
prerank,negative regulation of B cell activation (GO:0050869),-0.19556919924068158,-0.5551274538747224,0.9867674858223062,0.9918966010747564,1.0,7/21,26.70%,TNFRSF21;RC3H1;INHBA;TNFAIP3;LAPTM5;BANK1;INHA
prerank,rRNA catabolic process (GO:0016075),-0.20885540256283988,-0.5513505123927785,0.9706959706959707,0.9925731900144422,1.0,9/16,50.33%,EXOSC8;DIS3;EXOSC9;PELO;ERN2;TRIR;DIS3L;SLFN14;EXOSC7
prerank,positive regulation of acute inflammatory response (GO:0002675),0.21383726770467096,0.5509247144633194,0.9572072072072072,1.0,1.0,14/14,78.64%,OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;CREB3L3;TNF;ADAM8;PTGER3;PARK7;IL6ST
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.20411172316493748,0.5491968150323262,0.9558139534883721,1.0,1.0,3/18,12.96%,LYN;C3AR1;BCAR1
prerank,positive regulation of transporter activity (GO:0032411),0.21757825592845753,0.5462832892820549,0.9535962877030162,1.0,1.0,6/13,25.86%,KMT2A;WNK3;PDZK1;RXRA;NR1H3;SGK1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.23564116639421626,-0.5459634260127109,0.9657794676806084,0.9936289039569756,1.0,8/10,45.21%,TAF9;PIH1D2;ZNHIT6;RUVBL1;ZNHIT3;NUFIP1;NAF1;RUVBL2
prerank,apoptotic nuclear changes (GO:0030262),-0.18541486345966446,-0.5456420468374373,0.9843444227005871,0.9932848932618381,1.0,8/24,31.17%,KPNA1;TOP2A;FOXL2;CDK5RAP3;DFFB;ACIN1;HMGB2;ENDOG
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2310311280475953,0.5423778682801448,0.95625,1.0,1.0,2/10,14.22%,POGLUT2;MGAT5B
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2335917947854207,-0.5400507286974777,0.9644760213143873,0.9942958554116839,1.0,5/10,38.35%,RC3H1;LGALS9;SCRIB;CRTAM;PDCD1LG2
prerank,isotype switching (GO:0045190),0.23504319037869398,0.5384682801941475,0.9623893805309734,1.0,1.0,1/10,4.41%,CCR6
prerank,regulation of inclusion body assembly (GO:0090083),-0.22232910447863244,-0.5371620602807454,0.980072463768116,0.9946041131303184,1.0,5/11,29.24%,BAG5;HSPA1A;HSPA1B;DNAJB1;DNAJB6
prerank,synaptic vesicle transport (GO:0048489),0.2228576440182729,0.5358459186763816,0.9610655737704918,1.0,1.0,3/11,16.28%,KIF5C;SNAPIN;TMEM230
prerank,oligodendrocyte development (GO:0014003),0.20483317112130683,0.535249605346382,0.978448275862069,1.0,1.0,4/15,19.34%,HES5;EIF2B5;EIF2B2;B4GALT6
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.16978019123886134,-0.5350797069391623,0.9942748091603053,0.9946533316826865,1.0,11/31,37.21%,HSPD1;TIMM17A;TIMM21;CHCHD4;TIMM50;PEX14;PEX6;ROMO1;PEX7;DNLZ;GRPEL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.21794183748191442,-0.5344531918724228,0.9690346083788707,0.9943781808481837,1.0,7/12,47.79%,PAEP;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,negative regulation of cell communication (GO:0010648),-0.18618742835514746,-0.533706557553618,0.9832089552238806,0.9941254911026356,1.0,5/21,22.97%,IGFBP3;KIF26A;ACVR1;UBASH3B;PTPN1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.1967430127160793,0.5328070739885876,0.9717391304347827,1.0,1.0,6/18,20.06%,SFRP1;GSTP1;EMD;TP53;B4GALT7;PEX2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20900400101018154,-0.5269516639948382,0.9731182795698925,0.9952358079735982,1.0,7/14,43.61%,NAA60;METAP1D;NTMT1;NAA50;METAP2;PDF;NAA11
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17339338060253978,0.5242339389884051,0.9956896551724138,1.0,1.0,1/31,2.11%,MOCS2
prerank,positive regulation of chromosome organization (GO:2001252),0.2053097007629634,0.521653345118719,0.9782135076252724,1.0,1.0,4/15,19.73%,PPP1R10;NBN;SIRT6;RTEL1
prerank,base-excision repair (GO:0006284),-0.1512646904738502,-0.5214080624032709,1.0,0.9959561665310565,1.0,12/48,26.43%,SMUG1;PNKP;XRCC1;RPA3;NEIL1;POLQ;APEX2;RFC3;RFC2;POLL;DNA2;TDG
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.18675536981842555,-0.5211781781031211,0.9904214559386973,0.9946938363443614,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.18675536981842555,-0.5211781781031211,0.9904214559386973,0.9946938363443614,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.18675536981842555,-0.5211781781031211,0.9904214559386973,0.9946938363443614,1.0,8/20,34.18%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,negative regulation of telomere maintenance (GO:0032205),0.20514442916225595,0.5206420052334726,0.982646420824295,1.0,1.0,6/15,22.87%,PINX1;NBN;ATM;PARP1;RTEL1;TNKS
prerank,regulation of actin nucleation (GO:0051125),0.2119609889371729,0.5178881608803875,0.9532908704883227,1.0,1.0,2/12,14.26%,SCIN;ARPIN
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.22236138457049948,0.5178727198973769,0.971677559912854,1.0,1.0,4/11,24.09%,IL4;TAF7;SIRT1;CIITA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.18795584062640813,0.5161510063882008,0.9823008849557522,1.0,1.0,4/21,18.08%,MITF;PAXIP1;MED12;MED4
prerank,prostanoid metabolic process (GO:0006692),-0.20415436437082937,-0.5148871161956746,0.983754512635379,0.995454965497723,1.0,3/13,15.05%,PLAA;PTGS1;GSTM1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.1786349748315647,0.51352536835397,0.9919354838709677,1.0,1.0,4/23,15.26%,GUCY2F;METAP1;GUCA1B;PDE6G
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.18576331378347274,-0.5112506763753596,0.9907578558225508,0.9956536283048864,1.0,6/17,37.49%,SMUG1;NEIL1;TDG;TERF2IP;NEIL3;UNG
prerank,acyl-CoA metabolic process (GO:0006637),0.16112322667292953,0.5106242661107325,0.9933184855233853,1.0,1.0,8/35,20.77%,ACSM5;BAAT;ACOT11;ACSL6;ACACA;ACBD6;MCEE;HMGCS1
prerank,regulation of superoxide anion generation (GO:0032928),-0.19774952955267405,-0.5084506849386363,0.9847036328871893,0.995747454814324,1.0,5/14,31.23%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.15869678184622352,-0.5061194883232222,0.9925233644859813,0.9957370862914887,1.0,14/33,36.31%,HSP90AB1;DKC1;HSP90AA1;ZBTB48;PPP6R3;TNKS1BP1;MRE11;TERF2IP;PIF1;TERT;WRAP53;RAD50;NOP10;RAD51
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.18973921226236468,0.5034529570086251,0.9860788863109049,1.0,1.0,6/16,24.01%,EP300;NAA20;AANAT;NAA40;KAT2B;NAA15
prerank,negative regulation of defense response to virus (GO:0050687),-0.2146055207469354,-0.5025917345128335,0.9923076923076923,0.9958891112288393,1.0,3/10,28.21%,ITCH;TSPAN6;MUL1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.21468018081300075,-0.5016044633581089,0.9858657243816255,0.9955997926298792,1.0,7/10,56.72%,GNB1;PDE6B;RHO;GNAT1;PDE6A;CNGB1;SAG
prerank,lytic vacuole organization (GO:0080171),0.1610369913238282,0.501437085075707,0.9934497816593887,1.0,1.0,4/32,16.40%,ABCA1;AKTIP;SNAPIN;CLN3
prerank,signal peptide processing (GO:0006465),0.21527993604282397,0.4987378205774423,0.974155069582505,1.0,1.0,3/11,15.84%,HM13;PARL;SPCS3
prerank,DNA catabolic process (GO:0006308),0.20852426087502368,0.49822336092698055,0.986870897155361,1.0,1.0,11/11,79.16%,SETMAR;FBH1;MUS81;DNASE1L3;REXO4;DNASE1;DNASE1L1;ISG20;XRN2;DFFB;DNASE1L2
prerank,neuropeptide signaling pathway (GO:0007218),0.143239301815164,0.49793716471708777,0.9980314960629921,1.0,1.0,9/58,18.99%,SORCS1;GLRB;OPRK1;GLRA3;PNOC;HCRTR1;LTB4R2;SORT1;PDYN
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.19189007350565176,0.4971565933686114,0.9739130434782609,1.0,1.0,8/16,26.63%,PINX1;ATM;PARP1;SMG5;RTEL1;TNKS;TINF2;TNKS2
prerank,protein targeting to peroxisome (GO:0006625),0.16084846086989613,0.4915316430075899,0.9956989247311828,1.0,1.0,7/29,20.06%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,synaptonemal complex organization (GO:0070193),0.1893639731273935,0.4911798000528393,0.9800884955752213,1.0,1.0,15/15,81.08%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.1893639731273935,0.4911798000528393,0.9800884955752213,1.0,1.0,15/15,81.08%,SYCE2;P3H4;TEX11;SYCE3;SYCE1;SYCP1;TRIP13;SYCP2;BAG6;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.1821892452998945,0.4891799113702865,0.990990990990991,1.0,1.0,4/17,23.28%,SUMO1;KCNS1;KCNS2;KCNE4
prerank,regulation of T cell activation (GO:0050863),0.14641576538595663,0.48830852693528093,0.9978260869565218,1.0,1.0,6/42,15.77%,IL4I1;TBX21;IL27;PAG1;CD47;METTL3
prerank,positive regulation of viral transcription (GO:0050434),-0.16418244444732905,-0.48818888133799615,0.9961389961389961,0.9971134696855928,1.0,8/25,32.29%,DHX9;NELFE;GTF2F1;GTF2F2;POLR2F;POLR2L;POLR2I;POLR2C
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.207845184478268,-0.4854434655416091,0.9853747714808044,0.9970161626706378,1.0,2/10,16.28%,ELOVL5;NR1H2
prerank,regulation of biosynthetic process (GO:0009889),0.2055947275338404,0.48513347500196297,0.9823788546255506,1.0,1.0,1/11,6.08%,GSTP1
prerank,protein monoubiquitination (GO:0006513),0.15317173101889903,0.4811849789634191,0.9938524590163934,1.0,1.0,4/36,9.94%,PRKN;UBE2O;MGRN1;TOPORS
prerank,snRNA processing (GO:0016180),-0.18167896811469564,-0.48107618012902453,0.9907578558225508,0.9971623409807017,1.0,7/16,36.12%,INTS8;INTS1;INTS12;INTS2;INTS3;INTS14;INTS4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2000746004329571,0.4739197979087278,0.9884526558891455,1.0,1.0,3/10,21.95%,RIF1;RTEL1;DCLRE1B
prerank,regulation of cell aging (GO:0090342),0.19783852722560757,0.47226720555747104,0.9798657718120806,0.999956441442196,1.0,3/11,20.42%,PNPT1;MIF;NEK4
prerank,response to hydroxyurea (GO:0072710),0.19842324989200827,0.46913616927281954,0.9781181619256017,0.9997000059291962,1.0,1/11,8.95%,BLM
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.16431899248521858,0.4631865452709517,0.9917525773195877,0.9997652966115412,1.0,6/21,20.12%,KNTC1;ATM;ZWINT;KLHL22;FBXO5;APC
prerank,positive regulation of cilium assembly (GO:0045724),-0.1668516618360953,-0.4629689505318513,0.9947552447552448,0.9987214980276757,1.0,1/18,4.88%,HTT
prerank,telomere capping (GO:0016233),0.17242517764859916,0.45999904957022847,0.9869281045751634,0.9994568605920076,1.0,2/16,12.62%,STN1;NBN
prerank,cellular response to hydroxyurea (GO:0072711),0.1986220070225401,0.45983122763223183,0.991304347826087,0.9987919930857576,1.0,1/10,8.95%,BLM
prerank,transcription preinitiation complex assembly (GO:0070897),-0.18480853735091024,-0.4574466786590001,0.9926873857404022,0.9987294126953405,1.0,12/12,81.54%,BDP1;TAF1B;TBP;TAF7L;TAF12;DR1;GTF2A2;POLR1E;TAF11;TAF7;TAF1;GTF2B
prerank,regulation of receptor recycling (GO:0001919),-0.17050518811200693,-0.45018320300084036,0.9925093632958801,0.998870638501057,1.0,3/16,17.44%,ANXA2;KIF16B;NSF
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.1408802262675321,-0.4482674701266003,0.9959919839679359,0.9985768932148233,1.0,15/33,40.18%,SNRPD3;LSM11;SNRPG;CPSF4;NCBP2;LSM10;CSTF2T;SNRPB;MAZ;PCF11;CPSF1;CSTF3;SNRPE;SNRPF;NCBP1
prerank,DNA modification (GO:0006304),0.15624341214785553,0.4468263110578815,0.9936170212765958,0.9994428120214728,1.0,4/22,17.74%,MPG;PARP3;EXOSC3;PARP1
prerank,DNA packaging (GO:0006323),-0.16676735226582334,-0.4424400148386607,0.9961759082217974,0.9985267729990831,1.0,4/16,31.43%,CDAN1;RBBP4;BANF2;BANF1
prerank,peptidyl-amino acid modification (GO:0018193),0.1906226462465478,0.44226703178922244,0.9932735426008968,0.9991289628148297,1.0,10/10,80.95%,METAP1;TTLL4;FKBP7;ATP7A;APOA2;APOA1;FKBP10;PDF;METAP2;METAP1D
prerank,regulation of transposition (GO:0010528),0.17559402357548803,0.43638585397210544,0.9910112359550561,0.9989389890326564,1.0,3/13,20.49%,PIWIL2;TEX15;UBR2
prerank,regulation of response to stress (GO:0080134),-0.17928926404227175,-0.4209352560779388,0.9946524064171123,0.9992555333823877,1.0,5/10,37.66%,MLC1;EIF4G1;DYRK3;SLC38A2;CRHBP
prerank,regulation of rRNA processing (GO:2000232),0.15452402205276358,0.39933731760796415,0.9955257270693513,1.0,1.0,5/16,24.92%,SHQ1;DIMT1;HEATR1;KAT2B;BUD23
prerank,tRNA 5'-leader removal (GO:0001682),-0.14979559280788546,-0.38219498831221516,0.9962894248608535,0.9999591405595205,1.0,6/13,43.92%,RPP38;RPP21;RPP25L;RPP40;RPP30;RPP25
prerank,peptidyl-methionine modification (GO:0018206),-0.1576923905272488,-0.381365765053171,1.0,0.9995349069813962,1.0,2/12,19.06%,NAA60;METAP1D
prerank,protein import into mitochondrial matrix (GO:0030150),0.1398007353200287,0.3780950586787254,1.0,1.0,1.0,5/18,20.39%,TOMM70;PAM16;GRPEL2;TOMM40;TOMM40L
prerank,natural killer cell activation (GO:0030101),0.12340019852655669,0.3488646754260932,1.0,0.9998438741909844,1.0,3/23,17.12%,AXL;NFIL3;RABL3
